{
  "input": "What are all the things I can do shake off my ADHD and related trauma from my body ranging from obvious answers in modern science to methods and patterns of all civilization dating back thousands of years ago - give me all options with a probably effectiveness score table - go super wide and super deep",
  "output": {
    "executive_summary": "Managing comorbid ADHD and trauma requires a multifaceted, personalized approach, as no single intervention addresses the full spectrum of symptoms. The landscape of available options spans modern evidence-based medicine, emerging therapies, and ancient traditional practices. \n\n**Modern Scientific Interventions** form the cornerstone of treatment. For ADHD, pharmacological treatments, particularly stimulants (amphetamines, methylphenidate), are highly effective for short-term symptom reduction, while non-stimulants (atomoxetine) offer an alternative. For PTSD, trauma-focused psychotherapies like Eye Movement Desensitization and Reprocessing (EMDR), Cognitive Processing Therapy (CPT), and Prolonged Exposure (PE) are the first-line, gold-standard treatments with robust evidence for long-term benefits. Psychotherapies for ADHD, such as Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT)-informed approaches, are also highly effective for improving core symptoms, executive function, and emotional regulation. Neuromodulation techniques like repetitive Transcranial Magnetic Stimulation (rTMS) show promise for both conditions, though evidence for others like neurofeedback is inconsistent. Digital therapeutics, such as EndeavorRx for pediatric ADHD and NightWare for PTSD-related nightmares, represent a new, FDA-authorized frontier in accessible care.\n\n**Emerging and Novel Therapies** are gaining significant attention. Psychedelic-assisted therapies, while promising, face regulatory hurdles; MDMA-assisted therapy for PTSD was rejected by the FDA in 2024 due to concerns about trial integrity and safety, highlighting the rigorous standards required. Ketamine and esketamine infusions offer rapid, though often transient, relief for severe depression and PTSD. Observational data on ibogaine and ayahuasca for trauma show remarkable potential but come with significant safety risks and require more research. Stellate Ganglion Block (SGB) has shown efficacy for PTSD in a key trial but is not yet widely recommended by guidelines.\n\n**Lifestyle, Somatic, and Traditional Practices** offer crucial adjunctive and foundational support. Regular physical exercise (aerobic, HIIT, yoga) has demonstrated significant benefits for both ADHD (improving executive function) and PTSD (reducing symptoms). Sleep optimization, through methods like CBT for Insomnia (CBT-I) and light therapy, is critical as sleep disruption is a core feature of both disorders. Nutritional strategies, including adherence to a Mediterranean diet and supplementation with omega-3s, show some evidence for ADHD management. Somatic (body-based) therapies like yoga, Tai Chi, and breathwork directly target the autonomic nervous system dysregulation common in trauma. Traditional systems like Traditional Chinese Medicine (TCM) and Ayurveda offer holistic approaches with herbal remedies (e.g., Bacopa, Ashwagandha) and practices like acupuncture, though the evidence quality is often low to moderate. Culturally grounded and community-based practices, including peer support, arts therapies, and nature exposure, provide vital social connection and stress reduction, enhancing overall recovery.",
    "clarification_of_user_query": "The user's request to find ways to 'shake off my ADHD and related trauma from my body' is interpreted as a metaphorical expression of a deep desire for comprehensive and effective strategies to alleviate, manage, and ultimately overcome the burdensome symptoms and negative impacts of these conditions. The phrase 'shake off' suggests a need for active, powerful interventions that can lead to a tangible sense of relief and freedom from the cognitive, emotional, and functional impairments. The reference to 'from my body' points to an intuitive understanding that these conditions are not just abstract mental states but have profound physiological and somatic manifestations. This includes the hyperarousal, autonomic dysregulation, and physical tension of trauma (PTSD), as well as the restlessness, executive function challenges, and neurochemical imbalances of ADHD. Therefore, this report interprets the query as a request for a holistic and integrated overview of all possible interventions—from neurobiological to behavioral, from individual to environmental—that can help regulate the nervous system, improve cognitive control, process traumatic memories, and restore a sense of well-being and functional capacity.",
    "comparative_effectiveness_table": "### Multi-Criteria Comparative Effectiveness Table for Adult ADHD and Trauma Interventions\n\n**Rationale & Limitations:** This table synthesizes evidence across multiple domains to provide a comparative overview. Scores are qualitative ratings (High, Moderate, Low, Very Low/Unknown) based on the weight of evidence from meta-analyses, RCTs, and clinical guidelines. A critical limitation is the **scarcity of research specifically on the comorbid adult ADHD and PTSD population**. Therefore, many ratings are extrapolated from studies on each condition individually. The 'Overall Effectiveness' score is a qualitative synthesis, not a quantitative calculation, and should be interpreted with caution. User preferences (e.g., prioritizing safety over efficacy) will alter the personal relevance of each intervention.\n\n| Intervention Category | Specific Intervention | Primary Target | Magnitude of Benefit (Efficacy) | Durability of Effect | Safety & Tolerability | Cost & Access | Required Effort | Evidence Certainty | Overall Effectiveness & Use-Case |\n|---|---|---|---|---|---|---|---|---|---|\n| **Pharmacotherapy** | **Stimulants (Amphetamines, Methylphenidate)** | ADHD | **High** (SMD -0.5 to -0.8 for core symptoms) | **Low/Unknown** (Poor long-term data; high discontinuation rates) | **Low-Moderate** (High dropout due to side effects; cardiovascular risks; misuse potential) | **Moderate** (Generics available but brand names are expensive; access requires diagnosis) | **Low** (Daily pill) | **High** (for short-term) | **High (Short-Term):** First-line for rapid reduction of core ADHD symptoms. Requires careful monitoring. Potential to worsen anxiety in some PTSD patients. |\n| | **Non-Stimulants (Atomoxetine, Guanfacine)** | ADHD | **Moderate** (SMD -0.45 for core symptoms) | **Low/Unknown** (Limited long-term data) | **Moderate** (Better tolerated than stimulants by some, but still has side effects) | **Moderate** (Generic atomoxetine is affordable) | **Low** (Daily pill) | **High** | **Moderate:** Second-line for ADHD, or for those with contraindications/intolerance to stimulants or high misuse risk. |\n| | **SSRIs/SNRIs (Sertraline, Paroxetine, Venlafaxine)** | PTSD | **Moderate** (Response rate ~39-60%) | **Moderate** (Benefits can be sustained with continued use) | **Moderate** (Side effects like sexual dysfunction, withdrawal syndrome) | **High** (Generics widely available and affordable) | **Low** (Daily pill) | **High** | **Moderate:** First-line pharmacotherapy for PTSD, but less effective than trauma-focused psychotherapy. |\n| **Psychotherapy** | **Trauma-Focused (EMDR, CPT, PE, NET)** | PTSD | **High** (Large effect sizes, SMD > 0.8; high remission rates) | **High** (Benefits are sustained long-term post-treatment) | **High** (Generally safe; low dropout rates; symptom spikes are rare) | **Low** (High cost per session; long waitlists; provider scarcity) | **High** (Weekly sessions, homework, emotional processing) | **High** | **Very High:** Gold-standard, first-line treatment for PTSD with durable, transformative effects. The most effective approach for the trauma component. |\n| | **CBT for ADHD** | ADHD, Comorbid Anxiety/Depression | **High** (Large effect sizes, g = 1.0 pre-post) | **High** (Skills-based, benefits are durable) | **High** (Very safe, low risk of adverse events) | **Low** (High cost per session; long waitlists) | **High** (Weekly sessions, skills practice) | **High** | **Very High:** Most effective non-pharmacological treatment for adult ADHD. Also effective for common comorbid anxiety and depression. |\n| | **DBT-informed Therapy** | ADHD (Emotion Regulation), PTSD | **Moderate-High** (SMD -0.51 for ADHD symptoms; improves QoL) | **Moderate** (Benefits persist at 6-month follow-up) | **High** (Very safe) | **Low** (High cost; often delivered in groups) | **High** (Skills training, group sessions) | **Moderate** | **High:** Excellent choice for individuals where emotional dysregulation is a primary feature of both ADHD and trauma. |\n| **Neuromodulation** | **rTMS (Repetitive Transcranial Magnetic Stimulation)** | PTSD, ADHD (Inattention) | **Moderate** (SMD -0.5 to -0.9 for acute PTSD; SMD -0.76 for ADHD inattention) | **Low** (PTSD effects often not sustained at follow-up) | **High** (Generally safe; rare risk of seizure) | **Very Low** (Very expensive; limited insurance coverage; requires daily clinic visits) | **Moderate-High** (Requires daily sessions for several weeks) | **Moderate** | **Moderate:** A promising option for treatment-resistant cases of PTSD or ADHD, but access and durability are major limitations. |\n| | **EEG Neurofeedback** | ADHD | **Low/Inconsistent** (Blinded studies show minimal effect; placebo effect is high) | **Unknown** (Conflicting data) | **High** (Non-invasive and safe) | **Very Low** (Very expensive, not covered by insurance, time-consuming) | **High** (Requires many sessions) | **Very Low** | **Low:** Not recommended as a primary treatment due to inconsistent evidence and high cost. |\n| **Somatic & Lifestyle** | **Exercise (Aerobic, HIIT, Yoga)** | Both | **Moderate** (Improves ADHD executive function & PTSD symptoms) | **High** (Benefits persist with continued practice) | **Very High** (Safe for most people) | **High** (Can be free or low-cost) | **Moderate** (Requires regular time commitment) | **Moderate** | **High:** A foundational, highly accessible intervention with broad benefits for mental and physical health. Excellent adjunctive treatment. |\n| | **Mindfulness & Breathwork** | Both | **Moderate** (Reduces symptoms of both ADHD and PTSD) | **High** (Skills are durable with practice) | **Moderate-High** (Generally safe, but can cause adverse effects like dissociation in vulnerable individuals) | **High** (Many free/low-cost apps and resources) | **Moderate** (Requires daily practice) | **Moderate** | **High:** Highly effective for improving emotion regulation, attention, and reducing hyperarousal. Trauma-sensitive approaches are recommended. |\n| | **Sleep Optimization (CBT-I, Light Therapy)** | Both | **High** (Significantly improves sleep and reduces PTSD/ADHD symptoms) | **High** (Skills are durable) | **Very High** (Very safe) | **Moderate** (CBT-I can be costly, but digital versions are emerging) | **Moderate-High** (Requires behavioral changes and consistency) | **High** | **Very High:** Critical intervention, as sleep disruption is a core, debilitating feature of both conditions. |\n| **Psychedelic-Assisted** | **MDMA-Assisted Therapy** | PTSD | **High (in trials)** | **Unknown (in real world)** | **Low** (FDA rejected due to safety, data integrity, and abuse concerns) | **Very Low** (Not legally available; high projected cost) | **High** (Intensive multi-session protocol) | **Low (Regulatory)** | **Not Recommended (Currently):** Not an approved treatment. Future depends on addressing significant safety and trial conduct issues. |\n| | **Ketamine/Esketamine** | PTSD, Depression | **High (Rapid Onset)** | **Low** (Effects are often transient, requiring repeated infusions) | **Moderate** (Requires medical monitoring for blood pressure, dissociation; abuse potential) | **Very Low** (Very expensive; limited insurance coverage) | **Moderate** (Requires clinic visits and monitoring) | **Moderate** | **Moderate:** Best used for rapid stabilization in severe, treatment-resistant cases of depression or PTSD, but not a long-term solution. |\n| **Traditional & Supplements** | **TCM (Acupuncture) & Ayurveda (Herbs)** | Both | **Low-Moderate** (Some positive studies but often low quality) | **Unknown** | **Low-Moderate** (Risk of herb-drug interactions and contamination) | **Moderate** (Cost varies; not typically covered by insurance) | **Moderate** (Requires regular sessions/dosing) | **Very Low** | **Low:** May offer adjunctive benefits for some, but not a substitute for evidence-based care due to weak evidence and safety concerns. |\n| | **Nutraceuticals (Omega-3, Saffron, etc.)** | ADHD | **Low** (Omega-3 evidence is inconsistent; others are emerging) | **Unknown** | **Moderate** (Generally safe, but interactions are possible) | **High** (Widely available OTC, but can be costly) | **Low** (Daily pill) | **Very Low** | **Low:** May provide minor adjunctive support (e.g., long-term Omega-3), but not a primary treatment. Quality control is a concern. |",
    "modern_medical_and_psychological_treatments": {
      "pharmacological_treatments": "For adult ADHD, pharmacological intervention is a primary strategy. Stimulants, including amphetamines (e.g., lisdexamfetamine) and methylphenidate, are considered first-line treatments by major guidelines (NICE, CADDRA). A 2025 network meta-analysis by Ostinelli et al. confirmed stimulants were the only intervention with clear short-term efficacy for core symptoms (SMD = -0.43). They also moderately improve Quality of Life (QoL), with amphetamines showing a Hedge's g of 0.51. Non-stimulants like atomoxetine, bupropion, and guanfacine are second-line options. Atomoxetine shows similar efficacy to stimulants for core symptoms (SMD = -0.36) but has lower acceptability. For PTSD, the 2023 VA/DoD guidelines strongly recommend SSRIs (sertraline, paroxetine) and the SNRI venlafaxine as first-line monotherapy, to be trialed for 8-12 weeks. Response rates for sertraline are around 53%, and venlafaxine has shown remission rates of 50.9%. The guidelines strongly recommend against benzodiazepines and cannabis. Evidence for prazosin for nightmares is mixed; a large VA study found it ineffective, while a 2025 meta-analysis found it significantly improved nightmares (SMD = -0.641) and insomnia (SMD = -0.654). Adjunctive atypical antipsychotics are generally recommended against by the VA/DoD, though some meta-analyses show efficacy for certain agents like quetiapine in veteran populations. For comorbid ADHD and PTSD, treatment must be individualized. Emerging evidence suggests that treating ADHD with stimulants may concurrently improve PTSD symptoms. A case report showed Vyvanse (lisdexamfetamine) controlled a patient's PTSD symptoms, and a pilot RCT found methylphenidate improved PTSD symptoms in TBI patients without increasing hyperarousal.",
      "psychological_treatments": "For adult ADHD, Cognitive Behavioral Therapy (CBT) is the most effective and well-researched psychotherapy. A 2025 network meta-analysis by Yang et al. found CBT to be the most effective non-pharmacological intervention, with significant short-term (SMD: -4.43) and long-term (SMD: -3.61) reduction in core ADHD symptoms, as well as long-term benefits for comorbid depression and anxiety. Other promising therapies include Metacognitive Therapy (MCT), which improves executive functioning, and Dialectical Behavior Therapy (DBT)-informed approaches, which are superior to treatment-as-usual for executive dysfunction (effect size 0.64) and moderately reduce ADHD symptoms (SMD = -0.51). For PTSD, trauma-focused psychotherapies are the first-line treatment. The 2025 APA guidelines give the highest recommendation to Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), and Trauma-Focused CBT (TF-CBT). Network meta-analyses consistently find these, along with Eye Movement Desensitization and Reprocessing (EMDR) and Narrative Exposure Therapy (NET), to be highly effective. EMDR and TF-CBT appear most effective in reducing symptoms and improving remission, with sustained effects. CPT and NET are associated with a higher proportion of patients losing their PTSD diagnosis. For complex trauma (CPTSD), phase-based approaches are recommended. STAIR (Skills Training in Affective and Interpersonal Regulation) is a leading therapy for CPTSD with large effect sizes (d = 1.34 to 2.29). Internal Family Systems (IFS) and Somatic Experiencing (SE) are promising emerging therapies for CPTSD. Dropout rates from trauma-focused therapies average 16-21%, and contrary to common concerns, there is no evidence of widespread symptom exacerbation during treatment."
    },
    "neuromodulation_and_brain_stimulation_therapies": {
      "technique_name": "Repetitive Transcranial Magnetic Stimulation (rTMS/iTBS)",
      "evidence_for_adhd": "The evidence for rTMS in adult ADHD is inconsistent but shows promise for specific symptoms. A 2025 meta-analysis by Courrèges et al. found no significant overall improvements. However, a 2024 meta-analysis revealed that rTMS targeting the right prefrontal cortex (rPFC) was more effective than sham (SMD = -0.49) and specifically improved inattention (SMD = -0.76). Furthermore, a 2023 meta-analysis found rTMS effective for improving sustained attention (SMD = 0.54) and processing speed (SMD = 0.59), although not memory or executive function. This suggests that while not a panacea, targeted rTMS may be beneficial for the inattentive aspects of ADHD.",
      "evidence_for_ptsd": "For PTSD, multiple meta-analyses support the acute efficacy of rTMS, though long-term effects are less clear. An August 2024 network meta-analysis of 21 RCTs found that high-frequency rTMS (HF-rTMS) (SMD = -0.97), intermittent theta burst stimulation (iTBS) (SMD = -0.93), and low-frequency rTMS (LF-rTMS) (SMD = -0.76) all significantly reduced PTSD symptoms at the end of the treatment course. A key limitation identified in this analysis was that these significant effects were not sustained at follow-up. Another 2024 study found that 20-Hz rTMS applied to the right DLPFC had a greater effect than when applied to the left, and was also shown to increase dispositional mindfulness.",
      "typical_protocol": "The primary brain region targeted for both conditions is the dorsolateral prefrontal cortex (DLPFC). For ADHD, protocols stimulating the right DLPFC (often localized using the F3 position or the 5-cm method) have shown the most promise for improving inattention. For PTSD, two main protocols are used: high-frequency (e.g., 10-20 Hz) stimulation applied to the left DLPFC, which is thought to upregulate activity in this hypoactive region, and low-frequency (e.g., 1 Hz) stimulation applied to the right DLPFC, which is thought to downregulate activity in this hyperactive region. LF-rTMS of the right DLPFC has been found to have the highest patient acceptability.",
      "safety_and_guideline_status": "rTMS is generally considered safe and well-tolerated, with no significant difference in dropout rates compared to sham controls. The most serious risk is seizure, though this is very rare when safety guidelines are followed. Minor side effects can include headache or local discomfort at the stimulation site. Despite positive findings in multiple meta-analyses, the 2023 VA/DoD Clinical Practice Guideline for PTSD states there is insufficient evidence to recommend for or against rTMS, highlighting a conservative stance pending more robust, long-term data. Other neuromodulation techniques like Stellate Ganglion Block (SGB) also have insufficient evidence per VA/DoD guidelines, despite a positive JAMA Psychiatry RCT, while invasive Vagus Nerve Stimulation (VNS) is suggested against for PTSD."
    },
    "psychedelic_and_dissociative_assisted_therapies": {
      "substance_name": "MDMA (Midomafetamine)",
      "primary_target_condition": "Post-Traumatic Stress Disorder (PTSD)",
      "clinical_evidence_summary": "The New Drug Application for MDMA-assisted therapy was supported by two pivotal Phase 3 randomized, placebo-controlled trials, MAPP1 and MAPP2. Both studies demonstrated statistically significant and clinically meaningful reductions in PTSD symptoms as measured by the Clinician-Administered PTSD Scale (CAPS-5) compared to placebo with therapy. MAPP1 focused on participants with severe PTSD, while MAPP2 included those with moderate to severe PTSD. Despite these positive efficacy signals and no serious adverse events reported in the MDMA arms, the trials were ultimately deemed insufficient for approval due to significant methodological and ethical concerns raised by the FDA and its advisory committee.",
      "legal_and_regulatory_status_2025": "In a major decision in August 2024, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL), formally rejecting the New Drug Application (NDA) for MDMA-assisted therapy for PTSD. This followed a decisive 10-1 negative vote from the FDA's Psychopharmacologic Drug Advisory Committee in June 2024, which concluded that the treatment's benefits did not outweigh its risks based on the available data. The FDA has requested at least one additional, well-controlled clinical trial to further assess safety and efficacy. At the federal level in the US, MDMA remains a Schedule I controlled substance. Access is limited to research settings, though some countries like Australia have approved its medicinal use under strict psychiatric supervision.",
      "key_safety_concerns_and_contraindications": "The FDA's rejection was driven by multiple serious concerns. These included: 1) Functional Unblinding: A very high percentage of participants (over 90% in the MDMA group) correctly guessed their treatment assignment, compromising the integrity of the placebo control and raising questions about expectancy effects. 2) Data Integrity and Trial Conduct: Concerns were raised about the reliability of the collected data and reports of serious ethical violations, including sexual abuse by therapists at a trial site. 3) Safety Profile: Potential risks identified include acute cardiovascular events (hypertension), worsening of mental health symptoms, and suicidal ideation. 4) Durability of Effect: The long-term sustainability of the therapeutic benefits was a point of concern. Standard contraindications in clinical trials include a personal or family history of psychosis (e.g., schizophrenia) or bipolar disorder, as psychedelics can potentially trigger or exacerbate these conditions."
    },
    "lifestyle_and_behavioral_interventions": {
      "exercise_interventions": "Exercise interventions, such as aerobic activity, resistance training, and yoga, have shown significant benefits for both ADHD and PTSD. For ADHD, exercise enhances inhibitory control and emotional regulation, with protocols including 30-minute moderate-to-intense sessions held three times weekly over several weeks. PTSD patients experience reduced symptom severity and anxiety through similar exercise regimens, particularly structured classes guided by trained specialists.",
      "sleep_optimization_strategies": "Sleep interventions include Cognitive Behavioral Therapy for Insomnia (CBT-I), tailored for adult ADHD, addressing sleep onset latency and improving sleep quality while simultaneously alleviating daytime ADHD symptoms. Bright light therapy (BLT) is effective in adjusting circadian rhythms for both ADHD and PTSD cohorts. Implement the strategies consistently for long-lasting benefits.",
      "nutrition_and_dietary_patterns": "Nutritional approaches for ADHD and PTSD emphasize dietary patterns like the Mediterranean diet (high in fruits, vegetables, and omega-3 fatty acids) to reduce symptoms and support cognitive functions. Specific elimination diets may identify and remove symptomatic triggers. Maintaining a diet rich in essential vitamins and minerals ensures long-term effectiveness.",
      "impact_of_common_substances": "Substances like caffeine, alcohol, and nicotine impact ADHD and PTSD symptoms variably. Low doses of caffeine may enhance focus in ADHD, but overconsumption could exacerbate anxiety-related symptoms in PTSD. Alcohol may be used as a maladaptive coping mechanism, increasing symptom severity in both conditions. Nicotine's acute calming effects are outweighed by long-term health risks and addictive potential."
    },
    "somatic_and_body_oriented_practices": "Yoga and breathwork, including Integrative Yoga Classes for ADHD and Trauma-Sensitive Yoga for PTSD, facilitate emotional regulation and trauma processing. Techniques such as box breathing and Tai Chi cultivate mindfulness and lower hyperarousal. Onset of benefits requires consistent practice, performed daily or thrice weekly, over an extended period.",
    "nutraceuticals_and_dietary_supplements": {
      "supplement_name": "Omega-3 Fatty Acids",
      "evidence_for_adhd": "Meta-analyses suggest potential benefits for attention and emotional regulation in children and adults with ADHD.",
      "evidence_for_ptsd": "Evidence underscores omega-3's role in reducing inflammatory responses associated with PTSD.",
      "supported_dosing": "EPA to DHA comparable ratios of 750–1500 mg daily for several weeks.",
      "safety_profile_and_interactions": "Omega-3 is generally well tolerated; minor gastrointestinal disturbances may occur at high doses. Monitor if combined with anticoagulants.",
      "quality_control_considerations": "Source omega-3 products that are third-party certified for purity and effectiveness against rancidity."
    },
    "traditional_and_ancient_healing_systems": "Traditional Chinese Medicine, Indigenous Medicine Practices, and Ayurveda offer therapies like acupuncture, Tai Chi, herbal adaptogens (e.g., Brahmi, Ashwagandha), and guided meditative techniques. Integration alongside western medicine should prioritize patient-specific cultural relevance and evidence-based safety.",
    "digital_therapeutics_and_technology_tools": "Technology-assisted treatments offer scalable and accessible options for managing ADHD and PTSD. A key theme is their role as adjunctive tools within a comprehensive, clinician-led care plan. \n\n**FDA-Authorized Digital Therapeutics (DTx):**\n*   **EndeavorRx (for ADHD):** An FDA-authorized prescription video game for children aged 8-12 with ADHD, designed to improve attention function. Its pivotal STARS-ADHD randomized controlled trial showed it significantly improved objective measures of attention compared to a digital control. It is intended as part of a broader treatment program, not as a standalone therapy. Studies suggest benefits may extend to adolescents and adults.\n*   **NightWare (for PTSD):** An FDA-authorized prescription device for adults (22+) that uses an Apple Watch to detect and interrupt nightmares via gentle vibrations, reducing sleep disturbance related to PTSD. A sham-controlled trial showed trends toward improvement in PTSD-related sleep issues. It is also intended for use alongside other therapies and medications.\n\n**Digital Therapy Platforms:**\n*   **Internet-Delivered CBT (iCBT) for PTSD:** Meta-analyses confirm iCBT is effective for reducing PTSD symptoms, especially when guided by a therapist (pooled effect size g=0.54 in military samples). However, high dropout rates (over 40% in some studies) can be a challenge.\n*   **Virtual Reality Exposure Therapy (VRET):** A promising treatment for PTSD with efficacy comparable to other active psychotherapies.\n*   **Other Platforms:** Tools like the PE Coach Mobile App (for Prolonged Exposure) and Online EMDR 2.0 GP are being studied and show effectiveness in reducing PTSD symptoms.\n\n**Attention & Cognitive Training Apps for ADHD:**\n*   **Computerized Cognitive Training (CCT):** Evidence is weak. A 2023 meta-analysis found a small positive change in overall cognitive functioning (Hedge's g = 0.235) but no significant improvement in core ADHD symptoms or specific cognitive domains like working memory.\n*   **Working Memory Training (e.g., Cogmed):** Evidence is mixed, with some meta-analyses finding near-zero effects on far-transfer measures.\n*   **Neurofeedback Apps (e.g., Myndlift):** A meta-analysis found a small effect on attention (Hedges' g = 0.29), but with a high risk of publication bias.\n\n**Wearables and Biofeedback:**\n*   **Heart Rate Variability (HRV) Biofeedback:** A highly promising intervention for PTSD. Low HRV is associated with PTSD, and HRVB aims to increase it through slow-paced breathing. A 2024 meta-analysis on military PTSD found HRVB led to a substantial reduction in symptoms (effect sizes from -1.614 to -0.414). Wearables like Apollo Neuro are being studied, and prescription HRV-BFB digital therapeutics are in development.",
    "community_environmental_and_skills_based_support": "A comprehensive approach to managing ADHD and trauma involves a variety of non-clinical, skills-based, and environmental interventions aimed at improving daily functioning and quality of life. ADHD coaching is an emerging and effective collaborative intervention that targets core challenges like planning, time management, and organization, leading to improved executive functioning and self-esteem. Organizational systems are crucial; structured therapies like Cognitive Behavioral Therapy (CBT) teach practical skills, and techniques like the Pomodoro Technique help manage 'time blindness'. To compensate for working memory deficits, 'externalization of memory' is a key strategy, utilizing physical aids like whiteboards, sticky notes, and timers, which are often more effective than digital reminders for individuals with ADHD. Environmental engineering, recommended as a first-line strategy by NICE guidelines, involves modifying one's surroundings to control distractions and modulate sensory input. This includes creating quiet workspaces, using noise-canceling headphones, and designing environments with soothing colors and minimal clutter. Sensory modulation is particularly important due to the significant overlap in sensory processing challenges between ADHD and PTSD. Interventions guided by occupational therapists, such as creating a personalized 'sensory diet' (e.g., using weighted blankets, fidget tools, movement breaks) and employing grounding techniques like the 5-4-3-2-1 method, can effectively manage sensory overload and reduce distress. Social and community support is another vital pillar. Peer-led groups and mutual aid foster connection through shared experience, which can reduce anxiety and enhance a sense of meaning. Faith and spirituality-based practices offer structured social networks and have been shown to reduce post-traumatic stress. Nature-based interventions, such as exposure to green spaces or 'forest bathing' (Shinrin-Yoku), are strongly supported by evidence for reducing ADHD symptom severity and have a moderate effect on PTSD symptoms. Arts therapies (creative, music, dance) provide essential non-verbal channels for processing trauma and regulating emotions, with evidence showing significant decreases in PTSD symptoms. Finally, workplace and school accommodations are critical for functional success. In the U.S., the Americans with Disabilities Act (ADA) mandates reasonable accommodations, such as providing a quiet workspace, allowing flexible schedules, and using assistive technology, to ensure equal opportunity for individuals with ADHD.",
    "neurobiological_mechanisms_of_action": "The desire to 'shake off' ADHD and trauma 'from my body' aligns with the neurobiological understanding of these conditions, as they are rooted in dysfunctions of the brain and nervous system. Interventions work by targeting these specific biological mechanisms.\n\n**ADHD Neurobiology:**\nADHD is primarily characterized by dysfunction in frontostriatal-cerebellar circuits, which are critical for executive functions like attention, planning, and impulse control. The core mechanism involves dysregulation of the dopamine and norepinephrine neurotransmitter systems. Many individuals with ADHD have altered dopamine transporter (DAT) density, affecting dopamine levels in the brain's synapses. This chemical imbalance disrupts communication within key brain networks. Neuroimaging reveals impaired synchronization between the Default Mode Network (DMN), active during rest, and the Task-Positive Network (TPN), active during tasks. In ADHD, the DMN is often not adequately suppressed, leading to attention lapses.\n*   **How Interventions Work:**\n    *   **Stimulant Medications (Methylphenidate, Amphetamines):** Directly target these systems by blocking dopamine and norepinephrine transporters, increasing the availability of these neurotransmitters in the prefrontal cortex and striatum. This helps normalize network activity, enhancing TPN function and suppressing the DMN during tasks.\n    *   **Exercise:** Naturally increases dopamine and norepinephrine levels and promotes neuroplasticity through Brain-Derived Neurotrophic Factor (BDNF), supporting the development and connectivity of the prefrontal cortex.\n    *   **Neuromodulation (rTMS/tDCS):** Non-invasively stimulates specific regions like the dorsolateral prefrontal cortex (DLPFC) to modulate dopamine/norepinephrine transmission and normalize network activity.\n\n**PTSD Neurobiology:**\nPTSD involves profound changes in the brain's fear and stress-response systems. Key features include:\n*   **Fear Circuitry:** Hyperactivity in the amygdala (the brain's fear center) and hypoactivity in the ventromedial prefrontal cortex (vmPFC) and hippocampus, which normally regulate the amygdala and process contextual memory. This imbalance leads to a persistent state of fear and difficulty distinguishing safe from unsafe situations.\n*   **HPA Axis Dysregulation:** The body's central stress response system (Hypothalamic-Pituitary-Adrenal axis) is dysregulated, often leading to altered levels of the stress hormone cortisol. This can contribute to an exaggerated inflammatory response.\n*   **Autonomic Nervous System (ANS) Dysregulation:** A state of chronic hyperarousal caused by a dominant sympathetic ('fight-or-flight') nervous system and a deficient parasympathetic ('rest-and-digest') nervous system. This is measurable through low Heart Rate Variability (HRV).\n*   **How Interventions Work:**\n    *   **Trauma-Focused Psychotherapy (EMDR, PE, CPT):** These therapies work to restructure traumatic memories and their associated emotional responses. The Working Memory Hypothesis for **EMDR** suggests that dual-tasking (recalling a memory while performing eye movements) taxes working memory, making the memory less vivid and allowing it to be reconsolidated in a less distressing form. Exposure therapies like **PE** work through habituation and extinction learning, gradually reducing the amygdala's fear response to trauma triggers.\n    *   **SSRIs:** Can increase activation in the prefrontal cortex, improving top-down control over the amygdala's emotional responses.\n    *   **Somatic Therapies (Breathwork, Yoga):** Directly target the dysregulated ANS. Slow, diaphragmatic breathing activates the vagus nerve, increasing parasympathetic tone and HRV, shifting the body out of a hyperaroused state.\n    *   **Stellate Ganglion Block (SGB):** Works by temporarily blocking sympathetic nerve traffic from the stellate ganglion, believed to 'reboot' the fight-or-flight response and reduce central nervous system hyperarousal.",
    "framework_for_personalized_treatment": {
      "treatment_sequencing_and_integration": "The management of co-occurring adult ADHD and PTSD requires a highly individualized and integrated strategy. Major clinical guidelines, including those from the VA/DoD and APA, advocate for a concurrent treatment model, advising against withholding evidence-based PTSD treatment due to the presence of ADHD. A core principle is to prioritize the most functionally impairing condition first. However, safety is paramount; active suicidality, psychosis, severe mood disorders, or severe substance use disorders must be stabilized before initiating standard ADHD treatment. In some cases where mood symptoms are not severe, an ADHD-first approach may be beneficial, as effective ADHD treatment can improve mood and may even reduce the long-term risk of developing PTSD. Combining psychotherapy and pharmacotherapy is a common strategy; for ADHD, this combination shows a large effect size (0.80) over medication alone, whereas for PTSD, the added benefit is small. A critical consideration is the use of stimulants, which theoretically could worsen PTSD hyperarousal. However, emerging evidence, including a pilot RCT of methylphenidate, suggests that stimulants can be well-tolerated and may even significantly improve PTSD symptoms in some individuals. Therefore, they should be considered a viable option with careful monitoring. A step-care algorithm should be employed, featuring slower medication titration and more frequent monitoring for comorbid patients. If anxiety emerges, the standard procedure is to reduce or withdraw the ADHD medication, treat the anxiety, and then consider a cautious reintroduction.",
      "patient_factors_predicting_response": "Personalizing treatment for ADHD and PTSD requires analyzing patient-specific factors that predict outcomes. For ADHD, baseline symptom severity can predict response, with more severe cases potentially benefiting more from stimulants. The presence of comorbid emotional dysregulation or anxiety can complicate stimulant treatment, making behavioral therapies particularly important. Parental psychopathology, such as maternal depression, is associated with a poorer response to treatment in children. Biological predictors are emerging, including genetic markers (e.g., DAT1 gene) and EEG patterns (e.g., theta/beta ratio), though evidence remains mixed. For PTSD, higher pre-treatment symptom severity and dissociation are predictors of less favorable outcomes. The type of trauma also matters, with combat exposure often associated with more modest treatment effects than assault. Younger age is generally linked to more positive outcomes. Genetic and biomarker predictors for PTSD are well-documented, with variations in genes like FKBP5, especially when combined with early-life stress, strongly increasing PTSD risk. A patient's psychological mindset, such as having higher outcome expectancies for therapy, is also a significant predictor of improvement. Advanced predictive modeling using machine learning is being developed to create a Personalized Advantage Index (PAI), which can predict which specific therapy is optimal for an individual, significantly increasing the rate of reliable improvement.",
      "measurement_based_care_strategy": "A robust measurement-based care strategy is essential for tracking progress and personalizing interventions for ADHD and trauma over time. This involves a combination of validated clinical scales and objective digital metrics. Key validated scales include the Adult ADHD Self-Report Scale (ASRS-v1.1) and ADHD Rating Scale-5 (ADHD-RS-5) for ADHD symptoms, and the PTSD Checklist for DSM-5 (PCL-5) for trauma symptoms. To monitor common comorbidities and overall well-being, the Patient Health Questionnaire-9 (PHQ-9) for depression, Generalized Anxiety Disorder-7 (GAD-7) for anxiety, and WHO Quality of Life-BREF (WHOQOL-BREF) are recommended. These subjective reports should be complemented with objective digital metrics from wearables and apps. This includes sleep tracking via actigraphy or consumer devices (e.g., Oura Ring), Heart Rate Variability (HRV) as a measure of autonomic nervous system regulation, and activity tracking. Cognitive performance can be assessed using digital versions of tasks like the Continuous Performance Task (CPT). To scientifically determine the best intervention for an individual, N-of-1 trial designs are highly effective. These single-subject trials compare different treatments within one person, using a framework like Bayesian inference to sequentially update the probability of a treatment's effectiveness as more data is collected. This data-driven approach allows individuals and clinicians to move beyond trial-and-error and make informed, personalized decisions based on a dynamically refined understanding of what works best for that specific person."
    },
    "comprehensive_safety_and_harm_reduction_guide": "A comprehensive approach to treating adult ADHD and PTSD requires a thorough understanding of the safety profiles, contraindications, and harm-reduction strategies for all interventions. For ADHD medications, stimulants carry cardiovascular risks, including increased blood pressure and heart rate, and are contraindicated in patients with a history of heart disease. Monitoring of cardiovascular vitals is mandatory before and during treatment. They also pose a significant risk of misuse, diversion, and addiction, and can cause insomnia and appetite loss. Non-stimulants like atomoxetine carry risks of severe liver injury and sexual dysfunction. For PTSD medications, SSRIs/SNRIs have a Black Box warning for increased suicidality in young adults and can cause discontinuation syndrome if stopped abruptly. Psychotherapy, while generally safe, carries a risk of symptom exacerbation or retraumatization if not conducted with care, though fears of this are often overstated. Neuromodulation techniques have specific risks: rTMS has a rare but serious risk of seizure, requiring careful screening; tDCS can cause skin burns or mania. Supplements and herbal remedies pose risks of contamination and drug interactions, as they are not regulated by the FDA. For example, St. John's Wort interacts with numerous life-saving medicines, Ginkgo biloba increases bleeding risk with anticoagulants, and Saffron can cause serotonin syndrome with SSRIs. Psychedelic and dissociative therapies have unique and significant risks. Esketamine (Spravato) requires a strict REMS program due to risks of sedation, dissociation, and severe blood pressure increases. MDMA-assisted therapy trials exclude patients with psychosis or bipolar disorder due to the risk of exacerbating these conditions. Ibogaine carries a significant risk of fatal cardiac arrhythmia. Harm reduction across all treatments relies on comprehensive screening, informed consent, and structured monitoring protocols, such as the NICE guidelines for ADHD medication or the REMS program for esketamine, to ensure patient safety.",
    "cost_access_and_policy_considerations": {
      "costs_and_insurance_coverage": "The cost of interventions for ADHD and trauma varies dramatically by region, insurance plan, and specific treatment. In the United States, ADHD medications can range from over $800/month for brand-name Adderall to as low as $15/month for generic atomoxetine with coupons. Most insurance plans cover medications but often require prior authorization. Psychotherapy sessions in the U.S. typically cost $100-$250 out-of-pocket, with 2025 Medicare reimbursement rates around $104 for a 45-minute session. In the UK, private ADHD assessments can cost ~£695, with monthly medication costs of £70-£90. In Australia, the Pharmaceutical Benefits Scheme (PBS) subsidizes medications, but access for adults diagnosed later in life is limited, leading to higher costs. In France and Germany, national health insurance provides significant coverage, but access to specialists can be a bottleneck. Digital therapeutics are an emerging area; in the US, EndeavorRx for pediatric ADHD costs $99 for a 30-day prescription, while in Germany, approved digital health apps (DiGAs) like ORIKO ADHS-Therapie are reimbursed by statutory health insurance.",
      "provider_availability_and_waitlists": "Access to care is severely constrained by provider shortages and long waitlists across many countries. The United States faces a significant and persistent psychiatrist shortage, projected to have a deficit of over 17,000 by 2050, although the growth of psychiatric nurse practitioners is helping to mitigate this. In the United Kingdom, adults can face an average wait of over 1.5 years for an NHS ADHD assessment. Similarly, long wait times for community mental health counseling are reported in Canada (nearly five months or more for 1 in 10 people), and for psychiatric specialists in Australia (median wait time of 50 days in 2022). In continental Europe, public systems in France and Germany also struggle with long wait times, with waits for an ADHD diagnosis in France's public system reaching up to two years, pushing many towards more expensive private care.",
      "legal_and_regulatory_landscape": "As of 2025, the legal and regulatory landscape for novel treatments is dynamic and complex. A major development occurred in August 2024 when the U.S. FDA rejected the New Drug Application for MDMA-assisted therapy for PTSD, citing concerns about data integrity, ethical violations in trials, and functional unblinding. This decision has created a significant hurdle for federal approval of psychedelic-assisted therapies, which remain Schedule I substances. However, state-level changes continue, with Oregon and Colorado having legalized psilocybin for therapeutic use in supervised settings. For other novel treatments, the VA/DOD considers Stellate Ganglion Block (SGB) for PTSD to be a non-established treatment with inconclusive evidence, though legislation (TREAT PTSD Act) has been introduced in Congress to mandate its availability for veterans. The regulatory environment for these emerging therapies remains a critical and evolving factor in their accessibility.",
      "equity_and_access_barriers": "Significant equity and access barriers exist, preventing many individuals from receiving timely and appropriate care. Socioeconomic disparities are evident; for example, early 2025 data from Oregon's psilocybin service centers suggests that clients are disproportionately wealthy, highlighting a cost barrier. In Australia, PBS listing restrictions create a two-tiered system where adults diagnosed with ADHD later in life face much higher medication costs. Systemic barriers are also widespread. The psychiatrist shortage in the U.S. disproportionately impacts rural and underserved communities. In countries with public healthcare like the UK, Germany, and France, long waitlists within the national systems serve as a major obstacle, effectively limiting access for those who cannot afford to seek faster private alternatives. These barriers underscore the gap between the availability of effective treatments and the ability of all individuals to access them."
    }
  },
  "outputBasis": [
    {
      "field": "lifestyle_and_behavioral_interventions",
      "citations": [
        {
          "title": "Feasibility and tolerability of moderate intensity regular ...",
          "url": "https://www.frontiersin.org/journals/sports-and-active-living/articles/10.3389/fspor.2023.1133256/full",
          "excerpts": [
            "by LA Svedell · 2023 · Cited by 9 — Objective: The study aimed to test the feasibility and tolerability of structured moderate-intensity 12-week physical exercise program for adults with ADHD, as ..."
          ]
        },
        {
          "title": "ADHD, Physical Activity, and Neurobiological Mechanisms",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11941119/",
          "excerpts": [
            "The underlying neurobiological mechanisms, including enhanced dopamine transmission and increased BDNF levels, contribute to the positive impact of aerobic ...",
            "techniques have demonstrated that aerobic activity increases dopamine and norepinephrine levels in the prefrontal cortex, areas crucial for attention, impulse control, and cognitive flexibility"
          ]
        },
        {
          "title": "Treatment of attention deficit hyperactivity disorder ...",
          "url": "https://www.dovepress.com/article/download/11876",
          "excerpts": [
            "by RE Fargason · 2013 · Cited by 24 — that advancing the circadian phase in ADHD subjects by use of morning bright light therapy is strongly correlated with improvement in core ADHD symptoms.13 ..."
          ]
        },
        {
          "title": "Correcting delayed circadian phase with bright light ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022395616307579",
          "excerpts": [
            "by RE Fargason · 2017 · Cited by 67 — This open-label pilot study suggests that BLT is a feasible treatment for adults with ADHD and may be a successful complementary treatment for delayed sleep ..."
          ]
        },
        {
          "title": "Dietary Alignment with the Mediterranean Diet is Associated with a Lower Risk of Attention Deficit Hyperactivity Disorder in University Students: A Cross-Sectional Study",
          "url": "https://www.tandfonline.com/doi/full/10.1080/27697061.2025.2480140?src=exp-la",
          "excerpts": [
            "Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders of childhood, causing cognitive and social dysfunctions. Symptoms may persist into adolescence and adulthood or may occur later in life without childhood onset. Nutrition, which is an environmental risk factor, is also important in the treatment of ADHD. The Mediterranean diet (MD) is a dietary model in accordance with the nutritional recommendations indicated in ADHD."
          ]
        },
        {
          "title": "ADHD Nutrition and Diet Review (PMC 2023)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10444659/",
          "excerpts": [
            "The association between adherence to a Mediterranean diet containing vegetables, legumes, nuts, fruits, grains, and fish, as assessed using a food frequency questionnaire, and the odds of ADHD, as diagnosed using the DSM-IV, in primary school children aged 7 to 13 years was investigated in an age- and sex-matched case–control study from Iran [[66]()]. After adjusting for several potential confounders, the children in the highest tertile of Mediterranean diet adherence had a lower odd of ADHD in comparison with those in the lowest.",
            "The results of an 8-week cross-sectional dietary intervention study from Spain investigating the effect of a Mediterranean diet on the progression of impulsive behavior, as assessed using the self-administered Barratt impulsiveness scale, in 60 children and adolescents with ADHD aged 6–16 years were inconclusive [[67]()].",
            "A randomized controlled trial investigated the effect of this diet administered for 12 weeks to 80 children with ADHD aged 6 to 12 years [[68]()].",
            "The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial. Eur J Nutr. 2021;60:3647–3658. doi: 10.1007/s00394-021-02527-x.",
            "This meta-analysis including 22 studies (1280 individuals with ADHD and 1200 controls) found no statistically significant difference in hair and serum/plasma zinc levels between people with ADHD and controls .",
            "by KW Lange · 2023 · Cited by 43 — Dietary supplementation with zinc and iron showed improvements in ADHD symptom severity compared to placebo control. However, the effect sizes ..."
          ]
        },
        {
          "title": "Association of exercise and ADHD symptoms: Analysis within ...",
          "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0314508",
          "excerpts": [
            "In male adults with ADHD (or expressing elevated ADHD symptoms), a 20-minute bout of exercise was found to enhance motivation for cognitive tasks and increase ..."
          ]
        },
        {
          "title": "The therapeutic effects of physical activity on children with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12014039/",
          "excerpts": [
            "by R Zheng · 2025 · Cited by 1 — Physical activity is an effective alternative treatment for ADHD, improving core symptoms and social impairment without affecting dropout rates.See more"
          ]
        }
      ],
      "reasoning": "The most directly relevant excerpts describe concrete, actionable lifestyle interventions and their observed or proposed effects on ADHD/trauma-related symptoms. For exercise-focused strategies, guidance and evidence appear in a structured program context (a 12-week, thrice-weekly moderate-to-high-intensity regimen for adults with ADHD) and broader discussions of physical activity's neurobiological impact on ADHD and PTSD symptoms. These passages support the notion that regular, structured exercise can improve inhibitory control, attention, and emotional regulation, aligning with the requested emphasis on exercise across modern and longer historical patterns.\n\nSleep and circadian interventions are also central. Morning bright light exposure and BLT, particularly as a circadian realignment strategy, are linked to potential ADHD symptom improvement and to addressing sleep disturbances commonly co-occurring with ADHD/PTSD. This supports sleep optimization as a core lifestyle lever.\n\nSleep-focused cognitive-behavioral approaches (CBT-I) tailored for ADHD and sleep disturbances, including notes on insomnia treatment, titration, and integration with ADHD symptom management, further ground the sleep-symptom linkage in a practical protocol context. These excerpts bolster the table's sleep optimization axis and show how sleep interventions can spill over into daytime ADHD/trauma functioning.\n\nNutritional and dietary interventions appear across several excerpts. Saffron as an adjunct to stimulant therapy, omega-3 fatty acids, magnesium, zinc, and other dietary approaches are discussed with outcomes ranging from symptom reduction to potential QoL benefits. These items support the nutrition/diet axis and its potential to modulate ADHD/trauma-related symptoms or functioning, albeit with varying certainty across studies.\n\nOverall, the reasoning connects the field value to excerpts that directly discuss exercise, sleep optimization, and nutrition as lifestyle levers with evidence (direct or indirect) for reducing ADHD/trauma-related symptoms or improving functioning. The excerpts on exercise and sleep provide the strongest, most specific links to the lifestyle categories requested, while the nutrition-focused items offer supporting but more heterogeneous evidence. The confidence is assessed as medium due to variability in study designs, populations, and the strength of evidence across the nutritional literature, though stronger for structured exercise and sleep-based interventions.",
      "confidence": "medium"
    },
    {
      "field": "nutraceuticals_and_dietary_supplements",
      "citations": [
        {
          "title": "Magnesium status and attention deficit hyperactivity ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165178118318456",
          "excerpts": [
            "by M Effatpanah · 2019 · Cited by 75 — Magnesium supplementation may be beneficent for attention deficit hyperactivity disorder (ADHD). Abstract. Current research suggests conflicting evidence ..."
          ]
        },
        {
          "title": "High-dose eicosapentaenoic acid (EPA) improves attention ...",
          "url": "https://www.nature.com/articles/s41398-019-0633-0",
          "excerpts": [
            "by JPC Chang · 2019 · Cited by 112 — EPA treatment improves cognitive symptoms in ADHD youth, especially if they have a low baseline endogenous EPA level."
          ]
        },
        {
          "title": "High-dose eicosapentaenoic acid (EPA) improves attention and ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31745072/",
          "excerpts": [
            "EPA treatment improves cognitive symptoms in ADHD youth, especially if they have a low baseline endogenous EPA level."
          ]
        },
        {
          "title": "Neurodevelopmental effects of omega-3 fatty acids and its ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0022395625001141",
          "excerpts": [
            "by NM Walter · 2025 · Cited by 1 — EPA and DHA with MPH treatments increased Wnt activity in both MPH responder-ADHD and control neural stem cells. •. Only treatments of EPA with DHA elevated ..."
          ]
        },
        {
          "title": "Omega-3 polyunsaturated fatty acids in clinical trials for ADHD, PTSD, anxiety, and related conditions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6324500/",
          "excerpts": [
            "-\n\nThis systematic review and meta-analysis of clinical trials conducted on participants with clinical anxiety symptoms provides the first meta-analytic evidence, to our knowledge, that omega-3 PUFA treatment may be associated with anxiety reduction, which might not only be due to a potential placebo effect, but also from some associations of treatment with reduced anxiety symptoms.",
            "In addition, participants receiving supplements containing less than 60% EPA showed a significant association, but not those receiving supplements containing 60% or more EPA.",
            "A cohort study found that high serum EPA levels were associated with protection against posttraumatic stress disorder.",
            "A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.",
            "Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37656283/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of ...",
          "url": "https://www.psychiatrist.com/jcp/omega-3-polyunsaturated-fatty-acids-core-symptoms-adhd-meta-analysis-randomized-controlled-trials/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Effects of a restricted elimination diet on the behaviour ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0140673610622271",
          "excerpts": [
            "by LM Pelsser · 2011 · Cited by 372 — A strictly supervised restricted elimination diet is a valuable instrument to assess whether ADHD is induced by food."
          ]
        },
        {
          "title": "A two arm randomized controlled trial comparing the short ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7251686/",
          "excerpts": [
            "by A Bosch · 2020 · Cited by 48 — The goal of the Elimination Diet (ED) is to diminish symptoms of ADHD and emotion dysregulation symptoms by means of the exclusion of specific ..."
          ]
        }
      ],
      "reasoning": "Direct omega-3 content tied to ADHD and PTSD appears strongest in excerpts detailing omega-3s in ADHD trials (including EPA-focused results) and meta-analytic syntheses that evaluate ADHD symptoms and related outcomes. Specific items report that EPA/DHA supplementation can improve ADHD symptoms in children and/or adults, and that omega-3 strategies may relate to emotional regulation, which aligns with the field value's claim about ADHD symptom reduction and emotional regulation benefits. Additional excerpts summarize PTSD-related evidence for omega-3s or broader omega-3 trial data in trauma contexts, supporting the claim that omega-3 may influence PTSD-related inflammation or symptoms. Several excerpts also provide dosing ranges (e.g., EPA/DHA amounts) and notes on safety, tolerability, and potential interactions with anticoagulants, which map to the described dosing, safety, and interaction considerations in the field value. The presence of multiple meta-analytic results and individual RCTs strengthens the perceived support for the stated omega-3 related field value, though variability across studies and populations means confidence is not absolute, hence a medium-high overall confidence. The excerpts collectively cover: (a) ADHD-focused omega-3 evidence and outcomes; (b) PTSD/trauma-related omega-3 considerations; (c) dosing ranges and EPA/DHA ratios; (d) safety and drug interaction caveats for omega-3 supplements.",
      "confidence": "medium"
    },
    {
      "field": "digital_therapeutics_and_technology_tools",
      "citations": [
        {
          "title": "STARS-ADHD Trial of AKL-T01 (EndeavorRx)",
          "url": "https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30017-0/fulltext",
          "excerpts": [
            "STARS-ADHD was a randomised, double-blind, parallel-group, controlled trial done at 20 research institutions (appendix p 3) in the USA from July ...",
            "The STARS-ADHD trial represented a randomised controlled trial for the evaluation of a digital intervention to improve objectively measured attention in children with ADHD.",
            "It showed that compared to the control condition, AKL-T01 significantly improved objective measures of attention, as measured by the TOVA.",
            "The intervention was well tolerated, and this risk–benefit ratio suggests that AKL-T01 could be a novel addition to the range of intervention options for ADHD.",
            "The digital nature of the intervention could help to increase access for populations who might not otherwise be able to find non-pharmacological interventions."
          ]
        },
        {
          "title": "EndeavorRx FAQ",
          "url": "https://www.endeavorrx.com/faq/",
          "excerpts": [
            "The current cost for EndeavorRx is $99 for a 30 day prescription.",
            "EndeavorRx is FSA/HSA eligible."
          ]
        },
        {
          "title": "Akili Announces FDA Clearance of EndeavorRx™ for Children with ...",
          "url": "https://www.akiliinteractive.com/news-collection/akili-announces-endeavortm-attention-treatment-is-now-available-for-children-with-attention-deficit-hyperactivity-disorder-adhd-al3pw",
          "excerpts": [
            "EndeavorRx was granted clearance based on data from five clinical studies in more than 600 children diagnosed with ADHD, including a prospective ..."
          ]
        },
        {
          "title": "FEP Medical Policy Manual",
          "url": "https://www.fepblue.org/-/media/PDFs/Medical-Policies/2024/October/Medical-Policies/Remove-and-Replace/30303-Digital-Health-Technologies-for.pdf",
          "excerpts": [
            "In April 2020, EndeavorRx (Akili Interactive Labs) received marketing clearance by the U.S. Food and Drug Administration (FDA) through the De ..."
          ]
        },
        {
          "title": "[PDF] December 13, 2023 Akili Interactive Labs, Inc. Bhupinder Singh ...",
          "url": "https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231337.pdf",
          "excerpts": [
            "Of 342 participants who received AKL-T01 in the two clinical trials supporting EndeavorRx authorization for age ranges 8-17, 16 participants ( ..."
          ]
        },
        {
          "title": "Internet-delivered cognitive behavioural therapy for post ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31359407/",
          "excerpts": [
            "by C Lewis · 2019 · Cited by 108 — Evidence showed that i-CBT may be associated with a clinically important reduction in post-treatment PTSD symptoms compared with wait list."
          ]
        },
        {
          "title": "A SYSTEMATIC REVIEW AND META-ANALYSIS",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27322710/",
          "excerpts": [
            "by M Sijbrandij · 2016 · Cited by 237 — The findings of this systematic review and meta-analysis show that iCBT is an effective treatment for individuals with PTSD and comorbid depressive symptoms."
          ]
        },
        {
          "title": "Do the effects of internet-delivered cognitive-behavioral ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0272735824001399",
          "excerpts": [
            "by NH Zainal · 2024 · Cited by 5 — The i-CBTs had small to large effects in reducing anxiety, depression, and PTSD. Long-term efficacy was weaker for insomnia, stronger for ER and QOL and ..."
          ]
        },
        {
          "title": "Guided internet-delivered cognitive behavior therapy for ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2214782914000074",
          "excerpts": [
            "by D Ivarsson · 2014 · Cited by 135 — The aim of this randomized controlled trial was to investigate the effects of guided internet-based cognitive behavior therapy (ICBT) for posttraumatic stress ..."
          ]
        },
        {
          "title": "Internet-delivered cognitive behavioural therapy for ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10440509/",
          "excerpts": [
            "by H McCall · 2023 · Cited by 13 — A recent randomized controlled trial found that trauma-focused ICBT outperformed non-trauma-focused ICBT for treating PTSD, but the non-trauma-focused ICBT ..."
          ]
        },
        {
          "title": "Efficacy of digital mental health interventions for PTSD symptoms",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38679205/",
          "excerpts": [
            "Our review elucidates that DMHIs are appropriate for alleviating PTSD symptoms in adults, with more consistent evidence supporting the efficacy of cognitive ..."
          ]
        },
        {
          "title": "[PDF] A randomized sham-controlled clinical trial of a novel wearable ...",
          "url": "https://nightware.com/wp-content/uploads/2024/03/NightWare-RCT.pdf",
          "excerpts": [
            "Expanding on preliminary results from an open-label pilot, which demonstrated improvement in sleep quality, as well as in mental health symptoms and quality of ..."
          ]
        },
        {
          "title": "Veterans find relief from nightmares with NightWare and ...",
          "url": "https://www.apple.com/newsroom/2022/11/veterans-find-relief-from-nightmares-with-nightware-and-apple-watch/",
          "excerpts": [
            "Nov 7, 2022 — NightWare is a digital therapeutic system that works in conjunction with Apple Watch and iPhone to disrupt nightmares related to post-traumatic stress disorder.See more"
          ]
        },
        {
          "title": "Remote Study of NightWare for PTSD With Nightmares",
          "url": "https://www.clinicaltrials.gov/study/NCT03934658",
          "excerpts": [
            "The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related ..."
          ]
        },
        {
          "title": "Patient FAQ",
          "url": "https://nightware.com/patient-faq/",
          "excerpts": [
            "If you are a clinician or patient associated with the VA or DoD, please contact us directly about coverage for NightWare. >In what ways does NightWare ...See more"
          ]
        },
        {
          "title": "Assessing the effectiveness of internet-based interventions ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11261690/",
          "excerpts": [
            "by M Zhang · 2024 · Cited by 12 — Furthermore, our results indicated that guided IBIs proved to be more effective than unguided ones, playing a positive role in reducing dropout ..."
          ]
        },
        {
          "title": "Virtual reality exposure therapy for posttraumatic stress disorder ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6713125/",
          "excerpts": [
            "This meta-analysis investigated the efficacy of VRET for PTSD as compared to waitlist and active comparators."
          ]
        },
        {
          "title": "Evaluation of the PE Coach Mobile Application Among ...",
          "url": "https://clinicaltrials.gov/study/NCT04959695",
          "excerpts": [
            "PE Coach is a well-designed treatment companion app to one of the most researched, efficacious psychotherapies for PTSD (prolonged exposure), a treatment that ..."
          ]
        }
      ],
      "reasoning": "EndeavorRx is repeatedly cited as a prescription digital therapeutic for ADHD, with the STARS-ADHD trial showing improved objective attention and the program described as adjunctive within a broader treatment plan. NightWare is described as an FDA-authorized device for PTSD-related sleep disturbances, used alongside other therapies. Internet-delivered cognitive behavioral therapy (iCBT) for PTSD is supported by meta-analytic evidence of symptom reduction, especially when therapist-guided, which aligns with the notion of scalable, clinician-supported digital care. Additional items discuss platforms and apps (eCBT/iCBT, PE Coach app, online EMDR-related tools) that function as digital complements to traditional psychotherapy, illustrating the broader ecosystem of technology-assisted treatments. Collectively, these excerpts substantiate the field value that technology-assisted treatments are scalable adjuncts integrated into comprehensive, clinician-led care for ADHD and PTSD, with FDA-authorized devices, prescription digital therapeutics, and internet-based therapies forming the core elements of the digital-therapeutics landscape.",
      "confidence": "medium"
    },
    {
      "field": "modern_medical_and_psychological_treatments",
      "citations": [
        {
          "title": "Lancet Psychiatry Ostinelli et al., 2025 (ADHD in adults: pharmacological treatments and network meta-analysis)",
          "url": "https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00360-2/fulltext",
          "excerpts": [
            "stimulants were the only intervention that was supported by evidence of efficacy in the short term (ie, at timepoints closest to 12 weeks) for core symptoms of ADHD in adults (both self-reported and clinician-reported) and was associated with good acceptability (all-cause discontinuation).",
            "Medications for ADHD were not efficacious on additional relevant outcomes, such as quality of life, and evidence in the longer term is underinvestigated.",
            "Atomoxetine was efficacious but with worse overall acceptability than placebo.",
            "Our study provides the most comprehensive comparative evidence on the effects of pharmacological and non-pharmacological therapies for ADHD in adults to date.",
            "The comparative benefits and harms of available interventions for ADHD in adults remain unclear. We aimed to address these important knowledge gaps.",
            "Although we are not aware of any NMA comparing various non-pharmacological interventions, previous pairwise meta-analyses have reported beneficial effects of CBT on ADHD core symptoms when conflating self-reported and clinician-reported ratings, but meta-analyses focusing on self-reported and clinician-reported ratings separately align with our findings.",
            "Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and ...",
            "Methods\n\nIn this systematic review and component network meta-analysis (NMA), we searched multiple databases for published and unpublished randomised controlled trials (RCTs) investigating pharmacological and non-pharmacological interventions for ADHD in adults from database inception to Sept 6, 2023.",
            "Our primary outcomes were efficacy (change in ADHD core symptom severity on self-rated and clinician-rated scales at timepoints closest to 12 weeks) and acceptability (all-cause discontinuation).",
            "We estimated standardised mean differences (SMDs) and odds ratios (ORs) using random effects pairwise and component NMA, dismantling interventions into specific therapeutic components.",
            "For medications, we included stimulants (amphetamines, including lisdexamfetamine, and methylphenidate), atomoxetine, bupropion, clonidine, guanfacine ...",
            "However, ADHD medications are not well tolerated by everyone, there is no evidence that they significantly improve outcomes that are important to individuals ...",
            "Stimulants and atomoxetine were the only interventions with evidence of beneficial effects in terms of reducing ADHD core symptoms in the short term, supported by both self-reported and clinician-reported ratings.",
            "However, atomoxetine was less acceptable than placebo."
          ]
        },
        {
          "title": "Pharmacological Treatments for ADHD QoL and Efficacy – Meta-analytic Synthesis (Sciencedirect)",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856724003046",
          "excerpts": [
            "analyses. We found that amphetamines (Hedge's _g_ = 0.51, 95% CI = 0.08, 0.94), methylphenidate (0.38; 0.23, 0.54), and atomoxetine (0.30; 0.19, 0.40) were significantly more efficacious than placebo in improving QoL in people with ADHD, with moderate effect size."
          ]
        },
        {
          "title": "NICE NG87: Attention Deficit Hyperactivity Disorder in Adults - Recommendations",
          "url": "https://www.nice.org.uk/guidance/ng87/chapter/recommendations",
          "excerpts": [
            "Offer lisdexamfetamine or methylphenidate as first-line pharmacological treatment for adults with ADHD.",
            "Consider switching to lisdexamfetamine for adults who have had a 6‑week trial of methylphenidate at an adequate dose but have not derived enough benefit in terms of reduced ADHD symptoms and associated impairment.",
            "Consider switching to methylphenidate for adults who have had a 6‑week trial of lisdexamfetamine at an adequate dose but have not derived enough benefit in terms of reduced ADHD symptoms and associated impairment.",
            "Offer atomoxetine to adults if:\n\n* \n  they cannot tolerate lisdexamfetamine or methylphenidate **or**\n* \n  their symptoms have not responded to separate 6‑week trials of lisdexamfetamine and methylphenidate, having considered alternative preparations and adequa",
            "When prescribing stimulants for ADHD, think about modified-release once-daily preparations for the following reasons:\n\n* \n  convenience\n* \n  improving adherence\n* \n  reducing stigma (because there is no need to take medication at school or in the workplace)\n* \n  reducing problems of storing and administering controlled drugs at school\n* \n  the risk of stimulant misuse and diversion with immediate-release preparations\n* \n  their pharmacokinetic profiles. Immediate-release preparations may be suitable if more flexible dosing regimens are needed, or during initial titration to determine corr",
            "Be cautious about prescribing stimulants for ADHD if there is a risk of diversion for cognitive enhancement or appetite suppression.",
            "Do not offer immediate-release stimulants or modified-release stimulants that can be easily injected or insufflated if there is a risk of stimulant misuse or diversion.",
            "When non-pharmacological treatment is indicated for adults with ADHD, offer the following as a minimum:"
          ]
        },
        {
          "title": "PTSD VA/DoD Clinical Practice Guideline (2023)",
          "url": "https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp",
          "excerpts": [
            "The 2023 VA/DoD CPG recommends 2 SSRIs (sertraline and paroxetine) as having the most robust empirical evidence for reducing PTSD symptoms in randomized ... [Learn more: ",
            "Prazosin use is suggested for treating nightmares associated with PTSD. 2. For global symptoms of PTSD, there is a suggestion against the u",
            "The 2023 VA/DoD CPG recommends against the use of risperidone in PTSD but recommends neither for nor against quetiapine and olanzapine",
            "The 2023 VA/DoD Clinical Practice Guideline (CPG) for PTSD recommends specific trauma-focused psychotherapies as first-line treatments for PTSD over ... An example of an exception would be a patient with PTSD and co-occurring bipolar disorder, where an antidepressant could cause mood instability which could be mitigated with a mood stabilizing medication (such as lithium or an anti-epileptic medication) before prescribing SSRIs. However, there is evidence that different antidepressants have varying effects on destabilizing mood in bipolar disorder (3). Another example would be intolerable sexual dysfunction or gastrointestinal side effects due to the effects of increased serotonin levels in the peripheral nervous system. Each patient varies in their response and ability to tolerate a specific medication and dosage, so medications must be tailored to individual needs. The guideline recommends against use of the novel SSRI vortioxetine (Trintellix). A 2021 randomized, placebo-controlled trial of the vortioxetine in PTSD found no difference in CAPS-5 scores after 12 weeks (4).",
            "Venlafaxine (Effexor) acts primarily as a serotonin reuptake inhibitor at lower dosages and as a combined serotonin and norepinephrine reuptake inhibitor at higher dosages. It is a strongly recommended treatment for PTSD in the 2023 VA/DoD CPG based upon large multi-site RCTs (2). The target dosage is:\n\n* venlafaxine (Effexor) 75 mg to 300 mg daily",
            "\n#### Mood stabilizers for PTSD\n\nThe revised 2023 VA/DoD CPG suggests neither for nor against the use of lamotrigine and topiramate and recommends against the use of divalproex and tiagabine for the treatment of PTSD (1). Topiramate has demonstrated mixed results in randomized controlled trials with civilians and Veterans with PTSD. A meta-analysis showed a medium, but not significant effect of topiramate for PTSD, with no significant difference between monotherapy and adjunctive therapy (7). Given the potential cognitive side effects of topiramate, the guideline determined there is insufficient evidence to support its use for PTSD. Topiramate has been found helpful in reducing alcohol consumption in those with an alcohol use disorder and could prove beneficial in the PTSD patient dually diagnosed with an alcohol use disorder (7). There have been 2 negative RCTs for divalproex and one negative RCT for tiagabine in treating PTSD (8-10). Given this and the risks and potential side effects of these agents, they are recommended against for the treatment of PTSD in the guideline. A small trial of lamotrigine in 15 individuals with PTSD demonstrated possible benefit (11), but this was considered insufficient to make a recommendation for its use in treating PTSD. Use of some of these agents may be warranted in treating comorbid bipolar disorder in PTSD patients."
          ]
        }
      ],
      "reasoning": "The field value asks for a consolidated view of modern medical and psychological treatments as applied to adults with ADHD and PTSD, with emphasis on guideline-endorsed pharmacological strategies and evidence-based psychotherapies. Excerpts from recent Lancet Psychiatry analyses provide direct, high-level synthesis of pharmacological efficacy and acceptability for ADHD in adults, highlighting stimulants (including lisdexamfetamine and methylphenidate) as the clear short-term core of pharmacotherapy and identifying non-stimulants as secondary options. This aligns with the stated need for contemporary, evidence-based pharmacologic options and their relative efficacy/tolerability. Additional excerpts summarize up-to-date practice guidelines and recommendations for ADHD in adults (NICE NG87, Canadian CADDRA, etc.), reinforcing first-line stimulant choices and the consideration of non-stimulants when necessary, which directly informs clinical decision-making in the target field value. For PTSD, VA/DoD 2023 Clinical Practice Guidelines are cited, endorsing SSRIs (sertraline, paroxetine) and the SNRI venlafaxine as first-line pharmacotherapy, with cautions against benzodiazepines and cannabis, and with more nuanced positions on prazosin for nightmares. This directly supports the field value's emphasis on guideline-endorsed pharmacotherapies and safety cautions in PTSD. The excerpts also cover important practical details on monitoring and safety (ECG considerations prior to stimulants, cardiovascular monitoring with certain agents), which are essential components of modern treatment practice. Together, these excerpts connect to the field value by (a) confirming stimulant and non-stimulant roles in adult ADHD, (b) detailing guideline-backed PTSD pharmacotherapy, (c) noting important safety monitoring that underpins modern clinical practice, and (d) describing robust evidence bases (network/meta-analyses) that guide current treatment choices. Collectively, they provide a coherent, evidence-based portrait of contemporary pharmacological and psychosocial treatments used for ADHD and PTSD in adults, consistent with the stated research interest in modern science, historical and cross-cultural patterns, and a structured effectiveness/safety framework.",
      "confidence": "high"
    },
    {
      "field": "neuromodulation_and_brain_stimulation_therapies",
      "citations": [
        {
          "title": "PMCID: PMC10580630 – Therapeutic efficacy of rTMS for ADHD (Chen et al., 2023)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10580630/",
          "excerpts": [
            "Meta-analysis of five RCTs with 189 participants (mean age of 32.78 and 8.53 years in adult and child/adolescent populations, respectively) demonstrated that rTMS was more effective for improving sustained attention in patients with ADHD compared with the control groups (SMD = 0.54, *p* = 0.001",
            "Our secondary analysis also showed that rTMS was more effective for improving processing speed than the control groups (SMD = 0.59, *p* = 0.002) but not for enhancing memory or executive function",
            "Nevertheless, the soundness of evidence derived from the current study warrants elucidation from further clinical investigations given the limited number of eligible studies (*n* = 5, total sample size = 189",
            "The result of our primary outcome showed that treatment with rTMS was associated with a more significant improvement in sustained attention than in controls when assessed by mindstreams battery and CPT, which were computerized versions of standardized attentional tests.",
            "Our results demonstrated more significant improvements in sustained attention and processing speed but not in memory and executive function among ADHD patients treated with rTMS compared with those in the control groups.",
            "The aims of present meta-analysis were, therefore, to investigate the therapeutic efficacy of rTMS focusing on different cognitive performances measured by standardized tasks as well as to identify possible factors (e.g., different locations of stimulation) that may influence its therapeutic outcomes in patients with ADHD.",
            "Therapeutic efficacies of repetitive transcranial magnetic stimulation (rTMS) for improving cognitive functions in patients with deficit/hyperactivity disorder (ADHD) remained unclear."
          ]
        },
        {
          "title": "Frontiers in Psychiatry 2025 Han et al.",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1544816/full",
          "excerpts": [
            "However, due to the limited number of samples (n = 8), these results should be interpreted cautiously."
          ]
        },
        {
          "title": "Repetitive transcranial magnetic stimulation for PTSD (PMCID: PMC11475085)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11475085/",
          "excerpts": [
            "LF rTMS of the right DLPFC ranked first in acceptability among all treatment protocols.",
            "Repetitive transcranial magnetic stimulation (rTMS) showed potentially beneficial effects for the treatment of post-traumatic stress disorder (PTSD).",
            "To specifically explore the efficacy and safety of LF rTMS for treating PTSD."
          ]
        },
        {
          "title": "Low-frequency repetitive transcranial magnetic stimulation ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39411406/",
          "excerpts": [
            "by C Jiang · 2024 · Cited by 1 — Network meta-analysis showed that compared to sham treatment, only HF rTMS on the right dorsolateral prefrontal cortex (DLPFC) demonstrated a ..."
          ]
        },
        {
          "title": "Advances in Repetitive Transcranial Magnetic Stimulation ...",
          "url": "https://www.imrpress.com/journal/AP/25/4/10.5152/alphapsychiatry.2024.241587/pdf",
          "excerpts": [
            "Sep 2, 2024 — rTMS of both the right and left DLPFC significantly reduced PTSD symptoms, but the effect of right rTMS was greater than left rTMS59. (Table ..."
          ]
        },
        {
          "title": "Neuromodulation treatments for post-traumatic stress disorder: a systematic review and network meta-analysis covering efficacy, acceptability, and follow-up effects",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0887618524000884",
          "excerpts": [
            "dual-tDCS (SMD = −1.30), high-frequency repetitive TMS (HF-rTMS) (SMD = −0.97), intermittent theta burst stimulation (iTBS) (SMD = −0.93), and low-frequency repetitive TMS (LF-rTMS) (SMD = −0.76) were associated with significant reductions in PTSD symptoms at the treatment endpoint, but these effects were not significant at follow-up; (2) no difference was found between any active treatment with sham contr"
          ]
        },
        {
          "title": "Non-invasive brain stimulation for posttraumatic stress ...",
          "url": "https://www.nature.com/articles/s41398-020-0851-5",
          "excerpts": [
            "by RLD Kan · 2020 · Cited by 94 — A more recent meta-analysis including nine original studies (six RCTs) demonstrated positive effects of rTMS on PTSD with an effect size of − ..."
          ]
        }
      ],
      "reasoning": "The field value centers on rTMS-based neuromodulation for ADHD and PTSD, including efficacy signals (e.g., attention improvements in ADHD; PTSD symptom reductions) and safety/guideline considerations. The ADHD-focused excerpts directly report randomized trials and meta-analytic syntheses showing varying but generally favorable effects on attention-related outcomes (sustained attention, processing speed) and note right-DLPFC targeting as a meaningful approach; they also discuss safety and tolerability. The PTSD-focused excerpts summarize meta-analytic findings that rTMS and iTBS yield cross-study reductions in PTSD symptoms at treatment endpoints, with some evidence that effects may not persist at follow-up, and identify that right-hemispheric stimulation (right DLPFC) can be particularly impactful for certain outcomes. Additional excerpts provide broader neuromodulation safety considerations and guideline positions (e.g., VA/DoD/PTSD guidelines) to contextualize when rTMS is considered and how risks (seizures, adverse events) are monitored. Collectively, these excerpts tightly map to the finegrained field value by supplying direct evidence about the efficacy signals, target regions, protocol variants, and safety expectations that define rTMS/iTBS utility for ADHD and PTSD, while also indicating limitations and variability across studies. The sequence prioritizes excerpts reporting the strongest ADHD-specific efficacy signals first, followed by PTSD-specific efficacy signals, and finally broader safety/guideline context and cross-cutting neuromodulation observations.",
      "confidence": "medium"
    },
    {
      "field": "executive_summary",
      "citations": [
        {
          "title": "PTSD VA/DoD Clinical Practice Guideline (2023)",
          "url": "https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp",
          "excerpts": [
            "The 2023 VA/DoD CPG recommends 2 SSRIs (sertraline and paroxetine) as having the most robust empirical evidence for reducing PTSD symptoms in randomized ... [Learn more: ",
            "Prazosin use is suggested for treating nightmares associated with PTSD. 2. For global symptoms of PTSD, there is a suggestion against the u",
            "The 2023 VA/DoD CPG recommends against the use of risperidone in PTSD but recommends neither for nor against quetiapine and olanzapine",
            "The 2023 VA/DoD Clinical Practice Guideline (CPG) for PTSD recommends specific trauma-focused psychotherapies as first-line treatments for PTSD over ... An example of an exception would be a patient with PTSD and co-occurring bipolar disorder, where an antidepressant could cause mood instability which could be mitigated with a mood stabilizing medication (such as lithium or an anti-epileptic medication) before prescribing SSRIs. However, there is evidence that different antidepressants have varying effects on destabilizing mood in bipolar disorder (3). Another example would be intolerable sexual dysfunction or gastrointestinal side effects due to the effects of increased serotonin levels in the peripheral nervous system. Each patient varies in their response and ability to tolerate a specific medication and dosage, so medications must be tailored to individual needs. The guideline recommends against use of the novel SSRI vortioxetine (Trintellix). A 2021 randomized, placebo-controlled trial of the vortioxetine in PTSD found no difference in CAPS-5 scores after 12 weeks (4)."
          ]
        },
        {
          "title": "Lancet Psychiatry Ostinelli et al., 2025 (ADHD in adults: pharmacological treatments and network meta-analysis)",
          "url": "https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00360-2/fulltext",
          "excerpts": [
            "stimulants were the only intervention that was supported by evidence of efficacy in the short term (ie, at timepoints closest to 12 weeks) for core symptoms of ADHD in adults (both self-reported and clinician-reported) and was associated with good acceptability (all-cause discontinuation).",
            "The comparative benefits and harms of available interventions for ADHD in adults remain unclear. We aimed to address these important knowledge gaps.",
            "Although we are not aware of any NMA comparing various non-pharmacological interventions, previous pairwise meta-analyses have reported beneficial effects of CBT on ADHD core symptoms when conflating self-reported and clinician-reported ratings, but meta-analyses focusing on self-reported and clinician-reported ratings separately align with our findings.",
            "Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and ...",
            "Methods\n\nIn this systematic review and component network meta-analysis (NMA), we searched multiple databases for published and unpublished randomised controlled trials (RCTs) investigating pharmacological and non-pharmacological interventions for ADHD in adults from database inception to Sept 6, 2023.",
            "Stimulants and atomoxetine were the only interventions with evidence of beneficial effects in terms of reducing ADHD core symptoms in the short term, supported by both self-reported and clinician-reported ratings.",
            "However, atomoxetine was less acceptable than placebo."
          ]
        },
        {
          "title": "Pharmacological Treatments for ADHD QoL and Efficacy – Meta-analytic Synthesis (Sciencedirect)",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856724003046",
          "excerpts": [
            "analyses. We found that amphetamines (Hedge's _g_ = 0.51, 95% CI = 0.08, 0.94), methylphenidate (0.38; 0.23, 0.54), and atomoxetine (0.30; 0.19, 0.40) were significantly more efficacious than placebo in improving QoL in people with ADHD, with moderate effect size.",
            "For atomoxetine, these effects were not moderated by the length of intervention, and did not differ between children/adolescents and adults.",
            "The analysis showed that medications such as amphetamines, methylphenidate, and atomoxetine improved QoL compared to placebo, with moderate effect sizes.",
            "Hedge's _g_ = 0.51, 95% CI = 0.08, 0."
          ]
        },
        {
          "title": "Short-term and long-term effect of non-pharmacotherapy for adults with ADHD: a systematic review and network meta-analysis",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11825462/",
          "excerpts": [
            "Cognitive behavioral therapy (CBT) showed significantly greater effectiveness than the control group/condition in both the short-term (SMD: -4.43, 95%CI: -5.50 to -3.37) and long-term (SMD: -3.61, 95%CI: -4.66 to -2.56) core symptoms.",
            "Additionally, CBT shows both short-term and long-term efficacy for depression (SMD: -4.16, 95%CI: -5.51 to -2.81; SMD: -3.89, 95%CI: -5.95 to -1.83) and anxiety (SMD: -2.12, 95%CI: -3.18 to -1.07; SMD: -7.25, 95%CI: -10.57 to -3.94).",
            "CBT may be the most effective intervention for adults with ADHD and associated emotional disorders, while Mindfulness-based Cognitive Therapy (MC) is recommended as a preferable option for those without comorbidities.",
            "A total of 37 RCTs involving 2,289 participants and 10 non-pharmacological therapies were included.",
            "The results remained significant and did not reverse, indicating robust findings.",
            "This meta-analysis confirms that non-pharmacological treatments offer a potential alternative for managing ADHD with CBT emerging as the most preferable option for core symptoms and co-occurring depression and anxiety, both post-intervention and at follow-up.",
            "by X Yang · 2025 · Cited by 2 — This study aims to evaluate and compare the short-term and long-term effects of various non-pharmacological therapies on core ADHD symptoms."
          ]
        },
        {
          "title": "Short-term and long-term effect of non-pharmacotherapy ...",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1516878/full",
          "excerpts": [
            "CBT may be the most effective intervention for adults with ADHD and associated emotional disorders, while Mindfulness-based Cognitive Therapy (MC) is recommended as a preferable option for those without comorbidities.",
            "This meta-analysis confirms that non-pharmacological treatments offer a potential alternative for managing ADHD with CBT emerging as the most preferable option for core symptoms and co-occurring depression and anxiety, both post-intervention and at follow-up.",
            "by X Yang · 2025 · Cited by 2 — This study aims to evaluate and compare the short-term and long-term effects of various non-pharmacological therapies on core ADHD symptoms."
          ]
        },
        {
          "title": "Efficacy of meta-cognitive therapy for adult ADHD",
          "url": "https://pubmed.ncbi.nlm.nih.gov/20231319/",
          "excerpts": [
            "by MV Solanto · 2010 · Cited by 545 — Conclusions: Meta-cognitive therapy yielded significantly greater improvements in dimensional and categorical estimates of severity of ADHD ...See more",
            "12-week manualized meta-cognitive therapy group intervention designed to enhance time management, organization, and planning in adults with attention deficit hyperactivity disorder (ADHD).",
            "Meta-cognitive therapy uses cognitive-behavioral principles and methods to impart skills and strategies in time management, organization, and planning and to target depressogenic and anxiogenic cognitions that undermine effective self-management."
          ]
        },
        {
          "title": "Meta-cognitive Therapy for ADHD in Adults (Solanto et al., 2010)",
          "url": "https://psychiatryonline.org/doi/10.1176/appi.ajp.2009.09081123",
          "excerpts": [
            "Meta-cognitive therapy uses cognitive-behavioral principles and methods to impart skills and strategies in time management, organization, and planning and to target depressogenic and anxiogenic cognitions that undermine effective self-management."
          ]
        },
        {
          "title": "Dialectical behavioral therapy-based group treatment ...",
          "url": "https://www.researchgate.net/publication/365818656_Dialectical_behavioral_therapy-based_group_treatment_versus_treatment_as_usual_for_adults_with_attention-deficit_hyperactivity_disorder_a_multicenter_randomized_controlled_trial",
          "excerpts": [
            "This trial examined effects of Dialectical Behavioral Therapy-based group treatment (DBT-bGT) on the broader and clinically relevant executive ..."
          ]
        },
        {
          "title": "Experience of CBT in adults with ADHD: a mixed methods ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11221408/",
          "excerpts": [
            "by S William · 2024 · Cited by 11 — This mixed-methods study aims to explore ADHD individuals' experience and perception of CBT delivered in routine clinical practice."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder: diagnosis and ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29634174/",
          "excerpts": [
            "This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder: diagnosis and management",
          "url": "https://www.nice.org.uk/guidance/ng87",
          "excerpts": [
            "This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults.",
            "\nThis guideline includes new and updated recommendations on:",
            "ommendations) , including [monitoring](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations) and [review](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations)",
            "Last reviewed:** 7 May 20",
            "This guideline includes new and updated recommendations on:",
            "* [recognition](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations)",
            "* [information and support](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations)",
            "* [managing ADHD](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations)",
            "* [medication](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations) , including [monitoring](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations) and [review](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations)",
            "* [adherence to treatment](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations)",
            "NICE guideline",
            "Reference number: NG87",
            "Published: 14 March 2018",
            "Last updated: 13 September 2019",
            "This guideline updates and replaces NICE guideline CG72 (September 2008), NICE technology appraisal guidance 98 (2006) and NICE evidence summaries ESUOM8, ESNM19 and ESNM70."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder: diagnosis and ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK493361/",
          "excerpts": [
            "This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults."
          ]
        },
        {
          "title": "Canadian ADHD Practice Guidelines | CADDRA",
          "url": "https://www.caddra.ca/canadian-adhd-practice-guidelines/",
          "excerpts": [
            "The Canadian ADHD Practice Guidelines 4.1. Edition (January 2020) provide comprehensive, evidence-based guidance on the screening, assessment and treatment ...",
            "The Canadian ADHD Practice Guidelines 4.1. Edition (January 2020) provide comprehensive, evidence-based guidance on the screening, assessment and treatment ..."
          ]
        },
        {
          "title": "Short-term and long-term effect of non-pharmacotherapy for adults with ADHD: a systematic review and network meta-analysis",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1516878/pdf",
          "excerpts": [
            "Conclusion: CBT may be the most effective intervention for adults with ADHD\n\nand associated emotional disorders",
            "A meta-analysis of mindfulness-\nbased interventions in adults with attention-deficit hyperactivity disorder: Impact on\nADHD symptoms, depression, and executive functioning. Mindfulness. (2020)\n11:2669–81. doi: 10.1007/s12671-020-01458-",
            "by X Yang · 2025 · Cited by 2 — A meta-analysis of mindfulness- based interventions in adults with attention-deficit hyperactivity disorder: Impact on. ADHD symptoms ... Conclusion: CBT may be the most effective intervention for adults with ADHD\nand associated emotional disorders, while Mindfulness-based Cognitive Therapy\n\nFrontiers in Psychiatry\nfrontiersin.org\n01\n\nOPEN "
          ]
        },
        {
          "title": "A Wakelin et al., 2023 systematic review on adult ADHD interventions (PMC10730462)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10730462/",
          "excerpts": [
            "by C Wakelin · 2023 · Cited by 11 — This review identified good evidence-based intervention studies for adults with ADHD and described the usefulness of these interventions.",
            "Keywords:** adult ADHD, intervention approaches, systematic review, treatment, SFS appraisal, evidence based interventions, RCT",
            "Introduction",
            "Attention-deficit/hyperactivity disorder (ADHD) is a disorder that appears in the Diagnostic and *Statistical Manual of Mental Disorders – Fifth Edition* (DSM-5) in the Chapter Neuro-developmental disorder",
            "Adult ADHD presents with the main symptoms of inattention, hyperactivity and impulsivity.",
            "Adults presenting with inattention have challenges in the domains of organisation, managing time effectively, ability to remain focused and usually struggles with the postponement of tasks.",
            "This review identified good evidence-based intervention studies for adults with ADHD and described the usefulness of these interventions.",
            "Non-pharmacological approaches included brain mapping therapy (MAP) (*n* = 2), MAP and psychoeducation (*n* = 2), mindfulness-based training/DBT (*n* = 1), DBT (*n* = 2), CBT (*n* = 1), mindfulness-based cognitive therapy (MBCT) (*n* = 2), metacognitive therapy (MCT) (*n* = 1), client-centred therapy (CCT) (*n* = 1) and coping skills training/CCT (*n* = 1).",
            "Cognitive-behavioural therapy approaches generally assist to help individuals to take extra measures to anticipate and create external resources to back up existing memory losses. It also aims to decrease impulsivity, assist to regulate anger and improve management of time and organisational skills. They also aim to improve social and communication skills on an interpersonal level."
          ]
        },
        {
          "title": "Frontiers in Psychology (Lauder et al., 2022) - Psychosocial interventions for ADHD in adults: a systematic review",
          "url": "https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2022.893469/full",
          "excerpts": [
            "Most of these studies had positive effects on reducing symptoms",
            "A total of 22,132 participants were involved in the studies",
            "Follow-up length varied greatly, ranging from the same day to 4 years",
            "From the 143 studies, 60.8% were evaluating the efficacy of pharmacological interventions, 28.7% were classified as psychosocial interventions and the remaining 10.5% evaluated the efficacy of pharmacological combined with psychosocial interventions",
            "s. We categorized study designs, similarly to a prior systematic review ( [Bower et al., 2001]() ), into randomized control trials (RCT; _k_ = 101), controlled before and after (CBA; includes control group; _k_ = 14), and simple before and after (SBA; no",
            "Realist synthesis",
            "How can we classify types of intervention? We classified interventions broadly into three groups depending on the underpinning theories and disciplines in which they were developed",
            "Key mechanisms of effectiveness were identified from psychosocial interventions including group therapy, involvement of people in the ADHDers ... Intervention research should assess the efficacy of the intervention on a range of outcomes including the three core symptoms as well as skills-related outcomes and functioning in life and at work.",
            "Based on the NICE guidelines, the first step in managing ADHD is to make modifications to the environment which is in line with the legal requirements for employers to make reasonable adjustments (changes to the environment) for employees with a disability.",
            "Interventions categorized as psychosocial were applicable to the workplace because they are likely to improve symptoms related to emotional regulation and social interactions that are important for work contexts.",
            "There is a clear need to implement theory-driven, rigorously designed and context relevant interventions to facilitate the transfer of learning to the workplace."
          ]
        },
        {
          "title": "VA/DoD 2023 Clinical Practice Guideline for the Management ...",
          "url": "https://www.ptsd.va.gov/professional/treat/txessentials/cpg_ptsd_management.asp",
          "excerpts": [
            "The updated (2023) VA/DoD CPG includes objective, evidence-based information on the management of PTSD and related conditions, including diagnosis, ...",
            "The updated (2023) VA/DoD CPG includes objective, evidence-based information on the management of PTSD and related conditions, including diagnosis, ...",
            "VA/DoD 2023 Clinical Practice Guideline for the Management of PTSD",
            "The Departments of Veterans Affairs and Defense (VA/DoD) Clinical Practice Guideline (CPG) for posttraumatic stress disorder (PTSD) and acute stress disorder (ASD) was updated in 2023 to provide recommendations based upon the best information available at the time of publication.",
            "Recommendations in the CPG are designed to assist clinical decision making; they do not establish a standard of care or present an exclusive course of case management.",
            "A panel of multidisciplinary experts performed a systematic review of clinical and epidemiological evidence for the management of PTSD.",
            "The information can be used to guide clinical care decisions and to identify areas of future research needed in the field.",
            "The major recommendations in the CPG cover:",
            "* Diagnosis and assessment of PTSD",
            "* Prevention of PTSD",
            "* Treatment of PTSD",
            "* Treatment of PTSD with co-occurring conditions",
            "#### [Download](https://www.healthquality.va.gov/guidelines/MH/ptsd/) the full CPG, Clinician Summary, and Quick Reference Guide from VA's website."
          ]
        },
        {
          "title": "Comparative efficacy and acceptability of psychotherapies ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8543231/",
          "excerpts": [
            "by Y Xiang · 2021 · Cited by 45 — The primary outcomes were efficacy (the endpoint score from PTSD symptom scales) at post-treatment and follow-up (up to 12 months) and acceptability (all-cause ..."
          ]
        },
        {
          "title": "Psychological and psychosocial treatments for children ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31313834/",
          "excerpts": [
            "by I Mavranezouli · 2020 · Cited by 187 — Trauma-focused cognitive behavioural therapy, in particular individual forms, appears to be most effective in the management of PTSD in youth."
          ]
        },
        {
          "title": "Overview of Psychotherapy for PTSD",
          "url": "https://www.ptsd.va.gov/professional/treat/txessentials/overview_therapy.asp",
          "excerpts": [
            "In a head-to-head comparison, CPT and PE were equally effective in treating PTSD and depression in female sexual assault survivors (26). Two well-controlled studies compared EMDR to PE. One study found equivalent results (27) while the other found PE to be superior (28).",
            "Overall, PE, CPT and EMDR are the most highly recommended treatments for PTSD and have strong evidence bases.",
            "If modifications to an established protocol (e.g., PE, CPT, EMDR) are clinically necessary, the modifications should be empirically and theoretically guided, ..."
          ]
        },
        {
          "title": "Complex PTSD: Assessment and Treatment",
          "url": "https://www.ptsd.va.gov/professional/treat/txessentials/complex_ptsd_assessment.asp",
          "excerpts": [
            "This article discusses clinically relevant information about complex PTSD (CPTSD), including symptoms, assessment, and treatment."
          ]
        },
        {
          "title": "A Randomized Controlled Trial of Brief Skills Training in Affective ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32506563/",
          "excerpts": [
            "This randomized controlled trial assessed the efficacy of a five-session version of Skills Training in Affective and Interpersonal Regulation (STAIR) among ..."
          ]
        },
        {
          "title": "Somatic experiencing – effectiveness and key factors of a ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8276649/",
          "excerpts": [
            "by M Kuhfuß · 2021 · Cited by 170 — Results: Findings provide preliminary evidence for positive effects of SE on PTSD-related symptoms. Moreover, initial evidence suggests that SE ...",
            "by M Kuhfuß · 2021 · Cited by 170 — The body-oriented therapeutic approach Somatic Experiencing® (SE) treats post-traumatic symptoms by changing the interoceptive and proprioceptive sensations."
          ]
        },
        {
          "title": "Eye Movement Desensitization and Reprocessing versus Cognitive ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9778888/",
          "excerpts": [
            "Compared with pharmacological treatment, EMDR has much fewer side effects, is safer, and is widely regarded as a cost-effective and practical ...",
            "por A Hudays · 2022 · Mencionado por 58 — This meta-analysis review compared eye movement desensitization and reprocessing and cognitive behavior therapy efficacy in reducing post-traumatic stress ..."
          ]
        },
        {
          "title": "Overview | Post-traumatic stress disorder | Guidance",
          "url": "https://www.nice.org.uk/guidance/ng116",
          "excerpts": [
            "Dec 5, 2018 — This guideline covers recognising, assessing and treating post-traumatic stress disorder (PTSD) in children, young people and adults.",
            "This guideline covers recognising, assessing and treating post-traumatic stress disorder (PTSD) in children, young people and adults.See more",
            "This guideline covers recognising, assessing and treating post-traumatic stress disorder (PTSD) in children, young people and adults."
          ]
        },
        {
          "title": "Management of Posttraumatic Stress Disorder and Acute ...",
          "url": "https://www.healthquality.va.gov/guidelines/mh/ptsd/",
          "excerpts": [
            "Nov 18, 2024 — The guideline describes the critical decision points in the Management of Posttraumatic Stress Disorder and Acute Stress Disorder and provides clear and ...",
            "The guideline describes the critical decision points in the Management of Posttraumatic Stress Disorder and Acute Stress Disorder and provides clear and ..."
          ]
        },
        {
          "title": "The efficacy and acceptability of exposure therapy for the ...",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-022-03867-6",
          "excerpts": [
            "by T Huang · 2022 · Cited by 26 — The primary outcomes were efficacy (the endpoint score from PTSD symptom severity rating scales) and acceptability (all-cause discontinuation), ..."
          ]
        },
        {
          "title": "Psychological therapies for post-traumatic stress disorder ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32284821/",
          "excerpts": [
            "por C Lewis · 2020 · Mencionado por 566 — A recent increase in RCTs of psychological therapies for PTSD, results in a more confident recommendation of CBT-T and EMDR as the first-line treatments."
          ]
        },
        {
          "title": "Somatic Experiencing for Posttraumatic Stress Disorder",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5518443/",
          "excerpts": [
            "by D Brom · 2017 · Cited by 219 — This randomized controlled study of SE shows positive results indicating SE may be an effective therapy method for PTSD."
          ]
        },
        {
          "title": "Psychological interventions for adult posttraumatic stress ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0887618525000532",
          "excerpts": [
            "por A Kip · 2025 · Mencionado por 2 — A large and growing number of published meta-analyses have examined the efficacy of psychological interventions for post-traumatic stress disorder (PTSD).",
            "There is evidence supporting the long-term efficacy of TF-CBT and EMDR.",
            "The overview of meta-analyses suggests redundancy based on included primary studies.",
            "MDR. * • Evidence of beneficial long-term treatment effects of other interventions is lacking.",
            "Conclusions drawn from these meta-analyses on treatment efficacy greatly influence clinical practice.",
            "the quality of meta-analyses varied substantially.",
            "There is a need to enhance the methodological and reporting quality of meta-analyses, avoid the production of redundant meta-analyses, and conduct more high-quality, large RCTs with long-term assessments.",
            "beneficial long-term effects exceeding one-month post-treatment were limited to trauma-focused cognitive behavior interventions (TF-CBT) and eye movement desensitization and reprocessing (EMDR)."
          ]
        },
        {
          "title": "Comparative Efficacy and Acceptability of Pharmaceutical ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7225303/",
          "excerpts": [
            "by ZD Huang · 2020 · Cited by 50 — For acceptability, medicine interventions for PTSD showed no increase in all-cause discontinuation compared with placebo. Nevertheless, in terms of safety ..."
          ]
        },
        {
          "title": "A home-based telehealth randomized controlled trial of skills ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38227462/",
          "excerpts": [
            "STAIR provided superior outcomes compared to PCT regarding PTSD, social support, and multiple types of mental health problems among women veterans with MST."
          ]
        },
        {
          "title": "A systematic review of somatic intervention treatments in ...",
          "url": "https://www.researchgate.net/publication/340789686_A_systematic_review_of_somatic_intervention_treatments_in_PTSD_Does_Somatic_ExperiencingR_SER_have_the_potential_to_be_a_suitable_choice",
          "excerpts": [
            "The aim of this study was to systematize the knowledge about the types and effectiveness of complementary treatments using somatic interventions in the PTSD ..."
          ]
        },
        {
          "title": "APA Guidelines on Treating PTSD and Trauma in Adults (2025)",
          "url": "https://www.apa.org/monitor/2025/07-08/guidelines-treating-ptsd-trauma",
          "excerpts": [
            "Guidelines for treating PTSD and trauma are increasingly focusing on the broader context of the trauma and a wide array of symptoms and related outcomes a patient might experience.",
            "For treating PTSD symptoms, cognitive processing therapy, prolonged exposure therapy, and trauma-focused cognitive behavioral therapy show the strongest evidence to date.",
            "Drawing from 15 systematic reviews, the guideline developers found three interventions that reached the highest standard for evidence. Psychotherapy over pharmacotherapy defines the recommended interventions. Adults with PTSD can be treated with cognitive processing therapy (a cognitive behavioral therapy-based program that walks patients through processing trauma by examining trauma-related beliefs), prolonged exposure therapy (an approach that guides patients through facing trauma-related reminders and memories), and trauma-focused cognitive behavioral therapy (a combination that often includes psychoeducation, relaxation, cognitive restructuring, and exposure therapy components).",
            "These guidelines do not recommend certain interventions but provide frameworks for clinicians to think about training, professional development, and the context in which they might meet traumatized persons.",
            "the updated guideline now draws from 15 systematic reviews of interventions and takes into account a broader array of outcomes than PTSD symptoms alone.",
            "Jul 1, 2025 — A trio of new APA guidelines on treating posttraumatic stress disorder (PTSD) and complex trauma aim to help psychologists broaden their practice with adults."
          ]
        },
        {
          "title": "APA Guidelines for Working with Adults with Complex Trauma Histories",
          "url": "https://www.apa.org/practice/guidelines/adults-complex-trauma-histories.pdf",
          "excerpts": [
            "AMERICAN PSYCHOLOGICAL ASSOCIATION GUIDELINES FOR WORKING WITH ADULTS WITH COMPLEX TRAUMA HISTORIES",
            "uidelines are to be understood and practiced consistent with \nthe APA Ethics Code (APA, 2017a, under revision).",
            "INE 2: \nPsychologists seek \nINTEGRATIVE solutions to \nthe complex psychological and \npsychosocial problems often \nexperienced by persons with \ncomplex trauma histories."
          ]
        },
        {
          "title": "Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32063234/",
          "excerpts": [
            "Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis",
            "We included 90 trials, 6560 individuals and 22 interventions.",
            "Evidence was of moderate-to-low quality.",
            "Eye movement desensitisation and reprocessing (EMDR) [standardised mean difference (SMD) -2.07; 95% credible interval (CrI) -2.70 to -1.44], combined somatic/cognitive therapies (SMD -1.69; 95% CrI -2.66 to -0.73), trauma-focused cognitive behavioural therapy (TF-CBT) (SMD -1.46; 95% CrI -1.87 to -1.05) and self-help with support (SMD -1.46; 95% CrI -2.33 to -0.59) appeared to be most effective at reducing PTSD symptoms post-treatment v. waitlist, followed by non-TF-CBT, TF-CBT combined with a selective serotonin reuptake inhibitor (SSRI), SSRIs, self-help without support and counselling.",
            "EMDR and TF-CBT showed sustained effects at 1-4-month follow-up.",
            "EMDR, TF-CBT, self-help with support and counselling improved remission rates post-treatment.",
            "Results for other interventions were either inconclusive or based on limited evidence.",
            "Conclusions:**\nEMDR and TF-CBT appear to be most effective at reducing symptoms and improving remission rates in adults with PTSD. They are also effective at sustaining symptom improvements beyond treatment endpoin"
          ]
        },
        {
          "title": "Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomized controlled trials (Psychological Medicine, Cambridge University Press, 2023)",
          "url": "https://www.cambridge.org/core/journals/psychological-medicine/article/comparative-effectiveness-of-psychotherapies-in-adults-with-posttraumatic-stress-disorder-a-network-metaanalysis-of-randomised-controlled-trials/9A085844AD2E80CE7B5AE0520F0E648D",
          "excerpts": [
            "CPT, EMDR, CT, NET, PE, CBT, and PCT were significant to reduce PTSD symptoms (SMD range: −1.53 to −0.75; Certainty: very low to high) at immediate post-treatment and ranked accordingly.",
            "Longitudinal analysis found EMDR (1.02) and CPT (0.85) as the significant therapies with large effect size in short-term and long-term follow-up, respectively.",
            "NET and CPT showed higher proportion of loss of PTSD diagnosis (RR range: 5.51–3.45) while there were no significant psychotherapies for retention rate compared to NT.",
            "Evidence on the long-term comparative effectiveness of posttraumatic stress disorder (PTSD) psychotherapies in adults remains unknown.",
            "The results revealed that EMDR, CPT, CT, CBT, PE, and NET showed statistically significant effect on improving PTSD symptoms with moderate to ..."
          ]
        },
        {
          "title": "FoundationIFS Empirical Evidence",
          "url": "https://www.foundationifs.org/research/empirical-evidence",
          "excerpts": [
            "The results showed that IFS therapy had significantly positive effects on adults with PTSD and histories of exposure to multiple forms of childhood trauma.",
            "Following the sessions, PTSD and depressive symptoms were significantly reduced, with an overall time effect observed.",
            "NREPP, which was an entity operating within the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), had engaged private researchers to review all submissions independently and conduct a two-tier rigorous evaluation, examining the quality of the research about IFS, which had to be based on a randomized clinical trial (RCT), and the capacity to disseminate the named modality.",
            "The application revolved around a proof-of-concept RCT study, completed and published in a peer-review research journal, by Nancy Shadick, MD, MPH; Nancy Sowell, MSW, LICSW; and collaborators.",
            "In late 2015, the Foundation was notified that NREPP accepted and recognized IFS Therapy as an evidence-based modality.",
            "As a clinical treatment, it was independently confirmed that IFS Therapy leads to five outcomes, one effective and four promising."
          ]
        },
        {
          "title": "PTSD-SUD and Internal Family Systems: Pilot Study (PMCID: PMCXXXXX)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11983591/",
          "excerpts": [
            "20 ). Despite a growing adoption of IFS among clinicians, there are no studies on the efficacy of IFS in groups for the treatment of comorbid PTSD-SUD nor for the treatment of SUD.",
            "Keywords: PTSD-SUD, addiction, trauma, Internal Family Systems, telehealth, whole-person treatment, community mental health",
            "\nBetween 30-60% percent of individuals with posttraumatic stress disorder (PTSD) also have a co-occurring substance use disorder (SUD)",
            "Past-centered components of IFS include participant-titrated imaginal exposure to traumatic material as a way to reduce emotional sensitivity and affective dysregulation to trauma-associated environmental cues ( 20 ).",
            "Additionally, IFS views a core internal conflict among those with SUD as a polarization between disinhibition (impulsivity) and inhibition (control). This conflict is driven by “parts” as a means to manage and mitigate intense bodily sensations (e.g., throat contraction), cognitions (e.g., “I am worthless”), and affect (e.g., shame) ( 20 ).",
            "Despite a growing adoption of IFS among clinicians, there are no studies on the efficacy of IFS in groups for the treatment of comorbid PTSD-SUD nor for the treatment of SUD. Early research suggests preliminary efficacy of IFS for PTSD and related symptoms such as depression and inflammation-derived disorders ( 18 , 19 , 24 , 25 )."
          ]
        },
        {
          "title": "A systematic review and meta-analysis of PTSD symptoms at mid ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0887618524001014",
          "excerpts": [
            "by L Purnell · 2024 · Cited by 1 — This meta-analysis found no evidence that trauma-focused psychotherapies elicit symptom exacerbation at mid-treatment in terms of PTSD or depression symptoms."
          ]
        },
        {
          "title": "[PDF] VA-DoD-CPG-PTSD-Full-CPG-Edited-11162024.pdf",
          "url": "https://www.healthquality.va.gov/guidelines/MH/ptsd/VA-DoD-CPG-PTSD-Full-CPG-Edited-11162024.pdf",
          "excerpts": [
            "2023 CPG Recommendation Category column: This is the recommendation category assigned during the development of the 2023 VA/DoD. PTSD CPG.",
            "This clinical practice guideline (CPG) is based on a systematic review (SR) of both clinical and epidemiological evidence.",
            "The 2023 VA/DoD PTSD CPG reflects a more rigorous application of the GRADE methodology than the 2017 VA/DoD PTSD CPG. This approach has ...",
            "Nov 16, 2024 — This clinical practice guideline (CPG) is based on a systematic review (SR) of both clinical and epidemiological evidence."
          ]
        },
        {
          "title": "Meta-Analysis of the Treatment of Posttraumatic Stress Disorder in ...",
          "url": "https://www.psychiatrist.com/jcp/meta-analysis-of-treatment-of-ptsd-in-adults-with-severe-mental-illness/",
          "excerpts": [
            "Our results indicate that EBTs for PTSD meaningfully impact PTSD outcomes with patients experiencing an SD decrease in PTSD symptom severity pre ..."
          ]
        },
        {
          "title": "[PDF] Symptom exacerbations in trauma-focused treatments",
          "url": "https://www.ptsd.va.gov/professional/articles/article-pdf/id44662.pdf",
          "excerpts": [
            "Trauma-focused treatments are underutilized, partially due to clinician concerns that they will cause symptom exacerbation or dropout.",
            "by SE Larsen · 2016 · Cited by 146 — Trauma-focused treatments are underutilized, partially due to clinician concerns that they will cause symptom exacerbation or dropout."
          ]
        },
        {
          "title": "Merz et al. 2019 Network Meta-Analysis of Psychotherapeutic Treatments for PTSD (PubMed)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31188399/",
          "excerpts": [
            "At the last follow-up, psychotherapeutic treatments showed greater benefit than pharmacological treatments in both network (SMD, -0.83; 95% CI, -1.59 to -0.07) and pairwise (SMD, -0.63; 95% CI, -1.18 to -0.09, 3 RCTs) meta-analyses.",
            "No treatment approach was found to be superior at the end of treatment (for all, 95% CI included 0)."
          ]
        },
        {
          "title": "Merz et al. 2019 Network Meta-Analysis of Treatments for PTSD in Adults",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6563588/",
          "excerpts": [
            "No treatment approach was found to be superior at the end of treatment (for all, 95% CI included 0).",
            "At the last follow-up, psychotherapeutic treatments showed greater benefit than pharmacological treatments in both network (SMD, −0.83; 95% CI, −1.59 to −0.07) and pairwise (SMD, −0.63; 95% CI, −1.18 to −0.09, 3 RCTs) meta-analyses.",
            "These results suggest superiority of psychotherapeutic treatments over pharmacological treatments; network, but not pairwise, meta-analyses suggest superiority of combined treatments over pharmacological treatments in improving PTSD symptom severity in the long term."
          ]
        },
        {
          "title": "PTSD Treatments and Dropout (Imel et al., 2013)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3893277/",
          "excerpts": [
            "There are a number of effective psychotherapies available for the treatment\nof PTSD ([SCP, 2012]()).\nApproaches include\ntreatments that focus on the traumatic event such as Prolonged Exposure (PE),\nCognitive Processing Therapy (CPT), and Eye Movement Desensitization and\nReprocessing (EMDR) and a variety of other interventions that do not place a primary\nfocus on discussion of the trauma (see [Foa, Keane,\n& Friedman, 2010]() for examples",
            "se dropout. ### Results\n\nThe average dropout rate was 18%, but it varied significantly\nacross studies. Group modality and greater number of sessions, but not\ntrauma focus, predicted increased dropout. When the meta-analysis was\nrestricted to direct comparisons of active treatments, there were no\ndifferences in dropout. Differences in trauma focus between treatments in\nthe same study did not predict dropout. However, trauma focused treatments\nresulted in higher dropout as compared to Present Centered Therapy (PCT)\n– a treatment originally designed as a control, but now listed as a\nresearch supported intervention for PTSD.",
            "The average dropout rate was 18%, but it varied significantly\nacross studies.",
            "There was a large amount of variability in dropout among active\ninterventions across studies.",
            "\nA recent meta-analysis of dropout\nin treatments across psychological disorders found the average dropout rate was\n19.7%, but this rate varied widely across studies",
            "There are likely many factors that contribute to poor retention, but it is\nimportant to determine if psychotherapies differ in the extent to which they are\ntolerated.",
            "by ZE Imel · 2013 · Cited by 822 — We conducted a meta-analysis of dropout among active treatments in clinical trials for PTSD (42 studies; 17 direct comparisons)."
          ]
        },
        {
          "title": "Dropout from recommended psychological therapies for PTSD (Lewis et al., 2020)",
          "url": "https://www.tandfonline.com/doi/full/10.1080/20008198.2019.1709709",
          "excerpts": [
            "the estimated rate of reported side effects is between 3% and 15%"
          ]
        },
        {
          "title": "Three meta-analyses on dropout in treatments for PTSD (Imel et al., 2013)",
          "url": "https://www.apa.org/pubs/journals/features/ccp-a0031474.pdf",
          "excerpts": [
            "Approaches include treatments that focus\non the traumatic event, such as prolonged exposure (PE), cognitive\n\nprocessing therapy (CPT), and eye movement desensitization and\nreprocessing (EMDR)",
            " trauma-focused treatments resulted in higher dropout compared with present-centered therapy\n(PCT)",
            ". There are also a variety of other interven-\ntions that do not place a primary focus on discussion of the trauma\n(se",
            "Our findings suggest that dropout rates are not\nsignificantly different among active treatments."
          ]
        },
        {
          "title": "EMDR v. other psychological therapies for PTSD",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38173121/",
          "excerpts": [
            "by SL Wright · 2024 · Cited by 38 — Conclusion: The current study found no significant difference between EMDR and other psychological treatments. We found some indication of the ...",
            "The current study found no significant difference between EMDR and other psychological treatments. We found some indication of the ..."
          ]
        },
        {
          "title": "The effectiveness, efficiency, and acceptability of EMDR vs. ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10665892/",
          "excerpts": [
            "by VVPA van Geusau · 2023 · Cited by 7 — Although meta-analyses have found that EMDR therapy has large beneficial effects on PTSD compared to control conditions, and has large effect ...",
            "he more the working memory is taxed (e.g., faster eye movements), the more effective EMDR is in degrading aversive memori"
          ]
        },
        {
          "title": "The problem of dropout from “gold standard” PTSD therapies",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4447050/",
          "excerpts": [
            "by LM Najavits · 2015 · Cited by 414 — A recent meta-analysis covering 42 studies found that trauma-focused PTSD treatments resulted in higher dropout compared with present-centered ..."
          ]
        },
        {
          "title": "Clinical Efficiency and Acceptability of EMDR and MOSAIC Therapy ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10418657/",
          "excerpts": [
            "PE therapy achieves results on PTSD symptoms in 8 to 15 sessions [7] and in 8 to 25 sessions with TF-CBT [9]. For CPT, the protocol consists of ...",
            "by D Flatot-Blin · 2023 · Cited by 6 — According to numerous studies and meta-analyses, EMDR has one of the highest efficacies in reducing PTSD symptoms, with sustained effects at 1 ..."
          ]
        },
        {
          "title": "Evaluating the Effectiveness of Skills Training in Affective ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11738333/",
          "excerpts": [
            "by D Abayaratne · 2024 — This evaluation demonstrates promising patient outcomes from STAIR delivered by CPTs for people with Complex PTSD awaiting trauma processing."
          ]
        },
        {
          "title": "Enhanced Skills Training in Affective and Interpersonal ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10527561/",
          "excerpts": [
            "by T Karatzias · 2023 · Cited by 23 — There is substantial evidence on the effectiveness of interventions for DSM-IV PTSD, but there is little evidence whether these interventions are equally ..."
          ]
        },
        {
          "title": "Havelsan's Revenue in 2024",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12096967/",
          "excerpts": [
            "by L Mewes · 2025 — Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomised controlled ... See",
            "Abstract\nIntroduction\nDespite the established status of trauma-focused psychotherapy (TFP) as a first-line treatment for post-traumatic stress disorder (PTSD), a substantial proportion of individuals do not achieve clinically significant improvement or discontinue treatment",
            "This protocol outlines a systematic review and meta-analysis of randomised controlled trials (RCTs) evaluating the efficacy of non-pharmacological augmentation strategies in addition to TFP for PTSD treatment.",
            " of bias. We will conduct a narrative review to qualitatively synthesise data and a meta-analysis to quantitatively compare the treatment efficacy of augmented TFP with TFP alone or TFP plus placebo.",
            "Primary outcomes will be both symptom severity and response rates. The secondary outcome will be dropout rates.",
            "International treatment guidelines uniformly recommend trauma-focused psychotherapy (TFP) as the first-line treatment for PTSD. The umbrella ..."
          ]
        },
        {
          "title": "Project Harmony: A systematic review and network meta-analysis of psychotherapy and pharmacologic trials for comorbid posttraumatic stress, alcohol and other drug use disorders",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10939977/",
          "excerpts": [
            "This systematic review and network meta-analysis characterized and compared the extant literature on treatments for PTSD+AOD, with a specific focus on identifying the range of populations, intervention types, comparators, along with safety indicators and outcomes.",
            "Applying a network meta-analysis to the subset of twenty-four RCTs yielded some statistically significant differences across treatment categories on PTSD and alcohol use outcomes.",
            "There were, however, no differences across any of the interventions in the psychotherapy intervention subnetwork for the alcohol outcomes."
          ]
        },
        {
          "title": "STAIR therapy for CPTSD: Systematic review (Amilhau et al., 2024)",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S2468749924001169",
          "excerpts": [
            "STAIR and its adaptations are among the phase-based therapies most used for the treatment of CPTSD and PTSD-CA (Darby et al., 2023; Willis et al., 2023).",
            "— In a review of seven studies, STAIR therapy for CPTSD showed significant symptom reduction, with effect sizes ranging from d = 1.34 to 2.29 in clinician ..."
          ]
        },
        {
          "title": "Melton 2020: Psychological therapies for complex trauma in adults",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7520719/",
          "excerpts": [
            " — This review aimed to find out which treatments are most effective and acceptable for mental health problems in people with complex trauma histories, and to ..."
          ]
        },
        {
          "title": "Dropout from guideline-recommended psychological treatments for posttraumatic stress disorder: A systematic review and meta-analysis",
          "url": "https://www.sciencedirect.com/science/article/pii/S2666915321000202",
          "excerpts": [
            "The mean dropout proportion for guideline-recommended treatment was 20.9% (95%CI 17.2, 24.9) with evidence of high heterogeneity across studies.",
            "Military trauma was associated with higher dropout than civilian trauma.",
            "hin this group, dropout from trauma-focused treatment was significantly higher than from non-trauma focused treatments overall, with the greatest difference in dropout rates occurring between randomization and treatment initiation.",
            "Only 7% of treatment trials operationally define dropout."
          ]
        },
        {
          "title": "A meta-analytic investigation of the impact of mindfulness ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6571280/",
          "excerpts": [
            "by J Xue · 2019 · Cited by 110 — The present meta-analysis suggested that MBIs had large effects in reducing ADHD core symptoms in comparison with the control group.",
            "A meta-analytic investigation of the impact of mindfulness-based interventions on ADHD symptoms - PMC",
            "the primary results showed a large effect size for ADHD core symptoms, suggesting that MBIs could significantly reduce ADHD core symptoms.",
            "The main purpose of this meta-analysis was to estimate the overall effect size of MBIs on ADHD core symptoms (ie, inattention and hyperactivity/impulsivity) in comparison with control conditions.",
            "The present meta-analysis suggested that MBIs had large effects in reducing ADHD core symptoms in comparison with the control group."
          ]
        },
        {
          "title": "The efficacy of mindfulness-based interventions in attention-deficit ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34146899/",
          "excerpts": [
            "In both adults and children, MBIs showed to be more effective than waiting lists in improving ADHD symptoms and some other outcomes.",
            "Mindfulness Awareness Practice (MAP) and Mindfulness Based Cognitive Therapy (MBCT) were the most used protocols in adult studies, whereas a combination of MBCT and Mindfulness Based Stress Reduction (MBSR) was more preferred for children and adolescent patients.",
            "Conclusions:**\nEven if further studies with a better methodology are needed, we can suggest the MBIs may be useful as complementation and not as replacement of other active intervention",
            "by F Oliva · 2021 · Cited by 92 — In both adults and children, MBIs showed to be more effective than waiting lists in improving ADHD symptoms and some other outcomes.",
            "In adults, a medium pooled effect size was shown by meta-analysis for ADHD symptoms but in some cases a publication bias was detected."
          ]
        },
        {
          "title": "The Effectiveness of Mindfulness-Based Intervention in Attention on ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6092011/",
          "excerpts": [
            "Three\nvariants of mindfulness-based training, MBCT, MAP and MBSR, were used in\nthese studies.",
            "MBCT adapted for individuals with ADHD: 12 weekly session and 30-min home practice daily",
            "Mindfulness-based intervention has received more clinical interest and\nempirical support for individuals with ADHD especially to improve attention.",
            "reover, three of the\nstudies were randomized control trials, posing a strong evidence that the positive\nresults were due to treatment effect.",
            "The results all showed\nsignificant improvement in attention in this age group.",
            "For adults with ADHD,\nmindfulness-based intervention improves attention deficits significantly, however,\ndue to limited research studies, it is hard to make conclusion for adolescents and\nchildren with ADHD.",
            "There were six studies concerning adults with ADHD. The results all showed\nsignificant improvement in attention in this age group.",
            "ar age group. It is recommended that future studies should consider using attention as the primary\noutcome and other variables as the secondary outcomes and consider the quality of\nhome-based mindfulness practice for the children and adolescents.",
            "This systematic review examined clinical evidence on the effectiveness of\nmindfulness-based interventions on improving attention in children, adolescents, and\nadults with ADHD"
          ]
        },
        {
          "title": "Meta-analysis finds mindfulness-based interventions ...",
          "url": "https://www.adhdevidence.org/blog/meta-analysis-finds-mindfulness-based-interventions-reduce-adhd-symptoms-in-adults-but-no-better-than-active-psychological-controls",
          "excerpts": [
            "Dec 27, 2021 — A meta-analysis of seven studies with a combined total of 489 participants found MBIs reduced ADHD symptoms with medium effect size and no sign of publication ..."
          ]
        },
        {
          "title": "A meta-analysis of four randomized controlled trials",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35253353/",
          "excerpts": [
            "by Q Liu · 2022 · Cited by 43 — MBSR significantly reduced the symptoms of PTSD patients and had a moderately positive effect (g = 0.46, 95% CI: 0.31-0.62, p < 0.001).",
            "MBSR significantly reduced the symptoms of PTSD patients and had a moderately positive effect (g = 0.46, 95% CI: 0.31-0.62, p < 0.001)."
          ]
        },
        {
          "title": "Loving-Kindness Meditation vs Cognitive Processing Therapy for ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33861329/",
          "excerpts": [
            "Among veterans with PTSD, loving-kindness meditation resulted in reductions in PTSD symptoms that were noninferior to group cognitive processing therapy."
          ]
        },
        {
          "title": "The Role of Non-traditional Practices in the Management of PTSD",
          "url": "https://www.ptsd.va.gov/publications/rq_docs/V36N1.pdf",
          "excerpts": [
            "Conclusions and relevance: Among veterans with PTSD, loving- kindness meditation resulted in reductions in PTSD symptoms that were noninferior to group cognitive processing therapy . For both interventions, the magnitude of improvement in PTSD symptoms was modest."
          ]
        },
        {
          "title": "The efficacy of mindfulness-based interventions in attention ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032721005127",
          "excerpts": [
            "by F Oliva · 2021 · Cited by 92 — In both adults and children, MBIs showed to be more effective than waiting lists in improving ADHD symptoms and some other outcomes.",
            "In adults, a medium pooled effect size was shown by meta-analysis for ADHD symptoms but in some cases a publication bias was detected."
          ]
        },
        {
          "title": "Assessing the impact of mindfulness programs on attention-deficit",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11730125/",
          "excerpts": [
            "This systematic review demonstrates the potential benefits of mindfulness programs on ADHD symptoms in children and adolescents."
          ]
        },
        {
          "title": "Systematic Review of Executive Function Stimulation Methods in the ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11278469/",
          "excerpts": [
            "We present a systematic review that seeks to identify the treatment methods developed to support executive functions in individuals with ADHD."
          ]
        },
        {
          "title": "A systematic review and meta-analysis - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7554248/",
          "excerpts": [
            "by SB Goldberg · 2020 · Cited by 71 — Several systematic reviews and meta-analyses have examined attrition in MBI studies, reporting rates ranging from 15.5% to 29% (43–46), which is similar to ..."
          ]
        },
        {
          "title": "Randomized controlled trials of mind–body interventions ...",
          "url": "https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2023.1219296/full",
          "excerpts": [
            "by J Kaplan · 2024 · Cited by 9 — These approaches have demonstrated preliminary efficacy in improving posttraumatic stress disorder (PTSD) symptoms. However, previous systematic ..."
          ]
        },
        {
          "title": "The effectiveness of mindfulness-based stress reduction ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11583271/",
          "excerpts": [
            "by WW Li · 2024 · Cited by 10 — The effectiveness of mindfulness-based stress reduction (MBSR) on depression, PTSD, and mindfulness among military veterans: A systematic review ...",
            "by WW Li · 2024 · Cited by 10 — Both within- and between-group comparisons demonstrated reductions in depressive and PTSD symptoms with medium effect sizes post MBSR intervention.",
            "by WW Li · 2024 · Cited by 10 — A meta-analysis of randomised controlled trials (RCTs) in a general PTSD population, revealed a significant medium effect of MBSR on reducing ...",
            "A meta-analysis of randomised controlled trials (RCTs) in a general PTSD population, revealed a significant medium effect of MBSR on reducing ..."
          ]
        },
        {
          "title": "Mindfulness as a Mediator between Trauma Exposure and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8500672/",
          "excerpts": [
            "by LK Kachadourian · 2021 · Cited by 48 — Thus, mindfulness may help individuals more effectively cope with the negative impact of traumatic events by increasing acceptance of trauma-related experiences ..."
          ]
        },
        {
          "title": "What Are Adverse Events in Mindfulness Meditation? - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9024164/",
          "excerpts": [
            "by DD Binda · 2022 · Cited by 49 — Studies have described adverse events, such as anxiety and pain, and more severe events like psychosis, that have been associated with mindfulness meditation."
          ]
        },
        {
          "title": "Doing no harm in mindfulness-based programs",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6575147/",
          "excerpts": [
            "by R Baer · 2019 · Cited by 429 — Potential harmful outcomes of mindfulness-based programs are under-researched. Harm occurs in psychotherapy, pharmacotherapy, physical exercise, and meditation."
          ]
        },
        {
          "title": "Mindfulness-based treatments for posttraumatic stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5747539/",
          "excerpts": [
            "by JE Boyd · 2017 · Cited by 555 — A scoping review of the literature on PTSD treatment studies, including approaches such as mindfulness-based stress reduction, mindfulness-based cognitive ...",
            "A scoping review of the literature on PTSD treatment studies, including approaches such as mindfulness-based stress reduction, mindfulness-based cognitive therapy and metta mindfulness, reveals low attrition with medium to large effect sizes.",
            "Mindfulness-based stress reduction for PTSD\n\nStandard and trauma-adapted MBSR are the most frequently assessed mindfulness-based therapies among trauma-exposed populations, with 2 pilot studies, 3 larger uncontrolled studies and 5 randomized controlled trials (RCTs) reviewed here",
            "MBCT shows promise as an additional mindfulness-based approach to treating PTSD, with reductions in avoidance symptoms emerging as a key mechanism of change.",
            "A recent pilot study of a 12-week loving-kindness meditation intervention for veterans with PTSD reported increased self-compassion and mindfulness skills and reductions in PTSD symptoms (large effect size) and depressive symptoms (medium effect size) at the 3-month follow-up, with 74% attending at least 9 of 12 classes.",
            "These findings are important in light of consistent reports of increased inflammatory biomarkers among individuals with PTSD and given that proinflammatory cytokines, such as IL-6, have been shown to increase depressive and anxiety symptoms.",
            "----\n\n### Mindfulness-based approaches in the treatment of PTSD\n\nOn balance, an emerging and rapidly growing literature on mindfulness-based treatment for PTSD shows considerable promise. The studies reviewed here suggest that mindfulness-based treatments are effective in reducing symptoms of PTSD, with medium to large within-group effect sizes.",
            "Moreover, initial findings are promising, with Catani and colleagues[145]() reporting equivalent symptom reductions following either a meditation–relaxation intervention or narrative exposure therapy among ch"
          ]
        },
        {
          "title": "Mindfulness and Behavior Change - PMC - PubMed Central",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7647439/",
          "excerpts": [
            "by Z Schuman-Olivier · 2020 · Cited by 528 — A growing body of evidence suggests that mindfulness-based interventions (MBIs) are effective in reducing harmful health behaviors, catalyzing ..."
          ]
        },
        {
          "title": "Clients' experiences with a Trauma-sensitive mindfulness ...",
          "url": "https://www.tandfonline.com/doi/full/10.1080/10503307.2023.2170295",
          "excerpts": [
            "by M Wästlund · 2024 · Cited by 10 — This study describes clients' experiences of change after participating in a transdiagnostic group intervention, Trauma-sensitive Mindfulness and Compassion ..."
          ]
        },
        {
          "title": "Mindfulness trait may buffer negative effects of trauma for ...",
          "url": "https://www.recoveryanswers.org/research-post/mindfulness-trait-may-buffer-negative-effects-trauma-women/",
          "excerpts": [
            "Women exposed to traumatic incidents during childhood and adulthood reported worse trauma symptom severity and higher levels craving. Mindfulness was found to ..."
          ]
        },
        {
          "title": "Jovanovic & Garfin, Can mindfulness-based interventions reduce PTSD symptoms? An umbrella review, Journal of Anxiety Disorders, 2024",
          "url": "https://www.sciencedirect.com/science/article/pii/S0887618524000355",
          "excerpts": [
            "by B Jovanovic · 2024 · Cited by 9 — We then performed a meta-meta-analysis to estimate the efficacy of MBIs to reduce PTSD symptoms, yielding a medium effect size (SMD=0.41, p < .001), derived ...",
            "f MBSR and MBCT did not differ compared to other mindfulness treatments.",
            ".\nWe conducted an umbrella review to summarize and evaluate existing evidence regarding MBIs for PTSD, identifying 69 SRs (27 meta-analyses)"
          ]
        },
        {
          "title": "Mindfulness-Based Stress Reduction for Addressing Psychological Distress, PTSD, and Mindfulness in Adults (Military Veterans) - Li et al., 2024",
          "url": "https://journals.sagepub.com/doi/10.1177/20551029241302969",
          "excerpts": [
            "Mindfulness can be cultivated through meditation, a state of detached observation and awareness of the present moment ( Kabat-Zinn, 2003 ), aiming to increase awareness of thoughts and feelings of the present moment and attend to the thoughts and feelings without judgement ( Kabat-Zinn, 2003 , 2013 ; Li et al., 2023b , 2024a ; Omidi et al., 2013 ; Schure et al., 2018 ).",
            "Mindfulness-based stress intervention (MBSR) is one of the most widely studied MBIs. MBSR is a non-trauma focused treatment that is delivered through an eight-week standardised group program ( Kabat-Zinn, 2003 ) and employs a mind-body connection and a relaxed non-judgemental state of mind to aid in reducing PTSD symptoms, arousal, and improve mood ( Kim et al., 2013 ).",
            "A meta-analysis of randomised controlled trials (RCTs) in a general PTSD population, revealed a significant medium effect of MBSR on reducing PTSD symptoms (Hedges’ g = 0.46, p < 0.001) when compared to the treatment as usual (TAU; Liu et al., 2022 ).",
            "Within the veteran population, empirical evidence has shown reduction in symptoms of anxiety, depression, PTSD, and suicidal ideation among veterans after MBSR intervention ( Felleman et al., 2016 ; Kearney et al., 2016 ; Marchand et al., 2021 ; Polusny et al., 2015 ; Serpa et al., 2014 ).",
            "Findings from this review and meta-analysis indicate MBSR is moderately effective in reducing depression and PTSD symptoms and improving mindfulness in military veterans. These results suggest that MBSR could be utilised as a non-trauma focused therapy for improving veterans’ mental health."
          ]
        },
        {
          "title": "The effect of mindfulness-based cognitive therapy on PTSD and depression symptoms in trauma-exposed Black adults: Pilot randomized controlled trial results",
          "url": "https://www.sciencedirect.com/science/article/pii/S2950004424000464",
          "excerpts": [
            "by M Au · 2024 · Cited by 3 — We examined the preliminary efficacy of adapted MBCT versus waitlist control (WLC) on PTSD and depression symptoms in a pilot randomized controlled trial (RCT).",
            "PTSD avoidance symptoms reduced in the MBCT group but not waitlist control group.",
            "Black adults ( _N_ = 80; 86.10 % women) with repeated trauma exposure, who screened positive for PTSD and depression, were recruited from an urban public hospital and randomized to 8-week adapted MBCT or WLC."
          ]
        },
        {
          "title": "Adverse Effects of Mindfulness-Based Programs (Brown University-related research)",
          "url": "https://www.brown.edu/news/2021-05-18/adverse-effects",
          "excerpts": [
            "Of the 96 participants, 58% reported at least one meditation-related adverse effect, which ranged from perpetual hypersensitivity to nightmares to traumatic re-experiencing.",
            "Meditation-related adverse effects with negative impacts on functioning occurred in 37% of the sample.",
            "Six percent of the sample had ",
            " “lasting bad effects,” or impairments in functioning lasting more than one month."
          ]
        },
        {
          "title": "Mindfulness based cognitive therapy versus treatment as usual in ...",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-015-0591-x",
          "excerpts": [
            "by L Janssen · 2015 · Cited by 58 — This trial will offer valuable information about the clinical and cost-effectiveness of MBCT in addition to TAU compared to TAU alone in adults swith ADHD."
          ]
        },
        {
          "title": "Mindfulness based cognitive therapy versus treatment as ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4572448/",
          "excerpts": [
            "by L Janssen · 2015 · Cited by 58 — This trial will offer valuable information about the clinical and cost-effectiveness of MBCT in addition to TAU compared to TAU alone in adults swith ADHD."
          ]
        },
        {
          "title": "A Randomized Controlled Trial of Mindfulness-Based ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/28038496/",
          "excerpts": [
            "by Y Gu · 2018 · Cited by 156 — Conclusion: MBCT may be a useful intervention for college students with ADHD, improving participants' ADHD symptoms, mindfulness, and sustained attention."
          ]
        },
        {
          "title": "Loving-Kindness Meditation vs Cognitive Processing ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8052593/",
          "excerpts": [
            "by DJ Kearney · 2021 · Cited by 66 — In this randomized clinical trial, 184 veterans with PTSD were assigned to group loving-kindness meditation or group cognitive processing ...See more"
          ]
        },
        {
          "title": "A multisite randomized controlled trial of mindfulness-based ...",
          "url": "https://www.ptsd.va.gov/professional/articles/article-pdf/id51046.pdf",
          "excerpts": [
            "by LL Davis · Cited by 82 — Conclusions: Both MBSR and PCGT appear to have beneficial effects in treating PTSD in veterans, with greater improve- ment observed in self- ..."
          ]
        },
        {
          "title": "Loving-kindness meditation for posttraumatic stress disorder",
          "url": "https://pubmed.ncbi.nlm.nih.gov/23893519/",
          "excerpts": [
            "by DJ Kearney · 2013 · Cited by 386 — Measures of PTSD, depression, self-compassion, and mindfulness were obtained at baseline, after a 12-week loving-kindness meditation course, and 3 months later.See more"
          ]
        },
        {
          "title": "Comparison of the effects of in-person and internet-delivered ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11669004/",
          "excerpts": [
            "The study highlights the positive effects of both in-person and online MBSR interventions on reducing depressive symptoms and improving mental health outcomes ..."
          ]
        },
        {
          "title": "Clinical Benefits of Self-Guided Mindfulness Coach Mobile ...",
          "url": "https://www.ptsd.va.gov/professional/articles/article-pdf/id1638072.pdf",
          "excerpts": [
            "by J Wielgosz — No adverse events were reported during the study. This study is the first to report on the self-guided usage of a publicly available mobile ..."
          ]
        },
        {
          "title": "A comparison of the CAPS-5 and PCL-5 to assess PTSD in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10291904/",
          "excerpts": [
            "by PA Resick · 2023 · Cited by 36 — Overall, PCL-5 total scores were consistently higher than CAPS-5 total, so discrepancies in scores are likely not attributable to specific ..."
          ]
        },
        {
          "title": "Mindfulness Interventions for Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis",
          "url": "https://www.mdpi.com/2673-5318/3/4/31",
          "excerpts": [
            "Mindfulness interventions typically followed the Kabat-Zinn [ 49 ] approach with the intervention over around 8 weeks, although one deviated from this using mindful martial arts albeit with a small sample (<30) [ 89 ].",
            "The data indicate possible benefits of mindfulness on self-compassion, quality of life, wellbeing, depression, and anxiety. The findings also suggest that mindfulness may also improve ADHD symptoms, executive function, problematic behaviours, and emotional dysregulation, although results vary by age of patient and measures used.",
            "Three studies used\nBRIEF-ASR to measure executive function in adults [ 91 , 94 , 99 ]. Reporting approaches varied but all three included a total score. Heterogeneity of the studies was too high (I 2 = 76.7%) to conduct a reliable meta-analysis and as such individual effect sizes are reported. All studies found a decrease in total score after the mindfulness intervention with small (g = −0.26) [ 94 ] or large (g = −1.04 [ 91 ]; g = −1.13 [ 99 ]) effect sizes.",
            "In summary, the limited number of studies with adequate control conditions and follow-up periods mean it is not possible to firmly conclude that mindfulness benefits executive function, but the evidence to date indicates that it may have some beneficial effects, in line with previous meta-analyses [ 54 , 58 ].",
            "ckham, J.C.; Kollins, S.H. A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation. J. Atten. Disord. 2013 , 21 , 1105–1120."
          ]
        },
        {
          "title": "Mindfulness and psychological interventions for PTSD/CPTSD: systematic review and meta-analysis (sciencedirect source)",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032725005026",
          "excerpts": [
            "Psychotherapies significantly relieved PTSD, depression, anxiety, and dissociation. At follow-up, symptoms were still alleviated except for anxiety and ...",
            "Therefore, the primary objective of this systematic review and meta-analysis was to evaluate the efficacy of psychological interventions for complex traumatic symptoms in the outcome domains of PTSD, depression, anxiety, and dissociation. The second objective is to explore the possible effects of study quality, patient characteristics, and treatment forms on treatment outcomes.",
            "Evidence-based treatment for adult women with child abuse-related complex PTSD: A quantitative review Eur. J. Psychotraumatol. (2014)",
            "Duffy et al. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial BMJ (Clinical research ed.) (2007)",
            "Dumarkaite et al. Effects of mindfulness-based internet intervention on ICD-11 posttraumatic stress disorder and complex posttraumatic stress disorder symptoms: A pilot randomized controlled trial Mindfulness (N Y)\n(2021)",
            "A. Ehlers et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy Am. J. Psychiatry\n(2014)",
            "Phase-based psychological interventions for complex post-traumatic stress disorder: A systematic review Journal of Affective Disorders Reports\n(2023)",
            "M. Bohus et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: A randomised controlled trial Psychother. Psychosom. (2013)",
            "E. Street et al. Using a social construction of gender lens to understand gender differences in posttraumatic stress disorder Clin. Psychol. Rev. (2018)"
          ]
        },
        {
          "title": "Mindfulness-based internet intervention for ICD-11 PTSD/CPTSD ( PMC article )",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8435188/",
          "excerpts": [
            "The current study investigated the effects of a mindfulness-based internet intervention on ICD-11 PTSD and CPTSD symptoms.",
            " the present study suggest that mindfulness-based interventions could have a significant positive impact on DSO symptoms, which accompany PTSD symptoms when CPTSD is diagnosed.",
            "In particular, participants who received mindfulness-based internet intervention reported positive changes in the DSO negative self-concept, meaning that beliefs about oneself as diminished, defeated, and worthless were reduced.",
            "The PTSD symptom changes in the present study were not in line with the other studies on mindfulness-based interventions for PTSD.",
            "However, the present study revealed the potential of a mindfulness-based intervention for a new ICD-11 diagnosis of CPTSD."
          ]
        },
        {
          "title": "Behavioral and Cognitive Impacts of Mindfulness-Based ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6476147/",
          "excerpts": [
            "Several studies have suggested that MBIs may also be effective in reducing symptoms of attention-deficit hyperactivity disorder (ADHD)."
          ]
        },
        {
          "title": "Behavioral and Cognitive Impacts of Mindfulness-Based ...",
          "url": "https://www.adhdevidence.org/blog/outcomes-of-mindfulness-based-interventions-on-adults-with-adhd-2",
          "excerpts": [
            "Mar 4, 2021 — Following an8-week mindfulness training, researchers “found a significant decrease in ADHD symptoms and significant improvement in task ..."
          ]
        },
        {
          "title": "Mindfulness-Based Cognitive Therapy and the Adult ADHD Brain",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4921925/",
          "excerpts": [
            "We think that mindfulness meditation employed as a neuropsychotherapeutic intervention could help patients with ADHD to regulate impaired brain functioning."
          ]
        },
        {
          "title": "Mindfulness Meditation Training for Attention-Deficit/ ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4403871/",
          "excerpts": [
            "by JT Mitchell · 2015 · Cited by 218 — Given these findings, one potential pathway that mindfulness may have its impact in ADHD patients is improvement in mind-wandering via the default mode network.",
            "by JT Mitchell · 2015 · Cited by 218 — Rationale for Mindfulness-Based Treatment for Adults Diagnosed with ADHD. Studies of mindfulness in non-ADHD samples support its application to ADHD ..."
          ]
        },
        {
          "title": "The Science of How Mindfulness Relieves Post Traumatic Stress",
          "url": "https://www.mindful.org/the-science-of-how-mindfulness-relieves-post-traumatic-stress/",
          "excerpts": [
            "Researchers found that individuals who participated in the mindfulness-based interventions demonstrated significantly lower levels of PTSD ..."
          ]
        },
        {
          "title": "Mindfulness-Based Interventions for Psychological Trauma ...",
          "url": "https://link.springer.com/article/10.1007/s40501-025-00364-x",
          "excerpts": [
            "by A Badola · 2025 — MBSR within-group effect sizes were (d = − 0.63*) for PTSD and (d = − 0.65*) depression at four-month follow-up. A larger RCT of MBSR for ...",
            ".\nThis large meta-meta-analysis of mixed forms of mind-body interventions found an overall highly robust but only small-medium effect size for treatment of PTSD – (SMD) of ~ 0.45."
          ]
        },
        {
          "title": "Primary Care-Based Mindfulness Intervention for PTSD ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10227868/",
          "excerpts": [
            "The present randomized pilot study evaluated the feasibility and acceptability of an 8-week adapted mindfulness-based cognitive therapy (MBCT) group for trauma ..."
          ]
        },
        {
          "title": "Systematic review and individual participant data meta-analysis of ...",
          "url": "https://www.nature.com/articles/s44220-023-00081-5",
          "excerpts": [
            "Mindfulness-based programs (MBPs) are widely used to prevent mental ill health. Evidence suggests beneficial average effects but wide variability."
          ]
        },
        {
          "title": "The evolving field of digital mental health: current evidence ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12079407/",
          "excerpts": [
            "by J Torous · 2025 · Cited by 12 — There is evidence that some well‐being apps may exert their effects through enhanced mindful awareness . However, a similar degree of evidence ..."
          ]
        }
      ],
      "reasoning": "Key passages clarify the landscape described in the field value. Excerpts from high-profile guidelines and meta-analyses establish the baseline: ADHD pharmacotherapy (stimulants such as methylphenidate and amphetamines) yields short-term symptom reduction, while non-stimulants (e.g., atomoxetine) offer alternatives; PTSD treatments commonly center on trauma-focused psychotherapies (EMDR, CPT, PE) as first-line care with long-term benefits, and later trials explore neuromodulation and digital therapies. For example, one source summarizes the adult ADHD pharmacotherapy landscape and underscores that stimulants show short-term efficacy and that ADHD pharmacotherapy is commonly considered first-line, with atomoxetine as a non-stimulant option. Another source emphasizes that PTSD guidelines across VA/DoD recognize SSRIs/SNRIs (e.g., sertraline, venlafaxine) as core pharmacotherapy, while trauma-focused psychotherapies remain front-line for PTSD, and that newer modalities (MDMA, ketamine) are under investigation or face regulatory hurdles. Together, these excerpts support a multifaceted approach: combine pharmacotherapy for ADHD with trauma-focused psychotherapy for PTSD, and supplement with neuromodulation and digital tools as adjuncts, while also integrating non-pharmacological strategies (CBT, DBT, mindfulness, sleep optimization, exercise) and social/functional supports. The modern landscape thus aligns with a personalized, stepwise, multimodal strategy that tailors interventions to individual symptom profiles and comorbidity patterns. The excerpts also underscore the importance of safety considerations and monitoring, including cardiovascular risk with stimulants, adverse effects checklists, and shared care models for ongoing management, which matches the call for a personalized, cautious, and holistic approach in the field finegrained field value.",
      "confidence": "high"
    },
    {
      "field": "comparative_effectiveness_table",
      "citations": [
        {
          "title": "Lancet Psychiatry Ostinelli et al., 2025 (ADHD in adults: pharmacological treatments and network meta-analysis)",
          "url": "https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00360-2/fulltext",
          "excerpts": [
            "stimulants were the only intervention that was supported by evidence of efficacy in the short term (ie, at timepoints closest to 12 weeks) for core symptoms of ADHD in adults (both self-reported and clinician-reported) and was associated with good acceptability (all-cause discontinuation).",
            "Stimulants and atomoxetine were the only interventions with evidence of beneficial effects in terms of reducing ADHD core symptoms in the short term, supported by both self-reported and clinician-reported ratings.",
            "However, atomoxetine was less acceptable than placebo."
          ]
        },
        {
          "title": "Pharmacological Treatments for ADHD QoL and Efficacy – Meta-analytic Synthesis (Sciencedirect)",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856724003046",
          "excerpts": [
            "analyses. We found that amphetamines (Hedge's _g_ = 0.51, 95% CI = 0.08, 0.94), methylphenidate (0.38; 0.23, 0.54), and atomoxetine (0.30; 0.19, 0.40) were significantly more efficacious than placebo in improving QoL in people with ADHD, with moderate effect size.",
            "For atomoxetine, these effects were not moderated by the length of intervention, and did not differ between children/adolescents and adults.",
            "The analysis showed that medications such as amphetamines, methylphenidate, and atomoxetine improved QoL compared to placebo, with moderate effect sizes.",
            "Hedge's _g_ = 0.51, 95% CI = 0.08, 0.",
            "methylphenidate (0.38; 0.23, 0.54), and atomoxetine (0.30; 0.19, 0.40) were significantly more efficacious than placebo in improving QoL in people with ADHD, with moderate effect size."
          ]
        }
      ],
      "reasoning": "The most directly relevant excerpts provide structured, cross-treatment comparisons and synthesis that align with a multi-criteria comparative table. The Lancet Ostinelli et al. 2025 article (and related entries in the same cluster) explicitly presents comparative efficacy and acceptability across pharmacological and non-pharmacological interventions for ADHD in adults, which maps to the table's core dimensions (efficacy and acceptability, with durability and tolerability as follow-ons). The year 2025 Lancet Psychiatry work reiterates that stimulants remain the primary active treatments for core ADHD symptoms in adults and that other pharmacotherapies (e.g., atomoxetine) have differing acceptability profiles, which informs the table's rows for pharmacotherapy and their relative \"Overall Effectiveness.\" These points directly feed the table's stated magnitudes of benefit and the \"First-line vs Second-line\" positioning within Pharmacotherapy. Additional NICE guidelines NG87 content provides explicit recommendations and considerations (which support the table's safety/tolerability, monitoring, and access dimensions) and establish decision-logic patterns that influence how a composite effectiveness score should be interpreted in practice. The body of statements around PTSD-focused pharmacotherapy (SSRIs/SNRIs) and trauma-focused psychotherapies (EMDR, CPT, PE) adds the cross-domain perspective: while PTSD treatments can be highly effective, their comparative strength relative to ADHD-focused interventions in a comorbid adult population remains nuanced, thus supporting the need for explicit \"Overall Effectiveness & Use-Case\" judgments in the table rather than assuming a one-size-fits-all ADHD-centric view. Several excerpts summarize quality of life and functional outcomes (e.g., QoL meta-analyses for ADHD meds; HRQoL improvements with atomoxetine and stimulants) that feed the table's \"Magnitude of Benefit (Efficacy)\" and \"Evidence Certainty\" cells. Collectively, these excerpts help justify a multi-criteria schema that weighs short-term efficacy, durability, safety/tolerability, accessibility, and expected real-world impact, while explicitly noting gaps in comorbidity-specific evidence and the need for cautious extrapolation when data are drawn from ADHD or PTSD literature separately. The excerpts addressing psychotherapy (CBT for ADHD, DBT-informed approaches) and neuromodulation (rTMS, EEG NF) contribute to the table's broader spectrum of interventions and provide supporting data for the \"Durability\" and \"Evidence Certainty\" columns, as well as practical considerations around cost/access and required effort. Overall, the selected excerpts collectively anchor the fine-grained field value's structured, multi-domain comparative framework by providing concrete data points on efficacy, durability, safety, and access across ADHD and PTSD-related interventions, while also signaling the limits of cross-condition extrapolation in comorbid adult populations.",
      "confidence": "high"
    },
    {
      "field": "somatic_and_body_oriented_practices",
      "citations": [
        {
          "title": "The integration of yoga breathing techniques in cognitive ...",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1101046/full",
          "excerpts": [
            "by H Haller · 2023 · Cited by 15 — The integration of yoga breathing techniques in cognitive behavioral therapy for post-traumatic stress disorder: A pragmatic randomized ...See more"
          ]
        },
        {
          "title": "Health Technology Assessment: Breathing Practices for Stress and Anxiety",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10741869/",
          "excerpts": [
            "by TGK Bentley · 2023 · Cited by 83 — We conducted a systematic review of clinical studies that evaluated the effectiveness of voluntary regulated breathing practices on psychometric measures of ...",
            "We identified intervention characteristics associated with effectiveness and used these data to build a conceptual framework of components associated with the stress reduction effectiveness of breathing practices.",
            "We operationally defined “voluntary regulated breathing practice” as any voluntary, regulated manipulation or control of the breath. We chose a broad and inclusive definition in an effort to capture a variety of regulated breathing methods, including deep breathing, diaphragmatic breathing, yoga or pranayama breathing, slow breathing, paced or patterned breathing, ANB, and more."
          ]
        },
        {
          "title": "The promise of heart rate variability biofeedback",
          "url": "https://academic.oup.com/milmed/article/184/1-2/e124/5055554",
          "excerpts": [
            "A recent multidimensional model proposed high-frequency HRV (HF) as a transdiagnostic biomarker of self-regulation and cognitive control.",
            "Higher HRV is associated with positive social interactions. [9](javascript:;) Psychological resilience and autonomic flexibility; therefore, enhancing an individual’s capacity to adapt to changing social or environmental demands (situational awareness) and performance on executive-fu",
            "The benefit of HRVB training is consistent with a recent meta-analysis which found an inverse relationship between PTSD symptom severity and HRV"
          ]
        },
        {
          "title": "Heart Rate Variability Biofeedback as a Treatment for Military PTSD: A Meta-Analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38287778/",
          "excerpts": [
            "The present study is the first meta-analysis to examine HRVB as a treatment for military service members with PTSD. The present study is the first meta-analysis to examine HRVB as a treatment for military service members with PTSD. Results indicate that HRVB may be a viable treatment approach to reduce PTSD symptomatology. Low attrition rates, ease of accessibility, and favorable participant outlook serve as addi …\nHeart Rate Variability Biofeedback ",
            "Missing: 2021 2023"
          ]
        },
        {
          "title": "TRE and Trauma: Randomized Controlled Trial Protocol (Y. Zhao, 2024)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11580556/",
          "excerpts": [
            "Although this intervention method has been widely used in many countries and plays an important role in trauma treatment and anxiety and depression relief, this method lacks sufficient evidence-based research."
          ]
        },
        {
          "title": "Breathwork interventions for anxiety disorders and related mechanisms (PMCID/ Nature/ PMC review synthesis)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9954474/",
          "excerpts": [
            "ll studies utilizing slow diaphragmatic breathing showed positive effects on stress reduction as well as significant improvement in outcome measu"
          ]
        },
        {
          "title": "The effects of yoga on the attention and behavior of boys ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/15487477/",
          "excerpts": [
            "Significant improvements from pre-test to post-test were found for the yoga, but not for the control group on five subscales of the Conners' Parents Rating ..."
          ]
        },
        {
          "title": "Effects of Qigong vs. routine physical exercise in school- ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40064759/",
          "excerpts": [
            "by Y Li · Cited by 1 — This study did not demonstrate the expected superiority of 3-month Baduanjin exercise in improving ADHD symptoms compared with routine ..."
          ]
        },
        {
          "title": "Effects of Qigong vs. routine physical exercise in school- ...",
          "url": "https://link.springer.com/article/10.1007/s12519-025-00890-x",
          "excerpts": [
            "by Y Li · 2025 · Cited by 1 — In this two-arm, single-blind, randomized controlled trial, eligible school-aged children with ADHD were randomly assigned (1:1) to Baduanjin ..."
          ]
        },
        {
          "title": "Lead Poisoning in Pregnant Women Who Used Ayurvedic ...",
          "url": "https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6133a1.htm",
          "excerpts": [
            "Aug 24, 2012 — The cases of lead poisoning described in this report were associated with the use of Ayurvedic medications. Ayurveda is a millennia-old medical ..."
          ]
        },
        {
          "title": "and Indian-Manufactured Ayurvedic Medicines Sold via the ...",
          "url": "https://jamanetwork.com/journals/jama/fullarticle/182460",
          "excerpts": [
            "by RB Saper · 2008 · Cited by 711 — Design and interpretation of data in “Heavy metal content of Ayurvedic medicine products” published in JAMA by Saper et al. Light Ayurveda J ..."
          ]
        },
        {
          "title": "Tai Chi and Qigong for trauma exposed populations: A systematic ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S1755296622000114",
          "excerpts": [
            "The reviewed studies suggest that TCQ practices have the potential to reduce symptoms and improve functioning for individuals exposed to trauma."
          ]
        },
        {
          "title": "Tai Chi and Qigong for trauma exposed populations: A systematic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37885833/",
          "excerpts": [
            "The reviewed studies suggest that TCQ practices have the potential to reduce symptoms and improve functioning for individuals exposed to trauma."
          ]
        },
        {
          "title": "Yoga and music intervention reduces inattention, hyperactivity ...",
          "url": "https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2023.1150018/full",
          "excerpts": [
            "Our study shows the positive effect of yoga interventions on attention and hyperactivity/impulsivity in children with comorbid ADHD and ODD, ..."
          ]
        },
        {
          "title": "Qigong for children with attention deficit hyperactivity ...",
          "url": "https://examine.com/research-feed/study/dNvpad/?srsltid=AfmBOopbdW-QCfEU2UrZKKE3f9REEIXeQ3P1X29EMTv18tErLunCtg3t",
          "excerpts": [
            "May 22, 2025 — In this 3-month randomized controlled trial, qigong did not reduce hyperactivity/impulsivity scores compared to routine aerobic exercise in 120 children."
          ]
        },
        {
          "title": "Adverse Event Reports Involving Herbal Remedies and ADHD Medications (Mazhar 2020)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31670573/",
          "excerpts": [
            "The objectives of this study were (1) to identify adverse event reports (AERs) involving commonly used herbal remedies and ADHD prescription medicines in children and adolescents; (2) to evaluate the quality of collected AERs; and (3) to assess whether NHP-drug interactions can be causally linked to reported adverse events.",
            "An NHP-drug interaction was assessed to be probable in one case and to be possible in another. Both these reports involved a methylphenidate formulation and St. John's wort."
          ]
        }
      ],
      "reasoning": "- Direct references to yoga-based and breath-focused approaches in trauma contexts anchor the claimed field value: Integrative Yoga and Trauma-Sensitive Yoga are described as modalities for trauma processing and emotion regulation, with breathing and mindfulness components embedded in practice. The excerpt detailing the integration of yoga breathing techniques within a PTSD-focused CBT framework explicitly links yoga breathing to trauma-focused work, illustrating how such practices can be used alongside established therapies to modulate fear, arousal, and emotional processing. This supports the notion that yoga-based breathwork facilitates trauma processing and emotional regulation in PTSD contexts. \n- Breathing-focused somatic practices (breathwork) are described as tools for regulating arousal, with reviews and safety analyses noting their physiological effects and safety considerations. This provides mechanistic backing for the claim that structured breathing approaches (such as box breathing or diaphragmatic breathing) can influence autonomic balance and stress responses relevant to ADHD/trauma presentations. \n- Box/breathing and Tai Chi are highlighted as mindful body practices associated with reduced hyperarousal and improved regulation, aligning with the field value's emphasis on consistent practice patterns and extended durations to realize benefits. Several sources discuss box breathing, diaphragmatic breathing, and Tai Chi in the context of PTSD/trauma and mood regulation, indicating that regular practice over weeks can yield meaningful outcomes in emotional regulation and sleep quality. \n- Mindfulness-based interventions (MBIs) and MBCT/MBI variants are repeatedly shown to reduce PTSD symptoms and improve affective regulation, which complements the specific yoga/breathing modalities described. This broader literature base supports that body-centered mindfulness practices contribute to symptom relief and improved regulation, particularly when delivered consistently over time and integrated with other therapies. \n- ADHD-focused yoga and breathwork studies provide converging evidence that yoga-based and breath-focused practices can positively affect attention, hyperactivity, and executive functioning in ADHD populations, supporting the applicability of these somatic approaches beyond PTSD and into ADHD symptom domains. The ADHD-related yoga and mindfulness literature aligns with the field value's broader goal of improving self-regulation through embodied practice. \n- Taken together, these excerpts collectively corroborate that integrating yoga and breathwork into trauma-informed or trauma-focused regimens can facilitate emotional regulation and processing of traumatic material, with clinically meaningful change emerging with regular, sustained practice over weeks to months. They also suggest that similar embodied practices may support ADHD-related self-regulation, attention, and arousal modulation, particularly when part of a multimodal treatment plan. The convergence across PTSD-focused yoga, breathwork, MBIs, and ADHD-oriented yoga literature provides moderate-to-strong support for the proposed fine-grained field value.",
      "confidence": "high"
    },
    {
      "field": "lifestyle_and_behavioral_interventions.sleep_optimization_strategies",
      "citations": [
        {
          "title": "Treatment of attention deficit hyperactivity disorder ...",
          "url": "https://www.dovepress.com/article/download/11876",
          "excerpts": [
            "by RE Fargason · 2013 · Cited by 24 — that advancing the circadian phase in ADHD subjects by use of morning bright light therapy is strongly correlated with improvement in core ADHD symptoms.13 ..."
          ]
        },
        {
          "title": "Correcting delayed circadian phase with bright light ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022395616307579",
          "excerpts": [
            "by RE Fargason · 2017 · Cited by 67 — This open-label pilot study suggests that BLT is a feasible treatment for adults with ADHD and may be a successful complementary treatment for delayed sleep ..."
          ]
        }
      ],
      "reasoning": "The requested finegrained field focuses on sleep optimization strategies, including ADHD-tailored CBT-I approaches and circadian-related interventions such as Bright Light Therapy (BLT). Within the provided excerpts, evidence directly addressing circadian-based interventions for ADHD is present. One excerpt reports that advancing the circadian phase in ADHD subjects via morning bright light therapy is strongly correlated with improvement in core ADHD symptoms, indicating BLT can influence both sleep-related circadian timing and daytime ADHD manifestations. Another excerpt describes BLT as a feasible treatment for adults with ADHD and suggests it may be a successful complementary treatment for delayed sleep phases, which aligns with a sleep-optimization strategy targeting circadian alignment. Together, these excerpts ground the notion that BLT can modulate circadian rhythms and ADHD symptoms, supporting the aspect of sleep optimization through circadian interventions. Although there is robust discussion of BLT, there is less direct evidence in the excerpts for a cognitive-behavioral therapy for insomnia (CBT-I) tailored specifically to adult ADHD, which limits confirmation of the full CBT-I component within the finegrained field. The strongest support among the excerpts centers on BLT-related circadian adjustment and its relation to ADHD symptoms, with moderate inference possible toward sleep-phase optimization for ADHD populations.",
      "confidence": "medium"
    },
    {
      "field": "psychedelic_and_dissociative_assisted_therapies",
      "citations": [
        {
          "title": "MDMA-assisted therapy for moderate to severe PTSD: a randomized ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10579091/",
          "excerpts": [
            "Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms ..."
          ]
        },
        {
          "title": "A Multi-Site Phase 3 Study of MDMA-Assisted Therapy ...",
          "url": "https://maps.org/mdma/ptsd/mapp1/",
          "excerpts": [
            "Three sessions of MDMA-assisted therapy significantly reduced PTSD symptoms and functional impairment, compared to placebo."
          ]
        },
        {
          "title": "So how special is special K? A systematic review and meta ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10791091/",
          "excerpts": [
            "por NC Borgogna · 2024 · Mencionado por 11 — Ketamine-for-PTSD RCTs reveal a nominal initial therapeutic advantage relative to controls. However, bias and heterogeneity appear problematic."
          ]
        },
        {
          "title": "FDA advisers reject MDMA as treatment for PTSD",
          "url": "https://www.npr.org/sections/shots-health-news/2024/06/04/nx-s1-4991112/mdma-therapy-ptsd-fda-advisors",
          "excerpts": [
            "Jun 4, 2024 — Following public comment and discussion, the panel voted 9-2 that MDMA – in combination with talk therapy – is not effective for treating PTSD."
          ]
        },
        {
          "title": "Why FDA Panel Rejected MDMA for PTSD Treatment",
          "url": "https://www.psychiatrist.com/news/why-fda-panel-rejected-mdma-for-ptsd-treatment/",
          "excerpts": [
            "Jun 5, 2024 — Clinical relevance: An FDA advisory panel voted against the use of MDMA – or ecstasy – to treat post-traumatic stress disorder."
          ]
        },
        {
          "title": "MDMA-assisted psychotherapy for treatment of PTSD: study design ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31065731/",
          "excerpts": [
            "The between-group Cohen's d effect size was 0.8, indicating a large treatment effect. After two experimental sessions, more participants in ..."
          ]
        },
        {
          "title": "A Randomized Controlled Trial of Repeated Ketamine ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33397139/",
          "excerpts": [
            "This randomized controlled trial provides the first evidence of efficacy of repeated ketamine infusions in reducing symptom severity in ..."
          ]
        },
        {
          "title": "MDMA/PTSD Regulatory Update and Trial Data (Pharmacy Times / FDA Proceedings)",
          "url": "https://www.pharmacytimes.com/view/mdma-rejected-the-story-of-a-study-participant-entrenched-in-ethical-violations-and-a-data-breach",
          "excerpts": [
            "There were no serious adverse events in the MDMA arms of either trial."
          ]
        },
        {
          "title": "FDA Issues CRL to Lykos for MDMA-Assisted Therapy",
          "url": "https://www.psychiatrictimes.com/view/fda-issues-crl-to-lykos-for-mdma-assisted-therapy",
          "excerpts": [
            "The US Food and Drug Administration issues a complete response letter (CRL) for Lykos’s midomafetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder (PTSD), noting it cannot be approved based on the data submitted. The FDA has requested an additional Phase 3 trial examining safety and efficacy."
          ]
        },
        {
          "title": "Lykos Therapeutics Announces Complete Response Letter ...",
          "url": "https://www.prnewswire.com/news-releases/lykos-therapeutics-announces-complete-response-letter-for-midomafetamine-capsules-for-ptsd-302219182.html",
          "excerpts": [
            "Aug 9, 2024 — On February 9, 2024, the FDA accepted the company's NDA for midomafetamine used in combination with psychological intervention for adults with ..."
          ]
        },
        {
          "title": "MDMA-Assisted Therapy for PTSD",
          "url": "https://maps.org/mdma/ptsd/",
          "excerpts": [
            "The safety and efficacy of MDMA-assisted therapy is currently under investigation. It is not yet approved by the FDA, does not work for everyone, ..."
          ]
        },
        {
          "title": "FDA advisors voted against MDMA therapy – researchers ...",
          "url": "https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it",
          "excerpts": [
            "Jun 20, 2024 — A vote against using MDMA as part of therapy for PTSD has provoked a powerful backlash among researchers who study psychedelic drugs."
          ]
        },
        {
          "title": "Effectiveness of Ketamine for the Treatment of Post- ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38559428/",
          "excerpts": [
            "by TM Almeida · 2024 · Cited by 22 — Our findings suggest that ketamine holds promise as an effective treatment option for PTSD. However, further trials are imperative to establish robust data ..."
          ]
        },
        {
          "title": "Ketamine in the effective management of chronic pain ...",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1338581/full",
          "excerpts": [
            "by JJW Liu · 2024 · Cited by 5 — This review provides a preliminary synthesis of available evidence which suggests that ketamine may be a potential option for the treatment of depression, PTSD ..."
          ]
        },
        {
          "title": "FDA Psychopharmacologic Advisory Committee Votes ...",
          "url": "https://www.hcplive.com/view/live-updates-fda-psychopharmacologic-advisory-committee-meeting-mdma-ptsd",
          "excerpts": [
            "Jun 4, 2024 — The US Food and Drug Administration (FDA) Psychopharmacologic Advisory Committee (PDAC) voted 2-9 against supporting the effectiveness of MDMA in the treatment ..."
          ]
        }
      ],
      "reasoning": "The finegrained field value centers on MDMA-assisted therapy for PTSD, including detailed trial evidence and regulatory outcomes. The strongest direct support comes from explicit MDMA-AT trial reports and regulatory documents: MDMA-assisted therapy for PTSD (Mitchell et al., 2023) provides primary clinical efficacy signals from phase 3 trials (MAPP1/MAPP2) that MDMA plus psychotherapy reduced CAPS-5 PTSD symptoms versus placebo, which is the core efficacy claim of the description. This is complemented by later regulatory developments: a FDA Psychopharmacologic Advisory Committee vote against MDMA-AT in 2024 and a subsequent Complete Response Letter (CRL) in August 2024, which are the crucial regulatory endpoints noted in the field value. Together these excerpts establish the clinical promise of MDMA-AT and the later regulatory rejection, matching the description of efficacy signals but regulatory denial in 2024.\n\nOther excerpts reinforce the same narrative: summaries and analyses of the MAPP trials and FDA decision(s) help connect the claimed efficacy to the regulatory status. Reports describing NDA submissions, committee votes, and the CRL provide explicit links to the \"legal_and_regulatory_status_2025\" claim. Additional MDMA-related materials (NDA status, trial design details, safety considerations) support the clinical evidence backbone of the field value, while also illustrating why the regulatory body did not grant approval despite positive efficacy signals. While some excerpts also discuss MDMA-related safety concerns and data integrity debates, they align with the notion that regulatory authorities require robust, unambiguous evidence, helping explain the CRL outcome in 2024.\n\nIn terms of ordering by relevance, the most directly relevant items are those that name MDMA-assisted therapy for PTSD, report phase 3 trial findings, and document the FDA decision, in that order. Items detailing broader PTSD pharmacotherapies or other psychedelics are less directly tied to the precise finegrained field value (MDMA for PTSD) and are therefore ranked after for minimally relevant context. The cited MDMA-focused sources provide the core evidentiary chain for the finegrained field value, while associated regulatory and trial-design notes provide necessary context for understanding the final regulatory status.",
      "confidence": "high"
    },
    {
      "field": "lifestyle_and_behavioral_interventions.nutrition_and_dietary_patterns",
      "citations": [
        {
          "title": "Dietary Alignment with the Mediterranean Diet is Associated with a Lower Risk of Attention Deficit Hyperactivity Disorder in University Students: A Cross-Sectional Study",
          "url": "https://www.tandfonline.com/doi/full/10.1080/27697061.2025.2480140?src=exp-la",
          "excerpts": [
            "Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders of childhood, causing cognitive and social dysfunctions. Symptoms may persist into adolescence and adulthood or may occur later in life without childhood onset. Nutrition, which is an environmental risk factor, is also important in the treatment of ADHD. The Mediterranean diet (MD) is a dietary model in accordance with the nutritional recommendations indicated in ADHD."
          ]
        },
        {
          "title": "ADHD Nutrition and Diet Review (PMC 2023)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10444659/",
          "excerpts": [
            "The association between adherence to a Mediterranean diet containing vegetables, legumes, nuts, fruits, grains, and fish, as assessed using a food frequency questionnaire, and the odds of ADHD, as diagnosed using the DSM-IV, in primary school children aged 7 to 13 years was investigated in an age- and sex-matched case–control study from Iran [[66]()]. After adjusting for several potential confounders, the children in the highest tertile of Mediterranean diet adherence had a lower odd of ADHD in comparison with those in the lowest.",
            "A randomized controlled trial investigated the effect of this diet administered for 12 weeks to 80 children with ADHD aged 6 to 12 years [[68]()].",
            "The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial. Eur J Nutr. 2021;60:3647–3658. doi: 10.1007/s00394-021-02527-x.",
            "The results of an 8-week cross-sectional dietary intervention study from Spain investigating the effect of a Mediterranean diet on the progression of impulsive behavior, as assessed using the self-administered Barratt impulsiveness scale, in 60 children and adolescents with ADHD aged 6–16 years were inconclusive [[67]()].",
            "by KW Lange · 2023 · Cited by 43 — Dietary supplementation with zinc and iron showed improvements in ADHD symptom severity compared to placebo control. However, the effect sizes ...",
            "This meta-analysis including 22 studies (1280 individuals with ADHD and 1200 controls) found no statistically significant difference in hair and serum/plasma zinc levels between people with ADHD and controls ."
          ]
        }
      ],
      "reasoning": "The finest-grained field value centers on nutrition and dietary patterns, highlighting the Mediterranean diet as a potentially protective or beneficial pattern for ADHD symptoms, the role of elimination diets as possible triggers to identify, and ensuring adequate intake of essential vitamins and minerals for long-term efficacy. The most relevant excerpts directly address these points. The first excerpt notes an association between adherence to a Mediterranean dietary pattern and a lower risk of ADHD, aligning with the emphasis on dietary patterns and potential benefits. A closely related excerpt reinforces this by examining the same Mediterranean approach and its relationship with ADHD odds, showing supportive evidence for the proposed dietary pattern. A subsequent excerpt reports on a randomized dietary intervention study, illustrating how specific diet modifications (including a Mediterranean-style pattern) were studied for ADHD outcomes, which directly matches the request for practical, actionable dietary patterns and their effects. Another excerpt broadens the scope to include the DASH diet and its impact on ADHD symptoms, which sits within the same domain of nutrient-rich dietary patterns and lifestyle approaches for symptom management, expanding the catalog of viable dietary strategies. An additional excerpt discusses inconclusive findings on the Mediterranean diet's effect on impulsive behavior within ADHD populations, reflecting the nuanced evidence base and the need to consider variability in outcomes. Further, discussions about micronutrient supplementation (zinc and iron) are part of the broader nutrition narrative around ADHD management, relevant for long-term nutritional sufficiency, even if not restricted to Mediterranean patterns alone. Finally, an excerpt addressing zinc levels in ADHD provides context for micronutrient considerations, reinforcing the nutrient-sufficiency aspect of the research theme. Collectively, these excerpts map onto the field value by validating Mediterranean-style dietary patterns, exploring elimination or targeted dietary approaches, and emphasizing maintaining adequate micronutrient intake for sustained effects.",
      "confidence": "medium"
    },
    {
      "field": "comprehensive_safety_and_harm_reduction_guide",
      "citations": [
        {
          "title": "Safety of Stimulants Across Patient Populations: A Meta- ...",
          "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2833773",
          "excerpts": [
            "by HNP Oliva · 2025 · Cited by 1 — Stimulants such as methylphenidate, lisdexamfetamine, and other amphetamines were associated with an increased risk of overall AEs compared with placebo.",
            "by HNP Oliva · 2025 · Cited by 1 — This meta-analysis found an increased risk of AEs with stimulant use compared with placebo, without clinically significant cardiovascular ...",
            "Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. ﻿ _CNS Spectr_ . 2005;10(12﻿ suppl 20):16-25. doi: [10\\.1017/S1092852900002406](https://dx.doi.org/10.1017/S1092852900002406"
          ]
        },
        {
          "title": "Lancet Psychiatry Ostinelli et al., 2025 (ADHD in adults: pharmacological treatments and network meta-analysis)",
          "url": "https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00360-2/fulltext",
          "excerpts": [
            "stimulants were the only intervention that was supported by evidence of efficacy in the short term (ie, at timepoints closest to 12 weeks) for core symptoms of ADHD in adults (both self-reported and clinician-reported) and was associated with good acceptability (all-cause discontinuation).",
            "Atomoxetine was efficacious but with worse overall acceptability than placebo.",
            "However, atomoxetine was less acceptable than placebo."
          ]
        },
        {
          "title": "Pharmacological Treatments for ADHD QoL and Efficacy – Meta-analytic Synthesis (Sciencedirect)",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856724003046",
          "excerpts": [
            "analyses. We found that amphetamines (Hedge's _g_ = 0.51, 95% CI = 0.08, 0.94), methylphenidate (0.38; 0.23, 0.54), and atomoxetine (0.30; 0.19, 0.40) were significantly more efficacious than placebo in improving QoL in people with ADHD, with moderate effect size."
          ]
        },
        {
          "title": "NICE NG87: Attention Deficit Hyperactivity Disorder in Adults - Recommendations",
          "url": "https://www.nice.org.uk/guidance/ng87/chapter/recommendations",
          "excerpts": [
            "Offer lisdexamfetamine or methylphenidate as first-line pharmacological treatment for adults with ADHD.",
            "Consider switching to lisdexamfetamine for adults who have had a 6‑week trial of methylphenidate at an adequate dose but have not derived enough benefit in terms of reduced ADHD symptoms and associated impairment.",
            "Consider switching to methylphenidate for adults who have had a 6‑week trial of lisdexamfetamine at an adequate dose but have not derived enough benefit in terms of reduced ADHD symptoms and associated impairment.",
            " physical health conditions (for example, cardiac disease, epilepsy or acquired brain injury). **[2018",
            "Monitor young people and adults with ADHD for sexual dysfunction (that is, erectile and ejaculatory dysfunction) as potential adverse effects of atomoxetine. **[2018]**",
            ".8.10\n\nDo not offer routine blood tests (including liver function tests) or ECGs to people taking medication for ADHD unless there is a clinical indication. **[2018]**",
            ".8.11\n\nIf a person taking ADHD medication has sustained resting tachycardia (more than 120 beats per minute), arrhythmia or systolic blood pressure greater than the 95th percentile (or a clinically significant increase) measured on 2 occasions, reduce their dose and refer them to a paediatric hypertension specialist or adult physician. **[2018]**",
            "If a person with ADHD develops new seizures or a worsening of existing seizures, review their ADHD medication and stop any medication that might be contributing to the seizures. After investigation, cautiously reintroduce ADHD medication if it is unlikely to be the cause of the seizures. **[2018]**",
            "Healthcare professionals and parents or carers should monitor changes in the potential for stimulant misuse and diversion, which may come with changes in circumstances and age. **[2018]**",
            "Monitor the behavioural response to medication, and if behaviour worsens adjust medication and review the diagnosis. **[2018]**"
          ]
        },
        {
          "title": "SPRAVATO Prescribing Information",
          "url": "http://janssenlabels.com/package-insert/product-monograph/prescribing-information/SPRAVATO-pi.pdf",
          "excerpts": [
            "SPRAVATO may cause sedation or loss of consciousness. In some cases, patients\n\nmay display diminished or less apparent breathing. In clinical trials, 48% to 61% of\n\nSPRAVATO-treated patients developed sedation based on the Modified Observer’s\n\nAssessment of Alertness/Sedation scale (MOAA/S) _[see Adverse Reactions (6.1)]_ ,\n\nand 0.3% to 0.4% of SPRAVATO-treated patients experienced loss of consciousness\n\n(MOAA/S score o",
            "The most common psychological effects of SPRAVATO were dissociative or\n\nperceptual changes (including distortion of time, space and illusions), derealization\n\nand depersonalization (61% to 84% of SPRAVATO-treated patients developed\n\ndissociative or perceptual changes based on the Clinician-Administered Dissociative\n\nStates Scale) _[see Adverse Reactions (6."
          ]
        },
        {
          "title": "Clinical Practice Guidelines for the Use of Electroconvulsive Therapy - PMC",
          "url": "http://ncbi.nlm.nih.gov/pmc/articles/PMC10096214",
          "excerpts": [
            "\nElectroconvulsive therapy (ECT)"
          ]
        },
        {
          "title": "Label for Adderall - accessdata.fda.gov",
          "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/011522s043lbl.pdf",
          "excerpts": [
            "Sudden death has been reported in association with CNS stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or ...See more"
          ]
        },
        {
          "title": "[PDF] POTENTIAL CARDIOVASCULAR RISKS OF ADHD MEDICATIONS",
          "url": "https://www.caddra.ca/pdfs/caddraGuidelines2011Document7D_Cardiovascular.pdf",
          "excerpts": [
            "2. \"Stimulants such as the amphetamines and methylphenidate (Ritalin®) cause slight but clinically insignificant increases in heart rate and blood pressure.\"."
          ]
        },
        {
          "title": "Stimulants DSC",
          "url": "https://www.fda.gov/media/168066/download",
          "excerpts": [
            "May 11, 2023 — FDA Drug Safety Communication. FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions.See more"
          ]
        },
        {
          "title": "Adult ADHD Medications and Their Cardiovascular Implications - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4992783/",
          "excerpts": [
            "Cardiovascular response attributed to ADHD medication has mainly been observed in heart rate and blood pressure elevations, while less is known about the ..."
          ]
        },
        {
          "title": "ADHD Medications: How They Work & Side Effects",
          "url": "https://my.clevelandclinic.org/health/treatments/11766-adhd-medication",
          "excerpts": [
            "However, under the care and supervision of your provider, stimulant medication use is safe. Before they prescribe you a stimulant, your provider may order an ..."
          ]
        },
        {
          "title": "The adult ADHD assessment quality assurance standard",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11327143/",
          "excerpts": [
            "by M Adamou · 2024 · Cited by 6 — An electrocardiogram (ECG) is not routinely required. Always record baseline blood pressure, pulse and weight [essential]."
          ]
        },
        {
          "title": "Clinical Practice Guidelines for the Use ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10096214/",
          "excerpts": [
            "by J Thirthalli · 2023 · Cited by 43 — This guideline document is aimed at enabling consistent, safe, and effective practice of ECT in patients in applicable psychiatric disorders."
          ]
        },
        {
          "title": "Electroconvulsive Therapy: Contraindications",
          "url": "https://anconsultants.com/electroconvulsive-therapy-ect/",
          "excerpts": [
            "Aug 17, 2015 — The list of contraindications includes recent MI, heart failure, recent stroke, elevated ICP, aneurysm/AVM at risk of rupture, pheochromocytoma, severe HTN, ..."
          ]
        },
        {
          "title": "Anesthetic care for electroconvulsive therapy - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9091667/",
          "excerpts": [
            "by KW Joung · 2022 · Cited by 14 — Although ECT is a low-risk procedure, certain hemodynamic abnormalities may increase the risk of complications in patients with cardiovascular disease. Abrupt ..."
          ]
        },
        {
          "title": "Safety and recommendations for TMS use in healthy subjects and patient populations",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9094636/",
          "excerpts": [
            "The expansion of protocols and putative indications in psychiatry converges with the problem that psychiatric side effects are difficult to follow across studies."
          ]
        },
        {
          "title": "Basal Exposure Therapy: A New Approach for Treatment ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5165038/",
          "excerpts": [
            "by D Heggdal · 2016 · Cited by 12 — Such treatment-resistant patients often have diagnoses of psychotic or bipolar disorders or severe personality disorders and comorbid conditions ..."
          ]
        },
        {
          "title": "Prazosin - StatPearls",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK555959/",
          "excerpts": [
            "by R Basquez · 2023 · Cited by 16 — Serious adverse effects include first-dose hypotension ... first-dose phenomenon associated with the initiation of therapy with prazosin."
          ]
        },
        {
          "title": "[PDF] Ritalin - accessdata.fda.gov",
          "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/010187s092s096lbl.pdf",
          "excerpts": [
            "This label may not be the latest approved by FDA. For current labeling information, please visit https://www.fda.gov/drugsatfda. Page 2. FULL PRESCRIBING ..."
          ]
        },
        {
          "title": "[PDF] SPRAVATO® (esketamine) nasal spray, CIII - accessdata.fda.gov",
          "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf",
          "excerpts": [
            "5.7 Increase in Blood Pressure SPRAVATO causes increases in systolic and/or diastolic blood pressure (BP) at all recommended doses. Increases in BP peak ..."
          ]
        },
        {
          "title": "Lilly Announces Important Liver Safety Update to Strattera ...",
          "url": "https://investor.lilly.com/news-releases/news-release-details/lilly-announces-important-liver-safety-update-stratterar-label",
          "excerpts": [
            "This label change discusses two reported cases of severe liver injury out of the more than 2 million patients who have taken the medication since approval. Both ..."
          ]
        },
        {
          "title": "The MIT Press/HDSR article on N-of-1 trials and Bayesian inference",
          "url": "https://hdsr.mitpress.mit.edu/pub/b6efwlql",
          "excerpts": [
            "By combining the data from a collection of N-of-1 trials, Bayesian multilevel models also lead naturally to inferences about average treatment effects and heterogeneity of effects across subgroups in the population and to improved inferences about effects in individuals."
          ]
        },
        {
          "title": "Bayesian Methods in Clinical Trials",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10117244/",
          "excerpts": [
            "One particular appeal of Bayesian methods is the use of sequential learning and Bayesian interim decision-making."
          ]
        },
        {
          "title": "WHOQOL-BREF",
          "url": "https://depts.washington.edu/seaqol/docs/WHOQOL-BREF%20and%20Scoring%20Instructions.pdf",
          "excerpts": [
            "This questionnaire asks how you feel about your quality of life, health, or other areas of your life. Please answer all the questions. If you are unsure about."
          ]
        },
        {
          "title": "Validity of specific CPT indices in differentiating school ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11515130/",
          "excerpts": [
            "by JD Tsai · 2024 · Cited by 1 — To determine the validity of specific CPT indices in differentiating between school-aged children with ADHD from with non-ADHD, each student's ..."
          ]
        },
        {
          "title": "Digital interventions for ADHD: a meta-analysis (SciDirect)",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032724013910",
          "excerpts": [
            "The current meta-analysis investigates the effectiveness of digital mental health interventions for ADHD synthesising data across 23 randomised controlled trials, with 99 effect sizes across 1,472 participants.",
            "Results showed small, significant effects of digital mental health interventions in reducing overall ADHD symptoms ( _g_ = −0.32, _SE_ = 0.11, 95 % _CI_ = [-0.53, −0.11], _p_ = .003) and inattentive symptoms ( _g_ = −0.25, _SE_ = 0.11, 95 % _CI_ = [-0.47, −0.0",
            "eurofeedback interventions showing lower effectiveness compared to combination-based interventions, while telehealth and mHealth interventions showed no significant differences."
          ]
        },
        {
          "title": "Understanding Bayesian linear regression & Gaussian process with ...",
          "url": "https://jonathan-hui.medium.com/bayesian-linear-regression-gaussian-process-with-normal-distribution-e686f7846ad1",
          "excerpts": [
            "Bayesian linear regression takes advantage of the “convenience” of normal distribution operations and solves the regression problem analytically."
          ]
        },
        {
          "title": "Visualizing the differences between Bayesian posterior ...",
          "url": "https://www.andrewheiss.com/blog/2022/09/26/guide-visualizing-types-posteriors/",
          "excerpts": [
            "A guide to different types of Bayesian posterior distributions and the nuances of posterior_predict, posterior_epred, and posterior_linpred."
          ]
        },
        {
          "title": "PCL-5: Scoring and interpretation",
          "url": "https://comorbidityguidelines.org.au/appendix-s-ptsd-checklist-for-dsm5-pcl5/pcl5-scoring-and-interpretation",
          "excerpts": [
            "Summing all 20 items (range 0-80) and using a cut-point score of 31-33 which appears to be reasonable based upon current psychometric work."
          ]
        },
        {
          "title": "Coverage Policy - Transcranial Magnetic Stimulation",
          "url": "https://static.cigna.com/assets/chcp/pdf/coveragePolicies/medical/en_mm_0383_coveragepositioncriteria_transcranial_magnetic_stimulation.pdf",
          "excerpts": [
            "This Coverage Policy addresses the various types of transcranial magnetic stimulation (TMS) for the treatment of unipolar major depressive ..."
          ]
        },
        {
          "title": "ADHD Medication Costs 2025 - SingleCare article",
          "url": "https://www.singlecare.com/blog/adhd-medication-cost/",
          "excerpts": [
            "escription/amphetamine-dextroamphetamine/what-is) | $127 per 60, 20 mg tablets | $2 per 20 mg tablet | [See latest prices](https://www.singlecare.com/prescription/amphetamine-dextroamphetamine",
            "xr/what-is) | $346 per 30, 30 mg capsules | $12 per 30 mg capsule | [See latest prices](https://www.singlecare.com/prescription/adderall-xr)",
            "Generic Adderall XR (amphetamine-dextroamphetamine ER)](https://www.singlecare.com/prescription/amphetamine-dextroamphet-er/what-is) | $254 per 30, 30 mg capsules | $8 per 30 mg capsule | [See latest pr"
          ]
        },
        {
          "title": "MDMA-Assisted Therapy for PTSD - National Center for PTSD",
          "url": "https://www.ptsd.va.gov/understand_tx/mdma_assisted_therapy.asp",
          "excerpts": [
            "Although MDMA is not approved for clinical use by the FDA, it can be studied in research settings. There is hope that psychedelic-assisted therapy, including ..."
          ]
        },
        {
          "title": "How much does ADHD medication cost?",
          "url": "https://adhddirect.co.uk/help-center/how-much-does-adhd-medication-cost/",
          "excerpts": [
            "Methylphenidate Hydrochloride MR (£23 – £46 for a starting dose); Elvanse (Lisdexamfetamine Dimesylate) £85 for a starting dose). However, the cost can vary ..."
          ]
        },
        {
          "title": "Our Pricing",
          "url": "https://www.careadhd.co.uk/pricing",
          "excerpts": [
            "Our Pricing · ADHD Assessment £299.00 · Medication Initiation Service £499.00 · Psychological Support via our App £230.00."
          ]
        },
        {
          "title": "Pharmaceutic Pricing",
          "url": "https://pricingdoc.acfp.ca/pricing/",
          "excerpts": [
            "Stimulants (ADHD). Methylphenidate, Ritalin, 10 mg, BID, $60, BC ... © Copyright 2025 Pharmaceutic Pricing | Site by BubbleUP · BubbleUP · Statcounter · web ..."
          ]
        },
        {
          "title": "Average 618-day wait for adult ADHD assessment - BBC",
          "url": "https://www.bbc.com/news/articles/c5ypk245yp4o",
          "excerpts": [
            "On average, adults are waiting more than a year and a half for an ADHD assessment at TEWV NHS Trust."
          ]
        },
        {
          "title": "Wait Times for Psychiatric Specialist Services in Australia",
          "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830766",
          "excerpts": [
            "by O Yang · 2025 · Cited by 3 — Compared with 2011 when the median (IQR) wait time was 15 (1-52) days, wait time rose to 50 (10-113) days in 2022, with similar upward trends ..."
          ]
        },
        {
          "title": "Cortese et al. 2018 Network Meta-analysis of ADHD medications",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30097390/",
          "excerpts": [
            "by S Cortese · 2018 · Cited by 1453 — We aimed to estimate the comparative efficacy and tolerability of oral medications for ADHD in children, adolescents, and adults. M",
            "We did a literature search for published and unpublished double-blind randomised controlled trials comparing amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil with each other or placebo.",
            "Primary outcomes were efficacy (change in severity of ADHD core symptoms based on teachers' and clinicians' ratings) and tolerability (proportion of patients who dropped out of studies because of side-effects) at timepoints closest to 12 weeks, 26 weeks, and 52 weeks.",
            "ol and confidence of estimates with the Grading of Recommendations Assessment, Development, and Evaluation approach for network meta-analyses. This study ",
            "Interpretation:**\nOur findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADH",
            "by S Cortese · 2018 · Cited by 1453 — Evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for ..."
          ]
        },
        {
          "title": "Amphetamines for attention deficit hyperactivity disorder (ADHD) in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6513464/",
          "excerpts": [
            "Lisdexamfetamine and MAS also reduced the severity of ADHD symptoms as rated by clinicians, but dexamphetamine did not. Overall, amphetamines did not make ..."
          ]
        },
        {
          "title": "DBT for adults with ADHD: randomized controlled trial and meta-analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36443712/",
          "excerpts": [
            "This DBT-bGT was superior to TAU in reducing executive dysfunction, core symptoms of ADHD and in improving quality of life in adults with ADHD."
          ]
        },
        {
          "title": "Dialectical behavioral therapy-based group treatment versus ...",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-022-04356-6",
          "excerpts": [
            "This DBT-bGT was superior to TAU in reducing executive dysfunction, core symptoms of ADHD and in improving quality of life in adults with ADHD."
          ]
        },
        {
          "title": "Tolerance to Stimulant Medication for Attention Deficit ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9332474/",
          "excerpts": [
            "by K Handelman · 2022 · Cited by 28 — This may suggest chronic tolerance to the medication in adults treated for up to 26 weeks [18]."
          ]
        },
        {
          "title": "GRADE home",
          "url": "https://www.gradeworkinggroup.org/",
          "excerpts": [
            "GRADE evidence to decision frameworks for tests in clinical practice and public health. ... Act as an executive committee for the GRADE Working Group (GWG) ..."
          ]
        },
        {
          "title": "a framework for ranking evidence evaluating healthcare interventions",
          "url": "https://pubmed.ncbi.nlm.nih.gov/12519253/",
          "excerpts": [
            "The proposed hierarchy of evidence focuses on three dimensions of the evaluation: effectiveness, appropriateness and feasibility."
          ]
        },
        {
          "title": "Implementability of healthcare interventions: an overview of reviews ...",
          "url": "https://implementationscience.biomedcentral.com/articles/10.1186/s13012-021-01171-7",
          "excerpts": [
            "The aim of this paper is to develop a testable conceptual framework of implementability of healthcare interventions that includes these five concepts."
          ]
        },
        {
          "title": "protocol for a systematic review and network meta-analysis - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35277411/",
          "excerpts": [
            "Secondary outcomes will include tolerability (drop-out due to side effects) and change in the severity of emotional dysregulation, executive ..."
          ]
        },
        {
          "title": "Levelized cost-based learning analysis of utility-scale wind and ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2589004222006496",
          "excerpts": [
            "Missing: SMD responder mapping"
          ]
        },
        {
          "title": "[PDF] Utility-Scale Renewable Energy Generation Technology Roadmap",
          "url": "https://www.energy.ca.gov/sites/default/files/2021-05/CEC-500-2020-062.pdf",
          "excerpts": [
            "Missing: SMD responder"
          ]
        },
        {
          "title": "Is Cognitive Behavior Therapy Effective for Treating Adult ADHD?",
          "url": "https://www.adhdevidence.org/blog/is-cognitive-behavior-therapy-effective-for-treating-adult-adhd",
          "excerpts": [
            "For both types of study, the effect of CBT in reducing ADHD symptoms was statistically significant, with a standardized mean effect size of 0.4.",
            "Based on a meta-analysis by Young and colleagues, we know for certain that the number of published trials of CBT for adult ADHD is small; only nine trials are available.",
            "In all of these studies, patients in the CBT and control groups were also being treated with ADHD medications.",
            "the waiting list controlled studies and the placebo-controlled studies separately."
          ]
        },
        {
          "title": "Article: Multiple Criteria Decision Analysis for Health Care Decision Making - An Introduction",
          "url": "https://www.ispor.org/heor-resources/good-practices/article/multiple-criteria-decision-analysis-for-health-care-decision-making---an-introduction",
          "excerpts": [
            "Multiple Criteria Decision Analysis for Health Care Decision Making - An Introduction: Report 1"
          ]
        },
        {
          "title": "Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27021745/",
          "excerpts": [
            "This second task force report provides emerging good-practice guidance on the implementation of MCDA to support health care decisions.",
            "The report includes: a checklist to support the design, implementation and review of an MCDA; guidance to support the implementation of the checklist; the order in which the steps should be implemented; illustrates how to incorporate budget constraints into an MCDA; provides an overview of the skills and resources, including available software, required to implement MCDA; and future research directions."
          ]
        },
        {
          "title": "Post hoc Responder and Remission Analyses from Two ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7475095/",
          "excerpts": [
            "by LA Adler · 2020 · Cited by 4 — However, in a small crossover study of MAS IR and LDX, response rates (defined as ADHD-RS with adult prompt TS reductions ≥30%) were 76.2% (16/21) and 82.6% (19 ..."
          ]
        },
        {
          "title": "A Randomized Double-Blind Placebo-Controlled Trial",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3905180/",
          "excerpts": [
            "by M Huss · 2013 · Cited by 77 — Responder analysis showed that over 75% of all MPH-LA treated patients demonstrated greater than 30% improvement in the DSM-IV ADHD RS total score versus ..."
          ]
        },
        {
          "title": "A Phase III, Randomized, Double-Blind, Placebo- ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35896943/",
          "excerpts": [
            "by A Nasser · 2022 · Cited by 54 — Responder rates on CGI scales and the AISRS were also assessed. Results: A total of 374 subjects were randomized. At end of study, the mean ..."
          ]
        },
        {
          "title": "Methylphenidate dose optimization for ADHD treatment",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5505611/",
          "excerpts": [
            "by M Huss · 2017 · Cited by 101 — Overall, MPH is an effective ADHD treatment with a good safety profile; data suggest that dose optimization may enhance the safety and efficacy of treatment."
          ]
        },
        {
          "title": "Review of Lisdexamfetamine Dimesylate in Adults With ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5571766/",
          "excerpts": [
            "by J Najib · 2017 · Cited by 22 — Clinical response was defined as a decrease ≥30% in ADHD-RS-IV from baseline and a CGI-I score of 1 or 2, whereas symptomatic remission was ..."
          ]
        },
        {
          "title": "Long-Term Tolerability and Safety of Pharmacological Treatment of ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6039396/",
          "excerpts": [
            "Finally, a 4-year outcome questionnaire study of pharmacologically treated adults with ADHD reported a 37% discontinuation rate at the 4-year follow-up. Adverse ..."
          ]
        },
        {
          "title": "A Comparison of Cognitive-Behavioral Therapy and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6250816/",
          "excerpts": [
            "A review and meta-analyses of nine randomized controlled trials showed that CBT for adult ADHD was superior to waiting list with a moderate to large effect size (SMD = 0.76, 95% CI [0.21, 1.31], p = 0.006) and superior to active control groups with a small to moderate effect size (SMD = 0.43, 95% CI [0.14, 0.71], p = ..."
          ]
        },
        {
          "title": "A comparison of efficacy between cognitive behavioral therapy (CBT ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165178119307437",
          "excerpts": [
            "We demonstrated that CBT can be effective in adults with ADHD with or without medicine, with no significant differences between groups on core symptoms and ..."
          ]
        },
        {
          "title": "A meta-analysis of mindfulness-based interventions in ...",
          "url": "https://psycnet.apa.org/record/2020-57849-001",
          "excerpts": [
            "by H Poissant · 2020 · Cited by 41 — The results showed that MBIs are effective to treat ADHD symptoms in adults, as well as to reduce depression and dysexecutive problems post-intervention."
          ]
        },
        {
          "title": "A Case Study in Lung Cancer Patient Preferences - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10865764/",
          "excerpts": [
            "by J Veldwijk · 2024 · Cited by 3 — (A) Swing weighting (SW) ranking task in which respondents sort the swings in attributes from worst level to best level by priority for ..."
          ]
        },
        {
          "title": "When continuous outcomes are measured using different ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6890471/",
          "excerpts": [
            "by MH Murad · 2019 · Cited by 254 — Although several approaches are available, the most commonly used method is to multiply the SMD by π/√3 (about 1.81) to produce the natural ..."
          ]
        },
        {
          "title": "Methylphenidate hydrochloride Medicinal forms - Drugs - BNF - NICE",
          "url": "https://bnf.nice.org.uk/drugs/methylphenidate-hydrochloride/medicinal-forms/",
          "excerpts": [
            "NHS indicative price: £3.03. Drug tariff: Part VIIIA Category C. Drug tariff price: £3.03. Legal category: POM (Prescription-only medicine). Show. CD2 (Schedule ..."
          ]
        },
        {
          "title": "Drug Tariff | NHSBSA",
          "url": "https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff",
          "excerpts": [
            "You can view the Drug Tariff 3 working days before the 1 st of each month. The PDF format of the Drug Tariff can be downloaded and used offline."
          ]
        },
        {
          "title": "Discrete choice experiment versus swing-weighting",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10381030/",
          "excerpts": [
            "by C Whichello · 2023 · Cited by 9 — This study compares a discrete choice experiment (DCE) and swing-weighting (SW) by eliciting preferences for glucose-monitoring devices in a population of ..."
          ]
        },
        {
          "title": "Methods to convert continuous outcomes into odds ratios of ...",
          "url": "https://academic.oup.com/ije/article/41/5/1445/711693",
          "excerpts": [
            "by BR da Costa · 2012 · Cited by 153 — Our objective was to determine the performance of methods in converting SMDs or means to odds ratios of treatment response and numbers needed to ..."
          ]
        },
        {
          "title": "Open-label Long-Term Safety and Efficacy of SPN-812 ...",
          "url": "https://clinicaltrials.gov/study/NCT04143217",
          "excerpts": [
            "An additional secondary endpoint was the 30% Adult ADHD Investigator Symptom Rating Scale (AISRS) Responder Rate by visit. The AISRS is an ADHD-specific rating ..."
          ]
        },
        {
          "title": "Mean Difference, Standardized Mean Difference (SMD), ...",
          "url": "https://www.psychiatrist.com/jcp/mean-difference-standardized-mean-difference-smd-and-their-use-in-meta-analysis/",
          "excerpts": [
            "by C Andrade · 2020 · Cited by 686 — These mean differences can be divided by their respective standard deviations (SDs) to yield a statistic known as the standardized mean difference (SMD)."
          ]
        },
        {
          "title": "Non-pharmacological Interventions for Adult ADHD: A Systematic Review - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32036811/",
          "excerpts": [
            "The majority found an improvement in ADHD symptoms with CBT treatment.",
            "Additionally, mindfulness and cognitive remediation have evidence as effective interventions for the core symptoms of ADHD and there is evidence for the use of group dialectical behavioural therapy and hypnotherapy."
          ]
        },
        {
          "title": "GRADE EtD Framework and MCDA for Health Policy",
          "url": "https://www.valueinhealthjournal.com/article/S1098-3015(24)02848-1/fulltext",
          "excerpts": [
            "The GRADE Evidence to Decision (EtD) framework for health system and public health decisions. Health Res Policy Syst. 2018; 16:45. Crossref.",
            "GRADE Evidence to Decision (EtD) framework for different types of decisions (including coverage, health system and public health decisions) | [<sup>111</sup>]() <sup>,</sup> [<sup>112</sup>]()",
            "Stakeholder engagement | Key issues for stakeholder engagement in the development of health and healthcare guidelines."
          ]
        },
        {
          "title": "The GRADE Evidence to Decision (EtD) framework for health system and public health decisions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8653547/",
          "excerpts": [
            "The GRADE Evidence to Decision (EtD) framework for health system and public health decisions.",
            "ISPOR MCDA Emerging Good Practices Task Force.",
            "EtD frameworks are an extremely useful tool for recommendation formulation and decision making in healthcare and other scientific fields.",
            "The GRADE framework is the most well developed, with extensive information and guidance on its methods.",
            "An iterative development process will be needed: a draft framework should be pilot-tested, revised and evaluated."
          ]
        },
        {
          "title": "Trauma-Informed Care and Cultural Humility in the Mental Health Care of People From Minoritized Communities",
          "url": "https://psychiatryonline.org/doi/10.1176/appi.focus.20190027",
          "excerpts": [
            "trauma-informed care can be enhanced by adopting an attitude of cultural humility.",
            "In clinical care, cultural humility can serve as a guiding concept for the practice of trauma-informed care in centering and empowering patients on their journey of healing, rather than making assumptions about the patient’s experience or practicing an authoritative, power-over communication style.",
            "The enrichment that comes from culturally humble encounters with patients from various cultures is a form of ongoing growth that can benefit all psychiatrists both personally and professionally.",
            "Trauma-informed care conforms to the standards of ethical practice recognized in the profession and should not, therefore, be regarded as a development that steers psychiatry away from its core mission but rather as a way that the profession can more readily achieve that mission.",
            "Cultural humility is characterized by principles of mutual learning and critical self-reflection, recognition of power imbalances, and the existence of implicit bias"
          ]
        },
        {
          "title": "Ethical approval and informed consent in mental health research",
          "url": "https://link.springer.com/article/10.1007/s00146-025-02364-0",
          "excerpts": [
            "Informed consent is a crucial aspect of ethical human research, ensuring individuals'autonomy in decision-making. Failing to obtain informed ..."
          ]
        },
        {
          "title": "Social prescribing (SP) and community-based interventions - PMC9389950",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9389950/",
          "excerpts": [
            "Social prescribing (SP) aims to provide targeted psychosocial support and close the gap between medical and non-medical services.",
            "This review assesses the effectiveness of community-based SP interventions.",
            "Current evidence suggests positive effects of SP on a variety of relevant endpoints."
          ]
        },
        {
          "title": "Consent in psychiatry - concept, application & implications - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7055160/",
          "excerpts": [
            "Informed consent is about giving a patient the special knowledge that makes him/her competent to take decisions in a more informed way."
          ]
        },
        {
          "title": "Community-based Collaborative Care for Serious Mental ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12228660/",
          "excerpts": [
            "by S Abdulla · 2025 · Cited by 1 — Community-based collaborative care (CBCC) is an effective approach for addressing the needs of people with mental health conditions."
          ]
        },
        {
          "title": "Cultural Humility: A Key Element of Trauma-Informed Care",
          "url": "https://www.chcs.org/cultural-humility-key-element-trauma-informed-care/",
          "excerpts": [
            "Cultural humility — a respectful approach toward individuals of other cultures that continuously pushes one to challenge cultural biases ..."
          ]
        },
        {
          "title": "National-Practice-Guidelines-for-Peer-Specialists-and- ...",
          "url": "https://www.peersupportworks.org/wp-content/uploads/2021/07/National-Practice-Guidelines-for-Peer-Specialists-and-Supervisors-1.pdf",
          "excerpts": [
            "The original National Practice Guidelines for Peer Supporters (NPG) identified 12 core values of peer support including a short description of each value in ..."
          ]
        },
        {
          "title": "Supervision of Peer Workers",
          "url": "https://www.samhsa.gov/sites/default/files/programs_campaigns/brss_tacs/guidelines-peer-supervision-4-ppt-cp5.pdf",
          "excerpts": [
            "Benefits of Supervision for Peer Workers. • Provides opportunities to reflect on peer support practice. • Delivers better outcomes through learning that comes ..."
          ]
        },
        {
          "title": "Effectiveness and active ingredients of social prescribing ...",
          "url": "https://sirenetwork.ucsf.edu/tools-resources/resources/effectiveness-and-active-ingredients-social-prescribing-interventions",
          "excerpts": [
            "OBJECTIVE: This study aims to establish the effectiveness and active ingredients of UK-based social prescribing interventions targeting mental ..."
          ]
        },
        {
          "title": "Effectiveness of a whole health model of care emphasizing ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9387037/",
          "excerpts": [
            "by SB Zeliadt · 2022 · Cited by 35 — VHA's Whole Health national pilot program was associated with greater reductions in prescribed opioid doses compared to secular trends ..."
          ]
        },
        {
          "title": "Creative Arts Therapies for Trauma and Holistic Integration: Ethical, Cultural Humility, and Community-Based Approaches",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11725198/",
          "excerpts": [
            "The overall SMD using a random-effects model was −1.98, with a 95% CI from −3.80 to −0.16; *p* < 0.05, indicating a statistically significant effect size in favor of the experimental gr",
            "Subgroup analysis indicates that drama therapy was notably effective, while music, art, and dance/movement therapies exhibited less pronounced effects."
          ]
        },
        {
          "title": "Mind-body exercise interventions for PTSD prevention - BMJ Open",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10347470/",
          "excerpts": [
            "Mind-body exercise is widely practised and increasingly offered clinically as an adjunct or supplementary treatment for those with trauma-related disorders.",
            " To date, there is no consensus regarding the efficacy of MBE interventions in preventing the development of trauma-related disorders. Thus, this review aims to systematically examine if, and what type of MBE interventions are effective in preventing the development of PTSD or ASD in trauma-exposed populations.",
            "Although we did not find any studies assessing ASD symptoms, our review found overall limited evidence for MBE interventions in reducing the likelihood of developing PTSD in the short-term among populations with previous or ongoing exposure to trauma. However, these results should be considered tentative as the limited studies identified meant that caution must be applied to the interpretation of these results.",
            "the subgroup analyses on type of MBE interventions showed a relatively larger effect for yoga as a stand-alone intervention compared with yoga as part of the broader MBSR intervention, MBSR studies comprised larger sample sizes with lower variability and likely provided more reliable estimates than stand-alone yoga, which had smaller sample sizes and more variability."
          ]
        },
        {
          "title": "Cultural humility and trauma-informed practices",
          "url": "https://uwphi.pophealth.wisc.edu/evaluation-research/current-evaluation-projects-2/firearmcrisisstrategylibrary/cultural-humility-and-trauma-informed-practices/",
          "excerpts": [
            "Cultural humility includes principles of mutual learning, critical self-reflection, recognition of power imbalances, and existence of implicit biases serving as a guiding concept for the practice of trauma-informed practices 1 . Cultural humility includes principles of mutual learning, critical self-reflection,",
            "\nCultural Humility and Trauma-Informed Practices – Population Health Institute – UW–Madison",
            "Translating Research for Policy and Practice",
            "1 . Cultural humility includes principles of mutual learning, critical self-reflection,…\nCultural Humility and Trauma-Informed Practices – Population Health Institute – UW–Madison\n",
            "Cultural humility includes principles of mutual learning, critical self-reflection, recognition of power imbalances, and existence of implicit biases serving as a guiding concept for the practice of trauma-informed practices 1 . Cultural humility includes principles of mutual learning, critical self-reflection,…\nC"
          ]
        },
        {
          "title": "Study Shows the Success of Whole Health",
          "url": "https://www.va.gov/WHOLEHEALTH/features/Study_Shows_the_Success_of_Whole_Health.asp",
          "excerpts": [
            "A new progress report shows improvement in the lives of Veterans who use Whole Health services. The report gives updates from a three-year pilot study."
          ]
        },
        {
          "title": "Learn About the Collaborative Care Model",
          "url": "https://www.psychiatry.org/psychiatrists/practice/professional-interests/integrated-care/learn",
          "excerpts": [
            "A recent systematic review found strong evidence that collaborative care is effective for improving depression outcomes in racial ethnic minority populations."
          ]
        },
        {
          "title": "How co-locating public mental health interventions in community ...",
          "url": "https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-17404-x",
          "excerpts": [
            "This study evaluates how co-location in community-based settings can support adult mental health and reduce health inequalities."
          ]
        },
        {
          "title": "Homepage — CRF Behavioral Healthcare",
          "url": "https://www.crfbehavioralhealthcare.org/",
          "excerpts": [
            "Our mission is to design and deliver innovative behavioral healthcare and social services. We do so in a way that is trauma-informed and culturally competent."
          ]
        },
        {
          "title": "Community Interventions to Promote Mental Health and Social Equity",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6440941/",
          "excerpts": [
            "We define community interventions as those that involve multi-sector partnerships, emphasize community members as integral to the intervention, ..."
          ]
        },
        {
          "title": "Art Therapy and Cognitive Processing Therapy for Combat- ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5764181/",
          "excerpts": [
            "by M Campbell · 2016 · Cited by 168 — This randomized controlled trial was designed to determine if art therapy in conjunction with Cognitive Processing Therapy (CPT) was more effective for ..."
          ]
        },
        {
          "title": "Music interventions for posttraumatic stress disorder: A systematic ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2950004424000075",
          "excerpts": [
            "Nevertheless, some studies reported large effect sizes (e.g., [20]) and clinically significant reductions in PTSD scores (e.g., a 10 point reduction on the PSS ..."
          ]
        },
        {
          "title": "Impact of dance therapy on adults with psychological trauma",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10334851/",
          "excerpts": [
            "Dance therapy may be a useful technique for improving both psychological and physiological symptoms associated with trauma exposure."
          ]
        },
        {
          "title": "Art Therapy and Cognitive Processing Therapy for Combat ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29332989/",
          "excerpts": [
            "by M Campbell · 2016 · Cited by 168 — This randomized controlled trial was designed to determine if art therapy in conjunction with Cognitive Processing Therapy (CPT) was more effective for reducing ..."
          ]
        },
        {
          "title": "[PDF] Psychological Effects of Training in Martial Arts After Interpersonal ...",
          "url": "https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=7974&context=dissertations",
          "excerpts": [
            "This qualitative phenomenological study addressed the effectiveness of training in the martial arts as an intervention in the treatment of interpersonal trauma ..."
          ]
        },
        {
          "title": "Collaborative mental health care: A narrative review - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9803502/",
          "excerpts": [
            "by C Reist · 2022 · Cited by 121 — The Collaborative Care model is a systematic strategy for treating behavioral health conditions in primary care through the integration of care managers and ..."
          ]
        },
        {
          "title": "Community-Engaged Approaches to Address the Ethical ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7245652/",
          "excerpts": [
            "by ND Hernandez · 2019 · Cited by 5 — Community-based participatory research (CBPR) approaches have shown promise as powerful research tools for understanding and addressing health inequities."
          ]
        },
        {
          "title": "Community-Based Participatory Research Contributions to ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2837458/",
          "excerpts": [
            "by N Wallerstein · 2010 · Cited by 2630 — Community-based participatory research (CBPR) represents a transformative research opportunity to unite the growing interest of health professionals, academics, ..."
          ]
        },
        {
          "title": "Impact of dance therapy on adults with psychological trauma - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37427835/",
          "excerpts": [
            "Dance therapy may be a promising approach for the therapeutic management of psychological trauma as it can address both psychological and physical symptoms."
          ]
        },
        {
          "title": "PMCID: PMC8220835 - The Creative Commons Published Article on Peer Support and Recovery",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8220835/",
          "excerpts": [
            "Peer support is being integrated within mental health services to further the development of a recovery approach.",
            "Recovery was broadly defined as ",
            "a deeply personal, unique process of changing one’s attitudes, values, feelings, goals, skills, and/or roles. It is a way of living a satisfying, hopeful, and contributing life even with limitations caused by [mental health conditions].",
            ",",
            "Eight trials met eligibility criteria, providing data from 2131 participants.",
            " Group peer support interventions were excluded"
          ]
        },
        {
          "title": null,
          "url": "https://jcsm.aasm.org/doi/10.5664/jcsm.7230",
          "excerpts": [
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ","
          ]
        },
        {
          "title": "Systematic Review and Meta-Analysis of Peer-Delivered Interventions for Serious Mental Illness (SMI) – PMC11203176",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11203176/",
          "excerpts": [
            "Outcomes\n\nIncluded studies reported outcomes related to personal recovery such as hope, identity, personal confidence, self-efficacy, quality of life, relationships, empowerment, and working alliance",
            "The research methodology employed in this study is a systematic review and meta-analysis focused on RCTs and published trials while excluding other study types.",
            "Exclusions comprised studies where peer support provided by a peer worker was not the primary intervention method and those where mental health was not the primary focus of the intervention."
          ]
        },
        {
          "title": "The Mental Health and Faith Community Partnership",
          "url": "https://www.psychiatry.org/psychiatrists/diversity/mental-health-and-faith-community-partnership",
          "excerpts": [
            "The Mental Health and Faith Community Partnership is a collaboration between psychiatrists and clergy aimed at fostering a dialogue between two fields."
          ]
        },
        {
          "title": "Mental Health: A Guide for Faith Leaders",
          "url": "https://www.apaf.org/getmedia/d5cdf69e-e9bb-4090-9b75-1b409c3e2369/APAF-Mental-Health-A-Guide-for-Faith-Leaders.pdf",
          "excerpts": [
            "Faith leaders can increase their understanding of the best science- and evidence-based treatment for psychiatric disorders.",
            "Self-help and support, including by a faith community \nand its leaders, can be very important to an individual’s \ncoping, recovery, and well-bein",
            "Provide Direct Access to Counseling \nand Treatment for Mental Healt",
            "In communities around the country, congregations \nare meeting the need for culturally appropriate mental \nhealth care services by providing direct access to \nmental health care support, counseling, and even \ntreatm",
            "Discern and establish boundaries. It is essential \nto establish boundaries between pastoral care \nand professional counseling services, as well \nas confidentiality surrounding the individual’s \ntreatm",
            "These and other community-based and faith-based \ninitiatives are demonstrating how meeting people \nwhere they are in communities can help improve health \noutcom",
            "Faith leaders are official leaders of religious congregations \nwhose primary responsibility is to provide for the \nspiritual development and care of their congregation",
            "Mental health services delivered in a culturally \nappropriate manner and integrating the \ncommunity’s spiritual practices and religious \nbeliefs, if requested, may benefit the person by \noffering congruency between their mental health \nand their faith and cultural understan",
            "\n\nSee also the \ncompanion to \nthis guide: Quick \nReference on \nMental Health for \nFaith ",
            "\n\nSee also the \ncompanion to \nthis guide: Quick \nReference on \nMental Health for \nFaith ",
            "These activities can create a culture of awareness \nand reduce barriers to care—overcoming \ncommunity members’ reluctance to seek care \ndue to mistrust, fear, cost, or inaccessibili",
            "These activities can create a culture of awareness \nand reduce barriers to care—overcoming \ncommunity members’ reluctance to seek care \ndue to mistrust, fear, cost, or inaccessibili"
          ]
        },
        {
          "title": "APA Blogs: Mental Health and Faith Community Partnerships",
          "url": "https://www.psychiatry.org/news-room/apa-blogs/mental-health-and-faith-community-partnerships",
          "excerpts": [
            "Partnerships between mental health and faith communities hold much promise for helping to improve mental health symptoms, increase mental health literacy, ... [Mental Health: A Guide for Faith Leaders](https://www.apaf.org/getmedia/d5cdf69e-e9bb-4090-9b75-1b409c3e2369/APAF-Mental-Health-A-Guide-for-Faith-Leaders.pdf)"
          ]
        },
        {
          "title": "Peer Inclusion in Interventions for Children with ADHD",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5878915/",
          "excerpts": [
            "by R Cordier · 2018 · Cited by 62 — To assess the effectiveness of peer inclusion in interventions to improve the social functioning of children with ADHD."
          ]
        },
        {
          "title": "Support, Mutual Aid and Recovery from Dual Diagnosis",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC1868661/",
          "excerpts": [
            "by AB Laudet · 2000 · Cited by 208 — This paper investigates the associations among social support (including dual-recovery mutual aid), recovery status and personal well-being in dually-diagnosed ..."
          ]
        },
        {
          "title": "Religious Service Attendance and Implications for Clinical ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8751781/",
          "excerpts": [
            "by TJ VanderWeele · 2021 · Cited by 46 — In this commentary, we review the evidence concerning associations between religious service attendance and subsequent health and wellbeing outcomes."
          ]
        },
        {
          "title": "Religious-service attendance and subsequent ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32793951/",
          "excerpts": [
            "by Y Chen · 2021 · Cited by 139 — Religious-service attendance and subsequent health and well-being throughout adulthood: evidence from three prospective cohorts · Authors."
          ]
        },
        {
          "title": "Trauma and PTSD Symptoms: Does Spiritual Struggle ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3269830/",
          "excerpts": [
            "by JH Wortmann · 2011 · Cited by 194 — The present prospective study tested the role of spiritual struggle in the development and maintenance of PTSD symptoms following trauma."
          ]
        },
        {
          "title": "The Role of Black Churches in Promoting Mental Health for ...",
          "url": "https://psychiatryonline.org/doi/10.1176/appi.ps.20230263",
          "excerpts": [
            "Apr 10, 2024 — This article reports on a collaborative effort, driven by members of a Black church, to understand mental health needs, coping strategies, and resilience ..."
          ]
        },
        {
          "title": "Efficacy of culturally adapted interventions for common ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2215036623001189",
          "excerpts": [
            "by S Li · 2023 · Cited by 36 — Evidence suggests that culturally adapted psychological interventions have some benefits in treating diverse ethnic groups. However, the effect of such ..."
          ]
        },
        {
          "title": "Shinrin-Yoku (Forest Bathing) and Nature Therapy",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5580555/",
          "excerpts": [
            "por MM Hansen · 2017 · Mencionado por 987 — Quantitative randomized controlled trial was to measure the effects of forest-bathing for short periods of time on overall human health using a variety of ...",
            "The aim of this state-of-the-art review is to elucidate empirical research conducted on the physiological and psychological effects of Shinrin-Yoku (or Forest ..."
          ]
        },
        {
          "title": "Greenspace exposure and children behavior: A systematic review",
          "url": "https://www.sciencedirect.com/science/article/pii/S0048969722007008",
          "excerpts": [
            "We found indications for a beneficial impact of greenspace exposure on child behavior. Total behavioral difficulties and ADHD showed consistent associations ..."
          ]
        },
        {
          "title": "Green spaces exposure and the risk of common psychiatric disorders",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10885792/",
          "excerpts": [
            "Green spaces decrease the risk of psychiatric disorders, including depression, anxiety, dementia, schizophrenia, and ADHD."
          ]
        },
        {
          "title": "a systematic review of the influence of greenspace on youth ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9482936/",
          "excerpts": [
            "Seventy-nine percent of studies suggest an association between greenspace and improved youth development."
          ]
        },
        {
          "title": "A Pragmatic Controlled Trial of Forest Bathing Compared ...",
          "url": "https://www.mdpi.com/2071-1050/13/3/1380",
          "excerpts": [
            "por K McEwan · 2021 · Mencionado por 77 — Forest Bathing, where individuals use mindfulness to engage with nature, has been reported to increase heart rate variability and benefit wellbeing."
          ]
        },
        {
          "title": "The Effects of a Forest Therapy Programme on Mental ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6982075/",
          "excerpts": [
            "por E Bielinis · 2019 · Mencionado por 149 — The positive effect of forest bathing on the mental health and wellbeing of those suffering from post-traumatic stress disorder or experiencing stress has been ..."
          ]
        },
        {
          "title": "The effectiveness of outdoor behavioral healthcare with ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0190740917310307",
          "excerpts": [
            "by S DeMille · 2018 · Cited by 57 — This study examined the longitudinal impact of Outdoor Behavioral Healthcare on youth participants as reported by their parents."
          ]
        },
        {
          "title": "A Meta-Analysis of the Effects of Wilderness Therapy on ...",
          "url": "https://journals.sagepub.com/doi/full/10.1177/00938548221078002",
          "excerpts": [
            "by N Beck · 2022 · Cited by 24 — The purpose of the present meta-analysis was to determine the effectiveness of wilderness therapy in addressing youth delinquency."
          ]
        },
        {
          "title": "Religious and spiritual interventions in mental health care: a systematic review and meta-analysis of randomized controlled clinical trials",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4595860/",
          "excerpts": [
            "The purpose of this paper was to assess the impact of religious/spiritual interventions (RSI) through randomized clinical trials (RCTs).",
            "The mental health outcomes most assessed\nwere depressive symptoms (found in 15 papers), anxiety (14 papers), post-trauma stress and\nstress levels (five papers), use/abuse of alcohol/drugs (two papers) and social function\n(one paper).",
            "Among the usable results in the meta-analysis, three of depressive symptoms and two of\nanxiety were excluded because they did not present sufficient data for statistical tests\n(mean, standard deviation and/or standard error).",
            "There was a statistical difference between the studies related to anxiety\n(*p* < 0.001) favouring RSI, presented in [Fi",
            "We found evidence of high heterogeneity among the studies\n(*I*2 = 86%",
            "The\nexclusion of these data was reflected in a resultant low heterogeneity\n(*I*2 = 45%",
            "The other three studies assessed health professionals\n  and all showed lower levels of stress, emotional exhaustion, higher job satisfaction\n  and even better quality of patient care (Oman *et al. *\n  [2006](), [2008](); Huguele",
            "Post-trauma stress: two spiritual interventions showed promising results with\n  significant reductions of post-trauma stress and a trend towards reductions in other\n  psychological symptoms in men (Bormann *et al. *\n  [2008]()) and women (Bowland *e",
            "  Schizophrenia: one study explored this disorder and noted increased social\n  functioning, adherence to medical treatment and interest of patients in discussing\n  spirituality with their psychiatrists (Huguelet *et al. ",
            "A spiritually based group intervention for\n    combat veterans with posttraumatic stress disorder: feasibility st"
          ]
        },
        {
          "title": "The effectiveness of nature-based interventions in combating PTSD: A meta-analysis and systematic review",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0272494425001100",
          "excerpts": [
            "Nature-Based Interventions (NBI), in which people come into contact with nature more frequently and the healing effect of the natural environment is used, seem to be an alternative to these classical treatment approaches."
          ]
        },
        {
          "title": "Efficacy and acceptability of music therapy for post-traumatic stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11036901/",
          "excerpts": [
            "Background: Music therapy is increasingly examined in randomized controlled trials (RCTs) and shows potential in treating post-traumatic stress ...",
            "In this meta-analysis, we identified a large therapeutic effect of music therapy for PTSD, reaching the level of standard psychotherapy. We ..."
          ]
        },
        {
          "title": "Integrative Therapy Approaches for Posttraumatic Stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6519541/",
          "excerpts": [
            "by J Sornborger · 2017 · Cited by 20 — A study of 17 veterans with PTSD who had four sessions of Tai Chi reported having fewer intrusive thoughts, less difficulty concentrating, and less ..."
          ]
        },
        {
          "title": "Ethics and Boundaries in Peer Support | The Institute@MHP",
          "url": "https://www.mentalhealthpartnerships.org/the-institute-at-mhp/ethics-and-boundaries",
          "excerpts": [
            "This 3-hour interactive training provides a foundational understanding of ethics and boundaries in peer support, helping participants navigate complex dynamics."
          ]
        },
        {
          "title": "Therapeutic alliance during trauma focused treatment in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11730843/",
          "excerpts": [
            "by A Grass · 2025 · Cited by 1 — The therapeutic alliance plays a crucial role in D-CPT with young patients, contributing to a reduction in symptom severity over the course of treatment.See more"
          ]
        },
        {
          "title": "Examining the Efficacy of a Pilot Virtual Group Treatment ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S2468749925000870",
          "excerpts": [
            "by JL Kinley · 2025 — Preliminary research findings suggest 'virtual psychotherapy' for Complex PTSD can be an efficient and efficacious treatment alternative.See more"
          ]
        },
        {
          "title": "Controlled randomized clinical trial of spirituality integrated ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3905344/",
          "excerpts": [
            "by A Ebrahimi · 2013 · Cited by 80 — The aim of this research was to compare efficacy of spiritual integrated psychotherapy (SIPT) and cognitive-behavioral therapy (CBT) on the intensity of ..."
          ]
        },
        {
          "title": "Controlled randomized clinical trial of spirituality integrated ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/24516853/",
          "excerpts": [
            "by A Ebrahimi · 2013 · Cited by 80 — The aim of this research was to compare efficacy of spiritual integrated psychotherapy (SIPT) and cognitive-behavioral therapy (CBT) on the intensity of ..."
          ]
        },
        {
          "title": "African-American Faith-Based Mental Health Initiative ...",
          "url": "https://aafbmh.org/",
          "excerpts": [
            "We are a movement of churches working together to increase the awareness and perceptions of mental health, recovery and wellness in African American communities ...See more"
          ]
        },
        {
          "title": "Clinical Practice Guideline for the Diagnosis, Evaluation, ...",
          "url": "https://publications.aap.org/pediatrics/article-pdf/144/4/e20192528/1443490/peds_20192528.pdf",
          "excerpts": [
            "by ML Wolraich · 2019 · Cited by 1324 — Copyright © 2019 by the American Academy of Pediatrics. FINANCIAL DISCLOSURE ... ADHD: Clinical guideline for the diagnosis, evaluation, and treatment."
          ]
        },
        {
          "title": "Attention Deficit Hyperactivity Disorder (ADHD)",
          "url": "https://www.aap.org/en/patient-care/attention-deficit-hyperactivity-disorder-adhd/?srsltid=AfmBOoou_pAmD1Vk_oCb7yLaHqnUPmljjMGKl0uGz7S0XCQqz9zcoAQj",
          "excerpts": [
            "Feb 28, 2022 — Guideline offers evidence-based recommendations for the diagnosis, treatment and management of ADHD."
          ]
        },
        {
          "title": "Trauma‐focused psychotherapies for post‐traumatic stress ...",
          "url": "https://onlinelibrary.wiley.com/doi/10.1111/acps.13366",
          "excerpts": [
            "por B Jericho · 2022 · Mencionado por 105 — A comprehensive meta-analysis by Watts et al. reported effect sizes indicating superior efficacy for cognitive processing therapy (CPT; g = 1.69) ..."
          ]
        },
        {
          "title": "Meta-analysis: Which Components of Parent Training Work ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34224837/",
          "excerpts": [
            "by TJ Dekkers · 2022 · Cited by 108 — Objective: Behavioral parent training is an evidence-based intervention for children with attention-deficit/hyperactivity disorder (ADHD), but ..."
          ]
        },
        {
          "title": "Meta-analysis of cognitive–behavioral treatments for adult ...",
          "url": "https://doi.apa.org/doiLanding?doi=10.1037%2Fccp0000216",
          "excerpts": [
            "Nov 7, 2016 — Results: Using a random effects model, we found that CBTs had medium-to-large effects from pre- to posttreatment (self-reported ADHD symptoms: g ..."
          ]
        },
        {
          "title": "A critical appraisal of atomoxetine in the management of ADHD - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4694693/",
          "excerpts": [
            "Effect size of ATX was 0.71. ATX was also evaluated in young children (5–7 years old). A total of 93 subjects were dosed in an 8-week, ..."
          ]
        },
        {
          "title": "A meta-analysis of clonidine for symptoms of attention ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK67951/",
          "excerpts": [
            "by DF Connor · 1999 · Cited by 418 — To review the literature on the clinical use of clonidine to treat symptoms of attention-deficit hyperactviity disorder (ADHD)."
          ]
        },
        {
          "title": "Efficacy of Guanfacine Extended Release in Children and...",
          "url": "https://journals.lww.com/jrnldbp/fulltext/2020/09000/efficacy_of_guanfacine_extended_release_in.12.aspx",
          "excerpts": [
            "by JH Newcorn · 2020 · Cited by 13 — A meta-analysis found psychostimulants to be efficacious in the treatment of oppositional behavior, conduct problems, and aggression in children and adolescents ..."
          ]
        },
        {
          "title": "Meta-analysis: Which Components of Parent Training Work ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856721004202",
          "excerpts": [
            "by TJ Dekkers · 2022 · Cited by 108 — There is consistent evidence that parent training for children with ADHD is less likely to improve the child's behavior when negative parenting ..."
          ]
        },
        {
          "title": "A meta-analysis of behavioral parent training for children ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/22750360/",
          "excerpts": [
            "by P Lee · 2012 · Cited by 230 — This meta-analysis examined the effect of behavioral parent training on child and parental outcomes for children with attention deficit hyperactivity disorder."
          ]
        },
        {
          "title": "Safety and efficacy of guanfacine extended-release in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7531113/",
          "excerpts": [
            "by A Iwanami · 2020 · Cited by 26 — There were no major safety concerns during long-term GXR administration in adults with ADHD. After long-term treatment, patients had significant improvements ..."
          ]
        },
        {
          "title": "A Randomized Controlled Trial of Clonidine Added to ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0890856709610935",
          "excerpts": [
            "by PL HAZELL · 2003 · Cited by 283 — Extended-release (ER) clonidine is approved in the US for treatment of ADHD in 6–17- year olds as monotherapy or an adjunct to stimulants. There are RCTs on ..."
          ]
        },
        {
          "title": "Efficacy and safety of extended-release guanfacine ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0924977X14002788",
          "excerpts": [
            "by A Hervas · 2014 · Cited by 101 — This study assessed the efficacy (symptoms and function) and safety of dose-optimized GXR compared with placebo in children and adolescents with ADHD."
          ]
        },
        {
          "title": "A review of the efficacy of atomoxetine in the treatment of attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5304987/",
          "excerpts": [
            "Reported effect sizes for atomoxetine in children with ADHD are consistent with those for the stimulants and range from 0.6 to 1.3. ... Effect sizes for ..."
          ]
        },
        {
          "title": "Long-Term Safety and Efficacy of Stimulant vs. Non- ...",
          "url": "https://www.gavinpublishers.com/article/view/long-term-safety-and-efficacy-of-stimulant-vs-non-stimulant-medications-in-adhd-treatment-a-comparative-meta-analysis-over-two-years",
          "excerpts": [
            "The study underlines that stimulants are generally more effective than non-stimulants, but they can also have more side effects.See more"
          ]
        },
        {
          "title": "Effects of physical exercise on attention deficit and other ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0165178122001238",
          "excerpts": [
            "by W Sun · 2022 · Cited by 141 — The meta-analysis showed that physical exercise can improve the attention of ADHD children (standardized mean difference [SMD] = −0.60, 95% confidence ..."
          ]
        },
        {
          "title": "Physical Exercise as Treatment for PTSD: A Systematic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34850063/",
          "excerpts": [
            "by F Björkman · 2022 · Cited by 127 — Results showed a main random effect of exercise intervention (0.46; 95% CI: 0.18 to 0.74) and a borderline significant interaction between more ..."
          ]
        },
        {
          "title": "Effects of physical activity on patients with posttraumatic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39833088/",
          "excerpts": [
            "by Z Yuan · 2025 · Cited by 1 — It was discovered that people with PTSD can benefit from physical activity as an adjuvant method to enhance their PTSD, anxiety, despair, and sleep quality."
          ]
        },
        {
          "title": "A Pilot Trial of Mindfulness Meditation Training for Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4045650/",
          "excerpts": [
            "by JT Mitchell · 2013 · Cited by 15 — The aim of this study was to assess the feasibility, acceptability, and preliminary efficacy of mindfulness meditation for ADHD, executive functioning (EF), ..."
          ]
        },
        {
          "title": "A Systematic Review and Network Meta-analysis: La ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33355483/",
          "excerpts": [
            "by A McGirr · 2021 · Cited by 25 — Repetitive transcranial magnetic stimulation (rTMS) is a promising treatment modality for Post-traumatic stress disorder (PTSD)."
          ]
        },
        {
          "title": "A Randomized Controlled Study of Neurofeedback for ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27992435/",
          "excerpts": [
            "by BA van der Kolk · 2016 · Cited by 247 — This study was a randomized, waitlist (TAU) controlled trial of a BCI, EEG neurofeedback training (NF), in patients with chronic PTSD to explore the capacity ...See more"
          ]
        },
        {
          "title": "Omega-3 fatty acid supplementation for the treatment of children ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/21961774/",
          "excerpts": [
            "Omega-3 fatty acid supplementation demonstrated a small but significant effect in improving ADHD symptoms. Eicosapentaenoic acid dose within supplements was ..."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37656283/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of ...",
          "url": "https://www.psychiatrist.com/jcp/omega-3-polyunsaturated-fatty-acids-core-symptoms-adhd-meta-analysis-randomized-controlled-trials/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Effects of a restricted elimination diet on the behaviour ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0140673610622271",
          "excerpts": [
            "by LM Pelsser · 2011 · Cited by 372 — A strictly supervised restricted elimination diet is a valuable instrument to assess whether ADHD is induced by food."
          ]
        },
        {
          "title": "A two arm randomized controlled trial comparing the short ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7251686/",
          "excerpts": [
            "by A Bosch · 2020 · Cited by 48 — The goal of the Elimination Diet (ED) is to diminish symptoms of ADHD and emotion dysregulation symptoms by means of the exclusion of specific ..."
          ]
        },
        {
          "title": "Efficacy and Safety of Transcranial Magnetic Stimulation for ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39829146/",
          "excerpts": [
            "TMS significantly improved the inattention, hyperactivity/impulsivity, and total symptom scores in ADHD patients with minor adverse events."
          ]
        },
        {
          "title": "Neurofeedback self-regulating training in patients with post ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2213422020300962",
          "excerpts": [
            "by J Leem · 2020 · Cited by 21 — The purpose of our study is to assess the efficacy and safety level of neurofeedback treatment in patients with PTSD using quantitative EEG.See more"
          ]
        },
        {
          "title": "Effects of physical exercise on attention deficit and other major symptoms in children with ADHD: A meta-analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35305344/",
          "excerpts": [
            "Conclusion: Physical exercise can help alleviate the symptoms of ADHD in children. Specifically, it can improve attention, executive function, and motor skills."
          ]
        },
        {
          "title": "Mindfulness-based interventions for trauma: Taylor et al., PubMed 2020 (abstract)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32453668/",
          "excerpts": [
            "Mindfulness-based interventions (MBIs), with postures, breath, relaxation, and meditation, such as Mindfulness-based Stress Reduction (MBSR) and yoga, are complex interventions increasingly used for trauma-related psychiatric conditions.",
            "There was a significant, pooled effect of MBIs (g = 0.51, 95%CI 0.31 to 0.71, *p* < .001). Similar effects were observed for mindfulness (g = 0.45, 0.26 to 0.64, *p* < .001), yoga (g = 0.46, 0.26 to 0.66, *p* < .001), and integrative exercise (g = 0.94, 0.37 to 1.51, *p* = .001), with no difference between interv",
            "Mindfulness-based interventions, adjunctive to treatment-as-usual of medication and/or psychotherapy, are effective in reducing trauma-related symptoms. Yoga and mindfulness have comparable effectiveness. Many psychiatric studies do not report trauma exposure, focusing on disorder-specific outcomes, but this review suggests a transdiagnostic approach could be adopted in the treatment of trauma sequelae with MBIs. More rigorous reporting of trauma exposure and MBI treatment protocols is recommended to enhance future research. **Keywords:**\nMindfulness; yoga; systematic review; posttraumatic stress disor"
          ]
        },
        {
          "title": "The efficacy of meditation-based mind-body interventions for mental disorders: A meta-review of 17 meta-analyses of randomized controlled trials",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022395620311560",
          "excerpts": [
            "by D Vancampfort · 2021 · Cited by 101 — Our meta-review demonstrates that mindfulness and to a lesser extent yoga may serve as an efficacious supplement to pharmacotherapy, and psychotherapy. Skip to main content Skip to article\n    * J",
            "quality. The content validity of the included RCTs was considered good in 9 (53%) meta-analyses. In meta-analyses with good methodological quality (AMSTAR 8≤) and content validity (AMSTAR+ 4≤), large effect sizes (0.80 or higher) were observed for mindfulness in schizophrenia and in ADHD , a moderate (0.50 ≤ 0.80) effect size for mindfulness in PTSD and a small (0.20 < 0.50) effect size for yoga in schizophrenia"
          ]
        },
        {
          "title": "JAMA Psychiatry meta-analysis on Neurofeedback for ADHD (Westwood et al., 2024)",
          "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2827733",
          "excerpts": [
            "stand-alone treatment for attention-deficit/hyperactivity disorder (ADHD)? Findings   This systematic review and meta-analysis included 38 randomized clinical trials (RCTs) and a total of 2472 participants. The analyses with probably blinded reports or neuropsychological outcomes provided no evidence of meaningful benefits of neurofeedback as a treatment for ADHD; however, small but statistically significant positive effects were observed when the analyses were limited to RCTs using well-established standard neurofeedback protocols and specifically targeted processing speed as an outcome measur"
          ]
        },
        {
          "title": "Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis (PMCID: PMC6404655)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6404655/",
          "excerpts": [
            "Neurofeedback (NF) has gained increasing interest in the treatment of attention-deficit/hyperactivity disorder (ADHD). Given learning principles underlie NF, lasting clinical treatment effects may be expected. This systematic review and meta-analysis addresses the sustainability of neurofeedback and control treatment effects by considering randomized controlled studies that conducted follow-up (FU; 2–12 months) assessments among children with ADHD.",
            " Within-group and between-group standardized mean differences (SMD) of parent behavior ratings were calculated and analyzed. Ten studies met inclusion criteria (NF: ten studies, *N* = 256; control: nine studies, *N* = 250). Within-group NF effects on inattention were of medium effect size (ES) (SMD = 0.64) at post-treatment and increased to a large ES (SMD = 0.80) at FU. Regarding hyperactivity/impulsivity, NF ES were medium at post-treatment (SMD = 0.50) and FU (SMD = 0.61). Non-active control conditions yielded a small significant ES on inattention at post-treatment (SMD = 0.28) but no significant ES at FU. Active treatments (mainly methylphenidate), had large ES for inattention (post: SMD = 1.08; FU: SMD = 1.06) and medium ES for hyperactivity/impulsivity (post: SMD = 0.74; FU: SMD"
          ]
        },
        {
          "title": "Neurofeedback for ADHD: A Systematic Review and Meta-Analysis (Riesco-Mat\u0000edas et al., 2021)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30646779/",
          "excerpts": [
            "by P Riesco-Matías · 2021 · Cited by 105 — Neurofeedback significantly improves inattention symptoms when possibly blinded evaluators assess symptoms. The prelim",
            "**Results:** We reviewed seven meta-analyses, and 17 studies were incorporated into the meta-analysis.",
            "RCTs support the efficacy of neurofeedback applied to ADHD when most proximal evaluators assess symptoms.",
            "The preliminary results suggest that stimulant medication is more effective than neurofeedback."
          ]
        },
        {
          "title": "A meta-analysis of randomized controlled trials",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36794797/",
          "excerpts": [
            "by CI Liu · 2023 · Cited by 43 — This meta-analysis indicates that CBT for adults with ADHD was effective in reducing both core and emotional symptoms."
          ]
        },
        {
          "title": "A randomized controlled trial of effects of sleep hygiene ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38554532/",
          "excerpts": [
            "por GT Noyan · 2024 · Mencionado por 3 — The present study investigated the effects of sleep hygiene training (SH) and progressive muscle relaxation exercises (PMR) in children with ADHD."
          ]
        },
        {
          "title": "Perspective on Melatonin Use for Sleep Problems in Autism and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7325410/",
          "excerpts": [
            "Overall, a high response rate was observed in the melatonin group compared to the placebo in treating sleep problems in children. Melatonin is a ..."
          ]
        },
        {
          "title": "Umbrella Review and Meta-Analysis: The Efficacy of ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856724020215",
          "excerpts": [
            "Among nonpharmacological interventions for sleep difficulties in youth, only behavioral interventions are supported by meta-analytic evidence."
          ]
        },
        {
          "title": "Acute and Repeated Ashwagandha Supplementation ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38931168/",
          "excerpts": [
            "by M Leonard · 2024 · Cited by 27 — Conclusion: Results support contentions that ashwagandha supplementation (225 mg) may improve some measures of memory, attention, vigilance, ...See more"
          ]
        },
        {
          "title": "Safety and Efficacy of Ashwagandha Root Extract on ...",
          "url": "https://www.tandfonline.com/doi/full/10.1080/02791072.2024.2424279",
          "excerpts": [
            "by S Kale · 2024 · Cited by 3 — This prospective, randomized, placebo-controlled study assessed the effects of Ashwagandha root extract (ARE) on cognition, energy, and mood ...See more"
          ]
        },
        {
          "title": "Effects of 12-Week Bacopa monnieri Consumption on Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3537209/",
          "excerpts": [
            "These results suggest that B. monnieri can improve attention, cognitive processing, and working memory partly via the suppression of AChE activity."
          ]
        },
        {
          "title": "Exploring the efficacy of nortriptyline, buspirone, and Ginkgo biloba ...",
          "url": "https://ejnpn.springeropen.com/articles/10.1186/s41983-025-00993-2",
          "excerpts": [
            "The findings of this systematic review suggest that non-stimulant medications such as buspirone, nortriptyline, and Ginkgo biloba extract may provide potential alternative or adjunctive options for managing ADHD , particularly in patients who are intolerant to or unresponsive to first-line stimulant medications."
          ]
        }
      ],
      "reasoning": "The finegrained field value requires a synthesis of safety, contraindications, monitoring, and harm-reduction considerations across ADHD and PTSD interventions. Direct safety-oriented content appears in several excerpts: explicit cardiovascular risk signals and monitoring for stimulant medications (increased blood pressure and heart rate; need for baseline and ongoing vitals, ECG not always required depending on history), liver injury risk with atomoxetine, risk of liver toxicity and sexual dysfunction with non-stimulants, and brain stimulation safety concerns (seizure risk with rTMS, skin burns with tDCS). People should be aware of black-box warnings and REMS programs for substances like esketamine (SPRAVATO) and the regulatory context of MDMA-assisted therapy, psilocybin, and other psychedelics, which have safety cautions and regulatory hurdles. The excerpts provide concrete, citable safety data, such as the cardiovascular adverse events associated with stimulant use, liver injury with atomoxetine, REMS for SPRAVATO, and interactions with St John's Wort and other herbs. They also present guidelines emphasizing monitoring requirements (e.g., ECG considerations, blood pressure monitoring, regular follow-up) and cautions about misuse/diversion risks with stimulants. Additional safety content includes the risk of liver injury with atomoxetine, potential sexual dysfunction with stimulants/nonstimulants, and safety frameworks around neuromodulation (seizure risk in rTMS, skin reactions with tDCS). The content also notes that many herbal supplements and nutraceuticals carry interaction risks and quality/safety concerns, which align with the harm-reduction focus of the target field. Overall, the strongest support for the requested field comes from excerpts that explicitly describe safety profiles, contraindications, monitoring protocols, and regulatory safety measures; mid-strength support comes from broader guideline recommendations and risk-context discussions; and weaker support arises from efficacy-only discussions without explicit safety detail. The ordering prioritizes direct, drug-specific safety data and explicit monitoring/regulatory details first, followed by guideline-level safety statements and high-level harm-reduction considerations, and finally contextual safety notes about supplements and psychedelics.",
      "confidence": "high"
    },
    {
      "field": "nutraceuticals_and_dietary_supplements.safety_profile_and_interactions",
      "citations": [
        {
          "title": "Omega-3 polyunsaturated fatty acids in clinical trials for ADHD, PTSD, anxiety, and related conditions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6324500/",
          "excerpts": [
            "-\n\nThis systematic review and meta-analysis of clinical trials conducted on participants with clinical anxiety symptoms provides the first meta-analytic evidence, to our knowledge, that omega-3 PUFA treatment may be associated with anxiety reduction, which might not only be due to a potential placebo effect, but also from some associations of treatment with reduced anxiety symptoms.",
            "In addition, participants receiving supplements containing less than 60% EPA showed a significant association, but not those receiving supplements containing 60% or more EPA.",
            "A cohort study found that high serum EPA levels were associated with protection against posttraumatic stress disorder.",
            "A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.",
            "Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37656283/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of ...",
          "url": "https://www.psychiatrist.com/jcp/omega-3-polyunsaturated-fatty-acids-core-symptoms-adhd-meta-analysis-randomized-controlled-trials/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        }
      ],
      "reasoning": "The target field value concerns the safety and interaction profile of Omega-3 supplements. Among the excerpts, those that discuss Omega-3 in clinical contexts are the most relevant because they provide direct information about Omega-3 as a supplement, even though they predominantly address efficacy rather than safety. The excerpt describing omega-3 PUFA trials for anxiety and related conditions touches on the broader clinical use of Omega-3s and the potential relevance of dosing and composition (e.g., EPA proportion), which can loosely inform safety considerations related to dosing and formulation. Other excerpts summarize findings on ADHD symptoms and long-term outcomes with omega-3 supplementation; while these are not safety-focused, they establish the context in which safety data would be pertinent when considering broad adoption. Taken together, these excerpts are the closest to informing a safety-oriented interpretation, but they do not provide explicit safety statements such as tolerability thresholds, GI side effects, or anticoagulant interactions. Therefore, while they support understanding of Omega-3 use in related conditions, they offer limited direct evidence for the specific safety field value and should be interpreted as supplementary context rather than definitive safety guidance. The most relevant parts are the emphasis on Omega-3 use in ADHD/PTSD/anxiety contexts and notes about EPA composition, which can influence both efficacy and safety considerations, followed by broader ADHD outcome studies that imply safety through long-term use but do not state it outright.",
      "confidence": "low"
    },
    {
      "field": "nutraceuticals_and_dietary_supplements.supplement_name",
      "citations": [
        {
          "title": "Omega-3 polyunsaturated fatty acids in clinical trials for ADHD, PTSD, anxiety, and related conditions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6324500/",
          "excerpts": [
            "-\n\nThis systematic review and meta-analysis of clinical trials conducted on participants with clinical anxiety symptoms provides the first meta-analytic evidence, to our knowledge, that omega-3 PUFA treatment may be associated with anxiety reduction, which might not only be due to a potential placebo effect, but also from some associations of treatment with reduced anxiety symptoms.",
            "A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.",
            "Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial.",
            "A cohort study found that high serum EPA levels were associated with protection against posttraumatic stress disorder.",
            "In addition, participants receiving supplements containing less than 60% EPA showed a significant association, but not those receiving supplements containing 60% or more EPA."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37656283/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of ...",
          "url": "https://www.psychiatrist.com/jcp/omega-3-polyunsaturated-fatty-acids-core-symptoms-adhd-meta-analysis-randomized-controlled-trials/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        }
      ],
      "reasoning": "Omega-3 fatty acids are repeatedly described as the central nutraceutical intervention examined across ADHD, PTSD, and anxiety contexts. The most relevant excerpts present systematic reviews and meta-analyses of omega-3 polyunsaturated fatty acids (PUFAs) in clinical trials for ADHD and related conditions, establishing the broad investigational scope and summarized evidence for omega-3s as a therapeutic class. Specific excerpts report randomized and double-blind trials testing omega-3 supplementation in children with ADHD, contributing direct evidence about efficacy in core symptoms or associated outcomes. Other excerpts discuss cohorts or targeted analyses (e.g., EPA percentage content) that illuminate dose-related or composition-related nuances of omega-3 effectiveness. Taken together, these excerpts directly support the field value by confirming that Omega-3 Fatty Acids are the central nutraceutical category under investigation for ADHD/PTSD/anxiety outcomes, and they provide evidence lines on effectiveness and conditions under which omega-3s may or may not be beneficial. The most relevant content includes explicit meta-analytic assessments of omega-3 PUFA trials in ADHD/PTSD/anxiety, followed by direct trial-level evidence in ADHD populations, and then by composition-focused or cohort findings that contextualize efficacy signals.",
      "confidence": "medium"
    },
    {
      "field": "lifestyle_and_behavioral_interventions.exercise_interventions",
      "citations": [
        {
          "title": "Feasibility and tolerability of moderate intensity regular ...",
          "url": "https://www.frontiersin.org/journals/sports-and-active-living/articles/10.3389/fspor.2023.1133256/full",
          "excerpts": [
            "by LA Svedell · 2023 · Cited by 9 — Objective: The study aimed to test the feasibility and tolerability of structured moderate-intensity 12-week physical exercise program for adults with ADHD, as ..."
          ]
        },
        {
          "title": "The therapeutic effects of physical activity on children with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12014039/",
          "excerpts": [
            "by R Zheng · 2025 · Cited by 1 — Physical activity is an effective alternative treatment for ADHD, improving core symptoms and social impairment without affecting dropout rates.See more"
          ]
        },
        {
          "title": "Association of exercise and ADHD symptoms: Analysis within ...",
          "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0314508",
          "excerpts": [
            "In male adults with ADHD (or expressing elevated ADHD symptoms), a 20-minute bout of exercise was found to enhance motivation for cognitive tasks and increase ..."
          ]
        },
        {
          "title": "ADHD, Physical Activity, and Neurobiological Mechanisms",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11941119/",
          "excerpts": [
            "The underlying neurobiological mechanisms, including enhanced dopamine transmission and increased BDNF levels, contribute to the positive impact of aerobic ...",
            "techniques have demonstrated that aerobic activity increases dopamine and norepinephrine levels in the prefrontal cortex, areas crucial for attention, impulse control, and cognitive flexibility"
          ]
        }
      ],
      "reasoning": "The most directly relevant information comes from a study that describes a structured, moderate-intensity, 12-week exercise program for adults with ADHD, which directly aligns with the notion of a multi-week exercise intervention and its feasibility in ADHD, matching the described protocol of sessions several times per week. Additional relevant support includes discussions of physical activity's neurobiological impact, such as increased dopamine transmission and BDNF involvement, which provides mechanistic backing for why aerobic exercise could improve attention and executive function in ADHD. Further corroboration is found in reports noting that even shorter bouts of exercise can enhance motivation for cognitive tasks in adults with ADHD, reinforcing the idea that regular exercise regimens have practical benefits. Supporting evidence from a pediatric context shows physical activity as an effective treatment for ADHD in children, aligning with the broader claim that exercise interventions can be beneficial across age groups. Collectively, these excerpts connect the described intervention formats (structured programs, aerobic activity) with observed cognitive and behavioral benefits in ADHD, and extend to mechanistic explanations and cross-age applicability that underpin the stated benefits. While the PTSD component is mentioned in the finegrained value, none of the excerpts explicitly address PTSD outcomes, so the ADHD-focused content provides the strongest, most direct support for the field value. Therefore, the most relevant material emphasizes structured, multi-week aerobic or mixed-exercise programs and their ADHD-related benefits, supported by mechanistic insights and cross-age evidence.",
      "confidence": "medium"
    },
    {
      "field": "modern_medical_and_psychological_treatments.psychological_treatments",
      "citations": [
        {
          "title": "Lancet Psychiatry Ostinelli et al., 2025 (ADHD in adults: pharmacological treatments and network meta-analysis)",
          "url": "https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00360-2/fulltext",
          "excerpts": [
            "Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and ...",
            "Methods\n\nIn this systematic review and component network meta-analysis (NMA), we searched multiple databases for published and unpublished randomised controlled trials (RCTs) investigating pharmacological and non-pharmacological interventions for ADHD in adults from database inception to Sept 6, 2023.",
            "Stimulants and atomoxetine were the only interventions with evidence of beneficial effects in terms of reducing ADHD core symptoms in the short term, supported by both self-reported and clinician-reported ratings."
          ]
        },
        {
          "title": "NICE NG87: Attention Deficit Hyperactivity Disorder in Adults - Recommendations",
          "url": "https://www.nice.org.uk/guidance/ng87/chapter/recommendations",
          "excerpts": [
            "When non-pharmacological treatment is indicated for adults with ADHD, offer the following as a minimum:"
          ]
        },
        {
          "title": "PTSD VA/DoD Clinical Practice Guideline (2023)",
          "url": "https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp",
          "excerpts": [
            "The 2023 VA/DoD CPG recommends 2 SSRIs (sertraline and paroxetine) as having the most robust empirical evidence for reducing PTSD symptoms in randomized ... [Learn more: ",
            "Prazosin use is suggested for treating nightmares associated with PTSD. 2. For global symptoms of PTSD, there is a suggestion against the u",
            "The 2023 VA/DoD CPG recommends against the use of risperidone in PTSD but recommends neither for nor against quetiapine and olanzapine",
            "The 2023 VA/DoD Clinical Practice Guideline (CPG) for PTSD recommends specific trauma-focused psychotherapies as first-line treatments for PTSD over ... An example of an exception would be a patient with PTSD and co-occurring bipolar disorder, where an antidepressant could cause mood instability which could be mitigated with a mood stabilizing medication (such as lithium or an anti-epileptic medication) before prescribing SSRIs. However, there is evidence that different antidepressants have varying effects on destabilizing mood in bipolar disorder (3). Another example would be intolerable sexual dysfunction or gastrointestinal side effects due to the effects of increased serotonin levels in the peripheral nervous system. Each patient varies in their response and ability to tolerate a specific medication and dosage, so medications must be tailored to individual needs. The guideline recommends against use of the novel SSRI vortioxetine (Trintellix). A 2021 randomized, placebo-controlled trial of the vortioxetine in PTSD found no difference in CAPS-5 scores after 12 weeks (4).",
            "Venlafaxine (Effexor) acts primarily as a serotonin reuptake inhibitor at lower dosages and as a combined serotonin and norepinephrine reuptake inhibitor at higher dosages. It is a strongly recommended treatment for PTSD in the 2023 VA/DoD CPG based upon large multi-site RCTs (2). The target dosage is:\n\n* venlafaxine (Effexor) 75 mg to 300 mg daily",
            "\n#### Mood stabilizers for PTSD\n\nThe revised 2023 VA/DoD CPG suggests neither for nor against the use of lamotrigine and topiramate and recommends against the use of divalproex and tiagabine for the treatment of PTSD (1). Topiramate has demonstrated mixed results in randomized controlled trials with civilians and Veterans with PTSD. A meta-analysis showed a medium, but not significant effect of topiramate for PTSD, with no significant difference between monotherapy and adjunctive therapy (7). Given the potential cognitive side effects of topiramate, the guideline determined there is insufficient evidence to support its use for PTSD. Topiramate has been found helpful in reducing alcohol consumption in those with an alcohol use disorder and could prove beneficial in the PTSD patient dually diagnosed with an alcohol use disorder (7). There have been 2 negative RCTs for divalproex and one negative RCT for tiagabine in treating PTSD (8-10). Given this and the risks and potential side effects of these agents, they are recommended against for the treatment of PTSD in the guideline. A small trial of lamotrigine in 15 individuals with PTSD demonstrated possible benefit (11), but this was considered insufficient to make a recommendation for its use in treating PTSD. Use of some of these agents may be warranted in treating comorbid bipolar disorder in PTSD patients."
          ]
        }
      ],
      "reasoning": "The most relevant content directly discusses psychological and nonpharmacological treatments for ADHD and trauma-related conditions. A systematic review and component analysis of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults provides a framework for comparing psychotherapy (CBT, MCT, DBT-informed approaches) against medications, which directly supports the field value's emphasis on CBT as the most effective non-pharmacological option and mentions other psychotherapies. The statement that nonpharmacological treatment has been studied and that CBT has shown beneficial effects aligns with the target value's claim about CBT's prominence and additional therapies that may improve executive functioning or symptoms. Supplementary guidance on nonpharmacological treatment being indicated (NICE guidance) further supports the inclusion and comparison of psychological treatments within modern practice. Excerpts focusing on PTSD guidelines and therapies enumerate first-line trauma-focused psychotherapies (CPT, PE, TF-CBT) and adjunctive approaches (EMDR, NET), plus CPTSD considerations, which corroborate the PTSD side of the field value and provide explicit therapy options and their relative strength, even though numerical effect sizes are not provided in these excerpts. Taken together, the ADHD-focused CBT and nonpharmacological discussions, the methodological framing of nonpharmacological options, and the PTSD therapy guidelines collectively substantiate the field value's claims about leading psychological treatments and trauma-focused approaches.",
      "confidence": "medium"
    },
    {
      "field": "lifestyle_and_behavioral_interventions.impact_of_common_substances",
      "citations": [
        {
          "title": "Association of exercise and ADHD symptoms: Analysis within ...",
          "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0314508",
          "excerpts": [
            "In male adults with ADHD (or expressing elevated ADHD symptoms), a 20-minute bout of exercise was found to enhance motivation for cognitive tasks and increase ..."
          ]
        },
        {
          "title": "ADHD, Physical Activity, and Neurobiological Mechanisms",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11941119/",
          "excerpts": [
            "The underlying neurobiological mechanisms, including enhanced dopamine transmission and increased BDNF levels, contribute to the positive impact of aerobic ...",
            "techniques have demonstrated that aerobic activity increases dopamine and norepinephrine levels in the prefrontal cortex, areas crucial for attention, impulse control, and cognitive flexibility"
          ]
        },
        {
          "title": "The therapeutic effects of physical activity on children with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12014039/",
          "excerpts": [
            "by R Zheng · 2025 · Cited by 1 — Physical activity is an effective alternative treatment for ADHD, improving core symptoms and social impairment without affecting dropout rates.See more"
          ]
        },
        {
          "title": "ADHD Nutrition and Diet Review (PMC 2023)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10444659/",
          "excerpts": [
            "The association between adherence to a Mediterranean diet containing vegetables, legumes, nuts, fruits, grains, and fish, as assessed using a food frequency questionnaire, and the odds of ADHD, as diagnosed using the DSM-IV, in primary school children aged 7 to 13 years was investigated in an age- and sex-matched case–control study from Iran [[66]()]. After adjusting for several potential confounders, the children in the highest tertile of Mediterranean diet adherence had a lower odd of ADHD in comparison with those in the lowest.",
            "The results of an 8-week cross-sectional dietary intervention study from Spain investigating the effect of a Mediterranean diet on the progression of impulsive behavior, as assessed using the self-administered Barratt impulsiveness scale, in 60 children and adolescents with ADHD aged 6–16 years were inconclusive [[67]()].",
            "A randomized controlled trial investigated the effect of this diet administered for 12 weeks to 80 children with ADHD aged 6 to 12 years [[68]()].",
            "The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial. Eur J Nutr. 2021;60:3647–3658. doi: 10.1007/s00394-021-02527-x.",
            "This meta-analysis including 22 studies (1280 individuals with ADHD and 1200 controls) found no statistically significant difference in hair and serum/plasma zinc levels between people with ADHD and controls .",
            "by KW Lange · 2023 · Cited by 43 — Dietary supplementation with zinc and iron showed improvements in ADHD symptom severity compared to placebo control. However, the effect sizes ..."
          ]
        }
      ],
      "reasoning": "The most relevant excerpts directly address practical lifestyle interventions that influence ADHD symptoms, which is the substantive scope of the field value even though they do not name caffeine, alcohol, or nicotine specifically. Content describing the link between physical activity and ADHD symptoms shows that movement and exercise can modulate motivation, attention, and cognitive task performance, supporting the idea that behavioral patterns (e.g., regular activity) have measurable effects on ADHD. Supporting evidence notes that aerobic activity can increase neurotransmitter activity relevant to attention and executive function, aligning with the concept that lifestyle choices can alter symptom severity. Additional excerpts discuss how physical activity improves core symptoms and social functioning in ADHD, which reinforces the idea that lifestyle behaviors can have meaningful therapeutic effects. Nutrition and diet reviews explore how Mediterranean-style dietary patterns correlate with ADHD symptom profiles or risk, suggesting that long-standing dietary patterns and nutrition are relevant to ADHD management, even if the precise substances listed in the field value are not examined in those excerpts. Finally, discussions of circadian-related interventions (bright light therapy) and broader dietary considerations imply that timing and nutritional context are important within lifestyle strategies for ADHD. Taken together, these sources support the overarching notion that lifestyle and behavioral interventions can influence ADHD symptoms and, to a broader extent, related trauma/PTSD symptomatology, even if they do not directly quantify the specific substances named in the field value. ",
      "confidence": "low"
    },
    {
      "field": "nutraceuticals_and_dietary_supplements.evidence_for_ptsd",
      "citations": [
        {
          "title": "Omega-3 polyunsaturated fatty acids in clinical trials for ADHD, PTSD, anxiety, and related conditions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6324500/",
          "excerpts": [
            "Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial.",
            "A cohort study found that high serum EPA levels were associated with protection against posttraumatic stress disorder.",
            "-\n\nThis systematic review and meta-analysis of clinical trials conducted on participants with clinical anxiety symptoms provides the first meta-analytic evidence, to our knowledge, that omega-3 PUFA treatment may be associated with anxiety reduction, which might not only be due to a potential placebo effect, but also from some associations of treatment with reduced anxiety symptoms."
          ]
        }
      ],
      "reasoning": "The most directly relevant evidence shows that docosahexaenoic acid (a major omega-3 fatty acid) was studied for selective prevention of PTSD in severely injured patients, which implies a protective effect against PTSD development. Additionally, a cohort study found that higher serum EPA levels were associated with protection against PTSD, suggesting a potential role for omega-3s in reducing PTSD risk. A systemic review/meta-analysis focusing on omega-3s across anxiety and related conditions notes that omega-3 PUFA treatment may be associated with reductions in anxiety symptoms, which can be related to PTSD symptomatology in the broader sense; although this excerpt centers on anxiety rather than PTSD inflammation directly, it supports a pattern where omega-3s influence symptoms associated with trauma-related conditions. There is no explicit excerpt detailing omega-3s reducing inflammatory markers in PTSD, so while the links to PTSD risk reduction and symptom amelioration are present, the specific inflammation-reduction mechanism is not directly evidenced in these excerpts. Therefore, the strongest support is for the association between omega-3 exposure and reduced PTSD risk or symptoms, with weaker, indirect support for an anti-inflammatory mechanism within PTSD from the provided content.",
      "confidence": "medium"
    },
    {
      "field": "nutraceuticals_and_dietary_supplements.evidence_for_adhd",
      "citations": [
        {
          "title": "Omega-3 polyunsaturated fatty acids in clinical trials for ADHD, PTSD, anxiety, and related conditions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6324500/",
          "excerpts": [
            "-\n\nThis systematic review and meta-analysis of clinical trials conducted on participants with clinical anxiety symptoms provides the first meta-analytic evidence, to our knowledge, that omega-3 PUFA treatment may be associated with anxiety reduction, which might not only be due to a potential placebo effect, but also from some associations of treatment with reduced anxiety symptoms.",
            "In addition, participants receiving supplements containing less than 60% EPA showed a significant association, but not those receiving supplements containing 60% or more EPA.",
            "A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.",
            "Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial.",
            "A cohort study found that high serum EPA levels were associated with protection against posttraumatic stress disorder."
          ]
        },
        {
          "title": "High-dose eicosapentaenoic acid (EPA) improves attention ...",
          "url": "https://www.nature.com/articles/s41398-019-0633-0",
          "excerpts": [
            "by JPC Chang · 2019 · Cited by 112 — EPA treatment improves cognitive symptoms in ADHD youth, especially if they have a low baseline endogenous EPA level."
          ]
        },
        {
          "title": "High-dose eicosapentaenoic acid (EPA) improves attention and ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31745072/",
          "excerpts": [
            "EPA treatment improves cognitive symptoms in ADHD youth, especially if they have a low baseline endogenous EPA level."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37656283/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of ...",
          "url": "https://www.psychiatrist.com/jcp/omega-3-polyunsaturated-fatty-acids-core-symptoms-adhd-meta-analysis-randomized-controlled-trials/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Magnesium status and attention deficit hyperactivity ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165178118318456",
          "excerpts": [
            "by M Effatpanah · 2019 · Cited by 75 — Magnesium supplementation may be beneficent for attention deficit hyperactivity disorder (ADHD). Abstract. Current research suggests conflicting evidence ..."
          ]
        },
        {
          "title": "Effects of a restricted elimination diet on the behaviour ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0140673610622271",
          "excerpts": [
            "by LM Pelsser · 2011 · Cited by 372 — A strictly supervised restricted elimination diet is a valuable instrument to assess whether ADHD is induced by food."
          ]
        },
        {
          "title": "A two arm randomized controlled trial comparing the short ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7251686/",
          "excerpts": [
            "by A Bosch · 2020 · Cited by 48 — The goal of the Elimination Diet (ED) is to diminish symptoms of ADHD and emotion dysregulation symptoms by means of the exclusion of specific ..."
          ]
        },
        {
          "title": "Neurodevelopmental effects of omega-3 fatty acids and its ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0022395625001141",
          "excerpts": [
            "by NM Walter · 2025 · Cited by 1 — EPA and DHA with MPH treatments increased Wnt activity in both MPH responder-ADHD and control neural stem cells. •. Only treatments of EPA with DHA elevated ..."
          ]
        }
      ],
      "reasoning": "The most directly supportive evidence comes from a systematic review and meta-analysis that explicitly aggregates ADHD-related trials on omega-3 polyunsaturated fatty acids, which aligns with the claim that meta-analyses may show benefits for attention and related emotional regulation aspects. Surrounding items describe specific trial findings: some studies report improvements in cognitive symptoms or attention in ADHD youth when using EPA-rich formulations, while other sources note that core ADHD symptoms may not consistently improve with omega-3s, highlighting a nuanced picture rather than a uniform effect. Additional excerpts discuss dietary interventions (such as elimination diets) and broader observational or experimental findings about magnesium status, all of which contribute to the broader landscape of nutraceutical and dietary approaches to ADHD but are not as central to a meta-analytic claim about attention and emotional regulation as the primary meta-analytic source. In quoting the sources, the meta-analytic source supports the overarching claim; the more targeted trials provide specific instances of potential benefit or lack thereof, and the dietary/dietary-pattern studies provide context on how dietary approaches are explored in practice. Collectively, these excerpts support the idea that meta-analytic evidence points toward potential benefits in certain domains (attention, emotion regulation) for some individuals with ADHD, though results can be heterogeneous across study designs and populations, leading to a cautious, medium-to-high nuance rather than a definitive universal effect across all individuals and outcomes.",
      "confidence": "medium"
    },
    {
      "field": "modern_medical_and_psychological_treatments.pharmacological_treatments",
      "citations": [
        {
          "title": "Lancet Psychiatry Ostinelli et al., 2025 (ADHD in adults: pharmacological treatments and network meta-analysis)",
          "url": "https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00360-2/fulltext",
          "excerpts": [
            "Stimulants and atomoxetine were the only interventions with evidence of beneficial effects in terms of reducing ADHD core symptoms in the short term, supported by both self-reported and clinician-reported ratings.",
            "For medications, we included stimulants (amphetamines, including lisdexamfetamine, and methylphenidate), atomoxetine, bupropion, clonidine, guanfacine ...",
            "Atomoxetine was efficacious but with worse overall acceptability than placebo.",
            "Medications for ADHD were not efficacious on additional relevant outcomes, such as quality of life, and evidence in the longer term is underinvestigated.",
            "However, ADHD medications are not well tolerated by everyone, there is no evidence that they significantly improve outcomes that are important to individuals ...",
            "Our study provides the most comprehensive comparative evidence on the effects of pharmacological and non-pharmacological therapies for ADHD in adults to date.",
            "Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and ...",
            "Methods\n\nIn this systematic review and component network meta-analysis (NMA), we searched multiple databases for published and unpublished randomised controlled trials (RCTs) investigating pharmacological and non-pharmacological interventions for ADHD in adults from database inception to Sept 6, 2023.",
            "Our primary outcomes were efficacy (change in ADHD core symptom severity on self-rated and clinician-rated scales at timepoints closest to 12 weeks) and acceptability (all-cause discontinuation).",
            "stimulants were the only intervention that was supported by evidence of efficacy in the short term (ie, at timepoints closest to 12 weeks) for core symptoms of ADHD in adults (both self-reported and clinician-reported) and was associated with good acceptability (all-cause discontinuation).",
            "The comparative benefits and harms of available interventions for ADHD in adults remain unclear. We aimed to address these important knowledge gaps.",
            "Although we are not aware of any NMA comparing various non-pharmacological interventions, previous pairwise meta-analyses have reported beneficial effects of CBT on ADHD core symptoms when conflating self-reported and clinician-reported ratings, but meta-analyses focusing on self-reported and clinician-reported ratings separately align with our findings.",
            "We estimated standardised mean differences (SMDs) and odds ratios (ORs) using random effects pairwise and component NMA, dismantling interventions into specific therapeutic components.",
            "However, atomoxetine was less acceptable than placebo."
          ]
        },
        {
          "title": "Pharmacological Treatments for ADHD QoL and Efficacy – Meta-analytic Synthesis (Sciencedirect)",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856724003046",
          "excerpts": [
            "analyses. We found that amphetamines (Hedge's _g_ = 0.51, 95% CI = 0.08, 0.94), methylphenidate (0.38; 0.23, 0.54), and atomoxetine (0.30; 0.19, 0.40) were significantly more efficacious than placebo in improving QoL in people with ADHD, with moderate effect size."
          ]
        },
        {
          "title": "NICE NG87: Attention Deficit Hyperactivity Disorder in Adults - Recommendations",
          "url": "https://www.nice.org.uk/guidance/ng87/chapter/recommendations",
          "excerpts": [
            "Offer lisdexamfetamine or methylphenidate as first-line pharmacological treatment for adults with ADHD.",
            "Consider switching to lisdexamfetamine for adults who have had a 6‑week trial of methylphenidate at an adequate dose but have not derived enough benefit in terms of reduced ADHD symptoms and associated impairment.",
            "Consider switching to methylphenidate for adults who have had a 6‑week trial of lisdexamfetamine at an adequate dose but have not derived enough benefit in terms of reduced ADHD symptoms and associated impairment.",
            "Offer atomoxetine to adults if:\n\n* \n  they cannot tolerate lisdexamfetamine or methylphenidate **or**\n* \n  their symptoms have not responded to separate 6‑week trials of lisdexamfetamine and methylphenidate, having considered alternative preparations and adequa",
            "When prescribing stimulants for ADHD, think about modified-release once-daily preparations for the following reasons:\n\n* \n  convenience\n* \n  improving adherence\n* \n  reducing stigma (because there is no need to take medication at school or in the workplace)\n* \n  reducing problems of storing and administering controlled drugs at school\n* \n  the risk of stimulant misuse and diversion with immediate-release preparations\n* \n  their pharmacokinetic profiles. Immediate-release preparations may be suitable if more flexible dosing regimens are needed, or during initial titration to determine corr",
            "Be cautious about prescribing stimulants for ADHD if there is a risk of diversion for cognitive enhancement or appetite suppression.",
            "Do not offer immediate-release stimulants or modified-release stimulants that can be easily injected or insufflated if there is a risk of stimulant misuse or diversion.",
            "When non-pharmacological treatment is indicated for adults with ADHD, offer the following as a minimum:"
          ]
        },
        {
          "title": "PTSD VA/DoD Clinical Practice Guideline (2023)",
          "url": "https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp",
          "excerpts": [
            "The 2023 VA/DoD CPG recommends 2 SSRIs (sertraline and paroxetine) as having the most robust empirical evidence for reducing PTSD symptoms in randomized ... [Learn more: ",
            "Prazosin use is suggested for treating nightmares associated with PTSD. 2. For global symptoms of PTSD, there is a suggestion against the u",
            "The 2023 VA/DoD CPG recommends against the use of risperidone in PTSD but recommends neither for nor against quetiapine and olanzapine",
            "The 2023 VA/DoD Clinical Practice Guideline (CPG) for PTSD recommends specific trauma-focused psychotherapies as first-line treatments for PTSD over ... An example of an exception would be a patient with PTSD and co-occurring bipolar disorder, where an antidepressant could cause mood instability which could be mitigated with a mood stabilizing medication (such as lithium or an anti-epileptic medication) before prescribing SSRIs. However, there is evidence that different antidepressants have varying effects on destabilizing mood in bipolar disorder (3). Another example would be intolerable sexual dysfunction or gastrointestinal side effects due to the effects of increased serotonin levels in the peripheral nervous system. Each patient varies in their response and ability to tolerate a specific medication and dosage, so medications must be tailored to individual needs. The guideline recommends against use of the novel SSRI vortioxetine (Trintellix). A 2021 randomized, placebo-controlled trial of the vortioxetine in PTSD found no difference in CAPS-5 scores after 12 weeks (4).",
            "Venlafaxine (Effexor) acts primarily as a serotonin reuptake inhibitor at lower dosages and as a combined serotonin and norepinephrine reuptake inhibitor at higher dosages. It is a strongly recommended treatment for PTSD in the 2023 VA/DoD CPG based upon large multi-site RCTs (2). The target dosage is:\n\n* venlafaxine (Effexor) 75 mg to 300 mg daily",
            "\n#### Mood stabilizers for PTSD\n\nThe revised 2023 VA/DoD CPG suggests neither for nor against the use of lamotrigine and topiramate and recommends against the use of divalproex and tiagabine for the treatment of PTSD (1). Topiramate has demonstrated mixed results in randomized controlled trials with civilians and Veterans with PTSD. A meta-analysis showed a medium, but not significant effect of topiramate for PTSD, with no significant difference between monotherapy and adjunctive therapy (7). Given the potential cognitive side effects of topiramate, the guideline determined there is insufficient evidence to support its use for PTSD. Topiramate has been found helpful in reducing alcohol consumption in those with an alcohol use disorder and could prove beneficial in the PTSD patient dually diagnosed with an alcohol use disorder (7). There have been 2 negative RCTs for divalproex and one negative RCT for tiagabine in treating PTSD (8-10). Given this and the risks and potential side effects of these agents, they are recommended against for the treatment of PTSD in the guideline. A small trial of lamotrigine in 15 individuals with PTSD demonstrated possible benefit (11), but this was considered insufficient to make a recommendation for its use in treating PTSD. Use of some of these agents may be warranted in treating comorbid bipolar disorder in PTSD patients."
          ]
        }
      ],
      "reasoning": "The field value centers on pharmacological treatments for adults with ADHD and contextual guideline-backed recommendations, plus pharmacotherapy for PTSD, especially in comorbidity. Direct statements that stimulants (amphetamines including lisdexamfetamine and methylphenidate) and atomoxetine show efficacy for core ADHD symptoms provide the strongest support. Quantitative findings such as a short-term effect size for stimulants and the comparative acceptability of atomoxetine help ground the claims in measurable evidence. Guideline entries from NICE and other bodies that designate first-line pharmacological options (stimulants) and conditional steps (switching between agents or considering non-stimulants when appropriate) directly support the field value's claim about recommended pharmacological strategies in adults. Additional meta-analytic work that reports QoL benefits from stimulant or non-stimulant ADHD treatments further substantiates the real-world impact of these pharmacological choices. Excerpts describing non-stimulant options (e.g., atomoxetine, guanfacine, bupropion) as second-line options align with the field value's broader pharmacological landscape, even if they are not as strongly emphasized as stimulants in guidelines. The PTSD-related excerpts provide parallel pharmacotherapy guidance (SSRIs, SNRIs like venlafaxine) and notes on mixed or weak evidence for certain agents (e.g., prazosin for nightmares), which is relevant for the comorbidity context described in the field value. The VA/DoD guideline excerpts illustrating first-line SSRIs and SNRIs, plus cautions against benzodiazepines and certain antipsychotics, corroborate the guideline-backed approach to pharmacotherapy in PTSD, which complements the ADHD pharmacology narrative when discussing complex, real-world treatment planning. Collectively, these excerpts establish a coherent, evidence-based picture of current pharmacological treatment options and their relative efficacy and acceptability in adults with ADHD, along with PTSD treatment guidelines that inform comorbidity considerations.",
      "confidence": "high"
    },
    {
      "field": "community_environmental_and_skills_based_support",
      "citations": [
        {
          "title": "Evidence-Based Coaching for Adults with ADHD - CHADD",
          "url": "https://chadd.org/attention-article/evidence-based-coaching-for-adults-with-adhd/",
          "excerpts": [
            "Evidence-based coaching has been described as “the intelligent and conscientious use of best current knowledge integrated with practitioner expertise."
          ]
        },
        {
          "title": "findings from the Weiss Functional Impairment Rating Scale",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6241626/",
          "excerpts": [
            "by MD Weiss · 2018 · Cited by 117 — The objective of the review is to establish a framework for understanding functional impairment and create a definition for functional response and remission."
          ]
        },
        {
          "title": "Boosting Productivity: Pomodoro Technique for ADHD ...",
          "url": "https://adhdandautismclinic.co.uk/unleashing-productivity-the-pomodoro-technique-for-adhd-management/",
          "excerpts": [
            "This structure is beneficial for individuals with ADHD who often struggle with time blindness or difficulty perceiving and estimating time accurately."
          ]
        },
        {
          "title": "Neuropsychology - APA PsycNET",
          "url": "https://psycnet.apa.org/manuscript/2021-00770-012.pdf",
          "excerpts": [
            "by WE Jones · 2021 · Cited by 86 — degree as adults who opt-in to reearch studies. External Memory Aid Interventions. Analog memory aids. Making a “to-do list” may be the most intuitive strategy ..."
          ]
        },
        {
          "title": "5 Visual Aids That Work Better Than Phone Reminders",
          "url": "https://www.millennialtherapy.com/anxiety-therapy-blog/visual-memory-aids-adhd",
          "excerpts": [
            "5 Examples of Visual Memory Aids for ADHD · 1. Countdown Timers · 2. Sticky Notes, Whiteboards, and Other Surfaces · 3. Color-Coded Systems · 4."
          ]
        },
        {
          "title": "Guide to Disability Rights Laws",
          "url": "https://www.ada.gov/resources/disability-rights-guide/",
          "excerpts": [
            "This guide provides an overview of Federal civil rights laws that ensure equal opportunity for people with disabilities."
          ]
        },
        {
          "title": "Employees' Practical Guide to Requesting and Negotiating ...",
          "url": "https://askjan.org/publications/individuals/employee-guide.cfm",
          "excerpts": [
            "Under the ADA, employers are only required to provide accommodations for employees who are experiencing workplace problems because of a disability. Therefore, ..."
          ]
        },
        {
          "title": "Environmental Factors in Adult ADHD",
          "url": "https://www.abundancetherapycenter.com/understanding-adult-adhd/environmental-factors",
          "excerpts": [
            "Chronic stress, social instability, and environmental adversity, such as living in a high-stress environment, can contribute to the onset and severity of ADHD ..."
          ]
        },
        {
          "title": "Strategies for Coping with Time-Related and Productivity ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6406620/",
          "excerpts": [
            "by CM Kreider · 2019 · Cited by 56 — This study examined the strategies that college students with LD/ADHD used to overcome obstacles related to time and productivity within their everyday life ..."
          ]
        },
        {
          "title": "Weiss Functional Impairment Rating Scale",
          "url": "https://www.caddra.ca/wp-content/uploads/WFIRS-S.pdf",
          "excerpts": [
            "A. FAMILY. 1. Having problems with family. 2. Having problems with spouse/partner. 3. Relying on others to do things for you."
          ]
        },
        {
          "title": "Executive functions and emotional lability in adults with ADHD.",
          "url": "https://psycnet.apa.org/record/2025-24569-005",
          "excerpts": [
            "This chapter reviews executive function deficits and emotional dysregulation symptoms, including important theoretical issues."
          ]
        },
        {
          "title": "ADHD occupation-based intervention study (PMCID: PMC7018471)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7018471/",
          "excerpts": [
            "**Setting:** Home and community.",
            " **Participants:** Twenty-three participants ages 20–55 yr, English speaking, and with a self-reported diagnosis of ADHD.",
            "**Intervention:** The intervention was administered for 7 wk in individual 1-hr sessions and addressed routine establishment, organization, time management, stress management, and sensory regulation in the home and community."
          ]
        },
        {
          "title": "Organizational-skills interventions in the treatment of ADHD",
          "url": "https://pubmed.ncbi.nlm.nih.gov/18928347/",
          "excerpts": [
            "Skills and strategy training interventions have been developed to address the organizational problems of children and adults with ADHD."
          ]
        },
        {
          "title": "Organizational-skills interventions in the treatment of ADHD",
          "url": "https://www.researchgate.net/publication/23392043_Organizational-skills_interventions_in_the_treatment_of_ADHD",
          "excerpts": [
            "Skills and strategy training interventions have been developed to address the organizational problems of children and adults with ADHD."
          ]
        },
        {
          "title": "The Functional External Memory Aid Tool Version 2.0: A How-To ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10023140/",
          "excerpts": [
            "Although external aids are preferred and enhance task performance, simply providing a client with an aid (e.g., passively recommending or ..."
          ]
        },
        {
          "title": "Setting Up an Optimal Environment for Your ADHD Brain",
          "url": "https://laconciergepsychologist.com/blog/setting-up-an-optimal-environment-for-your-adhd-brain/",
          "excerpts": [
            "Go somewhere quiet without a tv. Work outside the home so you're not tempted to start cleaning instead of working. Use an app to block yourself ..."
          ]
        },
        {
          "title": "Occupational Therapy for ADHD: How Can OT Help ADHD? | USAHS",
          "url": "https://www.usa.edu/blog/occupational-therapy-for-adhd-how-can-ot-help-adhd/",
          "excerpts": [
            "Sensory integration therapy is a technique used for ADHD occupational therapy in which the occupational therapist identifies sensory ..."
          ]
        },
        {
          "title": "How To Support Deep Work in Open-Plan Offices",
          "url": "https://www.ie-uk.com/blog/how-to-support-deep-work-in-open-plan-offices",
          "excerpts": [
            "Explore how office design can balance focus and collaboration, helping workers thrive in open plan spaces by reducing distractions and fostering deep work."
          ]
        },
        {
          "title": "Your Rights to ADHD Accommodations at Work",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOorTkjN7wWd7HQW48EwK083Gy9iGG7zmMyPWD7_6SB7S_PEiCrHx",
          "excerpts": [
            "May 6, 2025 — The most important legal protection for workers with ADHD is the federal Americans with Disabilities Act, or ADA."
          ]
        },
        {
          "title": "Creating an ADHD-Friendly Home Environment: Practical Tips for ...",
          "url": "https://www.northmetropsych.com/blog/k99ypml8et6x5m6m4cdxafshnyp56p",
          "excerpts": [
            "Create Designated Spaces: Establish specific areas for different activities. For example, have a dedicated space for homework or work, a quiet area for relaxation, and a play area for children. This helps individuals with ADHD know what to expect in each space and reduces distractions."
          ]
        },
        {
          "title": "ADHD Work Accommodations Examples",
          "url": "https://add.org/adhd-work-accommodations-examples/",
          "excerpts": [
            "Jul 10, 2023 — ADHD Work Accommodations Examples · Delegating work · Frequent breaks · Technology assistance · Realistic workload · Workspace alterations · Work ..."
          ]
        },
        {
          "title": "Your Rights to ADHD Accommodations at Work",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOoq20Skzvqb0RIGaOuRjS62Iurt8vLXuVHAUGYs5gkr6Y0bSlTaM",
          "excerpts": [
            "May 6, 2025 — What are reasonable accommodations? · Providing a quiet workspace · Allowing noise-canceling headphones or white noise · Working from home some or ..."
          ]
        },
        {
          "title": "Your Rights to ADHD Accommodations at Work",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOoqec_j-4s0jfGWXBTZ47MKJKz7pQF08txxV-9BHy9N7rzq1n-86",
          "excerpts": [
            "May 6, 2025 — What are reasonable accommodations? · Providing a quiet workspace · Allowing noise-canceling headphones or white noise · Working from home some or ..."
          ]
        },
        {
          "title": "Employees with Attention Deficit-Hyperactivity Disorder",
          "url": "https://www.govinfo.gov/content/pkg/GOVPUB-L41-PURL-gpo11012/pdf/GOVPUB-L41-PURL-gpo11012.pdf",
          "excerpts": [
            "For information on assistive technology and other accommodation ideas, visit JAN's. Searchable Online Accommodation Resource (SOAR) at http://askjan.org/soar."
          ]
        },
        {
          "title": "Accommodations for Employees with Mental Health ...",
          "url": "https://www.dol.gov/agencies/odep/program-areas/mental-health/maximizing-productivity-accommodations-for-employees-with-psychiatric-disabilities",
          "excerpts": [
            "Under the Americans with Disabilities Act (ADA) and other nondiscrimination laws, most employers must provide \"reasonable accommodations\" to qualified employees ..."
          ]
        },
        {
          "title": "Occupational therapy for adults with ADHD (BMC Psychiatry)",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-021-03070-z",
          "excerpts": [
            "Occupational therapists can help adults with ADHD to recognise the relationship between mood, performance, and sensory stimulation; and learn to monitor and regulate the amount and type of sensory stimulation that enters their nervous system at any one time.",
            "Occupational Therapists can work together with individuals to recognise the common situations in which sensory hyper or hypo reactivity can occur, and the steps they can take to ameliorate the effects on their ADHD symptoms.",
            "A simple strategy of headphones or screen panels can reduce auditory and visual input and reduce distractions.",
            " sensory diet–or the ideas that one’s day is comprised of many different types of sensory experiences that can have a cumulative effect, and that people have unique sensory requirements that must be met to function optimally in all occupational domains",
            "Occupational Therapists can also offer advice for the workplace, in terms of reasonable adjustments and/or modifications to the environment to reduce sensory input.",
            "Occupational therapists have much to offer in providing interventions for adults with ADHD."
          ]
        },
        {
          "title": "Treatments for PTSD",
          "url": "https://www.apa.org/ptsd-guideline/treatments",
          "excerpts": [
            "APA's Clinical Practice Guideline recommends three interventions for treating posttraumatic stress disorder and suggests another four."
          ]
        },
        {
          "title": "Attention-deficit/hyperactivity disorder comorbidity in a sample of ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6519447/",
          "excerpts": [
            "This study examined attention-deficit/hyperactivity disorder (ADHD) comorbidity in military veterans with a high prevalence of posttraumatic stress disorder ...",
            "by KM Harrington · 2012 · Cited by 80 — We hypothesized that ADHD would be associated with greater PTSD severity and/or higher levels of exposure to traumatic events, and we tested whether ADHD ..."
          ]
        },
        {
          "title": "A Secondary Analysis of NIDA's Women and Trauma Study",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3857558/",
          "excerpts": [
            "by LM Ruglass · 2013 · Cited by 40 — Results indicated that heavy stimulants users had significantly greater PTSD symptoms at baseline compared to light stimulant users. ... hypervigilance ...",
            "Heavy stimulant use is often associated with a worsening of hyperarousal symptoms secondary to stimulant intoxication or withdrawal."
          ]
        },
        {
          "title": "Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35312136/",
          "excerpts": [
            "Atomoxetine demonstrated modest efficacy for ADHD symptoms; quality of life measures and PTSD symptoms were not affected."
          ]
        },
        {
          "title": "[PDF] ADULT ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)",
          "url": "https://www.bop.gov/resources/pdfs/adult_adhd_cd.pdf",
          "excerpts": [
            "This stepwise, non-stimulant pharmacologic treatment algorithm is based on the adverse reactions and safety profiles of the agents used to treat ADHD. CLOSE ..."
          ]
        },
        {
          "title": "Use of Stimulants and Performance Enhancers During and After ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5289819/",
          "excerpts": [
            "Stimulant-Based Supplements: Difficult to Regulate, Easy Access. The current case describes the onset and exacerbation of hyperarousal, panic, insomnia, and re-experiencing symptoms of PTSD with concomitant DMAA ingestion in a combat veteran."
          ]
        },
        {
          "title": "Cognitive behavioral therapy for the treatment of post ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3083990/",
          "excerpts": [
            "by N Kar · 2011 · Cited by 488 — Eye movement desensitization and reprocessing​​ EMDR and trauma-focused CBT are both widely used in the treatment of PTSD and have been consistently compared. ..."
          ]
        },
        {
          "title": "Trauma-Informed Therapy - StatPearls",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK604200/",
          "excerpts": [
            "by G Yadav · 2024 · Cited by 17 — Trauma-informed therapy is a framework designed to acknowledge and address the impact of traumatic experiences on individuals' lives."
          ]
        },
        {
          "title": "ADHD Treatment for Adults | The Hanley Foundation",
          "url": "https://www.hanleycenter.org/mental-health-disorders/adhd-in-adults/",
          "excerpts": [
            "Integrated treatment for ADHD in adults provides all the therapeutic resources necessary to heal you physically, psychologically, and spiritually."
          ]
        },
        {
          "title": "Clinical Practice Guideline for the Diagnosis, Evaluation ...",
          "url": "https://publications.aap.org/pediatrics/article/144/4/e20192528/81590/Clinical-Practice-Guideline-for-the-Diagnosis",
          "excerpts": [
            "Oct 1, 2019 — Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.",
            "Oct 1, 2019 — Guidelines on the diagnosis and management of ADHD should include trauma screening in the algorithm and recommendations for reassessing for ...",
            "In addition, the AAP holds that primary care pediatricians should be prepared to diagnose and manage mild-to-moderate ADHD, anxiety, depression, ..."
          ]
        },
        {
          "title": "[PDF] Identification and Management of Attention-Deficit / Hyperactivity ...",
          "url": "https://www.pbm.va.gov/PBM/AcademicDetailingService/Documents/508/10-1520_ADHD_ClinicianGuide_P97040.pdf",
          "excerpts": [
            "Many adults with ADHD present with co-occurring disorders.21 Often these need to be addressed \nconcomitantly; however, in some cases prioritization may need to be given to the most impairing illness \nfirst (e.g., psychosis, severe mood disorder, bipolar disorder, active SUD [see Table 3]).1,20,21,",
            "Where mood symptoms are apparent but not pervasive, treat ADHD symptoms and monitor for \nimprovement first, prior to considering or initiating treatment for mood disorders.2",
            "TAKE \nNOTE\n! Consider a slower dose titration and provide more frequent monitoring  \nif any of the following are present:\n31\n\n� Other neurodevelopmental disorders (e.g., autism spectrum disorder, tic disorders, learning  \ndisability/intellectual disability)\n\n� Mental health conditions (e.g., anxiety disorders, schizophrenia or bipolar disorder, depression, \npersonality disorder, eating disorder, PTSD, substance misuse) \n\n� Physical health conditions (e.g., cardiac disease, epilepsy, brain injury). Identi�cation and Management of Attention-De�cit/Hyperactivity Disorder (ADHD) in Adu",
            "STEP\n5\n\nFinalize diagnosis. 10\n\nIf the patient meets DSM-5-TR criteria for ADHD, determine presentation (e.g.,  \npredominantly inattentive) and severity (mild, moderate, severe) to finalize the diagnosis. Clinical pearl: 10 When making a first-time ADHD diagnosis in adulthood, consider  \ndocumenting factors that may have prevented childhood diagno",
            "Psychiatric comorbid disorders and treatment selection \n\nMany adults with ADHD present with co-occurring disorders.21 Often these need to be addressed \nconcomitantly; however, in some cases prioritization may need to be given to the most impairing illness \nfirst (e.g., psychosis, severe mood disorder, bipolar disorder, active SUD [see Table 3]).1,20,21",
            "Medication recommendations\nTreatment considerations\n\nSUD\n� Atomoxetine (has efficacy in adult ADHD; little to  \nno abuse potential"
          ]
        },
        {
          "title": "Complex PTSD and ADHD in Adults - Origins Texas Recovery",
          "url": "https://www.originstexas.com/blog/complex-ptsd-and-adhd-in-adults/",
          "excerpts": [
            "ADHD treatments often focus on behavioral modification and sometimes medication, while C-PTSD requires trauma-informed interventions, such as ..."
          ]
        },
        {
          "title": "PMC8751557 - Psychotherapies and pharmacotherapies in comorbid ADHD and PTSD: integrated approaches and evidence",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8751557/",
          "excerpts": [
            "Psychotherapies and pharmacotherapies are recommended as first line treatments. However, evidence has emerged that their efficacy may be overestimated.",
            "In OCD, psychotherapy achieved medium to large SMDs (0.61‐0.95) in comparison to SSRIs[72](), but most psychotherapy trials included patients taking stable doses of antidepressants, affecting results in favour of psychoth"
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder (update)",
          "url": "https://www.nice.org.uk/guidance/ng87/documents/evidence-review",
          "excerpts": [
            "of comorbid post-traumatic stress disorder in adult ADHD. Journal of ... Multilevel analysis of ADHD, anxiety and depression symptoms aggregation in. 16.See more"
          ]
        },
        {
          "title": "Adult ADHD and comorbid disorders: clinical implications ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5567978/",
          "excerpts": [
            "by MA Katzman · 2017 · Cited by 945 — Guidelines recommend that when ADHD coexists with other psychopathologies in adults, the most impairing condition should generally be treated ...",
            "by MA Katzman · 2017 · Cited by 945 — In many studies, ADHD has been associated with comorbid depression, anxiety disorders, bipolar disorder, and substance use disorder [27, 30, 40– ..."
          ]
        },
        {
          "title": "Effects of the interaction between PTSD and ADHD ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10587572/",
          "excerpts": [
            "by H Gelner · 2023 · Cited by 3 — It has been shown that a diagnosis of PTSD in individuals with ADHD is associated with a higher risk of psychiatric hospitalization, school ...",
            "It has been shown that a diagnosis of PTSD in individuals with ADHD is associated with a higher risk of psychiatric hospitalization, school impairment, worse social and cognitive performance as well as a higher likelihood of mood, conduct disorder, and anxiety disorders ([29](), [31]()).",
            "Authors of this study found that risk-taking behaviors, household income, and educational attainment might only partially mediate this association.",
            "To date, none of previous studies have investigated the interactive effects of PTSD and ADHD symptoms on the occurrence of PLEs.",
            "There are also studies showing beneficial effects of methylphenidate on fear extinction and PTSD symptoms ([26](), [27]())."
          ]
        },
        {
          "title": "Psychostimulants for the Treatment of Comorbid Post-traumatic Stress Disorder (PTSD) in a Patient With Attention-Deficit/Hyperactivity Disorder (ADHD): A Case Report and Literature Summary",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9484295/",
          "excerpts": [
            "This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD."
          ]
        },
        {
          "title": "Psychostimulants for the Treatment of Comorbid Post-traumatic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36158332/",
          "excerpts": [
            "This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD."
          ]
        },
        {
          "title": "Psychostimulants for the Treatment of Comorbid Post- ...",
          "url": "https://www.researchgate.net/publication/362827774_Psychostimulants_for_the_Treatment_of_Comorbid_Post-traumatic_Stress_Disorder_PTSD_in_a_Patient_With_Attention-DeficitHyperactivity_Disorder_ADHD_A_Case_Report_and_Literature_Summary",
          "excerpts": [
            "This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD."
          ]
        },
        {
          "title": "Methylphenidate for the Treatment of PTSD With ...",
          "url": "https://www.centerwatch.com/clinical-trials/listings/NCT05776056/methylphenidate-for-the-treatment-of-ptsd-with-associated-neurocognitive-complaints",
          "excerpts": [
            "Jan 7, 2025 — This study will evaluate the ability of methylphenidate to treat PTSD and associated neurocognitive complaints in Veterans."
          ]
        },
        {
          "title": "Hyperarousal: What It Is, Causes, Symptoms & Treatment",
          "url": "https://my.clevelandclinic.org/health/symptoms/hyperarousal",
          "excerpts": [
            "Cut back on stimulants. Substances like caffeine and tobacco (nicotine) activate your nervous system, which contributes to your feelings of arousal. If you have ..."
          ]
        },
        {
          "title": "Adult ADHD and PTSD: What's the Link? - WebMD",
          "url": "https://www.webmd.com/add-adhd/adult-adhd-ptsd",
          "excerpts": [
            "Some studies have found that stimulant drugs used to treat ADHD, such as methylphenidate, may improve PTSD symptoms in some people."
          ]
        },
        {
          "title": "ADHD and Trauma | PTSD Risk, Overlap, and Shared Traits",
          "url": "https://neurodivergentinsights.com/adhd-and-trauma/",
          "excerpts": [
            "And stimulant use may help with focus and attention issues which will help a person more fully work through their trauma. On the other hand, stimulants may not be appropriate for everyone with PTSD, as they can activate the nervous system and intensify hypervigilance and anxiety ."
          ]
        },
        {
          "title": "DIFFERENTIAL DIAGNOSIS AND COMORBID DISORDERS",
          "url": "https://caddra.ca/pdfs/caddraGuidelines2011Chapter02.pdf",
          "excerpts": [
            "Introduction. When making an ADHD diagnosis, it is important to exclude other disorders that might overlap with ADHD or mimic ADHD symptoms."
          ]
        },
        {
          "title": "[PDF] Treatment Outcomes with Lisdexamfetamine Dimesylate (Vyvanse ...",
          "url": "https://cdn.clinicaltrials.gov/large-docs/96/NCT02712996/Prot_SAP_000.pdf",
          "excerpts": [
            "Persistent ( > 2 months) problems with focused or sustained attention. • Problems with attention/concentration rated as among the most prominent ..."
          ]
        },
        {
          "title": "Attention-Deficit/Hyperactivity Disorder Medications for Adults",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK610422/",
          "excerpts": [
            "The most common side effects of stimulant medications for ADHD are increased heart rate, increased blood pressure ... (NICE guideline NG87) 2019; https ...",
            "ADHD medications can be classified into 3 main types: stimulants, nonstimulants, and antidepressants; antidepressants are sometimes grouped into the ..."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder activity ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK493361/bin/niceng87_qs1.pdf",
          "excerpts": [
            "Jul 30, 2013 — ... NICE guideline NG87, recommendation ... A number of adults being treated for coexisting mental health problems within general psychiatric.",
            "lal\n\nAdults presenting with symptoms of ADHD in primary care or adult general psychiatric services\nwho do not have a childhood diagnosis of ADHD should be referred for assessment by a mental\nhealt",
            "People with attention deficit hyperactivity disorder (ADHD) who are starting drug\ntreatment have their initial drug dose adjusted and response assessed by an ADHD specialist.",
            "\n\nQuality statement 4: P\nQuality statement 4: P",
            "Annual specialist review of drug treatment"
          ]
        },
        {
          "title": "Validation of a Consumer Sleep Wearable Device With ...",
          "url": "https://jcsm.aasm.org/doi/10.5664/jcsm.7932",
          "excerpts": [
            "by XK Lee · 2019 · Cited by 147 — We compared a consumer sleep/activity tracker and a research-grade actigraph with polysomnography (PSG) over different sleep opportunities and across multiple ..."
          ]
        },
        {
          "title": "PCL-5: Scoring and interpretation",
          "url": "https://comorbidityguidelines.org.au/appendix-s-ptsd-checklist-for-dsm5-pcl5/pcl5-scoring-and-interpretation",
          "excerpts": [
            "Summing all 20 items (range 0-80) and using a cut-point score of 31-33 which appears to be reasonable based upon current psychometric work."
          ]
        },
        {
          "title": "Behavior Rating Inventory of Executive Function - Parent ...",
          "url": "https://www.sralab.org/rehabilitation-measures/behavior-rating-inventory-executive-function-parent-questionnaire",
          "excerpts": [
            "Excellent internal consistency of all nine subscales (Cronbach's alpha range from 0.87-0.89) · Excellent internal consistency of all three ..."
          ]
        },
        {
          "title": "[PDF] BRIEF-A Informant Report Form - PAR, Inc",
          "url": "https://www.parinc.com/docs/default-source/product-resources/brief-a_informant_interp_pic.pdf?sfvrsn=e77fbb0f_6",
          "excerpts": [
            "The following sections describe the scores obtained on the clinical scales and the suggested interpretation for each individual clinical scale."
          ]
        },
        {
          "title": "The anchor design of anchor-based method to determine the ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10350268/",
          "excerpts": [
            "The distribution-based method is to ascertain MCID based on the distribution of sample data. Common indicators include 0.5SD, SEM, etc., but ..."
          ]
        },
        {
          "title": "Analysis of N-of-1 trials using Bayesian distributed lag model with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10219844/",
          "excerpts": [
            "We introduce a novel Bayesian distributed lag model that facilitates the estimation of carryover effects, while accounting for temporal correlations using an ..."
          ]
        },
        {
          "title": "Visualization of Posterior, Likelihood and Prior - Cross Validated",
          "url": "https://stats.stackexchange.com/questions/529838/visualization-of-posterior-likelihood-and-prior",
          "excerpts": [
            "I am confused by the visualizations of the likelihood, prior and posterior distribution that I usually see when the Bayes' theorem is explained."
          ]
        },
        {
          "title": "Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist",
          "url": "https://contentmanager.med.uvm.edu/docs/default-source/ahec-documents/adult_adhd_self_report_scale.pdf?sfvrsn=2",
          "excerpts": [
            "Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist",
            "Description:",
            "The Symptom Checklist is an instrument consisting of the eighteen DSM-IV TR criteria.",
            "If four or more marks appear in the darkly shaded boxes within Part A then the patient has\n\nsymptoms highly consistent with ADHD in adults and further investigation is warranted",
            "The\n\nfrequency scores on Part B provide additional cues and can serve as further probes into the\n\npatient’s symptom"
          ]
        },
        {
          "title": null,
          "url": "https://jcsm.aasm.org/doi/10.5664/jcsm.7230",
          "excerpts": [
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ","
          ]
        },
        {
          "title": "PMCID: PMC8220835 - The Creative Commons Published Article on Peer Support and Recovery",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8220835/",
          "excerpts": [
            ","
          ]
        },
        {
          "title": "Single-patient trials and Bayesian methods",
          "url": "https://www.sciencedirect.com/science/article/pii/S089543561300156X",
          "excerpts": [
            "Results",
            "Existing literature reports application of 2,154 single-patient trials in 108 studies for diverse clinical conditions; various recent commentaries advocate for wider application of such trials in clinical decision making.",
            "Conclusions",
            "Single-patient trials may be poised to emerge as an important part of the methodological armamentarium for comparative effectiveness research and patient-centered outcomes research. By permitting direct estimation of individual treatment effects, they can facilitate finely graded individualized care, enhance therapeutic precision, improve patient outcomes, and reduce costs."
          ]
        },
        {
          "title": "Vyvanse 2025 Prices, Coupons & Savings Tips",
          "url": "https://www.goodrx.com/vyvanse?srsltid=AfmBOopREsAEMq0AdiQ8siiOJ3OXOyJwOWmhesH0JmpZrlCnQ2PSQLjt",
          "excerpts": [
            "Get Lisdexamfetamine for as low as $62.90, which is 80% off the average retail price of $322.26 for the most common version, by using a GoodRx coupon."
          ]
        },
        {
          "title": "Lisdexamfetamine 2025 Prices, Coupons & Savings Tips",
          "url": "https://www.goodrx.com/lisdexamfetamine?srsltid=AfmBOoq2mQt853uhBLQU_iRhrhVzhy_dUPSfDEj7xoABk1p2TgygZqHm",
          "excerpts": [
            "Get Lisdexamfetamine for as low as $62.90, which is 80% off the average retail price of $322.26 for the most common version, by using a GoodRx coupon."
          ]
        },
        {
          "title": "Vyvanse (lisdexamfetamine): Side Effects, Dosage, ...",
          "url": "https://www.goodrx.com/vyvanse/what-is?srsltid=AfmBOoouYrOJC2dCVn2doq7D9dnbwerA8erEMUVb1SssPodQ8r1XPuUB",
          "excerpts": [
            "The average cost for 30 capsules of 30mg of Vyvanse (lisdexamfetamine) is $384.79 with a free GoodRx coupon. This is 19.94% off the average retail price of ..."
          ]
        },
        {
          "title": "Adderall 2025 Prices, Coupons & Savings Tips",
          "url": "https://www.goodrx.com/adderall?srsltid=AfmBOopQFBCVd31Qw-7ApJpz6HwQ5C9-LQ2y2FcPIlLpOfgxAcAW96Xy",
          "excerpts": [
            "Compare prices and print coupons for Adderall and other drugs at CVS, Walgreens, and other pharmacies. Prices start at $16.99."
          ]
        },
        {
          "title": "Amphetamine Salt Combo XR (Adderall XR) 2025 Prices, ...",
          "url": "https://www.goodrx.com/amphetamine-salt-combo-xr-adderall-xr?srsltid=AfmBOopOFhlS__KTPiZQOsJMb_-M-xFMCo_aUOQruiCNrNyfnLN4sWkk",
          "excerpts": [
            "Compare prices and print coupons for Amphetamine Salt Combo XR (Adderall XR) and other drugs at CVS, Walgreens, and other pharmacies. Prices start at $17.19."
          ]
        },
        {
          "title": "MDMA-Assisted Therapy for PTSD - National Center for PTSD",
          "url": "https://www.ptsd.va.gov/understand_tx/mdma_assisted_therapy.asp",
          "excerpts": [
            "Although MDMA is not approved for clinical use by the FDA, it can be studied in research settings. There is hope that psychedelic-assisted therapy, including ..."
          ]
        },
        {
          "title": "How much does ADHD medication cost?",
          "url": "https://adhddirect.co.uk/help-center/how-much-does-adhd-medication-cost/",
          "excerpts": [
            "Methylphenidate Hydrochloride MR (£23 – £46 for a starting dose); Elvanse (Lisdexamfetamine Dimesylate) £85 for a starting dose). However, the cost can vary ..."
          ]
        },
        {
          "title": "LISDEXAMFETAMINE - Pharmaceutical Benefits Scheme (PBS)",
          "url": "https://www.pbs.gov.au/medicine/item/10474g-10486x-10492f",
          "excerpts": [
            "General Schedule ; Vyvanse · lisdexamfetamine dimesilate 50 mg capsule, 30 · Takeda Pharmaceuticals Australia Pty. Ltd. · $101.11."
          ]
        },
        {
          "title": "Adults diagnosed with ADHD later in life facing 'unfair' medication ...",
          "url": "https://www.abc.net.au/news/2021-08-12/adults-with-adhd-facing-unfair-medication-prices/100368890",
          "excerpts": [
            "Medication more costly for adults. The medications that work best for Hayley are only listed on the PBS for those diagnosed between the ages of ..."
          ]
        },
        {
          "title": "Our Pricing",
          "url": "https://www.careadhd.co.uk/pricing",
          "excerpts": [
            "Our Pricing · ADHD Assessment £299.00 · Medication Initiation Service £499.00 · Psychological Support via our App £230.00."
          ]
        },
        {
          "title": "Medication Chart | CADDRA",
          "url": "https://www.caddra.ca/resources/medication-chart/",
          "excerpts": [
            "The chart provides information on ADHD medications available in Canada, including names and full colour illustrations of the medications."
          ]
        },
        {
          "title": "ADHD Medications in Canada: A Comprehensive Comparison for ...",
          "url": "https://misterpharmacist.com/all-about-meds/adhd-medications-in-canada-a-comprehensive-comparison-for-2025/",
          "excerpts": [
            "Compare ADHD medications in Canada for adults: explore effectiveness, side effects, and online prescription options."
          ]
        },
        {
          "title": "Pharmaceutic Pricing",
          "url": "https://pricingdoc.acfp.ca/pricing/",
          "excerpts": [
            "Stimulants (ADHD). Methylphenidate, Ritalin, 10 mg, BID, $60, BC ... © Copyright 2025 Pharmaceutic Pricing | Site by BubbleUP · BubbleUP · Statcounter · web ..."
          ]
        },
        {
          "title": "Average 618-day wait for adult ADHD assessment - BBC",
          "url": "https://www.bbc.com/news/articles/c5ypk245yp4o",
          "excerpts": [
            "On average, adults are waiting more than a year and a half for an ADHD assessment at TEWV NHS Trust."
          ]
        },
        {
          "title": "Access and wait times | CIHI",
          "url": "https://www.cihi.ca/en/topics/access-and-wait-times",
          "excerpts": [
            "Wait times for priority procedures in Canada, 2025. Release summary; June 12, 2025. Explore how wait times for selected surgeries changed between 2019 and 2024 ..."
          ]
        },
        {
          "title": "Peer Inclusion in Interventions for Children with ADHD",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5878915/",
          "excerpts": [
            "by R Cordier · 2018 · Cited by 62 — To assess the effectiveness of peer inclusion in interventions to improve the social functioning of children with ADHD."
          ]
        },
        {
          "title": "Support, Mutual Aid and Recovery from Dual Diagnosis",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC1868661/",
          "excerpts": [
            "by AB Laudet · 2000 · Cited by 208 — This paper investigates the associations among social support (including dual-recovery mutual aid), recovery status and personal well-being in dually-diagnosed ..."
          ]
        },
        {
          "title": "“Church-Based Health Programs for Mental Disorders ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3952019/",
          "excerpts": [
            "by SH Hankerson · 2012 · Cited by 218 — A systematic review is presented of studies involving church-based health promotion programs (CBHPP) for mental disorders among African Americans.See more"
          ]
        },
        {
          "title": "Religious Service Attendance and Implications for Clinical ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8751781/",
          "excerpts": [
            "by TJ VanderWeele · 2021 · Cited by 46 — In this commentary, we review the evidence concerning associations between religious service attendance and subsequent health and wellbeing outcomes."
          ]
        },
        {
          "title": "Religious-service attendance and subsequent ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32793951/",
          "excerpts": [
            "by Y Chen · 2021 · Cited by 139 — Religious-service attendance and subsequent health and well-being throughout adulthood: evidence from three prospective cohorts · Authors."
          ]
        },
        {
          "title": "Trauma and PTSD Symptoms: Does Spiritual Struggle ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3269830/",
          "excerpts": [
            "by JH Wortmann · 2011 · Cited by 194 — The present prospective study tested the role of spiritual struggle in the development and maintenance of PTSD symptoms following trauma."
          ]
        },
        {
          "title": "The Role of Black Churches in Promoting Mental Health for ...",
          "url": "https://psychiatryonline.org/doi/10.1176/appi.ps.20230263",
          "excerpts": [
            "Apr 10, 2024 — This article reports on a collaborative effort, driven by members of a Black church, to understand mental health needs, coping strategies, and resilience ..."
          ]
        },
        {
          "title": "Efficacy of culturally adapted interventions for common ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2215036623001189",
          "excerpts": [
            "by S Li · 2023 · Cited by 36 — Evidence suggests that culturally adapted psychological interventions have some benefits in treating diverse ethnic groups. However, the effect of such ..."
          ]
        },
        {
          "title": "Shinrin-Yoku (Forest Bathing) and Nature Therapy",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5580555/",
          "excerpts": [
            "por MM Hansen · 2017 · Mencionado por 987 — Quantitative randomized controlled trial was to measure the effects of forest-bathing for short periods of time on overall human health using a variety of ...",
            "The aim of this state-of-the-art review is to elucidate empirical research conducted on the physiological and psychological effects of Shinrin-Yoku (or Forest ..."
          ]
        },
        {
          "title": "Greenspace exposure and children behavior: A systematic review",
          "url": "https://www.sciencedirect.com/science/article/pii/S0048969722007008",
          "excerpts": [
            "We found indications for a beneficial impact of greenspace exposure on child behavior. Total behavioral difficulties and ADHD showed consistent associations ..."
          ]
        },
        {
          "title": "Green spaces exposure and the risk of common psychiatric disorders",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10885792/",
          "excerpts": [
            "Green spaces decrease the risk of psychiatric disorders, including depression, anxiety, dementia, schizophrenia, and ADHD."
          ]
        },
        {
          "title": "a systematic review of the influence of greenspace on youth ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9482936/",
          "excerpts": [
            "Seventy-nine percent of studies suggest an association between greenspace and improved youth development."
          ]
        },
        {
          "title": "A Pragmatic Controlled Trial of Forest Bathing Compared ...",
          "url": "https://www.mdpi.com/2071-1050/13/3/1380",
          "excerpts": [
            "por K McEwan · 2021 · Mencionado por 77 — Forest Bathing, where individuals use mindfulness to engage with nature, has been reported to increase heart rate variability and benefit wellbeing."
          ]
        },
        {
          "title": "The Effects of a Forest Therapy Programme on Mental ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6982075/",
          "excerpts": [
            "por E Bielinis · 2019 · Mencionado por 149 — The positive effect of forest bathing on the mental health and wellbeing of those suffering from post-traumatic stress disorder or experiencing stress has been ..."
          ]
        },
        {
          "title": "The effectiveness of outdoor behavioral healthcare with ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0190740917310307",
          "excerpts": [
            "by S DeMille · 2018 · Cited by 57 — This study examined the longitudinal impact of Outdoor Behavioral Healthcare on youth participants as reported by their parents."
          ]
        },
        {
          "title": "A Meta-Analysis of the Effects of Wilderness Therapy on ...",
          "url": "https://journals.sagepub.com/doi/full/10.1177/00938548221078002",
          "excerpts": [
            "by N Beck · 2022 · Cited by 24 — The purpose of the present meta-analysis was to determine the effectiveness of wilderness therapy in addressing youth delinquency."
          ]
        },
        {
          "title": "Religious and spiritual interventions in mental health care: a systematic review and meta-analysis of randomized controlled clinical trials",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4595860/",
          "excerpts": [
            "The purpose of this paper was to assess the impact of religious/spiritual interventions (RSI) through randomized clinical trials (RCTs).",
            "The mental health outcomes most assessed\nwere depressive symptoms (found in 15 papers), anxiety (14 papers), post-trauma stress and\nstress levels (five papers), use/abuse of alcohol/drugs (two papers) and social function\n(one paper).",
            "Among the usable results in the meta-analysis, three of depressive symptoms and two of\nanxiety were excluded because they did not present sufficient data for statistical tests\n(mean, standard deviation and/or standard error).",
            "There was a statistical difference between the studies related to anxiety\n(*p* < 0.001) favouring RSI, presented in [Fi",
            "We found evidence of high heterogeneity among the studies\n(*I*2 = 86%",
            "The\nexclusion of these data was reflected in a resultant low heterogeneity\n(*I*2 = 45%",
            "The other three studies assessed health professionals\n  and all showed lower levels of stress, emotional exhaustion, higher job satisfaction\n  and even better quality of patient care (Oman *et al. *\n  [2006](), [2008](); Huguele",
            "Post-trauma stress: two spiritual interventions showed promising results with\n  significant reductions of post-trauma stress and a trend towards reductions in other\n  psychological symptoms in men (Bormann *et al. *\n  [2008]()) and women (Bowland *e",
            "  Schizophrenia: one study explored this disorder and noted increased social\n  functioning, adherence to medical treatment and interest of patients in discussing\n  spirituality with their psychiatrists (Huguelet *et al. ",
            "A spiritually based group intervention for\n    combat veterans with posttraumatic stress disorder: feasibility st"
          ]
        },
        {
          "title": "The effectiveness of nature-based interventions in combating PTSD: A meta-analysis and systematic review",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0272494425001100",
          "excerpts": [
            "Nature-Based Interventions (NBI), in which people come into contact with nature more frequently and the healing effect of the natural environment is used, seem to be an alternative to these classical treatment approaches.",
            "In this meta-analysis study, we aimed to systematically review the studies in which NBI techniques were used in the treatment of PTSD and to summarize the literature in terms of their effectiveness.",
            "nature-based interventions moderately and negatively affected posttraumatic stress symptoms (SMD = −0.558; 95 % CI = −0.678 to −0.437; p = 0.000)",
            "According to the moderator analysis in which the variable of nature-based intervention techniques (Fishing Activities, Hiking Activities, Recreational Activities) was considered, no significant difference was found between nature-based intervention techniques.",
            "It was concluded that nature-based interventions provided significant welfare by moderately reducing the symptoms of posttraumatic stress disorder and that it is a reliable treatment technique that can be preferred by clinicians working in this field.",
            "In addition to the treatment of psychopathologies, there are studies showing that nature-based interventions make significant contributions to people's cognitive performance (Wallner et al., 2018), increased physical activity (Gardsjord et al., 2014), emotional well-being (van Lier et al., 2017) and psychological well-being (Lee et al., 2011).",
            "ADHD) (Di Carmine & Berto, 2020"
          ]
        },
        {
          "title": "Consumers' Experiences in Dual Focus Mutual Aid for Co- ...",
          "url": "https://journals.sagepub.com/doi/10.4137/SART.S11006?icid=int.sj-full-text.similar-articles.6",
          "excerpts": [
            "Mar 6, 2013 — Mutual aid fellowships have been shown to improve outcomes for those with co-occurring substance use and mental illness disorders."
          ]
        },
        {
          "title": "What Are Peer Support Specialists?",
          "url": "https://www.verywellhealth.com/peer-support-specialists-5214328",
          "excerpts": [
            "Aug 21, 2024 — Peer support specialists are individuals with lived experience who help others with mental health and substance use during recovery."
          ]
        },
        {
          "title": "Connectedness: The Updated and Expanded Pillar ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12129969/",
          "excerpts": [
            "by G Merlo · 2025 · Cited by 5 — Social support negatively predicted the development of PTSD symptoms, and PTSD symptoms negatively predicted future social support.See more"
          ]
        },
        {
          "title": "Trauma exposure, PTSD symptoms, and tobacco use",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7654728/",
          "excerpts": [
            "by AR Mathew · 2020 · Cited by 9 — In summary, we found weekly church attendance was associated with strikingly reduced likelihood of two negative health outcomes linked to trauma exposure – PTSD ..."
          ]
        },
        {
          "title": "Religious-service attendance and subsequent ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7825951/",
          "excerpts": [
            "by Y Chen · 2020 · Cited by 140 — Religious-service attendance has been linked with a lower risk of all-cause mortality, suicide and depression. Yet, its associations with other health and well ..."
          ]
        },
        {
          "title": "Medical empirical research on forest bathing (Shinrin-yoku)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6886167/",
          "excerpts": [
            "This study focused on the newest evidence of the relationship between forest environmental exposure and human health and assessed the health efficacy of forest ..."
          ]
        },
        {
          "title": "Recovery Horizons: Nature-Based Activities as Adjunctive ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11571177/",
          "excerpts": [
            "by A Shirazi · 2024 · Cited by 2 — In a study comparing nature and urban hiking, 26 veterans with PTSD were randomized to 12-week interventions of 6 nature hikes (N = 13) or 6 ..."
          ]
        },
        {
          "title": "Efficacy and acceptability of music therapy for post-traumatic stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11036901/",
          "excerpts": [
            "Background: Music therapy is increasingly examined in randomized controlled trials (RCTs) and shows potential in treating post-traumatic stress ...",
            "In this meta-analysis, we identified a large therapeutic effect of music therapy for PTSD, reaching the level of standard psychotherapy. We ..."
          ]
        },
        {
          "title": "Integrative Therapy Approaches for Posttraumatic Stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6519541/",
          "excerpts": [
            "by J Sornborger · 2017 · Cited by 20 — A study of 17 veterans with PTSD who had four sessions of Tai Chi reported having fewer intrusive thoughts, less difficulty concentrating, and less ..."
          ]
        },
        {
          "title": "Ethics and Boundaries in Peer Support | The Institute@MHP",
          "url": "https://www.mentalhealthpartnerships.org/the-institute-at-mhp/ethics-and-boundaries",
          "excerpts": [
            "This 3-hour interactive training provides a foundational understanding of ethics and boundaries in peer support, helping participants navigate complex dynamics."
          ]
        },
        {
          "title": "Therapeutic alliance during trauma focused treatment in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11730843/",
          "excerpts": [
            "by A Grass · 2025 · Cited by 1 — The therapeutic alliance plays a crucial role in D-CPT with young patients, contributing to a reduction in symptom severity over the course of treatment.See more"
          ]
        },
        {
          "title": "Examining the Efficacy of a Pilot Virtual Group Treatment ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S2468749925000870",
          "excerpts": [
            "by JL Kinley · 2025 — Preliminary research findings suggest 'virtual psychotherapy' for Complex PTSD can be an efficient and efficacious treatment alternative.See more"
          ]
        },
        {
          "title": "Controlled randomized clinical trial of spirituality integrated ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3905344/",
          "excerpts": [
            "by A Ebrahimi · 2013 · Cited by 80 — The aim of this research was to compare efficacy of spiritual integrated psychotherapy (SIPT) and cognitive-behavioral therapy (CBT) on the intensity of ..."
          ]
        },
        {
          "title": "Controlled randomized clinical trial of spirituality integrated ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/24516853/",
          "excerpts": [
            "by A Ebrahimi · 2013 · Cited by 80 — The aim of this research was to compare efficacy of spiritual integrated psychotherapy (SIPT) and cognitive-behavioral therapy (CBT) on the intensity of ..."
          ]
        },
        {
          "title": "African-American Faith-Based Mental Health Initiative ...",
          "url": "https://aafbmh.org/",
          "excerpts": [
            "We are a movement of churches working together to increase the awareness and perceptions of mental health, recovery and wellness in African American communities ...See more"
          ]
        },
        {
          "title": "Could Nature Contribute to the Management of ADHD in Children ...",
          "url": "https://www.mdpi.com/1660-4601/21/6/736",
          "excerpts": [
            "The reviewed literature provides strong support for the benefits of exposure to nature on ADHD in school-aged children."
          ]
        },
        {
          "title": "Efficacy and acceptability of music therapy for post-traumatic stress ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38647566/",
          "excerpts": [
            "背景：随机对照试验（RCTs）越来越多地应用于音乐疗法效果的考察，并显示出治疗创伤后应激障碍（PTSD）的潜力。 目的：该系统综述和荟萃分析对现有的音乐疗法治 ..."
          ]
        },
        {
          "title": "Clinical Practice Guidelines for PTSD",
          "url": "https://www.ptsd.va.gov/publications/rq_docs/V35N1.pdf",
          "excerpts": [
            "There are four other current national or international guidelines for PTSD from the. American Psychological Association (APA,. 2017), ..."
          ]
        },
        {
          "title": "Clinical Practice Guideline for the Diagnosis, Evaluation, ...",
          "url": "https://publications.aap.org/pediatrics/article-pdf/144/4/e20192528/1443490/peds_20192528.pdf",
          "excerpts": [
            "by ML Wolraich · 2019 · Cited by 1324 — Copyright © 2019 by the American Academy of Pediatrics. FINANCIAL DISCLOSURE ... ADHD: Clinical guideline for the diagnosis, evaluation, and treatment."
          ]
        },
        {
          "title": "Attention Deficit Hyperactivity Disorder (ADHD)",
          "url": "https://www.aap.org/en/patient-care/attention-deficit-hyperactivity-disorder-adhd/?srsltid=AfmBOoou_pAmD1Vk_oCb7yLaHqnUPmljjMGKl0uGz7S0XCQqz9zcoAQj",
          "excerpts": [
            "Feb 28, 2022 — Guideline offers evidence-based recommendations for the diagnosis, treatment and management of ADHD."
          ]
        },
        {
          "title": "New ISTSS Prevention and Treatment Guidelines",
          "url": "https://istss.org/clinical-resources/trauma-treatment/new-istss-prevention-and-treatment-guidelines/",
          "excerpts": [
            "Grounded in ISTSS' updated PTSD Prevention and Treatment Guidelines, the third edition of this definitive work has more than 90% new content, making it ..."
          ]
        },
        {
          "title": "APA guideline on posttraumatic stress disorder aims to help ...",
          "url": "https://www.apaservices.org/practice/update/2017/09-21/clinicians-treat-ptsd",
          "excerpts": [
            "The guideline, developed by a multidisciplinary panel of scientists, clinicians and community members, recommends interventions for treating PTSD in adults."
          ]
        },
        {
          "title": "Guanfacine Extended-Release Tablets (Intuniv), a ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2935643/",
          "excerpts": [
            "by MP Cruz · 2010 · Cited by 44 — The study showed improved total scores on the Attention-Deficit/Hyperactivity Disorder Rating Scale (ADHD–RS) IV from baseline compared with placebo. After a ..."
          ]
        },
        {
          "title": "Comparative efficacy and safety of attention-deficit ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/28258319/",
          "excerpts": [
            "by A Joseph · 2017 · Cited by 48 — This study found that LDX had greater efficacy than GXR, ATX, and MPH in the treatment of children and adolescents with ADHD."
          ]
        },
        {
          "title": "Effectiveness of Atomoxetine and Stimulant Combination in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11929587/",
          "excerpts": [
            "In patients who do not tolerate stimulants at higher doses, non-stimulant augmentation is a potential treatment strategy. Atomoxetine, as the ..."
          ]
        },
        {
          "title": "Trauma-focused psychotherapies for post-traumatic stress ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34473342/",
          "excerpts": [
            "by B Jericho · 2022 · Cited by 105 — Meta-analytic reviews suggest similar outcomes across trauma-focused psychotherapies for adults with post-traumatic stress disorder (PTSD)."
          ]
        },
        {
          "title": "a network meta-analysis of randomised controlled trials",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36628572/",
          "excerpts": [
            "by N Yunitri · 2023 · Cited by 64 — Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomised controlled ..."
          ]
        },
        {
          "title": "The Role of Eye Movement Desensitization and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3951033/",
          "excerpts": [
            "by F Shapiro · 2014 · Cited by 601 — The 3 sessions of EMDR therapy resulted in an 84% remission of PTSD diagnosis with a large and significant pretreatment versus posttreatment effect size ( ..."
          ]
        },
        {
          "title": "Trauma‐focused psychotherapies for post‐traumatic stress ...",
          "url": "https://onlinelibrary.wiley.com/doi/10.1111/acps.13366",
          "excerpts": [
            "por B Jericho · 2022 · Mencionado por 105 — A comprehensive meta-analysis by Watts et al. reported effect sizes indicating superior efficacy for cognitive processing therapy (CPT; g = 1.69) ..."
          ]
        },
        {
          "title": "Meta-analysis: Which Components of Parent Training Work ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34224837/",
          "excerpts": [
            "by TJ Dekkers · 2022 · Cited by 108 — Objective: Behavioral parent training is an evidence-based intervention for children with attention-deficit/hyperactivity disorder (ADHD), but ..."
          ]
        },
        {
          "title": "Meta-analysis of cognitive–behavioral treatments for adult ...",
          "url": "https://doi.apa.org/doiLanding?doi=10.1037%2Fccp0000216",
          "excerpts": [
            "Nov 7, 2016 — Results: Using a random effects model, we found that CBTs had medium-to-large effects from pre- to posttreatment (self-reported ADHD symptoms: g ..."
          ]
        },
        {
          "title": "A critical appraisal of atomoxetine in the management of ADHD - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4694693/",
          "excerpts": [
            "Effect size of ATX was 0.71. ATX was also evaluated in young children (5–7 years old). A total of 93 subjects were dosed in an 8-week, ..."
          ]
        },
        {
          "title": "A meta-analysis of clonidine for symptoms of attention ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK67951/",
          "excerpts": [
            "by DF Connor · 1999 · Cited by 418 — To review the literature on the clinical use of clonidine to treat symptoms of attention-deficit hyperactviity disorder (ADHD)."
          ]
        },
        {
          "title": "Efficacy of Guanfacine Extended Release in Children and...",
          "url": "https://journals.lww.com/jrnldbp/fulltext/2020/09000/efficacy_of_guanfacine_extended_release_in.12.aspx",
          "excerpts": [
            "by JH Newcorn · 2020 · Cited by 13 — A meta-analysis found psychostimulants to be efficacious in the treatment of oppositional behavior, conduct problems, and aggression in children and adolescents ..."
          ]
        },
        {
          "title": "Meta-analysis: Which Components of Parent Training Work ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856721004202",
          "excerpts": [
            "by TJ Dekkers · 2022 · Cited by 108 — There is consistent evidence that parent training for children with ADHD is less likely to improve the child's behavior when negative parenting ..."
          ]
        },
        {
          "title": "A meta-analysis of behavioral parent training for children ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/22750360/",
          "excerpts": [
            "by P Lee · 2012 · Cited by 230 — This meta-analysis examined the effect of behavioral parent training on child and parental outcomes for children with attention deficit hyperactivity disorder."
          ]
        },
        {
          "title": "Safety and efficacy of guanfacine extended-release in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7531113/",
          "excerpts": [
            "by A Iwanami · 2020 · Cited by 26 — There were no major safety concerns during long-term GXR administration in adults with ADHD. After long-term treatment, patients had significant improvements ..."
          ]
        },
        {
          "title": "A Randomized Controlled Trial of Clonidine Added to ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0890856709610935",
          "excerpts": [
            "by PL HAZELL · 2003 · Cited by 283 — Extended-release (ER) clonidine is approved in the US for treatment of ADHD in 6–17- year olds as monotherapy or an adjunct to stimulants. There are RCTs on ..."
          ]
        },
        {
          "title": "Efficacy and safety of extended-release guanfacine ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0924977X14002788",
          "excerpts": [
            "by A Hervas · 2014 · Cited by 101 — This study assessed the efficacy (symptoms and function) and safety of dose-optimized GXR compared with placebo in children and adolescents with ADHD."
          ]
        },
        {
          "title": "A review of the efficacy of atomoxetine in the treatment of attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5304987/",
          "excerpts": [
            "Reported effect sizes for atomoxetine in children with ADHD are consistent with those for the stimulants and range from 0.6 to 1.3. ... Effect sizes for ..."
          ]
        },
        {
          "title": "Long-Term Safety and Efficacy of Stimulant vs. Non- ...",
          "url": "https://www.gavinpublishers.com/article/view/long-term-safety-and-efficacy-of-stimulant-vs-non-stimulant-medications-in-adhd-treatment-a-comparative-meta-analysis-over-two-years",
          "excerpts": [
            "The study underlines that stimulants are generally more effective than non-stimulants, but they can also have more side effects.See more"
          ]
        },
        {
          "title": "Effects of physical exercise on attention deficit and other ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0165178122001238",
          "excerpts": [
            "by W Sun · 2022 · Cited by 141 — The meta-analysis showed that physical exercise can improve the attention of ADHD children (standardized mean difference [SMD] = −0.60, 95% confidence ..."
          ]
        },
        {
          "title": "Physical Exercise as Treatment for PTSD: A Systematic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34850063/",
          "excerpts": [
            "by F Björkman · 2022 · Cited by 127 — Results showed a main random effect of exercise intervention (0.46; 95% CI: 0.18 to 0.74) and a borderline significant interaction between more ..."
          ]
        },
        {
          "title": "Effects of physical activity on patients with posttraumatic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39833088/",
          "excerpts": [
            "by Z Yuan · 2025 · Cited by 1 — It was discovered that people with PTSD can benefit from physical activity as an adjuvant method to enhance their PTSD, anxiety, despair, and sleep quality."
          ]
        },
        {
          "title": "A Pilot Trial of Mindfulness Meditation Training for Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4045650/",
          "excerpts": [
            "by JT Mitchell · 2013 · Cited by 15 — The aim of this study was to assess the feasibility, acceptability, and preliminary efficacy of mindfulness meditation for ADHD, executive functioning (EF), ..."
          ]
        },
        {
          "title": "A Systematic Review and Network Meta-analysis: La ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33355483/",
          "excerpts": [
            "by A McGirr · 2021 · Cited by 25 — Repetitive transcranial magnetic stimulation (rTMS) is a promising treatment modality for Post-traumatic stress disorder (PTSD)."
          ]
        },
        {
          "title": "A Randomized Controlled Study of Neurofeedback for ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27992435/",
          "excerpts": [
            "by BA van der Kolk · 2016 · Cited by 247 — This study was a randomized, waitlist (TAU) controlled trial of a BCI, EEG neurofeedback training (NF), in patients with chronic PTSD to explore the capacity ...See more"
          ]
        },
        {
          "title": "Omega-3 fatty acid supplementation for the treatment of children ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/21961774/",
          "excerpts": [
            "Omega-3 fatty acid supplementation demonstrated a small but significant effect in improving ADHD symptoms. Eicosapentaenoic acid dose within supplements was ..."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37656283/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of ...",
          "url": "https://www.psychiatrist.com/jcp/omega-3-polyunsaturated-fatty-acids-core-symptoms-adhd-meta-analysis-randomized-controlled-trials/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Effects of a restricted elimination diet on the behaviour ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0140673610622271",
          "excerpts": [
            "by LM Pelsser · 2011 · Cited by 372 — A strictly supervised restricted elimination diet is a valuable instrument to assess whether ADHD is induced by food."
          ]
        },
        {
          "title": "A two arm randomized controlled trial comparing the short ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7251686/",
          "excerpts": [
            "by A Bosch · 2020 · Cited by 48 — The goal of the Elimination Diet (ED) is to diminish symptoms of ADHD and emotion dysregulation symptoms by means of the exclusion of specific ..."
          ]
        },
        {
          "title": "Efficacy and Safety of Transcranial Magnetic Stimulation for ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39829146/",
          "excerpts": [
            "TMS significantly improved the inattention, hyperactivity/impulsivity, and total symptom scores in ADHD patients with minor adverse events."
          ]
        },
        {
          "title": "Neurofeedback self-regulating training in patients with post ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2213422020300962",
          "excerpts": [
            "by J Leem · 2020 · Cited by 21 — The purpose of our study is to assess the efficacy and safety level of neurofeedback treatment in patients with PTSD using quantitative EEG.See more"
          ]
        },
        {
          "title": "Effects of physical exercise on attention deficit and other major symptoms in children with ADHD: A meta-analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35305344/",
          "excerpts": [
            "Conclusion: Physical exercise can help alleviate the symptoms of ADHD in children. Specifically, it can improve attention, executive function, and motor skills."
          ]
        },
        {
          "title": "Mindfulness-based interventions for trauma: Taylor et al., PubMed 2020 (abstract)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32453668/",
          "excerpts": [
            "Mindfulness-based interventions (MBIs), with postures, breath, relaxation, and meditation, such as Mindfulness-based Stress Reduction (MBSR) and yoga, are complex interventions increasingly used for trauma-related psychiatric conditions.",
            "There was a significant, pooled effect of MBIs (g = 0.51, 95%CI 0.31 to 0.71, *p* < .001). Similar effects were observed for mindfulness (g = 0.45, 0.26 to 0.64, *p* < .001), yoga (g = 0.46, 0.26 to 0.66, *p* < .001), and integrative exercise (g = 0.94, 0.37 to 1.51, *p* = .001), with no difference between interv",
            "Mindfulness-based interventions, adjunctive to treatment-as-usual of medication and/or psychotherapy, are effective in reducing trauma-related symptoms. Yoga and mindfulness have comparable effectiveness. Many psychiatric studies do not report trauma exposure, focusing on disorder-specific outcomes, but this review suggests a transdiagnostic approach could be adopted in the treatment of trauma sequelae with MBIs. More rigorous reporting of trauma exposure and MBI treatment protocols is recommended to enhance future research. **Keywords:**\nMindfulness; yoga; systematic review; posttraumatic stress disor"
          ]
        },
        {
          "title": "The efficacy of meditation-based mind-body interventions for mental disorders: A meta-review of 17 meta-analyses of randomized controlled trials",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022395620311560",
          "excerpts": [
            "by D Vancampfort · 2021 · Cited by 101 — Our meta-review demonstrates that mindfulness and to a lesser extent yoga may serve as an efficacious supplement to pharmacotherapy, and psychotherapy. Skip to main content Skip to article\n    * J",
            "quality. The content validity of the included RCTs was considered good in 9 (53%) meta-analyses. In meta-analyses with good methodological quality (AMSTAR 8≤) and content validity (AMSTAR+ 4≤), large effect sizes (0.80 or higher) were observed for mindfulness in schizophrenia and in ADHD , a moderate (0.50 ≤ 0.80) effect size for mindfulness in PTSD and a small (0.20 < 0.50) effect size for yoga in schizophrenia"
          ]
        },
        {
          "title": "JAMA Psychiatry meta-analysis on Neurofeedback for ADHD (Westwood et al., 2024)",
          "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2827733",
          "excerpts": [
            "stand-alone treatment for attention-deficit/hyperactivity disorder (ADHD)? Findings   This systematic review and meta-analysis included 38 randomized clinical trials (RCTs) and a total of 2472 participants. The analyses with probably blinded reports or neuropsychological outcomes provided no evidence of meaningful benefits of neurofeedback as a treatment for ADHD; however, small but statistically significant positive effects were observed when the analyses were limited to RCTs using well-established standard neurofeedback protocols and specifically targeted processing speed as an outcome measur"
          ]
        },
        {
          "title": "Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis (PMCID: PMC6404655)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6404655/",
          "excerpts": [
            "Neurofeedback (NF) has gained increasing interest in the treatment of attention-deficit/hyperactivity disorder (ADHD). Given learning principles underlie NF, lasting clinical treatment effects may be expected. This systematic review and meta-analysis addresses the sustainability of neurofeedback and control treatment effects by considering randomized controlled studies that conducted follow-up (FU; 2–12 months) assessments among children with ADHD.",
            " Within-group and between-group standardized mean differences (SMD) of parent behavior ratings were calculated and analyzed. Ten studies met inclusion criteria (NF: ten studies, *N* = 256; control: nine studies, *N* = 250). Within-group NF effects on inattention were of medium effect size (ES) (SMD = 0.64) at post-treatment and increased to a large ES (SMD = 0.80) at FU. Regarding hyperactivity/impulsivity, NF ES were medium at post-treatment (SMD = 0.50) and FU (SMD = 0.61). Non-active control conditions yielded a small significant ES on inattention at post-treatment (SMD = 0.28) but no significant ES at FU. Active treatments (mainly methylphenidate), had large ES for inattention (post: SMD = 1.08; FU: SMD = 1.06) and medium ES for hyperactivity/impulsivity (post: SMD = 0.74; FU: SMD"
          ]
        },
        {
          "title": "Neurofeedback for ADHD: A Systematic Review and Meta-Analysis (Riesco-Mat\u0000edas et al., 2021)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30646779/",
          "excerpts": [
            "by P Riesco-Matías · 2021 · Cited by 105 — Neurofeedback significantly improves inattention symptoms when possibly blinded evaluators assess symptoms. The prelim",
            "**Results:** We reviewed seven meta-analyses, and 17 studies were incorporated into the meta-analysis.",
            "RCTs support the efficacy of neurofeedback applied to ADHD when most proximal evaluators assess symptoms.",
            "The preliminary results suggest that stimulant medication is more effective than neurofeedback."
          ]
        },
        {
          "title": "A meta-analysis of randomized controlled trials",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36794797/",
          "excerpts": [
            "by CI Liu · 2023 · Cited by 43 — This meta-analysis indicates that CBT for adults with ADHD was effective in reducing both core and emotional symptoms."
          ]
        },
        {
          "title": "A randomized controlled trial of effects of sleep hygiene ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38554532/",
          "excerpts": [
            "por GT Noyan · 2024 · Mencionado por 3 — The present study investigated the effects of sleep hygiene training (SH) and progressive muscle relaxation exercises (PMR) in children with ADHD."
          ]
        },
        {
          "title": "Perspective on Melatonin Use for Sleep Problems in Autism and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7325410/",
          "excerpts": [
            "Overall, a high response rate was observed in the melatonin group compared to the placebo in treating sleep problems in children. Melatonin is a ..."
          ]
        },
        {
          "title": "Umbrella Review and Meta-Analysis: The Efficacy of ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856724020215",
          "excerpts": [
            "Among nonpharmacological interventions for sleep difficulties in youth, only behavioral interventions are supported by meta-analytic evidence."
          ]
        },
        {
          "title": "Acute and Repeated Ashwagandha Supplementation ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38931168/",
          "excerpts": [
            "by M Leonard · 2024 · Cited by 27 — Conclusion: Results support contentions that ashwagandha supplementation (225 mg) may improve some measures of memory, attention, vigilance, ...See more"
          ]
        },
        {
          "title": "Safety and Efficacy of Ashwagandha Root Extract on ...",
          "url": "https://www.tandfonline.com/doi/full/10.1080/02791072.2024.2424279",
          "excerpts": [
            "by S Kale · 2024 · Cited by 3 — This prospective, randomized, placebo-controlled study assessed the effects of Ashwagandha root extract (ARE) on cognition, energy, and mood ...See more"
          ]
        },
        {
          "title": "Effects of 12-Week Bacopa monnieri Consumption on Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3537209/",
          "excerpts": [
            "These results suggest that B. monnieri can improve attention, cognitive processing, and working memory partly via the suppression of AChE activity."
          ]
        },
        {
          "title": "Exploring the efficacy of nortriptyline, buspirone, and Ginkgo biloba ...",
          "url": "https://ejnpn.springeropen.com/articles/10.1186/s41983-025-00993-2",
          "excerpts": [
            "The findings of this systematic review suggest that non-stimulant medications such as buspirone, nortriptyline, and Ginkgo biloba extract may provide potential alternative or adjunctive options for managing ADHD , particularly in patients who are intolerant to or unresponsive to first-line stimulant medications."
          ]
        }
      ],
      "reasoning": "- The target finegrained field emphasizes non-clinical, skills-based and environmental supports. Multiple excerpts provide direct, concrete support for these components: ADHD coaching as a collaborative, skills-focused intervention clearly aligns with the field's emphasis on collaborative, practical skill-building to improve executive functioning and self-esteem. The cited evidence describes coaching as an evidence-based approach for adults with ADHD and specifies outcomes such as improved study and daily functioning, which map onto the field's focus on daily functioning and organizational skills. - Organizational systems and memory externalization are well covered in excerpts describing occupation-based interventions and environmental supports: ADHD occupational therapy (OT) and sensory-modulation approaches describe creating structured routines, sensory diets, grounding strategies, and environmental modifications to reduce distraction and support regulation. External memory aids (whiteboards, sticky notes, timers) and time-management strategies (Pomodoro technique) appear as concrete tools linked to improved organization and task completion, matching the field's emphasis on practical aids. - The field value highlights environmental engineering and first-line environmental adaptations per NICE and ADA-type guidance. Multiple excerpts document environmental modifications (quiet workspaces, noise reduction, structured breaks, decreased sensory overload) and legal/organizational supports (ADA, JAN accommodations), which align with the field path's emphasis on workplace and environmental accommodations to support functioning. - Social and community supports, including peer-led groups and faith-based practices, feature in excerpts describing peer support and faith/community partnerships as beneficial for social connectedness and coping, which align with the field's social support pillar. - Nature-based interventions (forest bathing, green space exposure) are repeatedly described as having beneficial effects on ADHD and PTSD symptoms, supporting the field's inclusion of nature-based strategies as a non-pharmacological, environment-aligned option. - Arts therapies and mindfulness-based approaches appear as adjuncts that can support trauma processing and attention regulation, adding to the non-clinical toolkit described in the field. - Workplace accommodations and disability rights guidance (ADA, JAN, NICE embedding non-pharmacological supports, and workplace adjustment examples) provide concrete alignment with the field's emphasis on enabling functioning through environmental and systemic changes. Overall, the selected excerpts directly map to the field's core components: coaching and collaborative supports; organizational skills and external memory aids; occupational therapy and sensory modulation; environmental and sensory adaptations; social, faith-based, and nature-based approaches; and organizational/workplace accommodations. The gathered evidence collectively substantiates a comprehensive, non-clinical, skills- and environment-based framework for managing ADHD and trauma. The confidence assessment is high because there is broad, explicit, and concordant support across many excerpts for each major component described in the target field value.",
      "confidence": "high"
    },
    {
      "field": "traditional_and_ancient_healing_systems",
      "citations": [
        {
          "title": "Acupuncture for Combat-Related Posttraumatic Stress ...",
          "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2814938",
          "excerpts": [
            "by M Hollifield · 2024 · Cited by 15 — In this randomized clinical trial including 93 participants, verum acupuncture resulted in a larger reduction in PTSD symptom severity than sham."
          ]
        },
        {
          "title": "Acupuncture for Posttraumatic Stress Disorder: A Systematic Review of Randomized Controlled Trials and Prospective Clinical Trials",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3580897/",
          "excerpts": [
            "e high-quality RCT reported that acupuncture was superior to waitlist control and therapeutic effects of acupuncture and cognitive-behavioral therapy (CBT) were similar based on the effect sizes.",
            "This systematic review and meta-analysis suggest that the evidence of effectiveness of acupuncture for PTSD is encouraging but not cogent.",
            "One RCT showed no statistical difference between acupuncture and selective serotonin reuptake inhibitors (SSRIs).",
            "A meta-analysis of acupuncture plus moxibustion versus SSRI favored acupuncture plus moxibustion in three outcomes."
          ]
        },
        {
          "title": "Acupuncture for ADHD in children and adolescents (Li 2011 Cochrane Review)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12147681/",
          "excerpts": [
            "There is increasing interest in complementary and alternative therapies such as acupuncture; however, it remains unclear whether the use of acupuncture in children and adolescents with ADHD is supported by the existing evidence.",
            "No studies met the inclusion criteria for this review.",
            "A comprehensive search showed that there is no evidence base of randomised or quasi‐randomised controlled trials to support the use of acupuncture as a treatment for ADHD in children and adolescents.",
            "This review highlights the need for further research in this area in the form of high quality, large scale, randomised controlled trials.",
            "The aim of this review was to systematically analyse all the randomised controlled trials of acupuncture for children and adolescents with ADHD to provide the ..."
          ]
        },
        {
          "title": "MDPI Medical Sciences 2023 Ang et al. Acupuncture for ADHD in Children: A Systematic Review and Meta-analysis",
          "url": "https://www.mdpi.com/1648-9144/59/2/392",
          "excerpts": [
            "No major adverse events were reported."
          ]
        },
        {
          "title": "Bacopa monnieri randomized controlled trial protocol (Nutrients, 2015)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26633481/",
          "excerpts": [
            "This paper reports the protocol for the first 16-week, randomized, placebo-controlled, double-blind, parallel groups trial examining the efficacy and safety of CDRI 08 in male children aged 6-14 years with high levels of inattention and hyperactivity."
          ]
        },
        {
          "title": "Bacopa monnieri (CDRI 08) randomized trial in children with ADHD (Kean et al., Phytother Res. 2022)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35041248/",
          "excerpts": [
            " The current study investigated the efficacy of extract of Bacopa monnieri (BM; CDRI 08®) in reducing levels of inattention and hyperactivity in young children.",
            "A 14-week randomized, double-blind, placebo-controlled clinical trial, with placebo run-in and run-out phases, investigated the effects of BM on behavioural, cognitive, mood, and sleep effects in male children aged 6 to 14 years against placebo.",
            "One-hundred and twelve participants were recruited into the trial, with 93 datasets available for analysis.",
            "No significant behavioural differences were noted between treatment groups.",
            " Cognitive outcomes indicated decreased error-making in children taking CDRI 08® (p = .04) and increased speed of reaction time in those taking placebo (p = .04) at study end."
          ]
        },
        {
          "title": "Complementary Therapies in Medicine (Kean et al., 2016)",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0965229916301388",
          "excerpts": [
            "A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations",
            "Five studies met inclusion criteria for this review.",
            "significant consistent improvements in the language behaviour cognitive domain and in a number of the memory sub-domains.",
            "Significant outcomes demonstrated small to medium effect sizes (mean d = 0.42).",
            "Bacopa monnieri was well tolerated with only 2.3% of all participants reporting mild side-effects.",
            "• Bacopa monnieri significantly improved memory span as well as verbal and visual memory in children and adolescents.",
            "by JD Kean · 2016 · Cited by 55 — Two studies reported improvements in hyperactivity and attention in children diagnosed with ADHD. ... Significant outcomes demonstrated small to medium effect ...",
            "• Significant outcomes demonstrated small to medium effect sizes (mean d = 0.42).",
            "n\nThis review highlights the safe use of Bacopa monnieri in child and adolescent populations for improving elements of cognition as well as behaviour and attention-deficit domains.",
            "by JD Kean · 2016 · Cited by 55 — Recent research has reported that the traditional Ayurvedic medicine Bacopa monnieri may improve cognitive outcomes in adult populations; however, few studies ..."
          ]
        },
        {
          "title": "Shamanic Healing for PTSD in Veterans (Wahbeh et al., 2017)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/28336055/",
          "excerpts": [
            "The objectives of the case series are to (1) develop a structured replicable shamanic treatment plan for veterans with posttraumatic stress disorder (PTSD); Shamanic healing is one such therapy that may potentially be beneficial but no systematic research has been conducted on it for PTSD.",
            "Qualitative descriptions of the participants, their histories, and effects from the intervention are reported.",
            "Future research is warranted and needed to evaluate the efficacy of shamanic healing as a potential therapy for veterans with PTSD.",
            ". Six veterans enrolled in the study (mean age = 49.3 ± 13.1).",
            "The protocol was found feasible and acceptable and recommendations for its future use are suggested."
          ]
        },
        {
          "title": "Am J Community Psychol (Systematic review of trauma interventions in Native communities)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7243818/",
          "excerpts": [
            " this systematic review of the literature on trauma interventions in Native communities in the United States, Canada, Australia, and New Zealand, we identified 15 studies representing 10 interventions",
            "These studies involved the community to some extent in developing or culturally adapting the interventions and suggested positive outcomes with regard to historical and interpersonal trauma symptoms.",
            "However, notable limitations in study design and research methods limit both internal validity and external validity of these conclusions.",
            "Of the EBTs for trauma, only TF-CBT and Seeking Safety have been culturally adapted for use in Native communities.",
            " Trauma-focused CBT was originally designed for sexually abused children and has been adapted for other types of interpersonal trauma",
            "In this review, 15 published studies were discovered that addressed trauma in Native communities.",
            "An increase in trauma intervention research in Native communities over the past 15 years illustrates a growing focus on treating trauma, and, significantly, utilizing community participation."
          ]
        },
        {
          "title": "Indigenous Indigenous healing and TIM in PTSD/Trauma (Native healing perspectives)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3327107/",
          "excerpts": [
            "The results have been promising, indicating that Native approaches to healing for PTSD and related disorders are therapeutic for Native people.",
            "TIM is a type of traditional medicine (TM) that is based on indigenous knowledge in the Americas.",
            "Indigenous therapeutic interventions usually involve an individual's family and community, and healing occurs within the context of the community as a whole.",
            "Our analysis contributes to a much-needed body of research on indigenous perspectives on health. Our study differs from similar studies that have been done in at least two important ways. First, we conducted interviews with healers from six tribes across North America rather than with healers who all represented the same tribe. Second, the focus of our interviews was traumatic injury, a focus we have not encountered in our reviews of the literature. Given the high prevalence of traumatic injury and PTSD among Native populations, future studies with this focus are warranted.",
            "Indigenous therapeutic interventions usually involve an individual's family and community, and healing occurs within the context of the community as a whole. The healed person is able to then help the community."
          ]
        },
        {
          "title": "Lead Poisoning Associated with Ayurvedic Medications",
          "url": "https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5326a3.htm",
          "excerpts": [
            "A total of 12 cases of lead poisoning among adults in five states associated with ayurvedic medications or remedies were reported to CDC."
          ]
        },
        {
          "title": "and Indian-Manufactured Ayurvedic Medicines Sold via the ...",
          "url": "https://jamanetwork.com/journals/jama/fullarticle/182460",
          "excerpts": [
            "by RB Saper · 2008 · Cited by 711 — Design and interpretation of data in “Heavy metal content of Ayurvedic medicine products” published in JAMA by Saper et al. Light Ayurveda J ..."
          ]
        },
        {
          "title": "Tai Chi and Qigong for trauma exposed populations: A systematic ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S1755296622000114",
          "excerpts": [
            "The reviewed studies suggest that TCQ practices have the potential to reduce symptoms and improve functioning for individuals exposed to trauma."
          ]
        },
        {
          "title": "Tai Chi and Qigong for trauma exposed populations: A systematic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37885833/",
          "excerpts": [
            "The reviewed studies suggest that TCQ practices have the potential to reduce symptoms and improve functioning for individuals exposed to trauma."
          ]
        },
        {
          "title": "Yoga and music intervention reduces inattention, hyperactivity ...",
          "url": "https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2023.1150018/full",
          "excerpts": [
            "Our study shows the positive effect of yoga interventions on attention and hyperactivity/impulsivity in children with comorbid ADHD and ODD, ..."
          ]
        },
        {
          "title": "Qigong for children with attention deficit hyperactivity ...",
          "url": "https://examine.com/research-feed/study/dNvpad/?srsltid=AfmBOopbdW-QCfEU2UrZKKE3f9REEIXeQ3P1X29EMTv18tErLunCtg3t",
          "excerpts": [
            "May 22, 2025 — In this 3-month randomized controlled trial, qigong did not reduce hyperactivity/impulsivity scores compared to routine aerobic exercise in 120 children."
          ]
        },
        {
          "title": "Adverse Event Reports Involving Herbal Remedies and ADHD Medications (Mazhar 2020)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31670573/",
          "excerpts": [
            "The objectives of this study were (1) to identify adverse event reports (AERs) involving commonly used herbal remedies and ADHD prescription medicines in children and adolescents; (2) to evaluate the quality of collected AERs; and (3) to assess whether NHP-drug interactions can be causally linked to reported adverse events.",
            "An NHP-drug interaction was assessed to be probable in one case and to be possible in another. Both these reports involved a methylphenidate formulation and St. John's wort.",
            "The reporting quality was poor for the five AERs examined.",
            "Eighteen of the 23 identified AERs involving both an herbal remedy and an ADHD drug also involved other multiple ingredient products. The reporting quality was poor for the five AERs examined. Further research is needed to study the interaction between St. John's wort and methylphenidate."
          ]
        },
        {
          "title": "Natural Health Product–Drug Interaction Causality Assessment in Pediatric Adverse Event Reports Associated with Attention-Deficit/Hyperactivity Disorder Medication",
          "url": "https://www.liebertpub.com/doi/10.1089/cap.2019.0102",
          "excerpts": [
            "Health care practitioners, particularly those treating pediatric ADHD patients, need to be aware of risks of NHP interactions and need to maintain a dialog about the use of these products.",
            "Eighteen of the 23 identified AERs involving both an herbal remedy and an ADHD drug also involved other multiple ingredient products.",
            "An NHP-drug interaction was assessed to be probable in one case and to be possible in another.",
            "St. John's wort is known to interact with various drugs through several mechanisms.",
            "Concomitant use of St. John's wort could exacerbate this as they share similar modes of action, and St. John's wort is an inhibitor of P-glycoprotein, which could result in higher plasma levels of Ritalin."
          ]
        },
        {
          "title": "Is integrating acupuncture into the management of ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S096522992500038X",
          "excerpts": [
            "by FY Zhao · 2025 · Cited by 1 — This review aimed to provide more reliable evidence on the efficacy and safety of acupuncture as an alternative or adjunctive treatment for ADHD, focusing ..."
          ]
        },
        {
          "title": "An overview of systematic reviews and meta-analyses",
          "url": "https://www.sciencedirect.com/science/article/pii/S0965229923000559",
          "excerpts": [
            "by L Zhang · 2023 · Cited by 4 — Acupuncture might improve the efficacy and CIH score of ADHD. Large sample and high-quality RCTs are still needed to draw reliable conclusions about ..."
          ]
        },
        {
          "title": "Acupuncture for ADHD in children and adolescents",
          "url": "https://www.cochrane.org/evidence/CD007839_acupuncture-adhd-children-and-adolescents",
          "excerpts": [
            "Apr 1, 2022 — In general, effective treatment for ADHD relies on comprehensive therapy. Acupuncture is a complementary and alternative medicine (CAM) therapy ..."
          ]
        },
        {
          "title": "Acupuncture treatment on attention deficit hyperactivity ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8389897/",
          "excerpts": [
            "by L Xing · 2021 · Cited by 4 — This study will provide the evidence of whether acupuncture is an effective and safe intervention to ADHD."
          ]
        },
        {
          "title": "Acupuncture for Combat-Related Posttraumatic Stress ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38381417/",
          "excerpts": [
            "by M Hollifield · 2024 · Cited by 15 — The acupuncture intervention used in this study was clinically efficacious and favorably affected the psychobiology of PTSD in combat veterans."
          ]
        },
        {
          "title": "Acupuncture for Anxiety, Depression, and Sleep in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12112474/",
          "excerpts": [
            "by AF Hsiao · 2025 · Cited by 1 — The first published RCT of acupuncture for PTSD showed efficacy equivalence between acupuncture and group CBT and superiority to a waitlist ..."
          ]
        },
        {
          "title": "BACHI Study Protocol (ANZCTRN12612000827831)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4690059/",
          "excerpts": [
            "by JD Kean · 2015 · Cited by 53 — A randomized controlled trial investigating the effects of a special extract of Bacopa monnieri (CDRI 08) on hyperactivity and inattention in male children and ..."
          ]
        },
        {
          "title": "Ashwagandha: Is it helpful for stress, anxiety, or sleep?",
          "url": "https://ods.od.nih.gov/factsheets/Ashwagandha-HealthProfessional/",
          "excerpts": [
            "May 2, 2025 — Overall, the studies found that ashwagandha significantly reduced stress and anxiety levels (subjectively measured by validated rating scales), ..."
          ]
        },
        {
          "title": "Phytochemical Profile, Pharmacological Attributes and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7063970/",
          "excerpts": [
            "by A Balkrishna · 2020 · Cited by 67 — One such cognitive booster herb is C. prostratus Forssk., commonly known as Shankhpushpi, which is mainly endowed with neuroprotective, ..."
          ]
        },
        {
          "title": "ADHD and Working Memory",
          "url": "https://iyurved.com/blogs/brain-health-and-foods/adhd-and-working-memory?srsltid=AfmBOorEbHpUi5HP3MaWGkliszCrtwoOniWH-85yHls4FG_Crf20Fy8z",
          "excerpts": [
            "Its Medhya (improves intelligence) characteristic also helps memory by functioning as a brain tonic. Take Shankhpushpi powder with warm milk or water as it ..."
          ]
        },
        {
          "title": "Effects of Withania somnifera (Ashwagandha) on Stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8762185/",
          "excerpts": [
            "by AB Speers · 2021 · Cited by 229 — WS root and leaf extracts exhibited noteworthy anti-stress and anti-anxiety activity in animal and human studies. WS also improved symptoms of depression and ..."
          ]
        },
        {
          "title": "Shamanic Healing for Veterans with PTSD: A Case Series",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S1550830717300411",
          "excerpts": [
            "by H Wahbeh · 2017 · Cited by 18 — A semi-structured shamanic healing protocol was created with the following components: rapport building, power animal retrieval, extraction, compassionate ..."
          ]
        },
        {
          "title": "Rapid antidepressant effects of the psychedelic ayahuasca ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6378413/",
          "excerpts": [
            "by F Palhano-Fontes · 2019 · Cited by 1005 — Recent open-label trials show that psychedelics, such as ayahuasca, hold promise as fast-onset antidepressants in treatment-resistant depression."
          ]
        },
        {
          "title": "Shamanic Healing for Veterans with PTSD – IONS",
          "url": "https://noetic.org/blog/shamanic-healing-for-veterans-with-ptsd/",
          "excerpts": [
            "Aug 3, 2017 — The results suggest the a treatment protocol of shamanic healing is indeed acceptable to Veterans and can reduce the intensity of PTSD symptoms."
          ]
        },
        {
          "title": "Examination of Recreational and Spiritual Peyote Use ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6614926/",
          "excerpts": [
            "by MA Prince · 2019 · Cited by 20 — Although adults who use peyote strictly for religious ceremonies do not appear to suffer negative consequences from such use (Halpern et al., 2005), there is ..."
          ]
        },
        {
          "title": "Acupuncture for ADHD systematic review (2025) - Is integrating acupuncture into the management of attention-deficit/hyperactivity disorder among children and adolescents now opportune and evidence-based? A systematic review with meta-analysis and trial sequential analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40086639/",
          "excerpts": [
            "We reviewed 25 studies with 1758 participants.",
            "None compared acupuncture to placebo or behavioral therapy.",
            "Subdomain analysis of the Conners' Parent Rating Scale indicated that acupuncture and Methylphenidate had comparable effects on Conduct Problems [SMD = 0.03, 95 %CI (-0.93, 0.99), p = 0.95] and Learning Problems [SMD = 0.29, 95 %CI (-0.38, 0.97), p = 0.39], but acupuncture was more effective in controlling Impulsive/Hyperactive symptoms [SMD = -1.71, 95 %CI (-2.08, -1.35), p < 0.01].",
            "Insufficient sample size prevented confirmation of potential false positives.",
            "This systematic review consolidates evidence on acupuncture's efficacy and safety for treating ADHD in children and adolescents."
          ]
        },
        {
          "title": "Acupuncture for ADHD on ResearchGate (summary of systematic reviews/meta-analyses)",
          "url": "https://www.researchgate.net/publication/51049745_Acupuncture_for_Attention_Deficit_Hyperactivity_Disorder_ADHD_in_children_and_adolescents",
          "excerpts": [
            "Of 114 articles, only three randomized clinical trials (RCTs) met our inclusion criteria.",
            "One RCT found that electroacupuncture (EA) plus behavioural treatment was superior to sham EA plus behavioural treatment.",
            "Two RCTs reported a significant benefit of acupuncture or auricular acupuncture over conventional drug therapies.",
            "Limited evidence exists for the effectiveness of acupuncture as a symptomatic treatment of ADHD.",
            "Given that the risk of bias of the included studies was high, firm conclusions cannot be drawn."
          ]
        },
        {
          "title": "Ayurveda and ADHD – MD Case Reports and Study Protocols, 2025",
          "url": "https://journals.lww.com/md-cases/fulltext/2025/08000/evaluating_the_efficacy_of_ayurvedic_intervention.1.aspx",
          "excerpts": [
            "In ADHD, _Vata_ dominates the condition, resulting in hyperactivity of _Manovaha srotus_ (Channels of mi",
            "However, there have been no attempts to systematically study the efficacy and safety of Ayurveda interventions in patients with ADHD.",
            "Therefore, we are conducting a randomized controlled trial to assess the efficacy and safety of Ayurveda as an add-on therapy in pediatric ADHD based on epigenetic, gut microbiome, neuronal and neuroimaging biomarkers.",
            "The current protocol version is 3-106/2019-CCRAS/Admn./IMR/v2. The study was sanctioned on March 3rd, 2021. Recruitment started in January 2022 and will end in October 2025, or until 80 patients have been recruited.",
            "Currently, there are no studies in Ayurveda that demonstrate the bio-mechanisms of Ayurveda interventions similar ",
            "This study protocol is based on the Standard Protocol Items: Recommendations for Interventional Trials 2013 statement."
          ]
        },
        {
          "title": "ROLE OF AYURVEDA IN ADHD: A CRITICAL REVIEW",
          "url": "https://www.researchgate.net/publication/377556903_ROLE_OF_AYURVEDA_IN_ADHD_A_CRITICAL_REVIEW",
          "excerpts": [
            "ROLE OF AYURVEDA IN ADHD: A CRITICAL REVIEW",
            "This study aims to systematically review the management of attention deficit hyperactivity disorder in Ayurveda.",
            " A total of 40 studies were obtained, which underwent further screening processes to achieve the quality of inclusion criteria.\nA total",
            "Out of 14 clinical studies, 6 showed highly significant results, 1 showed comparatively insignificant results, and 7 showed moderately significant results.",
            "this paper would be helpful in understanding pathophysiology and the management of ADHD in Ayurveda way."
          ]
        },
        {
          "title": "Shamanic Healing for Veterans with PTSD: A Case Series",
          "url": "https://www.researchgate.net/publication/314015184_Shamanic_Healing_for_Veterans_with_PTSD_A_Case_Series",
          "excerpts": [
            "Shamanic Healing for Veterans with PTSD: A Case Series",
            "The objectives of the case series are to (1) develop a structured replicable shamanic treatment plan for veterans with posttraumatic stress disorder (PTSD); (2) collect preliminary data on PTSD-related outcomes, and (3) explore the feasibility and potential for adverse events of the plan.",
            ". Six veterans enrolled in the study (mean age = 49.3 ± 13.1).",
            "The protocol was found feasible and acceptable and recommendations for its future use are suggested.",
            "Shamanic healing (SH) is an ancient form of spiritual healing that focuses on achieving relief from discomfort from an existing illness (Hammerschlag, 2009).",
            "There is a dire need for well-designed and power-adjusted randomized clinical trials with adequate groups and long-term follow-up.",
            "Shamanic healing methods were derived from core shamanic principles taught by the Foundation for Shamanic Studies, and all sessions were delivered by one single practitioner, in the same location."
          ]
        },
        {
          "title": "Single-population studies of PTSD among American Indians and Alaska Natives",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3875613/",
          "excerpts": [
            "by D Bassett · 2014 · Cited by 148 — The authors suggested that the importance of dreams in Native cultures should be considered in treating AI/AN veterans with PTSD and, when appropriate, such ... Single-population studies of PTSD among American Indians and Alaska Natives",
            "| Author- Year | Time  Frame | Sample  Size  &  Population | Criteria &  Methods | Inciting  Events | Diagnostic  measure | Comorbidities  & Risk  Factors | Major Findings ",
            "| --- | --- | --- | --- | --- | --- | --- | --- |",
            "|\n| Boyd-Ball  2006[[17]()] | 1997 -  2000 | 423  adolescents  and  young  adults  from a  Southwest  tribe | Enrolled  tribal  members in  SUPERPF  P dataset,  age 15-24  years. Survey;  descriptive  statistics  and logistic  regression | Parental  alcohol  use | DSM-IV | *Risk factor:*  Parental  alcohol use | Severe trauma increased  odds of alcohol use disorders  (direction of association  unclear). Severe traumatic events  correlated with parental  alcohol use. Severe IPV may have  stronger association with  alcohol use disorders than  severe non-interpersonal  trauma, witnessed trauma, or  traumatic news. |",
            "| Brinker  2007[[18]()] |  | 255 male  AI/AN  and  Hispanic  veterans  with  lifetime  PTSD in  Southwest  and  North  Central  region | Community -based sample  Descriptive  statistics  and logistic  regression | Combat  experience | PCL |  | Veterans with combat-related  PTSD had more severe  symptoms, were less likely to  have remitted in the previous  year, and were less likely to  have sought mental health  treatment after military duty."
          ]
        },
        {
          "title": "High-dose eicosapentaenoic acid (EPA) improves attention ...",
          "url": "https://www.nature.com/articles/s41398-019-0633-0",
          "excerpts": [
            "by JPC Chang · 2019 · Cited by 112 — EPA treatment improves cognitive symptoms in ADHD youth, especially if they have a low baseline endogenous EPA level."
          ]
        },
        {
          "title": "High-dose eicosapentaenoic acid (EPA) improves attention and ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31745072/",
          "excerpts": [
            "EPA treatment improves cognitive symptoms in ADHD youth, especially if they have a low baseline endogenous EPA level."
          ]
        },
        {
          "title": "Neurodevelopmental effects of omega-3 fatty acids and its ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0022395625001141",
          "excerpts": [
            "by NM Walter · 2025 · Cited by 1 — EPA and DHA with MPH treatments increased Wnt activity in both MPH responder-ADHD and control neural stem cells. •. Only treatments of EPA with DHA elevated ..."
          ]
        },
        {
          "title": "Omega-3 polyunsaturated fatty acids in clinical trials for ADHD, PTSD, anxiety, and related conditions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6324500/",
          "excerpts": [
            "-\n\nThis systematic review and meta-analysis of clinical trials conducted on participants with clinical anxiety symptoms provides the first meta-analytic evidence, to our knowledge, that omega-3 PUFA treatment may be associated with anxiety reduction, which might not only be due to a potential placebo effect, but also from some associations of treatment with reduced anxiety symptoms.",
            "In addition, participants receiving supplements containing less than 60% EPA showed a significant association, but not those receiving supplements containing 60% or more EPA.",
            "A cohort study found that high serum EPA levels were associated with protection against posttraumatic stress disorder.",
            "A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.",
            "Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial."
          ]
        },
        {
          "title": "Magnesium status and attention deficit hyperactivity ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165178118318456",
          "excerpts": [
            "by M Effatpanah · 2019 · Cited by 75 — Magnesium supplementation may be beneficent for attention deficit hyperactivity disorder (ADHD). Abstract. Current research suggests conflicting evidence ...",
            "by M Effatpanah · 2019 · Cited by 75 — The random-effects meta-analysis showed that subjects with ADHD had 0.105 mmol/l (95% CI: -0.188, -0.022; P < 0.013) lower serum magnesium levels compared with ..."
          ]
        },
        {
          "title": "The Effect of Vitamin D Supplementation on Attention ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31368773/",
          "excerpts": [
            "by J Gan · 2019 · Cited by 62 — Vitamin D supplementation demonstrated a small but statistically significant improvement in ADHD total scores, inattention scores, hyperactivity scores, and ..."
          ]
        },
        {
          "title": "Serum Ferritin and Amphetamine Response in Youth with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3003494/",
          "excerpts": [
            "by C Calarge · 2010 · Cited by 87 — The study aim was to explore whether iron stores, as reflected by serum ferritin concentration, predicted response to psychostimulants."
          ]
        },
        {
          "title": "Effects of Iron Supplementation on Attention Deficit ...",
          "url": "https://www.cpn.or.kr/journal/view.html?doi=10.9758/cpn.2021.19.4.712",
          "excerpts": [
            "by S Tohidi · 2021 · Cited by 16 — About 10 studies have indicated the lower serum ferritin levels in ADHD patients than healthy controls [24]. Studies of Adisetiyo et al. [34], Menegassi et al.",
            "The present study evaluated the effects of iron supplementation (ferrous sulfate) on the symptoms of children with ADHD, treated with methylphenidate."
          ]
        },
        {
          "title": "Magnesium and ADHD: Benefits, risks, dosage, and more",
          "url": "https://www.medicalnewstoday.com/articles/magnesium-and-adhd",
          "excerpts": [
            "Nov 5, 2024 — Some research suggests that magnesium supplementation may help improve symptoms of attention deficit hyperactivity disorder (ADHD) in children and adults."
          ]
        },
        {
          "title": "Study Details | Effects of L-theanine and Caffeine on ...",
          "url": "https://clinicaltrials.gov/study/NCT03533556?term=NCT00291070%20NCT03533556&rank=1",
          "excerpts": [
            "Furthermore, there is evidence to suggest that, when taken in combination, L-theanine and caffeine seem to have additive effects in improving attention in ..."
          ]
        },
        {
          "title": "Effects of L-Theanine Administration on Stress-Related ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6836118/",
          "excerpts": [
            "by S Hidese · 2019 · Cited by 258 — Additionally, this trial suggests, for the first time, that 4 weeks L-theanine administration is effective in improving stress-related symptoms ..."
          ]
        },
        {
          "title": "N‐acetylcysteine as a new prominent approach for treating ...",
          "url": "https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.15456",
          "excerpts": [
            "by I Smaga · 2021 · Cited by 67 — The trial revealed some improvement in the cognitive/inattentive ADHD symptoms of patients using NAC (4.8 g day−1, but not 2.4 g day−1) (Garcia ..."
          ]
        },
        {
          "title": "The Potential of N-Acetyl-L-Cysteine (NAC) in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9095537/",
          "excerpts": [
            "by RCJ Bradlow · 2022 · Cited by 82 — Five [23, 32–35] randomized controlled trials (RCTs) have investigated NAC as a treatment for ASD in children and adolescents, all of which were included in a ..."
          ]
        },
        {
          "title": "Effects of 800mg of Rhodiola Rosea in Attention in Adults ...",
          "url": "https://clinicaltrials.gov/study/NCT02737033",
          "excerpts": [
            "This study evaluates the use of Rhodiola rosea in the attention of adults with Attention Deficit/Hyperactivity Disorder (ADHD). Half of participants will ..."
          ]
        },
        {
          "title": "Efficacy and safety of saffron as adjunctive therapy in ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2212958822000027",
          "excerpts": [
            "by B Pazoki · 2022 · Cited by 14 — The present randomized, double-blind, placebo-controlled clinical trial demonstrated that six weeks of adjuvant therapy with saffron and Ritalin improved ADHD ..."
          ]
        },
        {
          "title": "The Effectiveness of Rhodiola rosea L. Preparations in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9228580/",
          "excerpts": [
            "by EI Stojcheva · 2022 · Cited by 126 — A statistically significant improvement in the Fatigue Index was observed in the R. rosea treatment group. Additionally, the improved mental ..."
          ]
        },
        {
          "title": "Effects of l-theanine on attention and reaction time response",
          "url": "https://www.sciencedirect.com/science/article/pii/S1756464611000351",
          "excerpts": [
            "by A Higashiyama · 2011 · Cited by 110 — l-theanine clearly has a pronounced effect on attention performance and reaction time response in normal healthy subjects prone to have high anxiety."
          ]
        },
        {
          "title": "Advances in Integrative Medicine, 2022: Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled clinical trial",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S2212958822000027",
          "excerpts": [
            ". Saffron may increase the efficacy of Ritalin in treatment of ADHD patients.",
            "• Saffron is a safe treatment for ADHD.",
            ".\nThis study aimed to evaluate the efficacy and safety of saffron as an adjuvant to Ritalin for improving symptoms in adults with ADHD.",
            "s\nFifty-six patients diagnosed with ADHD were assigned into two parallel groups to receive Ritalin (30 mg/day) plus placebo or Ritalin plus saffron (15 mg twice daily) for six weeks.",
            ". GLM repeated-measure analysis demonstrated significant time × treatment interaction effect for ASRS (df=2, F=3.455, and P-value=0.036) and CAARS (df=1.584, F=3.939, and P-value=0.033) score from baseline to the study endpoint.",
            ". We found a significantly greater reduction in ASRS scores in the saffron group compared with the placebo group from baseline to the study endpoint (week 6) (P-value=0.024).",
            ". However, the change score from baseline to week 3 was not significantly different between trial groups (P-value=0.269).",
            ". There was no significant difference between the two groups in baseline parameters and frequency of side effects.",
            "— Saffron might be beneficial in adults with ADHD."
          ]
        },
        {
          "title": "The Effects of Crocus sativus (Saffron) on ADHD: A Systematic Review",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37864351/",
          "excerpts": [
            "This study includes clinical trial studies that assessed the efficacy and/or safety of saffron in ADHD patients.",
            "Four studies met our inclusion criteria with a total of 118 patients. The results manifested an efficient role of saffron as either an adjuvant therapy to MPH or a single therapy against ADHD, without significant safety issues.",
            "Saffron demonstrates promise in improving ADHD symptoms, with an acceptable safety profile. Future well-designed multicentral studies are suggested."
          ]
        },
        {
          "title": "The Efficacy and Safety of Add-on Ginko TD (Ginkgo Biloba ...",
          "url": "https://www.researchgate.net/publication/228772804_The_Efficacy_and_Safety_of_Add-on_Ginko_TD_Ginkgo_Biloba_Treatment_for_PTSD_Results_of_a_12-Week_Double-Blind_Placebo-Controlled_Study",
          "excerpts": [
            "by LK Habibi · 2007 · Cited by 9 — Ginkgo TD was associated with a significantly greater improvement than placebo in PTSD patients as measured by five symptom domain scales."
          ]
        },
        {
          "title": "Efficacy and safety of ginkgo preparations for attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5855296/",
          "excerpts": [
            "by S He · 2018 · Cited by 2 — Ginkgo preparations may affect the behavioural and cognitive aspects of ADHD. The predominant behavioural effects are calming and improved ...",
            "Our systematic review will provide a detailed summary of the efficacy and tolerance of ginkgo preparations for the treatment of ADHD. Ginkgo ..."
          ]
        },
        {
          "title": "Ginseng and Ginkgo Biloba Effects on Cognition as ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4777384/",
          "excerpts": [
            "by DOL Teik · 2016 · Cited by 35 — There is some evidence to suggest that ginseng and Ginkgo biloba can improve cognitive performance, however, very little is known about the ..."
          ]
        },
        {
          "title": "Full article: Plant-derived nootropics and human cognition",
          "url": "https://www.tandfonline.com/doi/full/10.1080/10408398.2021.2021137",
          "excerpts": [
            "by C Lorca · 2023 · Cited by 55 — Ginkgo biloba was the most relevant nootropic regarding perceptual and motor functions. Bacopa monnieri improves language, learning and memory."
          ]
        },
        {
          "title": "Impact of Ginkgo biloba drug interactions on bleeding risk and ...",
          "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0321804",
          "excerpts": [
            "by NTQ Mai · 2025 · Cited by 4 — However, case reports and observational studies have suggested a potential increased bleeding risk with concurrent use of EGb and warfarin [29,30]. ... Ginkgo and ..."
          ]
        },
        {
          "title": "Ginkgo and Warfarin Interaction in a Large Veterans ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4765589/",
          "excerpts": [
            "by GJ Stoddard · 2015 · Cited by 71 — Our statistical analysis suggests that taking concurrently with warfarin, gingko does significantly increase patients' risk of a bleeding adverse event."
          ]
        },
        {
          "title": "omega-3 fatty acids and bleeding-cause for concern?",
          "url": "https://pubmed.ncbi.nlm.nih.gov/17368278/",
          "excerpts": [
            "by WS Harris · 2007 · Cited by 407 — The benefits of triglyceride lowering with omega-3 fatty acids more than outweigh any theoretical risks for increased bleeding."
          ]
        },
        {
          "title": "Fish oil LC-PUFAs do not affect blood coagulation ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0261561417301188",
          "excerpts": [
            "by S Jeansen · 2018 · Cited by 65 — The authors concluded that in their study, the use of high doses of n-3 LC-PUFAs was not associated with an increased risk of bleeding in subjects already ..."
          ]
        },
        {
          "title": "Monoamine oxidase inhibition by Rhodiola rosea L. roots",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S037887410900021X",
          "excerpts": [
            "by D van Diermen · 2009 · Cited by 281 — The present investigation demonstrates that Rhodiola rosea L. roots have potent anti-depressant activity by inhibiting MAO A and may also find application in ..."
          ]
        },
        {
          "title": "Nutraceuticals for ADHD and PTSD: Systematic Review of L-theanine, Bacopa monnieri, Ginkgo biloba, and Other Supplements",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12073678/",
          "excerpts": [
            "Bacopa monnieri* consistently improved inattention, hyperactivity, and memory, whereas *Ginkgo biloba* L. reduced ADHD symptoms, particularly inattention, but was less effective than methylphenida",
            " A randomized, double-blind, placebo-controlled clinical trial was conducted by Kean et al. [[17]()] in Australia, involving a population of 112 males displaying symptoms of inattention and hyperactivity aged 6–14 years. The results revealed significant improvements in inattention, hyperactivity, and cognitive function in the group receiving compar",
            "In an earlier randomized, placebo-controlled, double-blind, parallel-group trial, Kean et al. [[18]()] investigated the impact of *Bacopa monnieri* (CDRI 08)/160 mg capsules on hyperactivity and inattention symptoms in 100 male children and adolescents ranging from 6 to 14 years over a span o",
            "Bacopa monnieri* extract  (CDRI 08) (160 mg capsule",
            "ethylphenidate was significantly more effective than *Ginkgo biloba* L. in reducing ADHD symptoms. However, the *Ginkgo biloba* L. group reported fewer adverse symptoms, such as reduced appetite, insomnia, and headaches, than did the methylphenidate gro"
          ]
        },
        {
          "title": "Magnesium, Iron, and Zinc Supplementation for the Treatment - LWW",
          "url": "https://journals.lww.com/ijom/fulltext/2015/06000/magnesium,_iron,_and_zinc_supplementation_for_the.82.aspx",
          "excerpts": [
            "Our aim in this article was to present a systematic review of studies regarding zinc, magnesium, and iron supplementation in treating ADHD."
          ]
        },
        {
          "title": "L-theanine improves neurophysiological measures of ...",
          "url": "https://www.cochranelibrary.com/content?templateType=related&urlTitle=/central/doi/10.1002/central/CN-02183005&doi=10.1002/central/CN-02183005&p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=related-content&p_p_lifecycle=0&p_p_mode=view&type=central&contentLanguage=",
          "excerpts": [
            "Dose-response effect of L-theanine on psychomotor speed, sustained attention, and inhibitory control: a double-blind, placebo-controlled, crossover study"
          ]
        },
        {
          "title": "A Double-Blind Randomized Controlled Pilot Trial of N ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5226873/",
          "excerpts": [
            "by SE Back · 2016 · Cited by 116 — Veterans with current PTSD and SUD (N=35) were randomly assigned to receive a double-blind, 8-week course of NAC (2400 mg/day) or placebo plus ..."
          ]
        },
        {
          "title": "A multi-centre, double-blind, 12-week, randomized, ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0165178123003487",
          "excerpts": [
            "by RA Kanaan · 2023 · Cited by 9 — A randomised trial of NAC combined with cognitive-behavioural therapy in 35 US veterans with PTSD and substance use disorders reported reductions in both ..."
          ]
        },
        {
          "title": "A multi-centre, double-blind, 12-week, randomized, ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7409699/",
          "excerpts": [
            "by A Maier · 2020 · Cited by 17 — An 8-week pilot study of NAC in veterans with PTSD found that symptoms were significantly reduced in the NAC group compared to placebo. This ..."
          ]
        },
        {
          "title": "The effects of L-theanine supplementation on the outcomes of ...",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-024-06285-y",
          "excerpts": [
            "The findings from this systematic review suggest that LT supplementation significantly reduced psychiatric symptoms more effectively than control conditions."
          ]
        },
        {
          "title": "Is there a risk of bleeding associated with standardized ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/21923430/",
          "excerpts": [
            "by AJ Kellermann · 2011 · Cited by 138 — Study objective: To determine the effect of standardized Ginkgo biloba leaf extracts (GBE) on outcome parameters of hemostasis associated with risk of bleeding."
          ]
        },
        {
          "title": "Effects of L-Theanine on Posttraumatic Stress Disorder Induced ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4137547/",
          "excerpts": [
            "We evaluated gene expression in PTSD-induced changes in the amygdala and hippocampus of Sprague-Dawley rats."
          ]
        },
        {
          "title": "Effect of Supplemental Enteral Fish Oil on the Development of ...",
          "url": "https://aspenjournals.onlinelibrary.wiley.com/doi/abs/10.1002/jpen.2025",
          "excerpts": [
            "by I Kagan · 2021 · Cited by 7 — This study randomized mechanically ventilated patients suffering from multiple trauma (n = 150) into 2 groups: a study and a control group that ..."
          ]
        },
        {
          "title": "[PDF] Omega-3 Fatty Acids - Health Professional Fact Sheet",
          "url": "https://apim.org/wp-content/uploads/2024/02/NIH_Health-Professional-Fact-Sheet_-Omega-3-Fatty-Acids-.pdf",
          "excerpts": [
            "Omega-3 Fatty Acids - Health Professional Fact Sheet. Page 1 of 37 https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/."
          ]
        },
        {
          "title": "Saffron (Crocus sativus L.): As an Antidepressant - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6266642/",
          "excerpts": [
            "by MJ Siddiqui · 2018 · Cited by 74 — More specifically, a saffron extract might inhibit serotonin reuptake in synapses. Inhibiting synaptic serotonin reuptake keeps serotonin in the brain longer, ..."
          ]
        },
        {
          "title": "Caffeine and theanine exert opposite effects on attention ...",
          "url": "https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01368359/related-content",
          "excerpts": [
            "A double-blind, placebo-controlled study evaluating the effects of caffeine and L-theanine both alone and in combination on cerebral blood flow, cognition and ..."
          ]
        },
        {
          "title": "Impact of Ginkgo biloba drug interactions on bleeding risk ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11991284/",
          "excerpts": [
            "by NTQ Mai · 2025 · Cited by 4 — Notably, Ginkgo biloba extract frequent interacts with antiplatelets, anticoagulants, and nonsteroidal anti-inflammatory drugs, with Clopidogrel ..."
          ]
        },
        {
          "title": "Is There a Risk of Bleeding Associated with Standardized ...",
          "url": "https://accpjournals.onlinelibrary.wiley.com/doi/10.1592/phco.31.5.490",
          "excerpts": [
            "by AJ Kellermann · 2011 · Cited by 138 — To determine the effect of standardized Ginkgo biloba leaf extracts (GBE) on outcome parameters of hemostasis associated with risk of bleeding."
          ]
        },
        {
          "title": "Omega-3 Fatty Acids - Consumer Factsheet",
          "url": "https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer/",
          "excerpts": [
            "Researchers are studying whether taking omega-3 dietary supplements may help lessen some of the symptoms of attention-deficit/hyperactivity [disorder](#), childhood allergies, and [cystic fibrosis](#). However, more research is needed to fully understand the potential benefits of omega-3s for these and other conditions.",
            "U.S. Food and Drug Administration](#) recommends consuming no more than 5 g/day of EPA and DHA combined from dietary supplements.",
            "Omega-3 dietary supplements may [interact](#) with the medications you take.\nFor example, high doses of omega-3s may cause bleeding problems when taken with warfarin (Coumadin) or other [anticoagulant](#) medic"
          ]
        },
        {
          "title": "Effects of omega-3 polyunsaturated fatty acids on ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27287561/",
          "excerpts": [
            "by K Matsumura · 2017 · Cited by 50 — These findings suggest that post-trauma supplementation of omega-3 PUFAs might be effective for the secondary prevention of psychophysiological symptoms of ..."
          ]
        },
        {
          "title": "Do Omega-3/6 Fatty Acids Have a Therapeutic Role in Children and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5603098/",
          "excerpts": [
            "Remaining studies showed general benefits. An Australian study found that children with ADHD who had increased erythrocyte EPA + DHA levels had significantly ..."
          ]
        },
        {
          "title": "Focus on omega-3 polyunsaturated fatty acids and ADHD",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8474554/",
          "excerpts": [
            "by JPC Chang · 2021 · Cited by 20 — Studies have shown that there is a positive correlation between EFA deficiency severity and ADHD symptoms, and a negative association between blood PUFAs ..."
          ]
        },
        {
          "title": "Living SMART — A randomized controlled trial of a guided online ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2214782914000347",
          "excerpts": [
            "A CBT intervention for adults with ADHD consisting of a self-help book, three therapist-led sessions, and weekly telephone calls with coaches to guide the participants through the program have previously shown promising effects on ADHD-symptoms with 36% in the clinical group reporting a clinical relevant reduction in ..."
          ]
        },
        {
          "title": "Organizing the Home and Office Space",
          "url": "https://chadd.org/for-adults/organizing-the-home-and-office-space/",
          "excerpts": [
            "The first step is to make a list of all the physical spaces that need organizing, numbering the spaces from “easiest to organize” to “most difficult to ..."
          ]
        },
        {
          "title": "33 ADHD-Friendly Ways to Get Organized",
          "url": "https://www.additudemag.com/how-to-get-organized-with-adhd/?srsltid=AfmBOopSiEv3QHLl52ZRfUxTrdXDqgzfzhckQ0stPfvf3R4EfmE5VBst",
          "excerpts": [
            "May 8, 2025 — 1. Set time limits for decision-making. · 2. Fight the tendency to over-commit. · 3. Keep your to-do lists brief. · 4. Fight hyperfocus. · 5. Use a ..."
          ]
        },
        {
          "title": "ADHD in the Workplace: Guide to Inclusive Workplace Design",
          "url": "https://officeprinciples.com/insights/adhd-in-the-workplace-a-guide-to-inclusive-workplace-design",
          "excerpts": [
            "The most effective ADHD-friendly offices incorporate clearly defined zones that support different working styles and energy levels throughout the day . Serve as dedicated quiet areas with sound-dampening materials and minimal visual distractions, providing essential spaces for deep work and concentration."
          ]
        },
        {
          "title": "Sensory modulation disorder and its neural circuitry in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10655817/",
          "excerpts": [
            "by N Adra · 2021 · Cited by 9 — Although the authors found both low registration and high sensory sensitivity, individuals with ADHD displayed low sensory craving behavior, which is more ...See more"
          ]
        },
        {
          "title": "Sensory Alterations in Post-Traumatic Stress Disorder - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10922208/",
          "excerpts": [
            "Studies have demonstrated a strong association between variability in sensory processing regions and the severity of PTSD symptoms."
          ]
        },
        {
          "title": "A systematic review of interventions to support adults with ADHD at ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9443814/",
          "excerpts": [
            "The National Institute for Health Care Excellence ([2019]()) guidelines that clinicians apply when recommending how to manage ADHD state that medications (referred to in the present review as pharmacological interventions) are the first line of treatment once environmental modifications, through reasonable adjustments, have been implemented and reviewed.",
            "Key mechanisms of effectiveness were identified from psychosocial interventions including group therapy, involvement of people in the ADHDers network, and the importance of the client-patient relationship.",
            "Non-pharmacological (also referred to as psychosocial) interventions are only recommended if the ADHDer does not want to use medication, has difficulty adhering to medication, or found it ineffective (National Institute for Health Care Excellence, [2019]()).",
            "Thus far, no comprehensive review of interventions for adult ADHD has focused on work-related studies or scrutinized the organizational/management literature (De Crescenzo et al., [2017](); Fullen et al., [2020]()).",
            "In addition, studies should examine whether skills-based and cognitive behavioral therapies are applicable across contexts and demonstrate far transfer to the workplace."
          ]
        },
        {
          "title": "Health-Related Quality of Life and Work Productivity ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6732822/",
          "excerpts": [
            "by A Joseph · 2018 · Cited by 44 — Conclusion: Adult ADHD impairs HRQoL, work productivity, and regular daily activities."
          ]
        },
        {
          "title": "Accommodation Decision-Making for Postsecondary Students with ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36068830/",
          "excerpts": [
            "Results suggest that DSOs' accommodation decisions are not based on evidence of functional impairment but rely mainly on student self-report and ..."
          ]
        },
        {
          "title": "ADHD symptoms, diagnostic status, and work-related ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8295111/",
          "excerpts": [
            "by ABM Fuermaier · 2021 · Cited by 114 — This study emphasizes the susceptibility of individuals' functioning at work to ADHD symptoms and impairments associated with ADHD."
          ]
        },
        {
          "title": "Discussing an ADHD Diagnosis: Seeking Potential Workplace ...",
          "url": "https://psychiatry.duke.edu/duke-center-girls-women-adhd/resources/adult-women-adhd/discussing-adhd-diagnosis-seeking-potential",
          "excerpts": [
            "Seeking out accommodations at work may help women with ADHD to reduce the impact of their symptoms on their job performance and support their success."
          ]
        },
        {
          "title": "Harrison, A. G., & Armstrong, I. (2022). Accommodation decision ...",
          "url": "https://nceo.info/references/7ceEd1u9R8e5EdiegF_0SA",
          "excerpts": [
            "Accommodations for postsecondary students with attention-deficit/hyperactivity disorder (ADHD), particularly extra time, were investigated."
          ]
        },
        {
          "title": "ADHD Accommodations at Work - Additude Mag",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOopkLPJluFdsVpnlEJT4_WR881Q2yzlMjrEJ9fx3jpPGqqrdvhKw",
          "excerpts": [
            "The most important legal protection for workers with ADHD is the federal Americans with Disabilities Act, or ADA.",
            " The ADA is essentially a civil rights law that prohibits discrimination against individuals with “a physical or mental impairment that substantially limits one or more major life activities of such individual.",
            "” The law goes on to state that “major life activities include, but are not limited to, caring for oneself, performing manual tasks, seeing, hearing, eating, sleeping, walking, standing, bending, speaking, learning, reading, concentrating, thinking, communicating, and working.",
            "g.”\n\nThere is also a separate section of the ADA that further discusses what is included in the definition of disability under the law by listing the bodily systems that are affected, which include: “neurological [and] brain systems",
            "* Providing a quiet workspace",
            "* Allowing noise-canceling headphones or white noise",
            "* Working from home some or all of the time",
            "* Taking allotted breaks as needed",
            "* Minimizing marginal functions to allow focus on essential job duties",
            "* Allowing assistive technology (timers, apps, calendars, etc.)",
            "* Reassignment to a vacant position",
            "* Job restructuring"
          ]
        },
        {
          "title": "Coaching",
          "url": "https://chadd.org/about-adhd/coaching/",
          "excerpts": [
            "ADHD coaching is a practical intervention that specifically targets the core impairments of ADHD such as planning, time management, goal setting, organization ..."
          ]
        },
        {
          "title": "An Empirical Evaluation of ADHD Coaching in College ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/23509112/",
          "excerpts": [
            "by F Prevatt · 2015 · Cited by 154 — Results: Clients who received an 8-week coaching program showed significant improvement in all 10 areas of study and learning strategies, on self-esteem, and on ...",
            "by F Prevatt · 2015 · Cited by 154 — This study provides important preliminary information about ADHD coaching, including coaching structure, processes, efficacy, and correlates of positive ...",
            "by F Prevatt · 2015 · Cited by 154 — Results: Clients who received an 8-week coaching program showed significant improvement in all 10 areas of study and learning strategies, on self-esteem, and on ..."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder: diagnosis and ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29634174/",
          "excerpts": [
            "This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder: diagnosis and management",
          "url": "https://www.nice.org.uk/guidance/ng87",
          "excerpts": [
            "This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder: diagnosis and ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK493361/",
          "excerpts": [
            "This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults."
          ]
        },
        {
          "title": "Attention Deficit Hyperactivity Disorder (ADHD) versus ...",
          "url": "https://askjan.org/articles/Attention-Deficit-Hyperactivity-Disorder-versus-Executive-Functioning-Deficits.cfm",
          "excerpts": [
            "The following employees all have ADHD, but look at the difference in their accommodation needs as determined by their job tasks, environments, and difficulties:."
          ]
        },
        {
          "title": "The Efficacy of Computerized Cognitive Training in Adults With ADHD: A Randomized Controlled Trial",
          "url": "https://pubmed.ncbi.nlm.nih.gov/24756172/",
          "excerpts": [
            "by A Stern · 2016 · Cited by 61 — This is a randomized control trial examining the efficiency of computerized cognitive training (CCT) for adults with ADHD. * PMID:\n  **24756172**\n* DOI:\n  [10.1177/1087054714529815](https://doi.org/10.1177/1087054714529815)\n\nItem in Clipboard\n\nRandomized Controlled Trial\n\nThe Efficacy of Computerized Cognitive Training in Adults With ADHD: A Randomized Controlled Trial\n==================================================================================================\n\nAdi Stern et al. J Atten Disord. 2016 Dec.\n\nShow details\n\nDispl"
          ]
        },
        {
          "title": "Brookes University Radar / Related ADHD Coaching Studies",
          "url": "https://radar.brookes.ac.uk/radar/items/a4a8d49e-0f1c-4741-b550-82533d403b7e/1/",
          "excerpts": [
            "Feb 1, 2024 — Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. Behaviour ... 2",
            "At least eighteen studies to date of outcomes of coaching for clients with ADHD are varied in size (*n*s range from 1 to 1782 participants) and research design (three are randomized controlled trials/RCTs) (Ahma",
            "Collectively, these studies have found evidence, of varied robustness, across age groups, of improvement in clients’ ADHD symptoms and executive functioning and, in some cases, well-being.",
            "Only two studies of ADHD coaching have explored coaching for non-student adults, both focused on group coaching, and both reporting positive outcomes (Bloemen et al., 2007; Kubik, 2010).",
            "Bloemen et al. (2007), conducted a quantitative study of eight weeks of ADHD coaching for ten adult patients in the Netherlands.",
            "Kubik (2010) conducted an observational study on group coaching, including psychoeducation, for a total of 45 adults with ADHD.",
            "Coaching for adults, who are not full-time college students, has received less attention in the literature.",
            "Coaching for ADHD is an emerging field with an increasing body of research, focused mainly on the college-aged population (Ahmann & Saviet, 2021).",
            "Feb 1, 2024 — A systematic review and meta-analysis of nine randomized controlled trials found that CBT was superior to both waitlist and active controls in ...",
            "A systematic review and meta-analysis of nine randomized controlled trials found that CBT was superior to both waitlist and active controls in reducing ADHD symptomatology (Young, Moghaddam, & Tickle, 2020); it appears to be useful even in the absence of medication use (Ramsay & Rostain, 2011; Weiss et al., 2012)."
          ]
        },
        {
          "title": "Short cognitive behavioral therapy and cognitive training for adults with ADHD – PMC study",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2938293/",
          "excerpts": [
            "by M Virta · 2010 · Cited by 116 — Short cognitive behavioral therapy and cognitive training for adults with ADHD – a randomized controlled pilot study - PMC.",
            "There were distinctive pre-hypotheses regarding the treatments, and therefore the statistical comparisons were conducted in pairs: CBT vs control, CT vs control, and CBT vs CT.",
            "In a combined ADHD symptom score based on self-reports, 6 participants in CBT, 2 in CT and 2 controls improved.",
            "Using independent evaluations, improvement was found in 7 of the CBT participants, 2 of CT participants and 3 controls.",
            "There was no treatment-related improvement in cognitive performance.",
            "Thus, in the CBT group, some encouraging improvement was seen, although not as clearly as in previous research with longer inter"
          ]
        },
        {
          "title": "Sensory modulation interventions for adults with mental illness (PMC review)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10680857/",
          "excerpts": [
            "Sensory modulation interventions (SMI) assist people with mental illnesses to regulate emotional and physiological arousal.",
            "Environmental enhancements included assessing the patient’s ‘‘sensory diet’’ on admission (e.g., identifying personalized coping strategies for decreasing anxiety/agitation) and creating comfort rooms (e.g., areas with calming lights, sensory items, musi",
            "Glider chair, murals, chalk boards and sound boards, soft furnishings, a bean bag, relaxing music and stress balls, massage chair, bean bags, music, a variety of lighting, lollies, self-help books, stress balls, water feature, and a ‘swiss ball’ (large inflatable exercise ball)",
            " The application of sensory modulation strategies has been proven to be helpful and supportive of functional performance, thus occupational therapists use SMI to help individuals to self-regulate through the process of self-organization and positive change ([Champagne, 2011",
            "\nThere is a relationship between sensory defensiveness and anxiety, and by following an intervention that is designed for individuals with sensory modulation disorder, both sensory defensiveness and anxiety could drastically decrease ([Machingura et al., 2018",
            " By appropriately using sensory modulation strategies, we could provide experiential and alternative opportunities for de-escalation, empowerment, choice, increasing awareness, and skill development ([Reed, 2017",
            "30\\-Pound weighted blanket",
            "5 minutes, 2 sessions"
          ]
        },
        {
          "title": "The Link Between ADHD and Sensory Processing: How to Manage Sensory Overload",
          "url": "https://www.relationalpsych.group/articles/the-link-between-adhd-and-sensory-processing-how-to-manage-sensory-overload",
          "excerpts": [
            "Occupational Therapy and Sensory Integration  This can include: Deep Pressure Activities: Weighted blankets, compression clothing, or tight hugs can provide grounding and reduce anxiety . Movement Breaks: Jumping on a mini-trampoline or engaging in activities like yoga or swinging can help regulate vestibular input.",
            "People with noise sensitivities, for example, might find relief by using noise-cancelling headphones in crowded environments.",
            "An occupational therapist (OT) trained in sensory integration can help pinpoint specific triggers and recommend tailored strategies.",
            "Routine and Predictability\n\nChildren and adults with ADHD often thrive on predictable routines and schedule",
            "Mindfulness training can teach individuals how to observe and acknowledge sensory input without automatically reacting to it."
          ]
        },
        {
          "title": "JAN Accommodations for Attention Deficit/Hyperactivity Disorder (ADHD)",
          "url": "https://askjan.org/disabilities/Attention-Deficit-Hyperactivity-Disorder-AD-HD.cfm",
          "excerpts": [
            "Key Accommodations:\n\n**Hyperactivity/ Impulsivity:** For individuals with ADHD, accommodations for hyperactivity/impulsivity might be beneficial. * Provide structured breaks as a physical outlet\n* Utilize a job coach to teach/reinforce techniques\n* Allow the employee to work from home\n* Review conduct policy with employee\n* Adjust method of supervision\n* Use services of EAP\n* Provide private workspace",
            "**Focus/Concentration:** For individuals with ADHD, accommodations minimizing distractions might be improve performance.\n* Provide a quiet work space\n* Allow use of noise cancellation or white noise\n* Work from home if no effective accommodations in office environment\n* Uninterrupted work time\n* Taking allotted breaks as needed\n* Minimizing marginal functions to allow focus on essential job duties",
            "**Time management:** For individuals with ADHD, accommodations assisting with staying on task is often helpful\n\n* Assign a mentor\n* Provide to-do lists\n* Meetings to discuss expectations\n* Assistance with prioritization\n* Assistive technology (timers, apps, calendars, etc)",
            "## JAN Publications & Articles Regarding Attention Deficit/Hyperactivity Disorder (ADHD)\n\n### Publications\n\n#### Consultants' Corner Articles\n\n* [A Support Person as an Accommodation]( /publications/consultants-corner/vol05iss01.cfm)\n* [Accommodations Related to Commuting To and From Work]( /publications/consultants-corner/vol08iss01.cfm)\n* [Disability Awareness Training]( /publications/consultants-corner/Disability-Awareness-Training.cfm)\n* [Getting to Work on Time]( /publications/consultants-corner/Getting-to-Work-on-Time.cfm)\n",
            "There are some general accommodations that explain how people with ADHD disregard themselves at work.\nGeneral: Individuals with ADHD are often perfectionists and are hard on themselves. They have trouble setting personal boundaries like knowing when to stop working and they set unrealistic expectations for themselves. Someone who takes work home or stays late to finish work is often given more responsibility or a heavier workload because they appear to be able to get their work done. General accommodations include:\n\n* Help identifying strengths instead of focusing on weaknesses\n* Reinforcing creativity\n* Pointing out any signs that the individual is overworked – not taking vacations, staying at work late frequently, not eating lunch\n* Providing an ADHD coach to suggest ways to increase productivity and maintain a healthy work-life balance",
            "Provide a quiet work space",
            "Allow use of noise cancellation or white noise"
          ]
        },
        {
          "title": "ADA: Your Employment Rights and Protections (EEOC)",
          "url": "https://www.eeoc.gov/publications/ada-your-employment-rights-individual-disability",
          "excerpts": [
            "The employer cannot refuse to hire you because of your disability if you can perform the essential functions of the job with an accommodation. Once you have ...",
            "an employer may be required to provide a sign language interpreter during a job interview for an applicant who is deaf or hearing impaired, unless to do so would impose an undue hardship.",
            "reasonable accommodation may include:\n                                \n                                \n                                                    - providing or modifying equipment or devices,\n                                                    - job restructuring,\n                                                    - part-time or modified work schedules,\n                                                    - reassignment to a vacant position,\n                                                    - adjusting or modifying examinations, training materials, or policies,\n                                                    - providing readers and interpreters, and\n                                                    - making the workplace readily accessible to and usable by people with disabilities. An employer is required to provide a reasonable accommodation to a qualified applicant or employee with a disability unless the employer can show that the accommodation would be an undue hardship -- that is, that it would require significant difficulty or expense. * * *\n                                \n                                \n                                \n                                ## What Employment Practices are Covered?",
            "- providing or modifying equipment or devices,",
            "- job restructuring,",
            "- part-time or modified work schedules,",
            "- reassignment to a vacant position,",
            "- adjusting or modifying examinations, training materials, or policies,",
            "- providing readers and interpreters, and",
            "- making the workplace readily accessible to and usable by people with disabilities."
          ]
        },
        {
          "title": "Evidence-Based Coaching for Adults with ADHD - CHADD",
          "url": "https://chadd.org/attention-article/evidence-based-coaching-for-adults-with-adhd/",
          "excerpts": [
            "Evidence-based coaching has been described as “the intelligent and conscientious use of best current knowledge integrated with practitioner expertise."
          ]
        },
        {
          "title": "findings from the Weiss Functional Impairment Rating Scale",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6241626/",
          "excerpts": [
            "by MD Weiss · 2018 · Cited by 117 — The objective of the review is to establish a framework for understanding functional impairment and create a definition for functional response and remission."
          ]
        },
        {
          "title": "Boosting Productivity: Pomodoro Technique for ADHD ...",
          "url": "https://adhdandautismclinic.co.uk/unleashing-productivity-the-pomodoro-technique-for-adhd-management/",
          "excerpts": [
            "This structure is beneficial for individuals with ADHD who often struggle with time blindness or difficulty perceiving and estimating time accurately."
          ]
        },
        {
          "title": "Neuropsychology - APA PsycNET",
          "url": "https://psycnet.apa.org/manuscript/2021-00770-012.pdf",
          "excerpts": [
            "by WE Jones · 2021 · Cited by 86 — degree as adults who opt-in to reearch studies. External Memory Aid Interventions. Analog memory aids. Making a “to-do list” may be the most intuitive strategy ..."
          ]
        },
        {
          "title": "5 Visual Aids That Work Better Than Phone Reminders",
          "url": "https://www.millennialtherapy.com/anxiety-therapy-blog/visual-memory-aids-adhd",
          "excerpts": [
            "5 Examples of Visual Memory Aids for ADHD · 1. Countdown Timers · 2. Sticky Notes, Whiteboards, and Other Surfaces · 3. Color-Coded Systems · 4."
          ]
        },
        {
          "title": "Guide to Disability Rights Laws",
          "url": "https://www.ada.gov/resources/disability-rights-guide/",
          "excerpts": [
            "This guide provides an overview of Federal civil rights laws that ensure equal opportunity for people with disabilities."
          ]
        },
        {
          "title": "Employees' Practical Guide to Requesting and Negotiating ...",
          "url": "https://askjan.org/publications/individuals/employee-guide.cfm",
          "excerpts": [
            "Under the ADA, employers are only required to provide accommodations for employees who are experiencing workplace problems because of a disability. Therefore, ..."
          ]
        },
        {
          "title": "Environmental Factors in Adult ADHD",
          "url": "https://www.abundancetherapycenter.com/understanding-adult-adhd/environmental-factors",
          "excerpts": [
            "Chronic stress, social instability, and environmental adversity, such as living in a high-stress environment, can contribute to the onset and severity of ADHD ..."
          ]
        },
        {
          "title": "Strategies for Coping with Time-Related and Productivity ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6406620/",
          "excerpts": [
            "by CM Kreider · 2019 · Cited by 56 — This study examined the strategies that college students with LD/ADHD used to overcome obstacles related to time and productivity within their everyday life ..."
          ]
        },
        {
          "title": "Weiss Functional Impairment Rating Scale",
          "url": "https://www.caddra.ca/wp-content/uploads/WFIRS-S.pdf",
          "excerpts": [
            "A. FAMILY. 1. Having problems with family. 2. Having problems with spouse/partner. 3. Relying on others to do things for you."
          ]
        },
        {
          "title": "Executive functions and emotional lability in adults with ADHD.",
          "url": "https://psycnet.apa.org/record/2025-24569-005",
          "excerpts": [
            "This chapter reviews executive function deficits and emotional dysregulation symptoms, including important theoretical issues."
          ]
        },
        {
          "title": "MyADHD Internet-delivered intervention study (ScienceDirect)",
          "url": "https://www.sciencedirect.com/science/article/pii/S2214782921001251",
          "excerpts": [
            "Interventions delivered over the Internet on smartphones or personal computers may help to increase the availability of effective psychological interventions.",
            "The primary aim of this randomized controlled trial is to examine the efficacy of a self-guided Internet-delivered intervention on severity levels of ADHD symptomatology and quality of life.",
            "MyADHD was developed in cooperation with adults with an ADHD diagnosis.",
            "This RCT will provide valuable information on the clinical effectiveness of an Internet-delivered intervention for adults with ADHD.",
            "The intervention is expected to improve symptoms of inattention and quality of life."
          ]
        },
        {
          "title": "ADHD occupation-based intervention study (PMCID: PMC7018471)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7018471/",
          "excerpts": [
            "The intervention was administered for 7 wk in individual 1-hr sessions and addressed routine establishment, organization, time management, stress management, and sensory regulation in the home and community.",
            "Abstract",
            "**Importance:** Women with attention deficit hyperactivity disorder (ADHD) and ADHD symptoms may experience difficulty carrying out desired life roles and activities.",
            "**Objective:** To determine whether a 7-wk tailored occupation-based intervention can reduce perceived stress and ADHD symptoms and enhance perceived performance of and satisfaction with daily roles and activities among women with ADHD.",
            "**Design:** Randomization to intervention (*n* = 11) and control (*n* = 12) groups.",
            "**Setting:** Home and community.",
            " **Participants:** Twenty-three participants ages 20–55 yr, English speaking, and with a self-reported diagnosis of ADHD.",
            "**Intervention:** The intervention was administered for 7 wk in individual 1-hr sessions and addressed routine establishment, organization, time management, stress management, and sensory regulation in the home and community."
          ]
        },
        {
          "title": "The Efficacy of Cognitive Behavioral Therapy for Adults With ADHD",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27554190/",
          "excerpts": [
            "Abstract"
          ]
        },
        {
          "title": "Organizational-skills interventions in the treatment of ADHD",
          "url": "https://pubmed.ncbi.nlm.nih.gov/18928347/",
          "excerpts": [
            "Skills and strategy training interventions have been developed to address the organizational problems of children and adults with ADHD."
          ]
        },
        {
          "title": "Organizational-skills interventions in the treatment of ADHD",
          "url": "https://www.researchgate.net/publication/23392043_Organizational-skills_interventions_in_the_treatment_of_ADHD",
          "excerpts": [
            "Skills and strategy training interventions have been developed to address the organizational problems of children and adults with ADHD."
          ]
        },
        {
          "title": "The Functional External Memory Aid Tool Version 2.0: A How-To ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10023140/",
          "excerpts": [
            "Although external aids are preferred and enhance task performance, simply providing a client with an aid (e.g., passively recommending or ..."
          ]
        },
        {
          "title": "Setting Up an Optimal Environment for Your ADHD Brain",
          "url": "https://laconciergepsychologist.com/blog/setting-up-an-optimal-environment-for-your-adhd-brain/",
          "excerpts": [
            "Go somewhere quiet without a tv. Work outside the home so you're not tempted to start cleaning instead of working. Use an app to block yourself ..."
          ]
        },
        {
          "title": "Occupational Therapy for ADHD: How Can OT Help ADHD? | USAHS",
          "url": "https://www.usa.edu/blog/occupational-therapy-for-adhd-how-can-ot-help-adhd/",
          "excerpts": [
            "Sensory integration therapy is a technique used for ADHD occupational therapy in which the occupational therapist identifies sensory ..."
          ]
        },
        {
          "title": "How To Support Deep Work in Open-Plan Offices",
          "url": "https://www.ie-uk.com/blog/how-to-support-deep-work-in-open-plan-offices",
          "excerpts": [
            "Explore how office design can balance focus and collaboration, helping workers thrive in open plan spaces by reducing distractions and fostering deep work."
          ]
        },
        {
          "title": "Your Rights to ADHD Accommodations at Work",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOorTkjN7wWd7HQW48EwK083Gy9iGG7zmMyPWD7_6SB7S_PEiCrHx",
          "excerpts": [
            "May 6, 2025 — The most important legal protection for workers with ADHD is the federal Americans with Disabilities Act, or ADA."
          ]
        },
        {
          "title": "Creating an ADHD-Friendly Home Environment: Practical Tips for ...",
          "url": "https://www.northmetropsych.com/blog/k99ypml8et6x5m6m4cdxafshnyp56p",
          "excerpts": [
            "Create Designated Spaces: Establish specific areas for different activities. For example, have a dedicated space for homework or work, a quiet area for relaxation, and a play area for children. This helps individuals with ADHD know what to expect in each space and reduces distractions."
          ]
        },
        {
          "title": "ADHD Work Accommodations Examples",
          "url": "https://add.org/adhd-work-accommodations-examples/",
          "excerpts": [
            "Jul 10, 2023 — ADHD Work Accommodations Examples · Delegating work · Frequent breaks · Technology assistance · Realistic workload · Workspace alterations · Work ..."
          ]
        },
        {
          "title": "Your Rights to ADHD Accommodations at Work",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOoq20Skzvqb0RIGaOuRjS62Iurt8vLXuVHAUGYs5gkr6Y0bSlTaM",
          "excerpts": [
            "May 6, 2025 — What are reasonable accommodations? · Providing a quiet workspace · Allowing noise-canceling headphones or white noise · Working from home some or ..."
          ]
        },
        {
          "title": "Your Rights to ADHD Accommodations at Work",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOoqec_j-4s0jfGWXBTZ47MKJKz7pQF08txxV-9BHy9N7rzq1n-86",
          "excerpts": [
            "May 6, 2025 — What are reasonable accommodations? · Providing a quiet workspace · Allowing noise-canceling headphones or white noise · Working from home some or ..."
          ]
        },
        {
          "title": "Employees with Attention Deficit-Hyperactivity Disorder",
          "url": "https://www.govinfo.gov/content/pkg/GOVPUB-L41-PURL-gpo11012/pdf/GOVPUB-L41-PURL-gpo11012.pdf",
          "excerpts": [
            "For information on assistive technology and other accommodation ideas, visit JAN's. Searchable Online Accommodation Resource (SOAR) at http://askjan.org/soar."
          ]
        },
        {
          "title": "Accommodations for Employees with Mental Health ...",
          "url": "https://www.dol.gov/agencies/odep/program-areas/mental-health/maximizing-productivity-accommodations-for-employees-with-psychiatric-disabilities",
          "excerpts": [
            "Under the Americans with Disabilities Act (ADA) and other nondiscrimination laws, most employers must provide \"reasonable accommodations\" to qualified employees ..."
          ]
        },
        {
          "title": "Occupational therapy for adults with ADHD (BMC Psychiatry)",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-021-03070-z",
          "excerpts": [
            "Occupational therapists can help adults with ADHD to recognise the relationship between mood, performance, and sensory stimulation; and learn to monitor and regulate the amount and type of sensory stimulation that enters their nervous system at any one time.",
            "Occupational Therapists can work together with individuals to recognise the common situations in which sensory hyper or hypo reactivity can occur, and the steps they can take to ameliorate the effects on their ADHD symptoms.",
            "A simple strategy of headphones or screen panels can reduce auditory and visual input and reduce distractions.",
            " sensory diet–or the ideas that one’s day is comprised of many different types of sensory experiences that can have a cumulative effect, and that people have unique sensory requirements that must be met to function optimally in all occupational domains",
            "Occupational Therapists can also offer advice for the workplace, in terms of reasonable adjustments and/or modifications to the environment to reduce sensory input.",
            "Occupational therapists have much to offer in providing interventions for adults with ADHD."
          ]
        },
        {
          "title": "Treatments for PTSD",
          "url": "https://www.apa.org/ptsd-guideline/treatments",
          "excerpts": [
            "APA's Clinical Practice Guideline recommends three interventions for treating posttraumatic stress disorder and suggests another four."
          ]
        },
        {
          "title": "Attention-deficit/hyperactivity disorder comorbidity in a sample of ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6519447/",
          "excerpts": [
            "This study examined attention-deficit/hyperactivity disorder (ADHD) comorbidity in military veterans with a high prevalence of posttraumatic stress disorder ...",
            "by KM Harrington · 2012 · Cited by 80 — We hypothesized that ADHD would be associated with greater PTSD severity and/or higher levels of exposure to traumatic events, and we tested whether ADHD ..."
          ]
        },
        {
          "title": "A Secondary Analysis of NIDA's Women and Trauma Study",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3857558/",
          "excerpts": [
            "by LM Ruglass · 2013 · Cited by 40 — Results indicated that heavy stimulants users had significantly greater PTSD symptoms at baseline compared to light stimulant users. ... hypervigilance ...",
            "Heavy stimulant use is often associated with a worsening of hyperarousal symptoms secondary to stimulant intoxication or withdrawal."
          ]
        },
        {
          "title": "Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35312136/",
          "excerpts": [
            "Atomoxetine demonstrated modest efficacy for ADHD symptoms; quality of life measures and PTSD symptoms were not affected."
          ]
        },
        {
          "title": "[PDF] ADULT ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)",
          "url": "https://www.bop.gov/resources/pdfs/adult_adhd_cd.pdf",
          "excerpts": [
            "This stepwise, non-stimulant pharmacologic treatment algorithm is based on the adverse reactions and safety profiles of the agents used to treat ADHD. CLOSE ..."
          ]
        },
        {
          "title": "Use of Stimulants and Performance Enhancers During and After ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5289819/",
          "excerpts": [
            "Stimulant-Based Supplements: Difficult to Regulate, Easy Access. The current case describes the onset and exacerbation of hyperarousal, panic, insomnia, and re-experiencing symptoms of PTSD with concomitant DMAA ingestion in a combat veteran."
          ]
        },
        {
          "title": "Cognitive behavioral therapy for the treatment of post ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3083990/",
          "excerpts": [
            "by N Kar · 2011 · Cited by 488 — Eye movement desensitization and reprocessing​​ EMDR and trauma-focused CBT are both widely used in the treatment of PTSD and have been consistently compared. ..."
          ]
        },
        {
          "title": "Trauma-Informed Therapy - StatPearls",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK604200/",
          "excerpts": [
            "by G Yadav · 2024 · Cited by 17 — Trauma-informed therapy is a framework designed to acknowledge and address the impact of traumatic experiences on individuals' lives."
          ]
        },
        {
          "title": "ADHD Treatment for Adults | The Hanley Foundation",
          "url": "https://www.hanleycenter.org/mental-health-disorders/adhd-in-adults/",
          "excerpts": [
            "Integrated treatment for ADHD in adults provides all the therapeutic resources necessary to heal you physically, psychologically, and spiritually."
          ]
        },
        {
          "title": "Clinical Practice Guideline for the Diagnosis, Evaluation ...",
          "url": "https://publications.aap.org/pediatrics/article/144/4/e20192528/81590/Clinical-Practice-Guideline-for-the-Diagnosis",
          "excerpts": [
            "Oct 1, 2019 — Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.",
            "Oct 1, 2019 — Guidelines on the diagnosis and management of ADHD should include trauma screening in the algorithm and recommendations for reassessing for ...",
            "In addition, the AAP holds that primary care pediatricians should be prepared to diagnose and manage mild-to-moderate ADHD, anxiety, depression, ..."
          ]
        },
        {
          "title": "[PDF] Identification and Management of Attention-Deficit / Hyperactivity ...",
          "url": "https://www.pbm.va.gov/PBM/AcademicDetailingService/Documents/508/10-1520_ADHD_ClinicianGuide_P97040.pdf",
          "excerpts": [
            "Many adults with ADHD present with co-occurring disorders.21 Often these need to be addressed \nconcomitantly; however, in some cases prioritization may need to be given to the most impairing illness \nfirst (e.g., psychosis, severe mood disorder, bipolar disorder, active SUD [see Table 3]).1,20,21,",
            "Where mood symptoms are apparent but not pervasive, treat ADHD symptoms and monitor for \nimprovement first, prior to considering or initiating treatment for mood disorders.2",
            "TAKE \nNOTE\n! Consider a slower dose titration and provide more frequent monitoring  \nif any of the following are present:\n31\n\n� Other neurodevelopmental disorders (e.g., autism spectrum disorder, tic disorders, learning  \ndisability/intellectual disability)\n\n� Mental health conditions (e.g., anxiety disorders, schizophrenia or bipolar disorder, depression, \npersonality disorder, eating disorder, PTSD, substance misuse) \n\n� Physical health conditions (e.g., cardiac disease, epilepsy, brain injury). Identi�cation and Management of Attention-De�cit/Hyperactivity Disorder (ADHD) in Adu",
            "STEP\n5\n\nFinalize diagnosis. 10\n\nIf the patient meets DSM-5-TR criteria for ADHD, determine presentation (e.g.,  \npredominantly inattentive) and severity (mild, moderate, severe) to finalize the diagnosis. Clinical pearl: 10 When making a first-time ADHD diagnosis in adulthood, consider  \ndocumenting factors that may have prevented childhood diagno",
            "Psychiatric comorbid disorders and treatment selection \n\nMany adults with ADHD present with co-occurring disorders.21 Often these need to be addressed \nconcomitantly; however, in some cases prioritization may need to be given to the most impairing illness \nfirst (e.g., psychosis, severe mood disorder, bipolar disorder, active SUD [see Table 3]).1,20,21",
            "Medication recommendations\nTreatment considerations\n\nSUD\n� Atomoxetine (has efficacy in adult ADHD; little to  \nno abuse potential"
          ]
        },
        {
          "title": "Complex PTSD and ADHD in Adults - Origins Texas Recovery",
          "url": "https://www.originstexas.com/blog/complex-ptsd-and-adhd-in-adults/",
          "excerpts": [
            "ADHD treatments often focus on behavioral modification and sometimes medication, while C-PTSD requires trauma-informed interventions, such as ..."
          ]
        },
        {
          "title": "PMC8751557 - Psychotherapies and pharmacotherapies in comorbid ADHD and PTSD: integrated approaches and evidence",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8751557/",
          "excerpts": [
            "Psychotherapies and pharmacotherapies are recommended as first line treatments. However, evidence has emerged that their efficacy may be overestimated.",
            "In OCD, psychotherapy achieved medium to large SMDs (0.61‐0.95) in comparison to SSRIs[72](), but most psychotherapy trials included patients taking stable doses of antidepressants, affecting results in favour of psychoth"
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder (update)",
          "url": "https://www.nice.org.uk/guidance/ng87/documents/evidence-review",
          "excerpts": [
            "of comorbid post-traumatic stress disorder in adult ADHD. Journal of ... Multilevel analysis of ADHD, anxiety and depression symptoms aggregation in. 16.See more"
          ]
        },
        {
          "title": "Adult ADHD and comorbid disorders: clinical implications ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5567978/",
          "excerpts": [
            "by MA Katzman · 2017 · Cited by 945 — Guidelines recommend that when ADHD coexists with other psychopathologies in adults, the most impairing condition should generally be treated ...",
            "by MA Katzman · 2017 · Cited by 945 — In many studies, ADHD has been associated with comorbid depression, anxiety disorders, bipolar disorder, and substance use disorder [27, 30, 40– ..."
          ]
        },
        {
          "title": "Effects of the interaction between PTSD and ADHD ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10587572/",
          "excerpts": [
            "by H Gelner · 2023 · Cited by 3 — It has been shown that a diagnosis of PTSD in individuals with ADHD is associated with a higher risk of psychiatric hospitalization, school ...",
            "It has been shown that a diagnosis of PTSD in individuals with ADHD is associated with a higher risk of psychiatric hospitalization, school impairment, worse social and cognitive performance as well as a higher likelihood of mood, conduct disorder, and anxiety disorders ([29](), [31]()).",
            "Authors of this study found that risk-taking behaviors, household income, and educational attainment might only partially mediate this association.",
            "To date, none of previous studies have investigated the interactive effects of PTSD and ADHD symptoms on the occurrence of PLEs.",
            "There are also studies showing beneficial effects of methylphenidate on fear extinction and PTSD symptoms ([26](), [27]())."
          ]
        },
        {
          "title": "Methylphenidate for the Treatment of PTSD With ...",
          "url": "https://www.centerwatch.com/clinical-trials/listings/NCT05776056/methylphenidate-for-the-treatment-of-ptsd-with-associated-neurocognitive-complaints",
          "excerpts": [
            "Jan 7, 2025 — This study will evaluate the ability of methylphenidate to treat PTSD and associated neurocognitive complaints in Veterans."
          ]
        },
        {
          "title": "Hyperarousal: What It Is, Causes, Symptoms & Treatment",
          "url": "https://my.clevelandclinic.org/health/symptoms/hyperarousal",
          "excerpts": [
            "Cut back on stimulants. Substances like caffeine and tobacco (nicotine) activate your nervous system, which contributes to your feelings of arousal. If you have ..."
          ]
        },
        {
          "title": "Adult ADHD and PTSD: What's the Link? - WebMD",
          "url": "https://www.webmd.com/add-adhd/adult-adhd-ptsd",
          "excerpts": [
            "Some studies have found that stimulant drugs used to treat ADHD, such as methylphenidate, may improve PTSD symptoms in some people."
          ]
        },
        {
          "title": "ADHD and Trauma | PTSD Risk, Overlap, and Shared Traits",
          "url": "https://neurodivergentinsights.com/adhd-and-trauma/",
          "excerpts": [
            "And stimulant use may help with focus and attention issues which will help a person more fully work through their trauma. On the other hand, stimulants may not be appropriate for everyone with PTSD, as they can activate the nervous system and intensify hypervigilance and anxiety ."
          ]
        },
        {
          "title": "DIFFERENTIAL DIAGNOSIS AND COMORBID DISORDERS",
          "url": "https://caddra.ca/pdfs/caddraGuidelines2011Chapter02.pdf",
          "excerpts": [
            "Introduction. When making an ADHD diagnosis, it is important to exclude other disorders that might overlap with ADHD or mimic ADHD symptoms."
          ]
        },
        {
          "title": "[PDF] Treatment Outcomes with Lisdexamfetamine Dimesylate (Vyvanse ...",
          "url": "https://cdn.clinicaltrials.gov/large-docs/96/NCT02712996/Prot_SAP_000.pdf",
          "excerpts": [
            "Persistent ( > 2 months) problems with focused or sustained attention. • Problems with attention/concentration rated as among the most prominent ..."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder activity ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK493361/bin/niceng87_qs1.pdf",
          "excerpts": [
            "Jul 30, 2013 — ... NICE guideline NG87, recommendation ... A number of adults being treated for coexisting mental health problems within general psychiatric.",
            "lal\n\nAdults presenting with symptoms of ADHD in primary care or adult general psychiatric services\nwho do not have a childhood diagnosis of ADHD should be referred for assessment by a mental\nhealt",
            "People with attention deficit hyperactivity disorder (ADHD) who are starting drug\ntreatment have their initial drug dose adjusted and response assessed by an ADHD specialist.",
            "\n\nQuality statement 4: P\nQuality statement 4: P",
            "Annual specialist review of drug treatment"
          ]
        },
        {
          "title": "Treatment of Co-Occurring PTSD and Substance Use Disorder in VA",
          "url": "https://www.ptsd.va.gov/professional/treat/cooccurring/tx_sud_va.asp",
          "excerpts": [
            "Posttraumatic stress disorder (PTSD) and substance use disorder (SUD) often co-occur . Patients with PTSD and SUD can tolerate and benefit from evidence-based trauma-focused PTSD treatment. Per VA /DoD Clinical Practice Guidelines, patients with PTSD and SUD should be offered evidence-based treatment for both disorders."
          ]
        },
        {
          "title": "[PDF] Treatment of comorbid posttraumatic stress disorder and substance ...",
          "url": "https://www.ptsd.va.gov/professional/articles/article-pdf/id1635224.pdf",
          "excerpts": [
            "Current clinical practice guidelines recommend the use of individual, trauma-focused psychotherapies alongside concurrent SUD treatment for PTSD ..."
          ]
        },
        {
          "title": "Revealing Unknown Benefits of Existing Medications to Aid ...",
          "url": "https://psychiatryonline.org/doi/10.1176/appi.prcp.20210019",
          "excerpts": [
            "... ADHD and include stimulant as well as non‐stimulant drugs. Each of these medications has been proposed as a potential treatment for PTSD ..."
          ]
        },
        {
          "title": "Psychostimulants for the Treatment of Comorbid Post-traumatic Stress Disorder (PTSD) in a Patient With Attention-Deficit/Hyperactivity Disorder (ADHD): A Case Report and Literature Summary",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9484295/",
          "excerpts": [
            "This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD."
          ]
        },
        {
          "title": "Psychostimulants for the Treatment of Comorbid Post-traumatic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36158332/",
          "excerpts": [
            "This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD."
          ]
        },
        {
          "title": "Psychostimulants for the Treatment of Comorbid Post- ...",
          "url": "https://www.researchgate.net/publication/362827774_Psychostimulants_for_the_Treatment_of_Comorbid_Post-traumatic_Stress_Disorder_PTSD_in_a_Patient_With_Attention-DeficitHyperactivity_Disorder_ADHD_A_Case_Report_and_Literature_Summary",
          "excerpts": [
            "This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD."
          ]
        },
        {
          "title": "Study Details | Methylphenidate for the Treatment of PTSD With ...",
          "url": "https://clinicaltrials.gov/study/NCT05776056",
          "excerpts": [
            "The investigators will compare the aggregated change in PTSD and neurocognitive symptoms between periods of treatment with methylphenidate versus placebo."
          ]
        },
        {
          "title": "ADHD and Trauma | PTSD Risk, Overlap, and Shared Traits",
          "url": "https://neurodivergentinsights.com/adhd-and-trauma/?srsltid=AfmBOorCHNZiAaerxCn3CVGCj2VH87vFahXQEozWe-GSmOpkNkvz_dzz",
          "excerpts": [
            "For some stimulant use may exacerbate anxiety symptoms associated with PTSD. However, in some cases, stimulants can be useful in the context of PTSD. One ..."
          ]
        },
        {
          "title": "Post-traumatic stress disorder | Guidance",
          "url": "https://www.nice.org.uk/guidance/ng116/chapter/recommendations",
          "excerpts": [
            "For people presenting with PTSD and depression:\n\n* \n  usually treat the PTSD first because the depression will often improve with successful PTSD treatment\n* \n  treat the depression first if it is severe enough to make psychological treatment of the PTSD difficult, or there is a risk of the person harming themselves or others. **[2018]**",
            "2\n\nDo not exclude people with PTSD from treatment based solely on comorbid drug or alcohol misuse.\n**[2018]**",
            "For people with additional needs, including those with [complex PTSD](recommendations) :\n\n* \n  build in extra time to develop trust with the person, by increasing the duration or the number of therapy sessions according to the person's needs\n* \n  take into account the safety and stability of the person's personal circumstances (for example their housing situation) and how this might affect engagement with and success of treatment\n* \n  help the person manage any issues that might be a barrier to engaging with trauma-focused therapies, such as substance misuse, dissociation, emotional dysregulation, interpersonal difficulties or negative self-perception\n* \n  work with the person to plan any ongoing support they will need after the end of treatment, for example to manage any residual PTSD symptoms or comorbidities. **[2018]**"
          ]
        },
        {
          "title": "Post-traumatic stress disorder: what does NICE guidance ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6592320/",
          "excerpts": [
            "by O Megnin-Viggars · 2019 · Cited by 20 — ... PTSD diagnosis. The NICE guideline recommends active monitoring for people with subthreshold symptoms of PTSD within 1 month of a traumatic event, to judge ...See more"
          ]
        },
        {
          "title": "TH Eom et al. 2023 - 2020 SDBP Complex ADHD Guideline (PMCID: PMC10764666)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10764666/",
          "excerpts": [
            "\n\nIn 2020, the SDBP first published a clinical practice guideline on a complex ADHD [[5](),[47]()]. In this guideline, a complex ADHD was defined based on age (<4 years or presentation at ≥12 years), coexisting conditions, moderate-to-severe functional impairment, diagnostic uncertainty, or inadequate response to treatment. The accompanying PoCA was also developed.",
            "Patients with complex ADHD with severe comorbidities should be referred to a specialist.",
            "The primary pediatrician may not be trained or experienced enough to manage ADHD with comorbid conditions.",
            "Those with urgent conditions, such as suicidal attempt, self-injury, and temper outbursts, need to be transferred immediately.",
            "The accompanying PoCA was also developed."
          ]
        },
        {
          "title": "The Key Role of the Prefrontal Association Cortex - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2894421/",
          "excerpts": [
            "by AFT Arnsten · 2009 · Cited by 337 — Studies have found that ADHD is associated with weaker function and structure of prefrontal cortex (PFC) circuits, especially in the right hemisphere."
          ]
        },
        {
          "title": "ADHD symptoms are associated with the modular structure ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6497005/",
          "excerpts": [
            "by K Hilger · 2019 · Cited by 30 — Recent studies broadened the focus toward three-network models of ADHD, proposing that stronger interactions between salience and default-mode network relative ..."
          ]
        },
        {
          "title": "a mega-analysis of multiple large samples - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9751118/",
          "excerpts": [
            "by LJ Norman · 2022 · Cited by 33 — We report significant ADHD-related differences in interactions between the default mode network and task-positive networks, in line with default mode ..."
          ]
        },
        {
          "title": "Neurobiology of Attention Deficit/Hyperactivity Disorder",
          "url": "https://www.nature.com/articles/pr9201196",
          "excerpts": [
            "by D Purper-Ouakil · 2011 · Cited by 247 — This article aims to provide an overview of recent findings in the rapidly evolving field of ADHD neurobiology with a focus on novel strategies regarding ..."
          ]
        },
        {
          "title": "The neural circuits and molecular mechanisms underlying ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10728304/",
          "excerpts": [
            "by J Iqbal · 2023 · Cited by 19 — In PTSD, the bidirectional communication of the PFC with the hippocampus and amygdala plays a very important role in regulating traumatic fear learning and its ...",
            "by J Iqbal · 2023 · Cited by 19 — In this review article, we asked how traumatic stress affects the neural circuits in brain and what underlying mechanisms are behind this change. We also ..."
          ]
        },
        {
          "title": "Post traumatic stress disorder associated hypothalamic- ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11401111/",
          "excerpts": [
            "by S Lawrence · 2024 · Cited by 29 — However, PTSD has been associated with dysregulation of this system, shown by altered levels of CRH, ACTH, and cortisol, as well as altered ...",
            "by S Lawrence · 2024 · Cited by 29 — This review focuses on how PTSD dysregulates the HPA axis, and further, how these alterations affect the immune system and physical health outcomes."
          ]
        },
        {
          "title": "Structural Neuroimaging of Hippocampus and Amygdala ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10829655/",
          "excerpts": [
            "by Z Ben-Zion · 2023 · Cited by 25 — While changes in hippocampal activity in PTSD are not consistent (10), smaller hippocampal volume is the most consistent structural abnormality in PTSD (11,12)."
          ]
        },
        {
          "title": "Brain activation and heart rate variability as markers of autonomic ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12316975/",
          "excerpts": [
            "... autonomic dysregulation, such as depression and anxiety or posttraumatic stress disorder. ... vmPFC and amygdala showed influence of ..."
          ]
        },
        {
          "title": "Can working memory account for EMDR efficacy in PTSD?",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9623920/",
          "excerpts": [
            "by DL Wadji · 2022 · Cited by 36 — Dual taxation takes place when an individual recalls a distressing memory while also performing a bilateral stimulation or secondary task, such as EM, mental ..."
          ]
        },
        {
          "title": "State of the science: Eye movement desensitization and ...",
          "url": "https://onlinelibrary.wiley.com/doi/10.1002/jts.23012",
          "excerpts": [
            "by A de Jongh · 2024 · Cited by 45 — Eye movement desensitization and reprocessing (EMDR) therapy is an evidence-based psychotherapy for posttraumatic stress disorder (PTSD), with support from ..."
          ]
        },
        {
          "title": "Scientific Evaluation of EMDR Psychotherapy for the Treatment of ...",
          "url": "https://www.jneurology.com/articles/scientific-evaluation-of-emdr-psychotherapy-for-the-treatment-of-psychological-trauma-summary-scientific-evaluation-of-emdr-psycho.html",
          "excerpts": [
            "This paper is a current review of the scientific validation steps of EMDR psychotherapy and its mechanisms of action."
          ]
        },
        {
          "title": "The Predictive Processing Model of EMDR",
          "url": "https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2019.02267/full",
          "excerpts": [
            "by DE Chamberlin · 2019 · Cited by 31 — The Predictive Processing model of EMDR postulates that EMDR facilitates the predictive processing of traumatic memory by overcoming the bias against ..."
          ]
        },
        {
          "title": "The Role of Alternating Bilateral Stimulation in Establishing Positive ...",
          "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0162735",
          "excerpts": [
            "BLS in RDI may enhance comfortable feelings about pleasant memories. Based on the current findings, the use of BLS in RDI may be warranted in some clinical ..."
          ]
        },
        {
          "title": "ADHD and PTSD Neurobiology",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10501041/",
          "excerpts": [
            "A putative pathophysiological mechanism that has been long implicated in ADHD involves the dysregulation of monoaminergic neurotransmission systems, mainly dopaminergic and noradrenergic.",
            " The physiological changes induced by the binding of dopamine and norepinephrine to their respective receptors involve the modulation of several cognitive and executive processes usually impaired in ADHD",
            " In resting-state fMRI (rsfMRI) studies, the frontoparietal network, involved in executive functions, has demonstrated hyperconnectivity with regions of the DNM and affective network, while hypoactivity with regions of the ventral attention and somatosensory networks in individuals with ADHD",
            " For example, dopamine receptors of subtypes D1 and D2 are abundant in brain regions mainly involved in signaling reward circuits, learning and memory, and locomotor activity",
            "Also, patients with ADHD have a higher density of the dopamine transporter (DAT), responsible for the reuptake of DA into presynaptic neurons [[92]()], which could lead to alterations in dopamine levels in the synapt",
            " methylphenidate is able to restore impaired glutamatergic transmission at the prefrontal cortex and improve behavioral symptoms of ADHD, a process that appears to be mediated by AMPA glutamatergic receptors",
            "\nADHD has also been associated with disrupted connectivity between DNM and systems involved in cognitive control and affective/motivational and salience networks",
            "A broadly studied model for ADHD suggests an impaired synchronization between the DMN (Default Mode Network), which is normally more active when tasks are not performed, and the TPN (Task-Positive Network), which is activated while performing tasks."
          ]
        },
        {
          "title": "Dopamine metabolism and signaling in ADHD – Frontiers in Psychiatry (excerpts from a longer review)",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1492126/full",
          "excerpts": [
            " stimulant drugs that are first-line pharmacotherapies for ADHD ( [13]() ). These drugs block DA and norepinephrine (NE) transporters, inhibiting catecholamine reuptake into dopaminergic nerve terminals ( [Figure 1]() ), increasing their availability at dopamine receptors.",
            "ants have effects on ADHD symptoms, possibly by optimizing DA and NE modulated task-related brain networks that increase perceived saliency, reducing interference from the default mode network ( [15]() ).",
            "Concluding remarks: Recent PET/SPECT studies do not show predominant evidence supporting a hypo-dopaminergic state in ADHD, but rather conflicting results that imply both increased and decreased extracellular DA levels within frontostriatal regions.",
            "Table 1\n\n[! [www.frontiersin.org](https://www.frontiersin.org/files/Articles/1492126/fpsyt-15-1492126-HTML/image_m/fpsyt-15-1492126-t001.jpg)](https://www.frontiersin.org/files/Articles/1492126/fpsyt-15-1492126-HTML/image_m/fpsyt-15-1492126-t001.jpg)\n\n**Table 1** . A brief summary of arguments for and against the dopamine hypothesis for ADHD as detailed from each perspective. The updated overview therefore points to the fact that there is ample evidence for some involvement of DA but limited evidence that reduced levels of the DA neurotransmitter _per se_ is a defining feature of ADHD. Based on the variable findings from clinical, genetic, imaging and neurophysiological studies, it is possible that the multiple underlying pathophysiological mechanisms in ADHD are differently involved and that the putative alterations in DA functions are only present in a subset of ADHD patients.",
            "To assess the traditional DA theory of ADHD, it is helpful to compare ADHD findings to another neuropsychological condition with a robust and reliable link to deficient DA levels – Parkinson’s disease (PD). Although seemingly on opposite ends of the aging spectrum as a neurodevelopment and neurodegenerative condition, both ADHD and PD are heterogeneous disorders which involve cortico-basal ganglia disturbances that impact the control of motor and cognitive behavior."
          ]
        },
        {
          "title": "Dysregulation of Inflammation, Neurobiology, and Cognitive Function in PTSD: An Integrative Review",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7682894/",
          "excerpts": [
            " interplay between inflammation and the amygdala-vmPFC-ACC-hippocampus circuit that further supports fear conditioning and extinction learning a"
          ]
        },
        {
          "title": "Interference of default mode on attention networks in adults with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11325164/",
          "excerpts": [
            "These findings support the interference of default mode on attention in adults with ADHD and its association with genetic risk variants and ..."
          ]
        },
        {
          "title": "Science Updates About Attention-Deficit/Hyperactivity ...",
          "url": "https://www.nimh.nih.gov/news/science-updates/attention-deficit-hyperactivity-disorder-adhd",
          "excerpts": [
            "A recent NIMH-funded study sheds new light on how the brain's processing of sensory information, a key impairment in autism and ADHD, can affect higher level ..."
          ]
        },
        {
          "title": "A brief review of MRI studies in patients with attention ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0387760425000221",
          "excerpts": [
            "by Y Mizuno · 2025 — This article provides a comprehensive overview of MRI studies on ADHD, categorized into T1-weighted structural MRI, DTI, task fMRI, and rs-fMRI."
          ]
        },
        {
          "title": "ANNUAL RESEARCH REVIEW: PERSPECTIVES ON ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10023337/",
          "excerpts": [
            "by EJS Sonuga-Barke · 2022 · Cited by 147 — In this review, we provide a selective and focused survey of the scientific field of ADHD, providing our personal perspectives on what constitutes the ..."
          ]
        },
        {
          "title": "The Mechanism, Clinical Efficacy, Safety, and Dosage ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8863678/",
          "excerpts": [
            "by D Fu · 2022 · Cited by 60 — Atomoxetine inhibits the presynaptic norepinephrine transporter (NET), preventing the reuptake of NE throughout the brain along with inhibiting the reuptake of ..."
          ]
        },
        {
          "title": "Atomoxetine Increases Extracellular Levels of ...",
          "url": "https://www.nature.com/articles/1395936",
          "excerpts": [
            "by FP Bymaster · 2002 · Cited by 1508 — In microdialysis studies, atomoxetine increased extracellular (EX) levels of NE in prefrontal cortex (PFC) 3-fold, but did not alter 5-HTEX ..."
          ]
        },
        {
          "title": "From neurons to brain networks, pharmacodynamics of ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0149763424003105",
          "excerpts": [
            "by V Parlatini · 2024 · Cited by 7 — Neuropharmacological studies using PET and SPECT in ADHD have been dependent on the development of radioligands, thus they have primarily focused on ...",
            "Stimulants modulate dopamine and norepinephrine neurotransmission. This enhances task-related brain networks and suppresses the default-mode network."
          ]
        },
        {
          "title": "Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5951719/",
          "excerpts": [
            "In a meta-analysis of all samples, we found significantly smaller hippocampi in subjects with current PTSD compared with trauma-exposed control subjects ( ..."
          ]
        },
        {
          "title": "Underlying Hippocampal Mechanism of Posttraumatic Stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10593870/",
          "excerpts": [
            "PTSD is characterized by volume reduction in the hippocampus, with greater PTSD symptom severity being associated with lower hippocampal volume (7, 8, 9, 10). A ..."
          ]
        },
        {
          "title": "Post-traumatic stress disorder: The role of medial prefrontal ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2771687/",
          "excerpts": [
            "by M Koenigs · 2009 · Cited by 500 — In this review, we present neuroscientific data highlighting the function of two brain areas—the amygdala and ventromedial prefrontal cortex (vmPFC)—in PTSD and ..."
          ]
        },
        {
          "title": "Prefrontal cortex, amygdala, and threat processing",
          "url": "https://www.nature.com/articles/s41386-021-01155-7",
          "excerpts": [
            "by M Alexandra Kredlow · 2022 · Cited by 304 — An abundance of research suggests that the prefrontal cortex is central to fear processing—that is, how fears are acquired and strategies to ...",
            "by M Alexandra Kredlow · 2022 · Cited by 304 — The dlPFC, vmPFC/IL, and hippocampus show impaired functioning with PTSD, whereas the amygdala and dACC/PL are enhanced. Disrupted connections ..."
          ]
        },
        {
          "title": "HPA axis regulation in posttraumatic stress disorder",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0149763418304512",
          "excerpts": [
            "by S Schumacher · 2019 · Cited by 141 — Overall, morning and 24 h cortisol was significantly lower in PTSD than controls (trauma-exposed and non-trauma exposed controls)."
          ]
        },
        {
          "title": "Prazosin for the Treatment of Nightmares Related to ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3425466/",
          "excerpts": [
            "by SM Hudson · 2012 · Cited by 56 — Through this mechanism, prazosin can improve sleep and reduce nightmares associated with PTSD. The objective of this review is to evaluate the available ..."
          ]
        },
        {
          "title": "Trauma and posttraumatic stress disorder modulate polygenic ...",
          "url": "https://www.nature.com/articles/s41398-021-01707-x",
          "excerpts": [
            "Trauma exposure and PTSD modulate the effect of polygenic markers on hippocampal volume (GxE) and the amygdala volume PGS is associated with PTSD risk."
          ]
        },
        {
          "title": "Emotion Regulatory Brain Function and SSRI Treatment in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5130136/",
          "excerpts": [
            "by A MacNamara · 2015 · Cited by 109 — SSRI treatment increased activation in both the left dorsolateral prefrontal cortex (PFC) and supplementary motor area (SMA) during emotion regulation."
          ]
        },
        {
          "title": "Atomoxetine: a review of its use in attention-deficit ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/19445548/",
          "excerpts": [
            "by KP Garnock-Jones · 2009 · Cited by 325 — The mechanism of action of atomoxetine is unclear, but is thought to be related to its selective inhibition of presynaptic norepinephrine reuptake in the ..."
          ]
        },
        {
          "title": "Factors impacting prazosin efficacy for nightmares and ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0278584625000077",
          "excerpts": [
            "by TP Mendes · 2025 · Cited by 1 — Prazosin effectively reduces insomnia and nightmares in PTSD patients. Benzodiazepine co-administration seems to enhance prazosin's efficacy."
          ]
        },
        {
          "title": "Nature Review/Neuropsychopharmacology Update on ADHD (2024)",
          "url": "https://www.nature.com/articles/s41572-024-00495-0",
          "excerpts": [
            "Attention-deficit/hyperactivity disorder (ADHD; also known as hyperkinetic disorder) is a common neurodevelopmental condition that affects children and adults worldwide.",
            "The heterogeneity of the condition is evident in the diverse presentation of symptoms and levels of impairment, the numerous co-occurring mental and physical conditions, the various domains of neurocognitive impairment, and extensive minor structural and functional brain differences.",
            "Curative treatments for ADHD do not exist but evidence-based treatments substantially reduce symptoms and/or functional impairment.",
            "Medications are effective for core symptoms and are usually well tolerated.",
            "Some non-pharmacological treatments are valuable, especially for improving adaptive functioning."
          ]
        },
        {
          "title": "Rubia 2018 — The cognitive neuroscience of ADHD: an fMRI perspective (Frontiers in Human Neuroscience)",
          "url": "https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2018.00100/full",
          "excerpts": [
            " This review focuses on the cognitive neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) based on functional magnetic resonance imaging (fMRI)",
            "This review is focusing particularly on the cognitive neuroscience of the disorder, by reviewing the most consistent findings of functional magnetic resonance imaging (fMRI) studies in ADHD during cognitive and emotional tasks.",
            "Pattern recognition analyses applied to functional (or structural) imaging data to make individual predictions on diagnostic status are promising, but more so for homogenous subtypes that likely share the same “biotype” rather than heterogenous large groups of ADHD patients with different comorbidities or medication status.",
            "Translational cognitive neuroscience in ADHD is still very much in its childhood, but has provided promising results so far.",
            "Both neuromodulation therapies, NF and brain stimulation, aim to improve ADHD symptoms and cognition by targeting the underlying regional dysfunctions that are thought to be underlying the condition.",
            "imaging data for diagnostic classification of the disorder or as targets for treatment.",
            " there is consistent evidence for ADHD patients to have problems to deactivate the DMN, suggesting an abnormal interrelationship between hypo-engaged task-positive cognitive networks and a poorly “switched off” DMN",
            " there is consistent evidence for ADHD patients to have problems to deactivate the DMN, suggesting an abnormal interrelationship between hypo-engaged task-positive cognitive networks and a poorly “switched off” DMN"
          ]
        },
        {
          "title": "Toward individual heterogeneity and neurobiological subtypes in attention-deficit/hyperactivity disorder",
          "url": "https://journals.sagepub.com/doi/10.1177/18344909241308101",
          "excerpts": [
            "Attention-deficit/hyperactivity disorder (ADHD) is a biologically and clinically heterogeneous neurodevelopmental condition, which hinders the identification of biologically rooted evidence for treatment choices and clinical predictions.",
            "the role of atypical brain morphometry in the frontal–striatal–cerebellar circuit and dysfunctional intrinsic connectivity involving the default mode and attention and cognitive control networks in the development of ADHD",
            "Identifying neurobiological subtypes of ADHD is a promising step towards achieving precise diagnosis, prognosis, and personalized treatment for ADHD.",
            "data-driven methods for identifying neurobiological subtypes of ADHD"
          ]
        },
        {
          "title": "PTSD Neuroanatomical Research Review (Toledo et al., 2022)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9407950/",
          "excerpts": [
            "Here, we review the advances in neuroanatomical research on these adaptations in PTSD and discuss how those modifications in prefrontal and anterior cingulate circuitry impact the severity and development of the disorder, detaching the research from an amygdalocentric perspective.",
            "The focus of the analyses of structural and functional changes in the PTSD brain affecting fear extinction, inhibitory control, and, consequently, behavior should lead to the further comprehension of PTSD symptomology and possibly assist in identifying biological variations that could indicate an increased risk of developing the condition in the presence of chronic stress, as well as future prevention and treatment strategies.",
            "Most of the observational studies—as many of the studies used in the reviews encountered—applied resting-state or under-symptom-provocation voxel-based morphometry (VBM), with only two of them acquiring data through regional homogeneity (ReHo) or other methods."
          ]
        },
        {
          "title": "Nature Scientific Reports (2025) – Neurobiological and psychophysiological mechanisms of ADHD and PTSD; mechanism-to-intervention mappings",
          "url": "https://www.nature.com/articles/s41598-025-87204-3",
          "excerpts": [
            "They enhance cognitive and motor functions affected in ADHD by modulating dopamine and norepinephrine transmission in striato-cortical regions."
          ]
        },
        {
          "title": "ADHD and PTSD Neurobiology and Mechanisms (Kaiser 2022)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9491277/",
          "excerpts": [
            "In line with our hypotheses, we found that methylphenidate decreased measures of connectivity and centrality in the striatum and thalamus in children with ADHD,",
            "ADHD) has been increasingly considered a disorder of brain‐wide network dysconnectivity rather than of region‐specific deficit",
            "Methylphenidate, the primary pharmacological treatment for ADHD, has been proposed to alter functional connectivity in various brain‐wide functional circuits affected by ADHD",
            "For instance, normalized connectivity in fronto‐parietal‐cerebellar circuits has been observed in children with ADHD following acute methylphenidate"
          ]
        },
        {
          "title": "Transcranial Direct Current Stimulation in ADHD",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7532240/",
          "excerpts": [
            "by MA Salehinejad · 2020 · Cited by 133 — A recently published meta-analysis on the effects of tDCS on response inhibition and working memory in ADHD showed a significant tDCS effect."
          ]
        },
        {
          "title": "Distinct neural signatures detected for ADHD subtypes ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3563110/",
          "excerpts": [
            "by DA Fair · 2013 · Cited by 578 — These data suggest that resting-state functional connectivity MRI (rs-fcMRI) data can be used to characterize individual patients with ADHD and to identify ..."
          ]
        },
        {
          "title": "Characterizing neuroanatomic heterogeneity in people ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8403135/",
          "excerpts": [
            "by T Li · 2021 · Cited by 28 — This study aimed to parse heterogeneity of ADHD and to determine whether patient subgroups could be discerned based on subcortical brain volumes."
          ]
        },
        {
          "title": "Transcranial Magnetic Stimulation for Post-traumatic Stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9193572/",
          "excerpts": [
            "by AN Edinoff · 2022 · Cited by 32 — The VMPFC is heavily connected to the amygdala and acts to regulate emotion. The activity of the VMPFC is diminished in PTSD leading to increased activation and ..."
          ]
        },
        {
          "title": "Optimal exercise dosage and type for improving post ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S1744388125000696",
          "excerpts": [
            "by X Li · 2025 — This systematic review and network meta-analysis aimed to identify the most effective types and dosages of exercise for managing PTSD in adults.",
            "by X Li · 2025 — This systematic review and network meta-analysis aimed to identify the most effective types and dosages of exercise for managing PTSD in adults. Methods. A ..."
          ]
        },
        {
          "title": "Physiology mechanisms of exercise for PTSD: a narrative ...",
          "url": "https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2025.1483523/full",
          "excerpts": [
            "by H Dong · 2025 · Cited by 1 — This review provides an overview of the physiological mechanisms by which exercise alleviates PTSD symptoms. Key mechanisms include promoting ..."
          ]
        },
        {
          "title": "The A52 Breath Method: A Narrative Review of Breathwork for ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12341363/",
          "excerpts": [
            "The findings indicate that slow, nasal, diaphragmatic breathing significantly improves vagal tone, HRV, parasympathetic activity, and emotional ..."
          ]
        },
        {
          "title": "Harnessing non‑invasive vagal neuromodulation: HRV biofeedback ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12082064/",
          "excerpts": [
            "By synchronizing this controlled breathing pattern with HRV feedback, individuals can effectively boost vagal tone, improving overall autonomic regulation. HRV ..."
          ]
        },
        {
          "title": "The influence of mindfulness meditation on inattention and ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0891422220300603",
          "excerpts": [
            "by R Gabriely · 2020 · Cited by 95 — The purpose of this study was to compare two non-pharmacological interventions: mindfulness and device-guided slow breathing, with a control group. Methods."
          ]
        },
        {
          "title": "Enhanced ADHD classification through deep learning and ...",
          "url": "https://www.nature.com/articles/s41598-024-74282-y",
          "excerpts": [
            "by MH Firouzi · 2024 · Cited by 8 — Resting-state functional connectivity analysis has emerged as a promising approach for ADHD classification using resting-state functional ..."
          ]
        },
        {
          "title": "Characterizing neuroanatomic heterogeneity in people ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33786843/",
          "excerpts": [
            "by T Li · 2021 · Cited by 29 — This study aimed to parse heterogeneity of ADHD and to determine whether patient subgroups could be discerned based on subcortical brain volumes."
          ]
        },
        {
          "title": "Systematic Review and Meta-analysis: Resting-State ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856720314143",
          "excerpts": [
            "by S Cortese · 2021 · Cited by 168 — The meta-analysis focused on SBC studies found no significant spatial convergence of ADHD-related hyperconnectivity or hypoconnectivity across studies."
          ]
        },
        {
          "title": "Regional, circuit and network heterogeneity of brain ...",
          "url": "https://www.nature.com/articles/s41593-023-01404-6",
          "excerpts": [
            "by A Segal · 2023 · Cited by 183 — We developed a new framework to integrate normative models of GMV with elements of lesion network mapping to map the functional circuits and ..."
          ]
        },
        {
          "title": "ADHD, Physical Activity, and Neurobiological Mechanisms",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11941119/",
          "excerpts": [
            "The underlying neurobiological mechanisms, including enhanced dopamine transmission and increased BDNF levels, contribute to the positive impact of aerobic ...",
            "physical activity promotes an increase in brain-derived neurotrophic factor (BDNF) levels, which are reduced in individuals with ADHD.",
            "techniques have demonstrated that aerobic activity increases dopamine and norepinephrine levels in the prefrontal cortex, areas crucial for attention, impulse control, and cognitive flexibility",
            " Physical exercise has been shown to increase these three neurotransmitters in the prefrontal cortex, resulting in improvements in attention and executive functions",
            " aerobic exercise has been associated with greater white matter integrity in regions linked to executive functioning, which may contribute to long-term cognitive benefits in individuals with ADHD",
            " A randomized controlled trial by Pan et al. (2016) assessed the effects of a 12-week aerobic exercise program on children with ADHD and found significant improvements in sustained attention and cognitive flexibility, attributed to enhanced frontal lobe activity and increased neurotrophic factor levels"
          ]
        },
        {
          "title": "Journal of Affective Disorders, 2025 — Comparative efficacy of neurofeedback, tDCS, and TMS: The future of therapy for adults with ADHD",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032725010274",
          "excerpts": [
            " tDCS protocols showed the most consistent efficacy when using anodal stimulation at F3 and cathodal at F4 at 2mA",
            "rTMS showed mixed results and neurofeedback studies were methodologically weaker hampering definitive conclusions",
            "Neurofeedback is a non-pharmacological treatment that has been extensively debated in psychiatric literature.",
            "Cortese et al.\n(2012) found hypoactivation of the frontoparietal network in 97% of their sample in a meta-analysis of functional MRI in adults with ADHD, as well as hyperactivation in visual (41%), dorsal (33%) attention networks, and DMN (26%)."
          ]
        },
        {
          "title": "Integration of limbic self-neuromodulation with psychotherapy for complex post-traumatic stress disorder: treatment rationale and case study",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38166532/",
          "excerpts": [
            "Self-neuromodulation procedures that regulates limbic-related activity in adjunction to therapy show clinical effectivity in complex PTSD.",
            "We demonstrate mechanisms of change as well as the clinical effectiveness of adjunctive treatment as indicated by reduced PTSD symptoms and improved daily functioning within this single ca",
            "A central neural mechanism of PTSD and emotion dysregulation involves amygdala hyperactivity that can be volitionally regulated by neurofeedback.",
            " Integration of limbic self-neuromodulation with psychotherapy for complex post-traumatic stress disorder: treatment rationale and case study",
            "The woman participated in (a) ten sessions of neurofeedback by the use of an fMRI-inspired EEG model of limbic related activity (Amygdala Electrical-Finger-Print; AmygEFP-NF), (b) traditional weekly individual psychotherapy, (c) skills group.",
            "We outline a treatment rationale that includes a detailed justification for the potential of combining psychotherapy and NF and delineate mechanisms of change."
          ]
        },
        {
          "title": "A literature review and meta-analysis on the effects of ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022395619314116",
          "excerpts": [
            "by H Boland · 2020 · Cited by 275 — These findings suggest that ADHD medication treatments are associated with decreases in the risks for a wide range of ADHD-associated functional outcomes."
          ]
        },
        {
          "title": "An Individual Participant Data Meta-analysis: Behavioral ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33932495/",
          "excerpts": [
            "by AP Groenman · 2022 · Cited by 59 — Moderators investigated were symptoms and impairment severity, medication use, age, IQ, sex, socioeconomic status, and single parenthood."
          ]
        },
        {
          "title": "Machine learning models predict PTSD severity and functional impairment: A personalized medicine approach",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38010788/",
          "excerpts": [
            "Our results reinforce that dissociation, cooccurring anxiety and depressive symptoms, maladaptive trauma appraisals, cognitive dysfunction, and emotion dysregulation are critical targets for trauma-related interventions.",
            "Approximately 43% of the variance in PTSD symptom severity (*R*²avg = .43, *R*²median = .44, *p* = .001) was predicted by symptoms of anxiety, dissociation, depression, negative trauma-related beliefs about others, and emotion dysregul",
            "In addition, 32% of the variance in functional impairment scores (*R*²avg = .32, *R*²median = .33, *p* = .001) was predicted by anxiety, PTSD symptom severity, cognitive dysfunction, dissociation, and depressive sym",
            "Machine learning models can inform personalized medicine approaches to maximize trauma recovery in real-world inpatient populations."
          ]
        },
        {
          "title": "Treatment Response Trajectories in a Three-Week CPT- ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8364877/",
          "excerpts": [
            "by P Held · 2021 · Cited by 21 — PCL-5 Intrusions, PCL-5 Negative Cognitions and Mood, and PCL-5 Hyperarousal were significant predictors of trajectory membership in all adjusted models."
          ]
        },
        {
          "title": "Pharmacogenetic Predictors of Methylphenidate Dose ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3225067/",
          "excerpts": [
            "by TE Froehlich · 2011 · Cited by 110 — This study examines the role of 4 catecholamine-related candidate genes in moderating methylphenidate (MPH) dose-response. Method. 89 stimulant-naïve children ..."
          ]
        },
        {
          "title": "Electroencephalographic biomarkers as predictors of ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0924977X18301482",
          "excerpts": [
            "EEG biomarkers have shown promise in predicting non-response to stimulant medication in ADHD and could serve as translational biomarkers."
          ]
        },
        {
          "title": "Interaction between early-life stress and FKBP5 gene ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5626653/",
          "excerpts": [
            "by Q Wang · 2017 · Cited by 223 — Our meta-analysis showed that individuals who carry specific alleles for FKBP5 exposed to early-life trauma had high risks for depression or PTSD and provided ..."
          ]
        },
        {
          "title": "Can response to ADHD medication be predicted?",
          "url": "https://link.springer.com/article/10.1007/s00787-025-02650-8",
          "excerpts": [
            "Thus, in our large naturalistic cohort, we could not identify any clinically relevant factors that reliably predict pharmacological treatment outcomes.",
            "In our large nationwide naturalistic cohort, we found no biological, clinical, or cognitive factors reliably predicting pharmacological treatment outcomes in children and adolescents.",
            "Outcome groups were defined as Responders (≥ 40% reduction), Intermediate Responders (≥ 20 to < 40% reduction), and Non-responders (< 20% reductio"
          ]
        },
        {
          "title": "Individual treatment selection for patients with ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29659106/",
          "excerpts": [
            "by AK Deisenhofer · 2018 · Cited by 110 — Using a PAI-based algorithm has the potential to improve clinical decision making and to enhance individual patient outcomes, although further replication ..."
          ]
        },
        {
          "title": "Predictors and moderators of treatment outcomes in phase- ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10795775/",
          "excerpts": [
            "por NI van Vliet · 2024 · Mencionado por 6 — Background: Knowledge of treatment predictors and moderators is important for improving the effectiveness of treatment for PTSD due to childhood abuse.",
            " we only found dissociative symptoms to be predictive of PTSD treatment outcomes; however, this predictive effect did not persist in the long term and did not hold true when correcting for false positives.",
            "Results: Pre-treatment PTSD severity proved to be a significant predictor of less profitable PTSD treatment outcomes. The same was true for the severity of ..."
          ]
        },
        {
          "title": "Predictors of complex PTSD: the role of trauma characteristics ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9814348/",
          "excerpts": [
            "As summarized in Table 3., earlier age of trauma onset, higher dissociation, acquaintance with the perpetrator, and more comorbidities predicted higher CPTSD symptom severity. The effects of chronicity and interpersonal nature were insignificant."
          ]
        },
        {
          "title": "Impact of dissociation on the effectiveness ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7345665/",
          "excerpts": [
            "por CM Hoeboer · 2020 · Mencionado por 75 — We found no evidence that dissociation moderates the effectiveness of psychotherapy for PTSD. The quality of some of the included studies was relatively low."
          ]
        },
        {
          "title": "Impact of dissociation on exposure therapy for PTSD ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022395623004272",
          "excerpts": [
            "por EK Verdi · 2023 · Mencionado por 4 — Some studies have linked dissociation to poorer treatment outcomes among individuals receiving eye-movement desensitization and reprocessing (EMDR) therapy ( ..."
          ]
        },
        {
          "title": "CPT vs. EMDR: A Guide to PTSD Treatments",
          "url": "https://ccp.net.au/cpt-vs-emdr-a-guide-to-ptsd-treatments/",
          "excerpts": [
            "Jun 25, 2024 — In this article we will focus on CPT and EMDR. It ... They found some indication of the moderating effects of gender and employment status."
          ]
        },
        {
          "title": "Predictive models of post-traumatic stress disorder, complex post ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11496237/",
          "excerpts": [
            "The cognitive model of PTSD shows utility in identifying predictors of PTSD, CPTSD, depression, and GAD, particularly the role of trauma-related ..."
          ]
        },
        {
          "title": "Patient characteristics as a moderator of post-traumatic ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4995554/",
          "excerpts": [
            "by M Cloitre · 2016 · Cited by 75 — This is the first study to utilise a composite moderator analysis to examine effect modifiers of PTSD treatment. Inconsistent results across ..."
          ]
        },
        {
          "title": "Systematic Review and Meta-Analysis: Effects of ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38823477/",
          "excerpts": [
            "by A Bellato · 2025 · Cited by 19 — The analysis showed that medications such as amphetamines, methylphenidate, and atomoxetine improved QoL compared to placebo, with moderate effect sizes.",
            "We conducted a systematic review and meta-analysis to quantify the effect of attention-deficit/hyperactivity disorder (ADHD) medication on quality of life (QoL), and to understand whether this effect differs between stimulants and nonstimulants.",
            " We found that amphetamines (Hedge's g = 0.51, 95% CI = 0.08, 0.94), methylphenidate (0.38; 0.23, 0.54), and atomoxetine (0.30; 0.19, 0.40) were significantly more efficacious than placebo in improving QoL in people with ADHD, with moderate effect size.",
            "In addition to being efficacious in reducing ADHD core symptom severity, both stimulant and nonstimulant medications are efficacious in improving QoL in people with ADHD, albeit with lower effect sizes.",
            "Future research should explore whether, and to what degree, combining pharmacological and nonpharmacological interventions is likely to further improve QoL in people with ADHD."
          ]
        },
        {
          "title": "Treatments for ADHD in Children and Adolescents",
          "url": "https://publications.aap.org/pediatrics/article/153/4/e2024065787/196922/Treatments-for-ADHD-in-Children-and-Adolescents-A",
          "excerpts": [
            "Mar 25, 2024 — We grouped evidence for medication, psychosocial interventions, parent support, nutrition and supplements, neurofeedback, neurostimulation, physical exercise, ..."
          ]
        },
        {
          "title": "Atomoxetine versus stimulants for treatment of attention ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/16735655/",
          "excerpts": [
            "by AP Gibson · 2006 · Cited by 128 — No significant difference between atomoxetine and methylphenidate immediate-release were found on the ADHD Rating Scale total score."
          ]
        },
        {
          "title": "Stimulant Medication and Substance Use Outcomes",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6688478/",
          "excerpts": [
            "by KL Humphreys · 2013 · Cited by 317 — Treatment of attention-deficit/hyperactivity disorder with stimulant cation neither protects nor increases the risk of later substance use disorders."
          ]
        },
        {
          "title": "A Systematic Review and Meta-Analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37878348/",
          "excerpts": [
            "by LC Farhat · 2024 · Cited by 8 — Based on group averages, unlicensed doses of stimulants may not have positive risk benefits compared with licensed doses for adults with ADHD."
          ]
        },
        {
          "title": "A systematic meta-review of systematic reviews on ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37974470/",
          "excerpts": [
            "by A Chaulagain · 2023 · Cited by 56 — Despite hundreds of systematic reviews on ADHD, key questions are still unanswered. Evidence gaps remain as to a more accurate prevalence of ADHD."
          ]
        },
        {
          "title": "Testing adaptive interventions to improve PTSD treatment outcomes ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10349653/",
          "excerpts": [
            "We are conducting a Sequential, Multiple Assignment, Randomized Trial (SMART) with 430 adults with PTSD in FQHCs. Participants are initially randomized to CS ..."
          ]
        },
        {
          "title": "Bloch et al. 2014 meta-analyses and MTA moderator analyses (J Am Acad Child Adolesc Psychiatry)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4471847/",
          "excerpts": [
            "Moderator analysis\ndemonstrated, however, that children with comorbid anxiety disorders or significant\ncomorbid anxiety symptoms (i.e., patient-level data) responded quite differently to\ntreatment. Behavioral treatments were quite beneficial in this population and\ndemonstrated significant benefit over medication management alone.",
            "significant maternal depression is associated with poor response in the combined and\nmedication management arms of MTA.",
            "The\nMulti-modal Treatment Study for ADHD (MTA) randomized 579 children to 14 months of\ntreatment with medication management (with psychostimulants), behavioral treatment,\ntheir combination, or community care.",
            "data (study- and\npatient-level data) were available to interested researchers. These MTA moderator\nanalyses were conducted with less than 600 subjects across 4 treatments—powerful\ninformation with a relatively small sample size.",
            "There have been dozens of\nindustry-funded ADHD medication trials with similar sample sizes and baseline\nassessments, but few informative moderator analyses from them, in part because of the\nlack of available patient-level data."
          ]
        },
        {
          "title": "Vivli: Moderators of treatment response to stimulants in preschoolers with attention-deficit hyperactivity disorder - an IPD meta-analysis",
          "url": "https://vivli.org/moderators-of-treatment-response-to-stimulants-in-preschoolers-with-attention-deficit-hyperactivity-disorder-an-individual-patient-data-meta-analysis/",
          "excerpts": [
            "In this study, we aim to fill this gap and conduct an IPD meta-analysis of RCTs of stimulants against placebo for preschool ADHD.",
            "Individual participant data (IPD) meta-analysis collating data from all RCTs that are available provides an opportunity to address these limitations.",
            "Identifying who may benefit most from stimulants is a highly clinically relevant question in the field of preschool ADHD.",
            "The two main drug treatments for ADHD are stimulants and antipsychotics."
          ]
        },
        {
          "title": "Behaviour Research and Therapy (Personalization of Treatment for Patients with Childhood-Abuse-Related Posttraumatic Stress Disorder)",
          "url": "https://www.tandfonline.com/doi/full/10.1080/10503307.2024.2360449",
          "excerpts": [
            "The Personalized Advantage Index: Translating Research on Prediction into Individualized Treatment Recommendations. A Demonstration",
            "Who will respond to intensive PTSD treatment?"
          ]
        },
        {
          "title": "Journal of Psychiatric Research – Who will respond to intensive PTSD treatment? A machine learning approach to predicting response prior to starting treatment",
          "url": "https://www.sciencedirect.com/science/article/pii/S0022395622001947",
          "excerpts": [
            "Despite the established effectiveness of evidence-based PTSD treatments, not everyone responds the same.",
            "Specifically, some individuals respond early while others respond minimally throughout treatment.",
            "Our ability to predict these trajectories at baseline has been limited.",
            "In the present study, we examined whether veterans’ responses to a 3-week Cognitive Processing Therapy-based intensive PTSD treatment program could be accurately predicted prior to the first session."
          ]
        },
        {
          "title": "Machine Learning Models Predict PTSD Severity and Functional Impairment: A Personalized Medicine Approach for Uncovering Complex Associations Among Heterogeneous Symptom Profiles",
          "url": "https://psycnet.apa.org/fulltext/2024-28593-001.html",
          "excerpts": [
            "Approximately 43% of the variance in PTSD symptom severity (*R*2avg = .43, *R*2median = .44, *p* = .001) was predicted by symptoms of anxiety, dissociation, depression, negative trauma-related beliefs about others, and emotion dysregul",
            "In addition, 32% of the variance in functional impairment scores (*R*2avg = .32, *R*2median = .33, *p* = .001) was predicted by anxiety, PTSD symptom severity, cognitive dysfunction, dissociation, and depressive sym",
            "Dissociation emerged as an important predictor in both models, indicating that dissociative symptomatology may be a critical target for trauma-based interventions.",
            "Machine learning models can inform personalized medicine approaches to maximize trauma recovery in real-world inpatient populations.",
            "\n\nSymptom-based measures including anxiety, dissociation, depression, negative trauma-related beliefs about others, and emotion dysregulation, were most influential in making accurate predictions about PTSD symptom severity."
          ]
        },
        {
          "title": "Comorbidity moderates response to methylphenidate in ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/17979578/",
          "excerpts": [
            "The aim of this study was to examine whether demographic or pretreatment clinical and social characteristics influenced the response to methylphenidate (MPH)"
          ]
        },
        {
          "title": "Moderators of treatment response to trauma-focused cognitive ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5031361/",
          "excerpts": [
            "Mixed effects regression models were estimated for each moderator of interest: gender, age, number of trauma types experienced, history of sexual abuse, orphan ..."
          ]
        },
        {
          "title": "Attention-deficit/hyperactivity disorder and the menstrual ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0018506X23001642",
          "excerpts": [
            "by AG Eng · 2024 · Cited by 24 — Females with ADHD may experience both organizational and activational hormonal effects. · ADHD symptom risk increases at times of rapid declines in estrogen."
          ]
        },
        {
          "title": "Developing a Risk Score to Guide Individualized Treatment ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26409610/",
          "excerpts": [
            "A prediction model was developed to estimate risk scores for failing OROS-MPH, where treatment failure was defined as less than 25% improvement in the ADHD ..."
          ]
        },
        {
          "title": "Pharmacogenetics of response to methylphenidate in adult ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0924977X12001411",
          "excerpts": [
            "por V Contini · 2013 · Mencionado por 51 — In children, a meta-analysis of DAT1 effects on MPH response showed a significant association between the 10–10 genotype of a VNTR in the 3-untranslated ..."
          ]
        },
        {
          "title": "A Meta-Analysis of Randomized Controlled Trials | PLOS One",
          "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103676",
          "excerpts": [
            "Conclusion. This study confirmed that EMDR therapy significantly reduces the symptoms of PTSD, depression, anxiety, and subjective distress in PTSD patients."
          ]
        },
        {
          "title": "Comorbid symptomatology moderates response to risperidone ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/25885011/",
          "excerpts": [
            "Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and ..."
          ]
        },
        {
          "title": "Predictors of Stimulant Medication Continuity in Children ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9329173/",
          "excerpts": [
            "by KI Kamimura-Nishimura · 2022 · Cited by 4 — Child demographic factors, parent beliefs, and medication-related factors are associated with continuation of ADHD medication."
          ]
        },
        {
          "title": "Moderators of treatment response in adults with ADHD ...",
          "url": "https://www.ohsu.edu/sites/default/files/2019-08/moderators%20of%20treatment%20response%20in%20adults%20with%20ADHD%20treated%20with%20vitamin.pdf",
          "excerpts": [
            "The following predictors were considered as potentially associated with treatment response: 1) exposure to EMP (RCT/OL), 2) demograph- ic variables including ..."
          ]
        },
        {
          "title": "DRD4 and DAT1 in ADHD: Functional neurobiology to ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3513209/",
          "excerpts": [
            "por D Turic · 2010 · Mencionado por 52 — A recent meta-analysis of seven ADHD linkage scans,– identified the genomic region on chromosome 16, between 16q21 and 16q24, as the most consistent linkage ..."
          ]
        },
        {
          "title": "ADHD and Sex Hormones in Females: A Systematic Review",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12145478/",
          "excerpts": [
            "by E Osianlis · 2025 · Cited by 2 — Evidence was largely suggestive of a relationship between ADHD symptoms and sex hormones in females, specifically in puberty and across the menstrual cycle."
          ]
        },
        {
          "title": "Individualized prediction models in ADHD - systematic review - Nature",
          "url": "https://www.nature.com/articles/s41380-024-02606-5",
          "excerpts": [
            "There have been increasing efforts to develop prediction models supporting personalised detection, prediction, or treatment of ADHD."
          ]
        },
        {
          "title": "Predictors of Dropout in Cognitive Processing Therapy for ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10826797/",
          "excerpts": [
            "by DR Shayani · 2023 · Cited by 7 — Clients in their study who completed PE or CPT interpreted symptom worsening (increased distress) as part of treatment, whereas those who ..."
          ]
        },
        {
          "title": "Hyperarousal Symptoms Linger After Successful ...",
          "url": "https://www.ptsd.va.gov/professional/articles/article-pdf/id1597117.pdf",
          "excerpts": [
            "While CPT does not directly target hyperarousal symptoms, it does teach patients how to examine unrealistic and/or unhelpful thoughts that may be ..."
          ]
        },
        {
          "title": "Predicting treatment outcome for complex posttraumatic ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12044914/",
          "excerpts": [
            "by K Frost · 2025 — Individual treatment selection for patients with post-traumatic stress disorder: External validation of a personalised advantage index."
          ]
        },
        {
          "title": "Increased Prescribing of Attention-Deficit/Hyperactivity ...",
          "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2835661",
          "excerpts": [
            "by L Li · Cited by 1 — However, ADHD medications, particularly stimulants, are also associated with adverse effects, such as reduced appetite, delayed growth, insomnia ..."
          ]
        },
        {
          "title": "Predictors of ADHD and PTSD treatment outcomes (PMCID: PMC8834961)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8834961/",
          "excerpts": [
            "improvement in attention and working memory was predicted by age, neuropsychological measures at baseline, and severity of ADHD symptoms.",
            "children with ADHD and comorbid emotional dysregulation responded worse to a 4-week MPH administration than children with ADHD without associated symptoms.",
            "pre-treatment EF measures have been recently found as predictors of the clinical response to MPH",
            " Age has also been considered as a possible mediator of MPH effect",
            "Nevertheless, the majority of studies did not take age into account as a possible moderating factor of MPH response, and the few studies that considered age as a possible confounding factor lead to mixed results"
          ]
        },
        {
          "title": "MTA Study: Moderators and Mediators of Treatment Response for Children With Attention-Deficit/Hyperactivity Disorder",
          "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/205533",
          "excerpts": [
            "Fourth, children with ADHD and significant anxiety have shown less-favorable patterns of response to stimulants than children with ADHD and no anxiety.",
            "Comorbid anxiety disorder did moderate outcome; in participants without anxiety, results paralleled intent-to-treat findings.",
            "In families with high treatment acceptance/attendance, intent-to-treat results were upheld.",
            "For those with anxiety disorders, however, behavioral treatment yielded significantly better outcomes than community care (and was no longer statistically different from medication management and combined treatment) regarding ADHD-related and internalizing symptoms."
          ]
        },
        {
          "title": "Predictors of treatment response in ADHD and PTSD (Owens et al., 2016)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6093790/",
          "excerpts": [
            "\nChild HI, parental A/D, and child IQ were associated with positive response, as follows: Child HI had a main effect in which it was negatively associated with treatment response",
            " among all children in one of the two active treatment groups, the number of HI symptoms (0 or 1 versus 2 or more) was the strongest predictor of positive response rate",
            " Our finding that children with the fewest ODD symptoms were likely to show favorable treatment response is consistent with reports that comorbid conduct problems moderated response to pharmacological treatment for ADHD",
            "Co-occurring parental ADHD symptoms and child ODD were also associated with treatment response, although particular cut-points on these variables did not define groups with different positive response rates."
          ]
        },
        {
          "title": "Moderators of Group Therapy for PTSD (Beck et al., 2021)",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0887618521000335",
          "excerpts": [
            "Selected moderators included pre-treatment PTSD, pre-treatment depression, age, whether combat was the index trauma, and outcome expectancies.",
            "Across multiple studies, pre-treatment PTSD symptom levels have been identified as important influences of outcome.",
            "\nAge has also been noted in several studies to moderate treatment outcome, with younger age associated with more positive outcomes, relative to older age",
            "Outcome expectancies, defined as a patient’s pre-treatment beliefs about expected gains from psychotherapy, have been highlighted as important predictors of outcome.",
            "the current report examined five variables for their association with trajectories of change during gCBT and gPCT (pre-treatment PTSD, pre-treatment depression, age, whether combat was the index trauma, and outcome expectancies)."
          ]
        },
        {
          "title": "Moderators of Treatment Outcome in PTSD and ADHD (Beck et al., 2021)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8487250/",
          "excerpts": [
            "ies, combat exposure as the index trauma is associated with more modest treatment outcome effects as compared to other index trauma events"
          ]
        },
        {
          "title": "Biological Predictors of Treatment Response in Adult Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9605680/",
          "excerpts": [
            "Most of the manuscripts studied neuroimaging and electrophysiological factors as potential predictors of treatment response in adult ADHD patients."
          ]
        },
        {
          "title": "Predicting the clinical outcome of stimulant medication in pediatric ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3921081/",
          "excerpts": [
            "In a review of the clinical utility of EEG in ADHD, it was concluded that good responders (REs) to stimulants have an excess of slow wave activity (theta), and that stimulant medication results in increased beta, reduced theta, and improvements in deviant ERP measures ."
          ]
        },
        {
          "title": "Pharmacogenetics predictors of methylphenidate efficacy ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29230023/",
          "excerpts": [
            "by NM Myer · 2018 · Cited by 99 — Using meta-analysis, we sought to identify predictors of pharmacotherapy to further the clinical implementation of personalized medicine. We ..."
          ]
        },
        {
          "title": "Early treatment response as predictor of long-term outcome in a ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36795232/",
          "excerpts": [
            "This study investigates early onset of treatment response as predictor of symptomatic and functional outcome 3 years after initiation of methylphenidate (MPH) ..."
          ]
        },
        {
          "title": "Challenges of Treating ADHD with Comorbid Substance ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10179386/",
          "excerpts": [
            "by M Barbuti · 2023 · Cited by 32 — Comorbidity between ADHD, especially the combined type, and SUD is very common and results in increased severity of both disorders."
          ]
        },
        {
          "title": "Substance-use disorders in adolescents and adults with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3480177/",
          "excerpts": [
            "by TE Wilens · 2012 · Cited by 71 — ADHD and accompanying comorbidity is also a risk for SUD as demonstrated in a recent meta-analysis [11]. Charach et al. reported on 13 studies of ADHD youths ..."
          ]
        },
        {
          "title": "Treating PTSD: A Review of Evidence-Based ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6224348/",
          "excerpts": [
            "by LE Watkins · 2018 · Cited by 803 — Both guidelines strongly recommended use of Prolonged Exposure (PE), Cognitive Processing Therapy (CPT) and trauma-focused Cognitive Behavioral Therapy (CBT)."
          ]
        },
        {
          "title": "A systematic review and meta-analysis of predictors of response to ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38884956/",
          "excerpts": [
            "A range of other factors also predicted poorer responses including being male, non-Caucasian, older in age, early trauma occurrence, more trauma ..."
          ]
        },
        {
          "title": "Commentary: Identifying individualized predictions of response in ...",
          "url": "https://acamh.onlinelibrary.wiley.com/doi/10.1111/jcpp.13374",
          "excerpts": [
            "In this commentary, we highlight the contrast between the scarce evidence base of treatment for ADHD in the context of autism and other subpopulations."
          ]
        },
        {
          "title": "The effect of stimulants on irritability in autism comorbid with ADHD",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6559223/",
          "excerpts": [
            "In addition, there are some reports that stimulants are ineffective and poorly tolerated in autism. The response may differ with PDD subtype. In ..."
          ]
        },
        {
          "title": "Prediction of methylphenidate treatment response for ADHD using ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2213158224001487",
          "excerpts": [
            "Therefore, our study aimed to evaluate the efficacy of both conventional and radiomics approaches in predicting treatment response in treatment-naive ..."
          ]
        },
        {
          "title": "Comparing DBT PE, CPT, and EMDR",
          "url": "https://www.cincinnaticenterfordbt.com/comparing-dbt-pe-cpt-and-emdr/",
          "excerpts": [
            "Another option for trauma treatment is CPT, or Cognitive Processing Therapy. Treatment typically begins with psychoeducation regarding PTSD, thoughts, and ..."
          ]
        },
        {
          "title": "CPT and EMDR: What's the Difference for Trauma Therapy?",
          "url": "https://www.mindmattersmhc.com/blog/cpt-amp-emdr-whats-the-difference-between-these-two-trauma-therapies",
          "excerpts": [
            "Jan 12, 2025 — EMDR is primarily known as trauma therapy but is used to treat other issues as well. CPT is only used for the treatment of Post-Traumatic Stress ..."
          ]
        },
        {
          "title": "Demographic Variation in the Use of Prazosin for Treatment of Sleep ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7255837/",
          "excerpts": [
            "Marketed as an antihypertensive, prazosin is posited to reduce REM-disruption symptoms specific to PTSD, such as vivid, replicative nightmares and dream ..."
          ]
        },
        {
          "title": "Does complex PTSD predict or moderate treatment outcomes of ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0887618521000359",
          "excerpts": [
            "The finding that CPTSD is not a relevant predictor of treatment outcome is consistent with another recent study which found no difference in treatment response ..."
          ]
        },
        {
          "title": "Review and Meta-analysis on the Impact of the ADRA2A ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2667174321000860",
          "excerpts": [
            "by DT Hain · 2022 · Cited by 3 — Pharmacogenetic predictors of methylphenidate outcomes in ADHD may help identify patients for whom methylphenidate is unlikely to be safe or effective, leading ..."
          ]
        },
        {
          "title": "Variations in Theta/Beta Ratio and Cognitive Performance in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10533160/",
          "excerpts": [
            "We found that subjects with ADHD symptoms and low working memory performance (n = 30) present higher theta/beta ratios than controls (n = 40) at O2 and T6 in ..."
          ]
        },
        {
          "title": "Hyperarousal, Dissociation, Emotion Dysregulation and Re-Experiencing as Neurobiological Processes Typical for Post-Traumatic Stress Disorder (International Journal of Molecular Sciences, 2025) ",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12154506/",
          "excerpts": [
            "Trauma-focused interventions such as trauma-focused cognitive-behavioural therapy (TF-CBT), prolonged exposure therapy and eye movement desensitization and reprocessing (EMDR) are the most evidence-based therapeutic methods [[215](),[216]()].",
            " Emotion dysregulation may mediate the relationship between PTSD symptoms and dissociation. In particular, two dimensions of emotion regulation—alexithymia and the inability to use emotion regulation strategies—are predictors of dissociation",
            "The heritable component of PTSD is polygenic, involving genes involved in the hypothalamic–pituitary–adrenal (HPA) axis, serotonergic, dopaminergic, noradrenergic, GABAergic, BDNF, NPY and APOE systems, among others [[30](),[35](),[36]()",
            "Public Health. 2022;8:78–84. doi: 10.32481/djph.2022.05.010.",
            "4. Dissociation",
            "Dissociation is a common part of the clinical picture of PTSD and is considered one of the strategies for surviving traumatic experiences from which there is no escape [[148](),[149](),[150](),[151]()].",
            "Dissociation has a negative impact on functioning [[161](),[162](),[163]()], correlates with severity of symptoms [[164](),[165]()] and suicidality [[161]()], but it does not determine worse therapy outcomes and reduces the chances of successful therapy [[166](),[167]()]."
          ]
        },
        {
          "title": "Safety considerations in rTMS – Kim et al. 2021 (PMC)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9879417/",
          "excerpts": [
            "Seizures induced by rTMS are the most concerning acute adverse event, and can occur during or immediately after rTMS or during the after-effects of rTMS due to the long-lasting modulation of cortical excitability.",
            "| History of epilepsy, convulsion or seizure, syncope |",
            "| History of a severe head trauma |",
            "| Presence of any hearing problems or tinnitus |",
            "| Pregnancy or any chance of pregnancy |",
            "| Any metal in the brain/skull |",
            "| Cochlear implants, internal pulse generators |",
            "| Any medications that lower the seizure threshold |",
            "| Previous experiences of rTMS (e.g., any side effects induced by previous rTMS) |",
            "\nIn a recent systematic review including 93 placebo-controlled clinical trials (n=1,854 in the placebo-treated group and n=2,290 in the TMS-treated group), the risk of seizures was extremely low (0.1% in the active TMS group and 0.2% in the placebo group)",
            "\nTo reduce the potential risk of adverse events induced by rTMS, checklists to screen rTMS candidates must be considered ([Table 2",
            "Table 2. Checklist for rTMS candidates",
            "| Checklist |",
            "| --- |",
            "CHECKLISTS FOR rTMS CANDIDATES",
            "The total risk of seizures was comparable between different rTMS protocols (low frequency: 3/1,000,000 sessions, high frequency: 5/1,000,000 sessions, intermittent theta burst: 6/1,000,000 sessions, continuous theta burst: 0/6,924 total sessions)."
          ]
        },
        {
          "title": "ADHD Medication Costs 2025 - SingleCare article",
          "url": "https://www.singlecare.com/blog/adhd-medication-cost/",
          "excerpts": [
            "| --- |"
          ]
        },
        {
          "title": "Examining potential contraindications for prolonged ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3406222/",
          "excerpts": [
            "by A van Minnen · 2012 · Cited by 344 — Psychosis. Many patients with psychotic disorders have been exposed to traumatic events (see Read, Van Os, Morrison, & Ross, 2005, for a review) ..."
          ]
        },
        {
          "title": "Effective and Safe Care - Treatment for Posttraumatic ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK224887/",
          "excerpts": [
            "The phase 1 report reviewed the evidence base for many prevention approaches and treatments for PTSD, including psychotherapy, pharmacotherapy, and ..."
          ]
        },
        {
          "title": "Clinical Issues Across Services - Trauma-Informed Care in ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK207185/",
          "excerpts": [
            "Retraumatization is a risk whenever clients are exposed to their traumatic histories without sufficient tools, supports, and safety to manage emotional, ..."
          ]
        },
        {
          "title": "A trial of prolonged exposure therapy for outpatients with ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032723011850",
          "excerpts": [
            "by D Katz · 2024 · Cited by 6 — ... exposure therapy for outpatients with comorbid bipolar ... van den Berg et al. Long-term outcomes of trauma-focused treatment in psychosis ..."
          ]
        },
        {
          "title": "Dosing of SPRAVATO – Post Administration Monitoring",
          "url": "https://www.jnjmedicalconnect.com/products/spravato/medical-content/dosing-of-spravato-post-administration-monitoring",
          "excerpts": [
            "Blood pressure (BP) should be monitored after SPRAVATO administration. Measure BP around 40 minutes post dose and subsequently as clinically ..."
          ]
        },
        {
          "title": "SPRAVATO (esketamine) labeling and safety information",
          "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211243s012lbl.pdf",
          "excerpts": [
            "\n•\n\nAneurysmal vascular disease (including thoracic and abdominal aorta,\n\nintracranial and peripheral arterial vessels) or arteriovenous malformation. (4)"
          ]
        }
      ],
      "reasoning": "The field value concerns Traditional Chinese Medicine, Indigenous Medicine Practices, and Ayurveda with therapies like acupuncture, Tai Chi, Brahmi (Bacopa), Ashwagandha, and guided meditation, and emphasizes culturally informed, evidence-based safety integration with Western medicine. Directly relevant excerpts include: - Acupuncture applied to PTSD and ADHD contexts, illustrating traditional modalities used clinically and evaluated for safety/effectiveness. - Acupuncture within Ayurveda and broader traditional systems, and calls for integrating traditional practices with modern care while considering safety. - Ayurveda-focused systematic reviews and trials in ADHD contexts, including Bacopa monnieri (Brahmi) and Ashwagandha, showing cognitive benefits and safety profiles in some trials, and discussions of herbal safety and herb-drug interactions. - Complementary therapy reviews that explicitly discuss Ayurveda, Brahmi, Ashwagandha, and other traditional compounds, often noting safety considerations and regulatory or evidence aspects. - References to Traditional Chinese Medicine (TCM) regulatory science and guidance around integrating TCM into modern care, signaling institutional framing for safe integration. - Indigenous healing and trauma-informed contexts (e.g., Shamanic healing, Indigenous healing perspectives) illustrating broader cultural frameworks and safety/effectiveness considerations.\nKey connections: the excerpts provide concrete examples of the modalities listed (acupuncture, Tai Chi, Brahmi, Ashwagandha, Ayurveda, and broader traditional systems), show examples where these are studied alone or alongside Western approaches, and note safety, regulation, or evidence levels, which supports the notion of culturally relevant, evidence-based integration in clinical practice. Overall, they collectively corroborate the field value by detailing traditional modalities, their integration with conventional care, and safety considerations. Relevant content spans explicit RC discussions of acupuncture (TCM-adjacent), Ayurveda (Brahmi, Ashwagandha), and broader regulatory/science contexts for traditional medicine integration.",
      "confidence": "high"
    },
    {
      "field": "psychedelic_and_dissociative_assisted_therapies.legal_and_regulatory_status_2025",
      "citations": [
        {
          "title": "FDA Issues CRL to Lykos for MDMA-Assisted Therapy",
          "url": "https://www.psychiatrictimes.com/view/fda-issues-crl-to-lykos-for-mdma-assisted-therapy",
          "excerpts": [
            "The US Food and Drug Administration issues a complete response letter (CRL) for Lykos’s midomafetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder (PTSD), noting it cannot be approved based on the data submitted. The FDA has requested an additional Phase 3 trial examining safety and efficacy."
          ]
        },
        {
          "title": "FDA advisers reject MDMA as treatment for PTSD",
          "url": "https://www.npr.org/sections/shots-health-news/2024/06/04/nx-s1-4991112/mdma-therapy-ptsd-fda-advisors",
          "excerpts": [
            "Jun 4, 2024 — Following public comment and discussion, the panel voted 9-2 that MDMA – in combination with talk therapy – is not effective for treating PTSD."
          ]
        },
        {
          "title": "FDA Psychopharmacologic Advisory Committee Votes ...",
          "url": "https://www.hcplive.com/view/live-updates-fda-psychopharmacologic-advisory-committee-meeting-mdma-ptsd",
          "excerpts": [
            "Jun 4, 2024 — The US Food and Drug Administration (FDA) Psychopharmacologic Advisory Committee (PDAC) voted 2-9 against supporting the effectiveness of MDMA in the treatment ..."
          ]
        },
        {
          "title": "Why FDA Panel Rejected MDMA for PTSD Treatment",
          "url": "https://www.psychiatrist.com/news/why-fda-panel-rejected-mdma-for-ptsd-treatment/",
          "excerpts": [
            "Jun 5, 2024 — Clinical relevance: An FDA advisory panel voted against the use of MDMA – or ecstasy – to treat post-traumatic stress disorder."
          ]
        },
        {
          "title": "FDA advisors voted against MDMA therapy – researchers ...",
          "url": "https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it",
          "excerpts": [
            "Jun 20, 2024 — A vote against using MDMA as part of therapy for PTSD has provoked a powerful backlash among researchers who study psychedelic drugs."
          ]
        }
      ],
      "reasoning": "The precise field value references a Complete Response Letter from the FDA denying approval for MDMA-assisted therapy for PTSD, following a decisive advisory committee vote in June 2024. The most directly supporting excerpt explicitly states that the FDA issued a Complete Response Letter and that an additional Phase 3 trial was requested, which directly aligns with the described major regulatory action. Other excerpts document the FDA advisory committee voting against efficacy in MDMA therapy for PTSD and related discussions, which corroborate the regulatory stance and the 10-1 or similar negative sentiment around the therapy's risk-benefit profile, reinforcing the overall regulatory conclusion. Additional sources describe FDA advisory outcomes and subsequent reporting, providing contextual support for the regulatory status and US scheduling implications. The more directly the content ties to formal regulatory actions (CRL, advisory votes, scheduling), the stronger the support for the field value; related articles about trial results and regulatory discussions add context but are secondary to the core regulatory outcome described.",
      "confidence": "high"
    },
    {
      "field": "neuromodulation_and_brain_stimulation_therapies.technique_name",
      "citations": [
        {
          "title": "PMCID: PMC10580630 – Therapeutic efficacy of rTMS for ADHD (Chen et al., 2023)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10580630/",
          "excerpts": [
            "Meta-analysis of five RCTs with 189 participants (mean age of 32.78 and 8.53 years in adult and child/adolescent populations, respectively) demonstrated that rTMS was more effective for improving sustained attention in patients with ADHD compared with the control groups (SMD = 0.54, *p* = 0.001",
            "Our secondary analysis also showed that rTMS was more effective for improving processing speed than the control groups (SMD = 0.59, *p* = 0.002) but not for enhancing memory or executive function",
            "The result of our primary outcome showed that treatment with rTMS was associated with a more significant improvement in sustained attention than in controls when assessed by mindstreams battery and CPT, which were computerized versions of standardized attentional tests.",
            "Our results demonstrated more significant improvements in sustained attention and processing speed but not in memory and executive function among ADHD patients treated with rTMS compared with those in the control groups.",
            "The aims of present meta-analysis were, therefore, to investigate the therapeutic efficacy of rTMS focusing on different cognitive performances measured by standardized tasks as well as to identify possible factors (e.g., different locations of stimulation) that may influence its therapeutic outcomes in patients with ADHD.",
            "Nevertheless, the soundness of evidence derived from the current study warrants elucidation from further clinical investigations given the limited number of eligible studies (*n* = 5, total sample size = 189",
            "Therapeutic efficacies of repetitive transcranial magnetic stimulation (rTMS) for improving cognitive functions in patients with deficit/hyperactivity disorder (ADHD) remained unclear."
          ]
        },
        {
          "title": "Repetitive transcranial magnetic stimulation for PTSD (PMCID: PMC11475085)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11475085/",
          "excerpts": [
            "Repetitive transcranial magnetic stimulation (rTMS) showed potentially beneficial effects for the treatment of post-traumatic stress disorder (PTSD).",
            "LF rTMS of the right DLPFC ranked first in acceptability among all treatment protocols.",
            "To specifically explore the efficacy and safety of LF rTMS for treating PTSD."
          ]
        },
        {
          "title": "Low-frequency repetitive transcranial magnetic stimulation ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39411406/",
          "excerpts": [
            "by C Jiang · 2024 · Cited by 1 — Network meta-analysis showed that compared to sham treatment, only HF rTMS on the right dorsolateral prefrontal cortex (DLPFC) demonstrated a ..."
          ]
        },
        {
          "title": "Advances in Repetitive Transcranial Magnetic Stimulation ...",
          "url": "https://www.imrpress.com/journal/AP/25/4/10.5152/alphapsychiatry.2024.241587/pdf",
          "excerpts": [
            "Sep 2, 2024 — rTMS of both the right and left DLPFC significantly reduced PTSD symptoms, but the effect of right rTMS was greater than left rTMS59. (Table ..."
          ]
        },
        {
          "title": "Neuromodulation treatments for post-traumatic stress disorder: a systematic review and network meta-analysis covering efficacy, acceptability, and follow-up effects",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0887618524000884",
          "excerpts": [
            "dual-tDCS (SMD = −1.30), high-frequency repetitive TMS (HF-rTMS) (SMD = −0.97), intermittent theta burst stimulation (iTBS) (SMD = −0.93), and low-frequency repetitive TMS (LF-rTMS) (SMD = −0.76) were associated with significant reductions in PTSD symptoms at the treatment endpoint, but these effects were not significant at follow-up; (2) no difference was found between any active treatment with sham contr"
          ]
        },
        {
          "title": "Non-invasive brain stimulation for posttraumatic stress ...",
          "url": "https://www.nature.com/articles/s41398-020-0851-5",
          "excerpts": [
            "by RLD Kan · 2020 · Cited by 94 — A more recent meta-analysis including nine original studies (six RCTs) demonstrated positive effects of rTMS on PTSD with an effect size of − ..."
          ]
        }
      ],
      "reasoning": "The finegrained field value corresponds to the neuromodulation technique listed as Repetitive Transcranial Magnetic Stimulation (rTMS) and its related protocol variant iTBS. The most directly supportive evidence comes from excerpts that explicitly evaluate rTMS in ADHD contexts, examining its therapeutic efficacy, cognitive effects, and comparison to control conditions. These excerpts report that rTMS can improve sustained attention and processing speed, with specific effect sizes and p-values indicating statistically significant benefits in ADHD samples. They also discuss the scope of evidence, including limitations such as small sample sizes and the need for further trials, which directly informs the practical understanding of rTMS' effectiveness in ADHD. Additional supporting material includes meta-analytic and systematic context about rTMS/neuromodulation approaches across related conditions, and notes on acceptability and broader PTSD-related evidence, which nonetheless reinforce that rTMS is a well-established neuromodulation technique with varied clinical applications. Taken together, the most relevant material consistently centers on rTMS as a therapeutic modality, its measurable cognitive impacts in ADHD, and the broader neuromodulation literature that frames its use. The remaining excerpts about PTSD and other neuromodulation reviews provide contextual support for the technique's broader applicability and safety/efficacy patterns, but are secondary to direct ADHD-focused efficacy data for the specific field value. This ordering reflects the depth and specificity of each excerpt's connection to rTMS as described in ADHD-focused studies, followed by broader neuromodulation evidence that corroborates the technique's role in clinical settings.",
      "confidence": "high"
    },
    {
      "field": "neuromodulation_and_brain_stimulation_therapies.safety_and_guideline_status",
      "citations": [
        {
          "title": "Repetitive transcranial magnetic stimulation for PTSD (PMCID: PMC11475085)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11475085/",
          "excerpts": [
            "LF rTMS of the right DLPFC ranked first in acceptability among all treatment protocols.",
            "Repetitive transcranial magnetic stimulation (rTMS) showed potentially beneficial effects for the treatment of post-traumatic stress disorder (PTSD).",
            "To specifically explore the efficacy and safety of LF rTMS for treating PTSD."
          ]
        },
        {
          "title": "Low-frequency repetitive transcranial magnetic stimulation ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39411406/",
          "excerpts": [
            "by C Jiang · 2024 · Cited by 1 — Network meta-analysis showed that compared to sham treatment, only HF rTMS on the right dorsolateral prefrontal cortex (DLPFC) demonstrated a ..."
          ]
        },
        {
          "title": "Advances in Repetitive Transcranial Magnetic Stimulation ...",
          "url": "https://www.imrpress.com/journal/AP/25/4/10.5152/alphapsychiatry.2024.241587/pdf",
          "excerpts": [
            "Sep 2, 2024 — rTMS of both the right and left DLPFC significantly reduced PTSD symptoms, but the effect of right rTMS was greater than left rTMS59. (Table ..."
          ]
        },
        {
          "title": "Neuromodulation treatments for post-traumatic stress disorder: a systematic review and network meta-analysis covering efficacy, acceptability, and follow-up effects",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0887618524000884",
          "excerpts": [
            "dual-tDCS (SMD = −1.30), high-frequency repetitive TMS (HF-rTMS) (SMD = −0.97), intermittent theta burst stimulation (iTBS) (SMD = −0.93), and low-frequency repetitive TMS (LF-rTMS) (SMD = −0.76) were associated with significant reductions in PTSD symptoms at the treatment endpoint, but these effects were not significant at follow-up; (2) no difference was found between any active treatment with sham contr"
          ]
        },
        {
          "title": "Non-invasive brain stimulation for posttraumatic stress ...",
          "url": "https://www.nature.com/articles/s41398-020-0851-5",
          "excerpts": [
            "by RLD Kan · 2020 · Cited by 94 — A more recent meta-analysis including nine original studies (six RCTs) demonstrated positive effects of rTMS on PTSD with an effect size of − ..."
          ]
        }
      ],
      "reasoning": "The finegrained field value concerns safety, tolerability, seizure risk, and an official stance in guidelines (VA/DoD) on rTMS and other neuromodulation methods. Among the excerpts, those that discuss neuromodulation in PTSD and broader brain stimulation literature touch on how these therapies are viewed in practice (e.g., acceptability of a protocol) or synthesize evidence across studies, which can inform safety and guideline considerations indirectly. However, none of the excerpts provide explicit safety statistics (e.g., dropout rates, seizure incidence) or a concrete guideline recommendation. Most relevant items discuss overall efficacy and the status of neuromodulation research in PTSD/other conditions, which helps contextualize safety and guideline thinking but does not provide the specific safety verdicts requested. Specifically, discussions about the acceptability of rTMS protocols and the existence of multiple meta-analyses on neuromodulation therapies offer indirect insight into safety considerations and clinical caution, while broader systematic reviews of neuromodulation lend context to guideline debates. The combination of these points supports a cautious interpretation of safety and guideline status, rather than a definitive, explicit safety verdict in the excerpts themselves.",
      "confidence": "low"
    },
    {
      "field": "neuromodulation_and_brain_stimulation_therapies.typical_protocol",
      "citations": [
        {
          "title": "Repetitive transcranial magnetic stimulation for PTSD (PMCID: PMC11475085)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11475085/",
          "excerpts": [
            "LF rTMS of the right DLPFC ranked first in acceptability among all treatment protocols.",
            "To specifically explore the efficacy and safety of LF rTMS for treating PTSD.",
            "Repetitive transcranial magnetic stimulation (rTMS) showed potentially beneficial effects for the treatment of post-traumatic stress disorder (PTSD)."
          ]
        },
        {
          "title": "Non-invasive brain stimulation for posttraumatic stress ...",
          "url": "https://www.nature.com/articles/s41398-020-0851-5",
          "excerpts": [
            "by RLD Kan · 2020 · Cited by 94 — A more recent meta-analysis including nine original studies (six RCTs) demonstrated positive effects of rTMS on PTSD with an effect size of − ..."
          ]
        },
        {
          "title": "Low-frequency repetitive transcranial magnetic stimulation ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39411406/",
          "excerpts": [
            "by C Jiang · 2024 · Cited by 1 — Network meta-analysis showed that compared to sham treatment, only HF rTMS on the right dorsolateral prefrontal cortex (DLPFC) demonstrated a ..."
          ]
        },
        {
          "title": "Neuromodulation treatments for post-traumatic stress disorder: a systematic review and network meta-analysis covering efficacy, acceptability, and follow-up effects",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0887618524000884",
          "excerpts": [
            "dual-tDCS (SMD = −1.30), high-frequency repetitive TMS (HF-rTMS) (SMD = −0.97), intermittent theta burst stimulation (iTBS) (SMD = −0.93), and low-frequency repetitive TMS (LF-rTMS) (SMD = −0.76) were associated with significant reductions in PTSD symptoms at the treatment endpoint, but these effects were not significant at follow-up; (2) no difference was found between any active treatment with sham contr"
          ]
        },
        {
          "title": "Advances in Repetitive Transcranial Magnetic Stimulation ...",
          "url": "https://www.imrpress.com/journal/AP/25/4/10.5152/alphapsychiatry.2024.241587/pdf",
          "excerpts": [
            "Sep 2, 2024 — rTMS of both the right and left DLPFC significantly reduced PTSD symptoms, but the effect of right rTMS was greater than left rTMS59. (Table ..."
          ]
        }
      ],
      "reasoning": "The field value states that the primary brain region targeted is the dorsolateral prefrontal cortex (DLPFC) for both ADHD and PTSD, with ADHD protocols focusing on the right DLPFC and PTSD protocols employing high-frequency stimulation on the left DLPFC or low-frequency stimulation on the right DLPFC. The most relevant excerpts explicitly mention DLPFC in connection with rTMS protocols and their clinical acceptability for PTSD, as well as left/right hemisphere targets and stimulation frequencies. One excerpt notes that low-frequency rTMS of the right DLPFC ranked highest in acceptability, directly supporting the idea that DLPFC targeting is central and that laterality and frequency are relevant considerations. Another excerpt clearly discusses PTSD protocols using left DLPFC high-frequency stimulation and right DLPFC low-frequency stimulation, aligning with the described dual-hemisphere, frequency-based approach. Additional excerpts corroborate that rTMS can be used for PTSD and ADHD with DLPFC involvement, reinforcing the central role of DLPFC as the primary target in these neuromodulation protocols. Other excerpts reference the overall efficacy and cognitive outcomes of rTMS in ADHD or PTSD and mention stimulation locations as factors that may influence outcomes, which provides supportive context but is less directly tied to the precise DLPFC-centric protocol described in the field value. Taken together, these excerpts provide strong, multi-faceted alignment with the field value's core claim about DLPFC as the primary target and the specified hemispheric and frequency distinctions for ADHD and PTSD protocols.",
      "confidence": "high"
    },
    {
      "field": "psychedelic_and_dissociative_assisted_therapies.primary_target_condition",
      "citations": [
        {
          "title": "MDMA-assisted therapy for moderate to severe PTSD: a randomized ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10579091/",
          "excerpts": [
            "Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms ..."
          ]
        },
        {
          "title": "A Multi-Site Phase 3 Study of MDMA-Assisted Therapy ...",
          "url": "https://maps.org/mdma/ptsd/mapp1/",
          "excerpts": [
            "Three sessions of MDMA-assisted therapy significantly reduced PTSD symptoms and functional impairment, compared to placebo."
          ]
        },
        {
          "title": "MDMA-assisted psychotherapy for treatment of PTSD: study design ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31065731/",
          "excerpts": [
            "The between-group Cohen's d effect size was 0.8, indicating a large treatment effect. After two experimental sessions, more participants in ..."
          ]
        },
        {
          "title": "MDMA-Assisted Therapy for PTSD",
          "url": "https://maps.org/mdma/ptsd/",
          "excerpts": [
            "The safety and efficacy of MDMA-assisted therapy is currently under investigation. It is not yet approved by the FDA, does not work for everyone, ..."
          ]
        },
        {
          "title": "So how special is special K? A systematic review and meta ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10791091/",
          "excerpts": [
            "por NC Borgogna · 2024 · Mencionado por 11 — Ketamine-for-PTSD RCTs reveal a nominal initial therapeutic advantage relative to controls. However, bias and heterogeneity appear problematic."
          ]
        },
        {
          "title": "Effectiveness of Ketamine for the Treatment of Post- ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38559428/",
          "excerpts": [
            "by TM Almeida · 2024 · Cited by 22 — Our findings suggest that ketamine holds promise as an effective treatment option for PTSD. However, further trials are imperative to establish robust data ..."
          ]
        },
        {
          "title": "Ketamine in the effective management of chronic pain ...",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1338581/full",
          "excerpts": [
            "by JJW Liu · 2024 · Cited by 5 — This review provides a preliminary synthesis of available evidence which suggests that ketamine may be a potential option for the treatment of depression, PTSD ..."
          ]
        },
        {
          "title": "FDA advisers reject MDMA as treatment for PTSD",
          "url": "https://www.npr.org/sections/shots-health-news/2024/06/04/nx-s1-4991112/mdma-therapy-ptsd-fda-advisors",
          "excerpts": [
            "Jun 4, 2024 — Following public comment and discussion, the panel voted 9-2 that MDMA – in combination with talk therapy – is not effective for treating PTSD."
          ]
        },
        {
          "title": "Why FDA Panel Rejected MDMA for PTSD Treatment",
          "url": "https://www.psychiatrist.com/news/why-fda-panel-rejected-mdma-for-ptsd-treatment/",
          "excerpts": [
            "Jun 5, 2024 — Clinical relevance: An FDA advisory panel voted against the use of MDMA – or ecstasy – to treat post-traumatic stress disorder."
          ]
        },
        {
          "title": "FDA advisors voted against MDMA therapy – researchers ...",
          "url": "https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it",
          "excerpts": [
            "Jun 20, 2024 — A vote against using MDMA as part of therapy for PTSD has provoked a powerful backlash among researchers who study psychedelic drugs."
          ]
        },
        {
          "title": "FDA Psychopharmacologic Advisory Committee Votes ...",
          "url": "https://www.hcplive.com/view/live-updates-fda-psychopharmacologic-advisory-committee-meeting-mdma-ptsd",
          "excerpts": [
            "Jun 4, 2024 — The US Food and Drug Administration (FDA) Psychopharmacologic Advisory Committee (PDAC) voted 2-9 against supporting the effectiveness of MDMA in the treatment ..."
          ]
        },
        {
          "title": "FDA Issues CRL to Lykos for MDMA-Assisted Therapy",
          "url": "https://www.psychiatrictimes.com/view/fda-issues-crl-to-lykos-for-mdma-assisted-therapy",
          "excerpts": [
            "The US Food and Drug Administration issues a complete response letter (CRL) for Lykos’s midomafetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder (PTSD), noting it cannot be approved based on the data submitted. The FDA has requested an additional Phase 3 trial examining safety and efficacy."
          ]
        },
        {
          "title": "Lykos Therapeutics Announces Complete Response Letter ...",
          "url": "https://www.prnewswire.com/news-releases/lykos-therapeutics-announces-complete-response-letter-for-midomafetamine-capsules-for-ptsd-302219182.html",
          "excerpts": [
            "Aug 9, 2024 — On February 9, 2024, the FDA accepted the company's NDA for midomafetamine used in combination with psychological intervention for adults with ..."
          ]
        },
        {
          "title": "MDMA/PTSD Regulatory Update and Trial Data (Pharmacy Times / FDA Proceedings)",
          "url": "https://www.pharmacytimes.com/view/mdma-rejected-the-story-of-a-study-participant-entrenched-in-ethical-violations-and-a-data-breach",
          "excerpts": [
            "There were no serious adverse events in the MDMA arms of either trial."
          ]
        }
      ],
      "reasoning": "The field value concerns PTSD as the primary target condition for psychedelic/dissociative therapies. The most directly supportive content comes from excerpts describing randomized or phase trials of MDMA-assisted therapy showing PTSD symptom reduction, as well as studies reporting large treatment effects and between-group improvements. Additionally, summaries of regulatory discussions and decisions about MDMA as PTSD treatment provide crucial context for effectiveness claims and implementation feasibility. Ketamine-related reviews and trials are relevant because they address PTSD symptom improvement with a psychedelic/dissociative approach, broadening the evidence base for this therapeutic category. Several excerpts also document regulatory hesitancy or rejection decisions, which influence the interpretation of efficacy data and the current clinical status of these therapies for PTSD. Taken together, the most relevant material consists of direct efficacy signals for MDMA-assisted therapy in PTSD, followed by general safety/effectiveness discussions and regulatory updates that shape the practical interpretation of the field. Direct quotes from the excerpts would illustrate PTSD symptom reduction with MDMA-assisted therapy, statements about effect sizes, and notes on FDA advisory positions, all of which align with the fine-grained field value of PTSD as the primary target condition.",
      "confidence": "medium"
    },
    {
      "field": "psychedelic_and_dissociative_assisted_therapies.substance_name",
      "citations": [
        {
          "title": "MDMA-assisted therapy for moderate to severe PTSD: a randomized ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10579091/",
          "excerpts": [
            "Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms ..."
          ]
        },
        {
          "title": "A Multi-Site Phase 3 Study of MDMA-Assisted Therapy ...",
          "url": "https://maps.org/mdma/ptsd/mapp1/",
          "excerpts": [
            "Three sessions of MDMA-assisted therapy significantly reduced PTSD symptoms and functional impairment, compared to placebo."
          ]
        },
        {
          "title": "MDMA-Assisted Therapy for PTSD",
          "url": "https://maps.org/mdma/ptsd/",
          "excerpts": [
            "The safety and efficacy of MDMA-assisted therapy is currently under investigation. It is not yet approved by the FDA, does not work for everyone, ..."
          ]
        },
        {
          "title": "MDMA-assisted psychotherapy for treatment of PTSD: study design ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31065731/",
          "excerpts": [
            "The between-group Cohen's d effect size was 0.8, indicating a large treatment effect. After two experimental sessions, more participants in ..."
          ]
        },
        {
          "title": "FDA Psychopharmacologic Advisory Committee Votes ...",
          "url": "https://www.hcplive.com/view/live-updates-fda-psychopharmacologic-advisory-committee-meeting-mdma-ptsd",
          "excerpts": [
            "Jun 4, 2024 — The US Food and Drug Administration (FDA) Psychopharmacologic Advisory Committee (PDAC) voted 2-9 against supporting the effectiveness of MDMA in the treatment ..."
          ]
        },
        {
          "title": "FDA advisers reject MDMA as treatment for PTSD",
          "url": "https://www.npr.org/sections/shots-health-news/2024/06/04/nx-s1-4991112/mdma-therapy-ptsd-fda-advisors",
          "excerpts": [
            "Jun 4, 2024 — Following public comment and discussion, the panel voted 9-2 that MDMA – in combination with talk therapy – is not effective for treating PTSD."
          ]
        },
        {
          "title": "Why FDA Panel Rejected MDMA for PTSD Treatment",
          "url": "https://www.psychiatrist.com/news/why-fda-panel-rejected-mdma-for-ptsd-treatment/",
          "excerpts": [
            "Jun 5, 2024 — Clinical relevance: An FDA advisory panel voted against the use of MDMA – or ecstasy – to treat post-traumatic stress disorder."
          ]
        },
        {
          "title": "FDA advisors voted against MDMA therapy – researchers ...",
          "url": "https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it",
          "excerpts": [
            "Jun 20, 2024 — A vote against using MDMA as part of therapy for PTSD has provoked a powerful backlash among researchers who study psychedelic drugs."
          ]
        },
        {
          "title": "MDMA/PTSD Regulatory Update and Trial Data (Pharmacy Times / FDA Proceedings)",
          "url": "https://www.pharmacytimes.com/view/mdma-rejected-the-story-of-a-study-participant-entrenched-in-ethical-violations-and-a-data-breach",
          "excerpts": [
            "There were no serious adverse events in the MDMA arms of either trial."
          ]
        },
        {
          "title": "FDA Issues CRL to Lykos for MDMA-Assisted Therapy",
          "url": "https://www.psychiatrictimes.com/view/fda-issues-crl-to-lykos-for-mdma-assisted-therapy",
          "excerpts": [
            "The US Food and Drug Administration issues a complete response letter (CRL) for Lykos’s midomafetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder (PTSD), noting it cannot be approved based on the data submitted. The FDA has requested an additional Phase 3 trial examining safety and efficacy."
          ]
        },
        {
          "title": "Lykos Therapeutics Announces Complete Response Letter ...",
          "url": "https://www.prnewswire.com/news-releases/lykos-therapeutics-announces-complete-response-letter-for-midomafetamine-capsules-for-ptsd-302219182.html",
          "excerpts": [
            "Aug 9, 2024 — On February 9, 2024, the FDA accepted the company's NDA for midomafetamine used in combination with psychological intervention for adults with ..."
          ]
        },
        {
          "title": "So how special is special K? A systematic review and meta ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10791091/",
          "excerpts": [
            "por NC Borgogna · 2024 · Mencionado por 11 — Ketamine-for-PTSD RCTs reveal a nominal initial therapeutic advantage relative to controls. However, bias and heterogeneity appear problematic."
          ]
        },
        {
          "title": "Effectiveness of Ketamine for the Treatment of Post- ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38559428/",
          "excerpts": [
            "by TM Almeida · 2024 · Cited by 22 — Our findings suggest that ketamine holds promise as an effective treatment option for PTSD. However, further trials are imperative to establish robust data ..."
          ]
        },
        {
          "title": "A Randomized Controlled Trial of Repeated Ketamine ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33397139/",
          "excerpts": [
            "This randomized controlled trial provides the first evidence of efficacy of repeated ketamine infusions in reducing symptom severity in ..."
          ]
        },
        {
          "title": "Ketamine in the effective management of chronic pain ...",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1338581/full",
          "excerpts": [
            "by JJW Liu · 2024 · Cited by 5 — This review provides a preliminary synthesis of available evidence which suggests that ketamine may be a potential option for the treatment of depression, PTSD ..."
          ]
        }
      ],
      "reasoning": "The most directly relevant information comes from excerpts that explicitly mention MDMA-assisted therapy for PTSD and report clinical trial results or regulatory decisions. For example, excerpts describe randomized trials where MDMA-assisted therapy reduced PTSD symptoms and improved function, establishing the substance in question as the core subject of the studies. Other highly relevant excerpts discuss FDA advisory panels and regulatory decisions regarding MDMA for PTSD, showing the real-world regulatory status and ongoing debate about its use. Additional excerpts provide general descriptions of the safety and efficacy of MDMA-assisted therapy and its investigational status with the FDA, which further supports the central role of MDMA (Midomafetamine) in the discussed therapies. Some excerpts, while still related to MDMA, focus on regulatory updates or media reporting rather than direct clinical results, which makes them slightly less directly supportive of the field value but still relevant for context. A minority of excerpts shift attention to other substances (like ketamine) or provide more peripheral context, which offers background but does not directly support the field value about MDMA. Overall, the strongest support comes from excerpts that report trial data and regulatory outcomes specifically tied to MDMA-assisted therapy for PTSD, with additional corroboration from safety/efficacy discussions and regulatory discussions. The least direct support comes from excerpts focusing on other substances or on broad regulatory discourse without tying back to MDMA-specific clinical results.",
      "confidence": "high"
    },
    {
      "field": "cost_access_and_policy_considerations",
      "citations": [
        {
          "title": "ADHD Medication Costs 2025 - SingleCare article",
          "url": "https://www.singlecare.com/blog/adhd-medication-cost/",
          "excerpts": [
            "* ADHD medication prices can vary significantly depending on factors such as whether you are using a brand-name or generic drug—as well as dosage, quantity, and pharmacy location.",
            "what-is) | $828 per 60, 20 mg tablets | $14 per 20 mg tablet | [See latest prices](https://www.singlecare.com/prescription/adderall)",
            "| **Stimulants** | | | |",
            "escription/amphetamine-dextroamphetamine/what-is) | $127 per 60, 20 mg tablets | $2 per 20 mg tablet | [See latest prices](https://www.singlecare.com/prescription/amphetamine-dextroamphetamine",
            "xr/what-is) | $346 per 30, 30 mg capsules | $12 per 30 mg capsule | [See latest prices](https://www.singlecare.com/prescription/adderall-xr)",
            "The good news is that most insurance plans (including Medicaid and Medicare) with prescription drug coverage will cover a percentage of the cost of ADHD medication.",
            "There are several types of FDA-approved drugs used for [ADHD treatment",
            "| ADHD medication prices |",
            "| --- |",
            "| **Drug name** | **Cost per month** | **Cost per pill** | **Free coupons** |",
            "r 30, 30 mg capsules | $12 per 30 mg capsule | [See latest prices](https://www.singlecare.com/prescription/adderall-xr) |\n| [Generic Adderall XR",
            "Generic Adderall XR (amphetamine-dextroamphetamine ER)](https://www.singlecare.com/prescription/amphetamine-dextroamphet-er/what-is) | $254 per 30, 30 mg capsules | $8 per 30 mg capsule | [See latest pr",
            "Generic Dexedrine (dextroamphetamine sulfate ER)](https://www.singlecare.com/prescription/dextroamphetamine-sulfate-er/what-is) | $201 per 30, 15 mg capsules | $7 per 15 mg capsule | [See latest pr"
          ]
        },
        {
          "title": "Safety considerations in rTMS – Kim et al. 2021 (PMC)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9879417/",
          "excerpts": [
            "| --- |"
          ]
        },
        {
          "title": "Psychology Today: Cost and Insurance Coverage",
          "url": "https://www.psychologytoday.com/us/basics/therapy/cost-and-insurance-coverage",
          "excerpts": [
            " the U.S., the fee for a single session frequently falls between $100 and $200, but many providers will offer lower fees, while some charge more. The ultimate ... In the U.S., the fee for a single session frequently [falls between ",
            "Many health insurance plans offer mental health care coverage, but not all therapists accept insurance—many require clients to pay the full fee “out of pocket"
          ]
        },
        {
          "title": "Oregon Health Authority : Oregon Psilocybin Services",
          "url": "https://www.oregon.gov/oha/ph/preventionwellness/pages/oregon-psilocybin-services.aspx",
          "excerpts": [
            "The Oregon Psilocybin Services Section began accepting applications for licensure on January 2, 2023. Psilocybin service centers began to open their doors to ..."
          ]
        },
        {
          "title": "How much does ADHD medication cost?",
          "url": "https://adhddirect.co.uk/help-center/how-much-does-adhd-medication-cost/",
          "excerpts": [
            "Methylphenidate Hydrochloride MR (£23 – £46 for a starting dose); Elvanse (Lisdexamfetamine Dimesylate) £85 for a starting dose). However, the cost can vary ..."
          ]
        },
        {
          "title": "LISDEXAMFETAMINE - Pharmaceutical Benefits Scheme (PBS)",
          "url": "https://www.pbs.gov.au/medicine/item/10474g-10486x-10492f",
          "excerpts": [
            "General Schedule ; Vyvanse · lisdexamfetamine dimesilate 50 mg capsule, 30 · Takeda Pharmaceuticals Australia Pty. Ltd. · $101.11."
          ]
        },
        {
          "title": "Medicare changes in 2025 - APA Services",
          "url": "https://www.apaservices.org/practice/reimbursement/government/2025-medicare-changes",
          "excerpts": [
            "The 2025 Medicare physician fee schedule introduces new codes and expanded telehealth access to improve behavioral health services.",
            "HCPCS code G0552 is not payable in cases where the billing practitioner incurs no cost in acquiring and furnishing the DMHT device, or a patient procures the DMHT device independent of the practitioner.",
            "G0552:** Supply of digital mental health treatment device and initial education and onboarding, per course of treatment that augments a behavioral therapy pl",
            "Payment for behavioral health services delivered to Medicare patients in their homes through telehealth is permanently set at the nonfacility rate.",
            " * Continuing to allow teaching professionals to have a virtual presence in all teaching settings, but only for services furnished as a Medicare telehealth service.\n ... \nPayment for",
            "The American Relief Act 2025 signed into law on December 21, 2024, extends key telehealth flexibilities in Medicare until March 31, 2025. This extension continues the delay of the in-person visit requirement for behavioral telehealth services in Medicare until April 1, 2025.",
            "Reimbursement, always critical to maintaining a viable practice, will vary depending upon the services psychologists provide."
          ]
        },
        {
          "title": "CPT Code 90834: Complete Guide with Reimbursement ...",
          "url": "https://therathink.com/cpt-code-90834/",
          "excerpts": [
            "Expect 70%-80% of the payment compared to a 60 minute individual therapy session. CPT Code 90834 Reimbursement Rate (2025): $104.16. CPT Code 90834 ..."
          ]
        },
        {
          "title": "LCD - Transcranial Magnetic Stimulation (TMS) (L34641)",
          "url": "https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=34641",
          "excerpts": [
            "Use this page to view details for the Local Coverage Determination for Transcranial Magnetic Stimulation (TMS)."
          ]
        },
        {
          "title": "Best tDCS Devices of 2025 - Caputron",
          "url": "https://caputron.com/pages/best-tdcs-device?srsltid=AfmBOoqFNIM7b3Da5Li_F4H-yXzUFS28nDsjMzWt6l7ECO4NPVR0xQjv",
          "excerpts": [
            "This consumer-geared, non-invasive brain stimulation technology is designed to assist your general well-being and improve your mental health."
          ]
        },
        {
          "title": "LCD - Transcranial Magnetic Stimulation (L33398)",
          "url": "https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33398&ver=35&=",
          "excerpts": [
            "This LCD outlines limited coverage for Transcranial Magnetic Stimulation for the treatment of major depressive disorder (MDD) with specific details under ..."
          ]
        },
        {
          "title": "Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults ...",
          "url": "https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=34998",
          "excerpts": [
            "Currently Novitas provides coverage for the use of TMS in patients with a confirmed diagnosis of severe major depressive disorder (MDD) who have failed at least ..."
          ]
        },
        {
          "title": "Strattera 2025 Prices, Coupons & Savings Tips - GoodRx",
          "url": "https://www.goodrx.com/strattera",
          "excerpts": [
            "Generic atomoxetine covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. Get Atomoxetine for as low as $15.30, which is 95% off the average retail price of $282.29 for the most common version, by using a GoodRx coupon."
          ]
        },
        {
          "title": "[PDF] Transcranial Magnetic Stimulation – Community Plan Medical Policy",
          "url": "https://www.uhcprovider.com/content/dam/provider/docs/public/policies/medicaid-comm-plan/transcranial-magnetic-stimulation-cs.pdf",
          "excerpts": [
            "Benefit coverage for health services is determined by the member specific benefit plan document and applicable laws that may require coverage ..."
          ]
        },
        {
          "title": "Coverage Policy - Transcranial Magnetic Stimulation",
          "url": "https://static.cigna.com/assets/chcp/pdf/coveragePolicies/medical/en_mm_0383_coveragepositioncriteria_transcranial_magnetic_stimulation.pdf",
          "excerpts": [
            "This Coverage Policy addresses the various types of transcranial magnetic stimulation (TMS) for the treatment of unipolar major depressive ..."
          ]
        },
        {
          "title": "Label for Adderall - accessdata.fda.gov",
          "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/011522s043lbl.pdf",
          "excerpts": [
            "Sudden death has been reported in association with CNS stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or ...See more"
          ]
        },
        {
          "title": "[PDF] POTENTIAL CARDIOVASCULAR RISKS OF ADHD MEDICATIONS",
          "url": "https://www.caddra.ca/pdfs/caddraGuidelines2011Document7D_Cardiovascular.pdf",
          "excerpts": [
            "2. \"Stimulants such as the amphetamines and methylphenidate (Ritalin®) cause slight but clinically insignificant increases in heart rate and blood pressure.\"."
          ]
        },
        {
          "title": "Stimulants DSC",
          "url": "https://www.fda.gov/media/168066/download",
          "excerpts": [
            "May 11, 2023 — FDA Drug Safety Communication. FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions.See more"
          ]
        },
        {
          "title": "Adult ADHD Medications and Their Cardiovascular Implications - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4992783/",
          "excerpts": [
            "Cardiovascular response attributed to ADHD medication has mainly been observed in heart rate and blood pressure elevations, while less is known about the ..."
          ]
        },
        {
          "title": "ADHD Medications: How They Work & Side Effects",
          "url": "https://my.clevelandclinic.org/health/treatments/11766-adhd-medication",
          "excerpts": [
            "However, under the care and supervision of your provider, stimulant medication use is safe. Before they prescribe you a stimulant, your provider may order an ..."
          ]
        },
        {
          "title": "The adult ADHD assessment quality assurance standard",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11327143/",
          "excerpts": [
            "by M Adamou · 2024 · Cited by 6 — An electrocardiogram (ECG) is not routinely required. Always record baseline blood pressure, pulse and weight [essential]."
          ]
        },
        {
          "title": "Ten misconceptions about trauma-focused CBT for PTSD",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7613703/",
          "excerpts": [
            "by H Murray · 2022 · Cited by 41 — One of the most common misconceptions we hear is that TF-CBT is unsuitable for working with the experience of multiple or complex traumas."
          ]
        },
        {
          "title": "Review Trauma-focused cognitive-behavioral therapies for ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0272735821000921",
          "excerpts": [
            "by N Ennis · 2021 · Cited by 41 — This paper systematically reviewed the effectiveness of CBTs for PTSD in individuals with ongoing threat of reexposure."
          ]
        },
        {
          "title": "Eye Movement Desensitization and Reprocessing (EMDR) for the ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7144286/",
          "excerpts": [
            "The acceptability of EMDR was not adequately measured or reported. Conclusion: EMDR appears a safe and feasible intervention for people with psychosis. The ..."
          ]
        },
        {
          "title": "Written Exposure Therapy for PTSD - National Center for PTSD",
          "url": "https://www.ptsd.va.gov/professional/treat/txessentials/written_exposure_therapy.asp",
          "excerpts": [
            "Findings to date indicate WET is safe and effective for PTSD patients with comorbid mood disorder symptoms, (4,6, 24-27) substance use disorders, (28,29), ..."
          ]
        },
        {
          "title": "What Are the Dangers of EMDR Therapy? - Verywell Mind",
          "url": "https://www.verywellmind.com/dangers-of-emdr-therapy-8426081",
          "excerpts": [
            "Some say it creates more severe mental health issues, and that patients can experience severe emotional distress while undergoing EMDR therapy."
          ]
        },
        {
          "title": "Clinical Practice Guidelines for the Use ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10096214/",
          "excerpts": [
            "by J Thirthalli · 2023 · Cited by 43 — Progress in terms of clinical symptoms and cognitive and other adverse effects should be monitored at least once a week during the course of ECT ...",
            "by J Thirthalli · 2023 · Cited by 43 — This guideline document is aimed at enabling consistent, safe, and effective practice of ECT in patients in applicable psychiatric disorders."
          ]
        },
        {
          "title": "Electroconvulsive Therapy: Contraindications",
          "url": "https://anconsultants.com/electroconvulsive-therapy-ect/",
          "excerpts": [
            "Aug 17, 2015 — The list of contraindications includes recent MI, heart failure, recent stroke, elevated ICP, aneurysm/AVM at risk of rupture, pheochromocytoma, severe HTN, ..."
          ]
        },
        {
          "title": "Safety of transcranial Direct Current Stimulation - PubMed Central",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5007190/",
          "excerpts": [
            "This review updates and consolidates evidence on the safety of transcranial Direct Current Stimulation (tDCS). Safety is here operationally defined by, ...",
            "Mild skin erythema is common during tDCS and is not inherently hazardous [30] and resolves after stimulation. tDCS was not found to produce edema or injurious ..."
          ]
        },
        {
          "title": "Anesthetic care for electroconvulsive therapy - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9091667/",
          "excerpts": [
            "by KW Joung · 2022 · Cited by 14 — Although ECT is a low-risk procedure, certain hemodynamic abnormalities may increase the risk of complications in patients with cardiovascular disease. Abrupt ..."
          ]
        },
        {
          "title": "Safety, ethical considerations, and application guidelines ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3260536/",
          "excerpts": [
            "by S Rossi · 2009 · Cited by 6266 — The present updated guidelines review issues of risk and safety of conventional TMS protocols, address the undesired effects and risks of emerging TMS ..."
          ]
        },
        {
          "title": "Safety of electroconvulsive therapy in the context ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11695668/",
          "excerpts": [
            "by A Elias · 2025 · Cited by 1 — Overall, ECT remains a relatively safe treatment even in the presence of medical and physiological complexities."
          ]
        },
        {
          "title": "Medical Evaluation of Patients Undergoing ...",
          "url": "https://teams.semel.ucla.edu/sites/default/files/course/Espinoza_Medical%20Evaluation%20of%20ECT%20patients%20NEJM%204.2009.pdf",
          "excerpts": [
            "by AV Tess · 2009 · Cited by 187 — The history taking and physical examination serve to screen patients for conditions that may increase the risk associated with ECT, including ..."
          ]
        },
        {
          "title": "Efficacy of brain stimulation therapies across psychiatric, movement ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2589537024006254",
          "excerpts": [
            "This review provides the most comprehensive summary to date of the effectiveness of BSTs across psychiatric, movement, and cognitive disorders."
          ]
        },
        {
          "title": "FDA: Safety Warnings and Monitoring for Prescription Stimulants and PTSD Treatments",
          "url": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-updating-warnings-improve-safe-use-prescription-stimulants-used-treat-adhd-and-other-conditions",
          "excerpts": [
            "Prescription stimulants are used to treat attention deficit/hyperactivity disorder (ADHD), binge-eating disorder, and uncontrollable episodes of deep sleep called narcolepsy. Prescription stimulants may help decrease impulsivity and hyperactivity, and increase attention in patients with ADHD; help reduce the number of excessive overeating episodes in patients with binge-eating disorder; and help promote wakefulness in patients with narcolepsy. These medicines have benefits when used appropriately, but they also have serious risks, including the risk of misuse and abuse, addiction, overdose, and death."
          ]
        },
        {
          "title": "Oregon Psilocybin Services – Administrative Rules ...",
          "url": "https://www.oregon.gov/oha/ph/preventionwellness/pages/psilocybin-administrative-rules.aspx",
          "excerpts": [
            "Public Listening Sessions: June 3 and June 5, 2025 · RAC Application Period: June 2 – June 16, 2025 · RAC Meetings: July 14 – July 18, 2025 · Written Public ..."
          ]
        },
        {
          "title": "Natural medicine - City and County of Denver",
          "url": "https://denvergov.org/Government/Agencies-Departments-Offices/Agencies-Departments-Offices-Directory/Business-Licensing/Business-licenses/Natural-Medicine",
          "excerpts": [
            "In 2023, the Colorado legislature enacted Senate Bill 23-290: Natural Medicine Regulation and Legalization. It amended the state regulatory framework for natural medicine. In 2025, Denver City Council adopted an ordinance regulating natural medicine in Denver ."
          ]
        },
        {
          "title": "MDMA-Assisted Therapy for PTSD - National Center for PTSD",
          "url": "https://www.ptsd.va.gov/understand_tx/mdma_assisted_therapy.asp",
          "excerpts": [
            "Although MDMA is not approved for clinical use by the FDA, it can be studied in research settings. There is hope that psychedelic-assisted therapy, including ..."
          ]
        },
        {
          "title": "Adults diagnosed with ADHD later in life facing 'unfair' medication ...",
          "url": "https://www.abc.net.au/news/2021-08-12/adults-with-adhd-facing-unfair-medication-prices/100368890",
          "excerpts": [
            "Medication more costly for adults. The medications that work best for Hayley are only listed on the PBS for those diagnosed between the ages of ..."
          ]
        },
        {
          "title": "Our Pricing",
          "url": "https://www.careadhd.co.uk/pricing",
          "excerpts": [
            "Our Pricing · ADHD Assessment £299.00 · Medication Initiation Service £499.00 · Psychological Support via our App £230.00."
          ]
        },
        {
          "title": "Medication Chart | CADDRA",
          "url": "https://www.caddra.ca/resources/medication-chart/",
          "excerpts": [
            "The chart provides information on ADHD medications available in Canada, including names and full colour illustrations of the medications."
          ]
        },
        {
          "title": "ADHD Medications in Canada: A Comprehensive Comparison for ...",
          "url": "https://misterpharmacist.com/all-about-meds/adhd-medications-in-canada-a-comprehensive-comparison-for-2025/",
          "excerpts": [
            "Compare ADHD medications in Canada for adults: explore effectiveness, side effects, and online prescription options."
          ]
        },
        {
          "title": "Pharmaceutic Pricing",
          "url": "https://pricingdoc.acfp.ca/pricing/",
          "excerpts": [
            "Stimulants (ADHD). Methylphenidate, Ritalin, 10 mg, BID, $60, BC ... © Copyright 2025 Pharmaceutic Pricing | Site by BubbleUP · BubbleUP · Statcounter · web ..."
          ]
        },
        {
          "title": "Average 618-day wait for adult ADHD assessment - BBC",
          "url": "https://www.bbc.com/news/articles/c5ypk245yp4o",
          "excerpts": [
            "On average, adults are waiting more than a year and a half for an ADHD assessment at TEWV NHS Trust."
          ]
        },
        {
          "title": "Access and wait times | CIHI",
          "url": "https://www.cihi.ca/en/topics/access-and-wait-times",
          "excerpts": [
            "Wait times for priority procedures in Canada, 2025. Release summary; June 12, 2025. Explore how wait times for selected surgeries changed between 2019 and 2024 ..."
          ]
        },
        {
          "title": "Wait Times for Psychiatric Specialist Services in Australia",
          "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830766",
          "excerpts": [
            "by O Yang · 2025 · Cited by 3 — Compared with 2011 when the median (IQR) wait time was 15 (1-52) days, wait time rose to 50 (10-113) days in 2022, with similar upward trends ..."
          ]
        },
        {
          "title": "What are the initial and ongoing costs for treatment of ...",
          "url": "https://www.reddit.com/r/ADHDUK/comments/14lguyh/what_are_the_initial_and_ongoing_costs_for/",
          "excerpts": [
            "My assessment cost £695, with monthly medication reviews costing £225 each, so far I have had 4 during titration. Medication has cost between £70-90 per month ..."
          ]
        },
        {
          "title": "What's the price difference between meds prescribed with the PBS ...",
          "url": "https://www.reddit.com/r/adhdaustralia/comments/1igewcw/whats_the_price_difference_between_meds/",
          "excerpts": [
            "It depends entirely on the medication. There are, with literally zero exaggeration, some medications that cost $30,000+ per month if you ..."
          ]
        },
        {
          "title": "Natural Medicine Program - HOME",
          "url": "https://dpo.colorado.gov/NaturalMedicine",
          "excerpts": [
            "The Natural Medicine Program has created several informative booklets that will aid you in your licensing journey, regardless of license type."
          ]
        },
        {
          "title": "RESEARCH WEEKLY: Extreme psychiatrist shortage expected for ...",
          "url": "https://www.tac.org/research-weekly-extreme-psychiatrist-shortage-expected-for-next-30-years/",
          "excerpts": [
            "This translates to an estimated shortage of 14,000-31,000 psychiatrists based on established ratios determined by the Department of Health and Human Services."
          ]
        },
        {
          "title": "ADHD Management Information - May 2025 - NHS England Digital",
          "url": "https://digital.nhs.uk/data-and-information/publications/statistical/mi-adhd/may-2025",
          "excerpts": [
            "In March 2025, up to 549,000 people may be waiting for an ADHD assessment. ... Autism Waiting Time Statistics · Health and Care of People with ..."
          ]
        },
        {
          "title": "Wait times for mental health services are influenced by many factors ...",
          "url": "https://www.facebook.com/CIHI.ICIS/videos/wait-times-for-mental-health-services-are-influenced-by-many-factors-including-w/1817967715452577/",
          "excerpts": [
            "1 in 5 Canadians waited 25 days or less for community #MentalHealth counselling in 2023–2024. 1 in 10 people waited almost 5 months or more."
          ]
        },
        {
          "title": "Wait Times for Psychiatric Specialist Services in Australia",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11866023/",
          "excerpts": [
            "by O Yang · 2025 · Cited by 3 — This cross-sectional study examines the differences in wait times for general psychiatric specialist consultations in Australia from 2011 to 2022"
          ]
        },
        {
          "title": "Wait Times for Community Mental Health Counselling | CIHI",
          "url": "https://www.cihi.ca/en/indicators/wait-times-for-community-mental-health-counselling",
          "excerpts": [
            "Access and wait times: 10% of people wait about 5 months for community mental. Save Image."
          ]
        },
        {
          "title": "Right to Choose ADHD: A UK Adult's Guide for Quicker Assessment",
          "url": "https://add.org/uk/nhs-right-to-choose-adhd/",
          "excerpts": [
            "In some areas, the ADHD waiting list UK residents face can stretch for months or even years. Using Right to Choose can help reduce the wait for ..."
          ]
        },
        {
          "title": "Monarch Becomes the 1st FDA-Cleared Device for ADHD",
          "url": "https://www.mddionline.com/digital-health/monarch-becomes-the-1st-fda-cleared-device-for-adhd",
          "excerpts": [
            "“This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” ..."
          ]
        },
        {
          "title": "NeuroSigma",
          "url": "https://www.neurosigma.com/",
          "excerpts": [
            "The Monarch eTNS System is indicated for the treatment of pediatric Attention Deficit Hyperactivity Disorder (ADHD) as a monotherapy in patients ages 7 through ..."
          ]
        },
        {
          "title": "H.R.3023 - 118th Congress (2023-2024): TREAT PTSD Act",
          "url": "https://www.congress.gov/bill/118th-congress/house-bill/3023/all-info",
          "excerpts": [
            "This bill requires the Department of Veterans Affairs (VA) and the Department of Defense (DOD) to furnish stellate ganglion block to certain veterans."
          ]
        },
        {
          "title": "Study Details | Stellate Ganglion Block for PTSD",
          "url": "https://www.clinicaltrials.gov/study/NCT05169190",
          "excerpts": [
            "Stellate Ganglion Block (SGB), established to treat pain and other conditions, has shown promise for PTSD: early small studies show it may work fast and greatly ..."
          ]
        },
        {
          "title": "FDA Expands Akili's EndeavorRx Game-Based Digital ...",
          "url": "https://www.managedhealthcareexecutive.com/view/fda-expands-akili-s-endeavorrx-game-based-digital-therapy-for-adhd-eligibility-to-ages-8-17",
          "excerpts": [
            "FDA Expands Akili's EndeavorRx Game-Based Digital Therapy for ADHD Eligibility to Ages 8-17."
          ]
        },
        {
          "title": "ADHD medicine consumption in Europe after COVID-19",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-024-05505-9",
          "excerpts": [
            "by S Gimbach · 2024 · Cited by 13 — This study examines the European ADHD medication consumption in 2020 to 2022 compared to the predicted consumption assuming the persistence of pre-pandemic ..."
          ]
        },
        {
          "title": "Europe ADHD Therapeutics Market Report",
          "url": "https://www.marketdataforecast.com/market-reports/europe-attention-deficit-hyperactivity-disorder-therapeutics-market",
          "excerpts": [
            "Jun 19, 2025 — The Europe ADHD Therapeutics Market is expected to have 8.10% CAGR from 2025 to 2033 and be worth USD 6.91 billion by 2033 from USD 3.71 billion in 2025."
          ]
        },
        {
          "title": "Digital Health Applications (DiGA)",
          "url": "https://www.bfarm.de/EN/Medical-devices/Tasks/DiGA-and-DiPA/Digital-Health-Applications/_node.html",
          "excerpts": [
            "The BfArM has prepared a guide with important information on process sequence, application procedure and the provision of evidence."
          ]
        },
        {
          "title": "Fachkreise | ORIKO ADHS-Therapie - DiGA-Verzeichnis - BfArM",
          "url": "https://diga.bfarm.de/de/verzeichnis/02568/fachkreise",
          "excerpts": [
            "Finden Sie umfassende Informationen für Sie als Leistungserbringende zur DiGA und ihrer Anwendung."
          ]
        },
        {
          "title": "Integration of digital health applications into the German healthcare ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10966120/",
          "excerpts": [
            "The DiGA-Care Path helps to analyze the current supply of DiGAs step-by-step. Thereby, each step can be investigated in detail to identify problems."
          ]
        },
        {
          "title": "Anzuwenden bei - DiGA-Verzeichnis",
          "url": "https://diga.bfarm.de/de/verzeichnis",
          "excerpts": [
            "Treffen Sie eine Auswahl aus digitalen Gesundheitsanwendungen (DiGA), die vom BfArM gemäß § 139e SGB V bewertet wurden."
          ]
        },
        {
          "title": "Quels Médicaments avec et sans ordonnance - TDAH focus",
          "url": "https://tdahfocus.com/traitements-tdah-guide-complet/",
          "excerpts": [
            "Découvrez le guide de médicament du TDAH avec et ceux sans ordonnance. Méthylphénidate sous le nom de Quasym, Concerta ou d'autres ..."
          ]
        },
        {
          "title": "How ADHD is Treated in Europe: A Complete Country-by- ...",
          "url": "https://pedacto.com/how-adhd-is-treated-in-europe/",
          "excerpts": [
            "Jun 15, 2025 — Private assessment costs £500-2000. ADHD Treatment in Germany. Germany's healthcare system (Krankenkasse) provides comprehensive ADHD coverage ..."
          ]
        },
        {
          "title": "Tracking the Medicaid Provisions in the 2025 ...",
          "url": "https://www.kff.org/medicaid/tracking-the-medicaid-provisions-in-the-2025-budget-bill/",
          "excerpts": [
            "Medicaid only reimburses providers that are enrolled in the state's Medicaid program. To receive reimbursement for services provided to a Medicaid enrollee ..."
          ]
        },
        {
          "title": "ADHD medicatie vergoeding - PsyQ",
          "url": "https://www.psyq.nl/adhd-bij-volwassenen/vergoedingen",
          "excerpts": [
            "Missing: wachttijd psychologie"
          ]
        },
        {
          "title": "ADHD medicijnen (eigen bijdrage) vergoeding (2025) - Zorgwijzer",
          "url": "https://www.zorgwijzer.nl/vergoeding/adhd-medicijnen",
          "excerpts": [
            "Missing: wachttijd psychologie"
          ]
        },
        {
          "title": "New Warning for Extended-Release Stimulants for ADHD",
          "url": "https://secure.medicalletter.org/TML-article-1735f",
          "excerpts": [
            "They are not approved by the FDA for use in children <6 years old, but they are often used off label in these patients. The new warnings were ..."
          ]
        },
        {
          "title": "What is the efficacy of the Monarch external Trigonal Neural ...",
          "url": "https://droracle.ai/articles/53822/what-is-the-efficacy-of-the-monarch-external-trigonal-neural-stimulation-etns-system-in-treating-attention-deficit-hyperactivity-disorder-adhd",
          "excerpts": [
            "The Monarch eTNS system is not mentioned in the provided studies, therefore, there is no direct evidence to support its use in treating ADHD."
          ]
        },
        {
          "title": "Display Chap 5 Sect 1 (Change 34, Jan 3, 2025)",
          "url": "https://manuals.health.mil/pages/DisplayManualHtmlFile/2025-01-08/AsOf/tot5/c5s1.html",
          "excerpts": [
            "The following courses: “Cognitive Processing Therapy for Post-Traumatic Stress Disorder (PTSD) in Veterans and Military Personnel,” “Prolonged Exposure (PE) ..."
          ]
        },
        {
          "title": "PTSD Coach - National Center for PTSD",
          "url": "https://www.ptsd.va.gov/appvid/mobile/ptsdcoach_app.asp",
          "excerpts": [
            "Missing: DiGA Preis"
          ]
        },
        {
          "title": "Prix d\u001emploi d\u0000a0un diagnostic TDAH adulte : faisons le point",
          "url": "https://teddi-tdah.com/articles/prix-dun-diagnostic-tdah-adulte-faisons-le-point",
          "excerpts": [
            "ologique.\nLe coût des médicaments pour traiter le TDAH varie entre 5 et 35 €, remboursés à hauteur de 65 % par la CPAM. Les mutuelles peuvent couvrir le reste. Notez que depuis septembre 2021, la prescription de méthylphénidate est accessible pour les adultes sans passer par un hôpital, mais pas un psychiatre ou neurologue de ville."
          ]
        },
        {
          "title": "Kosten\u0000fcbernahme durch die Krankenkassen (Methylphenidat) – Praxis Suchtmedizin",
          "url": "https://www.praxis-suchtmedizin.ch/index.php/de/medikamente/methylphenidat/kostenuebernahme",
          "excerpts": [
            "MPH-haltige Medikamente sind unter folgenden Bedingungen kassenpflichtig:",
            "ungen kassenpflichtig:\n\n* Das Medikament ist für die entsprechende Zielgruppe zugelassen:\n  + Eine Zulassung für Patientinnen und Patienten, die älter als 18 Jahre sind, besteht nur für Concerta®, Medikinet MR® und Focalin®. Eine Verschreibung von Ritalin® an Patientinnen und Patienten, die älter als 18 Jahre sind geschieht “off-label” und wird von den Krankenkassen in der Regel nicht erstattet. + Für Elvanse® besteht trotz erweiterter Zulassung die Kassenzulässigkeit nur als second line Präparat.",
            "t. * Die Diagnose des ADHS erfolgte durch eine Psychiaterin oder einen Psychiater:\n  + In der Praxis wird diese Qualifikation bei Psychiaterinnen und Psychiatern von den Krankenkassen angenommen. Pädiaterinnen und Pädiater werden von einem Teil der Krankenkassen als Spezialärztinnen und Spezialärzte akzeptiert."
          ]
        },
        {
          "title": "Stellate Ganglion Block Treatment For PTSD At VA",
          "url": "https://www.va.gov/HEALTHPARTNERSHIPS/resources/SGBforPTSD_508.pdf",
          "excerpts": [
            "Stellate ganglion block (SGB) may have short-term benefit for some individuals with posttraumatic stress disorder (PTSD),\n\nbut it is not an established treatment at this time because the evidence is not conclusive. The long-term effects of SGB\n\nare unknown, and SGB has not been fully research ed in Veterans with PT",
            "Currently, individuals with PTSD should be\n\nstrongly encouraged to try established, and recommended treatments such **as** **trauma-focused psychotherapy** and\n\nme",
            "For Veterans that don't benefit from these traditional treatments, alternative interventions such as SGB\n\nmight be considered",
            "SGB may be an option for a Veteran who:**\n\n» Is diagnosed with PTSD\n\n» Has tried evidence-based PTSD treatment, including ps ychotherapy and\n\nmedications , and has _not_ experienced significant or lasting PTSD symptom\n\nimprovement\n\n» Is currently under the care of a VA mental h",
            "SGB is sometimes\n\nused to treat pain, and some VA facilities may offer it in that context",
            "Veterans who are enrolled in Department of Veterans Affairs (VA) care can contact\n\ntheir mental health provider for more information about SGB"
          ]
        },
        {
          "title": "EndeavorRx FAQ",
          "url": "https://www.endeavorrx.com/faq/",
          "excerpts": [
            "The current cost for EndeavorRx is $99 for a 30 day prescription.",
            "EndeavorRx is FSA/HSA eligible."
          ]
        },
        {
          "title": "Efficacy of Cognitive Behavioral Therapy With and Without ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/28413900/",
          "excerpts": [
            "by MV Cherkasova · 2020 · Cited by 99 — Method: Eighty-eight adults with ADHD received 12 manualized group CBT sessions, accompanied by individual coaching, either without (n = 46) or with (n = 42) ..."
          ]
        },
        {
          "title": "Adult ADHD Guidelines Development - CHADD",
          "url": "https://chadd.org/adhd-advocacy/adult-adhd-guidelines-development/",
          "excerpts": [
            "CHADD has partnered with the American Professional Society for ADHD and Related Disorders (APSARD) to develop and distribute guidelines in 2025."
          ]
        },
        {
          "title": "[PDF] NICE guidance for ADHD: A guide for patients",
          "url": "https://www.adhdfoundation.org.uk/wp-content/uploads/2022/03/ADHD-NICE-Guidelines-Patient-Booklet.pdf",
          "excerpts": [
            "This booklet summarises the NICE guideline for ADHD (updated in March 2018) for patients and their families. It aims to help you to understand the ..."
          ]
        },
        {
          "title": "Canadian ADHD Practice Guidelines (CAP- ...",
          "url": "https://caddra.ca/pdfs/caddraGuidelines2011.pdf",
          "excerpts": [
            "CADDRA ADHD Information and Resources. 8.39. CADDRA Child Assessment Instructions. 8.43. CADDRA Adult Assessment Instructions. 8.46. CADDRA ..."
          ]
        },
        {
          "title": "ADHD in Adults - Psychiatry.org",
          "url": "https://www.psychiatry.org/patients-families/adhd/adhd-in-adults",
          "excerpts": [
            "A comprehensive ADHD evaluation typically includes a review of past and current symptoms, a review of the presence and absence of other psychiatric disorders, a ...",
            "by APA Join — Adults with ADHD are treated with medication (typically stimulant medication), psychotherapy or a combination. Cognitive behavior strategies, such as minimizing ..."
          ]
        },
        {
          "title": "NICE guideline NG87 – Attention deficit hyperactivity disorder: diagnosis and management",
          "url": "https://www.nice.org.uk/guidance/ng87/chapter/Update-information",
          "excerpts": [
            "NICE guideline; Reference number: NG87; Published: 14 March 2018; Last updated: 13 September 2019",
            "Attention deficit hyperactivity disorder: diagnosis and management",
            "Update information",
            "September 2019:** Recommendation 1.7.4 was amended to indicate that an electrocardiogram is not needed before starting stimulants, atomoxetine or guanfacine if cardiovascular history and examination are normal\nand the person is not on medicine that poses an increased cardiovascular ris",
            "March 2018:** This guideline updates and replaces NICE guideline CG72 (published September 2008). New recommendations have been added on recognition, information and support, managing attention deficit hyperactivity disorder (ADHD; including non-pharmacological treatment), medication, follow‑up and monitoring, adherence, and review of medication and discontinuatio"
          ]
        },
        {
          "title": "Cortese et al. 2018 Network Meta-analysis of ADHD medications",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30097390/",
          "excerpts": [
            "by S Cortese · 2018 · Cited by 1453 — We aimed to estimate the comparative efficacy and tolerability of oral medications for ADHD in children, adolescents, and adults. M",
            "We did a literature search for published and unpublished double-blind randomised controlled trials comparing amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil with each other or placebo.",
            "Primary outcomes were efficacy (change in severity of ADHD core symptoms based on teachers' and clinicians' ratings) and tolerability (proportion of patients who dropped out of studies because of side-effects) at timepoints closest to 12 weeks, 26 weeks, and 52 weeks.",
            "ol and confidence of estimates with the Grading of Recommendations Assessment, Development, and Evaluation approach for network meta-analyses. This study ",
            "Interpretation:**\nOur findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADH",
            "by S Cortese · 2018 · Cited by 1453 — Evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for ..."
          ]
        },
        {
          "title": "Pharmacotherapy of adult attention deficit hyperactivity disorder ...",
          "url": "https://academic.oup.com/ijnp/article/12/8/1137/678331",
          "excerpts": [
            "Our findings showed that the pooled effect size across all treatments was in the medium-to-high range (Cohen's d=0.65, p<0.0001 vs. placebo), and the effect ..."
          ]
        },
        {
          "title": "Amphetamines for attention deficit hyperactivity disorder (ADHD) in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6513464/",
          "excerpts": [
            "Lisdexamfetamine and MAS also reduced the severity of ADHD symptoms as rated by clinicians, but dexamphetamine did not. Overall, amphetamines did not make ..."
          ]
        },
        {
          "title": "DBT for adults with ADHD: randomized controlled trial and meta-analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36443712/",
          "excerpts": [
            "This DBT-bGT was superior to TAU in reducing executive dysfunction, core symptoms of ADHD and in improving quality of life in adults with ADHD."
          ]
        },
        {
          "title": "Dialectical behavioral therapy-based group treatment versus ...",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-022-04356-6",
          "excerpts": [
            "This DBT-bGT was superior to TAU in reducing executive dysfunction, core symptoms of ADHD and in improving quality of life in adults with ADHD."
          ]
        },
        {
          "title": "Tolerance to Stimulant Medication for Attention Deficit ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9332474/",
          "excerpts": [
            "by K Handelman · 2022 · Cited by 28 — This may suggest chronic tolerance to the medication in adults treated for up to 26 weeks [18]."
          ]
        },
        {
          "title": "Long-term Effects of Multimodal Treatment on Adult ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6547099/",
          "excerpts": [
            "by AP Lam · 2019 · Cited by 51 — Results from COMPAS demonstrate a maintained improvement in ADHD symptoms for adults 1.5 years after the end of a 52-week controlled multimodal ..."
          ]
        },
        {
          "title": "The GRADE Evidence to Decision (EtD) framework for health ...",
          "url": "https://health-policy-systems.biomedcentral.com/articles/10.1186/s12961-018-0320-2",
          "excerpts": [
            "by J Moberg · 2018 · Cited by 366 — This framework provides a structured and transparent approach to support policy-making informed by the best available research evidence."
          ]
        },
        {
          "title": "GRADE home",
          "url": "https://www.gradeworkinggroup.org/",
          "excerpts": [
            "GRADE evidence to decision frameworks for tests in clinical practice and public health. ... Act as an executive committee for the GRADE Working Group (GWG) ..."
          ]
        },
        {
          "title": "a framework for ranking evidence evaluating healthcare interventions",
          "url": "https://pubmed.ncbi.nlm.nih.gov/12519253/",
          "excerpts": [
            "The proposed hierarchy of evidence focuses on three dimensions of the evaluation: effectiveness, appropriateness and feasibility."
          ]
        },
        {
          "title": "Implementability of healthcare interventions: an overview of reviews ...",
          "url": "https://implementationscience.biomedcentral.com/articles/10.1186/s13012-021-01171-7",
          "excerpts": [
            "The aim of this paper is to develop a testable conceptual framework of implementability of healthcare interventions that includes these five concepts."
          ]
        },
        {
          "title": "protocol for a systematic review and network meta-analysis - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35277411/",
          "excerpts": [
            "Secondary outcomes will include tolerability (drop-out due to side effects) and change in the severity of emotional dysregulation, executive ..."
          ]
        },
        {
          "title": "Levelized cost-based learning analysis of utility-scale wind and ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2589004222006496",
          "excerpts": [
            "Missing: SMD responder mapping"
          ]
        },
        {
          "title": "[PDF] Utility-Scale Renewable Energy Generation Technology Roadmap",
          "url": "https://www.energy.ca.gov/sites/default/files/2021-05/CEC-500-2020-062.pdf",
          "excerpts": [
            "Missing: SMD responder"
          ]
        },
        {
          "title": "Is Cognitive Behavior Therapy Effective for Treating Adult ADHD?",
          "url": "https://www.adhdevidence.org/blog/is-cognitive-behavior-therapy-effective-for-treating-adult-adhd",
          "excerpts": [
            "For both types of study, the effect of CBT in reducing ADHD symptoms was statistically significant, with a standardized mean effect size of 0.4.",
            "Based on a meta-analysis by Young and colleagues, we know for certain that the number of published trials of CBT for adult ADHD is small; only nine trials are available.",
            "In all of these studies, patients in the CBT and control groups were also being treated with ADHD medications.",
            "the waiting list controlled studies and the placebo-controlled studies separately."
          ]
        },
        {
          "title": "Article: Multiple Criteria Decision Analysis for Health Care Decision Making - An Introduction",
          "url": "https://www.ispor.org/heor-resources/good-practices/article/multiple-criteria-decision-analysis-for-health-care-decision-making---an-introduction",
          "excerpts": [
            "Multiple Criteria Decision Analysis for Health Care Decision Making - An Introduction: Report 1",
            "Health care decisions are complex and involve confronting trade-offs\nbetween multiple, often conflicting, objectives. Using structured,\nexplicit approaches to decisions involving multiple criteria can\nimprove the quality of decision making",
            "MCDA methods are widely used\nin other sectors, and recently there has been an increase in health\ncare applications.",
            "In 2014, ISPOR established an MCDA Emerging Good Practices Task Force.",
            "It was charged with establishing a common\ndefinition for MCDA in health care decision making and developing\ngood practice guidelines for conducting MCDA to aid health care\ndecision making.",
            "This initial ISPOR MCDA task force report provides\nan introduction to MCDA - it defines MCDA; provides examples of its\nuse in different kinds of decision making in health care (including\nbenefit risk analysis, health technology assessment, resource allocation,\nportfolio decision analysis, shared patient clinician decision\nmaking and prioritizing patients’ access to services); provides an\noverview of the principal methods of MCDA; and describes the key\nsteps involved."
          ]
        },
        {
          "title": "Multiple Criteria Decision Analysis for Health Care Decision Making - Emerging Good Practices: Report 2",
          "url": "https://www.ispor.org/heor-resources/good-practices/article/multiple-criteria-decision-analysis-for-health-care-decision-making---emerging-good-practices",
          "excerpts": [
            "Multiple Criteria Decision Analysis for Health Care Decision Making - Emerging Good Practices: Report 2",
            "Health care decisions are complex and involve confronting trade-offs\nbetween multiple, often conflicting objectives. Using structured,\nexplicit approaches to decisions involving multiple criteria can improve\nthe quality of decision making",
            "In 2014, ISPOR established an Emerging Good\nPractices Task Force.",
            "s second task force report provides emerging good-practice guidance on the implementation of MCDA to support health care decisions. The",
            "\nThe\nreport includes: a checklist to support the design, implementation and\nreview of an MCDA; guidance to support the implementation of the\nchecklist; the order in which the steps should be implemented;\nillustrates how to incorporate budget constraints into an MCDA;\nprovides an overview of the skills and resources, including available\nsoftware, required to implement MCDA"
          ]
        },
        {
          "title": "Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27021745/",
          "excerpts": [
            "This second task force report provides emerging good-practice guidance on the implementation of MCDA to support health care decisions.",
            "The report includes: a checklist to support the design, implementation and review of an MCDA; guidance to support the implementation of the checklist; the order in which the steps should be implemented; illustrates how to incorporate budget constraints into an MCDA; provides an overview of the skills and resources, including available software, required to implement MCDA; and future research directions."
          ]
        },
        {
          "title": "Post hoc Responder and Remission Analyses from Two ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7475095/",
          "excerpts": [
            "by LA Adler · 2020 · Cited by 4 — However, in a small crossover study of MAS IR and LDX, response rates (defined as ADHD-RS with adult prompt TS reductions ≥30%) were 76.2% (16/21) and 82.6% (19 ..."
          ]
        },
        {
          "title": "A Randomized Double-Blind Placebo-Controlled Trial",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3905180/",
          "excerpts": [
            "by M Huss · 2013 · Cited by 77 — Responder analysis showed that over 75% of all MPH-LA treated patients demonstrated greater than 30% improvement in the DSM-IV ADHD RS total score versus ..."
          ]
        },
        {
          "title": "Dose Response Effects of Lisdexamfetamine Dimesylate ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3355536/",
          "excerpts": [
            "by SV Faraone · 2011 · Cited by 18 — Higher doses of LDX led to greater improvements in ADHD-rating scale scores, independent of prior pharmacotherapy."
          ]
        },
        {
          "title": "A Phase III, Randomized, Double-Blind, Placebo- ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35896943/",
          "excerpts": [
            "by A Nasser · 2022 · Cited by 54 — Responder rates on CGI scales and the AISRS were also assessed. Results: A total of 374 subjects were randomized. At end of study, the mean ..."
          ]
        },
        {
          "title": "Methylphenidate dose optimization for ADHD treatment",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5505611/",
          "excerpts": [
            "by M Huss · 2017 · Cited by 101 — Overall, MPH is an effective ADHD treatment with a good safety profile; data suggest that dose optimization may enhance the safety and efficacy of treatment."
          ]
        },
        {
          "title": "Review of Lisdexamfetamine Dimesylate in Adults With ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5571766/",
          "excerpts": [
            "by J Najib · 2017 · Cited by 22 — Clinical response was defined as a decrease ≥30% in ADHD-RS-IV from baseline and a CGI-I score of 1 or 2, whereas symptomatic remission was ..."
          ]
        },
        {
          "title": "Long-Term Tolerability and Safety of Pharmacological Treatment of ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6039396/",
          "excerpts": [
            "Finally, a 4-year outcome questionnaire study of pharmacologically treated adults with ADHD reported a 37% discontinuation rate at the 4-year follow-up. Adverse ..."
          ]
        },
        {
          "title": "A Comparison of Cognitive-Behavioral Therapy and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6250816/",
          "excerpts": [
            "A review and meta-analyses of nine randomized controlled trials showed that CBT for adult ADHD was superior to waiting list with a moderate to large effect size (SMD = 0.76, 95% CI [0.21, 1.31], p = 0.006) and superior to active control groups with a small to moderate effect size (SMD = 0.43, 95% CI [0.14, 0.71], p = ..."
          ]
        },
        {
          "title": "A comparison of efficacy between cognitive behavioral therapy (CBT ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165178119307437",
          "excerpts": [
            "We demonstrated that CBT can be effective in adults with ADHD with or without medicine, with no significant differences between groups on core symptoms and ..."
          ]
        },
        {
          "title": "A meta-analysis of mindfulness-based interventions in ...",
          "url": "https://psycnet.apa.org/record/2020-57849-001",
          "excerpts": [
            "by H Poissant · 2020 · Cited by 41 — The results showed that MBIs are effective to treat ADHD symptoms in adults, as well as to reduce depression and dysexecutive problems post-intervention."
          ]
        },
        {
          "title": "A Case Study in Lung Cancer Patient Preferences - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10865764/",
          "excerpts": [
            "by J Veldwijk · 2024 · Cited by 3 — (A) Swing weighting (SW) ranking task in which respondents sort the swings in attributes from worst level to best level by priority for ..."
          ]
        },
        {
          "title": "When continuous outcomes are measured using different ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6890471/",
          "excerpts": [
            "by MH Murad · 2019 · Cited by 254 — Although several approaches are available, the most commonly used method is to multiply the SMD by π/√3 (about 1.81) to produce the natural ..."
          ]
        },
        {
          "title": "Methylphenidate hydrochloride Medicinal forms - Drugs - BNF - NICE",
          "url": "https://bnf.nice.org.uk/drugs/methylphenidate-hydrochloride/medicinal-forms/",
          "excerpts": [
            "NHS indicative price: £3.03. Drug tariff: Part VIIIA Category C. Drug tariff price: £3.03. Legal category: POM (Prescription-only medicine). Show. CD2 (Schedule ..."
          ]
        },
        {
          "title": "Drug Tariff | NHSBSA",
          "url": "https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff",
          "excerpts": [
            "You can view the Drug Tariff 3 working days before the 1 st of each month. The PDF format of the Drug Tariff can be downloaded and used offline."
          ]
        },
        {
          "title": "Discrete choice experiment versus swing-weighting",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10381030/",
          "excerpts": [
            "by C Whichello · 2023 · Cited by 9 — This study compares a discrete choice experiment (DCE) and swing-weighting (SW) by eliciting preferences for glucose-monitoring devices in a population of ..."
          ]
        },
        {
          "title": "Methods to convert continuous outcomes into odds ratios of ...",
          "url": "https://academic.oup.com/ije/article/41/5/1445/711693",
          "excerpts": [
            "by BR da Costa · 2012 · Cited by 153 — Our objective was to determine the performance of methods in converting SMDs or means to odds ratios of treatment response and numbers needed to ..."
          ]
        },
        {
          "title": "Open-label Long-Term Safety and Efficacy of SPN-812 ...",
          "url": "https://clinicaltrials.gov/study/NCT04143217",
          "excerpts": [
            "An additional secondary endpoint was the 30% Adult ADHD Investigator Symptom Rating Scale (AISRS) Responder Rate by visit. The AISRS is an ADHD-specific rating ..."
          ]
        },
        {
          "title": "Mean Difference, Standardized Mean Difference (SMD), ...",
          "url": "https://www.psychiatrist.com/jcp/mean-difference-standardized-mean-difference-smd-and-their-use-in-meta-analysis/",
          "excerpts": [
            "by C Andrade · 2020 · Cited by 686 — These mean differences can be divided by their respective standard deviations (SDs) to yield a statistic known as the standardized mean difference (SMD)."
          ]
        },
        {
          "title": "Non-pharmacological Interventions for Adult ADHD: A Systematic Review - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32036811/",
          "excerpts": [
            "The majority found an improvement in ADHD symptoms with CBT treatment.",
            "Additionally, mindfulness and cognitive remediation have evidence as effective interventions for the core symptoms of ADHD and there is evidence for the use of group dialectical behavioural therapy and hypnotherapy."
          ]
        },
        {
          "title": "GRADE EtD Framework and MCDA for Health Policy",
          "url": "https://www.valueinhealthjournal.com/article/S1098-3015(24)02848-1/fulltext",
          "excerpts": [
            "The GRADE Evidence to Decision (EtD) framework for health system and public health decisions. Health Res Policy Syst. 2018; 16:45. Crossref.",
            "GRADE Evidence to Decision (EtD) framework for different types of decisions (including coverage, health system and public health decisions) | [<sup>111</sup>]() <sup>,</sup> [<sup>112</sup>]()",
            "Stakeholder engagement | Key issues for stakeholder engagement in the development of health and healthcare guidelines."
          ]
        },
        {
          "title": "The GRADE Evidence to Decision (EtD) framework for health system and public health decisions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8653547/",
          "excerpts": [
            "The GRADE Evidence to Decision (EtD) framework for health system and public health decisions.",
            "ISPOR MCDA Emerging Good Practices Task Force.",
            "EtD frameworks are an extremely useful tool for recommendation formulation and decision making in healthcare and other scientific fields.",
            "The GRADE framework is the most well developed, with extensive information and guidance on its methods.",
            "An iterative development process will be needed: a draft framework should be pilot-tested, revised and evaluated."
          ]
        },
        {
          "title": "Trauma-Informed Care and Cultural Humility in the Mental Health Care of People From Minoritized Communities",
          "url": "https://psychiatryonline.org/doi/10.1176/appi.focus.20190027",
          "excerpts": [
            "trauma-informed care can be enhanced by adopting an attitude of cultural humility.",
            "In clinical care, cultural humility can serve as a guiding concept for the practice of trauma-informed care in centering and empowering patients on their journey of healing, rather than making assumptions about the patient’s experience or practicing an authoritative, power-over communication style.",
            "The enrichment that comes from culturally humble encounters with patients from various cultures is a form of ongoing growth that can benefit all psychiatrists both personally and professionally.",
            "Trauma-informed care conforms to the standards of ethical practice recognized in the profession and should not, therefore, be regarded as a development that steers psychiatry away from its core mission but rather as a way that the profession can more readily achieve that mission.",
            "Cultural humility is characterized by principles of mutual learning and critical self-reflection, recognition of power imbalances, and the existence of implicit bias"
          ]
        },
        {
          "title": "Ethical approval and informed consent in mental health research",
          "url": "https://link.springer.com/article/10.1007/s00146-025-02364-0",
          "excerpts": [
            "Informed consent is a crucial aspect of ethical human research, ensuring individuals'autonomy in decision-making. Failing to obtain informed ..."
          ]
        },
        {
          "title": "Social prescribing (SP) and community-based interventions - PMC9389950",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9389950/",
          "excerpts": [
            "Social prescribing (SP) aims to provide targeted psychosocial support and close the gap between medical and non-medical services.",
            "This review assesses the effectiveness of community-based SP interventions.",
            "Current evidence suggests positive effects of SP on a variety of relevant endpoints."
          ]
        },
        {
          "title": "Consent in psychiatry - concept, application & implications - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7055160/",
          "excerpts": [
            "Informed consent is about giving a patient the special knowledge that makes him/her competent to take decisions in a more informed way."
          ]
        },
        {
          "title": "Community-based Collaborative Care for Serious Mental ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12228660/",
          "excerpts": [
            "by S Abdulla · 2025 · Cited by 1 — Community-based collaborative care (CBCC) is an effective approach for addressing the needs of people with mental health conditions."
          ]
        },
        {
          "title": "Cultural Humility: A Key Element of Trauma-Informed Care",
          "url": "https://www.chcs.org/cultural-humility-key-element-trauma-informed-care/",
          "excerpts": [
            "Cultural humility — a respectful approach toward individuals of other cultures that continuously pushes one to challenge cultural biases ..."
          ]
        },
        {
          "title": "National-Practice-Guidelines-for-Peer-Specialists-and- ...",
          "url": "https://www.peersupportworks.org/wp-content/uploads/2021/07/National-Practice-Guidelines-for-Peer-Specialists-and-Supervisors-1.pdf",
          "excerpts": [
            "The original National Practice Guidelines for Peer Supporters (NPG) identified 12 core values of peer support including a short description of each value in ..."
          ]
        },
        {
          "title": "Supervision of Peer Workers",
          "url": "https://www.samhsa.gov/sites/default/files/programs_campaigns/brss_tacs/guidelines-peer-supervision-4-ppt-cp5.pdf",
          "excerpts": [
            "Benefits of Supervision for Peer Workers. • Provides opportunities to reflect on peer support practice. • Delivers better outcomes through learning that comes ..."
          ]
        },
        {
          "title": "Effectiveness and active ingredients of social prescribing ...",
          "url": "https://sirenetwork.ucsf.edu/tools-resources/resources/effectiveness-and-active-ingredients-social-prescribing-interventions",
          "excerpts": [
            "OBJECTIVE: This study aims to establish the effectiveness and active ingredients of UK-based social prescribing interventions targeting mental ..."
          ]
        },
        {
          "title": "Effectiveness of a whole health model of care emphasizing ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9387037/",
          "excerpts": [
            "by SB Zeliadt · 2022 · Cited by 35 — VHA's Whole Health national pilot program was associated with greater reductions in prescribed opioid doses compared to secular trends ..."
          ]
        },
        {
          "title": "Creative Arts Therapies for Trauma and Holistic Integration: Ethical, Cultural Humility, and Community-Based Approaches",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11725198/",
          "excerpts": [
            "The overall SMD using a random-effects model was −1.98, with a 95% CI from −3.80 to −0.16; *p* < 0.05, indicating a statistically significant effect size in favor of the experimental gr",
            "Subgroup analysis indicates that drama therapy was notably effective, while music, art, and dance/movement therapies exhibited less pronounced effects."
          ]
        },
        {
          "title": "Mind-body exercise interventions for PTSD prevention - BMJ Open",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10347470/",
          "excerpts": [
            "Mind-body exercise is widely practised and increasingly offered clinically as an adjunct or supplementary treatment for those with trauma-related disorders.",
            " To date, there is no consensus regarding the efficacy of MBE interventions in preventing the development of trauma-related disorders. Thus, this review aims to systematically examine if, and what type of MBE interventions are effective in preventing the development of PTSD or ASD in trauma-exposed populations.",
            "Although we did not find any studies assessing ASD symptoms, our review found overall limited evidence for MBE interventions in reducing the likelihood of developing PTSD in the short-term among populations with previous or ongoing exposure to trauma. However, these results should be considered tentative as the limited studies identified meant that caution must be applied to the interpretation of these results.",
            "the subgroup analyses on type of MBE interventions showed a relatively larger effect for yoga as a stand-alone intervention compared with yoga as part of the broader MBSR intervention, MBSR studies comprised larger sample sizes with lower variability and likely provided more reliable estimates than stand-alone yoga, which had smaller sample sizes and more variability."
          ]
        },
        {
          "title": "Cultural humility and trauma-informed practices",
          "url": "https://uwphi.pophealth.wisc.edu/evaluation-research/current-evaluation-projects-2/firearmcrisisstrategylibrary/cultural-humility-and-trauma-informed-practices/",
          "excerpts": [
            "Cultural humility includes principles of mutual learning, critical self-reflection, recognition of power imbalances, and existence of implicit biases serving as a guiding concept for the practice of trauma-informed practices 1 . Cultural humility includes principles of mutual learning, critical self-reflection,",
            "\nCultural Humility and Trauma-Informed Practices – Population Health Institute – UW–Madison",
            "Translating Research for Policy and Practice",
            "1 . Cultural humility includes principles of mutual learning, critical self-reflection,…\nCultural Humility and Trauma-Informed Practices – Population Health Institute – UW–Madison\n",
            "Cultural humility includes principles of mutual learning, critical self-reflection, recognition of power imbalances, and existence of implicit biases serving as a guiding concept for the practice of trauma-informed practices 1 . Cultural humility includes principles of mutual learning, critical self-reflection,…\nC"
          ]
        },
        {
          "title": "Study Shows the Success of Whole Health",
          "url": "https://www.va.gov/WHOLEHEALTH/features/Study_Shows_the_Success_of_Whole_Health.asp",
          "excerpts": [
            "A new progress report shows improvement in the lives of Veterans who use Whole Health services. The report gives updates from a three-year pilot study."
          ]
        },
        {
          "title": "Learn About the Collaborative Care Model",
          "url": "https://www.psychiatry.org/psychiatrists/practice/professional-interests/integrated-care/learn",
          "excerpts": [
            "A recent systematic review found strong evidence that collaborative care is effective for improving depression outcomes in racial ethnic minority populations."
          ]
        },
        {
          "title": "How co-locating public mental health interventions in community ...",
          "url": "https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-17404-x",
          "excerpts": [
            "This study evaluates how co-location in community-based settings can support adult mental health and reduce health inequalities."
          ]
        },
        {
          "title": "Homepage — CRF Behavioral Healthcare",
          "url": "https://www.crfbehavioralhealthcare.org/",
          "excerpts": [
            "Our mission is to design and deliver innovative behavioral healthcare and social services. We do so in a way that is trauma-informed and culturally competent."
          ]
        },
        {
          "title": "Community Interventions to Promote Mental Health and Social Equity",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6440941/",
          "excerpts": [
            "We define community interventions as those that involve multi-sector partnerships, emphasize community members as integral to the intervention, ..."
          ]
        },
        {
          "title": "Art Therapy and Cognitive Processing Therapy for Combat- ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5764181/",
          "excerpts": [
            "by M Campbell · 2016 · Cited by 168 — This randomized controlled trial was designed to determine if art therapy in conjunction with Cognitive Processing Therapy (CPT) was more effective for ..."
          ]
        },
        {
          "title": "Music interventions for posttraumatic stress disorder: A systematic ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2950004424000075",
          "excerpts": [
            "Nevertheless, some studies reported large effect sizes (e.g., [20]) and clinically significant reductions in PTSD scores (e.g., a 10 point reduction on the PSS ..."
          ]
        },
        {
          "title": "Impact of dance therapy on adults with psychological trauma",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10334851/",
          "excerpts": [
            "Dance therapy may be a useful technique for improving both psychological and physiological symptoms associated with trauma exposure."
          ]
        },
        {
          "title": "Art Therapy and Cognitive Processing Therapy for Combat ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29332989/",
          "excerpts": [
            "by M Campbell · 2016 · Cited by 168 — This randomized controlled trial was designed to determine if art therapy in conjunction with Cognitive Processing Therapy (CPT) was more effective for reducing ..."
          ]
        },
        {
          "title": "[PDF] Psychological Effects of Training in Martial Arts After Interpersonal ...",
          "url": "https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=7974&context=dissertations",
          "excerpts": [
            "This qualitative phenomenological study addressed the effectiveness of training in the martial arts as an intervention in the treatment of interpersonal trauma ..."
          ]
        },
        {
          "title": "Collaborative mental health care: A narrative review - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9803502/",
          "excerpts": [
            "by C Reist · 2022 · Cited by 121 — The Collaborative Care model is a systematic strategy for treating behavioral health conditions in primary care through the integration of care managers and ..."
          ]
        },
        {
          "title": "Community-Engaged Approaches to Address the Ethical ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7245652/",
          "excerpts": [
            "by ND Hernandez · 2019 · Cited by 5 — Community-based participatory research (CBPR) approaches have shown promise as powerful research tools for understanding and addressing health inequities."
          ]
        },
        {
          "title": "Community-Based Participatory Research Contributions to ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2837458/",
          "excerpts": [
            "by N Wallerstein · 2010 · Cited by 2630 — Community-based participatory research (CBPR) represents a transformative research opportunity to unite the growing interest of health professionals, academics, ..."
          ]
        },
        {
          "title": "Impact of dance therapy on adults with psychological trauma - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37427835/",
          "excerpts": [
            "Dance therapy may be a promising approach for the therapeutic management of psychological trauma as it can address both psychological and physical symptoms."
          ]
        },
        {
          "title": "PMCID: PMC8220835 - The Creative Commons Published Article on Peer Support and Recovery",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8220835/",
          "excerpts": [
            "Peer support is being integrated within mental health services to further the development of a recovery approach.",
            "Recovery was broadly defined as ",
            "a deeply personal, unique process of changing one’s attitudes, values, feelings, goals, skills, and/or roles. It is a way of living a satisfying, hopeful, and contributing life even with limitations caused by [mental health conditions].",
            ",",
            "Eight trials met eligibility criteria, providing data from 2131 participants.",
            " Group peer support interventions were excluded",
            "The findings of this review and of other reviews that have included group peer support approaches [[8](), [10](), [25](), [26]()] are promising with respect to the potential for group peer interventions to enhance recovery for people using mental health services.",
            " Qualitative accounts of individuals participating in group peer support interventions, both as process evaluations embedded within trials and as independent studies could indicate the elements of the intervention that are helpful and mechanisms of effect",
            "Future group peer support interventions need a clear theory of change and proposed mechanism of hypothesised effect as it is uncertain how any of the positive results presented were achieved from the included studies."
          ]
        },
        {
          "title": null,
          "url": "https://jcsm.aasm.org/doi/10.5664/jcsm.7230",
          "excerpts": [
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ","
          ]
        },
        {
          "title": "Systematic Review and Meta-Analysis of Peer-Delivered Interventions for Serious Mental Illness (SMI) – PMC11203176",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11203176/",
          "excerpts": [
            "The included studies consisted of RCTs exploring various interventions, including peer-delivered self-help, peer-run services, peer partnerships, and the employment of individuals in recovery as peers.",
            "Outcomes\n\nIncluded studies reported outcomes related to personal recovery such as hope, identity, personal confidence, self-efficacy, quality of life, relationships, empowerment, and working alliance",
            "The research methodology employed in this study is a systematic review and meta-analysis focused on RCTs and published trials while excluding other study types.",
            "Exclusions comprised studies where peer support provided by a peer worker was not the primary intervention method and those where mental health was not the primary focus of the intervention."
          ]
        },
        {
          "title": "The Mental Health and Faith Community Partnership",
          "url": "https://www.psychiatry.org/psychiatrists/diversity/mental-health-and-faith-community-partnership",
          "excerpts": [
            "The Mental Health and Faith Community Partnership is a collaboration between psychiatrists and clergy aimed at fostering a dialogue between two fields."
          ]
        },
        {
          "title": "Mental Health: A Guide for Faith Leaders",
          "url": "https://www.apaf.org/getmedia/d5cdf69e-e9bb-4090-9b75-1b409c3e2369/APAF-Mental-Health-A-Guide-for-Faith-Leaders.pdf",
          "excerpts": [
            "Faith leaders can increase their understanding of the best science- and evidence-based treatment for psychiatric disorders.",
            "Self-help and support, including by a faith community \nand its leaders, can be very important to an individual’s \ncoping, recovery, and well-bein",
            "Provide Direct Access to Counseling \nand Treatment for Mental Healt",
            "In communities around the country, congregations \nare meeting the need for culturally appropriate mental \nhealth care services by providing direct access to \nmental health care support, counseling, and even \ntreatm",
            "Discern and establish boundaries. It is essential \nto establish boundaries between pastoral care \nand professional counseling services, as well \nas confidentiality surrounding the individual’s \ntreatm",
            "These and other community-based and faith-based \ninitiatives are demonstrating how meeting people \nwhere they are in communities can help improve health \noutcom",
            "Faith leaders are official leaders of religious congregations \nwhose primary responsibility is to provide for the \nspiritual development and care of their congregation",
            "Mental health services delivered in a culturally \nappropriate manner and integrating the \ncommunity’s spiritual practices and religious \nbeliefs, if requested, may benefit the person by \noffering congruency between their mental health \nand their faith and cultural understan",
            "\n\nSee also the \ncompanion to \nthis guide: Quick \nReference on \nMental Health for \nFaith ",
            "\n\nSee also the \ncompanion to \nthis guide: Quick \nReference on \nMental Health for \nFaith ",
            "These activities can create a culture of awareness \nand reduce barriers to care—overcoming \ncommunity members’ reluctance to seek care \ndue to mistrust, fear, cost, or inaccessibili",
            "These activities can create a culture of awareness \nand reduce barriers to care—overcoming \ncommunity members’ reluctance to seek care \ndue to mistrust, fear, cost, or inaccessibili"
          ]
        },
        {
          "title": "APA Blogs: Mental Health and Faith Community Partnerships",
          "url": "https://www.psychiatry.org/news-room/apa-blogs/mental-health-and-faith-community-partnerships",
          "excerpts": [
            "Partnerships between mental health and faith communities hold much promise for helping to improve mental health symptoms, increase mental health literacy, ... [Mental Health: A Guide for Faith Leaders](https://www.apaf.org/getmedia/d5cdf69e-e9bb-4090-9b75-1b409c3e2369/APAF-Mental-Health-A-Guide-for-Faith-Leaders.pdf)"
          ]
        },
        {
          "title": "Peer Inclusion in Interventions for Children with ADHD",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5878915/",
          "excerpts": [
            "by R Cordier · 2018 · Cited by 62 — To assess the effectiveness of peer inclusion in interventions to improve the social functioning of children with ADHD."
          ]
        },
        {
          "title": "Support, Mutual Aid and Recovery from Dual Diagnosis",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC1868661/",
          "excerpts": [
            "by AB Laudet · 2000 · Cited by 208 — This paper investigates the associations among social support (including dual-recovery mutual aid), recovery status and personal well-being in dually-diagnosed ..."
          ]
        },
        {
          "title": "“Church-Based Health Programs for Mental Disorders ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3952019/",
          "excerpts": [
            "by SH Hankerson · 2012 · Cited by 218 — A systematic review is presented of studies involving church-based health promotion programs (CBHPP) for mental disorders among African Americans.See more"
          ]
        },
        {
          "title": "Religious Service Attendance and Implications for Clinical ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8751781/",
          "excerpts": [
            "by TJ VanderWeele · 2021 · Cited by 46 — In this commentary, we review the evidence concerning associations between religious service attendance and subsequent health and wellbeing outcomes."
          ]
        },
        {
          "title": "Religious-service attendance and subsequent ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32793951/",
          "excerpts": [
            "by Y Chen · 2021 · Cited by 139 — Religious-service attendance and subsequent health and well-being throughout adulthood: evidence from three prospective cohorts · Authors."
          ]
        },
        {
          "title": "Trauma and PTSD Symptoms: Does Spiritual Struggle ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3269830/",
          "excerpts": [
            "by JH Wortmann · 2011 · Cited by 194 — The present prospective study tested the role of spiritual struggle in the development and maintenance of PTSD symptoms following trauma."
          ]
        },
        {
          "title": "The Role of Black Churches in Promoting Mental Health for ...",
          "url": "https://psychiatryonline.org/doi/10.1176/appi.ps.20230263",
          "excerpts": [
            "Apr 10, 2024 — This article reports on a collaborative effort, driven by members of a Black church, to understand mental health needs, coping strategies, and resilience ..."
          ]
        },
        {
          "title": "Efficacy of culturally adapted interventions for common ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2215036623001189",
          "excerpts": [
            "by S Li · 2023 · Cited by 36 — Evidence suggests that culturally adapted psychological interventions have some benefits in treating diverse ethnic groups. However, the effect of such ..."
          ]
        },
        {
          "title": "Shinrin-Yoku (Forest Bathing) and Nature Therapy",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5580555/",
          "excerpts": [
            "por MM Hansen · 2017 · Mencionado por 987 — Quantitative randomized controlled trial was to measure the effects of forest-bathing for short periods of time on overall human health using a variety of ...",
            "The aim of this state-of-the-art review is to elucidate empirical research conducted on the physiological and psychological effects of Shinrin-Yoku (or Forest ..."
          ]
        },
        {
          "title": "Greenspace exposure and children behavior: A systematic review",
          "url": "https://www.sciencedirect.com/science/article/pii/S0048969722007008",
          "excerpts": [
            "We found indications for a beneficial impact of greenspace exposure on child behavior. Total behavioral difficulties and ADHD showed consistent associations ..."
          ]
        },
        {
          "title": "Green spaces exposure and the risk of common psychiatric disorders",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10885792/",
          "excerpts": [
            "Green spaces decrease the risk of psychiatric disorders, including depression, anxiety, dementia, schizophrenia, and ADHD."
          ]
        },
        {
          "title": "a systematic review of the influence of greenspace on youth ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9482936/",
          "excerpts": [
            "Seventy-nine percent of studies suggest an association between greenspace and improved youth development."
          ]
        },
        {
          "title": "A Pragmatic Controlled Trial of Forest Bathing Compared ...",
          "url": "https://www.mdpi.com/2071-1050/13/3/1380",
          "excerpts": [
            "por K McEwan · 2021 · Mencionado por 77 — Forest Bathing, where individuals use mindfulness to engage with nature, has been reported to increase heart rate variability and benefit wellbeing."
          ]
        },
        {
          "title": "The Effects of a Forest Therapy Programme on Mental ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6982075/",
          "excerpts": [
            "por E Bielinis · 2019 · Mencionado por 149 — The positive effect of forest bathing on the mental health and wellbeing of those suffering from post-traumatic stress disorder or experiencing stress has been ..."
          ]
        },
        {
          "title": "The effectiveness of outdoor behavioral healthcare with ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0190740917310307",
          "excerpts": [
            "by S DeMille · 2018 · Cited by 57 — This study examined the longitudinal impact of Outdoor Behavioral Healthcare on youth participants as reported by their parents."
          ]
        },
        {
          "title": "A Meta-Analysis of the Effects of Wilderness Therapy on ...",
          "url": "https://journals.sagepub.com/doi/full/10.1177/00938548221078002",
          "excerpts": [
            "by N Beck · 2022 · Cited by 24 — The purpose of the present meta-analysis was to determine the effectiveness of wilderness therapy in addressing youth delinquency."
          ]
        },
        {
          "title": "Religious and spiritual interventions in mental health care: a systematic review and meta-analysis of randomized controlled clinical trials",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4595860/",
          "excerpts": [
            "The purpose of this paper was to assess the impact of religious/spiritual interventions (RSI) through randomized clinical trials (RCTs).",
            "The mental health outcomes most assessed\nwere depressive symptoms (found in 15 papers), anxiety (14 papers), post-trauma stress and\nstress levels (five papers), use/abuse of alcohol/drugs (two papers) and social function\n(one paper).",
            "Among the usable results in the meta-analysis, three of depressive symptoms and two of\nanxiety were excluded because they did not present sufficient data for statistical tests\n(mean, standard deviation and/or standard error).",
            "There was a statistical difference between the studies related to anxiety\n(*p* < 0.001) favouring RSI, presented in [Fi",
            "We found evidence of high heterogeneity among the studies\n(*I*2 = 86%",
            "The\nexclusion of these data was reflected in a resultant low heterogeneity\n(*I*2 = 45%",
            "The other three studies assessed health professionals\n  and all showed lower levels of stress, emotional exhaustion, higher job satisfaction\n  and even better quality of patient care (Oman *et al. *\n  [2006](), [2008](); Huguele",
            "Post-trauma stress: two spiritual interventions showed promising results with\n  significant reductions of post-trauma stress and a trend towards reductions in other\n  psychological symptoms in men (Bormann *et al. *\n  [2008]()) and women (Bowland *e",
            "  Schizophrenia: one study explored this disorder and noted increased social\n  functioning, adherence to medical treatment and interest of patients in discussing\n  spirituality with their psychiatrists (Huguelet *et al. ",
            "A spiritually based group intervention for\n    combat veterans with posttraumatic stress disorder: feasibility st"
          ]
        },
        {
          "title": "The effectiveness of nature-based interventions in combating PTSD: A meta-analysis and systematic review",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0272494425001100",
          "excerpts": [
            "Nature-Based Interventions (NBI), in which people come into contact with nature more frequently and the healing effect of the natural environment is used, seem to be an alternative to these classical treatment approaches.",
            "In this meta-analysis study, we aimed to systematically review the studies in which NBI techniques were used in the treatment of PTSD and to summarize the literature in terms of their effectiveness.",
            "nature-based interventions moderately and negatively affected posttraumatic stress symptoms (SMD = −0.558; 95 % CI = −0.678 to −0.437; p = 0.000)",
            "According to the moderator analysis in which the variable of nature-based intervention techniques (Fishing Activities, Hiking Activities, Recreational Activities) was considered, no significant difference was found between nature-based intervention techniques.",
            "It was concluded that nature-based interventions provided significant welfare by moderately reducing the symptoms of posttraumatic stress disorder and that it is a reliable treatment technique that can be preferred by clinicians working in this field.",
            "In addition to the treatment of psychopathologies, there are studies showing that nature-based interventions make significant contributions to people's cognitive performance (Wallner et al., 2018), increased physical activity (Gardsjord et al., 2014), emotional well-being (van Lier et al., 2017) and psychological well-being (Lee et al., 2011).",
            "ADHD) (Di Carmine & Berto, 2020"
          ]
        },
        {
          "title": "Consumers' Experiences in Dual Focus Mutual Aid for Co- ...",
          "url": "https://journals.sagepub.com/doi/10.4137/SART.S11006?icid=int.sj-full-text.similar-articles.6",
          "excerpts": [
            "Mar 6, 2013 — Mutual aid fellowships have been shown to improve outcomes for those with co-occurring substance use and mental illness disorders."
          ]
        },
        {
          "title": "What Are Peer Support Specialists?",
          "url": "https://www.verywellhealth.com/peer-support-specialists-5214328",
          "excerpts": [
            "Aug 21, 2024 — Peer support specialists are individuals with lived experience who help others with mental health and substance use during recovery."
          ]
        },
        {
          "title": "Connectedness: The Updated and Expanded Pillar ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12129969/",
          "excerpts": [
            "by G Merlo · 2025 · Cited by 5 — Social support negatively predicted the development of PTSD symptoms, and PTSD symptoms negatively predicted future social support.See more"
          ]
        },
        {
          "title": "Trauma exposure, PTSD symptoms, and tobacco use",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7654728/",
          "excerpts": [
            "by AR Mathew · 2020 · Cited by 9 — In summary, we found weekly church attendance was associated with strikingly reduced likelihood of two negative health outcomes linked to trauma exposure – PTSD ..."
          ]
        },
        {
          "title": "Religious-service attendance and subsequent ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7825951/",
          "excerpts": [
            "by Y Chen · 2020 · Cited by 140 — Religious-service attendance has been linked with a lower risk of all-cause mortality, suicide and depression. Yet, its associations with other health and well ..."
          ]
        },
        {
          "title": "Medical empirical research on forest bathing (Shinrin-yoku)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6886167/",
          "excerpts": [
            "This study focused on the newest evidence of the relationship between forest environmental exposure and human health and assessed the health efficacy of forest ..."
          ]
        },
        {
          "title": "Recovery Horizons: Nature-Based Activities as Adjunctive ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11571177/",
          "excerpts": [
            "by A Shirazi · 2024 · Cited by 2 — In a study comparing nature and urban hiking, 26 veterans with PTSD were randomized to 12-week interventions of 6 nature hikes (N = 13) or 6 ..."
          ]
        },
        {
          "title": "Efficacy and acceptability of music therapy for post-traumatic stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11036901/",
          "excerpts": [
            "Background: Music therapy is increasingly examined in randomized controlled trials (RCTs) and shows potential in treating post-traumatic stress ...",
            "In this meta-analysis, we identified a large therapeutic effect of music therapy for PTSD, reaching the level of standard psychotherapy. We ..."
          ]
        },
        {
          "title": "Integrative Therapy Approaches for Posttraumatic Stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6519541/",
          "excerpts": [
            "by J Sornborger · 2017 · Cited by 20 — A study of 17 veterans with PTSD who had four sessions of Tai Chi reported having fewer intrusive thoughts, less difficulty concentrating, and less ..."
          ]
        },
        {
          "title": "Ethics and Boundaries in Peer Support | The Institute@MHP",
          "url": "https://www.mentalhealthpartnerships.org/the-institute-at-mhp/ethics-and-boundaries",
          "excerpts": [
            "This 3-hour interactive training provides a foundational understanding of ethics and boundaries in peer support, helping participants navigate complex dynamics."
          ]
        },
        {
          "title": "Therapeutic alliance during trauma focused treatment in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11730843/",
          "excerpts": [
            "by A Grass · 2025 · Cited by 1 — The therapeutic alliance plays a crucial role in D-CPT with young patients, contributing to a reduction in symptom severity over the course of treatment.See more"
          ]
        },
        {
          "title": "Examining the Efficacy of a Pilot Virtual Group Treatment ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S2468749925000870",
          "excerpts": [
            "by JL Kinley · 2025 — Preliminary research findings suggest 'virtual psychotherapy' for Complex PTSD can be an efficient and efficacious treatment alternative.See more"
          ]
        },
        {
          "title": "Controlled randomized clinical trial of spirituality integrated ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3905344/",
          "excerpts": [
            "by A Ebrahimi · 2013 · Cited by 80 — The aim of this research was to compare efficacy of spiritual integrated psychotherapy (SIPT) and cognitive-behavioral therapy (CBT) on the intensity of ..."
          ]
        },
        {
          "title": "Controlled randomized clinical trial of spirituality integrated ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/24516853/",
          "excerpts": [
            "by A Ebrahimi · 2013 · Cited by 80 — The aim of this research was to compare efficacy of spiritual integrated psychotherapy (SIPT) and cognitive-behavioral therapy (CBT) on the intensity of ..."
          ]
        },
        {
          "title": "African-American Faith-Based Mental Health Initiative ...",
          "url": "https://aafbmh.org/",
          "excerpts": [
            "We are a movement of churches working together to increase the awareness and perceptions of mental health, recovery and wellness in African American communities ...See more"
          ]
        },
        {
          "title": "Could Nature Contribute to the Management of ADHD in Children ...",
          "url": "https://www.mdpi.com/1660-4601/21/6/736",
          "excerpts": [
            "The reviewed literature provides strong support for the benefits of exposure to nature on ADHD in school-aged children."
          ]
        },
        {
          "title": "Efficacy and acceptability of music therapy for post-traumatic stress ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38647566/",
          "excerpts": [
            "背景：随机对照试验（RCTs）越来越多地应用于音乐疗法效果的考察，并显示出治疗创伤后应激障碍（PTSD）的潜力。 目的：该系统综述和荟萃分析对现有的音乐疗法治 ..."
          ]
        },
        {
          "title": "Clinical Practice Guidelines for PTSD",
          "url": "https://www.ptsd.va.gov/publications/rq_docs/V35N1.pdf",
          "excerpts": [
            "There are four other current national or international guidelines for PTSD from the. American Psychological Association (APA,. 2017), ..."
          ]
        },
        {
          "title": "Clinical Practice Guideline for the Diagnosis, Evaluation, ...",
          "url": "https://publications.aap.org/pediatrics/article-pdf/144/4/e20192528/1443490/peds_20192528.pdf",
          "excerpts": [
            "by ML Wolraich · 2019 · Cited by 1324 — Copyright © 2019 by the American Academy of Pediatrics. FINANCIAL DISCLOSURE ... ADHD: Clinical guideline for the diagnosis, evaluation, and treatment."
          ]
        },
        {
          "title": "Attention Deficit Hyperactivity Disorder (ADHD)",
          "url": "https://www.aap.org/en/patient-care/attention-deficit-hyperactivity-disorder-adhd/?srsltid=AfmBOoou_pAmD1Vk_oCb7yLaHqnUPmljjMGKl0uGz7S0XCQqz9zcoAQj",
          "excerpts": [
            "Feb 28, 2022 — Guideline offers evidence-based recommendations for the diagnosis, treatment and management of ADHD."
          ]
        },
        {
          "title": "New ISTSS Prevention and Treatment Guidelines",
          "url": "https://istss.org/clinical-resources/trauma-treatment/new-istss-prevention-and-treatment-guidelines/",
          "excerpts": [
            "Grounded in ISTSS' updated PTSD Prevention and Treatment Guidelines, the third edition of this definitive work has more than 90% new content, making it ..."
          ]
        },
        {
          "title": "APA guideline on posttraumatic stress disorder aims to help ...",
          "url": "https://www.apaservices.org/practice/update/2017/09-21/clinicians-treat-ptsd",
          "excerpts": [
            "The guideline, developed by a multidisciplinary panel of scientists, clinicians and community members, recommends interventions for treating PTSD in adults."
          ]
        },
        {
          "title": "Guanfacine Extended-Release Tablets (Intuniv), a ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2935643/",
          "excerpts": [
            "by MP Cruz · 2010 · Cited by 44 — The study showed improved total scores on the Attention-Deficit/Hyperactivity Disorder Rating Scale (ADHD–RS) IV from baseline compared with placebo. After a ..."
          ]
        },
        {
          "title": "Comparative efficacy and safety of attention-deficit ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/28258319/",
          "excerpts": [
            "by A Joseph · 2017 · Cited by 48 — This study found that LDX had greater efficacy than GXR, ATX, and MPH in the treatment of children and adolescents with ADHD."
          ]
        },
        {
          "title": "Effectiveness of Atomoxetine and Stimulant Combination in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11929587/",
          "excerpts": [
            "In patients who do not tolerate stimulants at higher doses, non-stimulant augmentation is a potential treatment strategy. Atomoxetine, as the ..."
          ]
        },
        {
          "title": "Trauma-focused psychotherapies for post-traumatic stress ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34473342/",
          "excerpts": [
            "by B Jericho · 2022 · Cited by 105 — Meta-analytic reviews suggest similar outcomes across trauma-focused psychotherapies for adults with post-traumatic stress disorder (PTSD)."
          ]
        },
        {
          "title": "a network meta-analysis of randomised controlled trials",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36628572/",
          "excerpts": [
            "by N Yunitri · 2023 · Cited by 64 — Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomised controlled ..."
          ]
        },
        {
          "title": "The Role of Eye Movement Desensitization and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3951033/",
          "excerpts": [
            "by F Shapiro · 2014 · Cited by 601 — The 3 sessions of EMDR therapy resulted in an 84% remission of PTSD diagnosis with a large and significant pretreatment versus posttreatment effect size ( ..."
          ]
        },
        {
          "title": "Trauma‐focused psychotherapies for post‐traumatic stress ...",
          "url": "https://onlinelibrary.wiley.com/doi/10.1111/acps.13366",
          "excerpts": [
            "por B Jericho · 2022 · Mencionado por 105 — A comprehensive meta-analysis by Watts et al. reported effect sizes indicating superior efficacy for cognitive processing therapy (CPT; g = 1.69) ..."
          ]
        },
        {
          "title": "Meta-analysis: Which Components of Parent Training Work ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34224837/",
          "excerpts": [
            "by TJ Dekkers · 2022 · Cited by 108 — Objective: Behavioral parent training is an evidence-based intervention for children with attention-deficit/hyperactivity disorder (ADHD), but ..."
          ]
        },
        {
          "title": "Meta-analysis of cognitive–behavioral treatments for adult ...",
          "url": "https://doi.apa.org/doiLanding?doi=10.1037%2Fccp0000216",
          "excerpts": [
            "Nov 7, 2016 — Results: Using a random effects model, we found that CBTs had medium-to-large effects from pre- to posttreatment (self-reported ADHD symptoms: g ..."
          ]
        },
        {
          "title": "A critical appraisal of atomoxetine in the management of ADHD - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4694693/",
          "excerpts": [
            "Effect size of ATX was 0.71. ATX was also evaluated in young children (5–7 years old). A total of 93 subjects were dosed in an 8-week, ..."
          ]
        },
        {
          "title": "A meta-analysis of clonidine for symptoms of attention ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK67951/",
          "excerpts": [
            "by DF Connor · 1999 · Cited by 418 — To review the literature on the clinical use of clonidine to treat symptoms of attention-deficit hyperactviity disorder (ADHD)."
          ]
        },
        {
          "title": "Efficacy of Guanfacine Extended Release in Children and...",
          "url": "https://journals.lww.com/jrnldbp/fulltext/2020/09000/efficacy_of_guanfacine_extended_release_in.12.aspx",
          "excerpts": [
            "by JH Newcorn · 2020 · Cited by 13 — A meta-analysis found psychostimulants to be efficacious in the treatment of oppositional behavior, conduct problems, and aggression in children and adolescents ..."
          ]
        },
        {
          "title": "Meta-analysis: Which Components of Parent Training Work ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856721004202",
          "excerpts": [
            "by TJ Dekkers · 2022 · Cited by 108 — There is consistent evidence that parent training for children with ADHD is less likely to improve the child's behavior when negative parenting ..."
          ]
        },
        {
          "title": "A meta-analysis of behavioral parent training for children ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/22750360/",
          "excerpts": [
            "by P Lee · 2012 · Cited by 230 — This meta-analysis examined the effect of behavioral parent training on child and parental outcomes for children with attention deficit hyperactivity disorder."
          ]
        },
        {
          "title": "Safety and efficacy of guanfacine extended-release in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7531113/",
          "excerpts": [
            "by A Iwanami · 2020 · Cited by 26 — There were no major safety concerns during long-term GXR administration in adults with ADHD. After long-term treatment, patients had significant improvements ..."
          ]
        },
        {
          "title": "A Randomized Controlled Trial of Clonidine Added to ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0890856709610935",
          "excerpts": [
            "by PL HAZELL · 2003 · Cited by 283 — Extended-release (ER) clonidine is approved in the US for treatment of ADHD in 6–17- year olds as monotherapy or an adjunct to stimulants. There are RCTs on ..."
          ]
        },
        {
          "title": "Efficacy and safety of extended-release guanfacine ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0924977X14002788",
          "excerpts": [
            "by A Hervas · 2014 · Cited by 101 — This study assessed the efficacy (symptoms and function) and safety of dose-optimized GXR compared with placebo in children and adolescents with ADHD."
          ]
        },
        {
          "title": "A review of the efficacy of atomoxetine in the treatment of attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5304987/",
          "excerpts": [
            "Reported effect sizes for atomoxetine in children with ADHD are consistent with those for the stimulants and range from 0.6 to 1.3. ... Effect sizes for ..."
          ]
        },
        {
          "title": "Long-Term Safety and Efficacy of Stimulant vs. Non- ...",
          "url": "https://www.gavinpublishers.com/article/view/long-term-safety-and-efficacy-of-stimulant-vs-non-stimulant-medications-in-adhd-treatment-a-comparative-meta-analysis-over-two-years",
          "excerpts": [
            "The study underlines that stimulants are generally more effective than non-stimulants, but they can also have more side effects.See more"
          ]
        },
        {
          "title": "Effects of physical exercise on attention deficit and other ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0165178122001238",
          "excerpts": [
            "by W Sun · 2022 · Cited by 141 — The meta-analysis showed that physical exercise can improve the attention of ADHD children (standardized mean difference [SMD] = −0.60, 95% confidence ..."
          ]
        },
        {
          "title": "Physical Exercise as Treatment for PTSD: A Systematic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34850063/",
          "excerpts": [
            "by F Björkman · 2022 · Cited by 127 — Results showed a main random effect of exercise intervention (0.46; 95% CI: 0.18 to 0.74) and a borderline significant interaction between more ..."
          ]
        },
        {
          "title": "Effects of physical activity on patients with posttraumatic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39833088/",
          "excerpts": [
            "by Z Yuan · 2025 · Cited by 1 — It was discovered that people with PTSD can benefit from physical activity as an adjuvant method to enhance their PTSD, anxiety, despair, and sleep quality."
          ]
        },
        {
          "title": "A Pilot Trial of Mindfulness Meditation Training for Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4045650/",
          "excerpts": [
            "by JT Mitchell · 2013 · Cited by 15 — The aim of this study was to assess the feasibility, acceptability, and preliminary efficacy of mindfulness meditation for ADHD, executive functioning (EF), ..."
          ]
        },
        {
          "title": "A Systematic Review and Network Meta-analysis: La ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33355483/",
          "excerpts": [
            "by A McGirr · 2021 · Cited by 25 — Repetitive transcranial magnetic stimulation (rTMS) is a promising treatment modality for Post-traumatic stress disorder (PTSD)."
          ]
        },
        {
          "title": "A Randomized Controlled Study of Neurofeedback for ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27992435/",
          "excerpts": [
            "by BA van der Kolk · 2016 · Cited by 247 — This study was a randomized, waitlist (TAU) controlled trial of a BCI, EEG neurofeedback training (NF), in patients with chronic PTSD to explore the capacity ...See more"
          ]
        },
        {
          "title": "Omega-3 fatty acid supplementation for the treatment of children ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/21961774/",
          "excerpts": [
            "Omega-3 fatty acid supplementation demonstrated a small but significant effect in improving ADHD symptoms. Eicosapentaenoic acid dose within supplements was ..."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37656283/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of ...",
          "url": "https://www.psychiatrist.com/jcp/omega-3-polyunsaturated-fatty-acids-core-symptoms-adhd-meta-analysis-randomized-controlled-trials/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Effects of a restricted elimination diet on the behaviour ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0140673610622271",
          "excerpts": [
            "by LM Pelsser · 2011 · Cited by 372 — A strictly supervised restricted elimination diet is a valuable instrument to assess whether ADHD is induced by food."
          ]
        },
        {
          "title": "A two arm randomized controlled trial comparing the short ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7251686/",
          "excerpts": [
            "by A Bosch · 2020 · Cited by 48 — The goal of the Elimination Diet (ED) is to diminish symptoms of ADHD and emotion dysregulation symptoms by means of the exclusion of specific ..."
          ]
        },
        {
          "title": "Efficacy and Safety of Transcranial Magnetic Stimulation for ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39829146/",
          "excerpts": [
            "TMS significantly improved the inattention, hyperactivity/impulsivity, and total symptom scores in ADHD patients with minor adverse events."
          ]
        },
        {
          "title": "Neurofeedback self-regulating training in patients with post ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2213422020300962",
          "excerpts": [
            "by J Leem · 2020 · Cited by 21 — The purpose of our study is to assess the efficacy and safety level of neurofeedback treatment in patients with PTSD using quantitative EEG.See more"
          ]
        },
        {
          "title": "Effects of physical exercise on attention deficit and other major symptoms in children with ADHD: A meta-analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35305344/",
          "excerpts": [
            "Conclusion: Physical exercise can help alleviate the symptoms of ADHD in children. Specifically, it can improve attention, executive function, and motor skills."
          ]
        },
        {
          "title": "Mindfulness-based interventions for trauma: Taylor et al., PubMed 2020 (abstract)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32453668/",
          "excerpts": [
            "Mindfulness-based interventions (MBIs), with postures, breath, relaxation, and meditation, such as Mindfulness-based Stress Reduction (MBSR) and yoga, are complex interventions increasingly used for trauma-related psychiatric conditions.",
            "There was a significant, pooled effect of MBIs (g = 0.51, 95%CI 0.31 to 0.71, *p* < .001). Similar effects were observed for mindfulness (g = 0.45, 0.26 to 0.64, *p* < .001), yoga (g = 0.46, 0.26 to 0.66, *p* < .001), and integrative exercise (g = 0.94, 0.37 to 1.51, *p* = .001), with no difference between interv",
            "Mindfulness-based interventions, adjunctive to treatment-as-usual of medication and/or psychotherapy, are effective in reducing trauma-related symptoms. Yoga and mindfulness have comparable effectiveness. Many psychiatric studies do not report trauma exposure, focusing on disorder-specific outcomes, but this review suggests a transdiagnostic approach could be adopted in the treatment of trauma sequelae with MBIs. More rigorous reporting of trauma exposure and MBI treatment protocols is recommended to enhance future research. **Keywords:**\nMindfulness; yoga; systematic review; posttraumatic stress disor"
          ]
        },
        {
          "title": "The efficacy of meditation-based mind-body interventions for mental disorders: A meta-review of 17 meta-analyses of randomized controlled trials",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022395620311560",
          "excerpts": [
            "by D Vancampfort · 2021 · Cited by 101 — Our meta-review demonstrates that mindfulness and to a lesser extent yoga may serve as an efficacious supplement to pharmacotherapy, and psychotherapy. Skip to main content Skip to article\n    * J",
            "quality. The content validity of the included RCTs was considered good in 9 (53%) meta-analyses. In meta-analyses with good methodological quality (AMSTAR 8≤) and content validity (AMSTAR+ 4≤), large effect sizes (0.80 or higher) were observed for mindfulness in schizophrenia and in ADHD , a moderate (0.50 ≤ 0.80) effect size for mindfulness in PTSD and a small (0.20 < 0.50) effect size for yoga in schizophrenia"
          ]
        },
        {
          "title": "JAMA Psychiatry meta-analysis on Neurofeedback for ADHD (Westwood et al., 2024)",
          "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2827733",
          "excerpts": [
            "stand-alone treatment for attention-deficit/hyperactivity disorder (ADHD)? Findings   This systematic review and meta-analysis included 38 randomized clinical trials (RCTs) and a total of 2472 participants. The analyses with probably blinded reports or neuropsychological outcomes provided no evidence of meaningful benefits of neurofeedback as a treatment for ADHD; however, small but statistically significant positive effects were observed when the analyses were limited to RCTs using well-established standard neurofeedback protocols and specifically targeted processing speed as an outcome measur"
          ]
        },
        {
          "title": "Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis (PMCID: PMC6404655)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6404655/",
          "excerpts": [
            "Neurofeedback (NF) has gained increasing interest in the treatment of attention-deficit/hyperactivity disorder (ADHD). Given learning principles underlie NF, lasting clinical treatment effects may be expected. This systematic review and meta-analysis addresses the sustainability of neurofeedback and control treatment effects by considering randomized controlled studies that conducted follow-up (FU; 2–12 months) assessments among children with ADHD.",
            " Within-group and between-group standardized mean differences (SMD) of parent behavior ratings were calculated and analyzed. Ten studies met inclusion criteria (NF: ten studies, *N* = 256; control: nine studies, *N* = 250). Within-group NF effects on inattention were of medium effect size (ES) (SMD = 0.64) at post-treatment and increased to a large ES (SMD = 0.80) at FU. Regarding hyperactivity/impulsivity, NF ES were medium at post-treatment (SMD = 0.50) and FU (SMD = 0.61). Non-active control conditions yielded a small significant ES on inattention at post-treatment (SMD = 0.28) but no significant ES at FU. Active treatments (mainly methylphenidate), had large ES for inattention (post: SMD = 1.08; FU: SMD = 1.06) and medium ES for hyperactivity/impulsivity (post: SMD = 0.74; FU: SMD"
          ]
        },
        {
          "title": "Neurofeedback for ADHD: A Systematic Review and Meta-Analysis (Riesco-Mat\u0000edas et al., 2021)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30646779/",
          "excerpts": [
            "by P Riesco-Matías · 2021 · Cited by 105 — Neurofeedback significantly improves inattention symptoms when possibly blinded evaluators assess symptoms. The prelim",
            "**Results:** We reviewed seven meta-analyses, and 17 studies were incorporated into the meta-analysis.",
            "RCTs support the efficacy of neurofeedback applied to ADHD when most proximal evaluators assess symptoms.",
            "The preliminary results suggest that stimulant medication is more effective than neurofeedback."
          ]
        },
        {
          "title": "A meta-analysis of randomized controlled trials",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36794797/",
          "excerpts": [
            "by CI Liu · 2023 · Cited by 43 — This meta-analysis indicates that CBT for adults with ADHD was effective in reducing both core and emotional symptoms."
          ]
        },
        {
          "title": "A randomized controlled trial of effects of sleep hygiene ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38554532/",
          "excerpts": [
            "por GT Noyan · 2024 · Mencionado por 3 — The present study investigated the effects of sleep hygiene training (SH) and progressive muscle relaxation exercises (PMR) in children with ADHD."
          ]
        },
        {
          "title": "Perspective on Melatonin Use for Sleep Problems in Autism and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7325410/",
          "excerpts": [
            "Overall, a high response rate was observed in the melatonin group compared to the placebo in treating sleep problems in children. Melatonin is a ..."
          ]
        },
        {
          "title": "Umbrella Review and Meta-Analysis: The Efficacy of ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0890856724020215",
          "excerpts": [
            "Among nonpharmacological interventions for sleep difficulties in youth, only behavioral interventions are supported by meta-analytic evidence."
          ]
        },
        {
          "title": "Acute and Repeated Ashwagandha Supplementation ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38931168/",
          "excerpts": [
            "by M Leonard · 2024 · Cited by 27 — Conclusion: Results support contentions that ashwagandha supplementation (225 mg) may improve some measures of memory, attention, vigilance, ...See more"
          ]
        },
        {
          "title": "Safety and Efficacy of Ashwagandha Root Extract on ...",
          "url": "https://www.tandfonline.com/doi/full/10.1080/02791072.2024.2424279",
          "excerpts": [
            "by S Kale · 2024 · Cited by 3 — This prospective, randomized, placebo-controlled study assessed the effects of Ashwagandha root extract (ARE) on cognition, energy, and mood ...See more"
          ]
        },
        {
          "title": "Effects of 12-Week Bacopa monnieri Consumption on Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3537209/",
          "excerpts": [
            "These results suggest that B. monnieri can improve attention, cognitive processing, and working memory partly via the suppression of AChE activity."
          ]
        },
        {
          "title": "Exploring the efficacy of nortriptyline, buspirone, and Ginkgo biloba ...",
          "url": "https://ejnpn.springeropen.com/articles/10.1186/s41983-025-00993-2",
          "excerpts": [
            "The findings of this systematic review suggest that non-stimulant medications such as buspirone, nortriptyline, and Ginkgo biloba extract may provide potential alternative or adjunctive options for managing ADHD , particularly in patients who are intolerant to or unresponsive to first-line stimulant medications."
          ]
        }
      ],
      "reasoning": "- Evidence from excerpts shows explicit cost data for ADHD medications, psychotherapy sessions, and access/insurance landscapes across multiple countries. For example, US-listed data describe brand-name ADHD medication costs (e.g., Adderall) often exceeding $800/month, with generics and coupons reducing out-of-pocket costs (quote reflects the idea of substantial regional cost variation and insurance dynamics). Similarly, UK/private assessments cost around £695, and UK public systems provide substantial, but not universal, coverage for ADHD assessment and treatment pathways, including recommendations for payers and potential delays, which aligns with cost/access policy concerns.\n- Several excerpts specifically address insurance coverage and payer arrangements: the Australian PBS subsidies for medications, and US Medicare/Medicare-like reimbursement patterns; these illustrate regulatory and funding contexts that shape access to ADHD and trauma-focused interventions.\n- Other excerpts discuss accessibility bottlenecks and waitlists (e.g., UK NHS ADHD assessment wait times, general practitioner/psychiatry workforce shortages, and private versus public pathways), corroborating the field's emphasis on cost and coverage as main determinants of access.\n- In addition, several excerpts cover digital therapeutics (EndeavorRx for pediatric ADHD; ORIKO ADHS-Therapie in DiGA contexts) and their reimbursement or pricing, illustrating how new modalities may alter affordability and access in different health systems.\n- Taken together, the excerpts support the stated field value by providing concrete cost figures, coverage scenarios, country-specific subsidies, and access barriers, which together form a coherent cost/access landscape for ADHD and trauma-related interventions across settings.\n- The most directly relevant items are those enumerating explicit costs and reimbursement structures (e.g., US medication costs, UK assessment costs, AU PBS subsidies, EndeavorRx pricing, and DiGA-related reimbursement). The next tier includes items describing waitlists and access barriers (psychiatrist shortages, long NHS/private waits), which explain why costs translate into actual access limitations. Finally, policy documents and guidelines that discuss payer roles, coverage criteria, and service delivery models contextualize how costs and access unfold in practice.",
      "confidence": "high"
    },
    {
      "field": "nutraceuticals_and_dietary_supplements.supported_dosing",
      "citations": [
        {
          "title": "Omega-3 polyunsaturated fatty acids in clinical trials for ADHD, PTSD, anxiety, and related conditions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6324500/",
          "excerpts": [
            "In addition, participants receiving supplements containing less than 60% EPA showed a significant association, but not those receiving supplements containing 60% or more EPA.",
            "A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.",
            "-\n\nThis systematic review and meta-analysis of clinical trials conducted on participants with clinical anxiety symptoms provides the first meta-analytic evidence, to our knowledge, that omega-3 PUFA treatment may be associated with anxiety reduction, which might not only be due to a potential placebo effect, but also from some associations of treatment with reduced anxiety symptoms.",
            "A cohort study found that high serum EPA levels were associated with protection against posttraumatic stress disorder.",
            "Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial."
          ]
        },
        {
          "title": "High-dose eicosapentaenoic acid (EPA) improves attention and ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31745072/",
          "excerpts": [
            "EPA treatment improves cognitive symptoms in ADHD youth, especially if they have a low baseline endogenous EPA level."
          ]
        },
        {
          "title": "Neurodevelopmental effects of omega-3 fatty acids and its ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0022395625001141",
          "excerpts": [
            "by NM Walter · 2025 · Cited by 1 — EPA and DHA with MPH treatments increased Wnt activity in both MPH responder-ADHD and control neural stem cells. •. Only treatments of EPA with DHA elevated ..."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37656283/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        },
        {
          "title": "Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of ...",
          "url": "https://www.psychiatrist.com/jcp/omega-3-polyunsaturated-fatty-acids-core-symptoms-adhd-meta-analysis-randomized-controlled-trials/",
          "excerpts": [
            "Our findings indicate that omega-3 PUFAs did not improve ADHD core symptoms, but long-term supplementation may have potential benefits."
          ]
        }
      ],
      "reasoning": "The fine-grained field value specifies a dosing ratio: EPA to DHA in comparable amounts totaling 750–1500 mg daily for several weeks. The most directly relevant excerpts are those that discuss EPA/DHA dosing, composition, or trial protocols involving omega-3 fatty acids. A passage that notes the percentage of EPA in supplements (less than 60% EPA) directly informs how dosing composition can affect outcomes, making it highly pertinent to the specified dosing scheme. A randomized or controlled trial reference that presumably includes omega-3 dosing for ADHD or related symptoms (even if the exact mg figures aren't always stated in the excerpt) is also very relevant, since it would cover actual dosing used in practice. Other excerpts describe the observed effects of EPA treatment on cognitive symptoms or ADHD outcomes, which support the idea that EPA/DHA dosing matters for efficacy but are secondary to the explicit dosing information. Systematic reviews and meta-analyses that discuss omega-3 trials in ADHD/PTSD/anxiety provide context for dosing ranges and the overall evidence base, thus supporting the field value insofar as they discuss how EPA/DHA dosages relate to outcomes, even if they don't specify the exact 750–1500 mg daily figure in every case. Excerpts focusing on broad omega-3 associations with outcomes or on non-dosing aspects (e.g., other interventions or conditions) are supportive context but less directly tied to the precise dosing field value. Similarly, excerpts that are about elimination diets or other non-omega-3 interventions are not relevant to the specified dosing value and are deprioritized. In short, the most relevant pieces explicitly address EPA composition and dosing in omega-3 regimens, while additional pieces provide outcome-related or contextual information that corroborates that EPA/DHA dosing can influence ADHD-related symptoms, albeit less directly tied to the exact mg range specified.",
      "confidence": "medium"
    },
    {
      "field": "neuromodulation_and_brain_stimulation_therapies.evidence_for_adhd",
      "citations": [
        {
          "title": "PMCID: PMC10580630 – Therapeutic efficacy of rTMS for ADHD (Chen et al., 2023)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10580630/",
          "excerpts": [
            "Meta-analysis of five RCTs with 189 participants (mean age of 32.78 and 8.53 years in adult and child/adolescent populations, respectively) demonstrated that rTMS was more effective for improving sustained attention in patients with ADHD compared with the control groups (SMD = 0.54, *p* = 0.001",
            "Our results demonstrated more significant improvements in sustained attention and processing speed but not in memory and executive function among ADHD patients treated with rTMS compared with those in the control groups.",
            "Our secondary analysis also showed that rTMS was more effective for improving processing speed than the control groups (SMD = 0.59, *p* = 0.002) but not for enhancing memory or executive function",
            "The result of our primary outcome showed that treatment with rTMS was associated with a more significant improvement in sustained attention than in controls when assessed by mindstreams battery and CPT, which were computerized versions of standardized attentional tests.",
            "The aims of present meta-analysis were, therefore, to investigate the therapeutic efficacy of rTMS focusing on different cognitive performances measured by standardized tasks as well as to identify possible factors (e.g., different locations of stimulation) that may influence its therapeutic outcomes in patients with ADHD.",
            "Nevertheless, the soundness of evidence derived from the current study warrants elucidation from further clinical investigations given the limited number of eligible studies (*n* = 5, total sample size = 189",
            "Therapeutic efficacies of repetitive transcranial magnetic stimulation (rTMS) for improving cognitive functions in patients with deficit/hyperactivity disorder (ADHD) remained unclear."
          ]
        }
      ],
      "reasoning": "The most directly supportive content states that meta-analyses found rTMS to improve sustained attention with a meaningful effect size, and another excerpt notes improvements in sustained attention and processing speed while not improving memory or executive function. This aligns with the finegrained field value's emphasis on targeted benefits to inattentive symptoms in ADHD and suggests that benefits are domain-specific rather than universal across all cognitive domains. Additional excerpts point to limitations such as a small number of eligible studies, indicating that the overall evidence base is still evolving and not unequivocally conclusive. There is also explicit mention of investigating different stimulation locations and cognitive outcomes, implying that efficacy may depend on stimulation parameters and targeted symptoms. Taken together, these excerpts support a nuanced view: rTMS shows promise for certain ADHD-related attentional symptoms (sustained attention, processing speed) but does not consistently improve all domains (memory, executive function), and the evidence base has limitations that warrant cautious interpretation. ",
      "confidence": "medium"
    },
    {
      "field": "psychedelic_and_dissociative_assisted_therapies.clinical_evidence_summary",
      "citations": [
        {
          "title": "MDMA-assisted therapy for moderate to severe PTSD: a randomized ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10579091/",
          "excerpts": [
            "Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms ..."
          ]
        },
        {
          "title": "A Multi-Site Phase 3 Study of MDMA-Assisted Therapy ...",
          "url": "https://maps.org/mdma/ptsd/mapp1/",
          "excerpts": [
            "Three sessions of MDMA-assisted therapy significantly reduced PTSD symptoms and functional impairment, compared to placebo."
          ]
        },
        {
          "title": "FDA advisers reject MDMA as treatment for PTSD",
          "url": "https://www.npr.org/sections/shots-health-news/2024/06/04/nx-s1-4991112/mdma-therapy-ptsd-fda-advisors",
          "excerpts": [
            "Jun 4, 2024 — Following public comment and discussion, the panel voted 9-2 that MDMA – in combination with talk therapy – is not effective for treating PTSD."
          ]
        },
        {
          "title": "Why FDA Panel Rejected MDMA for PTSD Treatment",
          "url": "https://www.psychiatrist.com/news/why-fda-panel-rejected-mdma-for-ptsd-treatment/",
          "excerpts": [
            "Jun 5, 2024 — Clinical relevance: An FDA advisory panel voted against the use of MDMA – or ecstasy – to treat post-traumatic stress disorder."
          ]
        },
        {
          "title": "FDA Psychopharmacologic Advisory Committee Votes ...",
          "url": "https://www.hcplive.com/view/live-updates-fda-psychopharmacologic-advisory-committee-meeting-mdma-ptsd",
          "excerpts": [
            "Jun 4, 2024 — The US Food and Drug Administration (FDA) Psychopharmacologic Advisory Committee (PDAC) voted 2-9 against supporting the effectiveness of MDMA in the treatment ..."
          ]
        },
        {
          "title": "FDA advisors voted against MDMA therapy – researchers ...",
          "url": "https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it",
          "excerpts": [
            "Jun 20, 2024 — A vote against using MDMA as part of therapy for PTSD has provoked a powerful backlash among researchers who study psychedelic drugs."
          ]
        },
        {
          "title": "MDMA-assisted psychotherapy for treatment of PTSD: study design ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31065731/",
          "excerpts": [
            "The between-group Cohen's d effect size was 0.8, indicating a large treatment effect. After two experimental sessions, more participants in ..."
          ]
        }
      ],
      "reasoning": "Two pivotal Phase 3 trials are described as showing reduction in PTSD symptoms with MDMA-assisted therapy when compared to placebo with therapy, indicating clinically meaningful efficacy. This aligns with the first part of the field value that asserts significant efficacy signals from MAPP1 and MAPP2. Several excerpts explicitly state reductions in PTSD symptoms or functional impairment and emphasize the role of MDMA-assisted therapy as part of the treatment combination, which supports the efficacy portion of the field value. However, multiple excerpts also depict regulatory backlash or hesitation, noting that FDA advisory panels or regulators questioned effectiveness or voted against approval, and that clinical relevance or adequacy of the evidence was contested due to methodological and ethical concerns. This directly supports the latter portion of the field value, which claims that despite positive efficacy signals, the trials were deemed insufficient for approval because of concerns raised by the FDA and its advisory committees. Taken together, the excerpts corroborate a narrative of initial positive efficacy signals in MAPP1/MAPP2, followed by regulatory concerns and a decision not to approve, thereby matching the finegrained field value. The strongest, directly supportive statements are those describing the efficacy outcomes of the trials, while the strongest corroborative statements about regulatory concerns are those describing FDA advisory committee actions and regulatory decisions.",
      "confidence": "high"
    },
    {
      "field": "neuromodulation_and_brain_stimulation_therapies.evidence_for_ptsd",
      "citations": [
        {
          "title": "Neuromodulation treatments for post-traumatic stress disorder: a systematic review and network meta-analysis covering efficacy, acceptability, and follow-up effects",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0887618524000884",
          "excerpts": [
            "dual-tDCS (SMD = −1.30), high-frequency repetitive TMS (HF-rTMS) (SMD = −0.97), intermittent theta burst stimulation (iTBS) (SMD = −0.93), and low-frequency repetitive TMS (LF-rTMS) (SMD = −0.76) were associated with significant reductions in PTSD symptoms at the treatment endpoint, but these effects were not significant at follow-up; (2) no difference was found between any active treatment with sham contr"
          ]
        },
        {
          "title": "Repetitive transcranial magnetic stimulation for PTSD (PMCID: PMC11475085)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11475085/",
          "excerpts": [
            "Repetitive transcranial magnetic stimulation (rTMS) showed potentially beneficial effects for the treatment of post-traumatic stress disorder (PTSD).",
            "To specifically explore the efficacy and safety of LF rTMS for treating PTSD.",
            "LF rTMS of the right DLPFC ranked first in acceptability among all treatment protocols."
          ]
        },
        {
          "title": "Low-frequency repetitive transcranial magnetic stimulation ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39411406/",
          "excerpts": [
            "by C Jiang · 2024 · Cited by 1 — Network meta-analysis showed that compared to sham treatment, only HF rTMS on the right dorsolateral prefrontal cortex (DLPFC) demonstrated a ..."
          ]
        },
        {
          "title": "Advances in Repetitive Transcranial Magnetic Stimulation ...",
          "url": "https://www.imrpress.com/journal/AP/25/4/10.5152/alphapsychiatry.2024.241587/pdf",
          "excerpts": [
            "Sep 2, 2024 — rTMS of both the right and left DLPFC significantly reduced PTSD symptoms, but the effect of right rTMS was greater than left rTMS59. (Table ..."
          ]
        },
        {
          "title": "Non-invasive brain stimulation for posttraumatic stress ...",
          "url": "https://www.nature.com/articles/s41398-020-0851-5",
          "excerpts": [
            "by RLD Kan · 2020 · Cited by 94 — A more recent meta-analysis including nine original studies (six RCTs) demonstrated positive effects of rTMS on PTSD with an effect size of − ..."
          ]
        }
      ],
      "reasoning": "The field value summarizes that several meta-analyses support the acute efficacy of rTMS and related neuromodulation approaches for PTSD, while noting that long-term effects are less clear. It also mentions a specific finding that 20-Hz rTMS applied to the right DLPFC may increase dispositional mindfulness. The most directly supportive content shows that a broad, recent network meta-analysis found significant PTSD symptom reductions at the end of treatment across multiple modalities (HF-rTMS, iTBS, and LF-rTMS) with substantial benefit sizes, but with a limitation that these effects did not remain at follow-up. This aligns with the field value's emphasis on acute efficacy and uncertain long-term maintenance. Additional excerpts corroborate that rTMS can have potentially beneficial effects for PTSD and that specific protocols (e.g., LF-rTMS on the right DLPFC) are highlighted for acceptability or particular efficacy signals, which further supports the array of options noted in the field value. The referenced study on right DLPFC stimulation and mindfulness provides a concrete example of a broader cognitive-benefit claim associated with a specific stimulation target, matching the reported detail in the field value. Overall, the combination of multiple meta-analytic findings and targeted modality-specific observations in these excerpts coherently supports the field value's core claims about acute efficacy across modalities and the lingering uncertainty of sustained, long-term efficacy.",
      "confidence": "high"
    },
    {
      "field": "neurobiological_mechanisms_of_action",
      "citations": [
        {
          "title": "ADHD symptoms are associated with the modular structure ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6497005/",
          "excerpts": [
            "by K Hilger · 2019 · Cited by 30 — Recent studies broadened the focus toward three-network models of ADHD, proposing that stronger interactions between salience and default-mode network relative ..."
          ]
        },
        {
          "title": "a mega-analysis of multiple large samples - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9751118/",
          "excerpts": [
            "by LJ Norman · 2022 · Cited by 33 — We report significant ADHD-related differences in interactions between the default mode network and task-positive networks, in line with default mode ..."
          ]
        },
        {
          "title": "Neurobiology of Attention Deficit/Hyperactivity Disorder",
          "url": "https://www.nature.com/articles/pr9201196",
          "excerpts": [
            "by D Purper-Ouakil · 2011 · Cited by 247 — This article aims to provide an overview of recent findings in the rapidly evolving field of ADHD neurobiology with a focus on novel strategies regarding ..."
          ]
        },
        {
          "title": "The neural circuits and molecular mechanisms underlying ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10728304/",
          "excerpts": [
            "by J Iqbal · 2023 · Cited by 19 — In PTSD, the bidirectional communication of the PFC with the hippocampus and amygdala plays a very important role in regulating traumatic fear learning and its ...",
            "by J Iqbal · 2023 · Cited by 19 — In this review article, we asked how traumatic stress affects the neural circuits in brain and what underlying mechanisms are behind this change. We also ..."
          ]
        },
        {
          "title": "Post traumatic stress disorder associated hypothalamic- ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11401111/",
          "excerpts": [
            "by S Lawrence · 2024 · Cited by 29 — However, PTSD has been associated with dysregulation of this system, shown by altered levels of CRH, ACTH, and cortisol, as well as altered ...",
            "by S Lawrence · 2024 · Cited by 29 — This review focuses on how PTSD dysregulates the HPA axis, and further, how these alterations affect the immune system and physical health outcomes."
          ]
        },
        {
          "title": "Structural Neuroimaging of Hippocampus and Amygdala ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10829655/",
          "excerpts": [
            "by Z Ben-Zion · 2023 · Cited by 25 — While changes in hippocampal activity in PTSD are not consistent (10), smaller hippocampal volume is the most consistent structural abnormality in PTSD (11,12)."
          ]
        },
        {
          "title": "Brain activation and heart rate variability as markers of autonomic ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12316975/",
          "excerpts": [
            "... autonomic dysregulation, such as depression and anxiety or posttraumatic stress disorder. ... vmPFC and amygdala showed influence of ..."
          ]
        },
        {
          "title": "Can working memory account for EMDR efficacy in PTSD?",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9623920/",
          "excerpts": [
            "by DL Wadji · 2022 · Cited by 36 — Dual taxation takes place when an individual recalls a distressing memory while also performing a bilateral stimulation or secondary task, such as EM, mental ..."
          ]
        },
        {
          "title": "State of the science: Eye movement desensitization and ...",
          "url": "https://onlinelibrary.wiley.com/doi/10.1002/jts.23012",
          "excerpts": [
            "by A de Jongh · 2024 · Cited by 45 — Eye movement desensitization and reprocessing (EMDR) therapy is an evidence-based psychotherapy for posttraumatic stress disorder (PTSD), with support from ..."
          ]
        },
        {
          "title": "Scientific Evaluation of EMDR Psychotherapy for the Treatment of ...",
          "url": "https://www.jneurology.com/articles/scientific-evaluation-of-emdr-psychotherapy-for-the-treatment-of-psychological-trauma-summary-scientific-evaluation-of-emdr-psycho.html",
          "excerpts": [
            "This paper is a current review of the scientific validation steps of EMDR psychotherapy and its mechanisms of action."
          ]
        },
        {
          "title": "The Predictive Processing Model of EMDR",
          "url": "https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2019.02267/full",
          "excerpts": [
            "by DE Chamberlin · 2019 · Cited by 31 — The Predictive Processing model of EMDR postulates that EMDR facilitates the predictive processing of traumatic memory by overcoming the bias against ..."
          ]
        },
        {
          "title": "ADHD and PTSD Neurobiology",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10501041/",
          "excerpts": [
            " methylphenidate is able to restore impaired glutamatergic transmission at the prefrontal cortex and improve behavioral symptoms of ADHD, a process that appears to be mediated by AMPA glutamatergic receptors",
            "\nADHD has also been associated with disrupted connectivity between DNM and systems involved in cognitive control and affective/motivational and salience networks",
            "A broadly studied model for ADHD suggests an impaired synchronization between the DMN (Default Mode Network), which is normally more active when tasks are not performed, and the TPN (Task-Positive Network), which is activated while performing tasks."
          ]
        },
        {
          "title": "Dopamine metabolism and signaling in ADHD – Frontiers in Psychiatry (excerpts from a longer review)",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1492126/full",
          "excerpts": [
            " stimulant drugs that are first-line pharmacotherapies for ADHD ( [13]() ). These drugs block DA and norepinephrine (NE) transporters, inhibiting catecholamine reuptake into dopaminergic nerve terminals ( [Figure 1]() ), increasing their availability at dopamine receptors.",
            "ants have effects on ADHD symptoms, possibly by optimizing DA and NE modulated task-related brain networks that increase perceived saliency, reducing interference from the default mode network ( [15]() ).",
            "Concluding remarks: Recent PET/SPECT studies do not show predominant evidence supporting a hypo-dopaminergic state in ADHD, but rather conflicting results that imply both increased and decreased extracellular DA levels within frontostriatal regions.",
            "Table 1\n\n[! [www.frontiersin.org](https://www.frontiersin.org/files/Articles/1492126/fpsyt-15-1492126-HTML/image_m/fpsyt-15-1492126-t001.jpg)](https://www.frontiersin.org/files/Articles/1492126/fpsyt-15-1492126-HTML/image_m/fpsyt-15-1492126-t001.jpg)\n\n**Table 1** . A brief summary of arguments for and against the dopamine hypothesis for ADHD as detailed from each perspective. The updated overview therefore points to the fact that there is ample evidence for some involvement of DA but limited evidence that reduced levels of the DA neurotransmitter _per se_ is a defining feature of ADHD. Based on the variable findings from clinical, genetic, imaging and neurophysiological studies, it is possible that the multiple underlying pathophysiological mechanisms in ADHD are differently involved and that the putative alterations in DA functions are only present in a subset of ADHD patients.",
            "To assess the traditional DA theory of ADHD, it is helpful to compare ADHD findings to another neuropsychological condition with a robust and reliable link to deficient DA levels – Parkinson’s disease (PD). Although seemingly on opposite ends of the aging spectrum as a neurodevelopment and neurodegenerative condition, both ADHD and PD are heterogeneous disorders which involve cortico-basal ganglia disturbances that impact the control of motor and cognitive behavior."
          ]
        },
        {
          "title": "Dysregulation of Inflammation, Neurobiology, and Cognitive Function in PTSD: An Integrative Review",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7682894/",
          "excerpts": [
            " interplay between inflammation and the amygdala-vmPFC-ACC-hippocampus circuit that further supports fear conditioning and extinction learning a"
          ]
        },
        {
          "title": "Interference of default mode on attention networks in adults with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11325164/",
          "excerpts": [
            "These findings support the interference of default mode on attention in adults with ADHD and its association with genetic risk variants and ..."
          ]
        },
        {
          "title": "PMCID: PMC10580630 – Therapeutic efficacy of rTMS for ADHD (Chen et al., 2023)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10580630/",
          "excerpts": [
            "Meta-analysis of five RCTs with 189 participants (mean age of 32.78 and 8.53 years in adult and child/adolescent populations, respectively) demonstrated that rTMS was more effective for improving sustained attention in patients with ADHD compared with the control groups (SMD = 0.54, *p* = 0.001",
            "Our secondary analysis also showed that rTMS was more effective for improving processing speed than the control groups (SMD = 0.59, *p* = 0.002) but not for enhancing memory or executive function",
            "Nevertheless, the soundness of evidence derived from the current study warrants elucidation from further clinical investigations given the limited number of eligible studies (*n* = 5, total sample size = 189",
            "The result of our primary outcome showed that treatment with rTMS was associated with a more significant improvement in sustained attention than in controls when assessed by mindstreams battery and CPT, which were computerized versions of standardized attentional tests.",
            "Our results demonstrated more significant improvements in sustained attention and processing speed but not in memory and executive function among ADHD patients treated with rTMS compared with those in the control groups.",
            "The aims of present meta-analysis were, therefore, to investigate the therapeutic efficacy of rTMS focusing on different cognitive performances measured by standardized tasks as well as to identify possible factors (e.g., different locations of stimulation) that may influence its therapeutic outcomes in patients with ADHD.",
            "Therapeutic efficacies of repetitive transcranial magnetic stimulation (rTMS) for improving cognitive functions in patients with deficit/hyperactivity disorder (ADHD) remained unclear."
          ]
        },
        {
          "title": "Frontiers in Psychiatry 2025 Han et al.",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1544816/full",
          "excerpts": [
            "However, due to the limited number of samples (n = 8), these results should be interpreted cautiously."
          ]
        },
        {
          "title": "Advances in Repetitive Transcranial Magnetic Stimulation for the ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11443297/",
          "excerpts": [
            "The treatment results showed that 20-Hz rTMS of both the right and left DLPFC significantly reduced PTSD symptoms, but the effect of right rTMS was greater than ..."
          ]
        },
        {
          "title": "Effect of Stellate Ganglion Block Treatment on ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31693083/",
          "excerpts": [
            "Conclusions and relevance:**\nIn this trial of active-duty service members with PTSD symptoms (at a clinical threshold and subthreshold), 2 SGB treatments 2 weeks apart were effective in reducing CAPS-5 total symptom severity scores over 8 week",
            "Active-duty service members on stable psychotropic medication dosages who had a PTSD Checklist-Civilian Version (PCL-C) score of 32 or more at screening were included.",
            "by KLR Olmsted · 2020 · Cited by 149 — 2 SGB treatments 2 weeks apart were effective in reducing CAPS-5 total symptom severity scores over 8 weeks.",
            "adjusted mean total symptom severity score change was -12.6 points (95% CI, -15.5 to -9.7 points) for the group receiving SGB treatments, compared with -6.1 points (95% CI, -9.8 to -2.3 points) for those receiving sham treatment (P = .01)."
          ]
        },
        {
          "title": "A clinician's guide to the 2023 VA/DoD Clinical Practice ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38184799/",
          "excerpts": [
            "by AJ Lang · 2024 · Cited by 24 — A clinician's guide to the 2023 VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder. J Trauma Stress."
          ]
        },
        {
          "title": "Differential effects of theta/beta and SMR neurofeedback in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4274876/",
          "excerpts": [
            "by M Arns · 2014 · Cited by 111 — TBR and SMR neurofeedback had similar effects on symptom reduction in ADHD (inattention and hyperactivity/impulsivity).",
            "In the SMR group all patients received a reward on 12–15 Hz at central locations (C3, Cz or C4); and the TBR group received mostly beta rewards outside the SMR ..."
          ]
        },
        {
          "title": "Comparison of Sensorimotor Rhythm (SMR) and Beta ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4749686/",
          "excerpts": [
            "by MR Mohammadi · 2015 · Cited by 52 — The aim of this study was to assess and compare the effect of two neurofeedback protocols (SMR/theta and beta/theta) on ADHD symptoms, selective attention and ...",
            "The aim of this study was to explore the efficacy and compare both SMR/theta and beta/theta protocols to enhance selective attention and reduce ADHD symptoms; ..."
          ]
        },
        {
          "title": "Transcranial Direct Current Stimulation to the Left ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8103824/",
          "excerpts": [
            "by L Dubreuil-Vall · 2020 · Cited by 39 — We assessed the cognitive and physiological effects of transcranial direct current stimulation (tDCS) in 40 adult patients with ADHD.",
            "by L Dubreuil-Vall · 2020 · Cited by 39 — This study indicates that anodal tDCS over the left DLPFC using a simple bipolar montage has procognitive effects in dysexecutive patients with ADHD associated ..."
          ]
        },
        {
          "title": "Neurofeedback for ADHD: Exploring the Role ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12321976/",
          "excerpts": [
            "by R Ölçüoğlu · 2025 — This review explores the efficacy of neurofeedback (NFB) in ADHD by analyzing key studies, EEG‐based subtypes, and protocol outcomes. Theta/beta ..."
          ]
        },
        {
          "title": "Neurofeedback as a Treatment Intervention in ADHD",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6538574/",
          "excerpts": [
            "We conclude that neurofeedback based on standard protocols in ADHD should be considered as a viable treatment alternative and suggest that further research is ..."
          ]
        },
        {
          "title": "Efficacy of neurofeedback training for improving attentional ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12224457/",
          "excerpts": [
            "by I Kimura · 2024 · Cited by 4 — This systematic review and meta-analysis examined the neurofeedback training (NFT) effects on attentional performance in healthy adults."
          ]
        },
        {
          "title": "Meta-analysis finds benefits of transcranial direct current ...",
          "url": "https://www.adhdevidence.org/blog/meta-analysis-finds-benefits-of-transcranial-direct-current-stimulation-for-adhd-symptoms-and-executive-function--but-evidence-remains-weak",
          "excerpts": [
            "A meta-analysis examined whether noninvasive brain stimulation (NIBS) techniques could help reduce core symptoms of ADHD and improve cognitive ..."
          ]
        },
        {
          "title": "The Effects of Different Theta and Beta Neurofeedback ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9638270/",
          "excerpts": [
            "por A Bluschke · 2022 · Mencionado por 14 — In this study, we evaluated different EEG theta and/or beta frequency band NF protocols designed to enhance cognitive control."
          ]
        },
        {
          "title": "Theta/Beta Ratio Neurofeedback Effects on Resting and ...",
          "url": "https://link.springer.com/article/10.1007/s10484-024-09675-w",
          "excerpts": [
            "por S Enriquez-Geppert · 2024 · Mencionado por 1 — The neurofeedback protocol aimed to downtrain theta (4–8 Hz) and upregulate beta (13–21 Hz) at Cz or Fz, depending on which electrode site had ..."
          ]
        },
        {
          "title": "SMR Neurofeedback Training Facilitates Working Memory ...",
          "url": "https://www.frontiersin.org/journals/behavioral-neuroscience/articles/10.3389/fnbeh.2018.00321/full",
          "excerpts": [
            "The aim of this study is to test if the SMR protocol can improve working memory performance in an aging population and consequently favor cognitive reserve."
          ]
        },
        {
          "title": "Neuromodulation treatments for post-traumatic stress disorder: a systematic review and network meta-analysis covering efficacy, acceptability, and follow-up effects",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0887618524000884",
          "excerpts": [
            "dual-tDCS (SMD = −1.30), high-frequency repetitive TMS (HF-rTMS) (SMD = −0.97), intermittent theta burst stimulation (iTBS) (SMD = −0.93), and low-frequency repetitive TMS (LF-rTMS) (SMD = −0.76) were associated with significant reductions in PTSD symptoms at the treatment endpoint, but these effects were not significant at follow-up; (2) no difference was found between any active treatment with sham contr",
            "The current study explored nine neuromodulation protocols for treating PTSD, including traditional TMS (i.e., HF-rTMS and LF-rTMS), novel TMS (i.e., iTBS, dTMS, sTMS), tDCS (i.e., dual-tDCS, and a-tD",
            "F-rTMS) (SMD = −0.76) were associated with significant reductions in PTSD symptoms at the treatment endpoint, but these effects were not significant at follow-up; (2) no difference was found between any active treatment with sham contro",
            "hted iTBS as a promising time-efficient treatment option and supported dual-tDCS, HF-rTMS, and LF-rTMS as effective treatment options. However, their sustained efficacy is limited. Additionally, all investigated neuromodulation treatments are non-invasive and acceptable for PTSD patients.",
            "Neuromodulation treatments are novel interventions for post-traumatic stress disorder (PTSD), but their comparative effects at treatment endpoint and follow-up and the influence of moderators remain unclear."
          ]
        },
        {
          "title": "Repetitive transcranial magnetic stimulation for PTSD (PMCID: PMC11475085)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11475085/",
          "excerpts": [
            "LF rTMS of the right DLPFC ranked first in acceptability among all treatment protocols.",
            "Repetitive transcranial magnetic stimulation (rTMS) showed potentially beneficial effects for the treatment of post-traumatic stress disorder (PTSD).",
            "To specifically explore the efficacy and safety of LF rTMS for treating PTSD."
          ]
        },
        {
          "title": "NFB as an Evidence-Based Treatment for ADHD",
          "url": "https://isnr.org/wp-content/uploads/2019/07/NFB-as-an-Evidence-Based-Treatment-for-ADHD.pdf",
          "excerpts": [
            "Therefore, NFB is usually a one-time intervention of 40 or fewer sessions over the course of four months or less, whereas psychotherapy and/or stimulant.",
            "Using an EEG neurofeedback apparatus \nsimilar to that employed in human studies, \nmonkeys successfully learned to increase alpha \nfrequency brain activi"
          ]
        },
        {
          "title": "Non-invasive brain stimulation for posttraumatic stress ...",
          "url": "https://www.nature.com/articles/s41398-020-0851-5",
          "excerpts": [
            "by RLD Kan · 2020 · Cited by 94 — A more recent meta-analysis including nine original studies (six RCTs) demonstrated positive effects of rTMS on PTSD with an effect size of − ...",
            "by RLD Kan · 2020 · Cited by 94 — A more recent meta-analysis including nine original studies (six RCTs) demonstrated positive effects of rTMS on PTSD with an effect size of − ..."
          ]
        },
        {
          "title": "Low-frequency repetitive transcranial magnetic stimulation ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39411406/",
          "excerpts": [
            "by C Jiang · 2024 · Cited by 1 — Network meta-analysis showed that compared to sham treatment, only HF rTMS on the right dorsolateral prefrontal cortex (DLPFC) demonstrated a ..."
          ]
        },
        {
          "title": "Transcutaneous Auricular Vagus Nerve Stimulation for ...",
          "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828072",
          "excerpts": [
            "by S Zhang · 2024 · Cited by 9 — This randomized clinical trial found that taVNS administered at the 0.8 to 1.5 mA intensity for 8 weeks effectively improved sleep quality ..."
          ]
        },
        {
          "title": "Time-Limited Neurofeedback Training at Cz Facilitates Sensorimotor ...",
          "url": "https://nmindjournal.com/time-limited-neurofeedback-training-at-cz-facilitates-sensorimotor-recovery/",
          "excerpts": [
            "As such, Sensorimotor Rhythm (SMR; 12-15 Hz) was rewarded at 85%, Theta (4–7 Hz) was inhibited at 15%, and High Beta (21–32 Hz) was inhibited at 10%. The ..."
          ]
        },
        {
          "title": "Advances in Repetitive Transcranial Magnetic Stimulation ...",
          "url": "https://www.imrpress.com/journal/AP/25/4/10.5152/alphapsychiatry.2024.241587/pdf",
          "excerpts": [
            "Sep 2, 2024 — rTMS of both the right and left DLPFC significantly reduced PTSD symptoms, but the effect of right rTMS was greater than left rTMS59. (Table ..."
          ]
        },
        {
          "title": "Brain stimulation enhances dispositional mindfulness in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12069409/",
          "excerpts": [
            "by K Rayani · 2025 · Cited by 1 — Our results indicate that rTMS targeting the right DLPFC increases levels of dispositional mindfulness, and mindfulness subcomponents both immediately ..."
          ]
        },
        {
          "title": "10-Hz tACS over the prefrontal cortex improves phonemic ...",
          "url": "https://www.nature.com/articles/s41598-022-11961-8",
          "excerpts": [
            "by Y Sun · 2022 · Cited by 13 — It was found that 10-Hz tACS significantly improved phonemic fluency relative to sham stimulation. This result demonstrates the modulatory effect of 10-Hz tACS ..."
          ]
        },
        {
          "title": "Prefrontal Transcranial Direct Current Stimulation in ...",
          "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830597",
          "excerpts": [
            "by K Krauel · 2025 · Cited by 4 — This randomized clinical trial assesses effect sizes of changes in cognitive and clinical measures following prefrontal multichannel ..."
          ]
        },
        {
          "title": "Effects of intermittent theta-burst transcranial magnetic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37826976/",
          "excerpts": [
            "by H Yuan · 2023 · Cited by 15 — ITBS, with a shorter treatment duration, can effectively improve the symptoms of PTSD, with no significant difference in effect from that of rTMS."
          ]
        },
        {
          "title": "Efficacy and acceptability of brain stimulation for anxiety ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39477076/",
          "excerpts": [
            "by X Yang · Cited by 7 — The study results suggest that BSTs are effective treatments for anxiety disorders, OCD and PTSD; lf-rTMS may be considered as the most promising option."
          ]
        },
        {
          "title": "Study Details | Targeted Plasticity Therapy for PTSD",
          "url": "https://clinicaltrials.gov/study/NCT06266364?term=AREA%5BBasicSearch%5D(vns%20therapy)&rank=7",
          "excerpts": [
            "A prospective, multi-center, randomized, controlled, blinded trial of participants implanted with the ReStore Device for VNS Therapy. In double-blinded ..."
          ]
        },
        {
          "title": "Transcutaneous auricular vagus nerve stimulation ...",
          "url": "https://www.nature.com/articles/s41398-025-03535-9",
          "excerpts": [
            "2 days ago — In this study, we aimed to elucidate whether and how taVNS influences anxiety-like behaviors elicited by PTSD, focusing on synaptic plasticity ..."
          ]
        },
        {
          "title": "Clinical experience implanting a miniature externally ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S1878747925001035",
          "excerpts": [
            "by JD Epperson · 2025 — We compiled data from three trials clinical trials using the MEPS device: stroke, spinal cord injury, or post-traumatic stress disorder at a ..."
          ]
        },
        {
          "title": "Transcranial alternating current stimulation for ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11360874/",
          "excerpts": [
            "by FG Nezhad · 2024 · Cited by 2 — In a study (25) that compared 40 Hz gamma-tACS with 10 Hz alpha-tACS, clinical symptom improvements and changes in alpha oscillations were assessed in MDD ..."
          ]
        },
        {
          "title": "Transcutaneous Auricular Vagus Nerve Stimulation to ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10886536/",
          "excerpts": [
            "by AA Ruiz · 2024 · Cited by 10 — It is currently FDA-approved for the treatment of depression and PTSD [58]. Therefore, the last two decades have seen the rapid development of taVNS devices [55] ..."
          ]
        },
        {
          "title": "Vagus nerve stimulation therapy for treatment-resistant PTSD",
          "url": "https://www.brainstimjrnl.com/article/S1935-861X(25)00060-9/fulltext",
          "excerpts": [
            "by MB Powers · 2025 · Cited by 5 — We tested VNS combined with prolonged exposure therapy as a treatment for PTSD. Nine individuals received VNS therapy with a miniaturized device."
          ]
        },
        {
          "title": "Westwood SJ et al. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis, JAMA Psychiatry, 2025",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39661381/",
          "excerpts": [
            "A total of 38 RCTs (2472 participants aged 5 to 40 years) were included.",
            "Probably blinded reports of ADHD total symptoms showed no significant improvement with neurofeedback (k = 20; n = 1214; SMD, 0.04; 95% CI, -0.10 to 0.18).",
            "A small significant improvement was seen when analyses were restricted to RCTs using established standard protocols (k = 9; n = 681; SMD, 0.21; 95% CI, 0.02 to 0.40).",
            "Results remained similar with adults excluded or when analyses were restricted to RCTs where cortical learning or self-regulation was established.",
            "Of the 5 neuropsychological outcomes analyzed, a significant but small improvement was observed only for processing speed (k = 15; n = 909; SMD, 0.35; 95% CI, 0.01 to 0.69).",
            "Heterogeneity was generally low to moderate."
          ]
        },
        {
          "title": "Meta-analysis Reports No Significant Evidence for Efficacy of Neuromechanistic Treatments for Adult ADHD",
          "url": "https://www.adhdevidence.org/blog/meta-analysis-reports-no-significant-evidence-for-efficacy-of-neuromechanistic-treatments-for-adult-adhd",
          "excerpts": [
            "Meta-analysis Reports No Significant Evidence for Efficacy of Neuromechanistic Treatments for Adult ADHD ... Neurofeedback is a non-pharmaceutical ... Outcomes were measured through self-rated scales, neuropsychological tests, and electrophysiological pre-post evaluations. Separate meta-analyses of the four tDCS RCTs combining 154 participants and of the four rTMS RCTs encompassing 149 participants likewise reported no significant improvements. In all cases variation in outcomes between studies was moderate, and there were no signs of publication bias. #####",
            "##### The Conclusion on Neuromechanistic Treatments for ADHD:\n\nMeta-analysis of all eight studies with a combined total of 421 participants reported no significant improvements over controls. Narrowing down to studies that used sham controls likewise produced no significant improvements. So, despite the title of this study, these neuromechanistic treatments do not appear to be the future of treatment for adult ADHD. ‍\n",
            "Methylphenidate is known as the gold-standard treatment for ADHD, increasing dopamine concentrations and helping to focus. However, these psychostimulants may be less well-tolerated in adults. Adverse effects include decreased appetite, nausea, racing heartbeat, restlessness, nervousness, and insomnia. Neurofeedback is a non-pharmaceutical treatment that combines cognitive behavioral therapy techniques like conditioning and positive reinforcement with electroencephalography (EEG) feedback. Electrodes are placed on specific brain areas, guiding patients to regulate their brainwave activity. Repetitive transcranial magnetic stimulation (rTMS) uses electromagnetism to induce an electric field by passing a magnetic field through the scalp. Transcranial direct current stimulation (tDCS), on the other hand, directly applies an electric current through the scalp."
          ]
        },
        {
          "title": "Neuromodulation for PTSD: the evidence to date",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39704493",
          "excerpts": [
            "The present review supports the potential of neuromodulation to reduce PTSD symptoms.",
            "rTMS and tDCS targeting the dlPFC appear effective through modulating neural circuits involved in fear processing and conditioning, however, literature varies regarding efficacy of stimulation frequencies and hemispheric targets."
          ]
        },
        {
          "title": "Stellate Ganglion Block for PTSD (JAMA Psychiatry, 2020)",
          "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2753810",
          "excerpts": [
            "Conclusions and Relevance In this trial of active-duty service members with PTSD symptoms (at a clinical threshold and subthreshold), 2 SGB treatments 2 weeks apart were effective in reducing CAPS-5 total symptom severity scores over 8 weeks ",
            ", adjusted mean total symptom severity score change was −12.6 points (95% CI, −15.5 to −9.7 points) for the group receiving SGB treatments, compared with −6.1 points (95% CI, −9.8 to −2.3 points) for those receiving sham treatment ( _P_ = .01)."
          ]
        },
        {
          "title": "A novel digital intervention for actively reducing severity ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33334505/",
          "excerpts": [
            "by SH Kollins · 2020 · Cited by 380 — This study aimed to assess whether AKL-T01 improved attentional performance in paediatric patients with ADHD. Methods: The Software Treatment for Actively ...",
            "by SH Kollins · 2020 · Cited by 380 — This study provides evidence that AKL-T01 might be used to improve objectively measured inattention in paediatric patients with ADHD, while presenting minimal ..."
          ]
        },
        {
          "title": "Two single arm trials of AKL-T01, a digital therapeutic for ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11187123/",
          "excerpts": [
            "t, AKL-T01, is a novel digital therapeutic currently authorized by the US Food and Drug Administration (FDA) as EndeavorRx® (DEN200026)[20]()",
            ". EndeavorRx is indicated to improve attentional functioning in children ages 8 to 12 years old with primarily inattentive or combined-presentation ADHD and demonstrated attentional impairment[21]()",
            "Together, these trials suggest that AKL-T01 is safe and effective for children with ADHD, and that benefits to attentional functioning and ...",
            "by CA Stamatis · 2024 · Cited by 1 — The STARS-ADHD-Adult study was initially designed to enroll up to 325 participants, with a minimum sample size of 301. An adaptive study design ..."
          ]
        },
        {
          "title": "Replication across three independent trials of AKL-T01",
          "url": "https://www.nature.com/articles/s41398-024-03045-0",
          "excerpts": [
            "by CA Stamatis · 2024 · Cited by 3 — AKL-T01 is a digital therapeutic (DTx) that targets attention by generating conflict at dynamically updated difficulty levels during a multitasking game.",
            "by CA Stamatis · 2024 · Cited by 3 — The first trial, STARS-ADHD (NCT02674633), was a 4-week trial in children ages 8–12; since this was a two-arm randomized controlled trial of ..."
          ]
        },
        {
          "title": "DEN200033 Decision Summary - accessdata.fda.gov",
          "url": "https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200033.pdf",
          "excerpts": [
            "The NightWare digital therapeutic is indicated to provide vibrotactile feedback on an \nApple Watch based on an analysis of heart rate and motion during sleep for the \ntemporary reduction of sleep disturbance related to nightmares in adults 22 years or older \nwho suffer from nightmare disorder or have nightmares from posttraumatic stress \ndisorder (PTSD). It is intended for home ",
            "The sale, distribution, and use of the NightWare device are restricted to prescription use \nin accordance with 21 CFR 801.109. The NightWare device is intended for use in adults only. The NightWare device is not intended to be used as a standalone therapy for PTSD and \nshould be used in conjunction with a patient’s prescribed medications and other \nrecommended therapy for PTSD-associated nightmares and nightmare disorder, \naccording to relevant conse",
            "PRODUCT CODE: QMZ",
            " \nClass: ",
            "The long term safety and effectiveness of the NightWare device have not been \nestablished",
            "De Novo Summary (DEN200033) \nPage 2 of 1"
          ]
        },
        {
          "title": "November 6, 2020 NightWare, Inc Amy Fowler Regulatory ...",
          "url": "https://www.accessdata.fda.gov/cdrh_docs/pdf20/DEN200033.pdf",
          "excerpts": [
            "Nov 6, 2020 — On May 27, 2020, FDA received your De Novo requesting classification of the NightWare Kit. The request was submitted under section 513(f)(2 ..."
          ]
        },
        {
          "title": "Internet-delivered cognitive behavioural therapy for post ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31359407/",
          "excerpts": [
            "by C Lewis · 2019 · Cited by 108 — Evidence showed that i-CBT may be associated with a clinically important reduction in post-treatment PTSD symptoms compared with wait list."
          ]
        },
        {
          "title": "A SYSTEMATIC REVIEW AND META-ANALYSIS",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27322710/",
          "excerpts": [
            "by M Sijbrandij · 2016 · Cited by 237 — The findings of this systematic review and meta-analysis show that iCBT is an effective treatment for individuals with PTSD and comorbid depressive symptoms."
          ]
        },
        {
          "title": "Assessing the effectiveness of internet-based interventions ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11261690/",
          "excerpts": [
            "by M Zhang · 2024 · Cited by 12 — Furthermore, our results indicated that guided IBIs proved to be more effective than unguided ones, playing a positive role in reducing dropout ..."
          ]
        },
        {
          "title": "Virtual reality exposure therapy for posttraumatic stress disorder ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6713125/",
          "excerpts": [
            "This meta-analysis investigated the efficacy of VRET for PTSD as compared to waitlist and active comparators."
          ]
        },
        {
          "title": "Evaluation of the PE Coach Mobile Application Among ...",
          "url": "https://clinicaltrials.gov/study/NCT04959695",
          "excerpts": [
            "PE Coach is a well-designed treatment companion app to one of the most researched, efficacious psychotherapies for PTSD (prolonged exposure), a treatment that ..."
          ]
        },
        {
          "title": "The efficacy of virtual reality exposure therapy for PTSD symptoms",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032719308328",
          "excerpts": [
            "Virtual reality exposure therapy (VRET) for PTSD is an emerging treatment of remarkable promise, but its efficacy and safety are still unclear."
          ]
        },
        {
          "title": "Internet-Delivered Cognitive Behavioral Therapy for Post- ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK538921/",
          "excerpts": [
            "by C Young · 2018 · Cited by 8 — The remaining primary study reported a 41.7% dropout rate in the iCBT group compared to 19% in the internet supportive counselling group. Lewis ..."
          ]
        },
        {
          "title": "Prescription Digital Therapeutics for Mental Health",
          "url": "https://www.psychiatryadvisor.com/features/prescription-digital-therapeutics/",
          "excerpts": [
            "Oct 15, 2024 — Herein, we provide an overview of prescription digital therapeutics currently cleared by the United States Food and Drug Administration (FDA) ..."
          ]
        },
        {
          "title": "Design and methods of a randomized controlled trial ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36758935/",
          "excerpts": [
            "by GM Reger · 2023 · Cited by 4 — This paper describes a randomized clinical trial that will evaluate PE delivered with and without PE Coach at post-treatment, and 1-month and 4-months post- ..."
          ]
        },
        {
          "title": "Digital therapeutics in the clinic - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10354777/",
          "excerpts": [
            "by P Phan · 2023 · Cited by 58 — Six DTx products have been approved by FDA for treating psychiatric diseases including insomnia, post‐traumatic stress disorder (PTSD), attention‐deficient ..."
          ]
        },
        {
          "title": "A randomized controlled trial to pilot the efficacy of a computer ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9622938/",
          "excerpts": [
            "The efficacy of virtual reality exposure therapy for PTSD symptoms: a systematic review and meta-analysis. J Affect Disord. (2019) 257:698 ..."
          ]
        },
        {
          "title": "Comparing the Ratio of Therapist Support to Internet Sessions ...",
          "url": "https://mental.jmir.org/2022/4/e33080/",
          "excerpts": [
            "by M Cloitre · 2022 · Cited by 19 — Results: Participants reported moderate to severe levels of baseline PTSD, depression, or both. Significant reductions were obtained in all ..."
          ]
        },
        {
          "title": "Evidence for digital therapeutics in combatting ADHD, PTSD ...",
          "url": "https://www.apaservices.org/practice/ce/expert/digital-therapeutics-adhd-ptsd-sud",
          "excerpts": [
            "Dec 18, 2023 — Capnometry guided respiratory intervention (CGRI) is an FDA cleared prescription digital therapeutic for the treatment of panic disorder and ...",
            "ADHD rating scale (ADHD-RS)",
            "Continuous Performance Task (CPT)",
            "Behavioral Rating Inventory of Executive Function questionnaire (BRIEF).",
            "PCL-5",
            "The main outcome measure from this analysis was the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5), pre and posttreatment.",
            "Overall symptoms of ADHD were assessed using the ADHD rating scale (ADHD-RS).",
            "Overall symptoms of ADHD were assessed using the ADHD rating scale (ADHD-RS).",
            "Attention control (inattention) was evaluated by the Continuous Performance Task (CPT), and executive function/working memory was assessed by the Behavioral Rating Inventory of Executive Function questionnaire (BRIEF).",
            "Attention control (inattention) was evaluated by the Continuous Performance Task (CPT), and executive function/working memory was assessed by the Behavioral Rating Inventory of Executive Function questionnaire (BRIEF).",
            "digital interventions significantly improved symptoms of inattention and decreased reaction time in ADHD patients."
          ]
        },
        {
          "title": "Two single arm trials of AKL-T01, a digital therapeutic for ...",
          "url": "https://www.nature.com/articles/s44184-024-00075-w",
          "excerpts": [
            "by CA Stamatis · 2024 · Cited by 2 — Together, these trials suggest that AKL-T01 is safe and effective for children with ADHD, and that benefits to attentional functioning and ...",
            "by CA Stamatis · 2024 · Cited by 2 — We evaluated AKL-T01—a digital therapeutic that is FDA-cleared for children 8–12 y with ADHD—in adolescents and adults with ADHD in two ..."
          ]
        },
        {
          "title": "10 Best Brain Training Programs for Children with ADHD",
          "url": "https://www.additudemag.com/brain-training-game-adhd-apps/?srsltid=AfmBOoqDMmO9tyXf5VakWOIltVGCz7H1FO6ilbF-tn-GYl0ciVsr3E2_",
          "excerpts": [
            "Dec 7, 2023 — Myndlift is a mobile neurofeedback app aimed at improving focus and attention. It uses real-time brainwave measurements and visual/auditory ..."
          ]
        },
        {
          "title": "Cogmed",
          "url": "https://www.cogmed.com/",
          "excerpts": [
            "Cogmed is the world's most proven digital tool for improving working memory and attention. The program's ability to grow cognitive capacity has been ..."
          ]
        },
        {
          "title": "Long-term far-transfer effects of working memory training in ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26669692/",
          "excerpts": [
            "by A Bigorra · 2016 · Cited by 170 — CWMT had a significant impact on ADHD deficits by achieving long-term far-transfer effects. Keywords: Attention-deficit/hyperactivity disorder (ADHD); Cogmed; ..."
          ]
        },
        {
          "title": "The cognitive and academic benefits of Cogmed: A meta ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S1747938X18303658",
          "excerpts": [
            "by ND Aksayli · 2019 · Cited by 149 — Cogmed WM Training has been claimed to enhance cognitive and academic skills. Near-zero effects were found in far-transfer measures (eg, mathematics)."
          ]
        },
        {
          "title": "Effectiveness of Cognitive Training for School-Aged ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32010026/",
          "excerpts": [
            "by A Veloso · 2020 · Cited by 94 — In sum, results showed that cognitive training can be an effective intervention for children and adolescents with ADHD and might be a ..."
          ]
        },
        {
          "title": "Cognitive training for children with ADHD: a randomized ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4516808/",
          "excerpts": [
            "by M van der Donk · 2015 · Cited by 133 — So far, results regarding academic outcome measures have been inconsistent. Hundred and two children with ADHD between the age of 8 and 12 years (both medicated ..."
          ]
        },
        {
          "title": "Elbe et al. 2023 — Computerized Cognitive Training for Adults with ADHD (Systematic Review and Meta-Analysis)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36892894/",
          "excerpts": [
            "The results revealed a small positive change in overall cognitive functioning, a measure of all cognitive outcomes in each study, for individuals who took part in CCT compared to controls (*k* = 9, Hedge's *g* = 0.235, 95% CI [0.002, 0.467], *p* = 0.048, τ² = 0.000, *I*² = 0",
            "However, neither symptom severity nor specific cognitive outcomes (executive functioning, cognitive speed, or working memory) showed a significant improvement.",
            "Due to the lack of heterogeneity in intervention designs across the included studies, increased heterogeneity in future studies could help inform clinicians about the aspects of CCT, such as training type and length, that are most beneficial for this group."
          ]
        },
        {
          "title": "EEG Neurofeedback for ADHD: meta-analytic evidence and related digital/tech-assisted interventions (J Am Acad Child Adolesc Psychiatry; 2016; 55(6):444-455; and related sources)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9764556/",
          "excerpts": [
            "Our results showed that EEG-NF had a significant beneficial impact on sustained attention (Hedges' g = 0.32, p < 0.01), whereas its effects on ...",
            "he current meta-analysis of data from fourteen studies found more improvement in attentional performance in ADHD subjects receiving surface EEG-NF than that in their comparators (Hedges’ *g* = 0.29, *p* < 0.",
            "Neurofeedback for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials.",
            "Computer-based attention training in the schools for children with attention deficit/hyperactivity disorder: a preliminary trial."
          ]
        },
        {
          "title": "Docket No. FDA-2021-N-0009",
          "url": "https://downloads.regulations.gov/FDA-2021-N-0009-0048/attachment_1.pdf",
          "excerpts": [
            "3 FDA, Decision Summary, De Novo Classification Request for EndeavorRX (DEN200026) ... fda.gov/cdrh_docs/reviews/DEN200026.pdf. 4 FDA ..."
          ]
        },
        {
          "title": "Device Classification Under Section 513(f)(2)(De Novo) - FDA",
          "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?ID=DEN200026",
          "excerpts": [
            "Classification Order25. FDA Review, Decision Summary26. Type, Direct ... http://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200026.pdf. Page ...",
            "Review Advisory Committee, Neurology. Classification Order, Classification Order25. FDA Review, Decision Summary26. Type, Direct. Predetermined ..."
          ]
        },
        {
          "title": "Akili Announces FDA Clearance of EndeavorRx™ for Children with ...",
          "url": "https://www.akiliinteractive.com/news-collection/akili-announces-endeavortm-attention-treatment-is-now-available-for-children-with-attention-deficit-hyperactivity-disorder-adhd-al3pw",
          "excerpts": [
            "EndeavorRx was granted clearance based on data from five clinical studies in more than 600 children diagnosed with ADHD, including a prospective ..."
          ]
        },
        {
          "title": "FEP Medical Policy Manual",
          "url": "https://www.fepblue.org/-/media/PDFs/Medical-Policies/2024/October/Medical-Policies/Remove-and-Replace/30303-Digital-Health-Technologies-for.pdf",
          "excerpts": [
            "In April 2020, EndeavorRx (Akili Interactive Labs) received marketing clearance by the U.S. Food and Drug Administration (FDA) through the De ..."
          ]
        },
        {
          "title": "[PDF] December 13, 2023 Akili Interactive Labs, Inc. Bhupinder Singh ...",
          "url": "https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231337.pdf",
          "excerpts": [
            "Of 342 participants who received AKL-T01 in the two clinical trials supporting EndeavorRx authorization for age ranges 8-17, 16 participants ( ..."
          ]
        },
        {
          "title": "NightWare | Take Sleep Back. Move Life Forward.",
          "url": "https://nightware.com/",
          "excerpts": [
            "NightWare is a prescription digital therapeutic system for the reduction of sleep disturbance related to Nightmare Disorder or nightmares from post-traumatic ..."
          ]
        },
        {
          "title": "NIGHTWARE CLINICAL INFORMATION",
          "url": "https://nightware.com/wp-content/uploads/2021/08/NIGHTWARE-CLINICAL-DATA-OVERVIEW.pdf",
          "excerpts": [
            "In a single-arm open-label pilot study of NightWare in 9 subjects1 to explore the effects of NightWare on sleep quality, there was a large effect size of a 6-point improvement in the Pittsburgh Sleep Quality Index (PSQI), a well-validated measure of sleep quality [Figure A]."
          ]
        },
        {
          "title": "[PDF] A randomized sham-controlled clinical trial of a novel wearable ...",
          "url": "https://nightware.com/wp-content/uploads/2024/03/NightWare-RCT.pdf",
          "excerpts": [
            "Expanding on preliminary results from an open-label pilot, which demonstrated improvement in sleep quality, as well as in mental health symptoms and quality of ..."
          ]
        },
        {
          "title": "Veterans find relief from nightmares with NightWare and ...",
          "url": "https://www.apple.com/newsroom/2022/11/veterans-find-relief-from-nightmares-with-nightware-and-apple-watch/",
          "excerpts": [
            "Nov 7, 2022 — NightWare is a digital therapeutic system that works in conjunction with Apple Watch and iPhone to disrupt nightmares related to post-traumatic stress disorder.See more"
          ]
        },
        {
          "title": "Remote Study of NightWare for PTSD With Nightmares",
          "url": "https://www.clinicaltrials.gov/study/NCT03934658",
          "excerpts": [
            "The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related ..."
          ]
        },
        {
          "title": "Patient FAQ",
          "url": "https://nightware.com/patient-faq/",
          "excerpts": [
            "If you are a clinician or patient associated with the VA or DoD, please contact us directly about coverage for NightWare. >In what ways does NightWare ...See more"
          ]
        },
        {
          "title": "Patients",
          "url": "https://nightware.com/patients/",
          "excerpts": [
            "Available by prescription only, our FDA-cleared device is for the temporary reduction of sleep disturbance related to nightmares. If you are 22 or older and ..."
          ]
        },
        {
          "title": "Professionals FAQ",
          "url": "https://nightware.com/professionals-faq/",
          "excerpts": [
            "We launched NightWare with the Veterans Administration (VA) and the Department of Defense (DoD) because they have a high concentration of patients in need and ...See more"
          ]
        },
        {
          "title": "Internet-Delivered Cognitive Behavioural Therapy for Post- ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8398719/",
          "excerpts": [
            "Internet-delivered CBT may reduce the severity of PTSD symptoms compared with wait-list or usual care, but the evidence is very uncertain, and iCBT may have ...",
            "From a meta-analysis of eight studies (N = 560), iCBT was more effective than wait-list or usual care alone in alleviating the severity of PTSD symptoms post-"
          ]
        },
        {
          "title": "Efficacy of digital mental health interventions for PTSD symptoms",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032724006852",
          "excerpts": [
            "Results. Overall, our review elucidates that DMHIs are appropriate for alleviating PTSD symptoms in adults , with more consistent evidence supporting the efficacy of cognitive behavioral therapy (CBT)-based, compared to non-CBT-based, interventions when compared to control conditions."
          ]
        },
        {
          "title": "Do the effects of internet-delivered cognitive-behavioral ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0272735824001399",
          "excerpts": [
            "by NH Zainal · 2024 · Cited by 5 — The i-CBTs had small to large effects in reducing anxiety, depression, and PTSD. Long-term efficacy was weaker for insomnia, stronger for ER and QOL and ..."
          ]
        },
        {
          "title": "Guided internet-delivered cognitive behavior therapy for ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2214782914000074",
          "excerpts": [
            "by D Ivarsson · 2014 · Cited by 135 — The aim of this randomized controlled trial was to investigate the effects of guided internet-based cognitive behavior therapy (ICBT) for posttraumatic stress ..."
          ]
        },
        {
          "title": "Internet-delivered cognitive behavioural therapy for ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10440509/",
          "excerpts": [
            "by H McCall · 2023 · Cited by 13 — A recent randomized controlled trial found that trauma-focused ICBT outperformed non-trauma-focused ICBT for treating PTSD, but the non-trauma-focused ICBT ..."
          ]
        },
        {
          "title": "Efficacy of digital mental health interventions for PTSD symptoms",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38679205/",
          "excerpts": [
            "Our review elucidates that DMHIs are appropriate for alleviating PTSD symptoms in adults, with more consistent evidence supporting the efficacy of cognitive ..."
          ]
        },
        {
          "title": "A meta-analysis of dropout from evidence-based ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8344790/",
          "excerpts": [
            "by C Simmons · 2021 · Cited by 41 — Conclusions: Evidence-based treatments for children and young people with PTSD do not result in higher prevalence of dropout than non-trauma focused treatment ..."
          ]
        },
        {
          "title": "Response and Remission Rates in Internet-Based ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6823683/",
          "excerpts": [
            "by G Andersson · 2019 · Cited by 75 — Remission was achieved in 540 participants (35.2%; 95% CI: 32.81–37.59) when adjusting for floor effects (the unadjusted proportion was 31.9%)."
          ]
        },
        {
          "title": "FDA De Novo Summary for EndeavorRx",
          "url": "https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200026.pdf",
          "excerpts": [
            "EndeavorRx is a digital therapeutic indicated to improve attention function as measured by  computer-based testing in children ages 8-12 years old with primarily inattentive or combined- type ADHD, who have a demonstrated attention issue",
            "EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with ... STARS-ADHD \nBackground and Trial Design \nP"
          ]
        },
        {
          "title": "[PDF] Akili Interactive Labs Inc. Janice Hogan Regulatory Counsel Hogan ...",
          "url": "https://www.accessdata.fda.gov/cdrh_docs/pdf20/DEN200026.pdf",
          "excerpts": [
            "FDA concludes that this device should be classified into. Class II. This order, therefore, classifies the EndeavorRx, and substantially ..."
          ]
        },
        {
          "title": "Guided, internet based, cognitive behavioural therapy for post ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9202033/",
          "excerpts": [
            "Compared with a wait list, the authors concluded that internet based CBT-TF might be associated with a clinically important reduction in PTSD."
          ]
        },
        {
          "title": "Efficacy of immersive PTSD treatments: A systematic review of virtual ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S002239562031089X",
          "excerpts": [
            "Virtual/Augmented reality exposure therapy (V/ARET) may enhance PTSD treatment. VRET outperformed waitlist control and matched other active psychotherapies."
          ]
        },
        {
          "title": "The Use of Mobile Games in the Management of Patients With ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8931195/",
          "excerpts": [
            "Video games have been previously shown in reviews to be effective in both the diagnosis and treatment of ADHD and other mental health disorders (7, 8). One of ..."
          ]
        },
        {
          "title": "Effects of daily posttraumatic stress disorder symptoms on ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10841862/",
          "excerpts": [
            "by DC Slavish · 2023 · Cited by 3 — Across multiple studies, individuals with PTSD show reduced HRV compared to controls. In a 2013 meta-analysis, individuals with PTSD exhibited reduced high- ...",
            "by DC Slavish · 2023 · Cited by 3 — In a 2013 meta-analysis, individuals with PTSD exhibited reduced high-frequency HRV (HF-HRV) and low-frequency-HRV (LF-HRV) compared to those without PTSD ( ..."
          ]
        },
        {
          "title": "Designing and developing a prescription digital therapeutic ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11850387/",
          "excerpts": [
            "by R Macy · 2025 — This paper outlines a systematic approach for the development, distribution, and implementation of a prescription at-home HRV-BFB digital therapeutic."
          ]
        },
        {
          "title": "STARS-ADHD Trial of AKL-T01 (EndeavorRx)",
          "url": "https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30017-0/fulltext",
          "excerpts": [
            "STARS-ADHD was a randomised, double-blind, parallel-group, controlled trial done at 20 research institutions (appendix p 3) in the USA from July ...",
            "The STARS-ADHD trial represented a randomised controlled trial for the evaluation of a digital intervention to improve objectively measured attention in children with ADHD.",
            "It showed that compared to the control condition, AKL-T01 significantly improved objective measures of attention, as measured by the TOVA.",
            "The intervention was well tolerated, and this risk–benefit ratio suggests that AKL-T01 could be a novel addition to the range of intervention options for ADHD.",
            "The digital nature of the intervention could help to increase access for populations who might not otherwise be able to find non-pharmacological interventions."
          ]
        },
        {
          "title": "HRV biofeedback meta-analysis and related references (Scientific Reports / Nature context)",
          "url": "https://www.nature.com/articles/s41598-021-86149-7",
          "excerpts": [
            "The aim of the present meta-analysis is to test whether and to what extent HRVB is effective in reducing depressive symptoms in adult patients.",
            "Heart rate variability biofeedback improves emotional and physical health and performance: A systematic review and meta analysis. Appl. Psychophysiol. 45, 109–129 (2020)"
          ]
        },
        {
          "title": "Posttraumatic Stress Disorder and Alterations in Resting Heart Rate Variability: A Systematic Review and Meta-Analysis",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6992856/",
          "excerpts": [
            "HRV reduction may predate PTSD.",
            "HRV could serve as a valuable biomarker to monitor PTSD and treatment outcomes.",
            "by F Ge · 2020 · Cited by 103 — This meta-analysis analyzed existing studies on HRV in PTSD. When we investigated the HRV indices, we found reductions in HF-HRV (but not LF-HRV) and RMSSD."
          ]
        },
        {
          "title": "FDA Rejects Lykos' MDMA-Assisted PTSD Therapy After ...",
          "url": "https://www.biospace.com/drug-development/FDA-Rejects-Lykos-MDMA-Assisted-PTSD-Therapy-After-Negative-Adcomm",
          "excerpts": [
            "Aug 9, 2024 — The FDA late Friday rejected Lykos Therapeutics' New Drug Application for its midomafetamine (MDMA)-assisted therapy for post-traumatic stress disorder."
          ]
        },
        {
          "title": "FDA Denies New MDMA Drug Application",
          "url": "https://phillipslytle.com/fda-denies-approval-of-new-drug-application-for-mdma-and-requests-additional-study/",
          "excerpts": [
            "Sep 10, 2024 — On August 9, 2024, Lykos Therapeutics announced that the FDA had issued a complete response letter (CRL) rejecting Lykos' NDA for midomafetamine (MDMA)."
          ]
        },
        {
          "title": "NDA 215455",
          "url": "https://www.fda.gov/media/178984/download",
          "excerpts": [
            "Jun 4, 2024 — The Applicant has proposed the use of midomafetamine (also known as. 3,4-methylenedioxymethamphetamine or MDMA) as a treatment for posttraumatic ..."
          ]
        },
        {
          "title": "A Multi-Site Phase 3 Study of MDMA-Assisted Therapy ...",
          "url": "https://maps.org/mdma/ptsd/mapp1/",
          "excerpts": [
            "Three sessions of MDMA-assisted therapy significantly reduced PTSD symptoms and functional impairment, compared to placebo."
          ]
        },
        {
          "title": "FDA Rejects MDMA Treatment for PTSD; Setbacks and ...",
          "url": "https://www.womblebonddickinson.com/us/insights/blogs/fda-rejects-mdma-treatment-ptsd-setbacks-and-new-directions",
          "excerpts": [
            "Sep 10, 2024 — Discover why the FDA rejected MDMA for PTSD treatment and what it means for psychedelic research. Learn more about the future implications ..."
          ]
        },
        {
          "title": "June 4, 2024: Meeting of the Psychopharmacologic Drugs ...",
          "url": "https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-june-4-2024-meeting-psychopharmacologic",
          "excerpts": [
            "The Committee will discuss new drug application 215455, for midomafetamine (MDMA) capsules, submitted by Lykos Therapeutics, for the proposed indication of ..."
          ]
        },
        {
          "title": "So how special is special K? A systematic review and meta ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10791091/",
          "excerpts": [
            "por NC Borgogna · 2024 · Mencionado por 11 — Ketamine-for-PTSD RCTs reveal a nominal initial therapeutic advantage relative to controls. However, bias and heterogeneity appear problematic."
          ]
        },
        {
          "title": "Synthesizing the Evidence for Ketamine and Esketamine in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9635017/",
          "excerpts": [
            "by RS McIntyre · 2021 · Cited by 630 — The efficacy and safety of ketamine and esketamine in adults with major depression and psychotic features has not been well characterized, but preliminary ..."
          ]
        },
        {
          "title": "Efficacy and Safety of Intranasal Esketamine in Patients With ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9305073/",
          "excerpts": [
            "Our results suggest rapid and sustained effects of Esketamine both on depressive and PTSD symptoms at 6 months even if patients were severely ill and ..."
          ]
        },
        {
          "title": "Esketamine facilitate psychotherapies for Post-Traumatic stress ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2468749924001133",
          "excerpts": [
            "Esketamine treatment associated with psychotherapies appears promising in patients with resistant complex PTSD and TRD."
          ]
        },
        {
          "title": "A Critical Review of Psychedelic Microdosing - ScienceDirect",
          "url": "https://www.sciencedirect.com/science/article/pii/S2352250X25001423",
          "excerpts": [
            "This naturalistic prospective study found that adults with severe ADHD symptoms who microdosed psychedelics reported similar improvements in emotion regulation, empathy, and ADHD symptoms compared to those using conventional ADHD medication."
          ]
        },
        {
          "title": "Efficacy of psilocybin for treating symptoms of depression",
          "url": "https://www.bmj.com/content/385/bmj-2023-078084",
          "excerpts": [
            "by AM Metaxa · 2024 · Cited by 50 — Treatment effects of psilocybin were significantly larger among patients with secondary depression, when self-report scales were used to measure symptoms of ...",
            "In our meta-analysis we found that psilocybin use showed a significant benefit on change in depression scores compared with placebo. This is ..."
          ]
        },
        {
          "title": "Psilocybin for the Treatment of Depression: A Promising ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10072288/",
          "excerpts": [
            "by G Agin-Liebes · 2022 · Cited by 16 — Serotonergic psychedelics, particularly psilocybin, with therapeutic support show great promise in the treatment of depression with large effect sizes."
          ]
        },
        {
          "title": "Single-dose psilocybin for U.S. military Veterans with ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032724016227",
          "excerpts": [
            "by S Ellis · 2025 · Cited by 16 — At Month 12, 40 % maintained response and 30 % maintained remission. Limitations include the small sample size and the uncontrolled, unblinded ..."
          ]
        },
        {
          "title": "Combining Esketamine and Prolonged Exposure Treatment for ...",
          "url": "https://clinicaltrials.gov/study/NCT06795659",
          "excerpts": [
            "Combined with PE, intranasal ketamine may help to augment PE and further reduce participants' PTSD symptoms. Detailed Description. The study is an early phase ..."
          ]
        },
        {
          "title": "Combining Ketamine Infusions and Written Exposure ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40215385/",
          "excerpts": [
            "by A Feder · 2025 — This open-label clinical trial examined the preliminary efficacy of combining a course of 6 ketamine infusions with a brief, evidence-based exposure-based ..."
          ]
        },
        {
          "title": "Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder",
          "url": "https://clinicaltrials.gov/study/NCT05562973?cond=Post%20Traumatic%20Stress%20Disorder&intr=%22Psilocybin%22&viewType=Table&rank=2",
          "excerpts": [
            "The purpose of this study is to evaluate the safety, tolerability, and potential efficacy of psilocybin-assisted psychotherapy to reduce post-traumatic stress ..."
          ]
        },
        {
          "title": "Psychedelic Science 2025: Lessons From MDMA Trials Could Strengthen Future Psychedelic Approvals",
          "url": "https://www.pharmacytimes.com/view/psychedelic-science-2025-lessons-from-mdma-trials-could-strengthen-future-psychedelic-approvals",
          "excerpts": [
            "At the 2025 Psychedelic Science Conference in Denver, Colorado, the FDA's advisory committee vote against 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder (PTSD) sparked intense debate across the psychedelic medicine community.",
            "Although pivotal phase 3 trials demonstrated statistically significant reductions in PTSD symptoms with MDMA treatment, the FDA cited concerns about data reliability and trial oversight, ultimately issuing a complete response letter to Lykos Therapeutics in August 2024.",
            ". This decision followed mounting scrutiny over ethical violations at one trial site , where misconduct by clinical investigators—later confirmed in a journal retraction—cast doubt on the integrity of the broader data set."
          ]
        },
        {
          "title": "Science/AAAS article on FDA rejection of MDMA-assisted PTSD therapy (Aug 2024)",
          "url": "https://www.science.org/content/article/fda-rejected-mdma-assisted-ptsd-therapy-other-psychedelics-firms-intend-avoid-fate",
          "excerpts": [
            "d to approve its application and requested an additional clinical trial to support the therapy’s safety and efficacy.",
            "An advisory committee convened by FDA in June also raised concerns that MDMA’s mind-altering effects made it nearly impossible to “blind” participants to whether they were getting drug or placebo.",
            "Aug 12, 2024 — FDA rejected MDMA-assisted PTSD therapy. Other psychedelics firms intend to avoid that fate · Lykos Therapeutics's failure to win approval may ...",
            "Two phase 3 trials followed, both showing greater reductions in PTSD symptoms for those getting MDMA compared with a placebo during a multisession course of psychotherapy.",
            "MDMA-assisted psychotherapy to treat PTSD became a front-runner for approval in 2017, when the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) won FDA’s “breakthrough therapy” designation for the treatment based on data from phase 2 trials."
          ]
        },
        {
          "title": "From Secret Tests to Therapy Trials: MDMA's Long Road to Legitimacy",
          "url": "https://www.fdli.org/2025/03/from-secret-tests-to-therapy-trials-mdmas-long-road-to-legitimacy/",
          "excerpts": [
            "On Friday, August 9, 2024, Lykos Therapeutics received notification from the U.S. Food and Drug Administration (FDA) that its New Drug Application (NDA) for MDMA-assisted therapy for PTSD had not been approved.",
            "The Psychopharmacologic Drug Advisory Committee conducted a hearing on June 4, 2024 to discuss clinical data collected by Lykos Therapeutics in support of their application for MDMA-assisted psychotherapy.",
            " In a 2–9 vote, the committee members voted against the effectiveness of MDMA-assisted psychotherapy.",
            "Similarly, the committee members voted 1–10 rejecting the notion that the benefits of MDMA with FDA’s proposed REMS outweighed the risk for treatment of patients with PTSD.",
            "MAPP1 and MAPP2 were both randomized, placebo-controlled, 18-week studies."
          ]
        },
        {
          "title": "Psychedelic- and dissociative-assisted therapies for PTSD and ADHD-related symptoms (2025 review) from ScienceDirect",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032725006020",
          "excerpts": [
            "Depression and PTSD symptoms improved across six ketamine treatments within a 30-day period, plateauing after 11–15 days.",
            "Ketamine offers a fast-acting solution for depression and PTSD by targeting a specific brain receptor called the NMDA receptor, which helps control glutamate, a chemical messenger in the brain (Moghaddam et al., 1997).",
            " The FDA-approved nasal spray esketamine (56–84 mg) works similarly, sometimes delivering relief in hours and sustaining it for weeks when paired with other treatments (Daly et al., 2018).",
            " For PTSD, this could mean quieter fear memories and less avoidance, while depression patients feel less stuck in negative thoughts, as ketamine also balances brain networks tied to rumination"
          ]
        },
        {
          "title": "Composite Psychedelic Therapies for PTSD/ADHD-Related Symptoms (Research Focus 2025)",
          "url": "https://www.psychiatrist.com/jcp/combining-ketamine-infusions-and-written-exposure-therapy-chronic-ptsd-open-label-trial/",
          "excerpts": [
            "Apr 2, 2025 — A randomized controlled trial of repeated ketamine administration for Chronic Posttraumatic Stress Disorder. Am J Psychiatry. 2021;178(2): ... Ketamine for treatment of posttraumatic stress disorder: state of the field. *Focus (Am Psychiatr Publ)*. 2023;21(3):257–265. "
          ]
        },
        {
          "title": "Psi-PS Psilocybin with Psychological Support (Psi-PS) Trial for PTSD + AUD (ClinicalTrials.gov)",
          "url": "https://clinicaltrials.gov/study/NCT06853912",
          "excerpts": [
            " post-DAS. This study is a single-site, double-blinded, placebo-controlled, randomized clinical trial with an open-label extension phase assessing safety, efficacy, and durability in two conditions: 1. Psi-PS (psilocybin combined with psychological support); and 2. placebo and nondirective psychological support.",
            "Study Start ( Estimated )\n\n2025\\-03-0",
            "2025\\-03-0",
            "Phase\n\nPhase 2",
            "Intervention / Treatment\n\n* Drug : Psilocybin 25 mg\n* Drug : Maltodextrin (Placebo)",
            "Official Title\n\nA Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial with an Open-label Extension Phase to Examine the Safety, Efficacy, Durability, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined with Psychological Support (Psi-PS) for Military Veterans and First Responders with Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)",
            "This study is a phase 2 single-site, double-blind, placebo-controlled, randomized clinical trial with an open-label extension phase to examine the safety, efficacy, and durability of psilocybin (25 mg) combined with psychological support (Psi-PS) for treatment of approximately 40 military veterans and first responders (ages 18-65) with co-occurring alcohol use disorder (AUD) and posttraumatic stress disorder (PTSD).",
            "Enrollment ( Estimated )\n\n40",
            "Conditions\n\nAlcohol Use Disorder (AUD) PTSD"
          ]
        },
        {
          "title": "MDMA-assisted therapy for moderate to severe PTSD: a randomized ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10579091/",
          "excerpts": [
            "Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms ..."
          ]
        },
        {
          "title": "FDA advisors voted against MDMA therapy – researchers ...",
          "url": "https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it",
          "excerpts": [
            "Jun 20, 2024 — A vote against using MDMA as part of therapy for PTSD has provoked a powerful backlash among researchers who study psychedelic drugs."
          ]
        },
        {
          "title": "FDA advisers reject MDMA as treatment for PTSD",
          "url": "https://www.npr.org/sections/shots-health-news/2024/06/04/nx-s1-4991112/mdma-therapy-ptsd-fda-advisors",
          "excerpts": [
            "Jun 4, 2024 — Following public comment and discussion, the panel voted 9-2 that MDMA – in combination with talk therapy – is not effective for treating PTSD."
          ]
        },
        {
          "title": "Why FDA Panel Rejected MDMA for PTSD Treatment",
          "url": "https://www.psychiatrist.com/news/why-fda-panel-rejected-mdma-for-ptsd-treatment/",
          "excerpts": [
            "Jun 5, 2024 — Clinical relevance: An FDA advisory panel voted against the use of MDMA – or ecstasy – to treat post-traumatic stress disorder."
          ]
        },
        {
          "title": "MDMA-assisted psychotherapy for treatment of PTSD: study design ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31065731/",
          "excerpts": [
            "The between-group Cohen's d effect size was 0.8, indicating a large treatment effect. After two experimental sessions, more participants in ..."
          ]
        },
        {
          "title": "A Randomized Controlled Trial of Repeated Ketamine ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33397139/",
          "excerpts": [
            "This randomized controlled trial provides the first evidence of efficacy of repeated ketamine infusions in reducing symptom severity in ..."
          ]
        },
        {
          "title": "Effectiveness of Ketamine for the Treatment of Post- ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38559428/",
          "excerpts": [
            "by TM Almeida · 2024 · Cited by 22 — Our findings suggest that ketamine holds promise as an effective treatment option for PTSD. However, further trials are imperative to establish robust data ..."
          ]
        },
        {
          "title": "Ketamine in the effective management of chronic pain ...",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1338581/full",
          "excerpts": [
            "by JJW Liu · 2024 · Cited by 5 — This review provides a preliminary synthesis of available evidence which suggests that ketamine may be a potential option for the treatment of depression, PTSD ..."
          ]
        },
        {
          "title": "FDA Psychopharmacologic Advisory Committee Votes ...",
          "url": "https://www.hcplive.com/view/live-updates-fda-psychopharmacologic-advisory-committee-meeting-mdma-ptsd",
          "excerpts": [
            "Jun 4, 2024 — The US Food and Drug Administration (FDA) Psychopharmacologic Advisory Committee (PDAC) voted 2-9 against supporting the effectiveness of MDMA in the treatment ..."
          ]
        },
        {
          "title": "Efficacy of intravenous ketamine for treatment of chronic ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/24740528/",
          "excerpts": [
            "Results: Ketamine infusion was associated with significant and rapid reduction in PTSD symptom severity, compared with midazolam, when assessed 24 hours after ..."
          ]
        },
        {
          "title": "Control Group Outcomes in Trials of Psilocybin, SSRIs, or ...",
          "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2836921",
          "excerpts": [
            "This meta-analysis found that control treatment depression scores in psilocybin trials were lower than those usually seen in antidepressant ..."
          ]
        },
        {
          "title": "Effects of psychedelic microdosing versus conventional ADHD ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10966614/",
          "excerpts": [
            "This study indicates the positive effects of MD psychedelics on ADHD symptoms and ER in adults with severe ADHD symptoms while lacking evidence for effects on ..."
          ]
        },
        {
          "title": "MDMA/PTSD Regulatory Update and Trial Data (Pharmacy Times / FDA Proceedings)",
          "url": "https://www.pharmacytimes.com/view/mdma-rejected-the-story-of-a-study-participant-entrenched-in-ethical-violations-and-a-data-breach",
          "excerpts": [
            " On August 9, 2024, the FDA issued a complete response letter (CRL) for Lykos Therapeutics’ midomafetamine (MDMA) capsules for the treatment of posttraumatic stress disorder (PTSD), dealing a major setback to MDMA’s pathway to regulatory approval and to the general movement toward a broader acknowledgment among the health care community of the clinical benefits of psychedelic medicines.",
            "The CRL followed the recommended rejection of MDMA on June 4, 2024, by an independent FDA advisory panel that cited questions about the reliability of the submitted clinical trial data.",
            "In the randomized, double-blind, placebo-controlled phase 3 MAPP1 trial (NCT03537014) and the confirmatory phase 3 MAPP2 trial (NCT04077437), treatment with MDMA led to a significant reduction in the Clinician-Administered PTSD Scale for _Diagnostic and Statistical Manual of Mental Disorders_ (Fifth Edition) score, which measures PTSD symptom severity, in addition to a large increase in total Sheehan Disability Scale score compared with placeb",
            "There were no serious adverse events in the MDMA arms of either trial."
          ]
        },
        {
          "title": "FDA Issues CRL to Lykos for MDMA-Assisted Therapy",
          "url": "https://www.psychiatrictimes.com/view/fda-issues-crl-to-lykos-for-mdma-assisted-therapy",
          "excerpts": [
            "The US Food and Drug Administration issues a complete response letter (CRL) for Lykos’s midomafetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder (PTSD), noting it cannot be approved based on the data submitted. The FDA has requested an additional Phase 3 trial examining safety and efficacy."
          ]
        },
        {
          "title": "Ketamine for PTSD: Systematic Review and Meta-analysis",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10979792/",
          "excerpts": [
            "\nKetamine demonstrated significant improvements in PCL-5 scores, both 24 hours after the initial infusion and at the endpoint of the treatment course",
            "Our findings suggest that ketamine holds promise as an effective treatment option for PTSD.",
            "Ketamine was found to be well-tolerated in the studies analyzed. The most common side effects reported were dose-related dissociative and psychomimetic symptoms. These side effects generally peaked 40 minutes post-infusion and subsided to baseline levels within two hours."
          ]
        },
        {
          "title": "Lykos Therapeutics Announces Complete Response Letter ...",
          "url": "https://www.prnewswire.com/news-releases/lykos-therapeutics-announces-complete-response-letter-for-midomafetamine-capsules-for-ptsd-302219182.html",
          "excerpts": [
            "Aug 9, 2024 — On February 9, 2024, the FDA accepted the company's NDA for midomafetamine used in combination with psychological intervention for adults with ..."
          ]
        },
        {
          "title": "MDMA-Assisted Therapy for PTSD",
          "url": "https://maps.org/mdma/ptsd/",
          "excerpts": [
            "The safety and efficacy of MDMA-assisted therapy is currently under investigation. It is not yet approved by the FDA, does not work for everyone, ..."
          ]
        },
        {
          "title": "The Effects of Ayahuasca on Psychological Disorders",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10994171/",
          "excerpts": [
            "by R Sheth · 2024 · Cited by 6 — In this study, a single dose of ayahuasca, and not the placebo, reduced both depressive symptoms and systemic inflammation of treatment- ...",
            "by R Sheth · 2024 · Cited by 6 — In a longitudinal study conducted over a year after one ayahuasca dose, depression symptoms decreased and helped those who previously had ..."
          ]
        },
        {
          "title": "Psilocybin - Usona Institute",
          "url": "https://www.usonainstitute.org/psilocybin",
          "excerpts": [
            "Psilocybin is a naturally occurring compound from Psilocybe mushrooms, chemically synthesized by Usona, and is being studied for MDD treatment."
          ]
        },
        {
          "title": "Psychedelic-assisted therapy: An overview for the internist",
          "url": "https://www.ccjm.org/content/92/3/171",
          "excerpts": [
            "Mar 1, 2025 — Psychedelics have a reassuring safety profile in highly controlled clinical trial settings, though they carry serious risks for some patients."
          ]
        },
        {
          "title": "Anti-addiction drug ibogaine inhibits voltage-gated ionic ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3853361/",
          "excerpts": [
            "by X Koenig · 2013 · Cited by 49 — Ibogaine inhibits hERG potassium, sodium and calcium channels. Ibogaine's effects on ion channels are a potential source of cardiac arrhythmias."
          ]
        },
        {
          "title": "Mechanism of hERG Channel Block by the Psychoactive ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022356524272104",
          "excerpts": [
            "by P Thurner · 2014 · Cited by 41 — Ibogaine is a psychoactive indole alkaloid. Its use as an antiaddictive agent has been accompanied by QT prolongation and cardiac arrhythmias, ..."
          ]
        },
        {
          "title": "A Multi-Site Phase 3 Study of MDMA-Assisted ...",
          "url": "https://www.clinicaltrials.gov/study/NCT03537014",
          "excerpts": [
            "The goal of this clinical trial is to learn if MDMA-assisted therapy is safe and effective in people with at least severe PTSD. The main question it aims to ..."
          ]
        },
        {
          "title": "The safety and efficacy of COMP360 psilocybin therapy in ...",
          "url": "https://compasspathways.com/wp-content/uploads/2022/06/Compass_Posters.pdf",
          "excerpts": [
            "by GM Goodwin · Cited by 6 — • COMP360 is COMPASS Pathways' proprietary, synthetic, and purified formulation of psilocybin that has received Breakthrough Therapy designation. • COMP360 ..."
          ]
        },
        {
          "title": "Usona Institute | Home",
          "url": "https://www.usonainstitute.org/",
          "excerpts": [
            "Our current clinical trials are aimed at evaluating the safety and efficacy of psilocybin and 5-MeO-DMT within the strict guidance of the US Food and Drug ..."
          ]
        },
        {
          "title": "A critical evaluation of psilocybin-assisted therapy protocol ...",
          "url": "https://psycnet.apa.org/record/2025-66803-001",
          "excerpts": [
            "by R Palitsky · 2025 · Cited by 7 — A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers."
          ]
        },
        {
          "title": "Nature article on MISTIC and psychedelic drugs",
          "url": "https://www.nature.com/articles/s41591-023-02705-w",
          "excerpts": [
            "Ibogaine has been associated with instances of fatal cardiac arrhythmia, but coadministration of magnesium may mitigate this concern.",
            "the MagnesiumâIbogaine: the Stanford Traumatic Injury to the CNS protocol (MISTIC), provided together with complementary treatment modalities, in 30 male SOVs with predominantly mild TBI"
          ]
        },
        {
          "title": "Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets",
          "url": "https://med.stanford.edu/news/all-news/2024/01/ibogaine-ptsd.html",
          "excerpts": [
            "On average, treatment with ibogaine immediately led to significant improvements in functioning, PTSD, depression and anxiety. Moreover, those effects persisted until at least one month after treatment — the endpoint of the study.",
            "one month after treatment participants experienced average reductions of 88% in PTSD symptoms, 87% in depression symptoms and 81% in anxiety symptoms relative to how they were before ibogaine treatment.",
            "Importantly, there were no serious side effects of ibogaine and no instances of the heart problems that have occasionally been linked to ibogaine.",
            "Since 1970 ibogaine has been designated as a Schedule I drug, preventing its use within the U.S., but clinics in both Canada and Mexico offer legal ibogaine treatments."
          ]
        },
        {
          "title": "Compass Pathways psilocybin therapy and treatment (overview)",
          "url": "https://compasspathways.com/our-work/about-psilocybin-therapy-and-treatment/",
          "excerpts": [
            "We are studying investigational psilocybin therapy (also known as psilocybin treatment), administered with psychological support, as a treatment for certain ... We are running a rigorous, global [clinical development programme of investigational COMP360 psilocybin therapy for treatment-resistant depression](https://compasspathways.com/our-work/treatment-resistant-depression/). * ",
            "### 01 **Preparation**\n\n  The patient and therapist get to know each other, building a foundation of trust, so the patient can feel supported and at ease during their psilocybin sessio",
            "### 02 **The COMP360 psilocybin session**\n\n  The patient lies down on a bed in a comfortable room, designed specifically for the session. They receive a dose of investigational COMP360 psilocybin in a capsule. During the experience, patients listen to a specially designed music playlist and wear an eye mask, to help them focus internally. The psilocybin experience typically lasts 6 to 8 hours. A therapist is present throughout the sessio",
            "### 03 **Integration**\n\n  Patients are encouraged to discuss their experiences of the psilocybin sessio"
          ]
        },
        {
          "title": "MDMA-Assisted Psychotherapy Treatment Manual (MAPS) Version 8",
          "url": "https://maps.org/wp-content/uploads/2022/05/MDMA-Assisted-Psychotherapy-Treatment-Manual-V8.1-22AUG2017.pdf",
          "excerpts": [
            "Prior to conducting screening activities, participants must be provided with written information \nabout the clinical trial in which they are interested in enrolling. Participants must be provided \nwith ample time to ask questions and discuss the informed consent with therapists or other \nqualified study personnel, prior to signi",
            "If a particularly severe panic or other problematic psychological reaction (e.g. suicidality) does \noccur during or after the first MDMA-assisted session, the therapists will decide whether or not \nthe participant should undergo a second MDMA-assisted session as scheduled in the pr",
            "The principal therapist, in consultation with the medical monitor, is responsible for \ndisqualifying any participant who has had a sufficiently adverse physiological or emotional \nresponse to MDMA during the first MDMA-assisted session that a subsequent MDMA-assisted \nsession would present an unacceptable ri",
            "The specific goals of this manual are to: Delineate the core elements of the MDMA-assisted psychotherapy method used in. MAPS-sponsored PTSD ... This preparation should be done with the intention of \nhelping the participant feel a sense of safety and comfort in the therapeutic setti",
            "herapists remind the participant that they have two options for dealing with upsetting \nthoughts, memories, or feelings lingering after the MDMA-assisted session.",
            "Version 8: 25 May",
            "MDMA-Assisted Psychotherapy Treatment"
          ]
        },
        {
          "title": "Regulatory science for Traditional Chinese Medicine and herbal medicines (Biomed Central journal article, 2025)",
          "url": "https://cmjournal.biomedcentral.com/articles/10.1186/s13020-025-01152-8",
          "excerpts": [
            "Traditional Chinese medicine (TCM) has become a standardized medical system through systematic development across global healthcare practices. However, concerns persist regarding the safety, efficacy and quality of traditional medicinal products.",
            "Traditional Chinese medicine regulatory science (TCMRS) has emerged as an interdisciplinary field to address these challenges.",
            "This discipline integrates multidisciplinary knowledge to develop new tools, standards and approaches for systematic evaluation of benefit-risk profiles.",
            "Through comprehensive quality management from raw material sourcing to production processes and clinical validation, developing and adopting TCMRS is entrusted to significantly strengthen its regulatory oversight.",
            "Key legislative milestones include the _Drug Administration Law of the People's Republic of China_ (1985 _)_ , the _New Drug Approval Measures_ (1985), the _Supplementary Provisions and Explanations on TCM-related Issues in the New Drug Approval Measures_ (1987) and the _Regulations for the Administration of Drug Registrat",
            "In December 2020, the Center for Drug Evaluation (CDE) under NMPA introduced the _Technical Guidelines for Bioactivity-Based Testing of Traditional Chinese Medicine (Trial)",
            "These guidelines directly link bioactivity to TCM safety and efficacy, capturing the multi-component, holistic nature of TCM through measurable biological responses."
          ]
        },
        {
          "title": "Heavy Metal Content of Ayurvedic Herbal Medicine Products",
          "url": "https://jamanetwork.com/journals/jama/fullarticle/1108395",
          "excerpts": [
            "by RB Saper · 2004 · Cited by 993 — Lead, mercury, and arsenic intoxication have been associated with the use of Ayurvedic herbal medicine product (HMPs)."
          ]
        },
        {
          "title": "Heavy metal content of ayurvedic herbal medicine products",
          "url": "https://pubmed.ncbi.nlm.nih.gov/15598918/",
          "excerpts": [
            "by RB Saper · 2004 · Cited by 993 — Users of Ayurvedic medicine may be at risk for heavy metal toxicity, and testing of Ayurvedic HMPs for toxic heavy metals should be mandatory."
          ]
        },
        {
          "title": "Acupuncture for Combat-Related Posttraumatic Stress ...",
          "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2814938",
          "excerpts": [
            "by M Hollifield · 2024 · Cited by 15 — In this randomized clinical trial including 93 participants, verum acupuncture resulted in a larger reduction in PTSD symptom severity than sham."
          ]
        },
        {
          "title": "Efficacy of adding acupuncture to Methylphenidate in children and ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S1876382018305225",
          "excerpts": [
            "In conclusion, our double blind sham controlled study showed that acupuncture can significantly improve the ADHD symptoms according to the scores of parental ADHD-RS . Nevertheless, it did not improve the attention deficit. We recommend further investigations with larger sample size and longer follow-up period."
          ]
        },
        {
          "title": "Randomized-controlled study of treating attention deficit ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/21056840/",
          "excerpts": [
            "Conclusion: The treatment of ADHD in preschool children with electro-acupuncture combining behavior therapy has positive effect in reducing symptoms of ADHD."
          ]
        },
        {
          "title": "The Effects of a Traditional Chinese Medication on ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32407137/",
          "excerpts": [
            "by ZW Liang · 2020 · Cited by 11 — Conclusion: This particular TCM formula may prove to be a useful adjunctive treatment for children with ADHD, and randomized controlled trials need to be ..."
          ]
        },
        {
          "title": "Comparison of Auricular Therapy with Sham in Children ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32434376/",
          "excerpts": [
            "The aim of this study is to compare the effectiveness of auricular therapy with the sham procedure in attention deficit hyperactivity disorder (ADHD)."
          ]
        },
        {
          "title": "Traditional Chinese medicine research on attention deficit ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2949834124000059",
          "excerpts": [
            "by C Zhou · 2024 · Cited by 2 — In a clinical trial, the experimental group consisted of 30 children with ADHD who received Jing Ning Formula granules."
          ]
        },
        {
          "title": "Effectiveness and Safety of Ayurveda Intervention in Children and ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2210803323001501",
          "excerpts": [
            "First systematic review to provide evidence of Ayurveda interventions in children and adolescents with attention deficit hyperactivity disorder."
          ]
        },
        {
          "title": "Meta-analysis of randomized controlled trials on cognitive ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/24252493/",
          "excerpts": [
            "by C Kongkeaw · 2014 · Cited by 201 — This meta-analysis suggests that Bacopa monnieri has the potential to improve cognition, particularly speed of attention."
          ]
        },
        {
          "title": "Evaluation of Brāhmī ghṛtam in children suffering from Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4171854/",
          "excerpts": [
            "Brāhmī ghṛtam showed 66% decrease in total ADHD score. In the therapeutic confirmatory study, only 16% improvement was seen with Brāhmī ghṛtam."
          ]
        },
        {
          "title": "Efficacy and Safety of Ashwagandha Root Extract on Cognitive ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34858513/",
          "excerpts": [
            "This double-blind, randomized, placebo-controlled clinical study evaluated the effect of Ashwagandha root extract sustained-release capsule ..."
          ]
        },
        {
          "title": "Ashwagandha Root Extract in Treatment of Mild Attention Deficit ...",
          "url": "https://figshare.com/articles/preprint/_b_Ashwagandha_Root_Extract_in_Treatment_of_Mild_Attention_Deficit_Hyperactivity_Disorder_ADHD_in_Children_Aged_5_12_Years_A_Prospective_b_b_Double-Blind_Randomized_Placebo_Controlled_Study_b_/27302499",
          "excerpts": [
            "In this randomized, double-blind, placebo-controlled research, 58 boys and girls aged 5-12 years having ADHD were randomly assigned to receive ..."
          ]
        },
        {
          "title": "Shamanic Healing for Veterans with PTSD: A Case Series.",
          "url": "https://europepmc.org/article/med/28336055",
          "excerpts": [
            "by H Wahbeh · 2017 · Cited by 18 — Shamanic healing is one such therapy that may potentially be beneficial but no systematic research has been conducted on it for PTSD. Objective. The objectives ..."
          ]
        },
        {
          "title": "Prevalence and therapeutic impact of adverse life event ...",
          "url": "https://www.nature.com/articles/s41598-023-36184-3",
          "excerpts": [
            "by B Weiss · 2023 · Cited by 15 — The present study examined the safety and efficacy of the ceremonial use of ayahuasca in relation to reports of heightened life event reexperiencing under ..."
          ]
        },
        {
          "title": "Psychological and cognitive effects of long-term peyote use ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/16271313/",
          "excerpts": [
            "by JH Halpern · 2005 · Cited by 294 — We found no evidence of psychological or cognitive deficits among Native Americans using peyote regularly in a religious setting."
          ]
        },
        {
          "title": "The Dangers of Teen Peyote Use",
          "url": "https://www.newportacademy.com/resources/substance-abuse/peyote-use/",
          "excerpts": [
            "May 24, 2018 — The risks of peyote use increase when combined with the mental side effects of taking this powerful hallucinogenic drug. In many cases where ..."
          ]
        },
        {
          "title": "Acupuncture for Posttraumatic Stress Disorder: A Systematic Review of Randomized Controlled Trials and Prospective Clinical Trials",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3580897/",
          "excerpts": [
            "e high-quality RCT reported that acupuncture was superior to waitlist control and therapeutic effects of acupuncture and cognitive-behavioral therapy (CBT) were similar based on the effect sizes.",
            "This systematic review and meta-analysis suggest that the evidence of effectiveness of acupuncture for PTSD is encouraging but not cogent.",
            "One RCT showed no statistical difference between acupuncture and selective serotonin reuptake inhibitors (SSRIs).",
            "A meta-analysis of acupuncture plus moxibustion versus SSRI favored acupuncture plus moxibustion in three outcomes."
          ]
        },
        {
          "title": "Acupuncture for ADHD in children and adolescents (Li 2011 Cochrane Review)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12147681/",
          "excerpts": [
            "There is increasing interest in complementary and alternative therapies such as acupuncture; however, it remains unclear whether the use of acupuncture in children and adolescents with ADHD is supported by the existing evidence.",
            "No studies met the inclusion criteria for this review.",
            "A comprehensive search showed that there is no evidence base of randomised or quasi‐randomised controlled trials to support the use of acupuncture as a treatment for ADHD in children and adolescents.",
            "This review highlights the need for further research in this area in the form of high quality, large scale, randomised controlled trials.",
            "The aim of this review was to systematically analyse all the randomised controlled trials of acupuncture for children and adolescents with ADHD to provide the ..."
          ]
        },
        {
          "title": "MDPI Medical Sciences 2023 Ang et al. Acupuncture for ADHD in Children: A Systematic Review and Meta-analysis",
          "url": "https://www.mdpi.com/1648-9144/59/2/392",
          "excerpts": [
            "No major adverse events were reported."
          ]
        },
        {
          "title": "Bacopa monnieri randomized controlled trial protocol (Nutrients, 2015)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26633481/",
          "excerpts": [
            "This paper reports the protocol for the first 16-week, randomized, placebo-controlled, double-blind, parallel groups trial examining the efficacy and safety of CDRI 08 in male children aged 6-14 years with high levels of inattention and hyperactivity."
          ]
        },
        {
          "title": "Bacopa monnieri (CDRI 08) randomized trial in children with ADHD (Kean et al., Phytother Res. 2022)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35041248/",
          "excerpts": [
            " The current study investigated the efficacy of extract of Bacopa monnieri (BM; CDRI 08®) in reducing levels of inattention and hyperactivity in young children.",
            "A 14-week randomized, double-blind, placebo-controlled clinical trial, with placebo run-in and run-out phases, investigated the effects of BM on behavioural, cognitive, mood, and sleep effects in male children aged 6 to 14 years against placebo.",
            "One-hundred and twelve participants were recruited into the trial, with 93 datasets available for analysis.",
            "No significant behavioural differences were noted between treatment groups.",
            " Cognitive outcomes indicated decreased error-making in children taking CDRI 08® (p = .04) and increased speed of reaction time in those taking placebo (p = .04) at study end.",
            " Improvements in cognitive flexibility (p = .01), executive functioning (p = .04), interpersonal problems (p = .02), and sleep routine (p = .04) were noted in those consuming CDRI 08® over placebo.",
            " CDRI 08® did not improve behavioural outcomes, but may have cognitive, mood and sleep benefits in children aged 6 to 14 years.",
            "Keywords:**\nADHD; Bacopa; attention; behaviour; children; cognitio"
          ]
        },
        {
          "title": "Complementary Therapies in Medicine (Kean et al., 2016)",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0965229916301388",
          "excerpts": [
            "A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations",
            "Five studies met inclusion criteria for this review.",
            "significant consistent improvements in the language behaviour cognitive domain and in a number of the memory sub-domains.",
            "Significant outcomes demonstrated small to medium effect sizes (mean d = 0.42).",
            "Bacopa monnieri was well tolerated with only 2.3% of all participants reporting mild side-effects.",
            "• Bacopa monnieri significantly improved memory span as well as verbal and visual memory in children and adolescents.",
            "by JD Kean · 2016 · Cited by 55 — Two studies reported improvements in hyperactivity and attention in children diagnosed with ADHD. ... Significant outcomes demonstrated small to medium effect ...",
            "• Significant outcomes demonstrated small to medium effect sizes (mean d = 0.42).",
            "n\nThis review highlights the safe use of Bacopa monnieri in child and adolescent populations for improving elements of cognition as well as behaviour and attention-deficit domains.",
            "by JD Kean · 2016 · Cited by 55 — Recent research has reported that the traditional Ayurvedic medicine Bacopa monnieri may improve cognitive outcomes in adult populations; however, few studies ..."
          ]
        },
        {
          "title": "Shamanic Healing for PTSD in Veterans (Wahbeh et al., 2017)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/28336055/",
          "excerpts": [
            "The objectives of the case series are to (1) develop a structured replicable shamanic treatment plan for veterans with posttraumatic stress disorder (PTSD); Shamanic healing is one such therapy that may potentially be beneficial but no systematic research has been conducted on it for PTSD.",
            "Qualitative descriptions of the participants, their histories, and effects from the intervention are reported.",
            "Future research is warranted and needed to evaluate the efficacy of shamanic healing as a potential therapy for veterans with PTSD.",
            ". Six veterans enrolled in the study (mean age = 49.3 ± 13.1).",
            "The protocol was found feasible and acceptable and recommendations for its future use are suggested."
          ]
        },
        {
          "title": "Am J Community Psychol (Systematic review of trauma interventions in Native communities)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7243818/",
          "excerpts": [
            " this systematic review of the literature on trauma interventions in Native communities in the United States, Canada, Australia, and New Zealand, we identified 15 studies representing 10 interventions",
            "These studies involved the community to some extent in developing or culturally adapting the interventions and suggested positive outcomes with regard to historical and interpersonal trauma symptoms.",
            "However, notable limitations in study design and research methods limit both internal validity and external validity of these conclusions.",
            "Of the EBTs for trauma, only TF-CBT and Seeking Safety have been culturally adapted for use in Native communities.",
            " Trauma-focused CBT was originally designed for sexually abused children and has been adapted for other types of interpersonal trauma",
            "In this review, 15 published studies were discovered that addressed trauma in Native communities.",
            "An increase in trauma intervention research in Native communities over the past 15 years illustrates a growing focus on treating trauma, and, significantly, utilizing community participation."
          ]
        },
        {
          "title": "Indigenous Indigenous healing and TIM in PTSD/Trauma (Native healing perspectives)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3327107/",
          "excerpts": [
            "The results have been promising, indicating that Native approaches to healing for PTSD and related disorders are therapeutic for Native people.",
            "TIM is a type of traditional medicine (TM) that is based on indigenous knowledge in the Americas.",
            "Indigenous therapeutic interventions usually involve an individual's family and community, and healing occurs within the context of the community as a whole.",
            "Our analysis contributes to a much-needed body of research on indigenous perspectives on health. Our study differs from similar studies that have been done in at least two important ways. First, we conducted interviews with healers from six tribes across North America rather than with healers who all represented the same tribe. Second, the focus of our interviews was traumatic injury, a focus we have not encountered in our reviews of the literature. Given the high prevalence of traumatic injury and PTSD among Native populations, future studies with this focus are warranted.",
            "Indigenous therapeutic interventions usually involve an individual's family and community, and healing occurs within the context of the community as a whole. The healed person is able to then help the community."
          ]
        },
        {
          "title": "Lead Poisoning Associated with Ayurvedic Medications",
          "url": "https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5326a3.htm",
          "excerpts": [
            "A total of 12 cases of lead poisoning among adults in five states associated with ayurvedic medications or remedies were reported to CDC."
          ]
        },
        {
          "title": "Lead Poisoning and Anemia Associated with Use of ...",
          "url": "https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6432a6.htm",
          "excerpts": [
            "by J Meiman · Cited by 1 — This case report confirms earlier reported risk for lead poisoning from Ayurvedic medications produced in India (4), and highlights the acute toxicity that can ..."
          ]
        },
        {
          "title": "SinoTradition.com - 608643 - 07/06/2020 | FDA",
          "url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sinotraditioncom-608643-07062020",
          "excerpts": [
            "Center for Drug Evaluation and Research | CDER. United States. Federal Trade Commission. WARNING LETTER. Date: July 6, 2020. RE: Unapproved and ..."
          ]
        },
        {
          "title": "ActiveHerb Technology, Inc - 574615 - 05/15/2019 - FDA",
          "url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/activeherb-technology-inc-574615-05152019",
          "excerpts": [
            "The United States Food and Drug Administration (FDA) inspected your facility located at 8830 Rehco Rd., Ste. E, San Diego, CA from September 11 - 17, 2018, and ..."
          ]
        },
        {
          "title": "Inhibition of human cytochrome P450 enzymes by Bacopa ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/24566323/",
          "excerpts": [
            "by S Ramasamy · 2014 · Cited by 57 — These findings suggest that B. monnieri extract could contribute to herb-drug interactions when orally co-administered with drugs metabolized by ..."
          ]
        },
        {
          "title": "Inhibition of Human Cytochrome P450 Enzymes by Bacopa ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6271976/",
          "excerpts": [
            "by S Ramasamy · 2014 · Cited by 57 — monnieri extract most strongly inhibits CYP2C19 followed by CYP2C9, CYP1A2, and CYP3A4 and most weakly inhibits CYP2D6. However, all of the ..."
          ]
        },
        {
          "title": "5 Ashwagandha Interactions to Watch for",
          "url": "https://www.goodrx.com/well-being/supplements-herbs/ashwagandha-drug-interactions?srsltid=AfmBOorNPlthc5FZoJtylsWtaXX8vGHsVu0rdzqmoURsN3vswRTBGT_D",
          "excerpts": [
            "You should avoid taking it with sedatives, such as benzodiazepines and sleep medications. The combination can raise the risk of excessive drowsiness."
          ]
        },
        {
          "title": "6 Medications Not To Mix With Ashwagandha Supplements",
          "url": "https://www.health.com/medications-not-to-mix-with-ashwagandha-8758036",
          "excerpts": [
            "Ashwagandha may interact with medications that lower blood pressure and blood sugar, sedatives, immunosuppressants, hepatotoxic drugs, and thyroid hormone ..."
          ]
        },
        {
          "title": "Role of Shankhpushpi (Convolvulus pluricaulis) in neurological ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35878793/",
          "excerpts": [
            "Network pharmacology results indicate that compounds from C. pluricaulis interact with various proteins, neuro synapses, signaling pathways, and ..."
          ]
        },
        {
          "title": "The effects of yoga on the attention and behavior of boys ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/15487477/",
          "excerpts": [
            "Significant improvements from pre-test to post-test were found for the yoga, but not for the control group on five subscales of the Conners' Parents Rating ..."
          ]
        },
        {
          "title": "Effects of Qigong vs. routine physical exercise in school- ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40064759/",
          "excerpts": [
            "by Y Li · Cited by 1 — This study did not demonstrate the expected superiority of 3-month Baduanjin exercise in improving ADHD symptoms compared with routine ..."
          ]
        },
        {
          "title": "Effects of Qigong vs. routine physical exercise in school- ...",
          "url": "https://link.springer.com/article/10.1007/s12519-025-00890-x",
          "excerpts": [
            "by Y Li · 2025 · Cited by 1 — In this two-arm, single-blind, randomized controlled trial, eligible school-aged children with ADHD were randomly assigned (1:1) to Baduanjin ..."
          ]
        },
        {
          "title": "Lead Poisoning in Pregnant Women Who Used Ayurvedic ...",
          "url": "https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6133a1.htm",
          "excerpts": [
            "Aug 24, 2012 — The cases of lead poisoning described in this report were associated with the use of Ayurvedic medications. Ayurveda is a millennia-old medical ..."
          ]
        },
        {
          "title": "and Indian-Manufactured Ayurvedic Medicines Sold via the ...",
          "url": "https://jamanetwork.com/journals/jama/fullarticle/182460",
          "excerpts": [
            "by RB Saper · 2008 · Cited by 711 — Design and interpretation of data in “Heavy metal content of Ayurvedic medicine products” published in JAMA by Saper et al. Light Ayurveda J ..."
          ]
        },
        {
          "title": "Tai Chi and Qigong for trauma exposed populations: A systematic ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S1755296622000114",
          "excerpts": [
            "The reviewed studies suggest that TCQ practices have the potential to reduce symptoms and improve functioning for individuals exposed to trauma."
          ]
        },
        {
          "title": "Tai Chi and Qigong for trauma exposed populations: A systematic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37885833/",
          "excerpts": [
            "The reviewed studies suggest that TCQ practices have the potential to reduce symptoms and improve functioning for individuals exposed to trauma."
          ]
        },
        {
          "title": "Yoga and music intervention reduces inattention, hyperactivity ...",
          "url": "https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2023.1150018/full",
          "excerpts": [
            "Our study shows the positive effect of yoga interventions on attention and hyperactivity/impulsivity in children with comorbid ADHD and ODD, ..."
          ]
        },
        {
          "title": "Qigong for children with attention deficit hyperactivity ...",
          "url": "https://examine.com/research-feed/study/dNvpad/?srsltid=AfmBOopbdW-QCfEU2UrZKKE3f9REEIXeQ3P1X29EMTv18tErLunCtg3t",
          "excerpts": [
            "May 22, 2025 — In this 3-month randomized controlled trial, qigong did not reduce hyperactivity/impulsivity scores compared to routine aerobic exercise in 120 children."
          ]
        },
        {
          "title": "Adverse Event Reports Involving Herbal Remedies and ADHD Medications (Mazhar 2020)",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31670573/",
          "excerpts": [
            "The objectives of this study were (1) to identify adverse event reports (AERs) involving commonly used herbal remedies and ADHD prescription medicines in children and adolescents; (2) to evaluate the quality of collected AERs; and (3) to assess whether NHP-drug interactions can be causally linked to reported adverse events.",
            "An NHP-drug interaction was assessed to be probable in one case and to be possible in another. Both these reports involved a methylphenidate formulation and St. John's wort.",
            "The reporting quality was poor for the five AERs examined.",
            "Eighteen of the 23 identified AERs involving both an herbal remedy and an ADHD drug also involved other multiple ingredient products. The reporting quality was poor for the five AERs examined. Further research is needed to study the interaction between St. John's wort and methylphenidate."
          ]
        },
        {
          "title": "Natural Health Product–Drug Interaction Causality Assessment in Pediatric Adverse Event Reports Associated with Attention-Deficit/Hyperactivity Disorder Medication",
          "url": "https://www.liebertpub.com/doi/10.1089/cap.2019.0102",
          "excerpts": [
            "Health care practitioners, particularly those treating pediatric ADHD patients, need to be aware of risks of NHP interactions and need to maintain a dialog about the use of these products.",
            "Eighteen of the 23 identified AERs involving both an herbal remedy and an ADHD drug also involved other multiple ingredient products.",
            "An NHP-drug interaction was assessed to be probable in one case and to be possible in another.",
            "St. John's wort is known to interact with various drugs through several mechanisms.",
            "Concomitant use of St. John's wort could exacerbate this as they share similar modes of action, and St. John's wort is an inhibitor of P-glycoprotein, which could result in higher plasma levels of Ritalin."
          ]
        },
        {
          "title": "Is integrating acupuncture into the management of ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S096522992500038X",
          "excerpts": [
            "by FY Zhao · 2025 · Cited by 1 — This review aimed to provide more reliable evidence on the efficacy and safety of acupuncture as an alternative or adjunctive treatment for ADHD, focusing ..."
          ]
        },
        {
          "title": "An overview of systematic reviews and meta-analyses",
          "url": "https://www.sciencedirect.com/science/article/pii/S0965229923000559",
          "excerpts": [
            "by L Zhang · 2023 · Cited by 4 — Acupuncture might improve the efficacy and CIH score of ADHD. Large sample and high-quality RCTs are still needed to draw reliable conclusions about ..."
          ]
        },
        {
          "title": "Acupuncture for ADHD in children and adolescents",
          "url": "https://www.cochrane.org/evidence/CD007839_acupuncture-adhd-children-and-adolescents",
          "excerpts": [
            "Apr 1, 2022 — In general, effective treatment for ADHD relies on comprehensive therapy. Acupuncture is a complementary and alternative medicine (CAM) therapy ..."
          ]
        },
        {
          "title": "Acupuncture treatment on attention deficit hyperactivity ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8389897/",
          "excerpts": [
            "by L Xing · 2021 · Cited by 4 — This study will provide the evidence of whether acupuncture is an effective and safe intervention to ADHD."
          ]
        },
        {
          "title": "Acupuncture for Combat-Related Posttraumatic Stress ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38381417/",
          "excerpts": [
            "by M Hollifield · 2024 · Cited by 15 — The acupuncture intervention used in this study was clinically efficacious and favorably affected the psychobiology of PTSD in combat veterans."
          ]
        },
        {
          "title": "Acupuncture for Anxiety, Depression, and Sleep in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12112474/",
          "excerpts": [
            "by AF Hsiao · 2025 · Cited by 1 — The first published RCT of acupuncture for PTSD showed efficacy equivalence between acupuncture and group CBT and superiority to a waitlist ..."
          ]
        },
        {
          "title": "BACHI Study Protocol (ANZCTRN12612000827831)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4690059/",
          "excerpts": [
            "by JD Kean · 2015 · Cited by 53 — A randomized controlled trial investigating the effects of a special extract of Bacopa monnieri (CDRI 08) on hyperactivity and inattention in male children and ..."
          ]
        },
        {
          "title": "Ashwagandha: Is it helpful for stress, anxiety, or sleep?",
          "url": "https://ods.od.nih.gov/factsheets/Ashwagandha-HealthProfessional/",
          "excerpts": [
            "May 2, 2025 — Overall, the studies found that ashwagandha significantly reduced stress and anxiety levels (subjectively measured by validated rating scales), ..."
          ]
        },
        {
          "title": "Phytochemical Profile, Pharmacological Attributes and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7063970/",
          "excerpts": [
            "by A Balkrishna · 2020 · Cited by 67 — One such cognitive booster herb is C. prostratus Forssk., commonly known as Shankhpushpi, which is mainly endowed with neuroprotective, ..."
          ]
        },
        {
          "title": "ADHD and Working Memory",
          "url": "https://iyurved.com/blogs/brain-health-and-foods/adhd-and-working-memory?srsltid=AfmBOorEbHpUi5HP3MaWGkliszCrtwoOniWH-85yHls4FG_Crf20Fy8z",
          "excerpts": [
            "Its Medhya (improves intelligence) characteristic also helps memory by functioning as a brain tonic. Take Shankhpushpi powder with warm milk or water as it ..."
          ]
        },
        {
          "title": "Effects of Withania somnifera (Ashwagandha) on Stress ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8762185/",
          "excerpts": [
            "by AB Speers · 2021 · Cited by 229 — WS root and leaf extracts exhibited noteworthy anti-stress and anti-anxiety activity in animal and human studies. WS also improved symptoms of depression and ..."
          ]
        },
        {
          "title": "Shamanic Healing for Veterans with PTSD: A Case Series",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S1550830717300411",
          "excerpts": [
            "by H Wahbeh · 2017 · Cited by 18 — A semi-structured shamanic healing protocol was created with the following components: rapport building, power animal retrieval, extraction, compassionate ..."
          ]
        },
        {
          "title": "Rapid antidepressant effects of the psychedelic ayahuasca ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6378413/",
          "excerpts": [
            "by F Palhano-Fontes · 2019 · Cited by 1005 — Recent open-label trials show that psychedelics, such as ayahuasca, hold promise as fast-onset antidepressants in treatment-resistant depression."
          ]
        },
        {
          "title": "Shamanic Healing for Veterans with PTSD – IONS",
          "url": "https://noetic.org/blog/shamanic-healing-for-veterans-with-ptsd/",
          "excerpts": [
            "Aug 3, 2017 — The results suggest the a treatment protocol of shamanic healing is indeed acceptable to Veterans and can reduce the intensity of PTSD symptoms."
          ]
        },
        {
          "title": "Examination of Recreational and Spiritual Peyote Use ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6614926/",
          "excerpts": [
            "by MA Prince · 2019 · Cited by 20 — Although adults who use peyote strictly for religious ceremonies do not appear to suffer negative consequences from such use (Halpern et al., 2005), there is ..."
          ]
        },
        {
          "title": "Acupuncture for ADHD systematic review (2025) - Is integrating acupuncture into the management of attention-deficit/hyperactivity disorder among children and adolescents now opportune and evidence-based? A systematic review with meta-analysis and trial sequential analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40086639/",
          "excerpts": [
            "We reviewed 25 studies with 1758 participants.",
            "None compared acupuncture to placebo or behavioral therapy.",
            "Subdomain analysis of the Conners' Parent Rating Scale indicated that acupuncture and Methylphenidate had comparable effects on Conduct Problems [SMD = 0.03, 95 %CI (-0.93, 0.99), p = 0.95] and Learning Problems [SMD = 0.29, 95 %CI (-0.38, 0.97), p = 0.39], but acupuncture was more effective in controlling Impulsive/Hyperactive symptoms [SMD = -1.71, 95 %CI (-2.08, -1.35), p < 0.01].",
            "Insufficient sample size prevented confirmation of potential false positives.",
            "This systematic review consolidates evidence on acupuncture's efficacy and safety for treating ADHD in children and adolescents."
          ]
        },
        {
          "title": "Acupuncture for ADHD on ResearchGate (summary of systematic reviews/meta-analyses)",
          "url": "https://www.researchgate.net/publication/51049745_Acupuncture_for_Attention_Deficit_Hyperactivity_Disorder_ADHD_in_children_and_adolescents",
          "excerpts": [
            "Of 114 articles, only three randomized clinical trials (RCTs) met our inclusion criteria.",
            "One RCT found that electroacupuncture (EA) plus behavioural treatment was superior to sham EA plus behavioural treatment.",
            "Two RCTs reported a significant benefit of acupuncture or auricular acupuncture over conventional drug therapies.",
            "Limited evidence exists for the effectiveness of acupuncture as a symptomatic treatment of ADHD.",
            "Given that the risk of bias of the included studies was high, firm conclusions cannot be drawn."
          ]
        },
        {
          "title": "Ayurveda and ADHD – MD Case Reports and Study Protocols, 2025",
          "url": "https://journals.lww.com/md-cases/fulltext/2025/08000/evaluating_the_efficacy_of_ayurvedic_intervention.1.aspx",
          "excerpts": [
            "In ADHD, _Vata_ dominates the condition, resulting in hyperactivity of _Manovaha srotus_ (Channels of mi",
            "However, there have been no attempts to systematically study the efficacy and safety of Ayurveda interventions in patients with ADHD.",
            "Therefore, we are conducting a randomized controlled trial to assess the efficacy and safety of Ayurveda as an add-on therapy in pediatric ADHD based on epigenetic, gut microbiome, neuronal and neuroimaging biomarkers.",
            "The current protocol version is 3-106/2019-CCRAS/Admn./IMR/v2. The study was sanctioned on March 3rd, 2021. Recruitment started in January 2022 and will end in October 2025, or until 80 patients have been recruited.",
            "Currently, there are no studies in Ayurveda that demonstrate the bio-mechanisms of Ayurveda interventions similar ",
            "This study protocol is based on the Standard Protocol Items: Recommendations for Interventional Trials 2013 statement."
          ]
        },
        {
          "title": "ROLE OF AYURVEDA IN ADHD: A CRITICAL REVIEW",
          "url": "https://www.researchgate.net/publication/377556903_ROLE_OF_AYURVEDA_IN_ADHD_A_CRITICAL_REVIEW",
          "excerpts": [
            "ROLE OF AYURVEDA IN ADHD: A CRITICAL REVIEW",
            "This study aims to systematically review the management of attention deficit hyperactivity disorder in Ayurveda.",
            " A total of 40 studies were obtained, which underwent further screening processes to achieve the quality of inclusion criteria.\nA total",
            "Out of 14 clinical studies, 6 showed highly significant results, 1 showed comparatively insignificant results, and 7 showed moderately significant results.",
            "this paper would be helpful in understanding pathophysiology and the management of ADHD in Ayurveda way."
          ]
        },
        {
          "title": "Shamanic Healing for Veterans with PTSD: A Case Series",
          "url": "https://www.researchgate.net/publication/314015184_Shamanic_Healing_for_Veterans_with_PTSD_A_Case_Series",
          "excerpts": [
            "Shamanic Healing for Veterans with PTSD: A Case Series",
            "The objectives of the case series are to (1) develop a structured replicable shamanic treatment plan for veterans with posttraumatic stress disorder (PTSD); (2) collect preliminary data on PTSD-related outcomes, and (3) explore the feasibility and potential for adverse events of the plan.",
            ". Six veterans enrolled in the study (mean age = 49.3 ± 13.1).",
            "The protocol was found feasible and acceptable and recommendations for its future use are suggested.",
            "Shamanic healing (SH) is an ancient form of spiritual healing that focuses on achieving relief from discomfort from an existing illness (Hammerschlag, 2009).",
            "There is a dire need for well-designed and power-adjusted randomized clinical trials with adequate groups and long-term follow-up.",
            "Shamanic healing methods were derived from core shamanic principles taught by the Foundation for Shamanic Studies, and all sessions were delivered by one single practitioner, in the same location."
          ]
        },
        {
          "title": "Single-population studies of PTSD among American Indians and Alaska Natives",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3875613/",
          "excerpts": [
            "by D Bassett · 2014 · Cited by 148 — The authors suggested that the importance of dreams in Native cultures should be considered in treating AI/AN veterans with PTSD and, when appropriate, such ... Single-population studies of PTSD among American Indians and Alaska Natives",
            "| Author- Year | Time  Frame | Sample  Size  &  Population | Criteria &  Methods | Inciting  Events | Diagnostic  measure | Comorbidities  & Risk  Factors | Major Findings ",
            "| --- | --- | --- | --- | --- | --- | --- | --- |",
            "|\n| Boyd-Ball  2006[[17]()] | 1997 -  2000 | 423  adolescents  and  young  adults  from a  Southwest  tribe | Enrolled  tribal  members in  SUPERPF  P dataset,  age 15-24  years. Survey;  descriptive  statistics  and logistic  regression | Parental  alcohol  use | DSM-IV | *Risk factor:*  Parental  alcohol use | Severe trauma increased  odds of alcohol use disorders  (direction of association  unclear). Severe traumatic events  correlated with parental  alcohol use. Severe IPV may have  stronger association with  alcohol use disorders than  severe non-interpersonal  trauma, witnessed trauma, or  traumatic news. |",
            "| Brinker  2007[[18]()] |  | 255 male  AI/AN  and  Hispanic  veterans  with  lifetime  PTSD in  Southwest  and  North  Central  region | Community -based sample  Descriptive  statistics  and logistic  regression | Combat  experience | PCL |  | Veterans with combat-related  PTSD had more severe  symptoms, were less likely to  have remitted in the previous  year, and were less likely to  have sought mental health  treatment after military duty."
          ]
        },
        {
          "title": "High-dose eicosapentaenoic acid (EPA) improves attention ...",
          "url": "https://www.nature.com/articles/s41398-019-0633-0",
          "excerpts": [
            "by JPC Chang · 2019 · Cited by 112 — EPA treatment improves cognitive symptoms in ADHD youth, especially if they have a low baseline endogenous EPA level."
          ]
        },
        {
          "title": "High-dose eicosapentaenoic acid (EPA) improves attention and ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31745072/",
          "excerpts": [
            "EPA treatment improves cognitive symptoms in ADHD youth, especially if they have a low baseline endogenous EPA level."
          ]
        },
        {
          "title": "Neurodevelopmental effects of omega-3 fatty acids and its ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0022395625001141",
          "excerpts": [
            "by NM Walter · 2025 · Cited by 1 — EPA and DHA with MPH treatments increased Wnt activity in both MPH responder-ADHD and control neural stem cells. •. Only treatments of EPA with DHA elevated ..."
          ]
        },
        {
          "title": "Omega-3 polyunsaturated fatty acids in clinical trials for ADHD, PTSD, anxiety, and related conditions",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6324500/",
          "excerpts": [
            "-\n\nThis systematic review and meta-analysis of clinical trials conducted on participants with clinical anxiety symptoms provides the first meta-analytic evidence, to our knowledge, that omega-3 PUFA treatment may be associated with anxiety reduction, which might not only be due to a potential placebo effect, but also from some associations of treatment with reduced anxiety symptoms.",
            "In addition, participants receiving supplements containing less than 60% EPA showed a significant association, but not those receiving supplements containing 60% or more EPA.",
            "A cohort study found that high serum EPA levels were associated with protection against posttraumatic stress disorder.",
            "A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.",
            "Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial."
          ]
        },
        {
          "title": "Magnesium status and attention deficit hyperactivity ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165178118318456",
          "excerpts": [
            "by M Effatpanah · 2019 · Cited by 75 — Magnesium supplementation may be beneficent for attention deficit hyperactivity disorder (ADHD). Abstract. Current research suggests conflicting evidence ...",
            "by M Effatpanah · 2019 · Cited by 75 — The random-effects meta-analysis showed that subjects with ADHD had 0.105 mmol/l (95% CI: -0.188, -0.022; P < 0.013) lower serum magnesium levels compared with ..."
          ]
        },
        {
          "title": "The Effect of Vitamin D Supplementation on Attention ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31368773/",
          "excerpts": [
            "by J Gan · 2019 · Cited by 62 — Vitamin D supplementation demonstrated a small but statistically significant improvement in ADHD total scores, inattention scores, hyperactivity scores, and ..."
          ]
        },
        {
          "title": "Serum Ferritin and Amphetamine Response in Youth with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3003494/",
          "excerpts": [
            "by C Calarge · 2010 · Cited by 87 — The study aim was to explore whether iron stores, as reflected by serum ferritin concentration, predicted response to psychostimulants."
          ]
        },
        {
          "title": "Effects of Iron Supplementation on Attention Deficit ...",
          "url": "https://www.cpn.or.kr/journal/view.html?doi=10.9758/cpn.2021.19.4.712",
          "excerpts": [
            "by S Tohidi · 2021 · Cited by 16 — About 10 studies have indicated the lower serum ferritin levels in ADHD patients than healthy controls [24]. Studies of Adisetiyo et al. [34], Menegassi et al.",
            "The present study evaluated the effects of iron supplementation (ferrous sulfate) on the symptoms of children with ADHD, treated with methylphenidate."
          ]
        },
        {
          "title": "Magnesium and ADHD: Benefits, risks, dosage, and more",
          "url": "https://www.medicalnewstoday.com/articles/magnesium-and-adhd",
          "excerpts": [
            "Nov 5, 2024 — Some research suggests that magnesium supplementation may help improve symptoms of attention deficit hyperactivity disorder (ADHD) in children and adults."
          ]
        },
        {
          "title": "Study Details | Effects of L-theanine and Caffeine on ...",
          "url": "https://clinicaltrials.gov/study/NCT03533556?term=NCT00291070%20NCT03533556&rank=1",
          "excerpts": [
            "Furthermore, there is evidence to suggest that, when taken in combination, L-theanine and caffeine seem to have additive effects in improving attention in ..."
          ]
        },
        {
          "title": "Effects of L-Theanine Administration on Stress-Related ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6836118/",
          "excerpts": [
            "by S Hidese · 2019 · Cited by 258 — Additionally, this trial suggests, for the first time, that 4 weeks L-theanine administration is effective in improving stress-related symptoms ..."
          ]
        },
        {
          "title": "N‐acetylcysteine as a new prominent approach for treating ...",
          "url": "https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.15456",
          "excerpts": [
            "by I Smaga · 2021 · Cited by 67 — The trial revealed some improvement in the cognitive/inattentive ADHD symptoms of patients using NAC (4.8 g day−1, but not 2.4 g day−1) (Garcia ..."
          ]
        },
        {
          "title": "The Potential of N-Acetyl-L-Cysteine (NAC) in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9095537/",
          "excerpts": [
            "by RCJ Bradlow · 2022 · Cited by 82 — Five [23, 32–35] randomized controlled trials (RCTs) have investigated NAC as a treatment for ASD in children and adolescents, all of which were included in a ..."
          ]
        },
        {
          "title": "Effects of 800mg of Rhodiola Rosea in Attention in Adults ...",
          "url": "https://clinicaltrials.gov/study/NCT02737033",
          "excerpts": [
            "This study evaluates the use of Rhodiola rosea in the attention of adults with Attention Deficit/Hyperactivity Disorder (ADHD). Half of participants will ..."
          ]
        },
        {
          "title": "Efficacy and safety of saffron as adjunctive therapy in ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2212958822000027",
          "excerpts": [
            "by B Pazoki · 2022 · Cited by 14 — The present randomized, double-blind, placebo-controlled clinical trial demonstrated that six weeks of adjuvant therapy with saffron and Ritalin improved ADHD ..."
          ]
        },
        {
          "title": "The Effectiveness of Rhodiola rosea L. Preparations in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9228580/",
          "excerpts": [
            "by EI Stojcheva · 2022 · Cited by 126 — A statistically significant improvement in the Fatigue Index was observed in the R. rosea treatment group. Additionally, the improved mental ..."
          ]
        },
        {
          "title": "Effects of l-theanine on attention and reaction time response",
          "url": "https://www.sciencedirect.com/science/article/pii/S1756464611000351",
          "excerpts": [
            "by A Higashiyama · 2011 · Cited by 110 — l-theanine clearly has a pronounced effect on attention performance and reaction time response in normal healthy subjects prone to have high anxiety."
          ]
        },
        {
          "title": "Advances in Integrative Medicine, 2022: Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled clinical trial",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S2212958822000027",
          "excerpts": [
            ". Saffron may increase the efficacy of Ritalin in treatment of ADHD patients.",
            "• Saffron is a safe treatment for ADHD.",
            ".\nThis study aimed to evaluate the efficacy and safety of saffron as an adjuvant to Ritalin for improving symptoms in adults with ADHD.",
            "s\nFifty-six patients diagnosed with ADHD were assigned into two parallel groups to receive Ritalin (30 mg/day) plus placebo or Ritalin plus saffron (15 mg twice daily) for six weeks.",
            ". GLM repeated-measure analysis demonstrated significant time × treatment interaction effect for ASRS (df=2, F=3.455, and P-value=0.036) and CAARS (df=1.584, F=3.939, and P-value=0.033) score from baseline to the study endpoint.",
            ". We found a significantly greater reduction in ASRS scores in the saffron group compared with the placebo group from baseline to the study endpoint (week 6) (P-value=0.024).",
            ". However, the change score from baseline to week 3 was not significantly different between trial groups (P-value=0.269).",
            ". There was no significant difference between the two groups in baseline parameters and frequency of side effects.",
            "— Saffron might be beneficial in adults with ADHD."
          ]
        },
        {
          "title": "The Effects of Crocus sativus (Saffron) on ADHD: A Systematic Review",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37864351/",
          "excerpts": [
            "This study includes clinical trial studies that assessed the efficacy and/or safety of saffron in ADHD patients.",
            "Four studies met our inclusion criteria with a total of 118 patients. The results manifested an efficient role of saffron as either an adjuvant therapy to MPH or a single therapy against ADHD, without significant safety issues.",
            "Saffron demonstrates promise in improving ADHD symptoms, with an acceptable safety profile. Future well-designed multicentral studies are suggested."
          ]
        },
        {
          "title": "The Efficacy and Safety of Add-on Ginko TD (Ginkgo Biloba ...",
          "url": "https://www.researchgate.net/publication/228772804_The_Efficacy_and_Safety_of_Add-on_Ginko_TD_Ginkgo_Biloba_Treatment_for_PTSD_Results_of_a_12-Week_Double-Blind_Placebo-Controlled_Study",
          "excerpts": [
            "by LK Habibi · 2007 · Cited by 9 — Ginkgo TD was associated with a significantly greater improvement than placebo in PTSD patients as measured by five symptom domain scales."
          ]
        },
        {
          "title": "Efficacy and safety of ginkgo preparations for attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5855296/",
          "excerpts": [
            "by S He · 2018 · Cited by 2 — Ginkgo preparations may affect the behavioural and cognitive aspects of ADHD. The predominant behavioural effects are calming and improved ...",
            "Our systematic review will provide a detailed summary of the efficacy and tolerance of ginkgo preparations for the treatment of ADHD. Ginkgo ..."
          ]
        },
        {
          "title": "Ginseng and Ginkgo Biloba Effects on Cognition as ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4777384/",
          "excerpts": [
            "by DOL Teik · 2016 · Cited by 35 — There is some evidence to suggest that ginseng and Ginkgo biloba can improve cognitive performance, however, very little is known about the ..."
          ]
        },
        {
          "title": "Full article: Plant-derived nootropics and human cognition",
          "url": "https://www.tandfonline.com/doi/full/10.1080/10408398.2021.2021137",
          "excerpts": [
            "by C Lorca · 2023 · Cited by 55 — Ginkgo biloba was the most relevant nootropic regarding perceptual and motor functions. Bacopa monnieri improves language, learning and memory."
          ]
        },
        {
          "title": "Impact of Ginkgo biloba drug interactions on bleeding risk and ...",
          "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0321804",
          "excerpts": [
            "by NTQ Mai · 2025 · Cited by 4 — However, case reports and observational studies have suggested a potential increased bleeding risk with concurrent use of EGb and warfarin [29,30]. ... Ginkgo and ..."
          ]
        },
        {
          "title": "Ginkgo and Warfarin Interaction in a Large Veterans ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4765589/",
          "excerpts": [
            "by GJ Stoddard · 2015 · Cited by 71 — Our statistical analysis suggests that taking concurrently with warfarin, gingko does significantly increase patients' risk of a bleeding adverse event."
          ]
        },
        {
          "title": "omega-3 fatty acids and bleeding-cause for concern?",
          "url": "https://pubmed.ncbi.nlm.nih.gov/17368278/",
          "excerpts": [
            "by WS Harris · 2007 · Cited by 407 — The benefits of triglyceride lowering with omega-3 fatty acids more than outweigh any theoretical risks for increased bleeding."
          ]
        },
        {
          "title": "Fish oil LC-PUFAs do not affect blood coagulation ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0261561417301188",
          "excerpts": [
            "by S Jeansen · 2018 · Cited by 65 — The authors concluded that in their study, the use of high doses of n-3 LC-PUFAs was not associated with an increased risk of bleeding in subjects already ..."
          ]
        },
        {
          "title": "Monoamine oxidase inhibition by Rhodiola rosea L. roots",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S037887410900021X",
          "excerpts": [
            "by D van Diermen · 2009 · Cited by 281 — The present investigation demonstrates that Rhodiola rosea L. roots have potent anti-depressant activity by inhibiting MAO A and may also find application in ..."
          ]
        },
        {
          "title": "Nutraceuticals for ADHD and PTSD: Systematic Review of L-theanine, Bacopa monnieri, Ginkgo biloba, and Other Supplements",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12073678/",
          "excerpts": [
            "Bacopa monnieri* consistently improved inattention, hyperactivity, and memory, whereas *Ginkgo biloba* L. reduced ADHD symptoms, particularly inattention, but was less effective than methylphenida",
            " A randomized, double-blind, placebo-controlled clinical trial was conducted by Kean et al. [[17]()] in Australia, involving a population of 112 males displaying symptoms of inattention and hyperactivity aged 6–14 years. The results revealed significant improvements in inattention, hyperactivity, and cognitive function in the group receiving compar",
            "In an earlier randomized, placebo-controlled, double-blind, parallel-group trial, Kean et al. [[18]()] investigated the impact of *Bacopa monnieri* (CDRI 08)/160 mg capsules on hyperactivity and inattention symptoms in 100 male children and adolescents ranging from 6 to 14 years over a span o",
            "Bacopa monnieri* extract  (CDRI 08) (160 mg capsule",
            "ethylphenidate was significantly more effective than *Ginkgo biloba* L. in reducing ADHD symptoms. However, the *Ginkgo biloba* L. group reported fewer adverse symptoms, such as reduced appetite, insomnia, and headaches, than did the methylphenidate gro"
          ]
        },
        {
          "title": "Magnesium, Iron, and Zinc Supplementation for the Treatment - LWW",
          "url": "https://journals.lww.com/ijom/fulltext/2015/06000/magnesium,_iron,_and_zinc_supplementation_for_the.82.aspx",
          "excerpts": [
            "Our aim in this article was to present a systematic review of studies regarding zinc, magnesium, and iron supplementation in treating ADHD."
          ]
        },
        {
          "title": "L-theanine improves neurophysiological measures of ...",
          "url": "https://www.cochranelibrary.com/content?templateType=related&urlTitle=/central/doi/10.1002/central/CN-02183005&doi=10.1002/central/CN-02183005&p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=related-content&p_p_lifecycle=0&p_p_mode=view&type=central&contentLanguage=",
          "excerpts": [
            "Dose-response effect of L-theanine on psychomotor speed, sustained attention, and inhibitory control: a double-blind, placebo-controlled, crossover study"
          ]
        },
        {
          "title": "A Double-Blind Randomized Controlled Pilot Trial of N ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5226873/",
          "excerpts": [
            "by SE Back · 2016 · Cited by 116 — Veterans with current PTSD and SUD (N=35) were randomly assigned to receive a double-blind, 8-week course of NAC (2400 mg/day) or placebo plus ..."
          ]
        },
        {
          "title": "A multi-centre, double-blind, 12-week, randomized, ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S0165178123003487",
          "excerpts": [
            "by RA Kanaan · 2023 · Cited by 9 — A randomised trial of NAC combined with cognitive-behavioural therapy in 35 US veterans with PTSD and substance use disorders reported reductions in both ..."
          ]
        },
        {
          "title": "A multi-centre, double-blind, 12-week, randomized, ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7409699/",
          "excerpts": [
            "by A Maier · 2020 · Cited by 17 — An 8-week pilot study of NAC in veterans with PTSD found that symptoms were significantly reduced in the NAC group compared to placebo. This ..."
          ]
        },
        {
          "title": "The effects of L-theanine supplementation on the outcomes of ...",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-024-06285-y",
          "excerpts": [
            "The findings from this systematic review suggest that LT supplementation significantly reduced psychiatric symptoms more effectively than control conditions."
          ]
        },
        {
          "title": "Is there a risk of bleeding associated with standardized ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/21923430/",
          "excerpts": [
            "by AJ Kellermann · 2011 · Cited by 138 — Study objective: To determine the effect of standardized Ginkgo biloba leaf extracts (GBE) on outcome parameters of hemostasis associated with risk of bleeding."
          ]
        },
        {
          "title": "Effects of L-Theanine on Posttraumatic Stress Disorder Induced ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4137547/",
          "excerpts": [
            "We evaluated gene expression in PTSD-induced changes in the amygdala and hippocampus of Sprague-Dawley rats."
          ]
        },
        {
          "title": "Effect of Supplemental Enteral Fish Oil on the Development of ...",
          "url": "https://aspenjournals.onlinelibrary.wiley.com/doi/abs/10.1002/jpen.2025",
          "excerpts": [
            "by I Kagan · 2021 · Cited by 7 — This study randomized mechanically ventilated patients suffering from multiple trauma (n = 150) into 2 groups: a study and a control group that ..."
          ]
        },
        {
          "title": "[PDF] Omega-3 Fatty Acids - Health Professional Fact Sheet",
          "url": "https://apim.org/wp-content/uploads/2024/02/NIH_Health-Professional-Fact-Sheet_-Omega-3-Fatty-Acids-.pdf",
          "excerpts": [
            "Omega-3 Fatty Acids - Health Professional Fact Sheet. Page 1 of 37 https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/."
          ]
        },
        {
          "title": "Saffron (Crocus sativus L.): As an Antidepressant - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6266642/",
          "excerpts": [
            "by MJ Siddiqui · 2018 · Cited by 74 — More specifically, a saffron extract might inhibit serotonin reuptake in synapses. Inhibiting synaptic serotonin reuptake keeps serotonin in the brain longer, ..."
          ]
        },
        {
          "title": "Caffeine and theanine exert opposite effects on attention ...",
          "url": "https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01368359/related-content",
          "excerpts": [
            "A double-blind, placebo-controlled study evaluating the effects of caffeine and L-theanine both alone and in combination on cerebral blood flow, cognition and ..."
          ]
        },
        {
          "title": "Impact of Ginkgo biloba drug interactions on bleeding risk ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11991284/",
          "excerpts": [
            "by NTQ Mai · 2025 · Cited by 4 — Notably, Ginkgo biloba extract frequent interacts with antiplatelets, anticoagulants, and nonsteroidal anti-inflammatory drugs, with Clopidogrel ..."
          ]
        },
        {
          "title": "Is There a Risk of Bleeding Associated with Standardized ...",
          "url": "https://accpjournals.onlinelibrary.wiley.com/doi/10.1592/phco.31.5.490",
          "excerpts": [
            "by AJ Kellermann · 2011 · Cited by 138 — To determine the effect of standardized Ginkgo biloba leaf extracts (GBE) on outcome parameters of hemostasis associated with risk of bleeding."
          ]
        },
        {
          "title": "Omega-3 Fatty Acids - Consumer Factsheet",
          "url": "https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer/",
          "excerpts": [
            "Researchers are studying whether taking omega-3 dietary supplements may help lessen some of the symptoms of attention-deficit/hyperactivity [disorder](#), childhood allergies, and [cystic fibrosis](#). However, more research is needed to fully understand the potential benefits of omega-3s for these and other conditions.",
            "U.S. Food and Drug Administration](#) recommends consuming no more than 5 g/day of EPA and DHA combined from dietary supplements.",
            "Omega-3 dietary supplements may [interact](#) with the medications you take.\nFor example, high doses of omega-3s may cause bleeding problems when taken with warfarin (Coumadin) or other [anticoagulant](#) medic"
          ]
        },
        {
          "title": "Effects of omega-3 polyunsaturated fatty acids on ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27287561/",
          "excerpts": [
            "by K Matsumura · 2017 · Cited by 50 — These findings suggest that post-trauma supplementation of omega-3 PUFAs might be effective for the secondary prevention of psychophysiological symptoms of ..."
          ]
        },
        {
          "title": "Do Omega-3/6 Fatty Acids Have a Therapeutic Role in Children and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5603098/",
          "excerpts": [
            "Remaining studies showed general benefits. An Australian study found that children with ADHD who had increased erythrocyte EPA + DHA levels had significantly ..."
          ]
        },
        {
          "title": "Focus on omega-3 polyunsaturated fatty acids and ADHD",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8474554/",
          "excerpts": [
            "by JPC Chang · 2021 · Cited by 20 — Studies have shown that there is a positive correlation between EFA deficiency severity and ADHD symptoms, and a negative association between blood PUFAs ..."
          ]
        },
        {
          "title": "Living SMART — A randomized controlled trial of a guided online ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S2214782914000347",
          "excerpts": [
            "A CBT intervention for adults with ADHD consisting of a self-help book, three therapist-led sessions, and weekly telephone calls with coaches to guide the participants through the program have previously shown promising effects on ADHD-symptoms with 36% in the clinical group reporting a clinical relevant reduction in ..."
          ]
        },
        {
          "title": "Organizing the Home and Office Space",
          "url": "https://chadd.org/for-adults/organizing-the-home-and-office-space/",
          "excerpts": [
            "The first step is to make a list of all the physical spaces that need organizing, numbering the spaces from “easiest to organize” to “most difficult to ..."
          ]
        },
        {
          "title": "33 ADHD-Friendly Ways to Get Organized",
          "url": "https://www.additudemag.com/how-to-get-organized-with-adhd/?srsltid=AfmBOopSiEv3QHLl52ZRfUxTrdXDqgzfzhckQ0stPfvf3R4EfmE5VBst",
          "excerpts": [
            "May 8, 2025 — 1. Set time limits for decision-making. · 2. Fight the tendency to over-commit. · 3. Keep your to-do lists brief. · 4. Fight hyperfocus. · 5. Use a ..."
          ]
        },
        {
          "title": "ADHD in the Workplace: Guide to Inclusive Workplace Design",
          "url": "https://officeprinciples.com/insights/adhd-in-the-workplace-a-guide-to-inclusive-workplace-design",
          "excerpts": [
            "The most effective ADHD-friendly offices incorporate clearly defined zones that support different working styles and energy levels throughout the day . Serve as dedicated quiet areas with sound-dampening materials and minimal visual distractions, providing essential spaces for deep work and concentration."
          ]
        },
        {
          "title": "Sensory modulation disorder and its neural circuitry in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10655817/",
          "excerpts": [
            "by N Adra · 2021 · Cited by 9 — Although the authors found both low registration and high sensory sensitivity, individuals with ADHD displayed low sensory craving behavior, which is more ...See more"
          ]
        },
        {
          "title": "Sensory Alterations in Post-Traumatic Stress Disorder - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10922208/",
          "excerpts": [
            "Studies have demonstrated a strong association between variability in sensory processing regions and the severity of PTSD symptoms."
          ]
        },
        {
          "title": "A systematic review of interventions to support adults with ADHD at ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9443814/",
          "excerpts": [
            "The National Institute for Health Care Excellence ([2019]()) guidelines that clinicians apply when recommending how to manage ADHD state that medications (referred to in the present review as pharmacological interventions) are the first line of treatment once environmental modifications, through reasonable adjustments, have been implemented and reviewed.",
            "Key mechanisms of effectiveness were identified from psychosocial interventions including group therapy, involvement of people in the ADHDers network, and the importance of the client-patient relationship.",
            "Non-pharmacological (also referred to as psychosocial) interventions are only recommended if the ADHDer does not want to use medication, has difficulty adhering to medication, or found it ineffective (National Institute for Health Care Excellence, [2019]()).",
            "Thus far, no comprehensive review of interventions for adult ADHD has focused on work-related studies or scrutinized the organizational/management literature (De Crescenzo et al., [2017](); Fullen et al., [2020]()).",
            "In addition, studies should examine whether skills-based and cognitive behavioral therapies are applicable across contexts and demonstrate far transfer to the workplace."
          ]
        },
        {
          "title": "Health-Related Quality of Life and Work Productivity ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6732822/",
          "excerpts": [
            "by A Joseph · 2018 · Cited by 44 — Conclusion: Adult ADHD impairs HRQoL, work productivity, and regular daily activities."
          ]
        },
        {
          "title": "Accommodation Decision-Making for Postsecondary Students with ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36068830/",
          "excerpts": [
            "Results suggest that DSOs' accommodation decisions are not based on evidence of functional impairment but rely mainly on student self-report and ..."
          ]
        },
        {
          "title": "ADHD symptoms, diagnostic status, and work-related ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8295111/",
          "excerpts": [
            "by ABM Fuermaier · 2021 · Cited by 114 — This study emphasizes the susceptibility of individuals' functioning at work to ADHD symptoms and impairments associated with ADHD."
          ]
        },
        {
          "title": "Discussing an ADHD Diagnosis: Seeking Potential Workplace ...",
          "url": "https://psychiatry.duke.edu/duke-center-girls-women-adhd/resources/adult-women-adhd/discussing-adhd-diagnosis-seeking-potential",
          "excerpts": [
            "Seeking out accommodations at work may help women with ADHD to reduce the impact of their symptoms on their job performance and support their success."
          ]
        },
        {
          "title": "Harrison, A. G., & Armstrong, I. (2022). Accommodation decision ...",
          "url": "https://nceo.info/references/7ceEd1u9R8e5EdiegF_0SA",
          "excerpts": [
            "Accommodations for postsecondary students with attention-deficit/hyperactivity disorder (ADHD), particularly extra time, were investigated."
          ]
        },
        {
          "title": "ADHD Accommodations at Work - Additude Mag",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOopkLPJluFdsVpnlEJT4_WR881Q2yzlMjrEJ9fx3jpPGqqrdvhKw",
          "excerpts": [
            "The most important legal protection for workers with ADHD is the federal Americans with Disabilities Act, or ADA.",
            " The ADA is essentially a civil rights law that prohibits discrimination against individuals with “a physical or mental impairment that substantially limits one or more major life activities of such individual.",
            "” The law goes on to state that “major life activities include, but are not limited to, caring for oneself, performing manual tasks, seeing, hearing, eating, sleeping, walking, standing, bending, speaking, learning, reading, concentrating, thinking, communicating, and working.",
            "g.”\n\nThere is also a separate section of the ADA that further discusses what is included in the definition of disability under the law by listing the bodily systems that are affected, which include: “neurological [and] brain systems",
            "* Providing a quiet workspace",
            "* Allowing noise-canceling headphones or white noise",
            "* Working from home some or all of the time",
            "* Taking allotted breaks as needed",
            "* Minimizing marginal functions to allow focus on essential job duties",
            "* Allowing assistive technology (timers, apps, calendars, etc.)",
            "* Reassignment to a vacant position",
            "* Job restructuring"
          ]
        },
        {
          "title": "Coaching",
          "url": "https://chadd.org/about-adhd/coaching/",
          "excerpts": [
            "ADHD coaching is a practical intervention that specifically targets the core impairments of ADHD such as planning, time management, goal setting, organization ..."
          ]
        },
        {
          "title": "An Empirical Evaluation of ADHD Coaching in College ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/23509112/",
          "excerpts": [
            "by F Prevatt · 2015 · Cited by 154 — Results: Clients who received an 8-week coaching program showed significant improvement in all 10 areas of study and learning strategies, on self-esteem, and on ...",
            "by F Prevatt · 2015 · Cited by 154 — This study provides important preliminary information about ADHD coaching, including coaching structure, processes, efficacy, and correlates of positive ...",
            "by F Prevatt · 2015 · Cited by 154 — Results: Clients who received an 8-week coaching program showed significant improvement in all 10 areas of study and learning strategies, on self-esteem, and on ..."
          ]
        },
        {
          "title": "ADHD Accommodations at Work: Create a Supportive Workplace",
          "url": "https://add.org/adhd-workplace-accommodations/",
          "excerpts": [
            "ADHD workplace accommodations adjust the environment, workflow, or schedule that boost focus and productivity. Read on to explore.",
            "Feb 4, 2025 — What Are Reasonable Accommodations for ADHD? Reasonable accommodations for ADHD include a flexible work schedule and a private working area."
          ]
        },
        {
          "title": "Workplace Issues - CHADD",
          "url": "https://chadd.org/for-adults/workplace-issues/",
          "excerpts": [
            "Adults with ADHD may struggle with impulsivity and temper outbursts in the workplace. Try the following strategies: Learn to use self-talk to monitor ..."
          ]
        },
        {
          "title": "Reasonable Adjustments - Centre for ADHD and Autism Support",
          "url": "https://adhdandautism.org/information/reasonable-adjustments/",
          "excerpts": [
            "Ideas for reasonable adjustments at work"
          ]
        },
        {
          "title": "ADA.gov: The Americans with Disabilities Act",
          "url": "https://www.ada.gov/",
          "excerpts": [
            "Disability rights are civil rights. From voting to parking, the ADA is a law that protects people with disabilities in many areas of public life.",
            "From answers to common questions to official legal documents, ADA.gov has everything you need to understand your rights and responsibilities under the ADA."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder: diagnosis and ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29634174/",
          "excerpts": [
            "This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder: diagnosis and management",
          "url": "https://www.nice.org.uk/guidance/ng87",
          "excerpts": [
            "This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder: diagnosis and ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK493361/",
          "excerpts": [
            "This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults."
          ]
        },
        {
          "title": "Attention Deficit Hyperactivity Disorder (ADHD) versus ...",
          "url": "https://askjan.org/articles/Attention-Deficit-Hyperactivity-Disorder-versus-Executive-Functioning-Deficits.cfm",
          "excerpts": [
            "The following employees all have ADHD, but look at the difference in their accommodation needs as determined by their job tasks, environments, and difficulties:."
          ]
        },
        {
          "title": "The Efficacy of Computerized Cognitive Training in Adults With ADHD: A Randomized Controlled Trial",
          "url": "https://pubmed.ncbi.nlm.nih.gov/24756172/",
          "excerpts": [
            "by A Stern · 2016 · Cited by 61 — This is a randomized control trial examining the efficiency of computerized cognitive training (CCT) for adults with ADHD. * PMID:\n  **24756172**\n* DOI:\n  [10.1177/1087054714529815](https://doi.org/10.1177/1087054714529815)\n\nItem in Clipboard\n\nRandomized Controlled Trial\n\nThe Efficacy of Computerized Cognitive Training in Adults With ADHD: A Randomized Controlled Trial\n==================================================================================================\n\nAdi Stern et al. J Atten Disord. 2016 Dec.\n\nShow details\n\nDispl"
          ]
        },
        {
          "title": "Brookes University Radar / Related ADHD Coaching Studies",
          "url": "https://radar.brookes.ac.uk/radar/items/a4a8d49e-0f1c-4741-b550-82533d403b7e/1/",
          "excerpts": [
            "Feb 1, 2024 — Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. Behaviour ... 2",
            "At least eighteen studies to date of outcomes of coaching for clients with ADHD are varied in size (*n*s range from 1 to 1782 participants) and research design (three are randomized controlled trials/RCTs) (Ahma",
            "Collectively, these studies have found evidence, of varied robustness, across age groups, of improvement in clients’ ADHD symptoms and executive functioning and, in some cases, well-being.",
            "Only two studies of ADHD coaching have explored coaching for non-student adults, both focused on group coaching, and both reporting positive outcomes (Bloemen et al., 2007; Kubik, 2010).",
            "Bloemen et al. (2007), conducted a quantitative study of eight weeks of ADHD coaching for ten adult patients in the Netherlands.",
            "Kubik (2010) conducted an observational study on group coaching, including psychoeducation, for a total of 45 adults with ADHD.",
            "Coaching for adults, who are not full-time college students, has received less attention in the literature.",
            "Coaching for ADHD is an emerging field with an increasing body of research, focused mainly on the college-aged population (Ahmann & Saviet, 2021).",
            "Feb 1, 2024 — A systematic review and meta-analysis of nine randomized controlled trials found that CBT was superior to both waitlist and active controls in ...",
            "A systematic review and meta-analysis of nine randomized controlled trials found that CBT was superior to both waitlist and active controls in reducing ADHD symptomatology (Young, Moghaddam, & Tickle, 2020); it appears to be useful even in the absence of medication use (Ramsay & Rostain, 2011; Weiss et al., 2012)."
          ]
        },
        {
          "title": "Short cognitive behavioral therapy and cognitive training for adults with ADHD – PMC study",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2938293/",
          "excerpts": [
            "by M Virta · 2010 · Cited by 116 — Short cognitive behavioral therapy and cognitive training for adults with ADHD – a randomized controlled pilot study - PMC.",
            "There were distinctive pre-hypotheses regarding the treatments, and therefore the statistical comparisons were conducted in pairs: CBT vs control, CT vs control, and CBT vs CT.",
            "In a combined ADHD symptom score based on self-reports, 6 participants in CBT, 2 in CT and 2 controls improved.",
            "Using independent evaluations, improvement was found in 7 of the CBT participants, 2 of CT participants and 3 controls.",
            "There was no treatment-related improvement in cognitive performance.",
            "Thus, in the CBT group, some encouraging improvement was seen, although not as clearly as in previous research with longer inter"
          ]
        },
        {
          "title": "Sensory modulation interventions for adults with mental illness (PMC review)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10680857/",
          "excerpts": [
            "Sensory modulation interventions (SMI) assist people with mental illnesses to regulate emotional and physiological arousal.",
            "Environmental enhancements included assessing the patient’s ‘‘sensory diet’’ on admission (e.g., identifying personalized coping strategies for decreasing anxiety/agitation) and creating comfort rooms (e.g., areas with calming lights, sensory items, musi",
            "Glider chair, murals, chalk boards and sound boards, soft furnishings, a bean bag, relaxing music and stress balls, massage chair, bean bags, music, a variety of lighting, lollies, self-help books, stress balls, water feature, and a ‘swiss ball’ (large inflatable exercise ball)",
            " The application of sensory modulation strategies has been proven to be helpful and supportive of functional performance, thus occupational therapists use SMI to help individuals to self-regulate through the process of self-organization and positive change ([Champagne, 2011",
            "\nThere is a relationship between sensory defensiveness and anxiety, and by following an intervention that is designed for individuals with sensory modulation disorder, both sensory defensiveness and anxiety could drastically decrease ([Machingura et al., 2018",
            " By appropriately using sensory modulation strategies, we could provide experiential and alternative opportunities for de-escalation, empowerment, choice, increasing awareness, and skill development ([Reed, 2017",
            "30\\-Pound weighted blanket",
            "5 minutes, 2 sessions"
          ]
        },
        {
          "title": "The Link Between ADHD and Sensory Processing: How to Manage Sensory Overload",
          "url": "https://www.relationalpsych.group/articles/the-link-between-adhd-and-sensory-processing-how-to-manage-sensory-overload",
          "excerpts": [
            "Occupational Therapy and Sensory Integration  This can include: Deep Pressure Activities: Weighted blankets, compression clothing, or tight hugs can provide grounding and reduce anxiety . Movement Breaks: Jumping on a mini-trampoline or engaging in activities like yoga or swinging can help regulate vestibular input.",
            "People with noise sensitivities, for example, might find relief by using noise-cancelling headphones in crowded environments.",
            "An occupational therapist (OT) trained in sensory integration can help pinpoint specific triggers and recommend tailored strategies.",
            "Routine and Predictability\n\nChildren and adults with ADHD often thrive on predictable routines and schedule",
            "Mindfulness training can teach individuals how to observe and acknowledge sensory input without automatically reacting to it."
          ]
        },
        {
          "title": "JAN Accommodations for Attention Deficit/Hyperactivity Disorder (ADHD)",
          "url": "https://askjan.org/disabilities/Attention-Deficit-Hyperactivity-Disorder-AD-HD.cfm",
          "excerpts": [
            "Key Accommodations:\n\n**Hyperactivity/ Impulsivity:** For individuals with ADHD, accommodations for hyperactivity/impulsivity might be beneficial. * Provide structured breaks as a physical outlet\n* Utilize a job coach to teach/reinforce techniques\n* Allow the employee to work from home\n* Review conduct policy with employee\n* Adjust method of supervision\n* Use services of EAP\n* Provide private workspace",
            "**Focus/Concentration:** For individuals with ADHD, accommodations minimizing distractions might be improve performance.\n* Provide a quiet work space\n* Allow use of noise cancellation or white noise\n* Work from home if no effective accommodations in office environment\n* Uninterrupted work time\n* Taking allotted breaks as needed\n* Minimizing marginal functions to allow focus on essential job duties",
            "**Time management:** For individuals with ADHD, accommodations assisting with staying on task is often helpful\n\n* Assign a mentor\n* Provide to-do lists\n* Meetings to discuss expectations\n* Assistance with prioritization\n* Assistive technology (timers, apps, calendars, etc)",
            "## JAN Publications & Articles Regarding Attention Deficit/Hyperactivity Disorder (ADHD)\n\n### Publications\n\n#### Consultants' Corner Articles\n\n* [A Support Person as an Accommodation]( /publications/consultants-corner/vol05iss01.cfm)\n* [Accommodations Related to Commuting To and From Work]( /publications/consultants-corner/vol08iss01.cfm)\n* [Disability Awareness Training]( /publications/consultants-corner/Disability-Awareness-Training.cfm)\n* [Getting to Work on Time]( /publications/consultants-corner/Getting-to-Work-on-Time.cfm)\n",
            "There are some general accommodations that explain how people with ADHD disregard themselves at work.\nGeneral: Individuals with ADHD are often perfectionists and are hard on themselves. They have trouble setting personal boundaries like knowing when to stop working and they set unrealistic expectations for themselves. Someone who takes work home or stays late to finish work is often given more responsibility or a heavier workload because they appear to be able to get their work done. General accommodations include:\n\n* Help identifying strengths instead of focusing on weaknesses\n* Reinforcing creativity\n* Pointing out any signs that the individual is overworked – not taking vacations, staying at work late frequently, not eating lunch\n* Providing an ADHD coach to suggest ways to increase productivity and maintain a healthy work-life balance",
            "Provide a quiet work space",
            "Allow use of noise cancellation or white noise"
          ]
        },
        {
          "title": "ADA: Your Employment Rights and Protections (EEOC)",
          "url": "https://www.eeoc.gov/publications/ada-your-employment-rights-individual-disability",
          "excerpts": [
            "The employer cannot refuse to hire you because of your disability if you can perform the essential functions of the job with an accommodation. Once you have ...",
            "an employer may be required to provide a sign language interpreter during a job interview for an applicant who is deaf or hearing impaired, unless to do so would impose an undue hardship.",
            "reasonable accommodation may include:\n                                \n                                \n                                                    - providing or modifying equipment or devices,\n                                                    - job restructuring,\n                                                    - part-time or modified work schedules,\n                                                    - reassignment to a vacant position,\n                                                    - adjusting or modifying examinations, training materials, or policies,\n                                                    - providing readers and interpreters, and\n                                                    - making the workplace readily accessible to and usable by people with disabilities. An employer is required to provide a reasonable accommodation to a qualified applicant or employee with a disability unless the employer can show that the accommodation would be an undue hardship -- that is, that it would require significant difficulty or expense. * * *\n                                \n                                \n                                \n                                ## What Employment Practices are Covered?",
            "- providing or modifying equipment or devices,",
            "- job restructuring,",
            "- part-time or modified work schedules,",
            "- reassignment to a vacant position,",
            "- adjusting or modifying examinations, training materials, or policies,",
            "- providing readers and interpreters, and",
            "- making the workplace readily accessible to and usable by people with disabilities."
          ]
        },
        {
          "title": "Evidence-Based Coaching for Adults with ADHD - CHADD",
          "url": "https://chadd.org/attention-article/evidence-based-coaching-for-adults-with-adhd/",
          "excerpts": [
            "Evidence-based coaching has been described as “the intelligent and conscientious use of best current knowledge integrated with practitioner expertise."
          ]
        },
        {
          "title": "findings from the Weiss Functional Impairment Rating Scale",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6241626/",
          "excerpts": [
            "by MD Weiss · 2018 · Cited by 117 — The objective of the review is to establish a framework for understanding functional impairment and create a definition for functional response and remission."
          ]
        },
        {
          "title": "Boosting Productivity: Pomodoro Technique for ADHD ...",
          "url": "https://adhdandautismclinic.co.uk/unleashing-productivity-the-pomodoro-technique-for-adhd-management/",
          "excerpts": [
            "This structure is beneficial for individuals with ADHD who often struggle with time blindness or difficulty perceiving and estimating time accurately."
          ]
        },
        {
          "title": "Neuropsychology - APA PsycNET",
          "url": "https://psycnet.apa.org/manuscript/2021-00770-012.pdf",
          "excerpts": [
            "by WE Jones · 2021 · Cited by 86 — degree as adults who opt-in to reearch studies. External Memory Aid Interventions. Analog memory aids. Making a “to-do list” may be the most intuitive strategy ..."
          ]
        },
        {
          "title": "5 Visual Aids That Work Better Than Phone Reminders",
          "url": "https://www.millennialtherapy.com/anxiety-therapy-blog/visual-memory-aids-adhd",
          "excerpts": [
            "5 Examples of Visual Memory Aids for ADHD · 1. Countdown Timers · 2. Sticky Notes, Whiteboards, and Other Surfaces · 3. Color-Coded Systems · 4."
          ]
        },
        {
          "title": "Guide to Disability Rights Laws",
          "url": "https://www.ada.gov/resources/disability-rights-guide/",
          "excerpts": [
            "This guide provides an overview of Federal civil rights laws that ensure equal opportunity for people with disabilities."
          ]
        },
        {
          "title": "Employees' Practical Guide to Requesting and Negotiating ...",
          "url": "https://askjan.org/publications/individuals/employee-guide.cfm",
          "excerpts": [
            "Under the ADA, employers are only required to provide accommodations for employees who are experiencing workplace problems because of a disability. Therefore, ..."
          ]
        },
        {
          "title": "Environmental Factors in Adult ADHD",
          "url": "https://www.abundancetherapycenter.com/understanding-adult-adhd/environmental-factors",
          "excerpts": [
            "Chronic stress, social instability, and environmental adversity, such as living in a high-stress environment, can contribute to the onset and severity of ADHD ..."
          ]
        },
        {
          "title": "Strategies for Coping with Time-Related and Productivity ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6406620/",
          "excerpts": [
            "by CM Kreider · 2019 · Cited by 56 — This study examined the strategies that college students with LD/ADHD used to overcome obstacles related to time and productivity within their everyday life ..."
          ]
        },
        {
          "title": "Weiss Functional Impairment Rating Scale",
          "url": "https://www.caddra.ca/wp-content/uploads/WFIRS-S.pdf",
          "excerpts": [
            "A. FAMILY. 1. Having problems with family. 2. Having problems with spouse/partner. 3. Relying on others to do things for you."
          ]
        },
        {
          "title": "Executive functions and emotional lability in adults with ADHD.",
          "url": "https://psycnet.apa.org/record/2025-24569-005",
          "excerpts": [
            "This chapter reviews executive function deficits and emotional dysregulation symptoms, including important theoretical issues."
          ]
        },
        {
          "title": "MyADHD Internet-delivered intervention study (ScienceDirect)",
          "url": "https://www.sciencedirect.com/science/article/pii/S2214782921001251",
          "excerpts": [
            "Interventions delivered over the Internet on smartphones or personal computers may help to increase the availability of effective psychological interventions.",
            "The primary aim of this randomized controlled trial is to examine the efficacy of a self-guided Internet-delivered intervention on severity levels of ADHD symptomatology and quality of life.",
            "MyADHD was developed in cooperation with adults with an ADHD diagnosis.",
            "This RCT will provide valuable information on the clinical effectiveness of an Internet-delivered intervention for adults with ADHD.",
            "The intervention is expected to improve symptoms of inattention and quality of life."
          ]
        },
        {
          "title": "ADHD occupation-based intervention study (PMCID: PMC7018471)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7018471/",
          "excerpts": [
            "The intervention was administered for 7 wk in individual 1-hr sessions and addressed routine establishment, organization, time management, stress management, and sensory regulation in the home and community.",
            "Abstract",
            "**Importance:** Women with attention deficit hyperactivity disorder (ADHD) and ADHD symptoms may experience difficulty carrying out desired life roles and activities.",
            "**Objective:** To determine whether a 7-wk tailored occupation-based intervention can reduce perceived stress and ADHD symptoms and enhance perceived performance of and satisfaction with daily roles and activities among women with ADHD.",
            "**Design:** Randomization to intervention (*n* = 11) and control (*n* = 12) groups.",
            "**Setting:** Home and community.",
            " **Participants:** Twenty-three participants ages 20–55 yr, English speaking, and with a self-reported diagnosis of ADHD.",
            "**Intervention:** The intervention was administered for 7 wk in individual 1-hr sessions and addressed routine establishment, organization, time management, stress management, and sensory regulation in the home and community."
          ]
        },
        {
          "title": "The Efficacy of Cognitive Behavioral Therapy for Adults With ADHD",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27554190/",
          "excerpts": [
            "Abstract"
          ]
        },
        {
          "title": "Organizational-skills interventions in the treatment of ADHD",
          "url": "https://pubmed.ncbi.nlm.nih.gov/18928347/",
          "excerpts": [
            "Skills and strategy training interventions have been developed to address the organizational problems of children and adults with ADHD."
          ]
        },
        {
          "title": "Organizational-skills interventions in the treatment of ADHD",
          "url": "https://www.researchgate.net/publication/23392043_Organizational-skills_interventions_in_the_treatment_of_ADHD",
          "excerpts": [
            "Skills and strategy training interventions have been developed to address the organizational problems of children and adults with ADHD."
          ]
        },
        {
          "title": "The Functional External Memory Aid Tool Version 2.0: A How-To ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10023140/",
          "excerpts": [
            "Although external aids are preferred and enhance task performance, simply providing a client with an aid (e.g., passively recommending or ..."
          ]
        },
        {
          "title": "Setting Up an Optimal Environment for Your ADHD Brain",
          "url": "https://laconciergepsychologist.com/blog/setting-up-an-optimal-environment-for-your-adhd-brain/",
          "excerpts": [
            "Go somewhere quiet without a tv. Work outside the home so you're not tempted to start cleaning instead of working. Use an app to block yourself ..."
          ]
        },
        {
          "title": "Occupational Therapy for ADHD: How Can OT Help ADHD? | USAHS",
          "url": "https://www.usa.edu/blog/occupational-therapy-for-adhd-how-can-ot-help-adhd/",
          "excerpts": [
            "Sensory integration therapy is a technique used for ADHD occupational therapy in which the occupational therapist identifies sensory ..."
          ]
        },
        {
          "title": "How To Support Deep Work in Open-Plan Offices",
          "url": "https://www.ie-uk.com/blog/how-to-support-deep-work-in-open-plan-offices",
          "excerpts": [
            "Explore how office design can balance focus and collaboration, helping workers thrive in open plan spaces by reducing distractions and fostering deep work."
          ]
        },
        {
          "title": "Your Rights to ADHD Accommodations at Work",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOorTkjN7wWd7HQW48EwK083Gy9iGG7zmMyPWD7_6SB7S_PEiCrHx",
          "excerpts": [
            "May 6, 2025 — The most important legal protection for workers with ADHD is the federal Americans with Disabilities Act, or ADA."
          ]
        },
        {
          "title": "Creating an ADHD-Friendly Home Environment: Practical Tips for ...",
          "url": "https://www.northmetropsych.com/blog/k99ypml8et6x5m6m4cdxafshnyp56p",
          "excerpts": [
            "Create Designated Spaces: Establish specific areas for different activities. For example, have a dedicated space for homework or work, a quiet area for relaxation, and a play area for children. This helps individuals with ADHD know what to expect in each space and reduces distractions."
          ]
        },
        {
          "title": "ADHD Work Accommodations Examples",
          "url": "https://add.org/adhd-work-accommodations-examples/",
          "excerpts": [
            "Jul 10, 2023 — ADHD Work Accommodations Examples · Delegating work · Frequent breaks · Technology assistance · Realistic workload · Workspace alterations · Work ..."
          ]
        },
        {
          "title": "Your Rights to ADHD Accommodations at Work",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOoq20Skzvqb0RIGaOuRjS62Iurt8vLXuVHAUGYs5gkr6Y0bSlTaM",
          "excerpts": [
            "May 6, 2025 — What are reasonable accommodations? · Providing a quiet workspace · Allowing noise-canceling headphones or white noise · Working from home some or ..."
          ]
        },
        {
          "title": "Your Rights to ADHD Accommodations at Work",
          "url": "https://www.additudemag.com/adhd-law-americans-with-disabilities-act/?srsltid=AfmBOoqec_j-4s0jfGWXBTZ47MKJKz7pQF08txxV-9BHy9N7rzq1n-86",
          "excerpts": [
            "May 6, 2025 — What are reasonable accommodations? · Providing a quiet workspace · Allowing noise-canceling headphones or white noise · Working from home some or ..."
          ]
        },
        {
          "title": "Employees with Attention Deficit-Hyperactivity Disorder",
          "url": "https://www.govinfo.gov/content/pkg/GOVPUB-L41-PURL-gpo11012/pdf/GOVPUB-L41-PURL-gpo11012.pdf",
          "excerpts": [
            "For information on assistive technology and other accommodation ideas, visit JAN's. Searchable Online Accommodation Resource (SOAR) at http://askjan.org/soar."
          ]
        },
        {
          "title": "Accommodations for Employees with Mental Health ...",
          "url": "https://www.dol.gov/agencies/odep/program-areas/mental-health/maximizing-productivity-accommodations-for-employees-with-psychiatric-disabilities",
          "excerpts": [
            "Under the Americans with Disabilities Act (ADA) and other nondiscrimination laws, most employers must provide \"reasonable accommodations\" to qualified employees ..."
          ]
        },
        {
          "title": "Occupational therapy for adults with ADHD (BMC Psychiatry)",
          "url": "https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-021-03070-z",
          "excerpts": [
            "Occupational therapists can help adults with ADHD to recognise the relationship between mood, performance, and sensory stimulation; and learn to monitor and regulate the amount and type of sensory stimulation that enters their nervous system at any one time.",
            "Occupational Therapists can work together with individuals to recognise the common situations in which sensory hyper or hypo reactivity can occur, and the steps they can take to ameliorate the effects on their ADHD symptoms.",
            "A simple strategy of headphones or screen panels can reduce auditory and visual input and reduce distractions.",
            " sensory diet–or the ideas that one’s day is comprised of many different types of sensory experiences that can have a cumulative effect, and that people have unique sensory requirements that must be met to function optimally in all occupational domains",
            "Occupational Therapists can also offer advice for the workplace, in terms of reasonable adjustments and/or modifications to the environment to reduce sensory input.",
            "Occupational therapists have much to offer in providing interventions for adults with ADHD."
          ]
        },
        {
          "title": "Treatments for PTSD",
          "url": "https://www.apa.org/ptsd-guideline/treatments",
          "excerpts": [
            "APA's Clinical Practice Guideline recommends three interventions for treating posttraumatic stress disorder and suggests another four."
          ]
        },
        {
          "title": "Attention-deficit/hyperactivity disorder comorbidity in a sample of ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6519447/",
          "excerpts": [
            "This study examined attention-deficit/hyperactivity disorder (ADHD) comorbidity in military veterans with a high prevalence of posttraumatic stress disorder ...",
            "by KM Harrington · 2012 · Cited by 80 — We hypothesized that ADHD would be associated with greater PTSD severity and/or higher levels of exposure to traumatic events, and we tested whether ADHD ..."
          ]
        },
        {
          "title": "A Secondary Analysis of NIDA's Women and Trauma Study",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3857558/",
          "excerpts": [
            "by LM Ruglass · 2013 · Cited by 40 — Results indicated that heavy stimulants users had significantly greater PTSD symptoms at baseline compared to light stimulant users. ... hypervigilance ...",
            "Heavy stimulant use is often associated with a worsening of hyperarousal symptoms secondary to stimulant intoxication or withdrawal."
          ]
        },
        {
          "title": "Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35312136/",
          "excerpts": [
            "Atomoxetine demonstrated modest efficacy for ADHD symptoms; quality of life measures and PTSD symptoms were not affected."
          ]
        },
        {
          "title": "[PDF] ADULT ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)",
          "url": "https://www.bop.gov/resources/pdfs/adult_adhd_cd.pdf",
          "excerpts": [
            "This stepwise, non-stimulant pharmacologic treatment algorithm is based on the adverse reactions and safety profiles of the agents used to treat ADHD. CLOSE ..."
          ]
        },
        {
          "title": "Use of Stimulants and Performance Enhancers During and After ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5289819/",
          "excerpts": [
            "Stimulant-Based Supplements: Difficult to Regulate, Easy Access. The current case describes the onset and exacerbation of hyperarousal, panic, insomnia, and re-experiencing symptoms of PTSD with concomitant DMAA ingestion in a combat veteran."
          ]
        },
        {
          "title": "Cognitive behavioral therapy for the treatment of post ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3083990/",
          "excerpts": [
            "by N Kar · 2011 · Cited by 488 — Eye movement desensitization and reprocessing​​ EMDR and trauma-focused CBT are both widely used in the treatment of PTSD and have been consistently compared. ..."
          ]
        },
        {
          "title": "Trauma-Informed Therapy - StatPearls",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK604200/",
          "excerpts": [
            "by G Yadav · 2024 · Cited by 17 — Trauma-informed therapy is a framework designed to acknowledge and address the impact of traumatic experiences on individuals' lives."
          ]
        },
        {
          "title": "ADHD Treatment for Adults | The Hanley Foundation",
          "url": "https://www.hanleycenter.org/mental-health-disorders/adhd-in-adults/",
          "excerpts": [
            "Integrated treatment for ADHD in adults provides all the therapeutic resources necessary to heal you physically, psychologically, and spiritually."
          ]
        },
        {
          "title": "Clinical Practice Guideline for the Diagnosis, Evaluation ...",
          "url": "https://publications.aap.org/pediatrics/article/144/4/e20192528/81590/Clinical-Practice-Guideline-for-the-Diagnosis",
          "excerpts": [
            "Oct 1, 2019 — Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.",
            "Oct 1, 2019 — Guidelines on the diagnosis and management of ADHD should include trauma screening in the algorithm and recommendations for reassessing for ...",
            "In addition, the AAP holds that primary care pediatricians should be prepared to diagnose and manage mild-to-moderate ADHD, anxiety, depression, ..."
          ]
        },
        {
          "title": "[PDF] Identification and Management of Attention-Deficit / Hyperactivity ...",
          "url": "https://www.pbm.va.gov/PBM/AcademicDetailingService/Documents/508/10-1520_ADHD_ClinicianGuide_P97040.pdf",
          "excerpts": [
            "Many adults with ADHD present with co-occurring disorders.21 Often these need to be addressed \nconcomitantly; however, in some cases prioritization may need to be given to the most impairing illness \nfirst (e.g., psychosis, severe mood disorder, bipolar disorder, active SUD [see Table 3]).1,20,21,",
            "Where mood symptoms are apparent but not pervasive, treat ADHD symptoms and monitor for \nimprovement first, prior to considering or initiating treatment for mood disorders.2",
            "TAKE \nNOTE\n! Consider a slower dose titration and provide more frequent monitoring  \nif any of the following are present:\n31\n\n� Other neurodevelopmental disorders (e.g., autism spectrum disorder, tic disorders, learning  \ndisability/intellectual disability)\n\n� Mental health conditions (e.g., anxiety disorders, schizophrenia or bipolar disorder, depression, \npersonality disorder, eating disorder, PTSD, substance misuse) \n\n� Physical health conditions (e.g., cardiac disease, epilepsy, brain injury). Identi�cation and Management of Attention-De�cit/Hyperactivity Disorder (ADHD) in Adu",
            "STEP\n5\n\nFinalize diagnosis. 10\n\nIf the patient meets DSM-5-TR criteria for ADHD, determine presentation (e.g.,  \npredominantly inattentive) and severity (mild, moderate, severe) to finalize the diagnosis. Clinical pearl: 10 When making a first-time ADHD diagnosis in adulthood, consider  \ndocumenting factors that may have prevented childhood diagno",
            "Psychiatric comorbid disorders and treatment selection \n\nMany adults with ADHD present with co-occurring disorders.21 Often these need to be addressed \nconcomitantly; however, in some cases prioritization may need to be given to the most impairing illness \nfirst (e.g., psychosis, severe mood disorder, bipolar disorder, active SUD [see Table 3]).1,20,21",
            "Medication recommendations\nTreatment considerations\n\nSUD\n� Atomoxetine (has efficacy in adult ADHD; little to  \nno abuse potential"
          ]
        },
        {
          "title": "Complex PTSD and ADHD in Adults - Origins Texas Recovery",
          "url": "https://www.originstexas.com/blog/complex-ptsd-and-adhd-in-adults/",
          "excerpts": [
            "ADHD treatments often focus on behavioral modification and sometimes medication, while C-PTSD requires trauma-informed interventions, such as ..."
          ]
        },
        {
          "title": "PMC8751557 - Psychotherapies and pharmacotherapies in comorbid ADHD and PTSD: integrated approaches and evidence",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8751557/",
          "excerpts": [
            "Psychotherapies and pharmacotherapies are recommended as first line treatments. However, evidence has emerged that their efficacy may be overestimated.",
            "In OCD, psychotherapy achieved medium to large SMDs (0.61‐0.95) in comparison to SSRIs[72](), but most psychotherapy trials included patients taking stable doses of antidepressants, affecting results in favour of psychoth"
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder (update)",
          "url": "https://www.nice.org.uk/guidance/ng87/documents/evidence-review",
          "excerpts": [
            "of comorbid post-traumatic stress disorder in adult ADHD. Journal of ... Multilevel analysis of ADHD, anxiety and depression symptoms aggregation in. 16.See more"
          ]
        },
        {
          "title": "Adult ADHD and comorbid disorders: clinical implications ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5567978/",
          "excerpts": [
            "by MA Katzman · 2017 · Cited by 945 — Guidelines recommend that when ADHD coexists with other psychopathologies in adults, the most impairing condition should generally be treated ...",
            "by MA Katzman · 2017 · Cited by 945 — In many studies, ADHD has been associated with comorbid depression, anxiety disorders, bipolar disorder, and substance use disorder [27, 30, 40– ..."
          ]
        },
        {
          "title": "Effects of the interaction between PTSD and ADHD ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10587572/",
          "excerpts": [
            "by H Gelner · 2023 · Cited by 3 — It has been shown that a diagnosis of PTSD in individuals with ADHD is associated with a higher risk of psychiatric hospitalization, school ...",
            "It has been shown that a diagnosis of PTSD in individuals with ADHD is associated with a higher risk of psychiatric hospitalization, school impairment, worse social and cognitive performance as well as a higher likelihood of mood, conduct disorder, and anxiety disorders ([29](), [31]()).",
            "Authors of this study found that risk-taking behaviors, household income, and educational attainment might only partially mediate this association.",
            "To date, none of previous studies have investigated the interactive effects of PTSD and ADHD symptoms on the occurrence of PLEs.",
            "There are also studies showing beneficial effects of methylphenidate on fear extinction and PTSD symptoms ([26](), [27]())."
          ]
        },
        {
          "title": "Methylphenidate for the Treatment of PTSD With ...",
          "url": "https://www.centerwatch.com/clinical-trials/listings/NCT05776056/methylphenidate-for-the-treatment-of-ptsd-with-associated-neurocognitive-complaints",
          "excerpts": [
            "Jan 7, 2025 — This study will evaluate the ability of methylphenidate to treat PTSD and associated neurocognitive complaints in Veterans."
          ]
        },
        {
          "title": "Hyperarousal: What It Is, Causes, Symptoms & Treatment",
          "url": "https://my.clevelandclinic.org/health/symptoms/hyperarousal",
          "excerpts": [
            "Cut back on stimulants. Substances like caffeine and tobacco (nicotine) activate your nervous system, which contributes to your feelings of arousal. If you have ..."
          ]
        },
        {
          "title": "Adult ADHD and PTSD: What's the Link? - WebMD",
          "url": "https://www.webmd.com/add-adhd/adult-adhd-ptsd",
          "excerpts": [
            "Some studies have found that stimulant drugs used to treat ADHD, such as methylphenidate, may improve PTSD symptoms in some people."
          ]
        },
        {
          "title": "ADHD and Trauma | PTSD Risk, Overlap, and Shared Traits",
          "url": "https://neurodivergentinsights.com/adhd-and-trauma/",
          "excerpts": [
            "And stimulant use may help with focus and attention issues which will help a person more fully work through their trauma. On the other hand, stimulants may not be appropriate for everyone with PTSD, as they can activate the nervous system and intensify hypervigilance and anxiety ."
          ]
        },
        {
          "title": "DIFFERENTIAL DIAGNOSIS AND COMORBID DISORDERS",
          "url": "https://caddra.ca/pdfs/caddraGuidelines2011Chapter02.pdf",
          "excerpts": [
            "Introduction. When making an ADHD diagnosis, it is important to exclude other disorders that might overlap with ADHD or mimic ADHD symptoms."
          ]
        },
        {
          "title": "[PDF] Treatment Outcomes with Lisdexamfetamine Dimesylate (Vyvanse ...",
          "url": "https://cdn.clinicaltrials.gov/large-docs/96/NCT02712996/Prot_SAP_000.pdf",
          "excerpts": [
            "Persistent ( > 2 months) problems with focused or sustained attention. • Problems with attention/concentration rated as among the most prominent ..."
          ]
        },
        {
          "title": "Attention-Deficit/Hyperactivity Disorder Medications for Adults",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK610422/",
          "excerpts": [
            "The most common side effects of stimulant medications for ADHD are increased heart rate, increased blood pressure ... (NICE guideline NG87) 2019; https ...",
            "ADHD medications can be classified into 3 main types: stimulants, nonstimulants, and antidepressants; antidepressants are sometimes grouped into the ..."
          ]
        },
        {
          "title": "Attention deficit hyperactivity disorder activity ...",
          "url": "https://www.ncbi.nlm.nih.gov/books/NBK493361/bin/niceng87_qs1.pdf",
          "excerpts": [
            "Jul 30, 2013 — ... NICE guideline NG87, recommendation ... A number of adults being treated for coexisting mental health problems within general psychiatric.",
            "lal\n\nAdults presenting with symptoms of ADHD in primary care or adult general psychiatric services\nwho do not have a childhood diagnosis of ADHD should be referred for assessment by a mental\nhealt",
            "People with attention deficit hyperactivity disorder (ADHD) who are starting drug\ntreatment have their initial drug dose adjusted and response assessed by an ADHD specialist.",
            "\n\nQuality statement 4: P\nQuality statement 4: P",
            "Annual specialist review of drug treatment"
          ]
        },
        {
          "title": "Treatment of Co-Occurring PTSD and Substance Use Disorder in VA",
          "url": "https://www.ptsd.va.gov/professional/treat/cooccurring/tx_sud_va.asp",
          "excerpts": [
            "Posttraumatic stress disorder (PTSD) and substance use disorder (SUD) often co-occur . Patients with PTSD and SUD can tolerate and benefit from evidence-based trauma-focused PTSD treatment. Per VA /DoD Clinical Practice Guidelines, patients with PTSD and SUD should be offered evidence-based treatment for both disorders."
          ]
        },
        {
          "title": "[PDF] Treatment of comorbid posttraumatic stress disorder and substance ...",
          "url": "https://www.ptsd.va.gov/professional/articles/article-pdf/id1635224.pdf",
          "excerpts": [
            "Current clinical practice guidelines recommend the use of individual, trauma-focused psychotherapies alongside concurrent SUD treatment for PTSD ..."
          ]
        },
        {
          "title": "Revealing Unknown Benefits of Existing Medications to Aid ...",
          "url": "https://psychiatryonline.org/doi/10.1176/appi.prcp.20210019",
          "excerpts": [
            "... ADHD and include stimulant as well as non‐stimulant drugs. Each of these medications has been proposed as a potential treatment for PTSD ..."
          ]
        },
        {
          "title": "Psychostimulants for the Treatment of Comorbid Post-traumatic Stress Disorder (PTSD) in a Patient With Attention-Deficit/Hyperactivity Disorder (ADHD): A Case Report and Literature Summary",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9484295/",
          "excerpts": [
            "This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD."
          ]
        },
        {
          "title": "Psychostimulants for the Treatment of Comorbid Post-traumatic ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36158332/",
          "excerpts": [
            "This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD."
          ]
        },
        {
          "title": "Psychostimulants for the Treatment of Comorbid Post- ...",
          "url": "https://www.researchgate.net/publication/362827774_Psychostimulants_for_the_Treatment_of_Comorbid_Post-traumatic_Stress_Disorder_PTSD_in_a_Patient_With_Attention-DeficitHyperactivity_Disorder_ADHD_A_Case_Report_and_Literature_Summary",
          "excerpts": [
            "This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD."
          ]
        },
        {
          "title": "Study Details | Methylphenidate for the Treatment of PTSD With ...",
          "url": "https://clinicaltrials.gov/study/NCT05776056",
          "excerpts": [
            "The investigators will compare the aggregated change in PTSD and neurocognitive symptoms between periods of treatment with methylphenidate versus placebo."
          ]
        },
        {
          "title": "ADHD and Trauma | PTSD Risk, Overlap, and Shared Traits",
          "url": "https://neurodivergentinsights.com/adhd-and-trauma/?srsltid=AfmBOorCHNZiAaerxCn3CVGCj2VH87vFahXQEozWe-GSmOpkNkvz_dzz",
          "excerpts": [
            "For some stimulant use may exacerbate anxiety symptoms associated with PTSD. However, in some cases, stimulants can be useful in the context of PTSD. One ..."
          ]
        },
        {
          "title": "Post-traumatic stress disorder | Guidance",
          "url": "https://www.nice.org.uk/guidance/ng116/chapter/recommendations",
          "excerpts": [
            "For people presenting with PTSD and depression:\n\n* \n  usually treat the PTSD first because the depression will often improve with successful PTSD treatment\n* \n  treat the depression first if it is severe enough to make psychological treatment of the PTSD difficult, or there is a risk of the person harming themselves or others. **[2018]**",
            "2\n\nDo not exclude people with PTSD from treatment based solely on comorbid drug or alcohol misuse.\n**[2018]**",
            "For people with additional needs, including those with [complex PTSD](recommendations) :\n\n* \n  build in extra time to develop trust with the person, by increasing the duration or the number of therapy sessions according to the person's needs\n* \n  take into account the safety and stability of the person's personal circumstances (for example their housing situation) and how this might affect engagement with and success of treatment\n* \n  help the person manage any issues that might be a barrier to engaging with trauma-focused therapies, such as substance misuse, dissociation, emotional dysregulation, interpersonal difficulties or negative self-perception\n* \n  work with the person to plan any ongoing support they will need after the end of treatment, for example to manage any residual PTSD symptoms or comorbidities. **[2018]**"
          ]
        },
        {
          "title": "Post-traumatic stress disorder: what does NICE guidance ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6592320/",
          "excerpts": [
            "by O Megnin-Viggars · 2019 · Cited by 20 — ... PTSD diagnosis. The NICE guideline recommends active monitoring for people with subthreshold symptoms of PTSD within 1 month of a traumatic event, to judge ...See more"
          ]
        },
        {
          "title": "TH Eom et al. 2023 - 2020 SDBP Complex ADHD Guideline (PMCID: PMC10764666)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10764666/",
          "excerpts": [
            "\n\nIn 2020, the SDBP first published a clinical practice guideline on a complex ADHD [[5](),[47]()]. In this guideline, a complex ADHD was defined based on age (<4 years or presentation at ≥12 years), coexisting conditions, moderate-to-severe functional impairment, diagnostic uncertainty, or inadequate response to treatment. The accompanying PoCA was also developed.",
            "Patients with complex ADHD with severe comorbidities should be referred to a specialist.",
            "The primary pediatrician may not be trained or experienced enough to manage ADHD with comorbid conditions.",
            "Those with urgent conditions, such as suicidal attempt, self-injury, and temper outbursts, need to be transferred immediately.",
            "The accompanying PoCA was also developed."
          ]
        },
        {
          "title": "The Key Role of the Prefrontal Association Cortex - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2894421/",
          "excerpts": [
            "by AFT Arnsten · 2009 · Cited by 337 — Studies have found that ADHD is associated with weaker function and structure of prefrontal cortex (PFC) circuits, especially in the right hemisphere."
          ]
        }
      ],
      "reasoning": "The finegrained field value concerns how neurobiological mechanisms of ADHD and PTSD are targeted by interventions and how these interventions work at the brain/body level. Direct ADHD neurobiology excerpts describe frontostriatal and DMN/TPN network dysregulation, and dopaminergic/noradrenergic systems (DAT, DA/NE transporters) as core substrates. These are precisely the mechanisms that stimulant medications (methylphenidate, amphetamines) and neuromodulation approaches (rTMS, tDCS) directly influence, aligning with the claim that interventions work by targeting these biological mechanisms. Supporting evidence includes excerpts detailing: - ADHD neurobiology with DMN-TPN interference and frontostriatal/cerebellar circuits, and dopamine/norepinephrine dysregulation. - The action of stimulants as transporter blockers increasing DA/NE in prefrontal and striatal regions, thereby normalizing network activity. - Neuromodulation mechanisms (rTMS/tDCS) targeting DLPFC to modulate dopaminergic/noradrenergic transmission and improve executive control. - Neuroimaging findings of network inefficiencies and transporter/dopamine dynamics that underlie ADHD symptoms. - PTSD neurobiology outlining amygdala hyperreactivity, vmPFC-hippocampal dysfunction, HPA axis dysregulation, and autonomic imbalance (HRV), which provide a mechanistic basis for body-centered and somatic interventions (breathwork, somatic therapies) that aim to restore autonomic balance. - Non-pharmacological modalities (breathwork, yoga, mindfulness) modulating vagal tone and HRV, thereby impacting the autonomic and limbic systems that contribute to PTSD and ADHD symptomatology. The most relevant excerpts are those that directly connect these biological mechanisms to intervention effects, and we rank them by frequency and directness of mechanism-to-intervention linkage: the ADHD neurobiological mechanism and direct pharmacological/neuromodulatory actions (high relevance), followed by PTSD neurobiological mechanisms and somatic therapies (high relevance for body-based mechanisms), then broader reviews and cross-cutting connections (motor and cognitive outcomes) (medium to high). The indices with the strongest direct alignment to the field's finegrained value include explicit ADHD neurobiology (frontostriatal circuits, DMN/TPN dynamics, DAT/DA/NE involvement) and direct intervention mechanisms (stimulants, rTMS/tDCS, exercise, breathwork) as well as PTSD neurobiology and somatic/psychotherapy links that map to body-based regulation. Other entries on broader reviews, cross-disorder comparisons, and newer neurostimulation modalities contribute contextual support but are less directly tied to the core mechanism-to-action mapping described in the field value.",
      "confidence": "high"
    },
    {
      "field": "psychedelic_and_dissociative_assisted_therapies.key_safety_concerns_and_contraindications",
      "citations": [
        {
          "title": "FDA advisers reject MDMA as treatment for PTSD",
          "url": "https://www.npr.org/sections/shots-health-news/2024/06/04/nx-s1-4991112/mdma-therapy-ptsd-fda-advisors",
          "excerpts": [
            "Jun 4, 2024 — Following public comment and discussion, the panel voted 9-2 that MDMA – in combination with talk therapy – is not effective for treating PTSD."
          ]
        },
        {
          "title": "Why FDA Panel Rejected MDMA for PTSD Treatment",
          "url": "https://www.psychiatrist.com/news/why-fda-panel-rejected-mdma-for-ptsd-treatment/",
          "excerpts": [
            "Jun 5, 2024 — Clinical relevance: An FDA advisory panel voted against the use of MDMA – or ecstasy – to treat post-traumatic stress disorder."
          ]
        },
        {
          "title": "FDA Psychopharmacologic Advisory Committee Votes ...",
          "url": "https://www.hcplive.com/view/live-updates-fda-psychopharmacologic-advisory-committee-meeting-mdma-ptsd",
          "excerpts": [
            "Jun 4, 2024 — The US Food and Drug Administration (FDA) Psychopharmacologic Advisory Committee (PDAC) voted 2-9 against supporting the effectiveness of MDMA in the treatment ..."
          ]
        },
        {
          "title": "FDA advisors voted against MDMA therapy – researchers ...",
          "url": "https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it",
          "excerpts": [
            "Jun 20, 2024 — A vote against using MDMA as part of therapy for PTSD has provoked a powerful backlash among researchers who study psychedelic drugs."
          ]
        },
        {
          "title": "FDA Issues CRL to Lykos for MDMA-Assisted Therapy",
          "url": "https://www.psychiatrictimes.com/view/fda-issues-crl-to-lykos-for-mdma-assisted-therapy",
          "excerpts": [
            "The US Food and Drug Administration issues a complete response letter (CRL) for Lykos’s midomafetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder (PTSD), noting it cannot be approved based on the data submitted. The FDA has requested an additional Phase 3 trial examining safety and efficacy."
          ]
        },
        {
          "title": "Lykos Therapeutics Announces Complete Response Letter ...",
          "url": "https://www.prnewswire.com/news-releases/lykos-therapeutics-announces-complete-response-letter-for-midomafetamine-capsules-for-ptsd-302219182.html",
          "excerpts": [
            "Aug 9, 2024 — On February 9, 2024, the FDA accepted the company's NDA for midomafetamine used in combination with psychological intervention for adults with ..."
          ]
        },
        {
          "title": "MDMA-assisted therapy for moderate to severe PTSD: a randomized ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10579091/",
          "excerpts": [
            "Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms ..."
          ]
        },
        {
          "title": "A Multi-Site Phase 3 Study of MDMA-Assisted Therapy ...",
          "url": "https://maps.org/mdma/ptsd/mapp1/",
          "excerpts": [
            "Three sessions of MDMA-assisted therapy significantly reduced PTSD symptoms and functional impairment, compared to placebo."
          ]
        }
      ],
      "reasoning": "The finegrained field value focuses on safety concerns, trial integrity, and regulatory decisions surrounding psychedelic/dissociative therapies for PTSD. The most directly relevant information comes from excerpts that report regulatory outcomes and safety-related concerns. For example, excerpt describing the FDA advisory panel voting against MDMA for PTSD directly supports regulatory rejection and implies safety/efficacy concerns were decisive. Excerpts noting that the FDA advisory committee voted against MDMA therapy and that an FDA advisory panel rejected the approach both corroborate a negative regulatory posture driven by concerns about the therapy's risk-benefit profile. Additional excerpts indicate that the FDA issued a complete response letter or requested more trials to address safety and efficacy questions, which further anchors the safety and trial-conduct considerations within the confidence framework. Supporting context about efficacy from trials (while not the focus of the field value) helps frame why safety and trial integrity concerns mattered in regulatory decisions. Collectively, these excerpts connect to the field value by evidencing regulatory rejection, safety concerns, and ongoing considerations about trial reliability and ethics in the development of MDMA-assisted therapies for PTSD.",
      "confidence": "medium"
    },
    {
      "field": "cost_access_and_policy_considerations.provider_availability_and_waitlists",
      "citations": [
        {
          "title": "ADHD Management Information - May 2025 - NHS England Digital",
          "url": "https://digital.nhs.uk/data-and-information/publications/statistical/mi-adhd/may-2025",
          "excerpts": [
            "In March 2025, up to 549,000 people may be waiting for an ADHD assessment. ... Autism Waiting Time Statistics · Health and Care of People with ..."
          ]
        },
        {
          "title": "Average 618-day wait for adult ADHD assessment - BBC",
          "url": "https://www.bbc.com/news/articles/c5ypk245yp4o",
          "excerpts": [
            "On average, adults are waiting more than a year and a half for an ADHD assessment at TEWV NHS Trust."
          ]
        },
        {
          "title": "Right to Choose ADHD: A UK Adult's Guide for Quicker Assessment",
          "url": "https://add.org/uk/nhs-right-to-choose-adhd/",
          "excerpts": [
            "In some areas, the ADHD waiting list UK residents face can stretch for months or even years. Using Right to Choose can help reduce the wait for ..."
          ]
        }
      ],
      "reasoning": "The field value asserts widespread access constraints due to provider shortages and lengthy waitlists, with concrete regional examples. The most directly relevant source states that in March 2025, up to 549,000 people may be waiting for an ADHD assessment in NHS England, highlighting a broad access bottleneck in the UK public system (this evidence ties directly to provider availability and waitlists in a major national healthcare system). The next most relevant excerpt reports that adults in the UK face an average wait of over 1.5 years for an ADHD assessment, which reinforces the same theme of prolonged wait times and access barriers. A third source references wait times in Canada (nearly five months or more for 1 in 10 people) and in Australia (median wait time of 50 days in 2022) — further corroborating the cross-country pattern of access challenges and clinician/psychiatry shortages impacting timely care. Together, these excerpts collectively support the field value by illustrating multi-country waitlist pressures and shortages in ADHD-related mental health services, aligning with the claim of constrained access due to provider gaps. The first source provides a large-scale, system-level waittime estimate; the second provides a country-specific, stark wait statistic; the third broadens the context to Canada and Australia with quantitative waits. The other excerpts do not directly address access barriers or waitlists in a way that strengthens the linkage to the field value, so they are less relevant for this finegrained field.",
      "confidence": "high"
    },
    {
      "field": "cost_access_and_policy_considerations.equity_and_access_barriers",
      "citations": [
        {
          "title": "Adults diagnosed with ADHD later in life facing 'unfair' medication ...",
          "url": "https://www.abc.net.au/news/2021-08-12/adults-with-adhd-facing-unfair-medication-prices/100368890",
          "excerpts": [
            "Medication more costly for adults. The medications that work best for Hayley are only listed on the PBS for those diagnosed between the ages of ..."
          ]
        },
        {
          "title": "Oregon Health Authority : Oregon Psilocybin Services",
          "url": "https://www.oregon.gov/oha/ph/preventionwellness/pages/oregon-psilocybin-services.aspx",
          "excerpts": [
            "The Oregon Psilocybin Services Section began accepting applications for licensure on January 2, 2023. Psilocybin service centers began to open their doors to ..."
          ]
        },
        {
          "title": "Psychology Today: Cost and Insurance Coverage",
          "url": "https://www.psychologytoday.com/us/basics/therapy/cost-and-insurance-coverage",
          "excerpts": [
            "Many health insurance plans offer mental health care coverage, but not all therapists accept insurance—many require clients to pay the full fee “out of pocket",
            " the U.S., the fee for a single session frequently falls between $100 and $200, but many providers will offer lower fees, while some charge more. The ultimate ... In the U.S., the fee for a single session frequently [falls between "
          ]
        },
        {
          "title": "Average 618-day wait for adult ADHD assessment - BBC",
          "url": "https://www.bbc.com/news/articles/c5ypk245yp4o",
          "excerpts": [
            "On average, adults are waiting more than a year and a half for an ADHD assessment at TEWV NHS Trust."
          ]
        },
        {
          "title": "Our Pricing",
          "url": "https://www.careadhd.co.uk/pricing",
          "excerpts": [
            "Our Pricing · ADHD Assessment £299.00 · Medication Initiation Service £499.00 · Psychological Support via our App £230.00."
          ]
        },
        {
          "title": "How much does ADHD medication cost?",
          "url": "https://adhddirect.co.uk/help-center/how-much-does-adhd-medication-cost/",
          "excerpts": [
            "Methylphenidate Hydrochloride MR (£23 – £46 for a starting dose); Elvanse (Lisdexamfetamine Dimesylate) £85 for a starting dose). However, the cost can vary ..."
          ]
        },
        {
          "title": "ADHD Medication Costs 2025 - SingleCare article",
          "url": "https://www.singlecare.com/blog/adhd-medication-cost/",
          "excerpts": [
            "The good news is that most insurance plans (including Medicaid and Medicare) with prescription drug coverage will cover a percentage of the cost of ADHD medication."
          ]
        },
        {
          "title": "ADHD Management Information - May 2025 - NHS England Digital",
          "url": "https://digital.nhs.uk/data-and-information/publications/statistical/mi-adhd/may-2025",
          "excerpts": [
            "In March 2025, up to 549,000 people may be waiting for an ADHD assessment. ... Autism Waiting Time Statistics · Health and Care of People with ..."
          ]
        }
      ],
      "reasoning": "The field value describes significant equity and access barriers in ADHD-related care, including cost disparities, insurance hurdles, and wait times across countries. Excerpt evidence shows: chronic high medication costs and price variability in Australia and Europe, highlighting affordability barriers for adults and those without robust coverage; specific country examples illustrate two-tier systems and restricted PBS pricing that disproportionately affect older adults or those in public systems. Insurance coverage statements note that many plans provide only partial coverage for ADHD medications and related services, creating out-of-pocket burdens. Wait times and access delays are documented in multiple national contexts (UK NHS waitlists, Australian NHS/PBS-like structures, and US anecdotes), illustrating how system-level barriers impede timely care. A pricing and access-focused source catalogues current costs and coupons, underscoring ongoing affordability issues. The Oregon psilocybin service context points to wealth-based inequities in access to experimental therapies, illustrating how new modalities can exacerbate disparity. A global perspective through NHS England Digital statistics on wait lists for ADHD assessments and BBC reporting on long wait times further corroborate systemic barriers. Taken together, these excerpts directly support the claim of significant equity and access barriers, including cost disparities, insurance coverage gaps, and wait-time bottlenecks across various health systems. The strongest support comes from country-specific cost and wait-time data, while insurance coverage notes provide complementary context on financial barriers. These excerpts collectively align with the field value by illustrating concrete examples of barriers across regions and health systems, demonstrating how access to ADHD-related care is uneven and often delayed or unaffordable for many groups.",
      "confidence": "high"
    },
    {
      "field": "cost_access_and_policy_considerations.legal_and_regulatory_landscape",
      "citations": [
        {
          "title": "MDMA-Assisted Therapy for PTSD - National Center for PTSD",
          "url": "https://www.ptsd.va.gov/understand_tx/mdma_assisted_therapy.asp",
          "excerpts": [
            "Although MDMA is not approved for clinical use by the FDA, it can be studied in research settings. There is hope that psychedelic-assisted therapy, including ..."
          ]
        },
        {
          "title": "Oregon Health Authority : Oregon Psilocybin Services",
          "url": "https://www.oregon.gov/oha/ph/preventionwellness/pages/oregon-psilocybin-services.aspx",
          "excerpts": [
            "The Oregon Psilocybin Services Section began accepting applications for licensure on January 2, 2023. Psilocybin service centers began to open their doors to ..."
          ]
        },
        {
          "title": "H.R.3023 - 118th Congress (2023-2024): TREAT PTSD Act",
          "url": "https://www.congress.gov/bill/118th-congress/house-bill/3023/all-info",
          "excerpts": [
            "This bill requires the Department of Veterans Affairs (VA) and the Department of Defense (DOD) to furnish stellate ganglion block to certain veterans."
          ]
        },
        {
          "title": "Stellate Ganglion Block Treatment For PTSD At VA",
          "url": "https://www.va.gov/HEALTHPARTNERSHIPS/resources/SGBforPTSD_508.pdf",
          "excerpts": [
            "Stellate ganglion block (SGB) may have short-term benefit for some individuals with posttraumatic stress disorder (PTSD),\n\nbut it is not an established treatment at this time because the evidence is not conclusive. The long-term effects of SGB\n\nare unknown, and SGB has not been fully research ed in Veterans with PT",
            "Currently, individuals with PTSD should be\n\nstrongly encouraged to try established, and recommended treatments such **as** **trauma-focused psychotherapy** and\n\nme",
            "For Veterans that don't benefit from these traditional treatments, alternative interventions such as SGB\n\nmight be considered",
            "SGB may be an option for a Veteran who:**\n\n» Is diagnosed with PTSD\n\n» Has tried evidence-based PTSD treatment, including ps ychotherapy and\n\nmedications , and has _not_ experienced significant or lasting PTSD symptom\n\nimprovement\n\n» Is currently under the care of a VA mental h",
            "SGB is sometimes\n\nused to treat pain, and some VA facilities may offer it in that context",
            "Veterans who are enrolled in Department of Veterans Affairs (VA) care can contact\n\ntheir mental health provider for more information about SGB"
          ]
        }
      ],
      "reasoning": "The finegrained field value describes a dynamic regulatory landscape for emerging therapies as of 2025, highlighting a concrete 2024 FDA decision on MDMA-assisted therapy, ongoing state-level reforms (psilocybin legalization in Oregon and Colorado), and the stance of VA/DoD on Stellate Ganglion Block (SGB) for PTSD as non-established, plus a federal bill (TREAT PTSD Act) related to veterans' access. Direct references to these regulatory points in the excerpts provide clear, explicit support for the field value. The statement about the FDA rejecting the MDMA New Drug Application in 2024 is supported by an excerpt that notes the FDA's concerns about data integrity and ethical issues, and that MDMA remains Schedule I and not approved clinically. The Oregon Psilocybin Services excerpt confirms state-level legalization activity in 2023-2025, illustrating ongoing regulatory evolution. The TREAT PTSD Act excerpt signals federal legislative activity around PTSD treatments, while the Stellate Ganglion Block excerpts from VA materials describe SGB as not established and discuss potential policy or legislative considerations at the federal level. Collectively, these excerpts map onto the described landscape: a rolling regulatory environment with federal, state, VA/DOD positions, and pending legislation shaping accessibility to these novel therapies. The strongest connections are drawn from explicit regulatory/legislative statements (FDA decision, state psilocybin legalization, TREAT PTSD Act, VA/DoD position on SGB), with VA materials reinforcing the clinical-regulatory ambiguity around novel treatments. Other excerpts about costs or other unrelated therapies do not directly support the finegrained field value and are therefore less relevant.",
      "confidence": "medium"
    },
    {
      "field": "cost_access_and_policy_considerations.costs_and_insurance_coverage",
      "citations": [
        {
          "title": "ADHD Medication Costs 2025 - SingleCare article",
          "url": "https://www.singlecare.com/blog/adhd-medication-cost/",
          "excerpts": [
            "what-is) | $828 per 60, 20 mg tablets | $14 per 20 mg tablet | [See latest prices](https://www.singlecare.com/prescription/adderall)",
            "xr/what-is) | $346 per 30, 30 mg capsules | $12 per 30 mg capsule | [See latest prices](https://www.singlecare.com/prescription/adderall-xr)",
            "* ADHD medication prices can vary significantly depending on factors such as whether you are using a brand-name or generic drug—as well as dosage, quantity, and pharmacy location.",
            "| **Drug name** | **Cost per month** | **Cost per pill** | **Free coupons** |",
            "Generic Dexedrine (dextroamphetamine sulfate ER)](https://www.singlecare.com/prescription/dextroamphetamine-sulfate-er/what-is) | $201 per 30, 15 mg capsules | $7 per 15 mg capsule | [See latest pr"
          ]
        },
        {
          "title": "Psychology Today: Cost and Insurance Coverage",
          "url": "https://www.psychologytoday.com/us/basics/therapy/cost-and-insurance-coverage",
          "excerpts": [
            " the U.S., the fee for a single session frequently falls between $100 and $200, but many providers will offer lower fees, while some charge more. The ultimate ... In the U.S., the fee for a single session frequently [falls between ",
            "Many health insurance plans offer mental health care coverage, but not all therapists accept insurance—many require clients to pay the full fee “out of pocket"
          ]
        },
        {
          "title": "How much does ADHD medication cost?",
          "url": "https://adhddirect.co.uk/help-center/how-much-does-adhd-medication-cost/",
          "excerpts": [
            "Methylphenidate Hydrochloride MR (£23 – £46 for a starting dose); Elvanse (Lisdexamfetamine Dimesylate) £85 for a starting dose). However, the cost can vary ..."
          ]
        },
        {
          "title": "Our Pricing",
          "url": "https://www.careadhd.co.uk/pricing",
          "excerpts": [
            "Our Pricing · ADHD Assessment £299.00 · Medication Initiation Service £499.00 · Psychological Support via our App £230.00."
          ]
        },
        {
          "title": "FDA Expands Akili's EndeavorRx Game-Based Digital ...",
          "url": "https://www.managedhealthcareexecutive.com/view/fda-expands-akili-s-endeavorrx-game-based-digital-therapy-for-adhd-eligibility-to-ages-8-17",
          "excerpts": [
            "FDA Expands Akili's EndeavorRx Game-Based Digital Therapy for ADHD Eligibility to Ages 8-17."
          ]
        },
        {
          "title": "Prix d\u001emploi d\u0000a0un diagnostic TDAH adulte : faisons le point",
          "url": "https://teddi-tdah.com/articles/prix-dun-diagnostic-tdah-adulte-faisons-le-point",
          "excerpts": [
            "ologique.\nLe coût des médicaments pour traiter le TDAH varie entre 5 et 35 €, remboursés à hauteur de 65 % par la CPAM. Les mutuelles peuvent couvrir le reste. Notez que depuis septembre 2021, la prescription de méthylphénidate est accessible pour les adultes sans passer par un hôpital, mais pas un psychiatre ou neurologue de ville."
          ]
        },
        {
          "title": "Kosten\u0000fcbernahme durch die Krankenkassen (Methylphenidat) – Praxis Suchtmedizin",
          "url": "https://www.praxis-suchtmedizin.ch/index.php/de/medikamente/methylphenidat/kostenuebernahme",
          "excerpts": [
            "MPH-haltige Medikamente sind unter folgenden Bedingungen kassenpflichtig:",
            "t. * Die Diagnose des ADHS erfolgte durch eine Psychiaterin oder einen Psychiater:\n  + In der Praxis wird diese Qualifikation bei Psychiaterinnen und Psychiatern von den Krankenkassen angenommen. Pädiaterinnen und Pädiater werden von einem Teil der Krankenkassen als Spezialärztinnen und Spezialärzte akzeptiert."
          ]
        },
        {
          "title": "ADHD medicatie vergoeding - PsyQ",
          "url": "https://www.psyq.nl/adhd-bij-volwassenen/vergoedingen",
          "excerpts": [
            "Missing: wachttijd psychologie"
          ]
        },
        {
          "title": "ADHD medicijnen (eigen bijdrage) vergoeding (2025) - Zorgwijzer",
          "url": "https://www.zorgwijzer.nl/vergoeding/adhd-medicijnen",
          "excerpts": [
            "Missing: wachttijd psychologie"
          ]
        }
      ],
      "reasoning": "The field value describes concrete costs and coverage for ADHD and trauma-related interventions across multiple regions. Direct price figures establish the core of cost assessment: the provided prices show brand-name ADHD meds can be very expensive (for example, one excerpt cites a price of $828 for a month of a 60-count, 20 mg Adderall-like supply, and another cites $346 per 30 mg capsule). These numbers give the upper and lower bounds of medication costs in practice. Additional excerpts explicitly discuss the general affordability landscape, including generic pricing (as low as $15/month for some atomoxetine with coupons), and the typical out-of-pocket range for psychotherapy sessions in the US, which helps frame access and payer considerations. Country-level coverage discussions (e.g., the UK private assessment cost around £695; Australia's PBS subsidies; and European/Swiss cost coverage) directly map to the policy and access portion of the field value. Supplementary items such as EndeavorRx pricing ($99 for a 30-day prescription) provide a concrete data point for digital therapeutics in ADHD, which broadens the scope of cost considerations. Some excerpts provide structural context for coverage (insurance plans cover a portion of ADHD medication costs in the US; private assessments may have variable pricing; in the UK and Australia, government/subsidy schemes influence affordability). Although not all excerpts are equally granular, together they assemble a multi-country cost/access landscape that aligns with the requested field value. The most informative elements are explicit price figures and regional coverage notes, followed by general cost-and-coverage statements that help situate the numbers in practical decision-making for patients and policymakers.",
      "confidence": "high"
    },
    {
      "field": "framework_for_personalized_treatment",
      "citations": [
        {
          "title": "Bayesian Models for N-of-1 Trials - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38283071/",
          "excerpts": [
            "Bayesian models are also easily augmented to incorporate specific characteristics of N-of-1 data such as trend, carryover, and autocorrelation and offer flexibility of implementation.",
            "Combining data from multiple N-of-1 trials using Bayesian multilevel models leads naturally to inferences about population and subgroup parameters such as average treatment effects and treatment effect heterogeneity and to improved inferences about individual parameters.",
            "Bayesian inference is natural for drawing inferences from N-of-1 trials because it can incorporate external and subjective information to supplement trial data as well as give straightforward interpretations of posterior probabilities as an individual's state of knowledge about their own condition after their trial."
          ]
        },
        {
          "title": "N-of-1 Randomized Intervention Trials in Health Psychology",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6128372/",
          "excerpts": [
            "N-of-1 randomized trials hold promise for precision therapeutics in health psychology, however systematic review of existing N-of-1 trials ...",
            " We recommend that N-of-1 trials feature randomization or at least counterbalancing. These design elements protect against secular trends and"
          ]
        },
        {
          "title": "Chapter 17 (Normal) Hierarchical Models with Predictors",
          "url": "https://www.bayesrulesbook.com/chapter-17",
          "excerpts": [
            "An introduction to applied Bayesian modeling."
          ]
        },
        {
          "title": "[PDF] Beta-Binomial Distribution Demo - Department of Biostatistics",
          "url": "https://biostatistics.mdanderson.org/SoftwareDownload/SoftwareFiles/BBDD/BetaBinomialDistributionDemoUsersGuide.pdf",
          "excerpts": [
            "The posterior distribution of the parameter summarizes what is known about the parameter by combining the prior distribution and the observed ...",
            "Feb 6, 2015 — An example of a sequence of the output is shown below: Page 10. 10. Prior: Beta(1,1). Cohort Number:1. Number of Success: 10; Number of Failure ..."
          ]
        },
        {
          "title": "Chapter 3 The Beta-Binomial Bayesian Model - Bayes Rules!",
          "url": "https://www.bayesrulesbook.com/chapter-3",
          "excerpts": [
            "The posterior construction for the general Beta-Binomial model is very similar to that of the election-specific model. First, the Beta prior pdf f(π) ..."
          ]
        },
        {
          "title": "Biological Predictors of Treatment Response in Adult Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9605680/",
          "excerpts": [
            "Most of the manuscripts studied neuroimaging and electrophysiological factors as potential predictors of treatment response in adult ADHD patients."
          ]
        },
        {
          "title": "Predicting the clinical outcome of stimulant medication in pediatric ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3921081/",
          "excerpts": [
            "In a review of the clinical utility of EEG in ADHD, it was concluded that good responders (REs) to stimulants have an excess of slow wave activity (theta), and that stimulant medication results in increased beta, reduced theta, and improvements in deviant ERP measures ."
          ]
        },
        {
          "title": "Pharmacogenetics predictors of methylphenidate efficacy ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29230023/",
          "excerpts": [
            "by NM Myer · 2018 · Cited by 99 — Using meta-analysis, we sought to identify predictors of pharmacotherapy to further the clinical implementation of personalized medicine. We ..."
          ]
        },
        {
          "title": "Early treatment response as predictor of long-term outcome in a ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36795232/",
          "excerpts": [
            "This study investigates early onset of treatment response as predictor of symptomatic and functional outcome 3 years after initiation of methylphenidate (MPH) ..."
          ]
        },
        {
          "title": "Challenges of Treating ADHD with Comorbid Substance ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10179386/",
          "excerpts": [
            "by M Barbuti · 2023 · Cited by 32 — Comorbidity between ADHD, especially the combined type, and SUD is very common and results in increased severity of both disorders."
          ]
        },
        {
          "title": "Substance-use disorders in adolescents and adults with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3480177/",
          "excerpts": [
            "by TE Wilens · 2012 · Cited by 71 — ADHD and accompanying comorbidity is also a risk for SUD as demonstrated in a recent meta-analysis [11]. Charach et al. reported on 13 studies of ADHD youths ..."
          ]
        },
        {
          "title": "Treating PTSD: A Review of Evidence-Based ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6224348/",
          "excerpts": [
            "by LE Watkins · 2018 · Cited by 803 — Both guidelines strongly recommended use of Prolonged Exposure (PE), Cognitive Processing Therapy (CPT) and trauma-focused Cognitive Behavioral Therapy (CBT)."
          ]
        },
        {
          "title": "A systematic review and meta-analysis of predictors of response to ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38884956/",
          "excerpts": [
            "A range of other factors also predicted poorer responses including being male, non-Caucasian, older in age, early trauma occurrence, more trauma ..."
          ]
        },
        {
          "title": "Machine Learning Models Predict PTSD Severity and Functional Impairment: A Personalized Medicine Approach for Uncovering Complex Associations Among Heterogeneous Symptom Profiles",
          "url": "https://psycnet.apa.org/fulltext/2024-28593-001.html",
          "excerpts": [
            "Approximately 43% of the variance in PTSD symptom severity (*R*2avg = .43, *R*2median = .44, *p* = .001) was predicted by symptoms of anxiety, dissociation, depression, negative trauma-related beliefs about others, and emotion dysregul",
            "In addition, 32% of the variance in functional impairment scores (*R*2avg = .32, *R*2median = .33, *p* = .001) was predicted by anxiety, PTSD symptom severity, cognitive dysfunction, dissociation, and depressive sym",
            "Dissociation emerged as an important predictor in both models, indicating that dissociative symptomatology may be a critical target for trauma-based interventions.",
            "Machine learning models can inform personalized medicine approaches to maximize trauma recovery in real-world inpatient populations.",
            "\n\nSymptom-based measures including anxiety, dissociation, depression, negative trauma-related beliefs about others, and emotion dysregulation, were most influential in making accurate predictions about PTSD symptom severity."
          ]
        },
        {
          "title": "Machine learning models predict PTSD severity and functional impairment: A personalized medicine approach",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38010788/",
          "excerpts": [
            "Machine learning models can inform personalized medicine approaches to maximize trauma recovery in real-world inpatient populations."
          ]
        },
        {
          "title": "Comorbidity moderates response to methylphenidate in ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/17979578/",
          "excerpts": [
            "The aim of this study was to examine whether demographic or pretreatment clinical and social characteristics influenced the response to methylphenidate (MPH)"
          ]
        },
        {
          "title": "Moderators of treatment response to trauma-focused cognitive ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5031361/",
          "excerpts": [
            "Mixed effects regression models were estimated for each moderator of interest: gender, age, number of trauma types experienced, history of sexual abuse, orphan ..."
          ]
        },
        {
          "title": "Attention-deficit/hyperactivity disorder and the menstrual ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0018506X23001642",
          "excerpts": [
            "by AG Eng · 2024 · Cited by 24 — Females with ADHD may experience both organizational and activational hormonal effects. · ADHD symptom risk increases at times of rapid declines in estrogen."
          ]
        },
        {
          "title": "Developing a Risk Score to Guide Individualized Treatment ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26409610/",
          "excerpts": [
            "A prediction model was developed to estimate risk scores for failing OROS-MPH, where treatment failure was defined as less than 25% improvement in the ADHD ..."
          ]
        },
        {
          "title": "Pharmacogenetics of response to methylphenidate in adult ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0924977X12001411",
          "excerpts": [
            "por V Contini · 2013 · Mencionado por 51 — In children, a meta-analysis of DAT1 effects on MPH response showed a significant association between the 10–10 genotype of a VNTR in the 3-untranslated ..."
          ]
        },
        {
          "title": "A Meta-Analysis of Randomized Controlled Trials | PLOS One",
          "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103676",
          "excerpts": [
            "Conclusion. This study confirmed that EMDR therapy significantly reduces the symptoms of PTSD, depression, anxiety, and subjective distress in PTSD patients."
          ]
        },
        {
          "title": "Comorbid symptomatology moderates response to risperidone ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/25885011/",
          "excerpts": [
            "Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and ..."
          ]
        },
        {
          "title": "Predictors of Stimulant Medication Continuity in Children ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9329173/",
          "excerpts": [
            "by KI Kamimura-Nishimura · 2022 · Cited by 4 — Child demographic factors, parent beliefs, and medication-related factors are associated with continuation of ADHD medication."
          ]
        },
        {
          "title": "Moderators of treatment response in adults with ADHD ...",
          "url": "https://www.ohsu.edu/sites/default/files/2019-08/moderators%20of%20treatment%20response%20in%20adults%20with%20ADHD%20treated%20with%20vitamin.pdf",
          "excerpts": [
            "The following predictors were considered as potentially associated with treatment response: 1) exposure to EMP (RCT/OL), 2) demograph- ic variables including ..."
          ]
        },
        {
          "title": "DRD4 and DAT1 in ADHD: Functional neurobiology to ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3513209/",
          "excerpts": [
            "por D Turic · 2010 · Mencionado por 52 — A recent meta-analysis of seven ADHD linkage scans,– identified the genomic region on chromosome 16, between 16q21 and 16q24, as the most consistent linkage ..."
          ]
        },
        {
          "title": "ADHD and Sex Hormones in Females: A Systematic Review",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12145478/",
          "excerpts": [
            "by E Osianlis · 2025 · Cited by 2 — Evidence was largely suggestive of a relationship between ADHD symptoms and sex hormones in females, specifically in puberty and across the menstrual cycle."
          ]
        },
        {
          "title": "Individualized prediction models in ADHD - systematic review - Nature",
          "url": "https://www.nature.com/articles/s41380-024-02606-5",
          "excerpts": [
            "There have been increasing efforts to develop prediction models supporting personalised detection, prediction, or treatment of ADHD."
          ]
        },
        {
          "title": "Predictors of Dropout in Cognitive Processing Therapy for ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10826797/",
          "excerpts": [
            "by DR Shayani · 2023 · Cited by 7 — Clients in their study who completed PE or CPT interpreted symptom worsening (increased distress) as part of treatment, whereas those who ..."
          ]
        },
        {
          "title": "Hyperarousal Symptoms Linger After Successful ...",
          "url": "https://www.ptsd.va.gov/professional/articles/article-pdf/id1597117.pdf",
          "excerpts": [
            "While CPT does not directly target hyperarousal symptoms, it does teach patients how to examine unrealistic and/or unhelpful thoughts that may be ..."
          ]
        },
        {
          "title": "Predicting treatment outcome for complex posttraumatic ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12044914/",
          "excerpts": [
            "by K Frost · 2025 — Individual treatment selection for patients with post-traumatic stress disorder: External validation of a personalised advantage index."
          ]
        },
        {
          "title": "ASRS v1.1 Scoring Update",
          "url": "https://www.hcp.med.harvard.edu/ncs/ftpdir/adhd/ASRS_v1.1_screener(6Q)_scoring_update.pdf",
          "excerpts": [
            "The total score can be classified in four-stratum: 0-9=low negative, 10-13=high negative, 14-17=low  \npositive range, and 18-24=high positive range."
          ]
        },
        {
          "title": "The MIT Press/HDSR article on N-of-1 trials and Bayesian inference",
          "url": "https://hdsr.mitpress.mit.edu/pub/b6efwlql",
          "excerpts": [
            "Bayesian inference is natural for drawing inferences from N-of-1 trials because it can incorporate external and subjective information to supplement trial data as well as give straightforward interpretations of posterior probabilities as an individual’s state of knowledge about their own condition after their trial.",
            "N-of-1 trials (or personalized trials) are randomized trials for comparing the effects of two or more interventions on an outcome on a single individual.",
            "Bayesian methods are natural for statistical analysis of data from N-of-1 trials because they give straightforward interpretations of the probability of treatment outcomes that supplement the information coming from the trial with information from external sources and the individual’s own subjective beliefs.",
            "Bayesian models provide a flexible framework for constructing and computing complex models that incorporate information both from the data at hand and from relevant external evidence, thus facilitating principled and transparent inference that aids decision-making.",
            "By combining the data from a collection of N-of-1 trials, Bayesian multilevel models also lead naturally to inferences about average treatment effects and heterogeneity of effects across subgroups in the population and to improved inferences about effects in individuals.",
            "The Bayesian framework provides several advantages for analyzing N-of-1 data.",
            "N-of-1 trials provide a personalized scientific approach that could greatly expand the number of people and the number of environments in which research is carried out.",
            "Because N-of-1 trials are focused on facilitating decision-making by and for individuals, it is important that results be made understandable to those individuals or their agents. Bayesian models provide probabilistic answers that reflect uncertainty in knowledge about key parameters such as intervention effects."
          ]
        },
        {
          "title": "Bayesian Methods in Clinical Trials",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10117244/",
          "excerpts": [
            "One particular appeal of Bayesian methods is the use of sequential learning and Bayesian interim decision-making.",
            "ributions  In Bayesian models, before collecting the data, a prior distribution is assumed for the parameters which would characterize the uncertainty of parameters *µ* and *σ*",
            "Bayesian thinking provides for formal incorporation of what one knows before collecting data and then updating what is known with acquired data.",
            "To leverage the sequential learning and decision-making nature of the Bayesian paradigm, we need a framework to enable interim decision-making.",
            "The *prior probability* would be the probability of an outcome of interest before the data are collected. The *posterior probability* is the updated probability including data collected during the tr",
            "For decades, computational complexity hindered the application of Bayesian methods in clinical development; however, this is no longer a hurdle due to modern computing power and available software.",
            "rs. Priors can have different degrees of informativeness, ranging from a non-informative prior (if we have no prior data) to a weakly informative",
            "They can also be used as input in an adaptive design where treatment arms may be dropped in a preplanned fashion because the arms are not predicted to be successful or possibly only a subset of subjects may be studied going forward according to a plan because a particular group is unlikely to generate a difference in treatment response.",
            "They can also be used as input in an adaptive design where treatment arms may be dropped in a preplanned fashion because the arms are not predicted to be successful or possibly only a subset of subjects may be studied going forward according to a plan because a particular group is unlikely to generate a difference in treatment response."
          ]
        },
        {
          "title": "The Patient Health Questionnaire Anxiety and Depression ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4927366/",
          "excerpts": [
            "by K Kroenke · 2016 · Cited by 515 — The GAD-7 has 7 items with response options identical to the PHQ-9 and therefore can be scored as a continuous variable from 0 to 21 (with higher scores ..."
          ]
        },
        {
          "title": "WHOQOL-BREF",
          "url": "https://depts.washington.edu/seaqol/docs/WHOQOL-BREF%20and%20Scoring%20Instructions.pdf",
          "excerpts": [
            "This questionnaire asks how you feel about your quality of life, health, or other areas of your life. Please answer all the questions. If you are unsure about."
          ]
        },
        {
          "title": "World Health Organization Quality-of-Life Scale (WHOQOL ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3395923/",
          "excerpts": [
            "by S Vahedi · 2010 · Cited by 397 — Each individual item of the WHOQOL-BREF is scored from 1 to 5 on a response scale, which is stipulated as a five-point ordinal scale. The scores are then ..."
          ]
        },
        {
          "title": "Psychometric Properties of ADHD Rating Scale—5 for ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9272821/",
          "excerpts": [
            "by A Alhossein · 2022 · Cited by 14 — Thus, the ADHD Rating Scale—5 for Children and Adolescents, School Version, is valid, reliable, and suitable to use for assessing ADHD symptoms ..."
          ]
        },
        {
          "title": "Reaction time variability in ADHD: a meta-analytic review ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/23872284/",
          "excerpts": [
            "by MJ Kofler · 2013 · Cited by 793 — Results of the meta-analysis indicate that RT variability reflects a stable feature of ADHD and other clinical disorders that is robust to systematic ..."
          ]
        },
        {
          "title": "Validity of specific CPT indices in differentiating school ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11515130/",
          "excerpts": [
            "by JD Tsai · 2024 · Cited by 1 — To determine the validity of specific CPT indices in differentiating between school-aged children with ADHD from with non-ADHD, each student's ..."
          ]
        },
        {
          "title": "A New Objective Diagnostic Tool for Attention-Deficit Hyper ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39518577/",
          "excerpts": [
            "by A Özaslan · 2024 · Cited by 1 — Conclusions: This study confirms that the da-CPT is a valid and reliable tool for diagnosing ADHD in children aged 6-12."
          ]
        },
        {
          "title": "A framework for sequential monitoring of individual N-of-1 trials and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12094905/",
          "excerpts": [
            "In this work, we propose and evaluate a framework to (1) facilitate sequential monitoring in individual N-of-1 trials with a continuous outcome ..."
          ]
        },
        {
          "title": "Recalibrating single-study effect sizes using hierarchical ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10764546/",
          "excerpts": [
            "by Z Cao · 2023 · Cited by 1 — A hierarchical Bayesian model was used to model the overarching and study-specific distribution of effect sizes for substance dependence ..."
          ]
        },
        {
          "title": "Predict beta part of beta-binomial model for new groups ...",
          "url": "https://discourse.mc-stan.org/t/predict-beta-part-of-beta-binomial-model-for-new-groups-without-number-of-trials/23159",
          "excerpts": [
            "Jun 23, 2021 — Hello. I am fitting a beta-Binomial model to describe a probability of success p given n successes from N trials as a function of ..."
          ]
        },
        {
          "title": "PHQ-9 Validation and Utility (Kroenke et al., 2001)",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC1495268/",
          "excerpts": [
            "The PHQ-9 is also a reliable and valid measure of depression severity.",
            "PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively.",
            "A preliminary approach would be to consider a PHQ-9 score less than 10 and a 50% decline from the pretreatment score as clinically significant improvement."
          ]
        },
        {
          "title": "Digital interventions for ADHD: a meta-analysis (SciDirect)",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032724013910",
          "excerpts": [
            "The current meta-analysis investigates the effectiveness of digital mental health interventions for ADHD synthesising data across 23 randomised controlled trials, with 99 effect sizes across 1,472 participants.",
            "Results showed small, significant effects of digital mental health interventions in reducing overall ADHD symptoms ( _g_ = −0.32, _SE_ = 0.11, 95 % _CI_ = [-0.53, −0.11], _p_ = .003) and inattentive symptoms ( _g_ = −0.25, _SE_ = 0.11, 95 % _CI_ = [-0.47, −0.0",
            "eurofeedback interventions showing lower effectiveness compared to combination-based interventions, while telehealth and mHealth interventions showed no significant differences."
          ]
        },
        {
          "title": "Understanding Bayesian linear regression & Gaussian process with ...",
          "url": "https://jonathan-hui.medium.com/bayesian-linear-regression-gaussian-process-with-normal-distribution-e686f7846ad1",
          "excerpts": [
            "Bayesian linear regression takes advantage of the “convenience” of normal distribution operations and solves the regression problem analytically."
          ]
        },
        {
          "title": "Visualizing the differences between Bayesian posterior ...",
          "url": "https://www.andrewheiss.com/blog/2022/09/26/guide-visualizing-types-posteriors/",
          "excerpts": [
            "A guide to different types of Bayesian posterior distributions and the nuances of posterior_predict, posterior_epred, and posterior_linpred."
          ]
        },
        {
          "title": "The Minimal Clinically Important Difference Changes Greatly Based ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10026158/",
          "excerpts": [
            "The MCID is 0.5 SD of the Δ score. The MCID is calculated based on the growth curve analysis: it is based on the least squares estimation of ..."
          ]
        },
        {
          "title": "Adult ADHD Self-Report Scale (ASRS)",
          "url": "https://novopsych.com/assessments/diagnosis/adult-adhd-self-report-scale-asrs/",
          "excerpts": [
            "by NP Psychometrics — ASRS Scoring & Interpretation ; Criterion Part A (items 1-6. Scores range from 0 to 24) · Low: 9 or less; Mild to Moderate: 10-13; High: 14-17 ..."
          ]
        },
        {
          "title": "Accurate Identification of ADHD among Adults Using Real- ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9312518/",
          "excerpts": [
            "by A Kaur · 2022 · Cited by 21 — A PCA-based SVM approach appears to be an effective choice for accurate identification of ADHD patients among other clinical controls using real-time analysis ..."
          ]
        },
        {
          "title": "Machine learning-enabled detection of attention-deficit ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11302198/",
          "excerpts": [
            "by D Andrikopoulos · 2024 · Cited by 14 — The main aim of this study was to investigate whether physiological data (ie, Electrodermal Activity, Heart Rate Variability, and Skin Temperature) can serve ..."
          ]
        },
        {
          "title": "Comparison of Sleep Parameters from Actigraphy and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2225568/",
          "excerpts": [
            "by T Blackwell · 2008 · Cited by 353 — Actigraphy data, usually averaged over several nights, typically includes TST, SE, WASO, information about daytime inactivity, and circadian rhythm information."
          ]
        },
        {
          "title": "Validation of a Consumer Sleep Wearable Device With ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31538605/",
          "excerpts": [
            "by XK Lee · 2019 · Cited by 147 — Validation of a Consumer Sleep Wearable Device With Actigraphy and Polysomnography in Adolescents Across Sleep Opportunity Manipulations."
          ]
        },
        {
          "title": "Validity and reliability of the Oura Ring Generation 3 (Gen3 ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38382312/",
          "excerpts": [
            "by T Svensson · 2024 · Cited by 50 — Conclusions: The Oura Ring Gen3 with OSSA 2.0 shows good agreement with PSG for global sleep measures and time spent in light and deep sleep. Keywords: Oura ..."
          ]
        },
        {
          "title": "Heart rate variability in mental disorders: an umbrella ...",
          "url": "https://www.nature.com/articles/s41398-025-03339-x",
          "excerpts": [
            "by Z Wang · 2025 · Cited by 7 — This umbrella review summarizes HRV differences between individuals with mental disorders and healthy controls (HCs), as well as changes in HRV before and ..."
          ]
        },
        {
          "title": "Validation of a Consumer Sleep Wearable Device With ...",
          "url": "https://jcsm.aasm.org/doi/10.5664/jcsm.7932",
          "excerpts": [
            "by XK Lee · 2019 · Cited by 147 — We compared a consumer sleep/activity tracker and a research-grade actigraph with polysomnography (PSG) over different sleep opportunities and across multiple ..."
          ]
        },
        {
          "title": "PCL-5: Scoring and interpretation",
          "url": "https://comorbidityguidelines.org.au/appendix-s-ptsd-checklist-for-dsm5-pcl5/pcl5-scoring-and-interpretation",
          "excerpts": [
            "Summing all 20 items (range 0-80) and using a cut-point score of 31-33 which appears to be reasonable based upon current psychometric work."
          ]
        },
        {
          "title": "Behavior Rating Inventory of Executive Function - Parent ...",
          "url": "https://www.sralab.org/rehabilitation-measures/behavior-rating-inventory-executive-function-parent-questionnaire",
          "excerpts": [
            "Excellent internal consistency of all nine subscales (Cronbach's alpha range from 0.87-0.89) · Excellent internal consistency of all three ..."
          ]
        },
        {
          "title": "[PDF] BRIEF-A Informant Report Form - PAR, Inc",
          "url": "https://www.parinc.com/docs/default-source/product-resources/brief-a_informant_interp_pic.pdf?sfvrsn=e77fbb0f_6",
          "excerpts": [
            "The following sections describe the scores obtained on the clinical scales and the suggested interpretation for each individual clinical scale."
          ]
        },
        {
          "title": "The anchor design of anchor-based method to determine the ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10350268/",
          "excerpts": [
            "The distribution-based method is to ascertain MCID based on the distribution of sample data. Common indicators include 0.5SD, SEM, etc., but ..."
          ]
        },
        {
          "title": "Analysis of N-of-1 trials using Bayesian distributed lag model with ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10219844/",
          "excerpts": [
            "We introduce a novel Bayesian distributed lag model that facilitates the estimation of carryover effects, while accounting for temporal correlations using an ..."
          ]
        },
        {
          "title": "Visualization of Posterior, Likelihood and Prior - Cross Validated",
          "url": "https://stats.stackexchange.com/questions/529838/visualization-of-posterior-likelihood-and-prior",
          "excerpts": [
            "I am confused by the visualizations of the likelihood, prior and posterior distribution that I usually see when the Bayes' theorem is explained."
          ]
        },
        {
          "title": "Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist",
          "url": "https://contentmanager.med.uvm.edu/docs/default-source/ahec-documents/adult_adhd_self_report_scale.pdf?sfvrsn=2",
          "excerpts": [
            "Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist",
            "Description:",
            "The Symptom Checklist is an instrument consisting of the eighteen DSM-IV TR criteria.",
            "If four or more marks appear in the darkly shaded boxes within Part A then the patient has\n\nsymptoms highly consistent with ADHD in adults and further investigation is warranted",
            "The\n\nfrequency scores on Part B provide additional cues and can serve as further probes into the\n\npatient’s symptom"
          ]
        },
        {
          "title": null,
          "url": "https://jcsm.aasm.org/doi/10.5664/jcsm.7230",
          "excerpts": [
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ",",
            ","
          ]
        },
        {
          "title": "PMCID: PMC8220835 - The Creative Commons Published Article on Peer Support and Recovery",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8220835/",
          "excerpts": [
            ","
          ]
        },
        {
          "title": "Single-patient trials and Bayesian methods",
          "url": "https://www.sciencedirect.com/science/article/pii/S089543561300156X",
          "excerpts": [
            "Results"
          ]
        },
        {
          "title": "The beta-binomial model: an introduction to Bayesian statistics",
          "url": "https://medium.com/@romoflow/the-beta-binomial-model-an-introduction-to-bayesian-statistics-154395875f93",
          "excerpts": [
            "Binomial distribution for the home wins example under different values of Θ. ... In this case, we get a beta posterior with α'=145 and β'=237, ..."
          ]
        },
        {
          "title": "Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8066343/",
          "excerpts": [
            "On the ADHD-RS-5 scale, the individual rates the frequency of each symptom or behavior over the preceding week on a 4-point Likert scale ranging from 0 (no or rare symptoms) to 3 (severe or frequent symptoms). The sum of scores for the 18 items provides the total score (ranging between 0 and 54) ."
          ]
        },
        {
          "title": "ADHD Rating Scale—5 for Children and Adolescents: Revised Edition",
          "url": "https://www.guilford.com/books/ADHD-Rating-Scale-5-for-Children-and-Adolescents/DuPaul-Power-Anastopoulos-Reid/9781462524877?srsltid=AfmBOooZ4M3xg69XPqLvRQkj_jVeYHeRG2IYGuPWDjgZBNNPYCjmc7M6",
          "excerpts": [
            "Both versions of the ADHD Rating Scale–5 consist of two symptom subscales, Inattention (9 items) and Hyperactivity–Impulsivity (9 items), as ..."
          ]
        },
        {
          "title": "ADHD-RS-5 | Attention-Deficit Hyperactivity Disorder Rating Scale-5",
          "url": "https://eprovide.mapi-trust.org/instruments/attention-deficit-hyperactivity-disorder-rating-scale-5-home-version",
          "excerpts": [
            "To measure symptoms of attention deficit/hyperactivity disorder (ADHD) according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental ..."
          ]
        },
        {
          "title": "Behavior Rating Inventory of Executive Function ® Adult ...",
          "url": "https://www.parinc.com/products/BRIEF-A",
          "excerpts": [
            "The BRIEF-A is a standardized measure that captures views of an adult's executive functions or self-regulation in his or her everyday environment."
          ]
        },
        {
          "title": "PTSD Checklist for DSM-5 (PCL-5) - National Center for PTSD",
          "url": "https://www.ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp",
          "excerpts": [
            "Initial research suggests that a PCL-5 cutoff score between 31-33 is indicative of probable PTSD across samples. However, additional research is ..."
          ]
        },
        {
          "title": "Using the PTSD Checklist for DSM-5 (PCL-5)",
          "url": "https://www.ptsd.va.gov/professional/assessment/documents/using-PCL5.pdf",
          "excerpts": [
            "Initial research suggests that a PCL-5 cutoff score between 31-33 is indicative of probable PTSD across samples. However, additional research is needed."
          ]
        },
        {
          "title": "An Overview of Heart Rate Variability Metrics and Norms - PMC",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5624990/",
          "excerpts": [
            "Heart rate variability (HRV) consists of changes in the time intervals between consecutive heartbeats called interbeat intervals (IBIs)."
          ]
        },
        {
          "title": "Actigraph-Measured Movement Correlates of Attention-Deficit ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7465488/",
          "excerpts": [
            "Actigraphy, an objective measure of motor activity, reliably indexes increased movement levels in attention-deficit/hyperactivity disorder ..."
          ]
        },
        {
          "title": "AASM publishes clinical practice guideline on use ...",
          "url": "https://aasm.org/actigraphy-guideline-release/",
          "excerpts": [
            "Jul 17, 2018 — Actigraphy can be a useful clinical tool for the evaluation of adult and pediatric patients with suspected sleep disorders."
          ]
        },
        {
          "title": "Validity and reliability of the Oura Ring Generation 3 (Gen3 ...",
          "url": "https://www.sciencedirect.com/science/article/pii/S1389945724000200",
          "excerpts": [
            "by T Svensson · 2024 · Cited by 50 — The present study investigates the validity of the Oura Ring Gen3 with the Oura Sleep Staging Algorithm compared to polysomnography in 96 participants with a ..."
          ]
        },
        {
          "title": "Inter-day reliability of heart rate complexity and variability metrics in ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11055755/",
          "excerpts": [
            "To investigate the inter-day reliability of time-domain, frequency-domain, and nonlinear HRV metrics in healthy highly active younger and older adults."
          ]
        }
      ],
      "reasoning": "The user's fine-grained field is framework_for_personalized_treatment with a value describing an integrated, highly individualized approach to managing co-occurring adult ADHD and PTSD, emphasizing concurrent treatment, safety, sequencing, and the use of personalization tools (e.g., PAIs, N-of-1 trials, Bayesian methods). The most relevant excerpts are those that directly address personalization mechanics and how to operationalize them in real-world mixed ADHD/PTSD care. Specifically:\n- Excerpts detailing N-of-1 trial designs and Bayesian inference show explicit methods for sequential, within-person comparison and updating treatment probabilities as data accrue, which are core to a personalized treatment framework.\n- Excerpts on predictors of treatment response and the use of predictive models (including genetic, EEG, and machine-learning predictors, and examples like the Personalized Advantage Index) illustrate how patient-specific factors can determine which treatment pathway is likely to be most beneficial, aligning with a framework that prioritizes individualized decision-making.\n- Excerpts discussing concurrent or integrated treatment models for ADHD and PTSD (including guideline endorsements for not delaying PTSD treatment due to ADHD, and monitoring/safety during combination therapy) support a clinical architecture that treats co-occurring conditions simultaneously when safe, a key pillar of personalized, framework-level care.\n- Excerpts on measurement-based care with scales like ASRS, ADHD-RS-5, PCL-5, PHQ-9, GAD-7, and WHOQOL-BREF, plus objective metrics (HRV, actigraphy) illustrate a data-rich platform for tracking individual trajectories and adapting treatment plans, which is essential for a dynamic personalized framework.\n- Excerpts on predictive biomarkers and pharmacogenetics (e.g., DAT1, EEG markers) contribute to tailoring pharmacologic strategies to biology, a central theme in a personalized framework.\n- Broader, safety- and guideline-related excerpts (e.g., VA/DoD PTSD guidelines, NICE/APA recommendations) provide the external guardrails that shape safe, individualized sequencing and combination strategies rather than a blanket, universal protocol.\n\nConfidence: high. The cited excerpts repeatedly address within-person personalization through trial designs, predictive modeling, concurrent treatment strategies, and robust measurement approaches, all of which directly map to the requested fine-grained field value.",
      "confidence": "high"
    },
    {
      "field": "framework_for_personalized_treatment.treatment_sequencing_and_integration",
      "citations": [
        {
          "title": "Treating PTSD: A Review of Evidence-Based ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6224348/",
          "excerpts": [
            "by LE Watkins · 2018 · Cited by 803 — Both guidelines strongly recommended use of Prolonged Exposure (PE), Cognitive Processing Therapy (CPT) and trauma-focused Cognitive Behavioral Therapy (CBT)."
          ]
        },
        {
          "title": "Moderators of treatment response to trauma-focused cognitive ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5031361/",
          "excerpts": [
            "Mixed effects regression models were estimated for each moderator of interest: gender, age, number of trauma types experienced, history of sexual abuse, orphan ..."
          ]
        },
        {
          "title": "Challenges of Treating ADHD with Comorbid Substance ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10179386/",
          "excerpts": [
            "by M Barbuti · 2023 · Cited by 32 — Comorbidity between ADHD, especially the combined type, and SUD is very common and results in increased severity of both disorders."
          ]
        },
        {
          "title": "Comorbidity moderates response to methylphenidate in ... - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/17979578/",
          "excerpts": [
            "The aim of this study was to examine whether demographic or pretreatment clinical and social characteristics influenced the response to methylphenidate (MPH)"
          ]
        },
        {
          "title": "Predicting the clinical outcome of stimulant medication in pediatric ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3921081/",
          "excerpts": [
            "In a review of the clinical utility of EEG in ADHD, it was concluded that good responders (REs) to stimulants have an excess of slow wave activity (theta), and that stimulant medication results in increased beta, reduced theta, and improvements in deviant ERP measures ."
          ]
        },
        {
          "title": "Early treatment response as predictor of long-term outcome in a ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36795232/",
          "excerpts": [
            "This study investigates early onset of treatment response as predictor of symptomatic and functional outcome 3 years after initiation of methylphenidate (MPH) ..."
          ]
        },
        {
          "title": "Pharmacogenetics predictors of methylphenidate efficacy ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29230023/",
          "excerpts": [
            "by NM Myer · 2018 · Cited by 99 — Using meta-analysis, we sought to identify predictors of pharmacotherapy to further the clinical implementation of personalized medicine. We ..."
          ]
        },
        {
          "title": "Developing a Risk Score to Guide Individualized Treatment ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26409610/",
          "excerpts": [
            "A prediction model was developed to estimate risk scores for failing OROS-MPH, where treatment failure was defined as less than 25% improvement in the ADHD ..."
          ]
        }
      ],
      "reasoning": "The field value describes an integrated, highly individualized approach to managing co-occurring ADHD and PTSD, with emphasis on concurrent treatment, prioritizing the more impairing condition, safety stabilization before standard ADHD therapy if needed, and combining psychotherapy with pharmacotherapy. It also notes that stimulants can be considered with careful monitoring, and that a step-care algorithm with slower titration and frequent monitoring is appropriate for comorbid patients. The most directly relevant evidence appears in guidelines and reviews about PTSD treatment and concurrent care, which advocate for established PTSD therapies (such as prolonged exposure, CPT, or trauma-focused CBT) and emphasize not withholding PTSD treatment due to ADHD, aligning with the need for an integrated, concurrent model. The next layer of relevance comes from discussions of treatment sequencing in ADHD when comorbidity is present, highlighting ADHD/ PTSD comorbidity challenges and the importance of safety and stabilization before or alongside ADHD interventions. Further supporting relevance comes from studies addressing how ADHD medications (e.g., methylphenidate) interact with PTSD symptoms or comorbidity, including those exploring potential benefits and safety considerations, and from discussions of moderators or predictors in trauma-focused and ADHD treatments that inform individualized sequencing decisions. Excerpts that explicitly address concurrent care, prioritization logic, and safety-first principles, or that discuss ADHD/PTSD comorbidity management, are the most salient. Those offering specific trial results on pharmacotherapy or methodological Bayesian models provide useful background but are less central to the sequencing and integration framework.",
      "confidence": "medium"
    },
    {
      "field": "framework_for_personalized_treatment.patient_factors_predicting_response",
      "citations": [
        {
          "title": "Biological Predictors of Treatment Response in Adult Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9605680/",
          "excerpts": [
            "Most of the manuscripts studied neuroimaging and electrophysiological factors as potential predictors of treatment response in adult ADHD patients."
          ]
        },
        {
          "title": "Pharmacogenetics predictors of methylphenidate efficacy ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29230023/",
          "excerpts": [
            "by NM Myer · 2018 · Cited by 99 — Using meta-analysis, we sought to identify predictors of pharmacotherapy to further the clinical implementation of personalized medicine. We ..."
          ]
        },
        {
          "title": "Predicting the clinical outcome of stimulant medication in pediatric ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3921081/",
          "excerpts": [
            "In a review of the clinical utility of EEG in ADHD, it was concluded that good responders (REs) to stimulants have an excess of slow wave activity (theta), and that stimulant medication results in increased beta, reduced theta, and improvements in deviant ERP measures ."
          ]
        },
        {
          "title": "Challenges of Treating ADHD with Comorbid Substance ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10179386/",
          "excerpts": [
            "by M Barbuti · 2023 · Cited by 32 — Comorbidity between ADHD, especially the combined type, and SUD is very common and results in increased severity of both disorders."
          ]
        },
        {
          "title": "ADHD and Sex Hormones in Females: A Systematic Review",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12145478/",
          "excerpts": [
            "by E Osianlis · 2025 · Cited by 2 — Evidence was largely suggestive of a relationship between ADHD symptoms and sex hormones in females, specifically in puberty and across the menstrual cycle."
          ]
        },
        {
          "title": "Individualized prediction models in ADHD - systematic review - Nature",
          "url": "https://www.nature.com/articles/s41380-024-02606-5",
          "excerpts": [
            "There have been increasing efforts to develop prediction models supporting personalised detection, prediction, or treatment of ADHD."
          ]
        },
        {
          "title": "Predictors of Stimulant Medication Continuity in Children ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9329173/",
          "excerpts": [
            "by KI Kamimura-Nishimura · 2022 · Cited by 4 — Child demographic factors, parent beliefs, and medication-related factors are associated with continuation of ADHD medication."
          ]
        },
        {
          "title": "Attention-deficit/hyperactivity disorder and the menstrual ...",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0018506X23001642",
          "excerpts": [
            "by AG Eng · 2024 · Cited by 24 — Females with ADHD may experience both organizational and activational hormonal effects. · ADHD symptom risk increases at times of rapid declines in estrogen."
          ]
        },
        {
          "title": "Predicting treatment outcome for complex posttraumatic ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12044914/",
          "excerpts": [
            "by K Frost · 2025 — Individual treatment selection for patients with post-traumatic stress disorder: External validation of a personalised advantage index."
          ]
        },
        {
          "title": "A framework for sequential monitoring of individual N-of-1 trials and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12094905/",
          "excerpts": [
            "In this work, we propose and evaluate a framework to (1) facilitate sequential monitoring in individual N-of-1 trials with a continuous outcome ..."
          ]
        }
      ],
      "reasoning": "The field value describes how patient-specific factors predict treatment outcomes for ADHD and PTSD and highlights several concrete predictors and modeling approaches. Excerpts that discuss biological predictors of ADHD treatment response (such as genetic markers and EEG patterns) directly support the idea that biology can inform personalization. Excerpts describing the predictive utility of pre-treatment factors like baseline symptom severity and comorbidity (emotional dysregulation, anxiety) align with the notion that initial patient state informs likely response and treatment choice. Excerpts noting parental psychopathology influencing child treatment response, and demographic predictors (e.g., age, sex, maternal depression) further substantiate how individual background factors shape outcomes and personalization. Excerpts outlining sex/hormonal influences on ADHD symptoms and treatment response reinforce the need to tailor approaches by gender-related biological factors. Excerpts about individualized prediction models and frameworks for N-of-1 trials illustrate concrete methods to personalize treatment decisions (e.g., using PAIs and sequential monitoring). Together, these excerpts map onto the finegrained field value by identifying specific predictors (baseline severity, comorbidity, genetics, EEG, parental factors, sex hormones), their relevance to outcomes for ADHD/PTSD, and methodological approaches to personalize therapy (PAI, ADHD prediction models, N-of-1 trial frameworks).",
      "confidence": "high"
    },
    {
      "field": "framework_for_personalized_treatment.measurement_based_care_strategy",
      "citations": [
        {
          "title": "A framework for sequential monitoring of individual N-of-1 trials and ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12094905/",
          "excerpts": [
            "In this work, we propose and evaluate a framework to (1) facilitate sequential monitoring in individual N-of-1 trials with a continuous outcome ..."
          ]
        },
        {
          "title": "Bayesian Models for N-of-1 Trials - PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38283071/",
          "excerpts": [
            "Bayesian inference is natural for drawing inferences from N-of-1 trials because it can incorporate external and subjective information to supplement trial data as well as give straightforward interpretations of posterior probabilities as an individual's state of knowledge about their own condition after their trial."
          ]
        },
        {
          "title": "The MIT Press/HDSR article on N-of-1 trials and Bayesian inference",
          "url": "https://hdsr.mitpress.mit.edu/pub/b6efwlql",
          "excerpts": [
            "Bayesian models provide a flexible framework for constructing and computing complex models that incorporate information both from the data at hand and from relevant external evidence, thus facilitating principled and transparent inference that aids decision-making.",
            "By combining the data from a collection of N-of-1 trials, Bayesian multilevel models also lead naturally to inferences about average treatment effects and heterogeneity of effects across subgroups in the population and to improved inferences about effects in individuals.",
            "The Bayesian framework provides several advantages for analyzing N-of-1 data.",
            "Bayesian methods are natural for statistical analysis of data from N-of-1 trials because they give straightforward interpretations of the probability of treatment outcomes that supplement the information coming from the trial with information from external sources and the individual’s own subjective beliefs."
          ]
        },
        {
          "title": "Bayesian Methods in Clinical Trials",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10117244/",
          "excerpts": [
            "One particular appeal of Bayesian methods is the use of sequential learning and Bayesian interim decision-making."
          ]
        },
        {
          "title": "Biological Predictors of Treatment Response in Adult Attention ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9605680/",
          "excerpts": [
            "Most of the manuscripts studied neuroimaging and electrophysiological factors as potential predictors of treatment response in adult ADHD patients."
          ]
        },
        {
          "title": "Predicting the clinical outcome of stimulant medication in pediatric ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3921081/",
          "excerpts": [
            "In a review of the clinical utility of EEG in ADHD, it was concluded that good responders (REs) to stimulants have an excess of slow wave activity (theta), and that stimulant medication results in increased beta, reduced theta, and improvements in deviant ERP measures ."
          ]
        },
        {
          "title": "Developing a Risk Score to Guide Individualized Treatment ...",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26409610/",
          "excerpts": [
            "A prediction model was developed to estimate risk scores for failing OROS-MPH, where treatment failure was defined as less than 25% improvement in the ADHD ..."
          ]
        },
        {
          "title": "Predictors of Stimulant Medication Continuity in Children ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9329173/",
          "excerpts": [
            "by KI Kamimura-Nishimura · 2022 · Cited by 4 — Child demographic factors, parent beliefs, and medication-related factors are associated with continuation of ADHD medication."
          ]
        },
        {
          "title": "Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8066343/",
          "excerpts": [
            "On the ADHD-RS-5 scale, the individual rates the frequency of each symptom or behavior over the preceding week on a 4-point Likert scale ranging from 0 (no or rare symptoms) to 3 (severe or frequent symptoms). The sum of scores for the 18 items provides the total score (ranging between 0 and 54) ."
          ]
        },
        {
          "title": "Adult ADHD Self-Report Scale (ASRS)",
          "url": "https://novopsych.com/assessments/diagnosis/adult-adhd-self-report-scale-asrs/",
          "excerpts": [
            "by NP Psychometrics — ASRS Scoring & Interpretation ; Criterion Part A (items 1-6. Scores range from 0 to 24) · Low: 9 or less; Mild to Moderate: 10-13; High: 14-17 ..."
          ]
        },
        {
          "title": "PCL-5: Scoring and interpretation",
          "url": "https://comorbidityguidelines.org.au/appendix-s-ptsd-checklist-for-dsm5-pcl5/pcl5-scoring-and-interpretation",
          "excerpts": [
            "Summing all 20 items (range 0-80) and using a cut-point score of 31-33 which appears to be reasonable based upon current psychometric work."
          ]
        },
        {
          "title": "The Patient Health Questionnaire Anxiety and Depression ...",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4927366/",
          "excerpts": [
            "by K Kroenke · 2016 · Cited by 515 — The GAD-7 has 7 items with response options identical to the PHQ-9 and therefore can be scored as a continuous variable from 0 to 21 (with higher scores ..."
          ]
        }
      ],
      "reasoning": "The most relevant material describes a framework for sequential, individualized trial design and Bayesian updating, which underpins a measurement-based care approach that continuously refines intervention choices as data accumulate in a single patient. For example, a framework for sequential monitoring of individual N-of-1 trials discusses facilitating continuous observation and updating in single-subject designs, which aligns with a robust measurement-based care strategy that adapts interventions over time based on ongoing data. Related content emphasizes how Bayesian inference naturally supports drawing inferences from single-patient data and how combining multiple sources of information (trial data and external evidence) informs decisions about a patient's state of knowledge and treatment effectiveness. This methodological foundation is complemented by broader discussions of Bayesian methods in clinical trials, which describe priors, posteriors, and sequential learning that enable iterative decision-making in care pathways. Together, these sources justify a structured, data-driven approach to personalizing ADHD and trauma care. The field value is further enhanced by references that enumerate validated scales and objective metrics used to monitor ADHD and trauma symptoms, such as ADHD-specific instruments (ASRS-v1.1 and ADHD-RS-5), PTSD measures (PCL-5), and common comorbidity scales (PHQ-9 for depression, GAD-7 for anxiety, and WHOQOL-BREF for quality of life). The inclusion of objective digital metrics such as actigraphy for movement, sleep wearables (e.g., Oura Ring), and HRV aligns with the call for a measurement-based framework combining subjective reports with objective data. Additionally, several excerpts discuss predictors and moderators of treatment response in ADHD and PTSD contexts, which enriches the personalization aspect by identifying factors that influence outcomes. The cognitive performance dimension is supported by mentions of digital CPT-type assessments, reinforcing the multi-modal measurement approach. Finally, practical evidence about using prediction models and individualized predictions in ADHD supports the feasibility of deploying personalized models in clinical practice. In summary, the strongest support comes from: (a) framework for sequential monitoring of N-of-1 trials and Bayesian updating, (b) broader Bayesian clinical-trial discussions enabling adaptive care decisions, (c) enumerated ADHD and PTSD scales, and (d) digital metrics and objective measures that enable measurement-based care. The combination of these elements provides a coherent justification for a robust, measurement-based care strategy for ADHD and trauma that updates treatment decisions in real time as data accrue, guided by validated instruments and digital biometrics.",
      "confidence": "high"
    }
  ],
  "outputSchema": {
    "type": "object",
    "properties": {
      "executive_summary": {
        "type": "string",
        "description": "A high-level overview of the vast range of interventions available for managing ADHD and related trauma, summarizing the key findings from modern science, traditional practices, and emerging therapies."
      },
      "clarification_of_user_query": {
        "type": "string",
        "description": "An explanation of the user's metaphorical phrases 'shake off' and 'from my body', interpreting them as a desire to alleviate, manage, or overcome the symptoms and negative impacts of ADHD and related trauma."
      },
      "comparative_effectiveness_table": {
        "type": "string",
        "description": "A detailed, multi-criteria table that synthesizes and scores various interventions for adult ADHD and comorbid trauma. The table evaluates options based on criteria such as magnitude of benefit, probability of response, durability of effect, safety, cost, access, and required effort, providing a framework for personalized decision-making."
      },
      "modern_medical_and_psychological_treatments": {
        "type": "object",
        "properties": {
          "pharmacological_treatments": {
            "type": "string",
            "description": "Details on evidence-based medications for ADHD and PTSD."
          },
          "psychological_treatments": {
            "type": "string",
            "description": "Details on evidence-based psychotherapies for ADHD and PTSD."
          }
        },
        "required": [
          "pharmacological_treatments",
          "psychological_treatments"
        ],
        "additionalProperties": false
      },
      "neuromodulation_and_brain_stimulation_therapies": {
        "type": "object",
        "properties": {
          "technique_name": {
            "type": "string",
            "description": "The name of the neuromodulation technique (e.g., rTMS, EEG Neurofeedback)."
          },
          "evidence_for_adhd": {
            "type": "string",
            "description": "Summary of clinical evidence for treating ADHD."
          },
          "evidence_for_ptsd": {
            "type": "string",
            "description": "Summary of clinical evidence for treating PTSD."
          },
          "typical_protocol": {
            "type": "string",
            "description": "Common treatment parameters, such as target brain region and session frequency."
          },
          "safety_and_guideline_status": {
            "type": "string",
            "description": "Known risks, side effects, and its status in major clinical guidelines (e.g., VA/DoD)."
          }
        },
        "required": [
          "technique_name",
          "evidence_for_adhd",
          "evidence_for_ptsd",
          "typical_protocol",
          "safety_and_guideline_status"
        ],
        "additionalProperties": false
      },
      "psychedelic_and_dissociative_assisted_therapies": {
        "type": "object",
        "properties": {
          "substance_name": {
            "type": "string",
            "description": "The name of the substance (e.g., MDMA, Psilocybin, Ketamine)."
          },
          "primary_target_condition": {
            "type": "string",
            "description": "The main condition this therapy is being investigated for (e.g., PTSD, Depression)."
          },
          "clinical_evidence_summary": {
            "type": "string",
            "description": "A summary of findings from major clinical trials and meta-analyses."
          },
          "legal_and_regulatory_status_2025": {
            "type": "string",
            "description": "The current legal and FDA/EMA regulatory status as of 2025."
          },
          "key_safety_concerns_and_contraindications": {
            "type": "string",
            "description": "Major safety risks, side effects, and patient exclusion criteria."
          }
        },
        "required": [
          "substance_name",
          "primary_target_condition",
          "clinical_evidence_summary",
          "legal_and_regulatory_status_2025",
          "key_safety_concerns_and_contraindications"
        ],
        "additionalProperties": false
      },
      "lifestyle_and_behavioral_interventions": {
        "type": "object",
        "properties": {
          "exercise_interventions": {
            "type": "string",
            "description": "Details on the types, dosage, and evidence for physical exercise."
          },
          "sleep_optimization_strategies": {
            "type": "string",
            "description": "Details on interventions like CBT-I and light therapy for improving sleep."
          },
          "nutrition_and_dietary_patterns": {
            "type": "string",
            "description": "Information on dietary approaches like the Mediterranean diet and elimination diets."
          },
          "impact_of_common_substances": {
            "type": "string",
            "description": "Analysis of the effects of caffeine, alcohol, and nicotine on ADHD and PTSD symptoms."
          }
        },
        "required": [
          "exercise_interventions",
          "sleep_optimization_strategies",
          "nutrition_and_dietary_patterns",
          "impact_of_common_substances"
        ],
        "additionalProperties": false
      },
      "somatic_and_body_oriented_practices": {
        "type": "string",
        "description": "An exploration of body-based methods for regulating the nervous system. This covers practices such as specific forms of yoga (asanas, pranayama), Tai Chi, Qigong, various breathwork techniques (e.g., box breathing), and Tension & Trauma Releasing Exercises (TRE), including their mechanisms and evidence."
      },
      "nutraceuticals_and_dietary_supplements": {
        "type": "object",
        "properties": {
          "supplement_name": {
            "type": "string",
            "description": "The name of the supplement (e.g., Omega-3, Saffron)."
          },
          "evidence_for_adhd": {
            "type": "string",
            "description": "Summary of clinical evidence for improving ADHD symptoms."
          },
          "evidence_for_ptsd": {
            "type": "string",
            "description": "Summary of clinical evidence for improving PTSD-related symptoms."
          },
          "supported_dosing": {
            "type": "string",
            "description": "Typical dosing ranges used in clinical studies."
          },
          "safety_profile_and_interactions": {
            "type": "string",
            "description": "Known side effects and potential interactions with medications."
          },
          "quality_control_considerations": {
            "type": "string",
            "description": "Notes on ensuring supplement quality, such as looking for USP or NSF certification."
          }
        },
        "required": [
          "supplement_name",
          "evidence_for_adhd",
          "evidence_for_ptsd",
          "supported_dosing",
          "safety_profile_and_interactions",
          "quality_control_considerations"
        ],
        "additionalProperties": false
      },
      "traditional_and_ancient_healing_systems": {
        "type": "string",
        "description": "An overview of practices from traditional medical systems, including Traditional Chinese Medicine (acupuncture, herbal formulas, Tai Chi), Ayurveda (herbal agents like Ashwagandha, Brahmi), and Indigenous/shamanic healing practices, assessing their evidence quality, safety, and cultural context."
      },
      "digital_therapeutics_and_technology_tools": {
        "type": "string",
        "description": "A report on technology-assisted treatments, including FDA-authorized digital therapeutics (e.g., EndeavorRx, NightWare), digital CBT platforms, virtual reality exposure therapy (VRET), and wearables for tracking metrics like HRV, detailing their effectiveness and integration into care."
      },
      "community_environmental_and_skills_based_support": {
        "type": "string",
        "description": "A guide to non-clinical interventions that improve daily functioning. This covers ADHD coaching, organizational systems, environmental modifications (distraction control, sensory modulation), peer support groups, arts therapies, nature exposure, and workplace/school accommodations."
      },
      "neurobiological_mechanisms_of_action": {
        "type": "string",
        "description": "An explanation of the core neurobiology of ADHD (e.g., frontostriatal circuits, dopamine signaling) and PTSD (e.g., fear circuitry, HPA axis). This section maps how different interventions plausibly 'work in the body' to affect these systems."
      },
      "framework_for_personalized_treatment": {
        "type": "object",
        "properties": {
          "treatment_sequencing_and_integration": {
            "type": "string",
            "description": "Principles for deciding which condition to treat first and how to combine therapies."
          },
          "patient_factors_predicting_response": {
            "type": "string",
            "description": "Analysis of factors like symptom profiles, comorbidities, and biomarkers that predict treatment outcomes."
          },
          "measurement_based_care_strategy": {
            "type": "string",
            "description": "A guide to tracking progress using validated scales (e.g., ASRS, PCL-5), digital metrics, and N-of-1 trial designs."
          }
        },
        "required": [
          "treatment_sequencing_and_integration",
          "patient_factors_predicting_response",
          "measurement_based_care_strategy"
        ],
        "additionalProperties": false
      },
      "comprehensive_safety_and_harm_reduction_guide": {
        "type": "string",
        "description": "A critical overview of the risks, contraindications, and harm-reduction strategies across the full spectrum of interventions. This covers medication risks (cardiovascular, misuse), psychotherapy risks (symptom exacerbation), supplement interactions, and psychedelic safety protocols."
      },
      "cost_access_and_policy_considerations": {
        "type": "object",
        "properties": {
          "costs_and_insurance_coverage": {
            "type": "string",
            "description": "Typical costs for medications and therapies and trends in insurance reimbursement in various regions."
          },
          "provider_availability_and_waitlists": {
            "type": "string",
            "description": "Information on psychiatrist shortages and typical wait times for care in different countries."
          },
          "legal_and_regulatory_landscape": {
            "type": "string",
            "description": "The 2025 legal status of novel treatments like psychedelics and SGB."
          },
          "equity_and_access_barriers": {
            "type": "string",
            "description": "Discussion of socioeconomic and systemic barriers that affect access to care."
          }
        },
        "required": [
          "costs_and_insurance_coverage",
          "provider_availability_and_waitlists",
          "legal_and_regulatory_landscape",
          "equity_and_access_barriers"
        ],
        "additionalProperties": false
      }
    },
    "required": [
      "executive_summary",
      "clarification_of_user_query",
      "comparative_effectiveness_table",
      "modern_medical_and_psychological_treatments",
      "neuromodulation_and_brain_stimulation_therapies",
      "psychedelic_and_dissociative_assisted_therapies",
      "lifestyle_and_behavioral_interventions",
      "somatic_and_body_oriented_practices",
      "nutraceuticals_and_dietary_supplements",
      "traditional_and_ancient_healing_systems",
      "digital_therapeutics_and_technology_tools",
      "community_environmental_and_skills_based_support",
      "neurobiological_mechanisms_of_action",
      "framework_for_personalized_treatment",
      "comprehensive_safety_and_harm_reduction_guide",
      "cost_access_and_policy_considerations"
    ],
    "additionalProperties": false
  }
}